{"html":"<!DOCTYPE html><html><body><h1>Primers used for RT-PCR analysis</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td/><td align=\"left\"><bold>Sense primer location</bold></td><td align=\"left\"><bold>Antisense primer location</bold></td><td align=\"center\"><bold>PCR product (bp)</bold></td><td align=\"left\"><bold>Reference</bold></td></tr></thead><tbody><tr><td align=\"left\"><bold>Histone 3.3</bold></td><td align=\"left\">GCGTGCTAGCTGGATGTCTT</td><td align=\"left\">CCACTGAACTTCTGATTCGC</td><td align=\"center\">150</td><td align=\"left\">[18]</td></tr><tr><td align=\"left\"><bold>CYP2C8-19</bold></td><td align=\"left\">GCTAAAGTCCAGGAAGAGATTGA</td><td align=\"left\">TCCTGCTGAGAAAGGCATGAAGT</td><td align=\"center\">332</td><td align=\"left\">[19]</td></tr><tr><td align=\"left\"><bold>CYP2E1</bold></td><td align=\"left\">AGCACAACTCTGAGATATGG</td><td align=\"left\">ATAGTCACTGTACTTGAACT</td><td align=\"center\">365</td><td align=\"left\">[19]</td></tr><tr><td align=\"left\"><bold>CYP3A4</bold></td><td align=\"left\">CCAAGCTATGCTCTTCACCG</td><td align=\"left\">TCAGGCTCCACTTACGGTGC</td><td align=\"center\">324</td><td align=\"left\">[20]</td></tr><tr><td align=\"left\"><bold>CYP3A5</bold></td><td align=\"left\">TGTCCAGCAGAAACTGCAAA</td><td align=\"left\">TTGAAGAAGTCCTTGCGTGTC</td><td align=\"center\">472</td><td align=\"left\">[20]</td></tr></tbody></table></body></html>","text":"Pmid= 1291361:Table= Table 2","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":-1998807428,"_task_hash":1362469475,"_view_id":"review","accept":[5],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":null,"sessions":["tableclass-test-params-100-frank","tableclass-test-params-100-gill","tableclass-test-params-100-joe","tableclass-test-params-100-vicky"],"versions":[{"html":"<!DOCTYPE html><html><body><h1>Primers used for RT-PCR analysis</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td/><td align=\"left\"><bold>Sense primer location</bold></td><td align=\"left\"><bold>Antisense primer location</bold></td><td align=\"center\"><bold>PCR product (bp)</bold></td><td align=\"left\"><bold>Reference</bold></td></tr></thead><tbody><tr><td align=\"left\"><bold>Histone 3.3</bold></td><td align=\"left\">GCGTGCTAGCTGGATGTCTT</td><td align=\"left\">CCACTGAACTTCTGATTCGC</td><td align=\"center\">150</td><td align=\"left\">[18]</td></tr><tr><td align=\"left\"><bold>CYP2C8-19</bold></td><td align=\"left\">GCTAAAGTCCAGGAAGAGATTGA</td><td align=\"left\">TCCTGCTGAGAAAGGCATGAAGT</td><td align=\"center\">332</td><td align=\"left\">[19]</td></tr><tr><td align=\"left\"><bold>CYP2E1</bold></td><td align=\"left\">AGCACAACTCTGAGATATGG</td><td align=\"left\">ATAGTCACTGTACTTGAACT</td><td align=\"center\">365</td><td align=\"left\">[19]</td></tr><tr><td align=\"left\"><bold>CYP3A4</bold></td><td align=\"left\">CCAAGCTATGCTCTTCACCG</td><td align=\"left\">TCAGGCTCCACTTACGGTGC</td><td align=\"center\">324</td><td align=\"left\">[20]</td></tr><tr><td align=\"left\"><bold>CYP3A5</bold></td><td align=\"left\">TGTCCAGCAGAAACTGCAAA</td><td align=\"left\">TTGAAGAAGTCCTTGCGTGTC</td><td align=\"center\">472</td><td align=\"left\">[20]</td></tr></tbody></table></body></html>","text":"Pmid= 1291361:Table= Table 2","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":-1998807428,"_task_hash":1362469475,"_view_id":"choice","accept":[5],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":"tableclass-test-params-100-gill","sessions":["tableclass-test-params-100-frank","tableclass-test-params-100-gill","tableclass-test-params-100-joe","tableclass-test-params-100-vicky"],"default":true}],"view_id":"choice"}
{"html":"<!DOCTYPE html><html><body><h1>Baseline characteristics of the patients (N = 1660)</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td align=\"left\"><bold>Characteristic</bold></td><td align=\"center\"><bold>n (% of total)*</bold></td></tr></thead><tbody><tr><td align=\"left\" colspan=\"2\">Gender</td></tr><tr><td align=\"left\">&#8195;Male</td><td align=\"center\">1183 (71.3%)</td></tr><tr><td align=\"left\">&#8195;Female</td><td align=\"center\">430 (25.9%)</td></tr><tr><td align=\"left\">&#8195;Not specified</td><td align=\"center\">47 (2.8%)</td></tr><tr><td align=\"left\" colspan=\"2\">Ethnicity</td></tr><tr><td align=\"left\">&#8195;White</td><td align=\"center\">1116 (67.2%)</td></tr><tr><td align=\"left\">&#8195;Mestizo</td><td align=\"center\">300 (18.1%)</td></tr><tr><td align=\"left\">&#8195;Black</td><td align=\"center\">154 (9.3%)</td></tr><tr><td align=\"left\">&#8195;Chinese</td><td align=\"center\">8 (0.5%)</td></tr><tr><td align=\"left\">&#8195;Not specified</td><td align=\"center\">82 (4.9%)</td></tr><tr><td align=\"left\">Age (yr) total (183 not specified)</td><td align=\"center\">61.6 &#177; 13.0</td></tr><tr><td align=\"left\">Onset-infusion time (hours)</td><td align=\"center\">4.9 &#177; 3.7</td></tr><tr><td align=\"left\" colspan=\"2\">Previous SK</td></tr><tr><td align=\"left\">&#8195;&lt; 1 year</td><td align=\"center\">5 (0.3%)</td></tr><tr><td align=\"left\">&#8195;&gt; 1 year</td><td align=\"center\">9 (0.5%)</td></tr><tr><td align=\"left\" colspan=\"2\">Concomitant therapy</td></tr><tr><td align=\"left\">&#8195;Aspirin</td><td align=\"center\">1341 (80.8%)</td></tr><tr><td align=\"left\">&#8195;Beta-blockers</td><td align=\"center\">943 (56.8%)</td></tr><tr><td align=\"left\">&#8195;Nitrosorbide</td><td align=\"center\">258 (15.5%)</td></tr><tr><td align=\"left\">&#8195;Lidocaine</td><td align=\"center\">66 (3.9%)</td></tr><tr><td align=\"left\">&#8195;Pentaerythritol tetranitrate</td><td align=\"center\">45 (2.7%)</td></tr><tr><td align=\"left\">&#8195;Others</td><td align=\"center\">641 (38.6%)</td></tr></tbody></table></body></html>","text":"Pmid= 1291362:Table= Table 1","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":642471200,"_task_hash":454166127,"_view_id":"review","accept":[5],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":null,"sessions":["tableclass-test-params-100-frank","tableclass-test-params-100-gill","tableclass-test-params-100-joe","tableclass-test-params-100-vicky"],"versions":[{"html":"<!DOCTYPE html><html><body><h1>Baseline characteristics of the patients (N = 1660)</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td align=\"left\"><bold>Characteristic</bold></td><td align=\"center\"><bold>n (% of total)*</bold></td></tr></thead><tbody><tr><td align=\"left\" colspan=\"2\">Gender</td></tr><tr><td align=\"left\">&#8195;Male</td><td align=\"center\">1183 (71.3%)</td></tr><tr><td align=\"left\">&#8195;Female</td><td align=\"center\">430 (25.9%)</td></tr><tr><td align=\"left\">&#8195;Not specified</td><td align=\"center\">47 (2.8%)</td></tr><tr><td align=\"left\" colspan=\"2\">Ethnicity</td></tr><tr><td align=\"left\">&#8195;White</td><td align=\"center\">1116 (67.2%)</td></tr><tr><td align=\"left\">&#8195;Mestizo</td><td align=\"center\">300 (18.1%)</td></tr><tr><td align=\"left\">&#8195;Black</td><td align=\"center\">154 (9.3%)</td></tr><tr><td align=\"left\">&#8195;Chinese</td><td align=\"center\">8 (0.5%)</td></tr><tr><td align=\"left\">&#8195;Not specified</td><td align=\"center\">82 (4.9%)</td></tr><tr><td align=\"left\">Age (yr) total (183 not specified)</td><td align=\"center\">61.6 &#177; 13.0</td></tr><tr><td align=\"left\">Onset-infusion time (hours)</td><td align=\"center\">4.9 &#177; 3.7</td></tr><tr><td align=\"left\" colspan=\"2\">Previous SK</td></tr><tr><td align=\"left\">&#8195;&lt; 1 year</td><td align=\"center\">5 (0.3%)</td></tr><tr><td align=\"left\">&#8195;&gt; 1 year</td><td align=\"center\">9 (0.5%)</td></tr><tr><td align=\"left\" colspan=\"2\">Concomitant therapy</td></tr><tr><td align=\"left\">&#8195;Aspirin</td><td align=\"center\">1341 (80.8%)</td></tr><tr><td align=\"left\">&#8195;Beta-blockers</td><td align=\"center\">943 (56.8%)</td></tr><tr><td align=\"left\">&#8195;Nitrosorbide</td><td align=\"center\">258 (15.5%)</td></tr><tr><td align=\"left\">&#8195;Lidocaine</td><td align=\"center\">66 (3.9%)</td></tr><tr><td align=\"left\">&#8195;Pentaerythritol tetranitrate</td><td align=\"center\">45 (2.7%)</td></tr><tr><td align=\"left\">&#8195;Others</td><td align=\"center\">641 (38.6%)</td></tr></tbody></table></body></html>","text":"Pmid= 1291362:Table= Table 1","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":642471200,"_task_hash":454166127,"_view_id":"choice","accept":[5],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":"tableclass-test-params-100-gill","sessions":["tableclass-test-params-100-frank","tableclass-test-params-100-gill","tableclass-test-params-100-joe","tableclass-test-params-100-vicky"],"default":true}],"view_id":"choice"}
{"html":"<!DOCTYPE html><html><body><h1>Suspected adverse reactions to streptokinase</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td align=\"center\"><bold>ADR</bold></td><td align=\"center\"><bold>n</bold></td><td align=\"center\"><bold>%*</bold></td></tr></thead><tbody><tr><td align=\"left\">Hypotension</td><td align=\"center\">285</td><td align=\"center\">36.0</td></tr><tr><td align=\"left\">Arrhythmias</td><td align=\"center\">281</td><td align=\"center\">35.5</td></tr><tr><td align=\"left\">Chills</td><td align=\"center\">212</td><td align=\"center\">26.8</td></tr><tr><td align=\"left\">Tremors</td><td align=\"center\">197</td><td align=\"center\">24.9</td></tr><tr><td align=\"left\">Vomiting</td><td align=\"center\">187</td><td align=\"center\">23.6</td></tr><tr><td align=\"left\">Nauseas</td><td align=\"center\">103</td><td align=\"center\">13.0</td></tr><tr><td align=\"left\">Allergy</td><td align=\"center\">47</td><td align=\"center\">5.9</td></tr><tr><td align=\"left\">Bleeding</td><td align=\"center\">43</td><td align=\"center\">5.4</td></tr><tr><td align=\"left\">Fever</td><td align=\"center\">41</td><td align=\"center\">5.2</td></tr><tr><td align=\"left\">Lumbar pain</td><td align=\"center\">10</td><td align=\"center\">1.3</td></tr><tr><td align=\"left\">Sweating</td><td align=\"center\">9</td><td align=\"center\">1.1</td></tr><tr><td align=\"left\">Muscular cramp</td><td align=\"center\">5</td><td align=\"center\">0.6</td></tr><tr><td align=\"left\">Others</td><td align=\"center\">76</td><td align=\"center\">9.6</td></tr></tbody></table></body></html>","text":"Pmid= 1291362:Table= Table 2","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":259770521,"_task_hash":-89864122,"_view_id":"review","accept":[5],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":null,"sessions":["tableclass-test-params-100-frank","tableclass-test-params-100-gill","tableclass-test-params-100-joe","tableclass-test-params-100-vicky"],"versions":[{"html":"<!DOCTYPE html><html><body><h1>Suspected adverse reactions to streptokinase</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td align=\"center\"><bold>ADR</bold></td><td align=\"center\"><bold>n</bold></td><td align=\"center\"><bold>%*</bold></td></tr></thead><tbody><tr><td align=\"left\">Hypotension</td><td align=\"center\">285</td><td align=\"center\">36.0</td></tr><tr><td align=\"left\">Arrhythmias</td><td align=\"center\">281</td><td align=\"center\">35.5</td></tr><tr><td align=\"left\">Chills</td><td align=\"center\">212</td><td align=\"center\">26.8</td></tr><tr><td align=\"left\">Tremors</td><td align=\"center\">197</td><td align=\"center\">24.9</td></tr><tr><td align=\"left\">Vomiting</td><td align=\"center\">187</td><td align=\"center\">23.6</td></tr><tr><td align=\"left\">Nauseas</td><td align=\"center\">103</td><td align=\"center\">13.0</td></tr><tr><td align=\"left\">Allergy</td><td align=\"center\">47</td><td align=\"center\">5.9</td></tr><tr><td align=\"left\">Bleeding</td><td align=\"center\">43</td><td align=\"center\">5.4</td></tr><tr><td align=\"left\">Fever</td><td align=\"center\">41</td><td align=\"center\">5.2</td></tr><tr><td align=\"left\">Lumbar pain</td><td align=\"center\">10</td><td align=\"center\">1.3</td></tr><tr><td align=\"left\">Sweating</td><td align=\"center\">9</td><td align=\"center\">1.1</td></tr><tr><td align=\"left\">Muscular cramp</td><td align=\"center\">5</td><td align=\"center\">0.6</td></tr><tr><td align=\"left\">Others</td><td align=\"center\">76</td><td align=\"center\">9.6</td></tr></tbody></table></body></html>","text":"Pmid= 1291362:Table= Table 2","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":259770521,"_task_hash":-89864122,"_view_id":"choice","accept":[5],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":"tableclass-test-params-100-gill","sessions":["tableclass-test-params-100-frank","tableclass-test-params-100-gill","tableclass-test-params-100-joe","tableclass-test-params-100-vicky"],"default":true}],"view_id":"choice"}
{"html":"<!DOCTYPE html><html><body><h1>Causes of death</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td align=\"center\"><bold>Cause</bold></td><td align=\"center\"><bold>n</bold></td><td align=\"center\"><bold>% of total deaths</bold></td></tr></thead><tbody><tr><td align=\"left\" colspan=\"3\"><bold>Cardiac causes</bold></td></tr><tr><td align=\"left\">&#8195;&#8195;Pump failure</td><td align=\"center\">32</td><td align=\"center\">44.4</td></tr><tr><td align=\"left\">&#8195;&#8195;Arrhythmias</td><td align=\"center\">15</td><td align=\"center\">20.8</td></tr><tr><td align=\"left\">&#8195;&#8195;Wall rupture</td><td align=\"center\">10</td><td align=\"center\">13.9</td></tr><tr><td align=\"left\" colspan=\"3\"><bold>Non cardiac causes</bold></td></tr><tr><td align=\"left\">&#8195;&#8195;Hemorrhagic stroke</td><td align=\"center\">3</td><td align=\"center\">4.2</td></tr><tr><td align=\"left\">&#8195;&#8195;Pulmonary embolism</td><td align=\"center\">1</td><td align=\"center\">1.4</td></tr><tr><td align=\"left\">&#8195;&#8195;Hypoxic encephalopathy</td><td align=\"center\">1</td><td align=\"center\">1.4</td></tr><tr><td align=\"left\">&#8195;&#8195;Sepsis</td><td align=\"center\">1</td><td align=\"center\">1.4</td></tr><tr><td align=\"left\"><bold>Unknown</bold></td><td align=\"center\">9</td><td align=\"center\">12.5</td></tr><tr><td align=\"left\"><bold>Total</bold></td><td align=\"center\">72</td><td align=\"center\">100</td></tr></tbody></table></body></html>","text":"Pmid= 1291362:Table= Table 3","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":-100622576,"_task_hash":253120848,"_view_id":"review","accept":[5],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":null,"sessions":["tableclass-test-params-100-frank","tableclass-test-params-100-gill","tableclass-test-params-100-joe","tableclass-test-params-100-vicky"],"versions":[{"html":"<!DOCTYPE html><html><body><h1>Causes of death</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td align=\"center\"><bold>Cause</bold></td><td align=\"center\"><bold>n</bold></td><td align=\"center\"><bold>% of total deaths</bold></td></tr></thead><tbody><tr><td align=\"left\" colspan=\"3\"><bold>Cardiac causes</bold></td></tr><tr><td align=\"left\">&#8195;&#8195;Pump failure</td><td align=\"center\">32</td><td align=\"center\">44.4</td></tr><tr><td align=\"left\">&#8195;&#8195;Arrhythmias</td><td align=\"center\">15</td><td align=\"center\">20.8</td></tr><tr><td align=\"left\">&#8195;&#8195;Wall rupture</td><td align=\"center\">10</td><td align=\"center\">13.9</td></tr><tr><td align=\"left\" colspan=\"3\"><bold>Non cardiac causes</bold></td></tr><tr><td align=\"left\">&#8195;&#8195;Hemorrhagic stroke</td><td align=\"center\">3</td><td align=\"center\">4.2</td></tr><tr><td align=\"left\">&#8195;&#8195;Pulmonary embolism</td><td align=\"center\">1</td><td align=\"center\">1.4</td></tr><tr><td align=\"left\">&#8195;&#8195;Hypoxic encephalopathy</td><td align=\"center\">1</td><td align=\"center\">1.4</td></tr><tr><td align=\"left\">&#8195;&#8195;Sepsis</td><td align=\"center\">1</td><td align=\"center\">1.4</td></tr><tr><td align=\"left\"><bold>Unknown</bold></td><td align=\"center\">9</td><td align=\"center\">12.5</td></tr><tr><td align=\"left\"><bold>Total</bold></td><td align=\"center\">72</td><td align=\"center\">100</td></tr></tbody></table></body></html>","text":"Pmid= 1291362:Table= Table 3","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":-100622576,"_task_hash":253120848,"_view_id":"choice","accept":[5],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":"tableclass-test-params-100-gill","sessions":["tableclass-test-params-100-frank","tableclass-test-params-100-gill","tableclass-test-params-100-joe","tableclass-test-params-100-vicky"],"default":true}],"view_id":"choice"}
{"html":"<!DOCTYPE html><html><body><h1>Standard human population PBPK organ parameters (not varied).</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td align=\"center\"><bold>Organ</bold></td><td align=\"center\"><bold>Weight (Kg)</bold></td><td align=\"center\"><bold>ECF water(L)</bold></td><td align=\"center\"><bold>Flow (L/min)</bold></td><td align=\"center\"><bold>ACE Tiss/Plasma</bold></td><td align=\"center\"><bold>Ramiprialat Ps (min<sup>-1</sup>)</bold></td><td align=\"center\"><bold>Ramiprilat fu_cell</bold></td><td align=\"center\"><bold>Ramipril Ps (min<sup>-1</sup>)</bold></td><td align=\"center\"><bold>Ramipril fu_cell</bold></td></tr></thead><tbody><tr><td align=\"center\"><bold>Blood</bold></td><td align=\"center\">5.5</td><td align=\"center\">2.68345</td><td/><td align=\"center\">0.52</td><td align=\"center\">0</td><td align=\"center\">----</td><td/><td/></tr><tr><td align=\"center\"><bold>liver</bold></td><td align=\"center\">1.8</td><td align=\"center\">0.2898</td><td align=\"center\">0.45</td><td align=\"center\">1.37</td><td align=\"center\">Adjustable</td><td align=\"center\">1</td><td align=\"center\">infinite</td><td align=\"center\">0.1</td></tr><tr><td align=\"center\"><bold>portal </bold></td><td align=\"center\">1.5</td><td align=\"center\">0.351</td><td align=\"center\">1.125</td><td align=\"center\">2.0</td><td align=\"center\">0</td><td align=\"center\">----</td><td align=\"center\">0.05</td><td align=\"center\">0.5</td></tr><tr><td align=\"center\"><bold>muscle</bold></td><td align=\"center\">26</td><td align=\"center\">3.042</td><td align=\"center\">0.585</td><td align=\"center\">1.0</td><td align=\"center\">0</td><td align=\"center\">----</td><td align=\"center\">0.05</td><td align=\"center\">0.5</td></tr><tr><td align=\"center\"><bold>kidney</bold></td><td align=\"center\">0.31</td><td align=\"center\">0.04092</td><td align=\"center\">1.24</td><td align=\"center\">5.62</td><td align=\"center\">Adjustable</td><td align=\"center\">10</td><td align=\"center\">infinite</td><td align=\"center\">0.01</td></tr><tr><td align=\"center\"><bold>brain</bold></td><td align=\"center\">1.4</td><td align=\"center\">0</td><td align=\"center\">0.784</td><td align=\"center\">0.8</td><td align=\"center\">0</td><td align=\"center\">----</td><td align=\"center\">0.05</td><td align=\"center\">0.5</td></tr><tr><td align=\"center\"><bold>heart</bold></td><td align=\"center\">0.33</td><td align=\"center\">0.066</td><td align=\"center\">0.264</td><td align=\"center\">1.7</td><td align=\"center\">0</td><td align=\"center\">----</td><td align=\"center\">0.05</td><td align=\"center\">0.5</td></tr><tr><td align=\"center\"><bold>lung</bold></td><td align=\"center\">0.536</td><td align=\"center\">0.08576</td><td align=\"center\">5.6184</td><td align=\"center\">34</td><td align=\"center\">0</td><td align=\"center\">----</td><td align=\"center\">0.05</td><td align=\"center\">0.5</td></tr><tr><td align=\"center\"><bold>skin</bold></td><td align=\"center\">2.6</td><td align=\"center\">1.092</td><td align=\"center\">0.26</td><td align=\"center\">3.51</td><td align=\"center\">0</td><td align=\"center\">----</td><td align=\"center\">0.05</td><td align=\"center\">0.5</td></tr><tr><td align=\"center\"><bold>tendon</bold></td><td align=\"center\">3</td><td align=\"center\">2.55</td><td align=\"center\">0.03</td><td align=\"center\">7.23</td><td align=\"center\">0</td><td align=\"center\">----</td><td align=\"center\">0.05</td><td align=\"center\">0.5</td></tr><tr><td align=\"center\"><bold>other</bold></td><td align=\"center\">5.524</td><td align=\"center\">3.75632</td><td align=\"center\">0.1104</td><td align=\"center\">5.79</td><td align=\"center\">0</td><td align=\"center\">----</td><td align=\"center\">0.05</td><td align=\"center\">0.5</td></tr><tr><td align=\"center\"><bold>bone</bold></td><td align=\"center\">4</td><td align=\"center\">0</td><td align=\"center\">0</td><td align=\"center\">0</td><td align=\"center\">0</td><td align=\"center\">----</td><td align=\"center\">0</td><td align=\"center\">0.5</td></tr><tr><td align=\"center\"><bold>adipose</bold></td><td align=\"center\">17.5</td><td align=\"center\">3.5</td><td align=\"center\">0.7385</td><td align=\"center\">6.81</td><td align=\"center\">0</td><td align=\"center\">----</td><td align=\"center\">0.05</td><td align=\"center\">0.5</td></tr><tr><td colspan=\"9\"><hr/></td></tr><tr><td align=\"center\"><bold>Total</bold></td><td align=\"center\">70</td><td align=\"center\">17.4572</td><td align=\"center\">5.5877</td><td/><td/><td/><td/><td/></tr></tbody></table></body></html>","text":"Pmid= 1373666:Table= Table 1","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":-2132909246,"_task_hash":-224971127,"_view_id":"review","accept":[4],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":null,"sessions":["tableclass-test-params-100-frank","tableclass-test-params-100-gill","tableclass-test-params-100-joe","tableclass-test-params-100-vicky"],"versions":[{"html":"<!DOCTYPE html><html><body><h1>Standard human population PBPK organ parameters (not varied).</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td align=\"center\"><bold>Organ</bold></td><td align=\"center\"><bold>Weight (Kg)</bold></td><td align=\"center\"><bold>ECF water(L)</bold></td><td align=\"center\"><bold>Flow (L/min)</bold></td><td align=\"center\"><bold>ACE Tiss/Plasma</bold></td><td align=\"center\"><bold>Ramiprialat Ps (min<sup>-1</sup>)</bold></td><td align=\"center\"><bold>Ramiprilat fu_cell</bold></td><td align=\"center\"><bold>Ramipril Ps (min<sup>-1</sup>)</bold></td><td align=\"center\"><bold>Ramipril fu_cell</bold></td></tr></thead><tbody><tr><td align=\"center\"><bold>Blood</bold></td><td align=\"center\">5.5</td><td align=\"center\">2.68345</td><td/><td align=\"center\">0.52</td><td align=\"center\">0</td><td align=\"center\">----</td><td/><td/></tr><tr><td align=\"center\"><bold>liver</bold></td><td align=\"center\">1.8</td><td align=\"center\">0.2898</td><td align=\"center\">0.45</td><td align=\"center\">1.37</td><td align=\"center\">Adjustable</td><td align=\"center\">1</td><td align=\"center\">infinite</td><td align=\"center\">0.1</td></tr><tr><td align=\"center\"><bold>portal </bold></td><td align=\"center\">1.5</td><td align=\"center\">0.351</td><td align=\"center\">1.125</td><td align=\"center\">2.0</td><td align=\"center\">0</td><td align=\"center\">----</td><td align=\"center\">0.05</td><td align=\"center\">0.5</td></tr><tr><td align=\"center\"><bold>muscle</bold></td><td align=\"center\">26</td><td align=\"center\">3.042</td><td align=\"center\">0.585</td><td align=\"center\">1.0</td><td align=\"center\">0</td><td align=\"center\">----</td><td align=\"center\">0.05</td><td align=\"center\">0.5</td></tr><tr><td align=\"center\"><bold>kidney</bold></td><td align=\"center\">0.31</td><td align=\"center\">0.04092</td><td align=\"center\">1.24</td><td align=\"center\">5.62</td><td align=\"center\">Adjustable</td><td align=\"center\">10</td><td align=\"center\">infinite</td><td align=\"center\">0.01</td></tr><tr><td align=\"center\"><bold>brain</bold></td><td align=\"center\">1.4</td><td align=\"center\">0</td><td align=\"center\">0.784</td><td align=\"center\">0.8</td><td align=\"center\">0</td><td align=\"center\">----</td><td align=\"center\">0.05</td><td align=\"center\">0.5</td></tr><tr><td align=\"center\"><bold>heart</bold></td><td align=\"center\">0.33</td><td align=\"center\">0.066</td><td align=\"center\">0.264</td><td align=\"center\">1.7</td><td align=\"center\">0</td><td align=\"center\">----</td><td align=\"center\">0.05</td><td align=\"center\">0.5</td></tr><tr><td align=\"center\"><bold>lung</bold></td><td align=\"center\">0.536</td><td align=\"center\">0.08576</td><td align=\"center\">5.6184</td><td align=\"center\">34</td><td align=\"center\">0</td><td align=\"center\">----</td><td align=\"center\">0.05</td><td align=\"center\">0.5</td></tr><tr><td align=\"center\"><bold>skin</bold></td><td align=\"center\">2.6</td><td align=\"center\">1.092</td><td align=\"center\">0.26</td><td align=\"center\">3.51</td><td align=\"center\">0</td><td align=\"center\">----</td><td align=\"center\">0.05</td><td align=\"center\">0.5</td></tr><tr><td align=\"center\"><bold>tendon</bold></td><td align=\"center\">3</td><td align=\"center\">2.55</td><td align=\"center\">0.03</td><td align=\"center\">7.23</td><td align=\"center\">0</td><td align=\"center\">----</td><td align=\"center\">0.05</td><td align=\"center\">0.5</td></tr><tr><td align=\"center\"><bold>other</bold></td><td align=\"center\">5.524</td><td align=\"center\">3.75632</td><td align=\"center\">0.1104</td><td align=\"center\">5.79</td><td align=\"center\">0</td><td align=\"center\">----</td><td align=\"center\">0.05</td><td align=\"center\">0.5</td></tr><tr><td align=\"center\"><bold>bone</bold></td><td align=\"center\">4</td><td align=\"center\">0</td><td align=\"center\">0</td><td align=\"center\">0</td><td align=\"center\">0</td><td align=\"center\">----</td><td align=\"center\">0</td><td align=\"center\">0.5</td></tr><tr><td align=\"center\"><bold>adipose</bold></td><td align=\"center\">17.5</td><td align=\"center\">3.5</td><td align=\"center\">0.7385</td><td align=\"center\">6.81</td><td align=\"center\">0</td><td align=\"center\">----</td><td align=\"center\">0.05</td><td align=\"center\">0.5</td></tr><tr><td colspan=\"9\"><hr/></td></tr><tr><td align=\"center\"><bold>Total</bold></td><td align=\"center\">70</td><td align=\"center\">17.4572</td><td align=\"center\">5.5877</td><td/><td/><td/><td/><td/></tr></tbody></table></body></html>","text":"Pmid= 1373666:Table= Table 1","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":-2132909246,"_task_hash":-224971127,"_view_id":"choice","accept":[4],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":"tableclass-test-params-100-gill","sessions":["tableclass-test-params-100-frank","tableclass-test-params-100-gill","tableclass-test-params-100-joe","tableclass-test-params-100-vicky"],"default":true}],"view_id":"choice"}
{"html":"<!DOCTYPE html><html><body><h1>Intestinal absorption parameters for oral ramipril: 1) the major ramipril absorption component (gamma function, A, a, and T); 2) a slow, long ramipril component (A</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td align=\"center\">Subject</td><td align=\"center\" colspan=\"3\">Ramipril- Major component</td><td align=\"center\">Slow absorp. Amount A<sub>slow </sub>(nmole)</td><td align=\"center\">Ramprilat Amount A<sub>R </sub>(nmole)</td><td align=\"center\">Total Absorption (nmole)</td></tr><tr><td/><td colspan=\"3\"><hr/></td><td/><td/><td/></tr><tr><td/><td align=\"center\">Amount (A) (nmole)</td><td align=\"center\">Time const. (T) (min)</td><td align=\"center\">Gamma (a)</td><td/><td/><td/></tr></thead><tbody><tr><td align=\"center\">1</td><td align=\"center\">2500</td><td align=\"center\">90</td><td align=\"center\">3</td><td align=\"center\">787</td><td align=\"center\">200</td><td align=\"center\">3487</td></tr><tr><td align=\"center\">3</td><td align=\"center\">1200</td><td align=\"center\">53</td><td align=\"center\">9</td><td align=\"center\">367</td><td align=\"center\">60</td><td align=\"center\">1627</td></tr><tr><td align=\"center\">4</td><td align=\"center\">1600</td><td align=\"center\">45</td><td align=\"center\">8</td><td align=\"center\">432</td><td align=\"center\">30</td><td align=\"center\">2062</td></tr><tr><td align=\"center\">5</td><td align=\"center\">1400</td><td align=\"center\">48</td><td align=\"center\">3.2</td><td align=\"center\">0</td><td align=\"center\">100</td><td align=\"center\">1500</td></tr><tr><td align=\"center\">6</td><td align=\"center\">1800</td><td align=\"center\">35</td><td align=\"center\">3</td><td align=\"center\">0</td><td align=\"center\">100</td><td align=\"center\">1900</td></tr><tr><td align=\"center\">7</td><td align=\"center\">800</td><td align=\"center\">25</td><td align=\"center\">3</td><td align=\"center\">320</td><td align=\"center\">41</td><td align=\"center\">1161</td></tr><tr><td align=\"center\">8</td><td align=\"center\">2100</td><td align=\"center\">70</td><td align=\"center\">2</td><td align=\"center\">756</td><td align=\"center\">200</td><td align=\"center\">3056</td></tr><tr><td align=\"center\">9</td><td align=\"center\">2200</td><td align=\"center\">65</td><td align=\"center\">6</td><td align=\"center\">0</td><td align=\"center\">100</td><td align=\"center\">2300</td></tr><tr><td align=\"center\">10</td><td align=\"center\">1800</td><td align=\"center\">60</td><td align=\"center\">5.5</td><td align=\"center\">0</td><td align=\"center\">100</td><td align=\"center\">1900</td></tr><tr><td align=\"center\">11</td><td align=\"center\">1100</td><td align=\"center\">35</td><td align=\"center\">3</td><td align=\"center\">346</td><td align=\"center\">100</td><td align=\"center\">1546</td></tr><tr><td align=\"center\">12</td><td align=\"center\">2700</td><td align=\"center\">80</td><td align=\"center\">4</td><td align=\"center\">0</td><td align=\"center\">400</td><td align=\"center\">3100</td></tr><tr><td colspan=\"7\"><hr/></td></tr><tr><td align=\"center\">Ave (SD)</td><td align=\"center\">1745 (597)</td><td align=\"center\">55.1 (20.1)</td><td align=\"center\">4.4 (2.3)</td><td align=\"center\">273 (301)</td><td align=\"center\">130 (105)</td><td align=\"center\">2149 (755)</td></tr></tbody></table></body></html>","text":"Pmid= 1373666:Table= Table 4","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":-1336425807,"_task_hash":182624219,"_view_id":"review","accept":[4],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":null,"sessions":["tableclass-test-params-100-frank","tableclass-test-params-100-joe","tableclass-test-params-100-vicky"],"versions":[{"html":"<!DOCTYPE html><html><body><h1>Intestinal absorption parameters for oral ramipril: 1) the major ramipril absorption component (gamma function, A, a, and T); 2) a slow, long ramipril component (A</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td align=\"center\">Subject</td><td align=\"center\" colspan=\"3\">Ramipril- Major component</td><td align=\"center\">Slow absorp. Amount A<sub>slow </sub>(nmole)</td><td align=\"center\">Ramprilat Amount A<sub>R </sub>(nmole)</td><td align=\"center\">Total Absorption (nmole)</td></tr><tr><td/><td colspan=\"3\"><hr/></td><td/><td/><td/></tr><tr><td/><td align=\"center\">Amount (A) (nmole)</td><td align=\"center\">Time const. (T) (min)</td><td align=\"center\">Gamma (a)</td><td/><td/><td/></tr></thead><tbody><tr><td align=\"center\">1</td><td align=\"center\">2500</td><td align=\"center\">90</td><td align=\"center\">3</td><td align=\"center\">787</td><td align=\"center\">200</td><td align=\"center\">3487</td></tr><tr><td align=\"center\">3</td><td align=\"center\">1200</td><td align=\"center\">53</td><td align=\"center\">9</td><td align=\"center\">367</td><td align=\"center\">60</td><td align=\"center\">1627</td></tr><tr><td align=\"center\">4</td><td align=\"center\">1600</td><td align=\"center\">45</td><td align=\"center\">8</td><td align=\"center\">432</td><td align=\"center\">30</td><td align=\"center\">2062</td></tr><tr><td align=\"center\">5</td><td align=\"center\">1400</td><td align=\"center\">48</td><td align=\"center\">3.2</td><td align=\"center\">0</td><td align=\"center\">100</td><td align=\"center\">1500</td></tr><tr><td align=\"center\">6</td><td align=\"center\">1800</td><td align=\"center\">35</td><td align=\"center\">3</td><td align=\"center\">0</td><td align=\"center\">100</td><td align=\"center\">1900</td></tr><tr><td align=\"center\">7</td><td align=\"center\">800</td><td align=\"center\">25</td><td align=\"center\">3</td><td align=\"center\">320</td><td align=\"center\">41</td><td align=\"center\">1161</td></tr><tr><td align=\"center\">8</td><td align=\"center\">2100</td><td align=\"center\">70</td><td align=\"center\">2</td><td align=\"center\">756</td><td align=\"center\">200</td><td align=\"center\">3056</td></tr><tr><td align=\"center\">9</td><td align=\"center\">2200</td><td align=\"center\">65</td><td align=\"center\">6</td><td align=\"center\">0</td><td align=\"center\">100</td><td align=\"center\">2300</td></tr><tr><td align=\"center\">10</td><td align=\"center\">1800</td><td align=\"center\">60</td><td align=\"center\">5.5</td><td align=\"center\">0</td><td align=\"center\">100</td><td align=\"center\">1900</td></tr><tr><td align=\"center\">11</td><td align=\"center\">1100</td><td align=\"center\">35</td><td align=\"center\">3</td><td align=\"center\">346</td><td align=\"center\">100</td><td align=\"center\">1546</td></tr><tr><td align=\"center\">12</td><td align=\"center\">2700</td><td align=\"center\">80</td><td align=\"center\">4</td><td align=\"center\">0</td><td align=\"center\">400</td><td align=\"center\">3100</td></tr><tr><td colspan=\"7\"><hr/></td></tr><tr><td align=\"center\">Ave (SD)</td><td align=\"center\">1745 (597)</td><td align=\"center\">55.1 (20.1)</td><td align=\"center\">4.4 (2.3)</td><td align=\"center\">273 (301)</td><td align=\"center\">130 (105)</td><td align=\"center\">2149 (755)</td></tr></tbody></table></body></html>","text":"Pmid= 1373666:Table= Table 4","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":-1336425807,"_task_hash":-1830020505,"_view_id":"choice","accept":[4,2],"config":{"choice_style":"multiple"},"user_input":"Unsure whether to classify this as a compartmental or PBPK analysis","answer":"accept","_session_id":"tableclass-test-params-100-gill","sessions":["tableclass-test-params-100-gill"],"default":false},{"html":"<!DOCTYPE html><html><body><h1>Intestinal absorption parameters for oral ramipril: 1) the major ramipril absorption component (gamma function, A, a, and T); 2) a slow, long ramipril component (A</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td align=\"center\">Subject</td><td align=\"center\" colspan=\"3\">Ramipril- Major component</td><td align=\"center\">Slow absorp. Amount A<sub>slow </sub>(nmole)</td><td align=\"center\">Ramprilat Amount A<sub>R </sub>(nmole)</td><td align=\"center\">Total Absorption (nmole)</td></tr><tr><td/><td colspan=\"3\"><hr/></td><td/><td/><td/></tr><tr><td/><td align=\"center\">Amount (A) (nmole)</td><td align=\"center\">Time const. (T) (min)</td><td align=\"center\">Gamma (a)</td><td/><td/><td/></tr></thead><tbody><tr><td align=\"center\">1</td><td align=\"center\">2500</td><td align=\"center\">90</td><td align=\"center\">3</td><td align=\"center\">787</td><td align=\"center\">200</td><td align=\"center\">3487</td></tr><tr><td align=\"center\">3</td><td align=\"center\">1200</td><td align=\"center\">53</td><td align=\"center\">9</td><td align=\"center\">367</td><td align=\"center\">60</td><td align=\"center\">1627</td></tr><tr><td align=\"center\">4</td><td align=\"center\">1600</td><td align=\"center\">45</td><td align=\"center\">8</td><td align=\"center\">432</td><td align=\"center\">30</td><td align=\"center\">2062</td></tr><tr><td align=\"center\">5</td><td align=\"center\">1400</td><td align=\"center\">48</td><td align=\"center\">3.2</td><td align=\"center\">0</td><td align=\"center\">100</td><td align=\"center\">1500</td></tr><tr><td align=\"center\">6</td><td align=\"center\">1800</td><td align=\"center\">35</td><td align=\"center\">3</td><td align=\"center\">0</td><td align=\"center\">100</td><td align=\"center\">1900</td></tr><tr><td align=\"center\">7</td><td align=\"center\">800</td><td align=\"center\">25</td><td align=\"center\">3</td><td align=\"center\">320</td><td align=\"center\">41</td><td align=\"center\">1161</td></tr><tr><td align=\"center\">8</td><td align=\"center\">2100</td><td align=\"center\">70</td><td align=\"center\">2</td><td align=\"center\">756</td><td align=\"center\">200</td><td align=\"center\">3056</td></tr><tr><td align=\"center\">9</td><td align=\"center\">2200</td><td align=\"center\">65</td><td align=\"center\">6</td><td align=\"center\">0</td><td align=\"center\">100</td><td align=\"center\">2300</td></tr><tr><td align=\"center\">10</td><td align=\"center\">1800</td><td align=\"center\">60</td><td align=\"center\">5.5</td><td align=\"center\">0</td><td align=\"center\">100</td><td align=\"center\">1900</td></tr><tr><td align=\"center\">11</td><td align=\"center\">1100</td><td align=\"center\">35</td><td align=\"center\">3</td><td align=\"center\">346</td><td align=\"center\">100</td><td align=\"center\">1546</td></tr><tr><td align=\"center\">12</td><td align=\"center\">2700</td><td align=\"center\">80</td><td align=\"center\">4</td><td align=\"center\">0</td><td align=\"center\">400</td><td align=\"center\">3100</td></tr><tr><td colspan=\"7\"><hr/></td></tr><tr><td align=\"center\">Ave (SD)</td><td align=\"center\">1745 (597)</td><td align=\"center\">55.1 (20.1)</td><td align=\"center\">4.4 (2.3)</td><td align=\"center\">273 (301)</td><td align=\"center\">130 (105)</td><td align=\"center\">2149 (755)</td></tr></tbody></table></body></html>","text":"Pmid= 1373666:Table= Table 4","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":-1336425807,"_task_hash":182624219,"_view_id":"choice","accept":[4],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":"tableclass-test-params-100-frank","sessions":["tableclass-test-params-100-frank","tableclass-test-params-100-joe","tableclass-test-params-100-vicky"],"default":true}],"view_id":"choice"}
{"html":"<!DOCTYPE html><html><body><h1>Anthropometic and life style data of subjects.</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td align=\"center\"><bold>Parameter</bold></td><td align=\"center\"><bold>Ascending Colon</bold></td><td align=\"center\"><bold>Descending Colon</bold></td><td align=\"center\"><bold>Sigmoid Colon</bold></td></tr></thead><tbody><tr><td align=\"left\"><bold>n</bold></td><td align=\"center\">10</td><td align=\"center\">7</td><td align=\"center\">24</td></tr><tr><td align=\"left\"><bold>Age</bold></td><td align=\"center\">52 &#177; 9</td><td align=\"center\">54 &#177; 15</td><td align=\"center\">55 &#177; 9</td></tr><tr><td align=\"left\"><bold>Sex : Female/male</bold></td><td align=\"center\">5/5</td><td align=\"center\">1/6</td><td align=\"center\">8/16</td></tr><tr><td align=\"left\"><bold>BMI</bold></td><td align=\"center\">26.5 &#177; 5.7</td><td align=\"center\">27.8 &#177; 4.9</td><td align=\"center\">25.4 &#177; 4.0</td></tr><tr><td align=\"left\" colspan=\"4\"><bold>Cigarette use</bold></td></tr><tr><td align=\"left\"><bold>Yes/No</bold></td><td align=\"center\">3/7</td><td align=\"center\">3/4</td><td align=\"center\">4/20</td></tr><tr><td align=\"left\"><bold>(number/d)</bold></td><td align=\"center\">2.8 &#177; 6.2</td><td align=\"center\">8.3 &#177; 9.8</td><td align=\"center\">1.5 &#177; 4.6</td></tr><tr><td align=\"left\" colspan=\"4\"><bold>Alcohol consumption</bold></td></tr><tr><td align=\"left\"><bold>Yes/No</bold></td><td align=\"center\">3/7</td><td align=\"center\">2/5</td><td align=\"center\">12/12</td></tr><tr><td align=\"left\"><bold>(g/d)</bold></td><td align=\"center\">9.4 &#177; 14.6</td><td align=\"center\">8.2 &#177; 7.8</td><td align=\"center\">9.8 &#177; 12.6</td></tr></tbody></table></body></html>","text":"Pmid= 1291361:Table= Table 1","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":-1935040266,"_task_hash":-1516588814,"_view_id":"review","config":{"choice_style":"multiple"},"accept":[5],"answer":"accept","_session_id":null,"sessions":["tableclass-test-params-100-frank","tableclass-test-params-100-gill","tableclass-test-params-100-joe","tableclass-test-params-100-vicky"],"versions":[{"html":"<!DOCTYPE html><html><body><h1>Anthropometic and life style data of subjects.</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td align=\"center\"><bold>Parameter</bold></td><td align=\"center\"><bold>Ascending Colon</bold></td><td align=\"center\"><bold>Descending Colon</bold></td><td align=\"center\"><bold>Sigmoid Colon</bold></td></tr></thead><tbody><tr><td align=\"left\"><bold>n</bold></td><td align=\"center\">10</td><td align=\"center\">7</td><td align=\"center\">24</td></tr><tr><td align=\"left\"><bold>Age</bold></td><td align=\"center\">52 &#177; 9</td><td align=\"center\">54 &#177; 15</td><td align=\"center\">55 &#177; 9</td></tr><tr><td align=\"left\"><bold>Sex : Female/male</bold></td><td align=\"center\">5/5</td><td align=\"center\">1/6</td><td align=\"center\">8/16</td></tr><tr><td align=\"left\"><bold>BMI</bold></td><td align=\"center\">26.5 &#177; 5.7</td><td align=\"center\">27.8 &#177; 4.9</td><td align=\"center\">25.4 &#177; 4.0</td></tr><tr><td align=\"left\" colspan=\"4\"><bold>Cigarette use</bold></td></tr><tr><td align=\"left\"><bold>Yes/No</bold></td><td align=\"center\">3/7</td><td align=\"center\">3/4</td><td align=\"center\">4/20</td></tr><tr><td align=\"left\"><bold>(number/d)</bold></td><td align=\"center\">2.8 &#177; 6.2</td><td align=\"center\">8.3 &#177; 9.8</td><td align=\"center\">1.5 &#177; 4.6</td></tr><tr><td align=\"left\" colspan=\"4\"><bold>Alcohol consumption</bold></td></tr><tr><td align=\"left\"><bold>Yes/No</bold></td><td align=\"center\">3/7</td><td align=\"center\">2/5</td><td align=\"center\">12/12</td></tr><tr><td align=\"left\"><bold>(g/d)</bold></td><td align=\"center\">9.4 &#177; 14.6</td><td align=\"center\">8.2 &#177; 7.8</td><td align=\"center\">9.8 &#177; 12.6</td></tr></tbody></table></body></html>","text":"Pmid= 1291361:Table= Table 1","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":-1935040266,"_task_hash":-1516588814,"_view_id":"choice","config":{"choice_style":"multiple"},"accept":[5],"answer":"accept","_session_id":"tableclass-test-params-100-gill","sessions":["tableclass-test-params-100-frank","tableclass-test-params-100-gill","tableclass-test-params-100-joe","tableclass-test-params-100-vicky"],"default":true}],"view_id":"choice"}
{"html":"<!DOCTYPE html><html><body><h1>Ramiprilat Adjustable PBPK Parameters: Intrinsic renal clearance, ACE plasma concentration, and liver and kidney cell membrane permeability coefficient. The \"average weighted residual error\" of the PBPK model for the IV ramiprilat input is listed in the last column.</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td align=\"center\">Subject</td><td align=\"center\">Renal Clear. Cl<sub>u </sub>(l/min)</td><td align=\"center\">ACE<sub>plasma </sub>(nM)</td><td align=\"center\" colspan=\"2\">Membrane Permeability (Ps min<sup>-1</sup>)</td><td align=\"center\">IV Ramiprilat Ave. Error</td></tr><tr><td/><td/><td/><td colspan=\"2\"><hr/></td><td/></tr><tr><td/><td/><td/><td align=\"center\">Liver</td><td align=\"center\">Kidney</td><td/></tr></thead><tbody><tr><td align=\"center\">1</td><td align=\"center\">0.55</td><td align=\"center\">1.5</td><td align=\"center\">0.015</td><td align=\"center\">0.0003</td><td align=\"center\">0.11</td></tr><tr><td align=\"center\">3</td><td align=\"center\">0.4</td><td align=\"center\">2.35</td><td align=\"center\">0.007</td><td align=\"center\">0.0015</td><td align=\"center\">0.10</td></tr><tr><td align=\"center\">4</td><td align=\"center\">0.4</td><td align=\"center\">1.65</td><td align=\"center\">0.018</td><td align=\"center\">0.001</td><td align=\"center\">0.17</td></tr><tr><td align=\"center\">5</td><td align=\"center\">0.55</td><td align=\"center\">1.13</td><td align=\"center\">0.01</td><td align=\"center\">0.0006</td><td align=\"center\">0.16</td></tr><tr><td align=\"center\">6</td><td align=\"center\">0.4</td><td align=\"center\">1.25</td><td align=\"center\">0.015</td><td align=\"center\">0.002</td><td align=\"center\">0.27</td></tr><tr><td align=\"center\">7</td><td align=\"center\">0.7</td><td align=\"center\">2.25</td><td align=\"center\">0.01</td><td align=\"center\">0.0006</td><td align=\"center\">0.18</td></tr><tr><td align=\"center\">8</td><td align=\"center\">0.4</td><td align=\"center\">2.9</td><td align=\"center\">0.01</td><td align=\"center\">0.0006</td><td align=\"center\">0.11</td></tr><tr><td align=\"center\">9</td><td align=\"center\">0.37</td><td align=\"center\">1.75</td><td align=\"center\">0.008</td><td align=\"center\">0.0003</td><td align=\"center\">0.32</td></tr><tr><td align=\"center\">10</td><td align=\"center\">0.45</td><td align=\"center\">1.45</td><td align=\"center\">0.015</td><td align=\"center\">0.002</td><td align=\"center\">0.13</td></tr><tr><td align=\"center\">11</td><td align=\"center\">0.45</td><td align=\"center\">1.4</td><td align=\"center\">0.01</td><td align=\"center\">0.0003</td><td align=\"center\">0.30</td></tr><tr><td align=\"center\">12</td><td align=\"center\">0.4</td><td align=\"center\">2.25</td><td align=\"center\">0.006</td><td align=\"center\">0.0003</td><td align=\"center\">0.14</td></tr><tr><td colspan=\"6\"><hr/></td></tr><tr><td align=\"center\">Ave (SD)</td><td align=\"center\">0.46 (0.10)</td><td align=\"center\">1.81 (0.55)</td><td align=\"center\">0.011 (0.0039)</td><td align=\"center\">0.00086 (0.00067)</td><td align=\"center\">0.18 (0.08)</td></tr></tbody></table></body></html>","text":"Pmid= 1373666:Table= Table 2","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":-441709111,"_task_hash":-149760072,"_view_id":"review","accept":[4],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":null,"sessions":["tableclass-test-params-100-frank","tableclass-test-params-100-gill","tableclass-test-params-100-joe","tableclass-test-params-100-vicky"],"versions":[{"html":"<!DOCTYPE html><html><body><h1>Ramiprilat Adjustable PBPK Parameters: Intrinsic renal clearance, ACE plasma concentration, and liver and kidney cell membrane permeability coefficient. The \"average weighted residual error\" of the PBPK model for the IV ramiprilat input is listed in the last column.</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td align=\"center\">Subject</td><td align=\"center\">Renal Clear. Cl<sub>u </sub>(l/min)</td><td align=\"center\">ACE<sub>plasma </sub>(nM)</td><td align=\"center\" colspan=\"2\">Membrane Permeability (Ps min<sup>-1</sup>)</td><td align=\"center\">IV Ramiprilat Ave. Error</td></tr><tr><td/><td/><td/><td colspan=\"2\"><hr/></td><td/></tr><tr><td/><td/><td/><td align=\"center\">Liver</td><td align=\"center\">Kidney</td><td/></tr></thead><tbody><tr><td align=\"center\">1</td><td align=\"center\">0.55</td><td align=\"center\">1.5</td><td align=\"center\">0.015</td><td align=\"center\">0.0003</td><td align=\"center\">0.11</td></tr><tr><td align=\"center\">3</td><td align=\"center\">0.4</td><td align=\"center\">2.35</td><td align=\"center\">0.007</td><td align=\"center\">0.0015</td><td align=\"center\">0.10</td></tr><tr><td align=\"center\">4</td><td align=\"center\">0.4</td><td align=\"center\">1.65</td><td align=\"center\">0.018</td><td align=\"center\">0.001</td><td align=\"center\">0.17</td></tr><tr><td align=\"center\">5</td><td align=\"center\">0.55</td><td align=\"center\">1.13</td><td align=\"center\">0.01</td><td align=\"center\">0.0006</td><td align=\"center\">0.16</td></tr><tr><td align=\"center\">6</td><td align=\"center\">0.4</td><td align=\"center\">1.25</td><td align=\"center\">0.015</td><td align=\"center\">0.002</td><td align=\"center\">0.27</td></tr><tr><td align=\"center\">7</td><td align=\"center\">0.7</td><td align=\"center\">2.25</td><td align=\"center\">0.01</td><td align=\"center\">0.0006</td><td align=\"center\">0.18</td></tr><tr><td align=\"center\">8</td><td align=\"center\">0.4</td><td align=\"center\">2.9</td><td align=\"center\">0.01</td><td align=\"center\">0.0006</td><td align=\"center\">0.11</td></tr><tr><td align=\"center\">9</td><td align=\"center\">0.37</td><td align=\"center\">1.75</td><td align=\"center\">0.008</td><td align=\"center\">0.0003</td><td align=\"center\">0.32</td></tr><tr><td align=\"center\">10</td><td align=\"center\">0.45</td><td align=\"center\">1.45</td><td align=\"center\">0.015</td><td align=\"center\">0.002</td><td align=\"center\">0.13</td></tr><tr><td align=\"center\">11</td><td align=\"center\">0.45</td><td align=\"center\">1.4</td><td align=\"center\">0.01</td><td align=\"center\">0.0003</td><td align=\"center\">0.30</td></tr><tr><td align=\"center\">12</td><td align=\"center\">0.4</td><td align=\"center\">2.25</td><td align=\"center\">0.006</td><td align=\"center\">0.0003</td><td align=\"center\">0.14</td></tr><tr><td colspan=\"6\"><hr/></td></tr><tr><td align=\"center\">Ave (SD)</td><td align=\"center\">0.46 (0.10)</td><td align=\"center\">1.81 (0.55)</td><td align=\"center\">0.011 (0.0039)</td><td align=\"center\">0.00086 (0.00067)</td><td align=\"center\">0.18 (0.08)</td></tr></tbody></table></body></html>","text":"Pmid= 1373666:Table= Table 2","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":-441709111,"_task_hash":-149760072,"_view_id":"choice","accept":[4],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":"tableclass-test-params-100-gill","sessions":["tableclass-test-params-100-frank","tableclass-test-params-100-gill","tableclass-test-params-100-joe","tableclass-test-params-100-vicky"],"default":true}],"view_id":"choice"}
{"html":"<!DOCTYPE html><html><body><h1>Ramipril adjustable PBPK parameters: 1) intrinsic liver clearance (Cl</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td align=\"center\">Subject</td><td align=\"center\">Cl<sub>int_L </sub>(l/min)</td><td align=\"center\">Cl<sub>int_K </sub>(l/min)</td><td align=\"center\">Fraction to ramiprilat</td><td align=\"center\">IV Ramipril Ave. Error</td><td align=\"center\">Oral Ramipril Ave. Error</td></tr></thead><tbody><tr><td align=\"center\">1</td><td align=\"center\">4.8</td><td align=\"center\">1.2</td><td align=\"center\">0.1</td><td align=\"center\">0.2</td><td align=\"center\">0.23</td></tr><tr><td align=\"center\">3</td><td align=\"center\">1</td><td align=\"center\">1.5</td><td align=\"center\">0.32</td><td align=\"center\">0.17</td><td align=\"center\">0.25</td></tr><tr><td align=\"center\">4</td><td align=\"center\">3.6</td><td align=\"center\">0.9</td><td align=\"center\">0.4</td><td align=\"center\">0.23</td><td align=\"center\">0.27</td></tr><tr><td align=\"center\">5</td><td align=\"center\">2</td><td align=\"center\">2</td><td align=\"center\">0.0</td><td align=\"center\">0.17</td><td align=\"center\">Poor fit</td></tr><tr><td align=\"center\">6</td><td align=\"center\">3</td><td align=\"center\">1</td><td align=\"center\">0.25</td><td align=\"center\">0.23</td><td align=\"center\">0.28</td></tr><tr><td align=\"center\">7</td><td align=\"center\">4</td><td align=\"center\">1</td><td align=\"center\">0.2</td><td align=\"center\">0.14</td><td align=\"center\">0.14</td></tr><tr><td align=\"center\">8</td><td align=\"center\">5.5</td><td align=\"center\">0</td><td align=\"center\">0.4</td><td align=\"center\">0.13</td><td align=\"center\">0.22</td></tr><tr><td align=\"center\">9</td><td align=\"center\">3.48</td><td align=\"center\">0.52</td><td align=\"center\">0.2</td><td align=\"center\">0.12</td><td align=\"center\">0.38</td></tr><tr><td align=\"center\">10</td><td align=\"center\">3.5</td><td align=\"center\">1.5</td><td align=\"center\">0.4</td><td align=\"center\">0.30</td><td align=\"center\">0.34</td></tr><tr><td align=\"center\">11</td><td align=\"center\">2.8</td><td align=\"center\">1.2</td><td align=\"center\">0.3</td><td align=\"center\">0.23</td><td align=\"center\">0.14</td></tr><tr><td align=\"center\">12</td><td align=\"center\">6.16</td><td align=\"center\">0.84</td><td align=\"center\">0.2</td><td align=\"center\">0.13</td><td align=\"center\">0.2</td></tr><tr><td colspan=\"6\"><hr/></td></tr><tr><td align=\"center\">Ave (SD)</td><td align=\"center\">3.62 (1.5)</td><td align=\"center\">1.06 (0.53)</td><td align=\"center\">0.25 (0.13)</td><td align=\"center\">0.19 (0.057)</td><td align=\"center\">0.24 (0.077)</td></tr></tbody></table></body></html>","text":"Pmid= 1373666:Table= Table 3","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":2040832772,"_task_hash":-1745027878,"_view_id":"review","accept":[4],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":null,"sessions":["tableclass-test-params-100-frank","tableclass-test-params-100-gill","tableclass-test-params-100-joe","tableclass-test-params-100-vicky"],"versions":[{"html":"<!DOCTYPE html><html><body><h1>Ramipril adjustable PBPK parameters: 1) intrinsic liver clearance (Cl</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td align=\"center\">Subject</td><td align=\"center\">Cl<sub>int_L </sub>(l/min)</td><td align=\"center\">Cl<sub>int_K </sub>(l/min)</td><td align=\"center\">Fraction to ramiprilat</td><td align=\"center\">IV Ramipril Ave. Error</td><td align=\"center\">Oral Ramipril Ave. Error</td></tr></thead><tbody><tr><td align=\"center\">1</td><td align=\"center\">4.8</td><td align=\"center\">1.2</td><td align=\"center\">0.1</td><td align=\"center\">0.2</td><td align=\"center\">0.23</td></tr><tr><td align=\"center\">3</td><td align=\"center\">1</td><td align=\"center\">1.5</td><td align=\"center\">0.32</td><td align=\"center\">0.17</td><td align=\"center\">0.25</td></tr><tr><td align=\"center\">4</td><td align=\"center\">3.6</td><td align=\"center\">0.9</td><td align=\"center\">0.4</td><td align=\"center\">0.23</td><td align=\"center\">0.27</td></tr><tr><td align=\"center\">5</td><td align=\"center\">2</td><td align=\"center\">2</td><td align=\"center\">0.0</td><td align=\"center\">0.17</td><td align=\"center\">Poor fit</td></tr><tr><td align=\"center\">6</td><td align=\"center\">3</td><td align=\"center\">1</td><td align=\"center\">0.25</td><td align=\"center\">0.23</td><td align=\"center\">0.28</td></tr><tr><td align=\"center\">7</td><td align=\"center\">4</td><td align=\"center\">1</td><td align=\"center\">0.2</td><td align=\"center\">0.14</td><td align=\"center\">0.14</td></tr><tr><td align=\"center\">8</td><td align=\"center\">5.5</td><td align=\"center\">0</td><td align=\"center\">0.4</td><td align=\"center\">0.13</td><td align=\"center\">0.22</td></tr><tr><td align=\"center\">9</td><td align=\"center\">3.48</td><td align=\"center\">0.52</td><td align=\"center\">0.2</td><td align=\"center\">0.12</td><td align=\"center\">0.38</td></tr><tr><td align=\"center\">10</td><td align=\"center\">3.5</td><td align=\"center\">1.5</td><td align=\"center\">0.4</td><td align=\"center\">0.30</td><td align=\"center\">0.34</td></tr><tr><td align=\"center\">11</td><td align=\"center\">2.8</td><td align=\"center\">1.2</td><td align=\"center\">0.3</td><td align=\"center\">0.23</td><td align=\"center\">0.14</td></tr><tr><td align=\"center\">12</td><td align=\"center\">6.16</td><td align=\"center\">0.84</td><td align=\"center\">0.2</td><td align=\"center\">0.13</td><td align=\"center\">0.2</td></tr><tr><td colspan=\"6\"><hr/></td></tr><tr><td align=\"center\">Ave (SD)</td><td align=\"center\">3.62 (1.5)</td><td align=\"center\">1.06 (0.53)</td><td align=\"center\">0.25 (0.13)</td><td align=\"center\">0.19 (0.057)</td><td align=\"center\">0.24 (0.077)</td></tr></tbody></table></body></html>","text":"Pmid= 1373666:Table= Table 3","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":2040832772,"_task_hash":-1745027878,"_view_id":"choice","accept":[4],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":"tableclass-test-params-100-gill","sessions":["tableclass-test-params-100-frank","tableclass-test-params-100-gill","tableclass-test-params-100-joe","tableclass-test-params-100-vicky"],"default":true}],"view_id":"choice"}
{"html":"<!DOCTYPE html><html><body><h1>Solid Phase Extraction</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td/><td align=\"center\" colspan=\"2\"><bold>Paclitaxel</bold></td><td align=\"center\" colspan=\"2\"><bold>Docetaxel</bold></td></tr></thead><tbody><tr><td align=\"center\"><bold>Author</bold></td><td align=\"center\"><bold>Willey [12]</bold></td><td align=\"center\"><bold>Andersen et al</bold></td><td align=\"center\"><bold>Rosing [24]</bold></td><td align=\"center\"><bold>Andersen et al</bold></td></tr><tr><td colspan=\"5\"><hr/></td></tr><tr><td align=\"center\"><bold>Columns</bold></td><td align=\"center\">1 ml CN-(?) 100 mg<sup>#</sup></td><td align=\"center\">LRC CN-U 100 mg</td><td align=\"center\">CN-E 100 mg</td><td align=\"center\">LRC CN-E 100 mg</td></tr><tr><td align=\"center\"><bold>Cond 1</bold></td><td align=\"center\">2 ml MeOH</td><td align=\"center\">10 ml MeOH</td><td align=\"center\">1 ml 0.1% TEA in MeCN</td><td align=\"center\">10 ml MeOH</td></tr><tr><td align=\"center\"><bold>Cond 2</bold></td><td align=\"center\">2 ml AmAc<sup>##</sup></td><td align=\"center\">5 ml AmAc</td><td align=\"center\">2 ml MeOH</td><td align=\"center\">2 ml AmAc</td></tr><tr><td align=\"center\"><bold>Cond 3</bold></td><td align=\"center\">None</td><td align=\"center\">None</td><td align=\"center\">2 ml AmAc</td><td align=\"center\">None</td></tr><tr><td align=\"center\"><bold>Load</bold></td><td align=\"center\">1 ml 50% plasma*</td><td align=\"center\">Up to 8 ml 50% plasma*</td><td align=\"center\">1.1 ml undiluted plasma</td><td align=\"center\">2 ml undiluted plasma</td></tr><tr><td align=\"center\"><bold>Wash 1</bold></td><td align=\"center\">2 ml AmAc</td><td align=\"center\">10 ml AmAc</td><td align=\"center\">2 ml AmAc</td><td align=\"center\">2 ml AmAc</td></tr><tr><td align=\"center\"><bold>Wash 2</bold></td><td align=\"center\">2 ml AmAc/20% MeOH</td><td align=\"center\">1 ml AmAc/20% MeOH</td><td align=\"center\">1 ml water/20% MeOH</td><td align=\"center\">1 ml AmAc/20% MeOH</td></tr><tr><td align=\"center\"><bold>Wash 3</bold></td><td align=\"center\">1 ml hexane</td><td align=\"center\">5 ml hexane</td><td align=\"center\">None</td><td align=\"center\">2 ml hexane</td></tr><tr><td align=\"center\"><bold>Elution</bold></td><td align=\"center\">2&#215; 1 ml 0.1% TEA in MeCN</td><td align=\"center\">2&#215; 250 &#956;l ethyl acetate</td><td align=\"center\">1&#215; 500 &#956;l 0.1% TEA in MeCN</td><td align=\"center\">2&#215; 250 &#956;l ethyl acetate</td></tr><tr><td align=\"center\"><bold>Evap</bold></td><td align=\"center\">Nitrogen gas blowdown</td><td align=\"center\">Vacuum centrifuge</td><td align=\"center\">Nitrogen gas blowdown</td><td align=\"center\">Vacuum centrifuge</td></tr><tr><td align=\"center\"><bold>Injection volume</bold></td><td align=\"center\">100 &#956;l (of 200 &#956;l) in MeOH/MeCN/AmAc</td><td align=\"center\">90 &#956;l (of 100 &#956;l) in 40% MeCN</td><td align=\"center\">50 &#956;l (of 100 &#956;l) in MeOH/MeCN/water</td><td align=\"center\">90 &#956;l (of 100 &#956;l) in 40% MeCN</td></tr></tbody></table></body></html>","text":"Pmid= 1382254:Table= Table 1","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":-848858815,"_task_hash":-669941439,"_view_id":"review","accept":[5],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":null,"sessions":["tableclass-test-params-100-frank","tableclass-test-params-100-gill","tableclass-test-params-100-joe","tableclass-test-params-100-vicky"],"versions":[{"html":"<!DOCTYPE html><html><body><h1>Solid Phase Extraction</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td/><td align=\"center\" colspan=\"2\"><bold>Paclitaxel</bold></td><td align=\"center\" colspan=\"2\"><bold>Docetaxel</bold></td></tr></thead><tbody><tr><td align=\"center\"><bold>Author</bold></td><td align=\"center\"><bold>Willey [12]</bold></td><td align=\"center\"><bold>Andersen et al</bold></td><td align=\"center\"><bold>Rosing [24]</bold></td><td align=\"center\"><bold>Andersen et al</bold></td></tr><tr><td colspan=\"5\"><hr/></td></tr><tr><td align=\"center\"><bold>Columns</bold></td><td align=\"center\">1 ml CN-(?) 100 mg<sup>#</sup></td><td align=\"center\">LRC CN-U 100 mg</td><td align=\"center\">CN-E 100 mg</td><td align=\"center\">LRC CN-E 100 mg</td></tr><tr><td align=\"center\"><bold>Cond 1</bold></td><td align=\"center\">2 ml MeOH</td><td align=\"center\">10 ml MeOH</td><td align=\"center\">1 ml 0.1% TEA in MeCN</td><td align=\"center\">10 ml MeOH</td></tr><tr><td align=\"center\"><bold>Cond 2</bold></td><td align=\"center\">2 ml AmAc<sup>##</sup></td><td align=\"center\">5 ml AmAc</td><td align=\"center\">2 ml MeOH</td><td align=\"center\">2 ml AmAc</td></tr><tr><td align=\"center\"><bold>Cond 3</bold></td><td align=\"center\">None</td><td align=\"center\">None</td><td align=\"center\">2 ml AmAc</td><td align=\"center\">None</td></tr><tr><td align=\"center\"><bold>Load</bold></td><td align=\"center\">1 ml 50% plasma*</td><td align=\"center\">Up to 8 ml 50% plasma*</td><td align=\"center\">1.1 ml undiluted plasma</td><td align=\"center\">2 ml undiluted plasma</td></tr><tr><td align=\"center\"><bold>Wash 1</bold></td><td align=\"center\">2 ml AmAc</td><td align=\"center\">10 ml AmAc</td><td align=\"center\">2 ml AmAc</td><td align=\"center\">2 ml AmAc</td></tr><tr><td align=\"center\"><bold>Wash 2</bold></td><td align=\"center\">2 ml AmAc/20% MeOH</td><td align=\"center\">1 ml AmAc/20% MeOH</td><td align=\"center\">1 ml water/20% MeOH</td><td align=\"center\">1 ml AmAc/20% MeOH</td></tr><tr><td align=\"center\"><bold>Wash 3</bold></td><td align=\"center\">1 ml hexane</td><td align=\"center\">5 ml hexane</td><td align=\"center\">None</td><td align=\"center\">2 ml hexane</td></tr><tr><td align=\"center\"><bold>Elution</bold></td><td align=\"center\">2&#215; 1 ml 0.1% TEA in MeCN</td><td align=\"center\">2&#215; 250 &#956;l ethyl acetate</td><td align=\"center\">1&#215; 500 &#956;l 0.1% TEA in MeCN</td><td align=\"center\">2&#215; 250 &#956;l ethyl acetate</td></tr><tr><td align=\"center\"><bold>Evap</bold></td><td align=\"center\">Nitrogen gas blowdown</td><td align=\"center\">Vacuum centrifuge</td><td align=\"center\">Nitrogen gas blowdown</td><td align=\"center\">Vacuum centrifuge</td></tr><tr><td align=\"center\"><bold>Injection volume</bold></td><td align=\"center\">100 &#956;l (of 200 &#956;l) in MeOH/MeCN/AmAc</td><td align=\"center\">90 &#956;l (of 100 &#956;l) in 40% MeCN</td><td align=\"center\">50 &#956;l (of 100 &#956;l) in MeOH/MeCN/water</td><td align=\"center\">90 &#956;l (of 100 &#956;l) in 40% MeCN</td></tr></tbody></table></body></html>","text":"Pmid= 1382254:Table= Table 1","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":-848858815,"_task_hash":-669941439,"_view_id":"choice","accept":[5],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":"tableclass-test-params-100-gill","sessions":["tableclass-test-params-100-frank","tableclass-test-params-100-gill","tableclass-test-params-100-joe","tableclass-test-params-100-vicky"],"default":true}],"view_id":"choice"}
{"html":"<!DOCTYPE html><html><body><h1>Intra- and inter-assay accuracy and precision (CV%) for paclitaxel and docetaxel determinations in plasma.</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td/><td align=\"center\">Concentration [nM]</td><td align=\"center\" colspan=\"3\">Intra-assay variability</td><td align=\"center\" colspan=\"3\">Inter-assay variability</td></tr><tr><td/><td/><td colspan=\"3\"><hr/></td><td colspan=\"3\"><hr/></td></tr><tr><td/><td/><td align=\"center\">n</td><td align=\"center\">Accuracy (%)</td><td align=\"center\">CV (%)</td><td align=\"center\">n</td><td align=\"center\">Accuracy (%)</td><td align=\"center\">CV (%)</td></tr></thead><tbody><tr><td align=\"center\">Paclitaxel</td><td align=\"center\">1000</td><td align=\"center\">3</td><td align=\"center\">89</td><td align=\"center\">2</td><td align=\"center\">5</td><td align=\"center\">100</td><td align=\"center\">2</td></tr><tr><td/><td align=\"center\">100</td><td align=\"center\">3</td><td align=\"center\">103</td><td align=\"center\">6</td><td align=\"center\">5</td><td align=\"center\">103</td><td align=\"center\">3</td></tr><tr><td/><td align=\"center\">10</td><td align=\"center\">3</td><td align=\"center\">111</td><td align=\"center\">2</td><td align=\"center\">5</td><td align=\"center\">104</td><td align=\"center\">9</td></tr><tr><td/><td align=\"center\">1.2</td><td align=\"center\">3</td><td align=\"center\">104</td><td align=\"center\">8</td><td align=\"center\">5</td><td align=\"center\">108</td><td align=\"center\">14</td></tr><tr><td/><td align=\"center\">0.7</td><td align=\"center\">3</td><td align=\"center\">105</td><td align=\"center\">20</td><td/><td align=\"center\">ND</td><td/></tr><tr><td align=\"center\">Docetaxel</td><td align=\"center\">750</td><td align=\"center\">3</td><td align=\"center\">100</td><td align=\"center\">1</td><td align=\"center\">5</td><td align=\"center\">101</td><td align=\"center\">3</td></tr><tr><td/><td align=\"center\">50</td><td align=\"center\">3</td><td align=\"center\">97</td><td align=\"center\">1</td><td align=\"center\">5</td><td align=\"center\">94</td><td align=\"center\">6</td></tr><tr><td/><td align=\"center\">5</td><td align=\"center\">3</td><td align=\"center\">99</td><td align=\"center\">4</td><td align=\"center\">5</td><td align=\"center\">100</td><td align=\"center\">5</td></tr><tr><td/><td align=\"center\">2</td><td align=\"center\">5</td><td align=\"center\">93</td><td align=\"center\">4</td><td/><td align=\"center\">ND</td><td/></tr><tr><td/><td align=\"center\">1</td><td align=\"center\">5</td><td align=\"center\">96</td><td align=\"center\">12</td><td/><td align=\"center\">ND</td><td/></tr></tbody></table></body></html>","text":"Pmid= 1382254:Table= Table 2","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":1532208085,"_task_hash":-1805938351,"_view_id":"review","accept":[5],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":null,"sessions":["tableclass-test-params-100-frank","tableclass-test-params-100-gill","tableclass-test-params-100-joe","tableclass-test-params-100-vicky"],"versions":[{"html":"<!DOCTYPE html><html><body><h1>Intra- and inter-assay accuracy and precision (CV%) for paclitaxel and docetaxel determinations in plasma.</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td/><td align=\"center\">Concentration [nM]</td><td align=\"center\" colspan=\"3\">Intra-assay variability</td><td align=\"center\" colspan=\"3\">Inter-assay variability</td></tr><tr><td/><td/><td colspan=\"3\"><hr/></td><td colspan=\"3\"><hr/></td></tr><tr><td/><td/><td align=\"center\">n</td><td align=\"center\">Accuracy (%)</td><td align=\"center\">CV (%)</td><td align=\"center\">n</td><td align=\"center\">Accuracy (%)</td><td align=\"center\">CV (%)</td></tr></thead><tbody><tr><td align=\"center\">Paclitaxel</td><td align=\"center\">1000</td><td align=\"center\">3</td><td align=\"center\">89</td><td align=\"center\">2</td><td align=\"center\">5</td><td align=\"center\">100</td><td align=\"center\">2</td></tr><tr><td/><td align=\"center\">100</td><td align=\"center\">3</td><td align=\"center\">103</td><td align=\"center\">6</td><td align=\"center\">5</td><td align=\"center\">103</td><td align=\"center\">3</td></tr><tr><td/><td align=\"center\">10</td><td align=\"center\">3</td><td align=\"center\">111</td><td align=\"center\">2</td><td align=\"center\">5</td><td align=\"center\">104</td><td align=\"center\">9</td></tr><tr><td/><td align=\"center\">1.2</td><td align=\"center\">3</td><td align=\"center\">104</td><td align=\"center\">8</td><td align=\"center\">5</td><td align=\"center\">108</td><td align=\"center\">14</td></tr><tr><td/><td align=\"center\">0.7</td><td align=\"center\">3</td><td align=\"center\">105</td><td align=\"center\">20</td><td/><td align=\"center\">ND</td><td/></tr><tr><td align=\"center\">Docetaxel</td><td align=\"center\">750</td><td align=\"center\">3</td><td align=\"center\">100</td><td align=\"center\">1</td><td align=\"center\">5</td><td align=\"center\">101</td><td align=\"center\">3</td></tr><tr><td/><td align=\"center\">50</td><td align=\"center\">3</td><td align=\"center\">97</td><td align=\"center\">1</td><td align=\"center\">5</td><td align=\"center\">94</td><td align=\"center\">6</td></tr><tr><td/><td align=\"center\">5</td><td align=\"center\">3</td><td align=\"center\">99</td><td align=\"center\">4</td><td align=\"center\">5</td><td align=\"center\">100</td><td align=\"center\">5</td></tr><tr><td/><td align=\"center\">2</td><td align=\"center\">5</td><td align=\"center\">93</td><td align=\"center\">4</td><td/><td align=\"center\">ND</td><td/></tr><tr><td/><td align=\"center\">1</td><td align=\"center\">5</td><td align=\"center\">96</td><td align=\"center\">12</td><td/><td align=\"center\">ND</td><td/></tr></tbody></table></body></html>","text":"Pmid= 1382254:Table= Table 2","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":1532208085,"_task_hash":-1805938351,"_view_id":"choice","accept":[5],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":"tableclass-test-params-100-gill","sessions":["tableclass-test-params-100-frank","tableclass-test-params-100-gill","tableclass-test-params-100-joe","tableclass-test-params-100-vicky"],"default":true}],"view_id":"choice"}
{"html":"<!DOCTYPE html><html><body><h1>Detectable plasma concentrations of compounds that revealed a mean degree of phase II conjugation of less than 100 %: catechin (n = 5), caffeic acid (n = 3), U2 (n = 5) and U7 (n = 3) in samples of volunteers after repeated intake of 200 mg Pycnogenol once daily for five days.</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td/><td align=\"center\">Total plasma concentration</td><td align=\"center\">Free plasma concentration</td><td align=\"center\">% conjugated</td></tr></thead><tbody><tr><td align=\"center\">Catechin [ng/ml]</td><td align=\"center\">48.6 &#177; 16.7</td><td align=\"center\">21.0 &#177; 13.1</td><td align=\"center\">56.5 &#177; 27.9</td></tr><tr><td align=\"center\">Caffeic acid [ng/ml]</td><td align=\"center\">2.42 &#177; 1.39</td><td align=\"center\">0.56 &#177; 0.02</td><td align=\"center\">69.4 &#177; 11.8</td></tr><tr><td align=\"center\">U2 [peak ratio]</td><td align=\"center\">0.0537 &#177; 0.0132</td><td align=\"center\">0.0105 &#177; 0.0084</td><td align=\"center\">77.1 &#177; 21.3</td></tr><tr><td align=\"center\">U7 [peak ratio]</td><td align=\"center\">0.0101 &#177; 0.0007</td><td align=\"center\">0.0057 &#177; 0.0020</td><td align=\"center\">45.0 &#177; 18.5</td></tr></tbody></table></body></html>","text":"Pmid= 1559639:Table= Table 1","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":1560195086,"_task_hash":-44113334,"_view_id":"review","accept":[4],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":null,"sessions":["tableclass-test-params-100-frank","tableclass-test-params-100-vicky"],"versions":[{"html":"<!DOCTYPE html><html><body><h1>Detectable plasma concentrations of compounds that revealed a mean degree of phase II conjugation of less than 100 %: catechin (n = 5), caffeic acid (n = 3), U2 (n = 5) and U7 (n = 3) in samples of volunteers after repeated intake of 200 mg Pycnogenol once daily for five days.</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td/><td align=\"center\">Total plasma concentration</td><td align=\"center\">Free plasma concentration</td><td align=\"center\">% conjugated</td></tr></thead><tbody><tr><td align=\"center\">Catechin [ng/ml]</td><td align=\"center\">48.6 &#177; 16.7</td><td align=\"center\">21.0 &#177; 13.1</td><td align=\"center\">56.5 &#177; 27.9</td></tr><tr><td align=\"center\">Caffeic acid [ng/ml]</td><td align=\"center\">2.42 &#177; 1.39</td><td align=\"center\">0.56 &#177; 0.02</td><td align=\"center\">69.4 &#177; 11.8</td></tr><tr><td align=\"center\">U2 [peak ratio]</td><td align=\"center\">0.0537 &#177; 0.0132</td><td align=\"center\">0.0105 &#177; 0.0084</td><td align=\"center\">77.1 &#177; 21.3</td></tr><tr><td align=\"center\">U7 [peak ratio]</td><td align=\"center\">0.0101 &#177; 0.0007</td><td align=\"center\">0.0057 &#177; 0.0020</td><td align=\"center\">45.0 &#177; 18.5</td></tr></tbody></table></body></html>","text":"Pmid= 1559639:Table= Table 1","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":1560195086,"_task_hash":-171559202,"_view_id":"choice","accept":[4],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":"tableclass-test-params-100-gill","sessions":["tableclass-test-params-100-gill"],"default":false},{"html":"<!DOCTYPE html><html><body><h1>Detectable plasma concentrations of compounds that revealed a mean degree of phase II conjugation of less than 100 %: catechin (n = 5), caffeic acid (n = 3), U2 (n = 5) and U7 (n = 3) in samples of volunteers after repeated intake of 200 mg Pycnogenol once daily for five days.</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td/><td align=\"center\">Total plasma concentration</td><td align=\"center\">Free plasma concentration</td><td align=\"center\">% conjugated</td></tr></thead><tbody><tr><td align=\"center\">Catechin [ng/ml]</td><td align=\"center\">48.6 &#177; 16.7</td><td align=\"center\">21.0 &#177; 13.1</td><td align=\"center\">56.5 &#177; 27.9</td></tr><tr><td align=\"center\">Caffeic acid [ng/ml]</td><td align=\"center\">2.42 &#177; 1.39</td><td align=\"center\">0.56 &#177; 0.02</td><td align=\"center\">69.4 &#177; 11.8</td></tr><tr><td align=\"center\">U2 [peak ratio]</td><td align=\"center\">0.0537 &#177; 0.0132</td><td align=\"center\">0.0105 &#177; 0.0084</td><td align=\"center\">77.1 &#177; 21.3</td></tr><tr><td align=\"center\">U7 [peak ratio]</td><td align=\"center\">0.0101 &#177; 0.0007</td><td align=\"center\">0.0057 &#177; 0.0020</td><td align=\"center\">45.0 &#177; 18.5</td></tr></tbody></table></body></html>","text":"Pmid= 1559639:Table= Table 1","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":1560195086,"_task_hash":-44113334,"_view_id":"choice","accept":[5],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":"tableclass-test-params-100-frank","sessions":["tableclass-test-params-100-frank","tableclass-test-params-100-vicky"],"default":true},{"html":"<!DOCTYPE html><html><body><h1>Detectable plasma concentrations of compounds that revealed a mean degree of phase II conjugation of less than 100 %: catechin (n = 5), caffeic acid (n = 3), U2 (n = 5) and U7 (n = 3) in samples of volunteers after repeated intake of 200 mg Pycnogenol once daily for five days.</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td/><td align=\"center\">Total plasma concentration</td><td align=\"center\">Free plasma concentration</td><td align=\"center\">% conjugated</td></tr></thead><tbody><tr><td align=\"center\">Catechin [ng/ml]</td><td align=\"center\">48.6 &#177; 16.7</td><td align=\"center\">21.0 &#177; 13.1</td><td align=\"center\">56.5 &#177; 27.9</td></tr><tr><td align=\"center\">Caffeic acid [ng/ml]</td><td align=\"center\">2.42 &#177; 1.39</td><td align=\"center\">0.56 &#177; 0.02</td><td align=\"center\">69.4 &#177; 11.8</td></tr><tr><td align=\"center\">U2 [peak ratio]</td><td align=\"center\">0.0537 &#177; 0.0132</td><td align=\"center\">0.0105 &#177; 0.0084</td><td align=\"center\">77.1 &#177; 21.3</td></tr><tr><td align=\"center\">U7 [peak ratio]</td><td align=\"center\">0.0101 &#177; 0.0007</td><td align=\"center\">0.0057 &#177; 0.0020</td><td align=\"center\">45.0 &#177; 18.5</td></tr></tbody></table></body></html>","text":"Pmid= 1559639:Table= Table 1","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":1560195086,"_task_hash":2012896176,"_view_id":"choice","accept":[1],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":"tableclass-test-params-100-joe","sessions":["tableclass-test-params-100-joe"],"default":false}],"view_id":"choice"}
{"html":"<!DOCTYPE html><html><body><h1>Calculated pharmacokinetic parameters of components or metabolites after intake of a single dose of 300 mg Pycnogenol.</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td align=\"center\">Compound</td><td align=\"center\">n</td><td align=\"center\">AUC<sub> [0-t] </sub>[ng/mL &#215; h]</td><td align=\"center\">AUC<sub> [t-8] </sub>[ng/mL &#215; h]</td><td align=\"center\">c<sub>max </sub>[ng/mL]</td><td align=\"center\">t<sub>max </sub>[h]</td><td align=\"center\">term t&#189; [h]</td></tr></thead><tbody><tr><td align=\"center\">Caffeic acid</td><td align=\"center\">9</td><td align=\"center\">75.66 &#177; 33.53</td><td align=\"center\">82.78 &#177; 36.47</td><td align=\"center\">16.67 &#177; 13.29</td><td align=\"center\">3.7 &#177; 2.4</td><td align=\"center\">4.42 &#177; 2.47</td></tr><tr><td align=\"center\">Catechin</td><td align=\"center\">9</td><td/><td/><td align=\"center\">107.22 &#177; 55.49</td><td align=\"center\">3.2 &#177; 1.7</td><td/></tr><tr><td align=\"center\">Taxifolin</td><td align=\"center\">6</td><td align=\"center\">231.11 &#177; 85.98</td><td align=\"center\">399.14 &#177; 98.95</td><td align=\"center\">33.34 &#177; 12.54</td><td align=\"center\">8.2 &#177; 2.5</td><td align=\"center\">8.89 &#177; 2.81</td></tr><tr><td align=\"center\">Ferulic acid</td><td align=\"center\">7</td><td align=\"center\">99.05 &#177; 28.09</td><td align=\"center\">141.19 &#177; 73.90</td><td align=\"center\">14.78 &#177; 5.89</td><td align=\"center\">1.2 &#177; 1.1</td><td align=\"center\">6.87 &#177; 3.83</td></tr><tr><td align=\"center\">M1</td><td align=\"center\">8</td><td/><td/><td align=\"center\">4.11 &#177; 2.08</td><td align=\"center\">10.0 &#177; 1.9</td><td/></tr></tbody></table></body></html>","text":"Pmid= 1559639:Table= Table 2","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":-1834307206,"_task_hash":-1939933644,"_view_id":"review","accept":[1],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":null,"sessions":["tableclass-test-params-100-frank","tableclass-test-params-100-gill","tableclass-test-params-100-joe","tableclass-test-params-100-vicky"],"versions":[{"html":"<!DOCTYPE html><html><body><h1>Calculated pharmacokinetic parameters of components or metabolites after intake of a single dose of 300 mg Pycnogenol.</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td align=\"center\">Compound</td><td align=\"center\">n</td><td align=\"center\">AUC<sub> [0-t] </sub>[ng/mL &#215; h]</td><td align=\"center\">AUC<sub> [t-8] </sub>[ng/mL &#215; h]</td><td align=\"center\">c<sub>max </sub>[ng/mL]</td><td align=\"center\">t<sub>max </sub>[h]</td><td align=\"center\">term t&#189; [h]</td></tr></thead><tbody><tr><td align=\"center\">Caffeic acid</td><td align=\"center\">9</td><td align=\"center\">75.66 &#177; 33.53</td><td align=\"center\">82.78 &#177; 36.47</td><td align=\"center\">16.67 &#177; 13.29</td><td align=\"center\">3.7 &#177; 2.4</td><td align=\"center\">4.42 &#177; 2.47</td></tr><tr><td align=\"center\">Catechin</td><td align=\"center\">9</td><td/><td/><td align=\"center\">107.22 &#177; 55.49</td><td align=\"center\">3.2 &#177; 1.7</td><td/></tr><tr><td align=\"center\">Taxifolin</td><td align=\"center\">6</td><td align=\"center\">231.11 &#177; 85.98</td><td align=\"center\">399.14 &#177; 98.95</td><td align=\"center\">33.34 &#177; 12.54</td><td align=\"center\">8.2 &#177; 2.5</td><td align=\"center\">8.89 &#177; 2.81</td></tr><tr><td align=\"center\">Ferulic acid</td><td align=\"center\">7</td><td align=\"center\">99.05 &#177; 28.09</td><td align=\"center\">141.19 &#177; 73.90</td><td align=\"center\">14.78 &#177; 5.89</td><td align=\"center\">1.2 &#177; 1.1</td><td align=\"center\">6.87 &#177; 3.83</td></tr><tr><td align=\"center\">M1</td><td align=\"center\">8</td><td/><td/><td align=\"center\">4.11 &#177; 2.08</td><td align=\"center\">10.0 &#177; 1.9</td><td/></tr></tbody></table></body></html>","text":"Pmid= 1559639:Table= Table 2","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":-1834307206,"_task_hash":-1939933644,"_view_id":"choice","accept":[1],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":"tableclass-test-params-100-gill","sessions":["tableclass-test-params-100-frank","tableclass-test-params-100-gill","tableclass-test-params-100-joe","tableclass-test-params-100-vicky"],"default":true}],"view_id":"choice"}
{"html":"<!DOCTYPE html><html><body><h1>Voriconazole (VOR) and sulphobutylether beta cyclodextrin sodium (SBECD) plasma levels in patients with intravenous voriconazole therapy and renal failure</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td align=\"left\">patient no.</td><td align=\"left\">day of VOR therapy</td><td align=\"left\">dose of intravenous VOR</td><td align=\"left\">dose of SBECD</td><td align=\"left\">dialysis information</td><td align=\"left\">VOR (&#956;g/ml)</td><td align=\"left\">SBECD (&#956;g/ml)</td></tr></thead><tbody><tr><td align=\"left\">1</td><td align=\"left\">2</td><td align=\"left\">2 &#215; 400 mg</td><td align=\"left\">2 &#215; 6400 mg</td><td align=\"left\">before dialysis</td><td align=\"left\">0.9</td><td align=\"left\">98.3</td></tr><tr><td align=\"left\">1</td><td align=\"left\">2</td><td align=\"left\">2 &#215; 200 mg</td><td align=\"left\">2 &#215; 3200 mg</td><td align=\"left\">after dialysis</td><td align=\"left\">1.1</td><td align=\"left\">145</td></tr><tr><td align=\"left\">1</td><td align=\"left\">3</td><td align=\"left\">2 &#215; 200 mg</td><td align=\"left\">2 &#215; 3200 mg</td><td align=\"left\">before dialysis</td><td align=\"left\">0.2</td><td align=\"left\">93.3</td></tr><tr><td align=\"left\">1</td><td align=\"left\">4</td><td align=\"left\">2 &#215; 200 mg</td><td align=\"left\">2 &#215; 3200 mg</td><td align=\"left\">after dialysis</td><td align=\"left\">&lt; 0.2</td><td align=\"left\">121</td></tr><tr><td align=\"left\">1</td><td align=\"left\">7</td><td align=\"left\">2 &#215; 200 mg</td><td align=\"left\">2 &#215; 3200 mg</td><td align=\"left\">after dialysis</td><td align=\"left\">0.4</td><td align=\"left\">78.9</td></tr><tr><td align=\"left\">1</td><td align=\"left\">8</td><td align=\"left\">2 &#215; 200 mg</td><td align=\"left\">2 &#215; 3200 mg</td><td align=\"left\">before dialysis</td><td align=\"left\">0.5</td><td align=\"left\">86.4</td></tr><tr><td align=\"left\">1</td><td align=\"left\">9</td><td align=\"left\">2 &#215; 200 mg</td><td align=\"left\">2 &#215; 3200 mg</td><td align=\"left\">before dialysis</td><td align=\"left\">0.4</td><td align=\"left\">59.6</td></tr><tr><td align=\"left\">1</td><td align=\"left\">9</td><td align=\"left\">2 &#215; 200 mg</td><td align=\"left\">2 &#215; 3200 mg</td><td align=\"left\">after dialysis</td><td align=\"left\">&lt; 0.2</td><td align=\"left\">31.4</td></tr><tr><td align=\"left\">1</td><td align=\"left\">10</td><td align=\"left\">2 &#215; 200 mg</td><td align=\"left\">2 &#215; 3200 mg</td><td align=\"left\">before dialysis</td><td align=\"left\">0.3</td><td align=\"left\">71.6</td></tr><tr><td align=\"left\">1</td><td align=\"left\">12</td><td align=\"left\">2 &#215; 200 mg</td><td align=\"left\">2 &#215; 3200 mg</td><td align=\"left\">no dialysis</td><td align=\"left\">&lt; 0.2</td><td align=\"left\">15.6</td></tr><tr><td align=\"left\">1</td><td align=\"left\">13</td><td align=\"left\">2 &#215; 200 mg</td><td align=\"left\">2 &#215; 3200 mg</td><td align=\"left\">no dialysis</td><td align=\"left\">&lt; 0.2</td><td align=\"left\">16.4</td></tr><tr><td align=\"left\">1</td><td align=\"left\">16</td><td align=\"left\">2 &#215; 200 mg</td><td align=\"left\">2 &#215; 3200 mg</td><td align=\"left\">no dialysis</td><td align=\"left\">&lt; 0.2</td><td align=\"left\">18.4</td></tr><tr><td align=\"left\">2</td><td align=\"left\">10</td><td align=\"left\">2 &#215; 200 mg</td><td align=\"left\">2 &#215; 3200 mg</td><td align=\"left\">before dialysis</td><td align=\"left\">0.4</td><td align=\"left\">523</td></tr><tr><td align=\"left\">2</td><td align=\"left\">11</td><td align=\"left\">2 &#215; 200 mg</td><td align=\"left\">2 &#215; 3200 mg</td><td align=\"left\">after dialysis</td><td align=\"left\">0.3</td><td align=\"left\">400</td></tr><tr><td align=\"left\">2</td><td align=\"left\">12</td><td align=\"left\">2 &#215; 200 mg</td><td align=\"left\">2 &#215; 3200 mg</td><td align=\"left\">no dialysis</td><td align=\"left\">0.3</td><td align=\"left\">348</td></tr><tr><td align=\"left\">2</td><td align=\"left\">13</td><td align=\"left\">2 &#215; 200 mg</td><td align=\"left\">2 &#215; 3200 mg</td><td align=\"left\">no dialysis</td><td align=\"left\">0.7</td><td align=\"left\">508</td></tr><tr><td align=\"left\">3</td><td align=\"left\">4</td><td align=\"left\">2 &#215; 400 mg</td><td align=\"left\">2 &#215; 6400 mg</td><td align=\"left\">no dialysis</td><td align=\"left\">3.8</td><td align=\"left\">110</td></tr><tr><td align=\"left\">3</td><td align=\"left\">8</td><td align=\"left\">2 &#215; 400 mg</td><td align=\"left\">2 &#215; 6400 mg</td><td align=\"left\">before dialysis</td><td align=\"left\">5.1</td><td align=\"left\">314</td></tr><tr><td align=\"left\">3</td><td align=\"left\">10</td><td align=\"left\">2 &#215; 400 mg</td><td align=\"left\">2 &#215; 6400 mg</td><td align=\"left\">after dialysis</td><td align=\"left\">3.2</td><td align=\"left\">409</td></tr><tr><td align=\"left\">3</td><td align=\"left\">11</td><td align=\"left\">2 &#215; 400 mg</td><td align=\"left\">2 &#215; 6400 mg</td><td align=\"left\">after dialysis</td><td align=\"left\">2.6</td><td align=\"left\">200</td></tr><tr><td align=\"left\">4</td><td align=\"left\">1</td><td align=\"left\">2 &#215; 400 mg</td><td align=\"left\">2 &#215; 6400 mg</td><td align=\"left\">before dialysis</td><td align=\"left\">1.4</td><td align=\"left\">344</td></tr><tr><td align=\"left\">4</td><td align=\"left\">5</td><td align=\"left\">2 &#215; 200 mg</td><td align=\"left\">2 &#215; 3200 mg</td><td align=\"left\">before dialysis</td><td align=\"left\">0.3</td><td align=\"left\">271</td></tr><tr><td align=\"left\">4</td><td align=\"left\">7</td><td align=\"left\">2 &#215; 200 mg</td><td align=\"left\">2 &#215; 3200 mg</td><td align=\"left\">before dialysis</td><td align=\"left\">0.3</td><td align=\"left\">451</td></tr><tr><td align=\"left\">4</td><td align=\"left\">8</td><td align=\"left\">2 &#215; 200 mg</td><td align=\"left\">2 &#215; 3200 mg</td><td align=\"left\">after dialysis</td><td align=\"left\">0.3</td><td align=\"left\">483</td></tr><tr><td align=\"left\">4</td><td align=\"left\">9</td><td align=\"left\">2 &#215; 200 mg</td><td align=\"left\">2 &#215; 3200 mg</td><td align=\"left\">no dialysis</td><td align=\"left\">0.9</td><td align=\"left\">456</td></tr><tr><td align=\"left\">4</td><td align=\"left\">12</td><td align=\"left\">2 &#215; 200 mg</td><td align=\"left\">2 &#215; 3200 mg</td><td align=\"left\">after dialysis</td><td align=\"left\">1.1</td><td align=\"left\">505</td></tr><tr><td align=\"left\">4</td><td align=\"left\">13</td><td align=\"left\">2 &#215; 200 mg</td><td align=\"left\">2 &#215; 3200 mg</td><td align=\"left\">before dialysis</td><td align=\"left\">1.3</td><td align=\"left\">581</td></tr><tr><td align=\"left\">4</td><td align=\"left\">13</td><td align=\"left\">2 &#215; 200 mg</td><td align=\"left\">2 &#215; 3200 mg</td><td align=\"left\">after dialysis</td><td align=\"left\">0.9</td><td align=\"left\">563</td></tr></tbody></table></body></html>","text":"Pmid= 1592308:Table= Table 1","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":-1660267316,"_task_hash":-171667203,"_view_id":"review","accept":[5],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":null,"sessions":["tableclass-test-params-100-frank","tableclass-test-params-100-gill","tableclass-test-params-100-vicky"],"versions":[{"html":"<!DOCTYPE html><html><body><h1>Voriconazole (VOR) and sulphobutylether beta cyclodextrin sodium (SBECD) plasma levels in patients with intravenous voriconazole therapy and renal failure</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td align=\"left\">patient no.</td><td align=\"left\">day of VOR therapy</td><td align=\"left\">dose of intravenous VOR</td><td align=\"left\">dose of SBECD</td><td align=\"left\">dialysis information</td><td align=\"left\">VOR (&#956;g/ml)</td><td align=\"left\">SBECD (&#956;g/ml)</td></tr></thead><tbody><tr><td align=\"left\">1</td><td align=\"left\">2</td><td align=\"left\">2 &#215; 400 mg</td><td align=\"left\">2 &#215; 6400 mg</td><td align=\"left\">before dialysis</td><td align=\"left\">0.9</td><td align=\"left\">98.3</td></tr><tr><td align=\"left\">1</td><td align=\"left\">2</td><td align=\"left\">2 &#215; 200 mg</td><td align=\"left\">2 &#215; 3200 mg</td><td align=\"left\">after dialysis</td><td align=\"left\">1.1</td><td align=\"left\">145</td></tr><tr><td align=\"left\">1</td><td align=\"left\">3</td><td align=\"left\">2 &#215; 200 mg</td><td align=\"left\">2 &#215; 3200 mg</td><td align=\"left\">before dialysis</td><td align=\"left\">0.2</td><td align=\"left\">93.3</td></tr><tr><td align=\"left\">1</td><td align=\"left\">4</td><td align=\"left\">2 &#215; 200 mg</td><td align=\"left\">2 &#215; 3200 mg</td><td align=\"left\">after dialysis</td><td align=\"left\">&lt; 0.2</td><td align=\"left\">121</td></tr><tr><td align=\"left\">1</td><td align=\"left\">7</td><td align=\"left\">2 &#215; 200 mg</td><td align=\"left\">2 &#215; 3200 mg</td><td align=\"left\">after dialysis</td><td align=\"left\">0.4</td><td align=\"left\">78.9</td></tr><tr><td align=\"left\">1</td><td align=\"left\">8</td><td align=\"left\">2 &#215; 200 mg</td><td align=\"left\">2 &#215; 3200 mg</td><td align=\"left\">before dialysis</td><td align=\"left\">0.5</td><td align=\"left\">86.4</td></tr><tr><td align=\"left\">1</td><td align=\"left\">9</td><td align=\"left\">2 &#215; 200 mg</td><td align=\"left\">2 &#215; 3200 mg</td><td align=\"left\">before dialysis</td><td align=\"left\">0.4</td><td align=\"left\">59.6</td></tr><tr><td align=\"left\">1</td><td align=\"left\">9</td><td align=\"left\">2 &#215; 200 mg</td><td align=\"left\">2 &#215; 3200 mg</td><td align=\"left\">after dialysis</td><td align=\"left\">&lt; 0.2</td><td align=\"left\">31.4</td></tr><tr><td align=\"left\">1</td><td align=\"left\">10</td><td align=\"left\">2 &#215; 200 mg</td><td align=\"left\">2 &#215; 3200 mg</td><td align=\"left\">before dialysis</td><td align=\"left\">0.3</td><td align=\"left\">71.6</td></tr><tr><td align=\"left\">1</td><td align=\"left\">12</td><td align=\"left\">2 &#215; 200 mg</td><td align=\"left\">2 &#215; 3200 mg</td><td align=\"left\">no dialysis</td><td align=\"left\">&lt; 0.2</td><td align=\"left\">15.6</td></tr><tr><td align=\"left\">1</td><td align=\"left\">13</td><td align=\"left\">2 &#215; 200 mg</td><td align=\"left\">2 &#215; 3200 mg</td><td align=\"left\">no dialysis</td><td align=\"left\">&lt; 0.2</td><td align=\"left\">16.4</td></tr><tr><td align=\"left\">1</td><td align=\"left\">16</td><td align=\"left\">2 &#215; 200 mg</td><td align=\"left\">2 &#215; 3200 mg</td><td align=\"left\">no dialysis</td><td align=\"left\">&lt; 0.2</td><td align=\"left\">18.4</td></tr><tr><td align=\"left\">2</td><td align=\"left\">10</td><td align=\"left\">2 &#215; 200 mg</td><td align=\"left\">2 &#215; 3200 mg</td><td align=\"left\">before dialysis</td><td align=\"left\">0.4</td><td align=\"left\">523</td></tr><tr><td align=\"left\">2</td><td align=\"left\">11</td><td align=\"left\">2 &#215; 200 mg</td><td align=\"left\">2 &#215; 3200 mg</td><td align=\"left\">after dialysis</td><td align=\"left\">0.3</td><td align=\"left\">400</td></tr><tr><td align=\"left\">2</td><td align=\"left\">12</td><td align=\"left\">2 &#215; 200 mg</td><td align=\"left\">2 &#215; 3200 mg</td><td align=\"left\">no dialysis</td><td align=\"left\">0.3</td><td align=\"left\">348</td></tr><tr><td align=\"left\">2</td><td align=\"left\">13</td><td align=\"left\">2 &#215; 200 mg</td><td align=\"left\">2 &#215; 3200 mg</td><td align=\"left\">no dialysis</td><td align=\"left\">0.7</td><td align=\"left\">508</td></tr><tr><td align=\"left\">3</td><td align=\"left\">4</td><td align=\"left\">2 &#215; 400 mg</td><td align=\"left\">2 &#215; 6400 mg</td><td align=\"left\">no dialysis</td><td align=\"left\">3.8</td><td align=\"left\">110</td></tr><tr><td align=\"left\">3</td><td align=\"left\">8</td><td align=\"left\">2 &#215; 400 mg</td><td align=\"left\">2 &#215; 6400 mg</td><td align=\"left\">before dialysis</td><td align=\"left\">5.1</td><td align=\"left\">314</td></tr><tr><td align=\"left\">3</td><td align=\"left\">10</td><td align=\"left\">2 &#215; 400 mg</td><td align=\"left\">2 &#215; 6400 mg</td><td align=\"left\">after dialysis</td><td align=\"left\">3.2</td><td align=\"left\">409</td></tr><tr><td align=\"left\">3</td><td align=\"left\">11</td><td align=\"left\">2 &#215; 400 mg</td><td align=\"left\">2 &#215; 6400 mg</td><td align=\"left\">after dialysis</td><td align=\"left\">2.6</td><td align=\"left\">200</td></tr><tr><td align=\"left\">4</td><td align=\"left\">1</td><td align=\"left\">2 &#215; 400 mg</td><td align=\"left\">2 &#215; 6400 mg</td><td align=\"left\">before dialysis</td><td align=\"left\">1.4</td><td align=\"left\">344</td></tr><tr><td align=\"left\">4</td><td align=\"left\">5</td><td align=\"left\">2 &#215; 200 mg</td><td align=\"left\">2 &#215; 3200 mg</td><td align=\"left\">before dialysis</td><td align=\"left\">0.3</td><td align=\"left\">271</td></tr><tr><td align=\"left\">4</td><td align=\"left\">7</td><td align=\"left\">2 &#215; 200 mg</td><td align=\"left\">2 &#215; 3200 mg</td><td align=\"left\">before dialysis</td><td align=\"left\">0.3</td><td align=\"left\">451</td></tr><tr><td align=\"left\">4</td><td align=\"left\">8</td><td align=\"left\">2 &#215; 200 mg</td><td align=\"left\">2 &#215; 3200 mg</td><td align=\"left\">after dialysis</td><td align=\"left\">0.3</td><td align=\"left\">483</td></tr><tr><td align=\"left\">4</td><td align=\"left\">9</td><td align=\"left\">2 &#215; 200 mg</td><td align=\"left\">2 &#215; 3200 mg</td><td align=\"left\">no dialysis</td><td align=\"left\">0.9</td><td align=\"left\">456</td></tr><tr><td align=\"left\">4</td><td align=\"left\">12</td><td align=\"left\">2 &#215; 200 mg</td><td align=\"left\">2 &#215; 3200 mg</td><td align=\"left\">after dialysis</td><td align=\"left\">1.1</td><td align=\"left\">505</td></tr><tr><td align=\"left\">4</td><td align=\"left\">13</td><td align=\"left\">2 &#215; 200 mg</td><td align=\"left\">2 &#215; 3200 mg</td><td align=\"left\">before dialysis</td><td align=\"left\">1.3</td><td align=\"left\">581</td></tr><tr><td align=\"left\">4</td><td align=\"left\">13</td><td align=\"left\">2 &#215; 200 mg</td><td align=\"left\">2 &#215; 3200 mg</td><td align=\"left\">after dialysis</td><td align=\"left\">0.9</td><td align=\"left\">563</td></tr></tbody></table></body></html>","text":"Pmid= 1592308:Table= Table 1","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":-1660267316,"_task_hash":-171667203,"_view_id":"choice","accept":[5],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":"tableclass-test-params-100-gill","sessions":["tableclass-test-params-100-frank","tableclass-test-params-100-gill","tableclass-test-params-100-vicky"],"default":true},{"html":"<!DOCTYPE html><html><body><h1>Voriconazole (VOR) and sulphobutylether beta cyclodextrin sodium (SBECD) plasma levels in patients with intravenous voriconazole therapy and renal failure</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td align=\"left\">patient no.</td><td align=\"left\">day of VOR therapy</td><td align=\"left\">dose of intravenous VOR</td><td align=\"left\">dose of SBECD</td><td align=\"left\">dialysis information</td><td align=\"left\">VOR (&#956;g/ml)</td><td align=\"left\">SBECD (&#956;g/ml)</td></tr></thead><tbody><tr><td align=\"left\">1</td><td align=\"left\">2</td><td align=\"left\">2 &#215; 400 mg</td><td align=\"left\">2 &#215; 6400 mg</td><td align=\"left\">before dialysis</td><td align=\"left\">0.9</td><td align=\"left\">98.3</td></tr><tr><td align=\"left\">1</td><td align=\"left\">2</td><td align=\"left\">2 &#215; 200 mg</td><td align=\"left\">2 &#215; 3200 mg</td><td align=\"left\">after dialysis</td><td align=\"left\">1.1</td><td align=\"left\">145</td></tr><tr><td align=\"left\">1</td><td align=\"left\">3</td><td align=\"left\">2 &#215; 200 mg</td><td align=\"left\">2 &#215; 3200 mg</td><td align=\"left\">before dialysis</td><td align=\"left\">0.2</td><td align=\"left\">93.3</td></tr><tr><td align=\"left\">1</td><td align=\"left\">4</td><td align=\"left\">2 &#215; 200 mg</td><td align=\"left\">2 &#215; 3200 mg</td><td align=\"left\">after dialysis</td><td align=\"left\">&lt; 0.2</td><td align=\"left\">121</td></tr><tr><td align=\"left\">1</td><td align=\"left\">7</td><td align=\"left\">2 &#215; 200 mg</td><td align=\"left\">2 &#215; 3200 mg</td><td align=\"left\">after dialysis</td><td align=\"left\">0.4</td><td align=\"left\">78.9</td></tr><tr><td align=\"left\">1</td><td align=\"left\">8</td><td align=\"left\">2 &#215; 200 mg</td><td align=\"left\">2 &#215; 3200 mg</td><td align=\"left\">before dialysis</td><td align=\"left\">0.5</td><td align=\"left\">86.4</td></tr><tr><td align=\"left\">1</td><td align=\"left\">9</td><td align=\"left\">2 &#215; 200 mg</td><td align=\"left\">2 &#215; 3200 mg</td><td align=\"left\">before dialysis</td><td align=\"left\">0.4</td><td align=\"left\">59.6</td></tr><tr><td align=\"left\">1</td><td align=\"left\">9</td><td align=\"left\">2 &#215; 200 mg</td><td align=\"left\">2 &#215; 3200 mg</td><td align=\"left\">after dialysis</td><td align=\"left\">&lt; 0.2</td><td align=\"left\">31.4</td></tr><tr><td align=\"left\">1</td><td align=\"left\">10</td><td align=\"left\">2 &#215; 200 mg</td><td align=\"left\">2 &#215; 3200 mg</td><td align=\"left\">before dialysis</td><td align=\"left\">0.3</td><td align=\"left\">71.6</td></tr><tr><td align=\"left\">1</td><td align=\"left\">12</td><td align=\"left\">2 &#215; 200 mg</td><td align=\"left\">2 &#215; 3200 mg</td><td align=\"left\">no dialysis</td><td align=\"left\">&lt; 0.2</td><td align=\"left\">15.6</td></tr><tr><td align=\"left\">1</td><td align=\"left\">13</td><td align=\"left\">2 &#215; 200 mg</td><td align=\"left\">2 &#215; 3200 mg</td><td align=\"left\">no dialysis</td><td align=\"left\">&lt; 0.2</td><td align=\"left\">16.4</td></tr><tr><td align=\"left\">1</td><td align=\"left\">16</td><td align=\"left\">2 &#215; 200 mg</td><td align=\"left\">2 &#215; 3200 mg</td><td align=\"left\">no dialysis</td><td align=\"left\">&lt; 0.2</td><td align=\"left\">18.4</td></tr><tr><td align=\"left\">2</td><td align=\"left\">10</td><td align=\"left\">2 &#215; 200 mg</td><td align=\"left\">2 &#215; 3200 mg</td><td align=\"left\">before dialysis</td><td align=\"left\">0.4</td><td align=\"left\">523</td></tr><tr><td align=\"left\">2</td><td align=\"left\">11</td><td align=\"left\">2 &#215; 200 mg</td><td align=\"left\">2 &#215; 3200 mg</td><td align=\"left\">after dialysis</td><td align=\"left\">0.3</td><td align=\"left\">400</td></tr><tr><td align=\"left\">2</td><td align=\"left\">12</td><td align=\"left\">2 &#215; 200 mg</td><td align=\"left\">2 &#215; 3200 mg</td><td align=\"left\">no dialysis</td><td align=\"left\">0.3</td><td align=\"left\">348</td></tr><tr><td align=\"left\">2</td><td align=\"left\">13</td><td align=\"left\">2 &#215; 200 mg</td><td align=\"left\">2 &#215; 3200 mg</td><td align=\"left\">no dialysis</td><td align=\"left\">0.7</td><td align=\"left\">508</td></tr><tr><td align=\"left\">3</td><td align=\"left\">4</td><td align=\"left\">2 &#215; 400 mg</td><td align=\"left\">2 &#215; 6400 mg</td><td align=\"left\">no dialysis</td><td align=\"left\">3.8</td><td align=\"left\">110</td></tr><tr><td align=\"left\">3</td><td align=\"left\">8</td><td align=\"left\">2 &#215; 400 mg</td><td align=\"left\">2 &#215; 6400 mg</td><td align=\"left\">before dialysis</td><td align=\"left\">5.1</td><td align=\"left\">314</td></tr><tr><td align=\"left\">3</td><td align=\"left\">10</td><td align=\"left\">2 &#215; 400 mg</td><td align=\"left\">2 &#215; 6400 mg</td><td align=\"left\">after dialysis</td><td align=\"left\">3.2</td><td align=\"left\">409</td></tr><tr><td align=\"left\">3</td><td align=\"left\">11</td><td align=\"left\">2 &#215; 400 mg</td><td align=\"left\">2 &#215; 6400 mg</td><td align=\"left\">after dialysis</td><td align=\"left\">2.6</td><td align=\"left\">200</td></tr><tr><td align=\"left\">4</td><td align=\"left\">1</td><td align=\"left\">2 &#215; 400 mg</td><td align=\"left\">2 &#215; 6400 mg</td><td align=\"left\">before dialysis</td><td align=\"left\">1.4</td><td align=\"left\">344</td></tr><tr><td align=\"left\">4</td><td align=\"left\">5</td><td align=\"left\">2 &#215; 200 mg</td><td align=\"left\">2 &#215; 3200 mg</td><td align=\"left\">before dialysis</td><td align=\"left\">0.3</td><td align=\"left\">271</td></tr><tr><td align=\"left\">4</td><td align=\"left\">7</td><td align=\"left\">2 &#215; 200 mg</td><td align=\"left\">2 &#215; 3200 mg</td><td align=\"left\">before dialysis</td><td align=\"left\">0.3</td><td align=\"left\">451</td></tr><tr><td align=\"left\">4</td><td align=\"left\">8</td><td align=\"left\">2 &#215; 200 mg</td><td align=\"left\">2 &#215; 3200 mg</td><td align=\"left\">after dialysis</td><td align=\"left\">0.3</td><td align=\"left\">483</td></tr><tr><td align=\"left\">4</td><td align=\"left\">9</td><td align=\"left\">2 &#215; 200 mg</td><td align=\"left\">2 &#215; 3200 mg</td><td align=\"left\">no dialysis</td><td align=\"left\">0.9</td><td align=\"left\">456</td></tr><tr><td align=\"left\">4</td><td align=\"left\">12</td><td align=\"left\">2 &#215; 200 mg</td><td align=\"left\">2 &#215; 3200 mg</td><td align=\"left\">after dialysis</td><td align=\"left\">1.1</td><td align=\"left\">505</td></tr><tr><td align=\"left\">4</td><td align=\"left\">13</td><td align=\"left\">2 &#215; 200 mg</td><td align=\"left\">2 &#215; 3200 mg</td><td align=\"left\">before dialysis</td><td align=\"left\">1.3</td><td align=\"left\">581</td></tr><tr><td align=\"left\">4</td><td align=\"left\">13</td><td align=\"left\">2 &#215; 200 mg</td><td align=\"left\">2 &#215; 3200 mg</td><td align=\"left\">after dialysis</td><td align=\"left\">0.9</td><td align=\"left\">563</td></tr></tbody></table></body></html>","text":"Pmid= 1592308:Table= Table 1","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":-1660267316,"_task_hash":173100658,"_view_id":"choice","accept":[1],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":"tableclass-test-params-100-joe","sessions":["tableclass-test-params-100-joe"],"default":false}],"view_id":"choice"}
{"html":"<!DOCTYPE html><html><body><h1>Liver function tests in patients with renal failure at start and end of intravenous voriconazole therapy</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td/><td align=\"center\" colspan=\"2\">ASAT (IU/l)<sup><italic>a</italic></sup></td><td align=\"center\" colspan=\"2\">&#947;-GT (IU/l)<sup><italic>b</italic></sup></td><td align=\"center\" colspan=\"2\">Total bilirubin (mg/dl)<sup><italic>c</italic></sup></td></tr></thead><tbody><tr><td/><td align=\"center\">start</td><td align=\"center\">end</td><td align=\"center\">start</td><td align=\"center\">end</td><td align=\"center\">start</td><td align=\"center\">end</td></tr><tr><td colspan=\"7\"><hr/></td></tr><tr><td align=\"left\">patient no. 1</td><td align=\"center\">104</td><td align=\"center\">24</td><td align=\"center\">119</td><td align=\"center\">264</td><td align=\"center\">2.32</td><td align=\"center\">1.39</td></tr><tr><td align=\"left\">patient no. 2</td><td align=\"center\">100</td><td align=\"center\">26</td><td align=\"center\">93</td><td align=\"center\">71</td><td align=\"center\">0.83</td><td align=\"center\">0.32</td></tr><tr><td align=\"left\">patient no. 3</td><td align=\"center\">54</td><td align=\"center\">25</td><td align=\"center\">288</td><td align=\"center\">443</td><td align=\"center\">4.93</td><td align=\"center\">7.27</td></tr><tr><td align=\"left\">patient no. 4</td><td align=\"center\">30</td><td align=\"center\">22</td><td align=\"center\">238</td><td align=\"center\">216</td><td align=\"center\">3.29</td><td align=\"center\">1.34</td></tr></tbody></table></body></html>","text":"Pmid= 1592308:Table= Table 2","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":1521292461,"_task_hash":-878103451,"_view_id":"review","accept":[5],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":null,"sessions":["tableclass-test-params-100-frank","tableclass-test-params-100-gill","tableclass-test-params-100-joe","tableclass-test-params-100-vicky"],"versions":[{"html":"<!DOCTYPE html><html><body><h1>Liver function tests in patients with renal failure at start and end of intravenous voriconazole therapy</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td/><td align=\"center\" colspan=\"2\">ASAT (IU/l)<sup><italic>a</italic></sup></td><td align=\"center\" colspan=\"2\">&#947;-GT (IU/l)<sup><italic>b</italic></sup></td><td align=\"center\" colspan=\"2\">Total bilirubin (mg/dl)<sup><italic>c</italic></sup></td></tr></thead><tbody><tr><td/><td align=\"center\">start</td><td align=\"center\">end</td><td align=\"center\">start</td><td align=\"center\">end</td><td align=\"center\">start</td><td align=\"center\">end</td></tr><tr><td colspan=\"7\"><hr/></td></tr><tr><td align=\"left\">patient no. 1</td><td align=\"center\">104</td><td align=\"center\">24</td><td align=\"center\">119</td><td align=\"center\">264</td><td align=\"center\">2.32</td><td align=\"center\">1.39</td></tr><tr><td align=\"left\">patient no. 2</td><td align=\"center\">100</td><td align=\"center\">26</td><td align=\"center\">93</td><td align=\"center\">71</td><td align=\"center\">0.83</td><td align=\"center\">0.32</td></tr><tr><td align=\"left\">patient no. 3</td><td align=\"center\">54</td><td align=\"center\">25</td><td align=\"center\">288</td><td align=\"center\">443</td><td align=\"center\">4.93</td><td align=\"center\">7.27</td></tr><tr><td align=\"left\">patient no. 4</td><td align=\"center\">30</td><td align=\"center\">22</td><td align=\"center\">238</td><td align=\"center\">216</td><td align=\"center\">3.29</td><td align=\"center\">1.34</td></tr></tbody></table></body></html>","text":"Pmid= 1592308:Table= Table 2","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":1521292461,"_task_hash":-878103451,"_view_id":"choice","accept":[5],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":"tableclass-test-params-100-gill","sessions":["tableclass-test-params-100-frank","tableclass-test-params-100-gill","tableclass-test-params-100-joe","tableclass-test-params-100-vicky"],"default":true}],"view_id":"choice"}
{"html":"<!DOCTYPE html><html><body><h1>Comparison of BDI and HADS scores</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td/><td align=\"left\"><bold>Before treatment</bold></td><td align=\"left\"><bold>After treatment</bold></td><td align=\"left\"><bold>Sig.</bold></td></tr></thead><tbody><tr><td align=\"left\"><bold>BDI</bold></td><td align=\"left\">12.11 (&#177; 7.50)</td><td align=\"left\">12.80 (&#177; 7.64)</td><td align=\"left\">&lt; 0.001</td></tr><tr><td align=\"left\"><bold>HADS-D</bold></td><td align=\"left\">4.04 (&#177; 2.52)</td><td align=\"left\">4.61 (&#177; 3.19)</td><td align=\"left\">0.005</td></tr><tr><td align=\"left\"><bold>HADS-A</bold></td><td align=\"left\">6.24 (&#177; 3.17)</td><td align=\"left\">6.60 (&#177; 3.06)</td><td align=\"left\">0.061</td></tr></tbody></table></body></html>","text":"Pmid= 1622749:Table= Table 1","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":-1779524715,"_task_hash":-1159389101,"_view_id":"review","accept":[5],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":null,"sessions":["tableclass-test-params-100-frank","tableclass-test-params-100-gill","tableclass-test-params-100-vicky"],"versions":[{"html":"<!DOCTYPE html><html><body><h1>Comparison of BDI and HADS scores</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td/><td align=\"left\"><bold>Before treatment</bold></td><td align=\"left\"><bold>After treatment</bold></td><td align=\"left\"><bold>Sig.</bold></td></tr></thead><tbody><tr><td align=\"left\"><bold>BDI</bold></td><td align=\"left\">12.11 (&#177; 7.50)</td><td align=\"left\">12.80 (&#177; 7.64)</td><td align=\"left\">&lt; 0.001</td></tr><tr><td align=\"left\"><bold>HADS-D</bold></td><td align=\"left\">4.04 (&#177; 2.52)</td><td align=\"left\">4.61 (&#177; 3.19)</td><td align=\"left\">0.005</td></tr><tr><td align=\"left\"><bold>HADS-A</bold></td><td align=\"left\">6.24 (&#177; 3.17)</td><td align=\"left\">6.60 (&#177; 3.06)</td><td align=\"left\">0.061</td></tr></tbody></table></body></html>","text":"Pmid= 1622749:Table= Table 1","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":-1779524715,"_task_hash":-1159389101,"_view_id":"choice","accept":[5],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":"tableclass-test-params-100-gill","sessions":["tableclass-test-params-100-frank","tableclass-test-params-100-gill","tableclass-test-params-100-vicky"],"default":true},{"html":"<!DOCTYPE html><html><body><h1>Comparison of BDI and HADS scores</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td/><td align=\"left\"><bold>Before treatment</bold></td><td align=\"left\"><bold>After treatment</bold></td><td align=\"left\"><bold>Sig.</bold></td></tr></thead><tbody><tr><td align=\"left\"><bold>BDI</bold></td><td align=\"left\">12.11 (&#177; 7.50)</td><td align=\"left\">12.80 (&#177; 7.64)</td><td align=\"left\">&lt; 0.001</td></tr><tr><td align=\"left\"><bold>HADS-D</bold></td><td align=\"left\">4.04 (&#177; 2.52)</td><td align=\"left\">4.61 (&#177; 3.19)</td><td align=\"left\">0.005</td></tr><tr><td align=\"left\"><bold>HADS-A</bold></td><td align=\"left\">6.24 (&#177; 3.17)</td><td align=\"left\">6.60 (&#177; 3.06)</td><td align=\"left\">0.061</td></tr></tbody></table></body></html>","text":"Pmid= 1622749:Table= Table 1","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":-1779524715,"_task_hash":-592825637,"_view_id":"choice","accept":[4],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":"tableclass-test-params-100-joe","sessions":["tableclass-test-params-100-joe"],"default":false}],"view_id":"choice"}
{"html":"<!DOCTYPE html><html><body><h1>Individuals in different depression categories measured by BDI and HADS-A</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td align=\"left\"><bold>Depression categories</bold></td><td align=\"left\"><bold>N</bold></td><td align=\"left\"><bold>Percent</bold></td><td align=\"left\"><bold>Mean (&#177; SD)</bold></td></tr></thead><tbody><tr><td align=\"left\"><bold>Normal</bold></td><td align=\"left\">60</td><td align=\"left\">46.9</td><td align=\"left\">6.47 (&#177; 2.14)</td></tr><tr><td align=\"left\"><bold>Minimal depressive</bold></td><td align=\"left\">40</td><td align=\"left\">31.3</td><td align=\"left\">12.20 (&#177; 1.70)</td></tr><tr><td align=\"left\"><bold>symptoms</bold></td><td align=\"left\">23</td><td align=\"left\">18.0</td><td align=\"left\">22.26 (&#177; 4.25)</td></tr><tr><td align=\"left\"><bold>Mild depression</bold></td><td align=\"left\">5</td><td align=\"left\">3.9</td><td align=\"left\">32.60 (&#177; 0.55)</td></tr><tr><td align=\"left\"><bold>Moderate depression</bold></td><td align=\"left\">0</td><td align=\"left\">0</td><td/></tr><tr><td align=\"left\"><bold>Severe depression</bold></td><td align=\"left\">0</td><td align=\"left\">0</td><td/></tr><tr><td colspan=\"4\"><hr/></td></tr><tr><td align=\"left\"><bold>Anxiety categories</bold></td><td align=\"left\"><bold>N</bold></td><td align=\"left\"><bold>Percent</bold></td><td align=\"left\"><bold>Mean (&#177; SD)</bold></td></tr><tr><td colspan=\"4\"><hr/></td></tr><tr><td align=\"left\"><bold>Normal</bold></td><td align=\"left\">78</td><td align=\"left\">60.9</td><td align=\"left\">3.99 (&#177; 2.14)</td></tr><tr><td align=\"left\"><bold>Mild anxiety</bold></td><td align=\"left\">37</td><td align=\"left\">28.9</td><td align=\"left\">8.95 (&#177; 0.78)</td></tr><tr><td align=\"left\"><bold>Moderate anxiety</bold></td><td align=\"left\">13</td><td align=\"left\">10.2</td><td align=\"left\">12.08 (&#177; 0.95)</td></tr><tr><td align=\"left\"><bold>Sever anxiety</bold></td><td align=\"left\">0</td><td align=\"left\">0</td><td/></tr></tbody></table></body></html>","text":"Pmid= 1622749:Table= Table 2","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":1879528218,"_task_hash":-463038262,"_view_id":"review","accept":[5],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":null,"sessions":["tableclass-test-params-100-frank","tableclass-test-params-100-gill","tableclass-test-params-100-joe","tableclass-test-params-100-vicky"],"versions":[{"html":"<!DOCTYPE html><html><body><h1>Individuals in different depression categories measured by BDI and HADS-A</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td align=\"left\"><bold>Depression categories</bold></td><td align=\"left\"><bold>N</bold></td><td align=\"left\"><bold>Percent</bold></td><td align=\"left\"><bold>Mean (&#177; SD)</bold></td></tr></thead><tbody><tr><td align=\"left\"><bold>Normal</bold></td><td align=\"left\">60</td><td align=\"left\">46.9</td><td align=\"left\">6.47 (&#177; 2.14)</td></tr><tr><td align=\"left\"><bold>Minimal depressive</bold></td><td align=\"left\">40</td><td align=\"left\">31.3</td><td align=\"left\">12.20 (&#177; 1.70)</td></tr><tr><td align=\"left\"><bold>symptoms</bold></td><td align=\"left\">23</td><td align=\"left\">18.0</td><td align=\"left\">22.26 (&#177; 4.25)</td></tr><tr><td align=\"left\"><bold>Mild depression</bold></td><td align=\"left\">5</td><td align=\"left\">3.9</td><td align=\"left\">32.60 (&#177; 0.55)</td></tr><tr><td align=\"left\"><bold>Moderate depression</bold></td><td align=\"left\">0</td><td align=\"left\">0</td><td/></tr><tr><td align=\"left\"><bold>Severe depression</bold></td><td align=\"left\">0</td><td align=\"left\">0</td><td/></tr><tr><td colspan=\"4\"><hr/></td></tr><tr><td align=\"left\"><bold>Anxiety categories</bold></td><td align=\"left\"><bold>N</bold></td><td align=\"left\"><bold>Percent</bold></td><td align=\"left\"><bold>Mean (&#177; SD)</bold></td></tr><tr><td colspan=\"4\"><hr/></td></tr><tr><td align=\"left\"><bold>Normal</bold></td><td align=\"left\">78</td><td align=\"left\">60.9</td><td align=\"left\">3.99 (&#177; 2.14)</td></tr><tr><td align=\"left\"><bold>Mild anxiety</bold></td><td align=\"left\">37</td><td align=\"left\">28.9</td><td align=\"left\">8.95 (&#177; 0.78)</td></tr><tr><td align=\"left\"><bold>Moderate anxiety</bold></td><td align=\"left\">13</td><td align=\"left\">10.2</td><td align=\"left\">12.08 (&#177; 0.95)</td></tr><tr><td align=\"left\"><bold>Sever anxiety</bold></td><td align=\"left\">0</td><td align=\"left\">0</td><td/></tr></tbody></table></body></html>","text":"Pmid= 1622749:Table= Table 2","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":1879528218,"_task_hash":-463038262,"_view_id":"choice","accept":[5],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":"tableclass-test-params-100-gill","sessions":["tableclass-test-params-100-frank","tableclass-test-params-100-gill","tableclass-test-params-100-joe","tableclass-test-params-100-vicky"],"default":true}],"view_id":"choice"}
{"html":"<!DOCTYPE html><html><body><h1>Scores compared between two groups of libido loss positive and negative patients</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td/><td align=\"left\"><bold>Sig.</bold></td></tr></thead><tbody><tr><td align=\"left\">BDI Before treatment</td><td align=\"left\">0.73</td></tr><tr><td align=\"left\">HADS-D Before treatment</td><td align=\"left\">0.61</td></tr><tr><td align=\"left\">HADS-A Before treatment</td><td align=\"left\">0.42</td></tr><tr><td align=\"left\">BDI After treatment</td><td align=\"left\">0.94</td></tr><tr><td align=\"left\">HADS-D After treatment</td><td align=\"left\">0.45</td></tr><tr><td align=\"left\">HADS-A After treatment</td><td align=\"left\">0.30</td></tr></tbody></table></body></html>","text":"Pmid= 1622749:Table= Table 3","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":-614848219,"_task_hash":-1719138714,"_view_id":"review","config":{"choice_style":"multiple"},"accept":[5],"answer":"accept","_session_id":null,"sessions":["tableclass-test-params-100-frank","tableclass-test-params-100-gill","tableclass-test-params-100-vicky"],"versions":[{"html":"<!DOCTYPE html><html><body><h1>Scores compared between two groups of libido loss positive and negative patients</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td/><td align=\"left\"><bold>Sig.</bold></td></tr></thead><tbody><tr><td align=\"left\">BDI Before treatment</td><td align=\"left\">0.73</td></tr><tr><td align=\"left\">HADS-D Before treatment</td><td align=\"left\">0.61</td></tr><tr><td align=\"left\">HADS-A Before treatment</td><td align=\"left\">0.42</td></tr><tr><td align=\"left\">BDI After treatment</td><td align=\"left\">0.94</td></tr><tr><td align=\"left\">HADS-D After treatment</td><td align=\"left\">0.45</td></tr><tr><td align=\"left\">HADS-A After treatment</td><td align=\"left\">0.30</td></tr></tbody></table></body></html>","text":"Pmid= 1622749:Table= Table 3","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":-614848219,"_task_hash":-1719138714,"_view_id":"choice","config":{"choice_style":"multiple"},"accept":[5],"answer":"accept","_session_id":"tableclass-test-params-100-gill","sessions":["tableclass-test-params-100-frank","tableclass-test-params-100-gill","tableclass-test-params-100-vicky"],"default":true},{"html":"<!DOCTYPE html><html><body><h1>Scores compared between two groups of libido loss positive and negative patients</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td/><td align=\"left\"><bold>Sig.</bold></td></tr></thead><tbody><tr><td align=\"left\">BDI Before treatment</td><td align=\"left\">0.73</td></tr><tr><td align=\"left\">HADS-D Before treatment</td><td align=\"left\">0.61</td></tr><tr><td align=\"left\">HADS-A Before treatment</td><td align=\"left\">0.42</td></tr><tr><td align=\"left\">BDI After treatment</td><td align=\"left\">0.94</td></tr><tr><td align=\"left\">HADS-D After treatment</td><td align=\"left\">0.45</td></tr><tr><td align=\"left\">HADS-A After treatment</td><td align=\"left\">0.30</td></tr></tbody></table></body></html>","text":"Pmid= 1622749:Table= Table 3","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":-614848219,"_task_hash":-476687288,"_view_id":"choice","accept":[4],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":"tableclass-test-params-100-joe","sessions":["tableclass-test-params-100-joe"],"default":false}],"view_id":"choice"}
{"html":"<!DOCTYPE html><html><body><h1>Data on PMs and EMs in Gujratis and Marwadis</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td/><td/><td align=\"center\"><bold>Gujratis n = 122</bold></td><td align=\"center\"><bold>Marwadis n = 42</bold></td><td align=\"center\"><bold>Total N = 164</bold></td></tr></thead><tbody><tr><td align=\"center\"><bold>Males n = 109</bold></td><td align=\"center\"><bold>PM n = 12</bold></td><td align=\"center\">10 (12.98%)</td><td align=\"center\">2 (06.25%)</td><td align=\"center\">12 (11.00%)</td></tr><tr><td/><td align=\"center\"><bold>EM n = 97</bold></td><td align=\"center\">67 (87.02%)</td><td align=\"center\">30 (93.75%)</td><td align=\"center\">97 (89%)</td></tr><tr><td/><td align=\"center\"><bold>total</bold></td><td align=\"center\">77</td><td align=\"center\">32</td><td align=\"center\">109</td></tr><tr><td colspan=\"5\"><hr/></td></tr><tr><td align=\"center\"><bold>Females n = 55</bold></td><td align=\"center\"><bold>PM n = 5</bold></td><td align=\"center\">4 (08.88%)</td><td align=\"center\">1 (10.00%)</td><td align=\"center\">5 (09.09%)</td></tr><tr><td/><td align=\"center\"><bold>EM n = 50</bold></td><td align=\"center\">41 (91.12%)</td><td align=\"center\">9 (90.00%)</td><td align=\"center\">50 (91.91%)</td></tr><tr><td/><td align=\"center\"><bold>total</bold></td><td align=\"center\">45</td><td align=\"center\">10</td><td align=\"center\">55</td></tr></tbody></table></body></html>","text":"Pmid= 1630702:Table= Table 1","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":-1981011624,"_task_hash":1345887600,"_view_id":"review","accept":[5],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":null,"sessions":["tableclass-test-params-100-frank","tableclass-test-params-100-gill","tableclass-test-params-100-joe","tableclass-test-params-100-vicky"],"versions":[{"html":"<!DOCTYPE html><html><body><h1>Data on PMs and EMs in Gujratis and Marwadis</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td/><td/><td align=\"center\"><bold>Gujratis n = 122</bold></td><td align=\"center\"><bold>Marwadis n = 42</bold></td><td align=\"center\"><bold>Total N = 164</bold></td></tr></thead><tbody><tr><td align=\"center\"><bold>Males n = 109</bold></td><td align=\"center\"><bold>PM n = 12</bold></td><td align=\"center\">10 (12.98%)</td><td align=\"center\">2 (06.25%)</td><td align=\"center\">12 (11.00%)</td></tr><tr><td/><td align=\"center\"><bold>EM n = 97</bold></td><td align=\"center\">67 (87.02%)</td><td align=\"center\">30 (93.75%)</td><td align=\"center\">97 (89%)</td></tr><tr><td/><td align=\"center\"><bold>total</bold></td><td align=\"center\">77</td><td align=\"center\">32</td><td align=\"center\">109</td></tr><tr><td colspan=\"5\"><hr/></td></tr><tr><td align=\"center\"><bold>Females n = 55</bold></td><td align=\"center\"><bold>PM n = 5</bold></td><td align=\"center\">4 (08.88%)</td><td align=\"center\">1 (10.00%)</td><td align=\"center\">5 (09.09%)</td></tr><tr><td/><td align=\"center\"><bold>EM n = 50</bold></td><td align=\"center\">41 (91.12%)</td><td align=\"center\">9 (90.00%)</td><td align=\"center\">50 (91.91%)</td></tr><tr><td/><td align=\"center\"><bold>total</bold></td><td align=\"center\">45</td><td align=\"center\">10</td><td align=\"center\">55</td></tr></tbody></table></body></html>","text":"Pmid= 1630702:Table= Table 1","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":-1981011624,"_task_hash":1345887600,"_view_id":"choice","accept":[5],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":"tableclass-test-params-100-gill","sessions":["tableclass-test-params-100-frank","tableclass-test-params-100-gill","tableclass-test-params-100-joe","tableclass-test-params-100-vicky"],"default":true}],"view_id":"choice"}
{"html":"<!DOCTYPE html><html><body><h1>Model human adipose blood flow heterogeneity.</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td align=\"left\"><bold>Solute</bold></td><td align=\"left\"><bold>Ref</bold></td><td align=\"left\"><bold>Ave F l/kg/min</bold></td><td align=\"left\"><bold>F<sub>1 </sub>l/kg/min</bold></td><td align=\"left\"><bold>V<sub>1 </sub>fract</bold></td><td align=\"left\"><bold>F<sub>2 </sub>l/kg/min</bold></td><td align=\"left\"><bold>V<sub>2 </sub>fract</bold></td><td align=\"left\"><bold>F<sub>3 </sub>l/kg/min</bold></td><td align=\"left\"><bold>V<sub>2 </sub>fract</bold></td><td align=\"left\"><bold>Time</bold></td><td align=\"left\"><bold>Method</bold></td></tr></thead><tbody><tr><td align=\"left\"><bold>Volatile Anesthetics</bold></td><td align=\"left\">This ms.</td><td align=\"left\">0.044</td><td align=\"left\">0.0739</td><td align=\"left\">0.5</td><td align=\"left\">0.0141</td><td align=\"left\">0.5</td><td/><td/><td align=\"left\">6 days</td><td align=\"left\">PBPK N = 2</td></tr><tr><td/><td/><td align=\"left\">0.044</td><td align=\"left\">0.095</td><td align=\"left\">0.33</td><td align=\"left\">0.031</td><td align=\"left\">0.33</td><td align=\"left\">0.0059</td><td align=\"left\">0.33</td><td align=\"left\">6 days</td><td align=\"left\">PBPK N = 3</td></tr><tr><td/><td align=\"left\">[38]</td><td align=\"left\">0.071</td><td align=\"left\">0.213</td><td align=\"left\">.26</td><td align=\"left\">0.022</td><td align=\"left\">0.74</td><td/><td/><td align=\"left\">5 days</td><td align=\"left\">PBPK N = 2</td></tr><tr><td/><td/><td align=\"left\">0.05</td><td align=\"left\">0.097</td><td align=\"left\">.41</td><td align=\"left\">0.019</td><td align=\"left\">0.59</td><td/><td/><td/><td/></tr><tr><td/><td align=\"left\">[4, 5]</td><td align=\"left\">0.06&#8211;0.071</td><td align=\"left\">.11&#8211;.15</td><td align=\"left\">&#8776; 0.5</td><td align=\"left\">0.021&#8211;0.024</td><td align=\"left\">&#8776; 0.5</td><td/><td/><td align=\"left\">6 days</td><td align=\"left\">Compartmental</td></tr><tr><td align=\"left\"><bold>Propofol</bold></td><td align=\"left\">[14]</td><td align=\"left\">0.042</td><td align=\"left\">0.042</td><td align=\"left\">1.0</td><td/><td/><td/><td/><td align=\"left\">600 min</td><td align=\"left\">PBPK N = 1</td></tr><tr><td align=\"left\"><bold>Toluene</bold></td><td align=\"left\">[55]</td><td align=\"left\">0.032</td><td align=\"left\">0.032</td><td align=\"left\">1.0</td><td/><td/><td/><td/><td align=\"left\">4 days</td><td align=\"left\">PBPK N = 1</td></tr><tr><td align=\"left\"><bold>Toluene</bold></td><td align=\"left\">[53]</td><td align=\"left\">0.024</td><td align=\"left\">0.042</td><td align=\"left\">0.4</td><td align=\"left\">0.013</td><td align=\"left\">0.5</td><td align=\"left\">0.0</td><td align=\"left\">0.1</td><td align=\"left\">20 hr</td><td align=\"left\">PBPK N = 2</td></tr><tr><td align=\"left\"><bold>Styrene</bold></td><td align=\"left\">[54]</td><td align=\"left\">0.028</td><td align=\"left\">0.052</td><td align=\"left\">0.4</td><td align=\"left\">0.014</td><td align=\"left\">0.5</td><td align=\"left\">0.0</td><td align=\"left\">0.1</td><td align=\"left\">20 hr</td><td align=\"left\">PBPK N = 2</td></tr></tbody></table></body></html>","text":"Pmid= 1797001:Table= Table 1","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":1174904639,"_task_hash":1084720082,"_view_id":"review","accept":[4],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":null,"sessions":["tableclass-test-params-100-frank","tableclass-test-params-100-joe","tableclass-test-params-100-vicky"],"versions":[{"html":"<!DOCTYPE html><html><body><h1>Model human adipose blood flow heterogeneity.</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td align=\"left\"><bold>Solute</bold></td><td align=\"left\"><bold>Ref</bold></td><td align=\"left\"><bold>Ave F l/kg/min</bold></td><td align=\"left\"><bold>F<sub>1 </sub>l/kg/min</bold></td><td align=\"left\"><bold>V<sub>1 </sub>fract</bold></td><td align=\"left\"><bold>F<sub>2 </sub>l/kg/min</bold></td><td align=\"left\"><bold>V<sub>2 </sub>fract</bold></td><td align=\"left\"><bold>F<sub>3 </sub>l/kg/min</bold></td><td align=\"left\"><bold>V<sub>2 </sub>fract</bold></td><td align=\"left\"><bold>Time</bold></td><td align=\"left\"><bold>Method</bold></td></tr></thead><tbody><tr><td align=\"left\"><bold>Volatile Anesthetics</bold></td><td align=\"left\">This ms.</td><td align=\"left\">0.044</td><td align=\"left\">0.0739</td><td align=\"left\">0.5</td><td align=\"left\">0.0141</td><td align=\"left\">0.5</td><td/><td/><td align=\"left\">6 days</td><td align=\"left\">PBPK N = 2</td></tr><tr><td/><td/><td align=\"left\">0.044</td><td align=\"left\">0.095</td><td align=\"left\">0.33</td><td align=\"left\">0.031</td><td align=\"left\">0.33</td><td align=\"left\">0.0059</td><td align=\"left\">0.33</td><td align=\"left\">6 days</td><td align=\"left\">PBPK N = 3</td></tr><tr><td/><td align=\"left\">[38]</td><td align=\"left\">0.071</td><td align=\"left\">0.213</td><td align=\"left\">.26</td><td align=\"left\">0.022</td><td align=\"left\">0.74</td><td/><td/><td align=\"left\">5 days</td><td align=\"left\">PBPK N = 2</td></tr><tr><td/><td/><td align=\"left\">0.05</td><td align=\"left\">0.097</td><td align=\"left\">.41</td><td align=\"left\">0.019</td><td align=\"left\">0.59</td><td/><td/><td/><td/></tr><tr><td/><td align=\"left\">[4, 5]</td><td align=\"left\">0.06&#8211;0.071</td><td align=\"left\">.11&#8211;.15</td><td align=\"left\">&#8776; 0.5</td><td align=\"left\">0.021&#8211;0.024</td><td align=\"left\">&#8776; 0.5</td><td/><td/><td align=\"left\">6 days</td><td align=\"left\">Compartmental</td></tr><tr><td align=\"left\"><bold>Propofol</bold></td><td align=\"left\">[14]</td><td align=\"left\">0.042</td><td align=\"left\">0.042</td><td align=\"left\">1.0</td><td/><td/><td/><td/><td align=\"left\">600 min</td><td align=\"left\">PBPK N = 1</td></tr><tr><td align=\"left\"><bold>Toluene</bold></td><td align=\"left\">[55]</td><td align=\"left\">0.032</td><td align=\"left\">0.032</td><td align=\"left\">1.0</td><td/><td/><td/><td/><td align=\"left\">4 days</td><td align=\"left\">PBPK N = 1</td></tr><tr><td align=\"left\"><bold>Toluene</bold></td><td align=\"left\">[53]</td><td align=\"left\">0.024</td><td align=\"left\">0.042</td><td align=\"left\">0.4</td><td align=\"left\">0.013</td><td align=\"left\">0.5</td><td align=\"left\">0.0</td><td align=\"left\">0.1</td><td align=\"left\">20 hr</td><td align=\"left\">PBPK N = 2</td></tr><tr><td align=\"left\"><bold>Styrene</bold></td><td align=\"left\">[54]</td><td align=\"left\">0.028</td><td align=\"left\">0.052</td><td align=\"left\">0.4</td><td align=\"left\">0.014</td><td align=\"left\">0.5</td><td align=\"left\">0.0</td><td align=\"left\">0.1</td><td align=\"left\">20 hr</td><td align=\"left\">PBPK N = 2</td></tr></tbody></table></body></html>","text":"Pmid= 1797001:Table= Table 1","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":1174904639,"_task_hash":-1012232746,"_view_id":"choice","accept":[4,2],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":"tableclass-test-params-100-gill","sessions":["tableclass-test-params-100-gill"],"default":false},{"html":"<!DOCTYPE html><html><body><h1>Model human adipose blood flow heterogeneity.</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td align=\"left\"><bold>Solute</bold></td><td align=\"left\"><bold>Ref</bold></td><td align=\"left\"><bold>Ave F l/kg/min</bold></td><td align=\"left\"><bold>F<sub>1 </sub>l/kg/min</bold></td><td align=\"left\"><bold>V<sub>1 </sub>fract</bold></td><td align=\"left\"><bold>F<sub>2 </sub>l/kg/min</bold></td><td align=\"left\"><bold>V<sub>2 </sub>fract</bold></td><td align=\"left\"><bold>F<sub>3 </sub>l/kg/min</bold></td><td align=\"left\"><bold>V<sub>2 </sub>fract</bold></td><td align=\"left\"><bold>Time</bold></td><td align=\"left\"><bold>Method</bold></td></tr></thead><tbody><tr><td align=\"left\"><bold>Volatile Anesthetics</bold></td><td align=\"left\">This ms.</td><td align=\"left\">0.044</td><td align=\"left\">0.0739</td><td align=\"left\">0.5</td><td align=\"left\">0.0141</td><td align=\"left\">0.5</td><td/><td/><td align=\"left\">6 days</td><td align=\"left\">PBPK N = 2</td></tr><tr><td/><td/><td align=\"left\">0.044</td><td align=\"left\">0.095</td><td align=\"left\">0.33</td><td align=\"left\">0.031</td><td align=\"left\">0.33</td><td align=\"left\">0.0059</td><td align=\"left\">0.33</td><td align=\"left\">6 days</td><td align=\"left\">PBPK N = 3</td></tr><tr><td/><td align=\"left\">[38]</td><td align=\"left\">0.071</td><td align=\"left\">0.213</td><td align=\"left\">.26</td><td align=\"left\">0.022</td><td align=\"left\">0.74</td><td/><td/><td align=\"left\">5 days</td><td align=\"left\">PBPK N = 2</td></tr><tr><td/><td/><td align=\"left\">0.05</td><td align=\"left\">0.097</td><td align=\"left\">.41</td><td align=\"left\">0.019</td><td align=\"left\">0.59</td><td/><td/><td/><td/></tr><tr><td/><td align=\"left\">[4, 5]</td><td align=\"left\">0.06&#8211;0.071</td><td align=\"left\">.11&#8211;.15</td><td align=\"left\">&#8776; 0.5</td><td align=\"left\">0.021&#8211;0.024</td><td align=\"left\">&#8776; 0.5</td><td/><td/><td align=\"left\">6 days</td><td align=\"left\">Compartmental</td></tr><tr><td align=\"left\"><bold>Propofol</bold></td><td align=\"left\">[14]</td><td align=\"left\">0.042</td><td align=\"left\">0.042</td><td align=\"left\">1.0</td><td/><td/><td/><td/><td align=\"left\">600 min</td><td align=\"left\">PBPK N = 1</td></tr><tr><td align=\"left\"><bold>Toluene</bold></td><td align=\"left\">[55]</td><td align=\"left\">0.032</td><td align=\"left\">0.032</td><td align=\"left\">1.0</td><td/><td/><td/><td/><td align=\"left\">4 days</td><td align=\"left\">PBPK N = 1</td></tr><tr><td align=\"left\"><bold>Toluene</bold></td><td align=\"left\">[53]</td><td align=\"left\">0.024</td><td align=\"left\">0.042</td><td align=\"left\">0.4</td><td align=\"left\">0.013</td><td align=\"left\">0.5</td><td align=\"left\">0.0</td><td align=\"left\">0.1</td><td align=\"left\">20 hr</td><td align=\"left\">PBPK N = 2</td></tr><tr><td align=\"left\"><bold>Styrene</bold></td><td align=\"left\">[54]</td><td align=\"left\">0.028</td><td align=\"left\">0.052</td><td align=\"left\">0.4</td><td align=\"left\">0.014</td><td align=\"left\">0.5</td><td align=\"left\">0.0</td><td align=\"left\">0.1</td><td align=\"left\">20 hr</td><td align=\"left\">PBPK N = 2</td></tr></tbody></table></body></html>","text":"Pmid= 1797001:Table= Table 1","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":1174904639,"_task_hash":1084720082,"_view_id":"choice","accept":[4],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":"tableclass-test-params-100-frank","sessions":["tableclass-test-params-100-frank","tableclass-test-params-100-joe","tableclass-test-params-100-vicky"],"default":true}],"view_id":"choice"}
{"html":"<!DOCTYPE html><html><body><h1>Volatile anesthetic partition coefficients at 37\u00b0C.</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td align=\"left\"><bold>Solute</bold></td><td align=\"left\"><bold>Blood/air</bold></td><td align=\"left\"><bold>Water/air</bold></td><td align=\"left\"><bold>Oil/air</bold></td><td align=\"left\"><bold>Adipose/Blood</bold></td></tr></thead><tbody><tr><td align=\"left\"><bold>Isoflurane</bold></td><td align=\"left\">1.33 [56]</td><td align=\"left\">.544 [57]</td><td align=\"left\">88.2 [57]</td><td align=\"left\">53.2</td></tr><tr><td align=\"left\"><bold>Sevoflurane</bold></td><td align=\"left\">0.62 [58]</td><td align=\"left\">.37 [59]</td><td align=\"left\">47 [59]</td><td align=\"left\">60.8</td></tr><tr><td align=\"left\"><bold>Desflurane</bold></td><td align=\"left\">0.52 [58]</td><td align=\"left\">.225 [57]</td><td align=\"left\">17.9 [57]</td><td align=\"left\">27.7</td></tr></tbody></table></body></html>","text":"Pmid= 1797001:Table= Table 2","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":1814387217,"_task_hash":38893436,"_view_id":"review","accept":[4],"config":{"choice_style":"multiple"},"answer":"accept","user_input":"Assuming physchem params for PBPK","_session_id":null,"sessions":["tableclass-test-params-100-gill","tableclass-test-params-100-joe"],"versions":[{"html":"<!DOCTYPE html><html><body><h1>Volatile anesthetic partition coefficients at 37\u00b0C.</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td align=\"left\"><bold>Solute</bold></td><td align=\"left\"><bold>Blood/air</bold></td><td align=\"left\"><bold>Water/air</bold></td><td align=\"left\"><bold>Oil/air</bold></td><td align=\"left\"><bold>Adipose/Blood</bold></td></tr></thead><tbody><tr><td align=\"left\"><bold>Isoflurane</bold></td><td align=\"left\">1.33 [56]</td><td align=\"left\">.544 [57]</td><td align=\"left\">88.2 [57]</td><td align=\"left\">53.2</td></tr><tr><td align=\"left\"><bold>Sevoflurane</bold></td><td align=\"left\">0.62 [58]</td><td align=\"left\">.37 [59]</td><td align=\"left\">47 [59]</td><td align=\"left\">60.8</td></tr><tr><td align=\"left\"><bold>Desflurane</bold></td><td align=\"left\">0.52 [58]</td><td align=\"left\">.225 [57]</td><td align=\"left\">17.9 [57]</td><td align=\"left\">27.7</td></tr></tbody></table></body></html>","text":"Pmid= 1797001:Table= Table 2","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":1814387217,"_task_hash":38893436,"_view_id":"choice","accept":[4],"config":{"choice_style":"multiple"},"answer":"accept","user_input":"Assuming physchem params for PBPK","_session_id":"tableclass-test-params-100-gill","sessions":["tableclass-test-params-100-gill","tableclass-test-params-100-joe"],"default":true},{"html":"<!DOCTYPE html><html><body><h1>Volatile anesthetic partition coefficients at 37\u00b0C.</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td align=\"left\"><bold>Solute</bold></td><td align=\"left\"><bold>Blood/air</bold></td><td align=\"left\"><bold>Water/air</bold></td><td align=\"left\"><bold>Oil/air</bold></td><td align=\"left\"><bold>Adipose/Blood</bold></td></tr></thead><tbody><tr><td align=\"left\"><bold>Isoflurane</bold></td><td align=\"left\">1.33 [56]</td><td align=\"left\">.544 [57]</td><td align=\"left\">88.2 [57]</td><td align=\"left\">53.2</td></tr><tr><td align=\"left\"><bold>Sevoflurane</bold></td><td align=\"left\">0.62 [58]</td><td align=\"left\">.37 [59]</td><td align=\"left\">47 [59]</td><td align=\"left\">60.8</td></tr><tr><td align=\"left\"><bold>Desflurane</bold></td><td align=\"left\">0.52 [58]</td><td align=\"left\">.225 [57]</td><td align=\"left\">17.9 [57]</td><td align=\"left\">27.7</td></tr></tbody></table></body></html>","text":"Pmid= 1797001:Table= Table 2","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":1814387217,"_task_hash":1473766420,"_view_id":"choice","accept":[5],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":"tableclass-test-params-100-frank","sessions":["tableclass-test-params-100-frank","tableclass-test-params-100-vicky"],"default":false}],"view_id":"choice"}
{"html":"<!DOCTYPE html><html><body><h1>Physiological tissue model parameters</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td align=\"left\"><bold>Tissue</bold></td><td align=\"right\"><bold>Weight Kg</bold></td><td align=\"right\"><bold>Perfusion l/Kg/min</bold></td><td align=\"right\"><bold>Flow l/min</bold></td><td align=\"right\"><bold>Fat Fraction</bold></td><td align=\"right\"><bold>Total Fat Kg</bold></td></tr></thead><tbody><tr><td align=\"left\"><bold>Blood</bold></td><td align=\"right\">5.6</td><td/><td/><td align=\"right\">0.0075</td><td align=\"right\">0.042</td></tr><tr><td align=\"left\"><bold>Liver</bold></td><td align=\"right\">1.83</td><td align=\"right\">0.25</td><td align=\"right\">0.4575</td><td align=\"right\">0.02</td><td align=\"right\">0.0366</td></tr><tr><td align=\"left\"><bold>Portal</bold></td><td align=\"right\">1.525</td><td align=\"right\">0.75</td><td align=\"right\">1.14375</td><td align=\"right\">0.016</td><td align=\"right\">0.0244</td></tr><tr><td align=\"left\"><bold>Muscle</bold></td><td align=\"right\">26.43</td><td align=\"right\">0.0225</td><td align=\"right\">0.594675</td><td align=\"right\">0.0136</td><td align=\"right\">0.359448</td></tr><tr><td align=\"left\"><bold>Kidney</bold></td><td align=\"right\">0.3152</td><td align=\"right\">4</td><td align=\"right\">1.2608</td><td align=\"right\">0.0136</td><td align=\"right\">0.004287</td></tr><tr><td align=\"left\"><bold>Brain</bold></td><td align=\"right\">1.423</td><td align=\"right\">0.56</td><td align=\"right\">0.79688</td><td align=\"right\">0.0176</td><td align=\"right\">0.025045</td></tr><tr><td align=\"left\"><bold>Heart</bold></td><td align=\"right\">0.3355</td><td align=\"right\">0.8</td><td align=\"right\">0.2684</td><td align=\"right\">0.0136</td><td align=\"right\">0.004563</td></tr><tr><td align=\"left\"><bold>Lung</bold></td><td align=\"right\">0.5449</td><td align=\"right\">0</td><td align=\"right\">0</td><td align=\"right\">0.0136</td><td align=\"right\">0.007411</td></tr><tr><td align=\"left\"><bold>Skin</bold></td><td align=\"right\">2.643</td><td align=\"right\">0.1</td><td align=\"right\">0.2643</td><td align=\"right\">0.0136</td><td align=\"right\">0.035945</td></tr><tr><td align=\"left\"><bold>Tendon</bold></td><td align=\"right\">3.05</td><td align=\"right\">0.01</td><td align=\"right\">0.0305</td><td align=\"right\">0.0136</td><td align=\"right\">0.04148</td></tr><tr><td align=\"left\"><bold>Other</bold></td><td align=\"right\">5.616</td><td align=\"right\">0.02</td><td align=\"right\">0.11232</td><td align=\"right\">0.0136</td><td align=\"right\">0.076378</td></tr><tr><td align=\"left\"><bold>Bone</bold></td><td align=\"right\">4.0617</td><td align=\"right\">0</td><td align=\"right\">0</td><td align=\"right\">0</td><td align=\"right\">0</td></tr><tr><td align=\"left\"><bold>Adipose 1</bold></td><td align=\"right\">5.5419</td><td align=\"right\">0.095</td><td align=\"right\">0.5264805</td><td align=\"right\">0.8</td><td align=\"right\">4.43352</td></tr><tr><td align=\"left\"><bold>Adipose 2</bold></td><td align=\"right\">5.5419</td><td align=\"right\">0.031</td><td align=\"right\">0.1717989</td><td align=\"right\">0.8</td><td align=\"right\">4.43352</td></tr><tr><td align=\"left\"><bold>Adipose 3</bold></td><td align=\"right\">5.5419</td><td align=\"right\">0.0059</td><td align=\"right\">0.0326972</td><td align=\"right\">0.8</td><td align=\"right\">4.43352</td></tr><tr><td colspan=\"6\"><hr/></td></tr><tr><td align=\"left\"><bold>Total</bold></td><td align=\"right\">70</td><td/><td align=\"right\">5.6601016</td><td/><td align=\"right\">14</td></tr></tbody></table></body></html>","text":"Pmid= 1797001:Table= Table 3","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":-1584820666,"_task_hash":1149441944,"_view_id":"review","accept":[4],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":null,"sessions":["tableclass-test-params-100-frank","tableclass-test-params-100-gill","tableclass-test-params-100-joe","tableclass-test-params-100-vicky"],"versions":[{"html":"<!DOCTYPE html><html><body><h1>Physiological tissue model parameters</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td align=\"left\"><bold>Tissue</bold></td><td align=\"right\"><bold>Weight Kg</bold></td><td align=\"right\"><bold>Perfusion l/Kg/min</bold></td><td align=\"right\"><bold>Flow l/min</bold></td><td align=\"right\"><bold>Fat Fraction</bold></td><td align=\"right\"><bold>Total Fat Kg</bold></td></tr></thead><tbody><tr><td align=\"left\"><bold>Blood</bold></td><td align=\"right\">5.6</td><td/><td/><td align=\"right\">0.0075</td><td align=\"right\">0.042</td></tr><tr><td align=\"left\"><bold>Liver</bold></td><td align=\"right\">1.83</td><td align=\"right\">0.25</td><td align=\"right\">0.4575</td><td align=\"right\">0.02</td><td align=\"right\">0.0366</td></tr><tr><td align=\"left\"><bold>Portal</bold></td><td align=\"right\">1.525</td><td align=\"right\">0.75</td><td align=\"right\">1.14375</td><td align=\"right\">0.016</td><td align=\"right\">0.0244</td></tr><tr><td align=\"left\"><bold>Muscle</bold></td><td align=\"right\">26.43</td><td align=\"right\">0.0225</td><td align=\"right\">0.594675</td><td align=\"right\">0.0136</td><td align=\"right\">0.359448</td></tr><tr><td align=\"left\"><bold>Kidney</bold></td><td align=\"right\">0.3152</td><td align=\"right\">4</td><td align=\"right\">1.2608</td><td align=\"right\">0.0136</td><td align=\"right\">0.004287</td></tr><tr><td align=\"left\"><bold>Brain</bold></td><td align=\"right\">1.423</td><td align=\"right\">0.56</td><td align=\"right\">0.79688</td><td align=\"right\">0.0176</td><td align=\"right\">0.025045</td></tr><tr><td align=\"left\"><bold>Heart</bold></td><td align=\"right\">0.3355</td><td align=\"right\">0.8</td><td align=\"right\">0.2684</td><td align=\"right\">0.0136</td><td align=\"right\">0.004563</td></tr><tr><td align=\"left\"><bold>Lung</bold></td><td align=\"right\">0.5449</td><td align=\"right\">0</td><td align=\"right\">0</td><td align=\"right\">0.0136</td><td align=\"right\">0.007411</td></tr><tr><td align=\"left\"><bold>Skin</bold></td><td align=\"right\">2.643</td><td align=\"right\">0.1</td><td align=\"right\">0.2643</td><td align=\"right\">0.0136</td><td align=\"right\">0.035945</td></tr><tr><td align=\"left\"><bold>Tendon</bold></td><td align=\"right\">3.05</td><td align=\"right\">0.01</td><td align=\"right\">0.0305</td><td align=\"right\">0.0136</td><td align=\"right\">0.04148</td></tr><tr><td align=\"left\"><bold>Other</bold></td><td align=\"right\">5.616</td><td align=\"right\">0.02</td><td align=\"right\">0.11232</td><td align=\"right\">0.0136</td><td align=\"right\">0.076378</td></tr><tr><td align=\"left\"><bold>Bone</bold></td><td align=\"right\">4.0617</td><td align=\"right\">0</td><td align=\"right\">0</td><td align=\"right\">0</td><td align=\"right\">0</td></tr><tr><td align=\"left\"><bold>Adipose 1</bold></td><td align=\"right\">5.5419</td><td align=\"right\">0.095</td><td align=\"right\">0.5264805</td><td align=\"right\">0.8</td><td align=\"right\">4.43352</td></tr><tr><td align=\"left\"><bold>Adipose 2</bold></td><td align=\"right\">5.5419</td><td align=\"right\">0.031</td><td align=\"right\">0.1717989</td><td align=\"right\">0.8</td><td align=\"right\">4.43352</td></tr><tr><td align=\"left\"><bold>Adipose 3</bold></td><td align=\"right\">5.5419</td><td align=\"right\">0.0059</td><td align=\"right\">0.0326972</td><td align=\"right\">0.8</td><td align=\"right\">4.43352</td></tr><tr><td colspan=\"6\"><hr/></td></tr><tr><td align=\"left\"><bold>Total</bold></td><td align=\"right\">70</td><td/><td align=\"right\">5.6601016</td><td/><td align=\"right\">14</td></tr></tbody></table></body></html>","text":"Pmid= 1797001:Table= Table 3","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":-1584820666,"_task_hash":1149441944,"_view_id":"choice","accept":[4],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":"tableclass-test-params-100-gill","sessions":["tableclass-test-params-100-frank","tableclass-test-params-100-gill","tableclass-test-params-100-joe","tableclass-test-params-100-vicky"],"default":true}],"view_id":"choice"}
{"html":"<!DOCTYPE html><html><body><h1>Cannabinoid partition coefficients</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td align=\"left\"><bold>Solute</bold></td><td align=\"left\"><bold>Oil/Water</bold></td><td align=\"left\"><bold>Blood/water</bold></td><td align=\"left\"><bold>Adipose/Blood</bold></td></tr></thead><tbody><tr><td align=\"left\"><bold>Cannabinol</bold></td><td align=\"left\">257,000</td><td align=\"left\">1928</td><td align=\"left\">106.6</td></tr><tr><td align=\"left\"><bold>Cannibidiol</bold></td><td align=\"left\">24,000</td><td align=\"left\">181</td><td align=\"left\">106.1</td></tr></tbody></table></body></html>","text":"Pmid= 1797001:Table= Table 4","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":356281066,"_task_hash":289405320,"_view_id":"review","accept":[4],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":null,"sessions":["tableclass-test-params-100-frank","tableclass-test-params-100-gill","tableclass-test-params-100-joe"],"versions":[{"html":"<!DOCTYPE html><html><body><h1>Cannabinoid partition coefficients</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td align=\"left\"><bold>Solute</bold></td><td align=\"left\"><bold>Oil/Water</bold></td><td align=\"left\"><bold>Blood/water</bold></td><td align=\"left\"><bold>Adipose/Blood</bold></td></tr></thead><tbody><tr><td align=\"left\"><bold>Cannabinol</bold></td><td align=\"left\">257,000</td><td align=\"left\">1928</td><td align=\"left\">106.6</td></tr><tr><td align=\"left\"><bold>Cannibidiol</bold></td><td align=\"left\">24,000</td><td align=\"left\">181</td><td align=\"left\">106.1</td></tr></tbody></table></body></html>","text":"Pmid= 1797001:Table= Table 4","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":356281066,"_task_hash":289405320,"_view_id":"choice","accept":[4],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":"tableclass-test-params-100-gill","sessions":["tableclass-test-params-100-frank","tableclass-test-params-100-gill","tableclass-test-params-100-joe"],"default":true},{"html":"<!DOCTYPE html><html><body><h1>Cannabinoid partition coefficients</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td align=\"left\"><bold>Solute</bold></td><td align=\"left\"><bold>Oil/Water</bold></td><td align=\"left\"><bold>Blood/water</bold></td><td align=\"left\"><bold>Adipose/Blood</bold></td></tr></thead><tbody><tr><td align=\"left\"><bold>Cannabinol</bold></td><td align=\"left\">257,000</td><td align=\"left\">1928</td><td align=\"left\">106.6</td></tr><tr><td align=\"left\"><bold>Cannibidiol</bold></td><td align=\"left\">24,000</td><td align=\"left\">181</td><td align=\"left\">106.1</td></tr></tbody></table></body></html>","text":"Pmid= 1797001:Table= Table 4","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":356281066,"_task_hash":1847041729,"_view_id":"choice","accept":[5],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":"tableclass-test-params-100-vicky","sessions":["tableclass-test-params-100-vicky"],"default":false}],"view_id":"choice"}
{"html":"<!DOCTYPE html><html><body><h1>Weighted residual error (WRE), weighted residual sum of squares (WRSS) and Akaike number for each solute, adipose model and time period</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td align=\"left\"><bold>Solute</bold></td><td align=\"center\"><bold>Time period</bold></td><td align=\"center\"><bold>Data (# pts)</bold></td><td align=\"center\" colspan=\"3\"><bold>N = 1</bold></td><td align=\"center\" colspan=\"3\"><bold>N = 2</bold></td><td align=\"center\" colspan=\"3\"><bold>N = 3</bold></td></tr><tr><td/><td/><td/><td align=\"right\"><bold>WRE</bold></td><td align=\"right\"><bold>WRSS</bold></td><td align=\"right\"><bold>Akaike</bold></td><td align=\"right\"><bold>WRE</bold></td><td align=\"right\"><bold>WRSS</bold></td><td align=\"right\"><bold>Akaike</bold></td><td align=\"right\"><bold>WRE</bold></td><td align=\"right\"><bold>WRSS</bold></td><td align=\"right\"><bold>Akaike</bold></td></tr></thead><tbody><tr><td align=\"left\"><bold>Isoflurane_S</bold></td><td align=\"center\">1</td><td align=\"center\">45</td><td align=\"right\">0.062</td><td align=\"right\">0.329</td><td align=\"right\">-50.0264</td><td align=\"right\">0.0572</td><td align=\"right\">0.285</td><td align=\"right\">-54.487</td><td align=\"right\">0.0575</td><td align=\"right\">0.284</td><td align=\"right\">-52.6451</td></tr><tr><td/><td align=\"center\">2</td><td align=\"center\">5</td><td align=\"right\">0.41</td><td align=\"right\">1.004</td><td align=\"right\">0.01996</td><td align=\"right\">0.0224</td><td align=\"right\">0.329</td><td align=\"right\">-3.55849</td><td align=\"right\">0.169</td><td align=\"right\">0.182</td><td align=\"right\">-4.51874</td></tr><tr><td/><td align=\"center\">3</td><td align=\"center\">10</td><td align=\"right\">0.44</td><td align=\"right\">3.94</td><td align=\"right\">13.71181</td><td align=\"right\">0.12</td><td align=\"right\">0.24</td><td align=\"right\">-12.2712</td><td align=\"right\">0.125</td><td align=\"right\">0.226</td><td align=\"right\">-10.8722</td></tr><tr><td align=\"left\"><bold>Isoflurane_D</bold></td><td align=\"center\">1</td><td align=\"center\">45</td><td align=\"right\">0.047</td><td align=\"right\">0.186</td><td align=\"right\">-75.6904</td><td align=\"right\">0.0385</td><td align=\"right\">0.116</td><td align=\"right\">-94.9374</td><td align=\"right\">0.0375</td><td align=\"right\">0.11</td><td align=\"right\">-95.3274</td></tr><tr><td/><td align=\"center\">2</td><td align=\"center\">6</td><td align=\"right\">0.37</td><td align=\"right\">1.044</td><td align=\"right\">0.258357</td><td align=\"right\">0.189</td><td align=\"right\">0.285</td><td align=\"right\">-5.5316</td><td align=\"right\">0.131</td><td align=\"right\">0.14</td><td align=\"right\">-7.79668</td></tr><tr><td/><td align=\"center\">3</td><td align=\"center\">9</td><td align=\"right\">0.32</td><td align=\"right\">1.096</td><td align=\"right\">0.825005</td><td align=\"right\">0.127</td><td align=\"right\">0.248</td><td align=\"right\">-10.5489</td><td align=\"right\">0.119</td><td align=\"right\">0.16</td><td align=\"right\">-12.4932</td></tr><tr><td align=\"left\"><bold>Sevoflurane</bold></td><td align=\"center\">1</td><td align=\"center\">45</td><td align=\"right\">0.0729</td><td align=\"right\">0.386</td><td align=\"right\">-42.8363</td><td align=\"right\">0.0664</td><td align=\"right\">0.332</td><td align=\"right\">-47.6179</td><td align=\"right\">0.0648</td><td align=\"right\">0.32</td><td align=\"right\">-47.2745</td></tr><tr><td/><td align=\"center\">2</td><td align=\"center\">5</td><td align=\"right\">0.39</td><td align=\"right\">0.955</td><td align=\"right\">-0.23022</td><td align=\"right\">0.242</td><td align=\"right\">0.364</td><td align=\"right\">-3.05301</td><td align=\"right\">0.192</td><td align=\"right\">0.225</td><td align=\"right\">-3.45827</td></tr><tr><td/><td align=\"center\">3</td><td align=\"center\">10</td><td align=\"right\">0.36</td><td align=\"right\">1.657</td><td align=\"right\">5.050087</td><td align=\"right\">0.215</td><td align=\"right\">0.573</td><td align=\"right\">-3.5687</td><td align=\"right\">0.103</td><td align=\"right\">0.171</td><td align=\"right\">-13.6609</td></tr><tr><td align=\"left\"><bold>Desflurane</bold></td><td align=\"center\">1</td><td align=\"center\">45</td><td align=\"right\">0.0869</td><td align=\"right\">0.866</td><td align=\"right\">-6.47417</td><td align=\"right\">0.0586</td><td align=\"right\">0.32</td><td align=\"right\">-49.2745</td><td align=\"right\">0.0477</td><td align=\"right\">0.195</td><td align=\"right\">-69.564</td></tr><tr><td/><td align=\"center\">2</td><td align=\"center\">6</td><td align=\"right\">0.323</td><td align=\"right\">0.768</td><td align=\"right\">-1.58379</td><td align=\"right\">0.167</td><td align=\"right\">0.204</td><td align=\"right\">-7.53781</td><td align=\"right\">0.119</td><td align=\"right\">0.114</td><td align=\"right\">-9.02934</td></tr><tr><td/><td align=\"center\">3</td><td align=\"center\">9</td><td align=\"right\">5.08</td><td align=\"right\">1416</td><td align=\"right\">65.30032</td><td align=\"right\">0.196</td><td align=\"right\">0.641</td><td align=\"right\">-2.00253</td><td align=\"right\">0.139</td><td align=\"right\">0.338</td><td align=\"right\">-5.76238</td></tr></tbody></table></body></html>","text":"Pmid= 1797001:Table= Table 5","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":1074047687,"_task_hash":-1807370364,"_view_id":"review","accept":[5],"config":{"choice_style":"multiple"},"flagged":true,"user_input":"Interesting one - these are goodness of fit criteria for a PK or PKPD model - not parameters themselves.  Based on that I'm going to class as 5","answer":"accept","_session_id":null,"sessions":["tableclass-test-params-100-frank","tableclass-test-params-100-gill","tableclass-test-params-100-joe","tableclass-test-params-100-vicky"],"versions":[{"html":"<!DOCTYPE html><html><body><h1>Weighted residual error (WRE), weighted residual sum of squares (WRSS) and Akaike number for each solute, adipose model and time period</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td align=\"left\"><bold>Solute</bold></td><td align=\"center\"><bold>Time period</bold></td><td align=\"center\"><bold>Data (# pts)</bold></td><td align=\"center\" colspan=\"3\"><bold>N = 1</bold></td><td align=\"center\" colspan=\"3\"><bold>N = 2</bold></td><td align=\"center\" colspan=\"3\"><bold>N = 3</bold></td></tr><tr><td/><td/><td/><td align=\"right\"><bold>WRE</bold></td><td align=\"right\"><bold>WRSS</bold></td><td align=\"right\"><bold>Akaike</bold></td><td align=\"right\"><bold>WRE</bold></td><td align=\"right\"><bold>WRSS</bold></td><td align=\"right\"><bold>Akaike</bold></td><td align=\"right\"><bold>WRE</bold></td><td align=\"right\"><bold>WRSS</bold></td><td align=\"right\"><bold>Akaike</bold></td></tr></thead><tbody><tr><td align=\"left\"><bold>Isoflurane_S</bold></td><td align=\"center\">1</td><td align=\"center\">45</td><td align=\"right\">0.062</td><td align=\"right\">0.329</td><td align=\"right\">-50.0264</td><td align=\"right\">0.0572</td><td align=\"right\">0.285</td><td align=\"right\">-54.487</td><td align=\"right\">0.0575</td><td align=\"right\">0.284</td><td align=\"right\">-52.6451</td></tr><tr><td/><td align=\"center\">2</td><td align=\"center\">5</td><td align=\"right\">0.41</td><td align=\"right\">1.004</td><td align=\"right\">0.01996</td><td align=\"right\">0.0224</td><td align=\"right\">0.329</td><td align=\"right\">-3.55849</td><td align=\"right\">0.169</td><td align=\"right\">0.182</td><td align=\"right\">-4.51874</td></tr><tr><td/><td align=\"center\">3</td><td align=\"center\">10</td><td align=\"right\">0.44</td><td align=\"right\">3.94</td><td align=\"right\">13.71181</td><td align=\"right\">0.12</td><td align=\"right\">0.24</td><td align=\"right\">-12.2712</td><td align=\"right\">0.125</td><td align=\"right\">0.226</td><td align=\"right\">-10.8722</td></tr><tr><td align=\"left\"><bold>Isoflurane_D</bold></td><td align=\"center\">1</td><td align=\"center\">45</td><td align=\"right\">0.047</td><td align=\"right\">0.186</td><td align=\"right\">-75.6904</td><td align=\"right\">0.0385</td><td align=\"right\">0.116</td><td align=\"right\">-94.9374</td><td align=\"right\">0.0375</td><td align=\"right\">0.11</td><td align=\"right\">-95.3274</td></tr><tr><td/><td align=\"center\">2</td><td align=\"center\">6</td><td align=\"right\">0.37</td><td align=\"right\">1.044</td><td align=\"right\">0.258357</td><td align=\"right\">0.189</td><td align=\"right\">0.285</td><td align=\"right\">-5.5316</td><td align=\"right\">0.131</td><td align=\"right\">0.14</td><td align=\"right\">-7.79668</td></tr><tr><td/><td align=\"center\">3</td><td align=\"center\">9</td><td align=\"right\">0.32</td><td align=\"right\">1.096</td><td align=\"right\">0.825005</td><td align=\"right\">0.127</td><td align=\"right\">0.248</td><td align=\"right\">-10.5489</td><td align=\"right\">0.119</td><td align=\"right\">0.16</td><td align=\"right\">-12.4932</td></tr><tr><td align=\"left\"><bold>Sevoflurane</bold></td><td align=\"center\">1</td><td align=\"center\">45</td><td align=\"right\">0.0729</td><td align=\"right\">0.386</td><td align=\"right\">-42.8363</td><td align=\"right\">0.0664</td><td align=\"right\">0.332</td><td align=\"right\">-47.6179</td><td align=\"right\">0.0648</td><td align=\"right\">0.32</td><td align=\"right\">-47.2745</td></tr><tr><td/><td align=\"center\">2</td><td align=\"center\">5</td><td align=\"right\">0.39</td><td align=\"right\">0.955</td><td align=\"right\">-0.23022</td><td align=\"right\">0.242</td><td align=\"right\">0.364</td><td align=\"right\">-3.05301</td><td align=\"right\">0.192</td><td align=\"right\">0.225</td><td align=\"right\">-3.45827</td></tr><tr><td/><td align=\"center\">3</td><td align=\"center\">10</td><td align=\"right\">0.36</td><td align=\"right\">1.657</td><td align=\"right\">5.050087</td><td align=\"right\">0.215</td><td align=\"right\">0.573</td><td align=\"right\">-3.5687</td><td align=\"right\">0.103</td><td align=\"right\">0.171</td><td align=\"right\">-13.6609</td></tr><tr><td align=\"left\"><bold>Desflurane</bold></td><td align=\"center\">1</td><td align=\"center\">45</td><td align=\"right\">0.0869</td><td align=\"right\">0.866</td><td align=\"right\">-6.47417</td><td align=\"right\">0.0586</td><td align=\"right\">0.32</td><td align=\"right\">-49.2745</td><td align=\"right\">0.0477</td><td align=\"right\">0.195</td><td align=\"right\">-69.564</td></tr><tr><td/><td align=\"center\">2</td><td align=\"center\">6</td><td align=\"right\">0.323</td><td align=\"right\">0.768</td><td align=\"right\">-1.58379</td><td align=\"right\">0.167</td><td align=\"right\">0.204</td><td align=\"right\">-7.53781</td><td align=\"right\">0.119</td><td align=\"right\">0.114</td><td align=\"right\">-9.02934</td></tr><tr><td/><td align=\"center\">3</td><td align=\"center\">9</td><td align=\"right\">5.08</td><td align=\"right\">1416</td><td align=\"right\">65.30032</td><td align=\"right\">0.196</td><td align=\"right\">0.641</td><td align=\"right\">-2.00253</td><td align=\"right\">0.139</td><td align=\"right\">0.338</td><td align=\"right\">-5.76238</td></tr></tbody></table></body></html>","text":"Pmid= 1797001:Table= Table 5","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":1074047687,"_task_hash":-1807370364,"_view_id":"choice","accept":[5],"config":{"choice_style":"multiple"},"flagged":true,"user_input":"Interesting one - these are goodness of fit criteria for a PK or PKPD model - not parameters themselves.  Based on that I'm going to class as 5","answer":"accept","_session_id":"tableclass-test-params-100-gill","sessions":["tableclass-test-params-100-frank","tableclass-test-params-100-gill","tableclass-test-params-100-joe","tableclass-test-params-100-vicky"],"default":true}],"view_id":"choice"}
{"html":"<!DOCTYPE html><html><body><h1>Baseline characteristics</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td align=\"left\"><bold>Characteristic</bold></td><td align=\"center\"><bold>All Participants (<italic>n </italic>= 32)</bold></td></tr></thead><tbody><tr><td align=\"left\">Sex, <italic>n </italic>(%)</td><td/></tr><tr><td align=\"left\">&#8195;Male</td><td align=\"center\">20 (62.5)</td></tr><tr><td align=\"left\">&#8195;Female</td><td align=\"center\">12 (37.5)</td></tr><tr><td align=\"left\">Race, <italic>n </italic>(%)</td><td/></tr><tr><td align=\"left\">&#8195;Caucasian</td><td align=\"center\">26 (81.3)</td></tr><tr><td align=\"left\">&#8195;Asian</td><td align=\"center\">3 (9.4)</td></tr><tr><td align=\"left\">&#8195;Black</td><td align=\"center\">1 (3.1)</td></tr><tr><td align=\"left\">&#8195;Hispanic</td><td align=\"center\">1 (3.1)</td></tr><tr><td align=\"left\">&#8195;American Indian</td><td align=\"center\">1 (3.1)</td></tr><tr><td align=\"left\">Age (years)</td><td/></tr><tr><td align=\"left\">&#8195;Mean</td><td align=\"center\">33</td></tr><tr><td align=\"left\">&#8195;Range</td><td align=\"center\">20&#8211;50</td></tr><tr><td align=\"left\">Height (cm)</td><td/></tr><tr><td align=\"left\">&#8195;Mean</td><td align=\"center\">175</td></tr><tr><td align=\"left\">&#8195;Range</td><td align=\"center\">163&#8211;191</td></tr><tr><td align=\"left\">Weight (kg)</td><td/></tr><tr><td align=\"left\">&#8195;Mean</td><td align=\"center\">76.4</td></tr><tr><td align=\"left\">&#8195;Range</td><td align=\"center\">61.4&#8211;96.4</td></tr></tbody></table></body></html>","text":"Pmid= 1808051:Table= Table 1","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":-505995497,"_task_hash":1292455872,"_view_id":"review","accept":[5],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":null,"sessions":["tableclass-test-params-100-frank","tableclass-test-params-100-gill","tableclass-test-params-100-joe","tableclass-test-params-100-vicky"],"versions":[{"html":"<!DOCTYPE html><html><body><h1>Baseline characteristics</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td align=\"left\"><bold>Characteristic</bold></td><td align=\"center\"><bold>All Participants (<italic>n </italic>= 32)</bold></td></tr></thead><tbody><tr><td align=\"left\">Sex, <italic>n </italic>(%)</td><td/></tr><tr><td align=\"left\">&#8195;Male</td><td align=\"center\">20 (62.5)</td></tr><tr><td align=\"left\">&#8195;Female</td><td align=\"center\">12 (37.5)</td></tr><tr><td align=\"left\">Race, <italic>n </italic>(%)</td><td/></tr><tr><td align=\"left\">&#8195;Caucasian</td><td align=\"center\">26 (81.3)</td></tr><tr><td align=\"left\">&#8195;Asian</td><td align=\"center\">3 (9.4)</td></tr><tr><td align=\"left\">&#8195;Black</td><td align=\"center\">1 (3.1)</td></tr><tr><td align=\"left\">&#8195;Hispanic</td><td align=\"center\">1 (3.1)</td></tr><tr><td align=\"left\">&#8195;American Indian</td><td align=\"center\">1 (3.1)</td></tr><tr><td align=\"left\">Age (years)</td><td/></tr><tr><td align=\"left\">&#8195;Mean</td><td align=\"center\">33</td></tr><tr><td align=\"left\">&#8195;Range</td><td align=\"center\">20&#8211;50</td></tr><tr><td align=\"left\">Height (cm)</td><td/></tr><tr><td align=\"left\">&#8195;Mean</td><td align=\"center\">175</td></tr><tr><td align=\"left\">&#8195;Range</td><td align=\"center\">163&#8211;191</td></tr><tr><td align=\"left\">Weight (kg)</td><td/></tr><tr><td align=\"left\">&#8195;Mean</td><td align=\"center\">76.4</td></tr><tr><td align=\"left\">&#8195;Range</td><td align=\"center\">61.4&#8211;96.4</td></tr></tbody></table></body></html>","text":"Pmid= 1808051:Table= Table 1","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":-505995497,"_task_hash":1292455872,"_view_id":"choice","accept":[5],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":"tableclass-test-params-100-gill","sessions":["tableclass-test-params-100-frank","tableclass-test-params-100-gill","tableclass-test-params-100-joe","tableclass-test-params-100-vicky"],"default":true}],"view_id":"choice"}
{"html":"<!DOCTYPE html><html><body><h1>Untransformed pharmacokinetic parameters after administration of OROS</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td align=\"left\"><bold>Parameter</bold></td><td align=\"center\"><bold>8 mg</bold></td><td align=\"center\"><bold>16 mg</bold></td><td align=\"center\"><bold>32 mg</bold></td><td align=\"center\"><bold>64 mg</bold></td></tr></thead><tbody><tr><td align=\"left\">C<sub>max </sub>(ng/mL)</td><td/><td/><td/><td/></tr><tr><td align=\"left\">&#8195;Mean</td><td align=\"center\">0.929</td><td align=\"center\">1.69</td><td align=\"center\">3.25</td><td align=\"center\">6.61</td></tr><tr><td align=\"left\">&#8195;SD</td><td align=\"center\">1.01</td><td align=\"center\">0.78</td><td align=\"center\">1.37</td><td align=\"center\">1.75</td></tr><tr><td align=\"left\">T<sub>max </sub>(hour)</td><td/><td/><td/><td/></tr><tr><td align=\"left\">&#8195;Median</td><td align=\"center\">12.0</td><td align=\"center\">16.0</td><td align=\"center\">16.0</td><td align=\"center\">16.0</td></tr><tr><td align=\"left\">&#8195;Range</td><td align=\"center\">4.0&#8211;30.0</td><td align=\"center\">6.0&#8211;30.0</td><td align=\"center\">4.0&#8211;24.0</td><td align=\"center\">6.0&#8211;30.0</td></tr><tr><td align=\"left\">AUC<sub>0&#8211;48 </sub>(ng&#183;hr/mL)</td><td/><td/><td/><td/></tr><tr><td align=\"left\">&#8195;Mean</td><td align=\"center\">18.1</td><td align=\"center\">36.5</td><td align=\"center\">72.2</td><td align=\"center\">156</td></tr><tr><td align=\"left\">&#8195;SD</td><td align=\"center\">5.8</td><td align=\"center\">11.3</td><td align=\"center\">24.3</td><td align=\"center\">30.6</td></tr><tr><td align=\"left\">AUC<sub>0&#8211;&#8734; </sub>(ng&#183;hr/mL)</td><td/><td/><td/><td/></tr><tr><td align=\"left\">&#8195;Mean</td><td align=\"center\">19.5</td><td align=\"center\">40.8</td><td align=\"center\">80.3</td><td align=\"center\">178.7</td></tr><tr><td align=\"left\">&#8195;SD</td><td align=\"center\">5.9</td><td align=\"center\">13.7</td><td align=\"center\">29.6</td><td align=\"center\">35.2</td></tr><tr><td align=\"left\">t<sub>1/2 </sub>(hour)</td><td/><td/><td/><td/></tr><tr><td align=\"left\">&#8195;Mean</td><td align=\"center\">10.6</td><td align=\"center\">10.3</td><td align=\"center\">11.0</td><td align=\"center\">10.9</td></tr><tr><td align=\"left\">&#8195;SD</td><td align=\"center\">4.3</td><td align=\"center\">2.4</td><td align=\"center\">3.2</td><td align=\"center\">3.8</td></tr></tbody></table></body></html>","text":"Pmid= 1808051:Table= Table 2","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":646461282,"_task_hash":-558024936,"_view_id":"review","accept":[1],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":null,"sessions":["tableclass-test-params-100-frank","tableclass-test-params-100-gill","tableclass-test-params-100-joe","tableclass-test-params-100-vicky"],"versions":[{"html":"<!DOCTYPE html><html><body><h1>Untransformed pharmacokinetic parameters after administration of OROS</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td align=\"left\"><bold>Parameter</bold></td><td align=\"center\"><bold>8 mg</bold></td><td align=\"center\"><bold>16 mg</bold></td><td align=\"center\"><bold>32 mg</bold></td><td align=\"center\"><bold>64 mg</bold></td></tr></thead><tbody><tr><td align=\"left\">C<sub>max </sub>(ng/mL)</td><td/><td/><td/><td/></tr><tr><td align=\"left\">&#8195;Mean</td><td align=\"center\">0.929</td><td align=\"center\">1.69</td><td align=\"center\">3.25</td><td align=\"center\">6.61</td></tr><tr><td align=\"left\">&#8195;SD</td><td align=\"center\">1.01</td><td align=\"center\">0.78</td><td align=\"center\">1.37</td><td align=\"center\">1.75</td></tr><tr><td align=\"left\">T<sub>max </sub>(hour)</td><td/><td/><td/><td/></tr><tr><td align=\"left\">&#8195;Median</td><td align=\"center\">12.0</td><td align=\"center\">16.0</td><td align=\"center\">16.0</td><td align=\"center\">16.0</td></tr><tr><td align=\"left\">&#8195;Range</td><td align=\"center\">4.0&#8211;30.0</td><td align=\"center\">6.0&#8211;30.0</td><td align=\"center\">4.0&#8211;24.0</td><td align=\"center\">6.0&#8211;30.0</td></tr><tr><td align=\"left\">AUC<sub>0&#8211;48 </sub>(ng&#183;hr/mL)</td><td/><td/><td/><td/></tr><tr><td align=\"left\">&#8195;Mean</td><td align=\"center\">18.1</td><td align=\"center\">36.5</td><td align=\"center\">72.2</td><td align=\"center\">156</td></tr><tr><td align=\"left\">&#8195;SD</td><td align=\"center\">5.8</td><td align=\"center\">11.3</td><td align=\"center\">24.3</td><td align=\"center\">30.6</td></tr><tr><td align=\"left\">AUC<sub>0&#8211;&#8734; </sub>(ng&#183;hr/mL)</td><td/><td/><td/><td/></tr><tr><td align=\"left\">&#8195;Mean</td><td align=\"center\">19.5</td><td align=\"center\">40.8</td><td align=\"center\">80.3</td><td align=\"center\">178.7</td></tr><tr><td align=\"left\">&#8195;SD</td><td align=\"center\">5.9</td><td align=\"center\">13.7</td><td align=\"center\">29.6</td><td align=\"center\">35.2</td></tr><tr><td align=\"left\">t<sub>1/2 </sub>(hour)</td><td/><td/><td/><td/></tr><tr><td align=\"left\">&#8195;Mean</td><td align=\"center\">10.6</td><td align=\"center\">10.3</td><td align=\"center\">11.0</td><td align=\"center\">10.9</td></tr><tr><td align=\"left\">&#8195;SD</td><td align=\"center\">4.3</td><td align=\"center\">2.4</td><td align=\"center\">3.2</td><td align=\"center\">3.8</td></tr></tbody></table></body></html>","text":"Pmid= 1808051:Table= Table 2","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":646461282,"_task_hash":-558024936,"_view_id":"choice","accept":[1],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":"tableclass-test-params-100-gill","sessions":["tableclass-test-params-100-frank","tableclass-test-params-100-gill","tableclass-test-params-100-joe","tableclass-test-params-100-vicky"],"default":true}],"view_id":"choice"}
{"html":"<!DOCTYPE html><html><body><h1>Mean (SD) of the dose-normalized pharmacokinetic parameters after administration of OROS</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td align=\"left\"><bold>Parameter</bold></td><td align=\"center\"><bold>8 mg</bold></td><td align=\"center\"><bold>16 mg</bold></td><td align=\"center\"><bold>32 mg</bold></td><td align=\"center\"><bold>64 mg</bold></td></tr></thead><tbody><tr><td align=\"left\">C<sub>max</sub>, ng/mL/mg</td><td align=\"center\">0.116 (0.127)</td><td align=\"center\">0.106 (0.049)</td><td align=\"center\">0.102 (0.043)</td><td align=\"center\">0.103 (0.027)</td></tr><tr><td align=\"left\">AUC<sub>0&#8211;48</sub>, ng&#183;hr/mL/mg</td><td align=\"center\">2.26 (0.72)</td><td align=\"center\">2.28 (0.71)</td><td align=\"center\">2.26 (0.76)</td><td align=\"center\">2.44 (0.48)</td></tr><tr><td align=\"left\">AUC<sub>0&#8211;&#8734;</sub>, ng&#183;hr/mL/mg</td><td align=\"center\">2.44 (0.74)</td><td align=\"center\">2.55 (0.86)</td><td align=\"center\">2.51 (0.93)</td><td align=\"center\">2.79 (0.55)</td></tr></tbody></table></body></html>","text":"Pmid= 1808051:Table= Table 3","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":318053864,"_task_hash":-1216195703,"_view_id":"review","accept":[1],"config":{"choice_style":"multiple"},"user_input":"I was going to also include category 3, but decided against this, as although these parameters have been divided by dose, to fulfil category 3 I'm assuming that there needs to be a ratio of two groups, eg, young vs elderly, healthy vs renal failure, fed vs fasted","answer":"accept","_session_id":null,"sessions":["tableclass-test-params-100-frank","tableclass-test-params-100-gill","tableclass-test-params-100-joe","tableclass-test-params-100-vicky"],"versions":[{"html":"<!DOCTYPE html><html><body><h1>Mean (SD) of the dose-normalized pharmacokinetic parameters after administration of OROS</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td align=\"left\"><bold>Parameter</bold></td><td align=\"center\"><bold>8 mg</bold></td><td align=\"center\"><bold>16 mg</bold></td><td align=\"center\"><bold>32 mg</bold></td><td align=\"center\"><bold>64 mg</bold></td></tr></thead><tbody><tr><td align=\"left\">C<sub>max</sub>, ng/mL/mg</td><td align=\"center\">0.116 (0.127)</td><td align=\"center\">0.106 (0.049)</td><td align=\"center\">0.102 (0.043)</td><td align=\"center\">0.103 (0.027)</td></tr><tr><td align=\"left\">AUC<sub>0&#8211;48</sub>, ng&#183;hr/mL/mg</td><td align=\"center\">2.26 (0.72)</td><td align=\"center\">2.28 (0.71)</td><td align=\"center\">2.26 (0.76)</td><td align=\"center\">2.44 (0.48)</td></tr><tr><td align=\"left\">AUC<sub>0&#8211;&#8734;</sub>, ng&#183;hr/mL/mg</td><td align=\"center\">2.44 (0.74)</td><td align=\"center\">2.55 (0.86)</td><td align=\"center\">2.51 (0.93)</td><td align=\"center\">2.79 (0.55)</td></tr></tbody></table></body></html>","text":"Pmid= 1808051:Table= Table 3","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":318053864,"_task_hash":-1216195703,"_view_id":"choice","accept":[1],"config":{"choice_style":"multiple"},"user_input":"I was going to also include category 3, but decided against this, as although these parameters have been divided by dose, to fulfil category 3 I'm assuming that there needs to be a ratio of two groups, eg, young vs elderly, healthy vs renal failure, fed vs fasted","answer":"accept","_session_id":"tableclass-test-params-100-gill","sessions":["tableclass-test-params-100-frank","tableclass-test-params-100-gill","tableclass-test-params-100-joe","tableclass-test-params-100-vicky"],"default":true}],"view_id":"choice"}
{"html":"<!DOCTYPE html><html><body><h1>Adverse events occurring in \u226510% of subjects in any treatment group</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td align=\"left\"><bold>Event, <italic>n </italic>(%)</bold></td><td align=\"center\"><bold>8 mg (<italic>n </italic>= 31)</bold></td><td align=\"center\"><bold>16 mg (<italic>n </italic>= 31)</bold></td><td align=\"center\"><bold>32 mg (<italic>n </italic>= 31)</bold></td><td align=\"center\"><bold>64 mg (<italic>n </italic>= 32)</bold></td></tr></thead><tbody><tr><td align=\"left\">Asthenia</td><td align=\"center\">2 (6)</td><td align=\"center\">5 (16)</td><td align=\"center\">3 (10)</td><td align=\"center\">5 (16)</td></tr><tr><td align=\"left\">Nausea</td><td align=\"center\">4 (13)</td><td align=\"center\">5 (16)</td><td align=\"center\">3 (10)</td><td align=\"center\">3 (9)</td></tr><tr><td align=\"left\">Headache</td><td align=\"center\">2 (6)</td><td align=\"center\">3 (10)</td><td align=\"center\">5 (16)</td><td align=\"center\">3 (9)</td></tr><tr><td align=\"left\">Chest pain</td><td align=\"center\">0 (0)</td><td align=\"center\">0 (0)</td><td align=\"center\">3 (10)</td><td align=\"center\">2 (6)</td></tr></tbody></table></body></html>","text":"Pmid= 1808051:Table= Table 4","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":1552945533,"_task_hash":274588317,"_view_id":"review","accept":[5],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":null,"sessions":["tableclass-test-params-100-frank","tableclass-test-params-100-gill","tableclass-test-params-100-joe","tableclass-test-params-100-vicky"],"versions":[{"html":"<!DOCTYPE html><html><body><h1>Adverse events occurring in \u226510% of subjects in any treatment group</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td align=\"left\"><bold>Event, <italic>n </italic>(%)</bold></td><td align=\"center\"><bold>8 mg (<italic>n </italic>= 31)</bold></td><td align=\"center\"><bold>16 mg (<italic>n </italic>= 31)</bold></td><td align=\"center\"><bold>32 mg (<italic>n </italic>= 31)</bold></td><td align=\"center\"><bold>64 mg (<italic>n </italic>= 32)</bold></td></tr></thead><tbody><tr><td align=\"left\">Asthenia</td><td align=\"center\">2 (6)</td><td align=\"center\">5 (16)</td><td align=\"center\">3 (10)</td><td align=\"center\">5 (16)</td></tr><tr><td align=\"left\">Nausea</td><td align=\"center\">4 (13)</td><td align=\"center\">5 (16)</td><td align=\"center\">3 (10)</td><td align=\"center\">3 (9)</td></tr><tr><td align=\"left\">Headache</td><td align=\"center\">2 (6)</td><td align=\"center\">3 (10)</td><td align=\"center\">5 (16)</td><td align=\"center\">3 (9)</td></tr><tr><td align=\"left\">Chest pain</td><td align=\"center\">0 (0)</td><td align=\"center\">0 (0)</td><td align=\"center\">3 (10)</td><td align=\"center\">2 (6)</td></tr></tbody></table></body></html>","text":"Pmid= 1808051:Table= Table 4","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":1552945533,"_task_hash":274588317,"_view_id":"choice","accept":[5],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":"tableclass-test-params-100-gill","sessions":["tableclass-test-params-100-frank","tableclass-test-params-100-gill","tableclass-test-params-100-joe","tableclass-test-params-100-vicky"],"default":true}],"view_id":"choice"}
{"html":"<!DOCTYPE html><html><body><h1>Baseline characteristics</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td align=\"left\"><bold>Characteristic</bold></td><td align=\"center\"><bold>All Participants (<italic>n </italic>= 30)</bold></td></tr></thead><tbody><tr><td align=\"left\">Sex, <italic>n </italic>(%)</td><td/></tr><tr><td align=\"left\">&#8195;Male</td><td align=\"center\">21 (70)</td></tr><tr><td align=\"left\">&#8195;Female</td><td align=\"center\">9 (30)</td></tr><tr><td align=\"left\">Race, <italic>n </italic>(%)</td><td/></tr><tr><td align=\"left\">&#8195;Caucasian</td><td align=\"center\">27 (90)</td></tr><tr><td align=\"left\">&#8195;Black</td><td align=\"center\">2 (7)</td></tr><tr><td align=\"left\">&#8195;Hispanic</td><td align=\"center\">1 (3)</td></tr><tr><td align=\"left\">Age (years)</td><td/></tr><tr><td align=\"left\">&#8195;Mean</td><td align=\"center\">33.1</td></tr><tr><td align=\"left\">&#8195;Range</td><td align=\"center\">19&#8211;49</td></tr><tr><td align=\"left\">Height (cm)</td><td/></tr><tr><td align=\"left\">&#8195;Mean</td><td align=\"center\">176</td></tr><tr><td align=\"left\">&#8195;Range</td><td align=\"center\">163&#8211;191</td></tr><tr><td align=\"left\">Weight (kg)</td><td/></tr><tr><td align=\"left\">&#8195;Mean</td><td align=\"center\">77.2</td></tr><tr><td align=\"left\">&#8195;Range</td><td align=\"center\">64.5&#8211;94.5</td></tr></tbody></table></body></html>","text":"Pmid= 1810515:Table= Table 1","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":1182797139,"_task_hash":790149729,"_view_id":"review","accept":[5],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":null,"sessions":["tableclass-test-params-100-frank","tableclass-test-params-100-gill","tableclass-test-params-100-joe","tableclass-test-params-100-vicky"],"versions":[{"html":"<!DOCTYPE html><html><body><h1>Baseline characteristics</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td align=\"left\"><bold>Characteristic</bold></td><td align=\"center\"><bold>All Participants (<italic>n </italic>= 30)</bold></td></tr></thead><tbody><tr><td align=\"left\">Sex, <italic>n </italic>(%)</td><td/></tr><tr><td align=\"left\">&#8195;Male</td><td align=\"center\">21 (70)</td></tr><tr><td align=\"left\">&#8195;Female</td><td align=\"center\">9 (30)</td></tr><tr><td align=\"left\">Race, <italic>n </italic>(%)</td><td/></tr><tr><td align=\"left\">&#8195;Caucasian</td><td align=\"center\">27 (90)</td></tr><tr><td align=\"left\">&#8195;Black</td><td align=\"center\">2 (7)</td></tr><tr><td align=\"left\">&#8195;Hispanic</td><td align=\"center\">1 (3)</td></tr><tr><td align=\"left\">Age (years)</td><td/></tr><tr><td align=\"left\">&#8195;Mean</td><td align=\"center\">33.1</td></tr><tr><td align=\"left\">&#8195;Range</td><td align=\"center\">19&#8211;49</td></tr><tr><td align=\"left\">Height (cm)</td><td/></tr><tr><td align=\"left\">&#8195;Mean</td><td align=\"center\">176</td></tr><tr><td align=\"left\">&#8195;Range</td><td align=\"center\">163&#8211;191</td></tr><tr><td align=\"left\">Weight (kg)</td><td/></tr><tr><td align=\"left\">&#8195;Mean</td><td align=\"center\">77.2</td></tr><tr><td align=\"left\">&#8195;Range</td><td align=\"center\">64.5&#8211;94.5</td></tr></tbody></table></body></html>","text":"Pmid= 1810515:Table= Table 1","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":1182797139,"_task_hash":790149729,"_view_id":"choice","accept":[5],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":"tableclass-test-params-100-gill","sessions":["tableclass-test-params-100-frank","tableclass-test-params-100-gill","tableclass-test-params-100-joe","tableclass-test-params-100-vicky"],"default":true}],"view_id":"choice"}
{"html":"<!DOCTYPE html><html><body><h1>Pharmacokinetic parameters for hydromorphone after administration of OROS</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td align=\"left\"><bold>Parameter</bold></td><td align=\"center\"><bold>Treatment Regimen A (fasting; <italic>n </italic>= 25)</bold></td><td align=\"center\"><bold>Treatment Regimen B (fed; <italic>n </italic>= 27)</bold></td><td align=\"center\"><bold>Treatment Regimen C (fasting with naltrexone block; <italic>n </italic>= 26)</bold></td></tr></thead><tbody><tr><td align=\"left\">C<sub>max </sub>(ng/mL)</td><td/><td/><td/></tr><tr><td align=\"left\">&#8195;Mean</td><td align=\"center\">1.107</td><td align=\"center\">1.352</td><td align=\"center\">1.635</td></tr><tr><td align=\"left\">&#8195;SD</td><td align=\"center\">0.2058</td><td align=\"center\">0.3633</td><td align=\"center\">0.5708</td></tr><tr><td align=\"left\">T<sub>max </sub>(h)</td><td/><td/><td/></tr><tr><td align=\"left\">&#8195;Median</td><td align=\"center\">16.0</td><td align=\"center\">12.0</td><td align=\"center\">12.0</td></tr><tr><td align=\"left\">&#8195;Range</td><td align=\"center\">6.0&#8211;36.0</td><td align=\"center\">6.0&#8211;20.0</td><td align=\"center\">6.0&#8211;24.0</td></tr><tr><td align=\"left\">t<sub>1/2 </sub>(h)</td><td/><td/><td/></tr><tr><td align=\"left\">&#8195;Mean</td><td align=\"center\">14.7</td><td align=\"center\">12.5</td><td align=\"center\">10.1</td></tr><tr><td align=\"left\">&#8195;SD</td><td align=\"center\">6.07</td><td align=\"center\">5.22</td><td align=\"center\">3.95</td></tr><tr><td align=\"left\">AUC<sub>0-t </sub>(ng&#183; h/mL)</td><td/><td/><td/></tr><tr><td align=\"left\">&#8195;Mean</td><td align=\"center\">31.12</td><td align=\"center\">30.20</td><td align=\"center\">33.97</td></tr><tr><td align=\"left\">&#8195;SD</td><td align=\"center\">7.063</td><td align=\"center\">8.738</td><td align=\"center\">9.007</td></tr><tr><td align=\"left\">AUC<sub>0-&#8734;</sub>(ng&#183;h/mL)</td><td/><td/><td/></tr><tr><td align=\"left\">&#8195;Mean</td><td align=\"center\">38.84</td><td align=\"center\">36.09</td><td align=\"center\">37.24</td></tr><tr><td align=\"left\">&#8195;SD</td><td align=\"center\">9.566</td><td align=\"center\">10.04</td><td align=\"center\">9.921</td></tr></tbody></table></body></html>","text":"Pmid= 1810515:Table= Table 2","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":1699592841,"_task_hash":-1535894366,"_view_id":"review","accept":[1],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":null,"sessions":["tableclass-test-params-100-frank","tableclass-test-params-100-gill","tableclass-test-params-100-joe","tableclass-test-params-100-vicky"],"versions":[{"html":"<!DOCTYPE html><html><body><h1>Pharmacokinetic parameters for hydromorphone after administration of OROS</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td align=\"left\"><bold>Parameter</bold></td><td align=\"center\"><bold>Treatment Regimen A (fasting; <italic>n </italic>= 25)</bold></td><td align=\"center\"><bold>Treatment Regimen B (fed; <italic>n </italic>= 27)</bold></td><td align=\"center\"><bold>Treatment Regimen C (fasting with naltrexone block; <italic>n </italic>= 26)</bold></td></tr></thead><tbody><tr><td align=\"left\">C<sub>max </sub>(ng/mL)</td><td/><td/><td/></tr><tr><td align=\"left\">&#8195;Mean</td><td align=\"center\">1.107</td><td align=\"center\">1.352</td><td align=\"center\">1.635</td></tr><tr><td align=\"left\">&#8195;SD</td><td align=\"center\">0.2058</td><td align=\"center\">0.3633</td><td align=\"center\">0.5708</td></tr><tr><td align=\"left\">T<sub>max </sub>(h)</td><td/><td/><td/></tr><tr><td align=\"left\">&#8195;Median</td><td align=\"center\">16.0</td><td align=\"center\">12.0</td><td align=\"center\">12.0</td></tr><tr><td align=\"left\">&#8195;Range</td><td align=\"center\">6.0&#8211;36.0</td><td align=\"center\">6.0&#8211;20.0</td><td align=\"center\">6.0&#8211;24.0</td></tr><tr><td align=\"left\">t<sub>1/2 </sub>(h)</td><td/><td/><td/></tr><tr><td align=\"left\">&#8195;Mean</td><td align=\"center\">14.7</td><td align=\"center\">12.5</td><td align=\"center\">10.1</td></tr><tr><td align=\"left\">&#8195;SD</td><td align=\"center\">6.07</td><td align=\"center\">5.22</td><td align=\"center\">3.95</td></tr><tr><td align=\"left\">AUC<sub>0-t </sub>(ng&#183; h/mL)</td><td/><td/><td/></tr><tr><td align=\"left\">&#8195;Mean</td><td align=\"center\">31.12</td><td align=\"center\">30.20</td><td align=\"center\">33.97</td></tr><tr><td align=\"left\">&#8195;SD</td><td align=\"center\">7.063</td><td align=\"center\">8.738</td><td align=\"center\">9.007</td></tr><tr><td align=\"left\">AUC<sub>0-&#8734;</sub>(ng&#183;h/mL)</td><td/><td/><td/></tr><tr><td align=\"left\">&#8195;Mean</td><td align=\"center\">38.84</td><td align=\"center\">36.09</td><td align=\"center\">37.24</td></tr><tr><td align=\"left\">&#8195;SD</td><td align=\"center\">9.566</td><td align=\"center\">10.04</td><td align=\"center\">9.921</td></tr></tbody></table></body></html>","text":"Pmid= 1810515:Table= Table 2","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":1699592841,"_task_hash":-1535894366,"_view_id":"choice","accept":[1],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":"tableclass-test-params-100-gill","sessions":["tableclass-test-params-100-frank","tableclass-test-params-100-gill","tableclass-test-params-100-joe","tableclass-test-params-100-vicky"],"default":true}],"view_id":"choice"}
{"html":"<!DOCTYPE html><html><body><h1>Adverse events [</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td align=\"left\"><bold>Event</bold></td><td align=\"center\"><bold>Treatment Regimen A (fasting; <italic>n </italic>= 28)</bold></td><td align=\"center\"><bold>Treatment Regimen B (fed; <italic>n </italic>= 29)</bold></td><td align=\"center\"><bold>Treatment Regimen C (fasting with naltrexone block; <italic>n </italic>= 27)</bold></td></tr></thead><tbody><tr><td align=\"left\">Nausea</td><td align=\"center\">6 (21.4)</td><td align=\"center\">9 (31.0)</td><td align=\"center\">7 (25.9)</td></tr><tr><td align=\"left\">Asthenia</td><td align=\"center\">6 (21.4)</td><td align=\"center\">8 (27.6)</td><td align=\"center\">7 (25.9)</td></tr><tr><td align=\"left\">Dizziness</td><td align=\"center\">8 (28.6)</td><td align=\"center\">5 (17.2)</td><td align=\"center\">3 (11.1)</td></tr><tr><td align=\"left\">Pruritus</td><td align=\"center\">2 (7.1)</td><td align=\"center\">4 (13.8)</td><td align=\"center\">9 (33.3)</td></tr><tr><td align=\"left\">Headache</td><td align=\"center\">6 (21.4)</td><td align=\"center\">3 (10.3)</td><td align=\"center\">4 (14.8)</td></tr><tr><td align=\"left\">Vomiting</td><td align=\"center\">2 (7.1)</td><td align=\"center\">3 (10.3)</td><td align=\"center\">5 (18.5)</td></tr></tbody></table></body></html>","text":"Pmid= 1810515:Table= Table 3","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":-805188551,"_task_hash":-1668627948,"_view_id":"review","accept":[5],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":null,"sessions":["tableclass-test-params-100-frank","tableclass-test-params-100-gill","tableclass-test-params-100-joe","tableclass-test-params-100-vicky"],"versions":[{"html":"<!DOCTYPE html><html><body><h1>Adverse events [</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td align=\"left\"><bold>Event</bold></td><td align=\"center\"><bold>Treatment Regimen A (fasting; <italic>n </italic>= 28)</bold></td><td align=\"center\"><bold>Treatment Regimen B (fed; <italic>n </italic>= 29)</bold></td><td align=\"center\"><bold>Treatment Regimen C (fasting with naltrexone block; <italic>n </italic>= 27)</bold></td></tr></thead><tbody><tr><td align=\"left\">Nausea</td><td align=\"center\">6 (21.4)</td><td align=\"center\">9 (31.0)</td><td align=\"center\">7 (25.9)</td></tr><tr><td align=\"left\">Asthenia</td><td align=\"center\">6 (21.4)</td><td align=\"center\">8 (27.6)</td><td align=\"center\">7 (25.9)</td></tr><tr><td align=\"left\">Dizziness</td><td align=\"center\">8 (28.6)</td><td align=\"center\">5 (17.2)</td><td align=\"center\">3 (11.1)</td></tr><tr><td align=\"left\">Pruritus</td><td align=\"center\">2 (7.1)</td><td align=\"center\">4 (13.8)</td><td align=\"center\">9 (33.3)</td></tr><tr><td align=\"left\">Headache</td><td align=\"center\">6 (21.4)</td><td align=\"center\">3 (10.3)</td><td align=\"center\">4 (14.8)</td></tr><tr><td align=\"left\">Vomiting</td><td align=\"center\">2 (7.1)</td><td align=\"center\">3 (10.3)</td><td align=\"center\">5 (18.5)</td></tr></tbody></table></body></html>","text":"Pmid= 1810515:Table= Table 3","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":-805188551,"_task_hash":-1668627948,"_view_id":"choice","accept":[5],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":"tableclass-test-params-100-gill","sessions":["tableclass-test-params-100-frank","tableclass-test-params-100-gill","tableclass-test-params-100-joe","tableclass-test-params-100-vicky"],"default":true}],"view_id":"choice"}
{"html":"<!DOCTYPE html><html><body><h1>Risk ratios for myocardial infarction among hypertensive patients treated with non-atenolol versus atenolol \u03b2-blockers</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td/><td align=\"left\">Number of studies</td><td align=\"left\">Mean Risk ratio</td><td align=\"left\">Median risk ratio</td><td align=\"left\" colspan=\"2\">Credibility interval</td><td align=\"left\">Probability of risk ratio &#8804; 0.90</td></tr><tr><td/><td/><td/><td/><td align=\"left\">2.5 &#8211; 97.5 %</td><td align=\"left\">5 &#8211; 95 %</td><td/></tr></thead><tbody><tr><td align=\"left\">Studies that only included comparison with non-&#946;-blockers</td><td align=\"left\">8</td><td align=\"left\">0.836</td><td align=\"left\">0.828</td><td align=\"left\">0.633 &#8211; 1.078</td><td align=\"left\">0.664 &#8211; 1.031</td><td align=\"left\">0.836</td></tr><tr><td align=\"left\">Studies that only included comparison with placebo</td><td align=\"left\">6</td><td align=\"left\">0.918</td><td align=\"left\">0.906</td><td align=\"left\">0.711 &#8211; 1.172</td><td align=\"left\">0.734 &#8211; 1.125</td><td align=\"left\">0.475</td></tr><tr><td align=\"left\">All studies included</td><td align=\"left\">14</td><td align=\"left\">0.868</td><td align=\"left\">0.867</td><td align=\"left\">0.727 &#8211; 1.023</td><td align=\"left\">0.750 &#8211; 0.992</td><td align=\"left\">0.689</td></tr><tr><td align=\"left\">All studies except MRC Old atenolol versus other antihypertensive drugs</td><td align=\"left\">13</td><td align=\"left\">0.882</td><td align=\"left\">0.883</td><td align=\"left\">0.742 &#8211; 1.039</td><td align=\"left\">0.758 &#8211; 1.016</td><td align=\"left\">0.616</td></tr></tbody></table></body></html>","text":"Pmid= 1876203:Table= Table 1","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":900565850,"_task_hash":478166811,"_view_id":"review","accept":[5],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":null,"sessions":["tableclass-test-params-100-frank","tableclass-test-params-100-gill","tableclass-test-params-100-joe","tableclass-test-params-100-vicky"],"versions":[{"html":"<!DOCTYPE html><html><body><h1>Risk ratios for myocardial infarction among hypertensive patients treated with non-atenolol versus atenolol \u03b2-blockers</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td/><td align=\"left\">Number of studies</td><td align=\"left\">Mean Risk ratio</td><td align=\"left\">Median risk ratio</td><td align=\"left\" colspan=\"2\">Credibility interval</td><td align=\"left\">Probability of risk ratio &#8804; 0.90</td></tr><tr><td/><td/><td/><td/><td align=\"left\">2.5 &#8211; 97.5 %</td><td align=\"left\">5 &#8211; 95 %</td><td/></tr></thead><tbody><tr><td align=\"left\">Studies that only included comparison with non-&#946;-blockers</td><td align=\"left\">8</td><td align=\"left\">0.836</td><td align=\"left\">0.828</td><td align=\"left\">0.633 &#8211; 1.078</td><td align=\"left\">0.664 &#8211; 1.031</td><td align=\"left\">0.836</td></tr><tr><td align=\"left\">Studies that only included comparison with placebo</td><td align=\"left\">6</td><td align=\"left\">0.918</td><td align=\"left\">0.906</td><td align=\"left\">0.711 &#8211; 1.172</td><td align=\"left\">0.734 &#8211; 1.125</td><td align=\"left\">0.475</td></tr><tr><td align=\"left\">All studies included</td><td align=\"left\">14</td><td align=\"left\">0.868</td><td align=\"left\">0.867</td><td align=\"left\">0.727 &#8211; 1.023</td><td align=\"left\">0.750 &#8211; 0.992</td><td align=\"left\">0.689</td></tr><tr><td align=\"left\">All studies except MRC Old atenolol versus other antihypertensive drugs</td><td align=\"left\">13</td><td align=\"left\">0.882</td><td align=\"left\">0.883</td><td align=\"left\">0.742 &#8211; 1.039</td><td align=\"left\">0.758 &#8211; 1.016</td><td align=\"left\">0.616</td></tr></tbody></table></body></html>","text":"Pmid= 1876203:Table= Table 1","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":900565850,"_task_hash":478166811,"_view_id":"choice","accept":[5],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":"tableclass-test-params-100-gill","sessions":["tableclass-test-params-100-frank","tableclass-test-params-100-gill","tableclass-test-params-100-joe","tableclass-test-params-100-vicky"],"default":true}],"view_id":"choice"}
{"html":"<!DOCTYPE html><html><body><h1>Group demographics</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td/><td align=\"left\">Methadone<break/> (<italic>n </italic>= 16)</td><td align=\"left\">Buprenorphine/Naloxone<break/> (<italic>n </italic>= 17)</td><td align=\"left\">Control<break/> (<italic>n </italic>= 17)</td><td align=\"left\">Group comparison<break/><italic>p</italic>-values</td></tr></thead><tbody><tr><td align=\"left\">Age, years (<italic>M, SD</italic>)</td><td align=\"left\">30.8 (8.8)</td><td align=\"left\">28.1 (6.3)</td><td align=\"left\">31.1 (11.2)</td><td align=\"left\"><italic>ns</italic></td></tr><tr><td align=\"left\">Sex: females/males</td><td align=\"left\">9/7</td><td align=\"left\">7/10</td><td align=\"left\">9/8</td><td align=\"left\"><italic>ns</italic></td></tr><tr><td align=\"left\">Verbal intelligence <sup>a </sup>(<italic>M, SD</italic>)</td><td align=\"left\">98.4 (8.7)</td><td align=\"left\">102.4 (8.4)</td><td align=\"left\">105.4 (9.8)</td><td align=\"left\">C &gt; M*</td></tr><tr><td align=\"left\">Education, years (M, SD)</td><td align=\"left\">10.4 (2.0)</td><td align=\"left\">11.1 (2.2)</td><td align=\"left\">13,0 (1.7)</td><td align=\"left\">C &gt; M**<break/> C &gt; BN**</td></tr><tr><td align=\"left\">Dependencies</td><td/><td/><td/><td/></tr><tr><td align=\"left\">&#8195;Opioid</td><td align=\"left\">100%</td><td align=\"left\">100%</td><td align=\"left\">-</td><td align=\"left\"><italic>ns</italic><sup><italic>b</italic></sup></td></tr><tr><td align=\"left\">&#8195;Alcohol</td><td align=\"left\">0%</td><td align=\"left\">6%</td><td/><td align=\"left\"><italic>ns</italic><sup><italic>b</italic></sup></td></tr><tr><td align=\"left\">&#8195;Amphetamine</td><td align=\"left\">0%</td><td align=\"left\">11%</td><td/><td align=\"left\"><italic>ns</italic><sup><italic>b</italic></sup></td></tr><tr><td align=\"left\">&#8195;Benzodiazepines</td><td align=\"left\">100%</td><td align=\"left\">89%</td><td/><td align=\"left\"><italic>ns</italic><sup><italic>b</italic></sup></td></tr><tr><td align=\"left\">&#8195;Cannabis</td><td align=\"left\">6%</td><td align=\"left\">11%</td><td/><td align=\"left\"><italic>ns</italic><sup><italic>b</italic></sup></td></tr><tr><td align=\"left\">Main opioid of abuse used within last month (%)</td><td/><td/><td/><td/></tr><tr><td align=\"left\">&#8195;Buprenorphine</td><td align=\"left\">75%</td><td align=\"left\">100%</td><td align=\"left\">-</td><td align=\"left\"><italic>ns</italic><sup><italic>b</italic></sup></td></tr><tr><td align=\"left\">&#8195;Heroin</td><td align=\"left\">13%</td><td align=\"left\">0%</td><td/><td align=\"left\"><italic>ns</italic><sup><italic>b</italic></sup></td></tr><tr><td align=\"left\">&#8195;Methadone</td><td align=\"left\">13%</td><td align=\"left\">0%</td><td/><td align=\"left\"><italic>ns</italic><sup><italic>b</italic></sup></td></tr><tr><td align=\"left\">Other substances of abuse used within last month (%)</td><td/><td/><td/><td/></tr><tr><td align=\"left\">&#8195;Alcohol (heavy use)<sup>c</sup></td><td align=\"left\">6%</td><td align=\"left\">17%</td><td align=\"left\">6%</td><td align=\"left\"><italic>ns</italic></td></tr><tr><td align=\"left\">&#8195;Amphetamine</td><td align=\"left\">19%</td><td align=\"left\">29%</td><td align=\"left\">0%</td><td align=\"left\"><italic>ns</italic></td></tr><tr><td align=\"left\">&#8195;Benzodiazepine<sup>d</sup></td><td align=\"left\">94%</td><td align=\"left\">94%</td><td align=\"left\">0%</td><td align=\"left\">M &amp; BN &gt; C**</td></tr><tr><td align=\"left\">&#8195;Cannabis</td><td align=\"left\">38%</td><td align=\"left\">24%</td><td align=\"left\">0%</td><td align=\"left\">M &gt; C*</td></tr><tr><td align=\"left\">&#8195;Nicotine (daily use)</td><td align=\"left\">100%</td><td align=\"left\">100%</td><td align=\"left\">35%</td><td align=\"left\">M &amp; BN &gt; C**</td></tr><tr><td align=\"left\">Duration of opioid substitution treatment in the day of testing, days (M, SD)</td><td align=\"left\">14.3 (7.4)</td><td align=\"left\">11.0 (8.1)</td><td align=\"left\">-</td><td align=\"left\"><italic>ns</italic><sup><italic>b</italic></sup></td></tr><tr><td align=\"left\">Duration of opioid abuse, years (M, SD)</td><td align=\"left\">12.1 (7.7)</td><td align=\"left\">10.0 (3.5)</td><td align=\"left\">-</td><td align=\"left\"><italic>ns</italic><sup><italic>b</italic></sup></td></tr><tr><td align=\"left\">Duration of any substance abuse, years (M, SD)</td><td align=\"left\">16.9 (8.7)</td><td align=\"left\">15.7 (5.0)</td><td align=\"left\">-</td><td align=\"left\"><italic>ns</italic><sup><italic>b</italic></sup></td></tr></tbody></table></body></html>","text":"Pmid= 1914339:Table= Table 1","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":-256907071,"_task_hash":745961354,"_view_id":"review","accept":[5],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":null,"sessions":["tableclass-test-params-100-frank","tableclass-test-params-100-gill","tableclass-test-params-100-joe","tableclass-test-params-100-vicky"],"versions":[{"html":"<!DOCTYPE html><html><body><h1>Group demographics</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td/><td align=\"left\">Methadone<break/> (<italic>n </italic>= 16)</td><td align=\"left\">Buprenorphine/Naloxone<break/> (<italic>n </italic>= 17)</td><td align=\"left\">Control<break/> (<italic>n </italic>= 17)</td><td align=\"left\">Group comparison<break/><italic>p</italic>-values</td></tr></thead><tbody><tr><td align=\"left\">Age, years (<italic>M, SD</italic>)</td><td align=\"left\">30.8 (8.8)</td><td align=\"left\">28.1 (6.3)</td><td align=\"left\">31.1 (11.2)</td><td align=\"left\"><italic>ns</italic></td></tr><tr><td align=\"left\">Sex: females/males</td><td align=\"left\">9/7</td><td align=\"left\">7/10</td><td align=\"left\">9/8</td><td align=\"left\"><italic>ns</italic></td></tr><tr><td align=\"left\">Verbal intelligence <sup>a </sup>(<italic>M, SD</italic>)</td><td align=\"left\">98.4 (8.7)</td><td align=\"left\">102.4 (8.4)</td><td align=\"left\">105.4 (9.8)</td><td align=\"left\">C &gt; M*</td></tr><tr><td align=\"left\">Education, years (M, SD)</td><td align=\"left\">10.4 (2.0)</td><td align=\"left\">11.1 (2.2)</td><td align=\"left\">13,0 (1.7)</td><td align=\"left\">C &gt; M**<break/> C &gt; BN**</td></tr><tr><td align=\"left\">Dependencies</td><td/><td/><td/><td/></tr><tr><td align=\"left\">&#8195;Opioid</td><td align=\"left\">100%</td><td align=\"left\">100%</td><td align=\"left\">-</td><td align=\"left\"><italic>ns</italic><sup><italic>b</italic></sup></td></tr><tr><td align=\"left\">&#8195;Alcohol</td><td align=\"left\">0%</td><td align=\"left\">6%</td><td/><td align=\"left\"><italic>ns</italic><sup><italic>b</italic></sup></td></tr><tr><td align=\"left\">&#8195;Amphetamine</td><td align=\"left\">0%</td><td align=\"left\">11%</td><td/><td align=\"left\"><italic>ns</italic><sup><italic>b</italic></sup></td></tr><tr><td align=\"left\">&#8195;Benzodiazepines</td><td align=\"left\">100%</td><td align=\"left\">89%</td><td/><td align=\"left\"><italic>ns</italic><sup><italic>b</italic></sup></td></tr><tr><td align=\"left\">&#8195;Cannabis</td><td align=\"left\">6%</td><td align=\"left\">11%</td><td/><td align=\"left\"><italic>ns</italic><sup><italic>b</italic></sup></td></tr><tr><td align=\"left\">Main opioid of abuse used within last month (%)</td><td/><td/><td/><td/></tr><tr><td align=\"left\">&#8195;Buprenorphine</td><td align=\"left\">75%</td><td align=\"left\">100%</td><td align=\"left\">-</td><td align=\"left\"><italic>ns</italic><sup><italic>b</italic></sup></td></tr><tr><td align=\"left\">&#8195;Heroin</td><td align=\"left\">13%</td><td align=\"left\">0%</td><td/><td align=\"left\"><italic>ns</italic><sup><italic>b</italic></sup></td></tr><tr><td align=\"left\">&#8195;Methadone</td><td align=\"left\">13%</td><td align=\"left\">0%</td><td/><td align=\"left\"><italic>ns</italic><sup><italic>b</italic></sup></td></tr><tr><td align=\"left\">Other substances of abuse used within last month (%)</td><td/><td/><td/><td/></tr><tr><td align=\"left\">&#8195;Alcohol (heavy use)<sup>c</sup></td><td align=\"left\">6%</td><td align=\"left\">17%</td><td align=\"left\">6%</td><td align=\"left\"><italic>ns</italic></td></tr><tr><td align=\"left\">&#8195;Amphetamine</td><td align=\"left\">19%</td><td align=\"left\">29%</td><td align=\"left\">0%</td><td align=\"left\"><italic>ns</italic></td></tr><tr><td align=\"left\">&#8195;Benzodiazepine<sup>d</sup></td><td align=\"left\">94%</td><td align=\"left\">94%</td><td align=\"left\">0%</td><td align=\"left\">M &amp; BN &gt; C**</td></tr><tr><td align=\"left\">&#8195;Cannabis</td><td align=\"left\">38%</td><td align=\"left\">24%</td><td align=\"left\">0%</td><td align=\"left\">M &gt; C*</td></tr><tr><td align=\"left\">&#8195;Nicotine (daily use)</td><td align=\"left\">100%</td><td align=\"left\">100%</td><td align=\"left\">35%</td><td align=\"left\">M &amp; BN &gt; C**</td></tr><tr><td align=\"left\">Duration of opioid substitution treatment in the day of testing, days (M, SD)</td><td align=\"left\">14.3 (7.4)</td><td align=\"left\">11.0 (8.1)</td><td align=\"left\">-</td><td align=\"left\"><italic>ns</italic><sup><italic>b</italic></sup></td></tr><tr><td align=\"left\">Duration of opioid abuse, years (M, SD)</td><td align=\"left\">12.1 (7.7)</td><td align=\"left\">10.0 (3.5)</td><td align=\"left\">-</td><td align=\"left\"><italic>ns</italic><sup><italic>b</italic></sup></td></tr><tr><td align=\"left\">Duration of any substance abuse, years (M, SD)</td><td align=\"left\">16.9 (8.7)</td><td align=\"left\">15.7 (5.0)</td><td align=\"left\">-</td><td align=\"left\"><italic>ns</italic><sup><italic>b</italic></sup></td></tr></tbody></table></body></html>","text":"Pmid= 1914339:Table= Table 1","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":-256907071,"_task_hash":745961354,"_view_id":"choice","accept":[5],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":"tableclass-test-params-100-gill","sessions":["tableclass-test-params-100-frank","tableclass-test-params-100-gill","tableclass-test-params-100-joe","tableclass-test-params-100-vicky"],"default":true}],"view_id":"choice"}
{"html":"<!DOCTYPE html><html><body><h1>Comedications among OST patients within the last 24 h before testing</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td align=\"left\">Medications used within 24 hours of test</td><td align=\"left\">Methadone-treated patients<break/> (<italic>n </italic>= 16)</td><td/><td align=\"left\">Buprenorphine/Naloxone- treated patients<break/> (<italic>n </italic>= 17)</td><td/></tr></thead><tbody><tr><td/><td align=\"left\">Proportion of patients</td><td align=\"left\">Dose, range</td><td align=\"left\">Proportion of patients</td><td align=\"left\">Dose, range</td></tr><tr><td colspan=\"5\"><hr/></td></tr><tr><td align=\"left\">Antidepressives (any)</td><td align=\"left\">44 %</td><td/><td align=\"left\">35\\'%</td><td/></tr><tr><td align=\"left\">&#8195;Essitalopram</td><td align=\"left\">6%</td><td align=\"left\">5 mg</td><td/><td/></tr><tr><td align=\"left\">&#8195;Citalopram</td><td align=\"left\">6 %</td><td align=\"left\">20 mg</td><td/><td/></tr><tr><td align=\"left\">&#8195;Doxepine</td><td/><td/><td align=\"left\">12%</td><td align=\"left\">75 &#8211; 100 mg</td></tr><tr><td align=\"left\">&#8195;Fluoxetine</td><td align=\"left\">13%</td><td align=\"left\">20 &#8211; 30 mg</td><td/><td/></tr><tr><td align=\"left\">&#8195;Mirtazapine</td><td align=\"left\">13%</td><td align=\"left\">15 mg</td><td/><td/></tr><tr><td align=\"left\">&#8195;Paroxetine</td><td/><td/><td align=\"left\">6%</td><td align=\"left\">50 mg</td></tr><tr><td align=\"left\">&#8195;Sertraline</td><td align=\"left\">6%</td><td align=\"left\">50 mg</td><td align=\"left\">12%</td><td align=\"left\">50 mg</td></tr><tr><td align=\"left\">&#8195;Venlaflaxine</td><td/><td/><td align=\"left\">12%</td><td align=\"left\">75 mg</td></tr><tr><td align=\"left\">Anxiolytics, sedatives and hypnotics:</td><td/><td/><td/><td/></tr><tr><td align=\"left\">Benzodiazepines (any)</td><td align=\"left\">81 %</td><td/><td align=\"left\">76%</td><td/></tr><tr><td align=\"left\">&#8195;Diazepam</td><td align=\"left\">38%</td><td align=\"left\">5&#8211;20 mg</td><td align=\"left\">29%</td><td align=\"left\">15 -40 mg</td></tr><tr><td align=\"left\">&#8195;Oxazepam</td><td align=\"left\">44%</td><td align=\"left\">45 &#8211; 120 mg</td><td align=\"left\">47%</td><td align=\"left\">30 &#8211; 90 mg</td></tr><tr><td align=\"left\">&#8195;Nitratzepam*</td><td align=\"left\">6%</td><td align=\"left\">20 mg</td><td/><td/></tr><tr><td align=\"left\">&#8195;Tematzepam *</td><td align=\"left\">19%</td><td align=\"left\">20 mg</td><td align=\"left\">12%</td><td align=\"left\">20 mg</td></tr><tr><td align=\"left\">Non-benzodiazepine hypnotics (any)</td><td align=\"left\">25%</td><td/><td align=\"left\">35%</td><td/></tr><tr><td align=\"left\">&#8195;Zolpidem *</td><td align=\"left\">6%</td><td align=\"left\">10 mg</td><td align=\"left\">6%</td><td align=\"left\">15 mg</td></tr><tr><td align=\"left\">&#8195;Zopiclone *</td><td align=\"left\">19%</td><td align=\"left\">7.5 &#8211; 15 mg</td><td align=\"left\">24%</td><td align=\"left\">7.5 &#8211; 15 mg</td></tr><tr><td align=\"left\">Neuroleptics &#8224; (any)</td><td align=\"left\">25%</td><td/><td align=\"left\">18%</td><td/></tr><tr><td align=\"left\">&#8195;Chlorpromazine</td><td/><td/><td align=\"left\">6%</td><td align=\"left\">50 mg</td></tr><tr><td align=\"left\">&#8195;Flupenthixole</td><td align=\"left\">6%</td><td align=\"left\">0.5 mg</td><td/><td/></tr><tr><td align=\"left\">&#8195;Levomepromazine</td><td align=\"left\">6%</td><td align=\"left\">150 mg</td><td align=\"left\">6%</td><td align=\"left\">100 mg</td></tr><tr><td align=\"left\">&#8195;Quetiapine</td><td align=\"left\">13%</td><td align=\"left\">50&#8211;100 mg</td><td align=\"left\">6%</td><td align=\"left\">300 mg</td></tr><tr><td align=\"left\">Opioid withdrawal symptom or pain relievers (any)</td><td align=\"left\">69 %</td><td/><td align=\"left\">53%</td><td/></tr><tr><td align=\"left\">&#8195;Hydroxyzine</td><td align=\"left\">38%</td><td align=\"left\">25&#8211;200 mg</td><td align=\"left\">24%</td><td align=\"left\">75 &#8211; 300 mg</td></tr><tr><td align=\"left\">&#8195;Ibuprofeine</td><td align=\"left\">13%</td><td align=\"left\">600&#8211; 2400 mg</td><td align=\"left\">6%</td><td align=\"left\">400 mg</td></tr><tr><td align=\"left\">&#8195;Lofexidine</td><td align=\"left\">6%</td><td align=\"left\">0.2mg</td><td align=\"left\">18%</td><td align=\"left\">0.2 &#8211; 0.6 mg</td></tr><tr><td align=\"left\">&#8195;Metoclopramide</td><td align=\"left\">6%</td><td align=\"left\">10 mg</td><td align=\"left\"/><td/></tr><tr><td align=\"left\">&#8195;Naproxen</td><td align=\"left\">6%</td><td align=\"left\">500 mg</td><td>6%</td><td align=\"left\">500 mg</td></tr><tr><td align=\"left\">&#8195;Propranol</td><td align=\"left\">6%</td><td align=\"left\">20 mg</td><td align=\"left\"/><td/></tr><tr><td align=\"left\">&#8195;Valproate</td><td align=\"left\">13%</td><td align=\"left\">500 &#8211; 1000 mg</td><td align=\"left\">24%</td><td align=\"left\">500 &#8211; 1000 mg</td></tr><tr><td align=\"left\">None medication</td><td align=\"left\">13%</td><td/><td align=\"left\">12%</td><td/></tr></tbody></table></body></html>","text":"Pmid= 1914339:Table= Table 2","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":1060163519,"_task_hash":1657873681,"_view_id":"review","accept":[5],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":null,"sessions":["tableclass-test-params-100-frank","tableclass-test-params-100-gill","tableclass-test-params-100-joe","tableclass-test-params-100-vicky"],"versions":[{"html":"<!DOCTYPE html><html><body><h1>Comedications among OST patients within the last 24 h before testing</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td align=\"left\">Medications used within 24 hours of test</td><td align=\"left\">Methadone-treated patients<break/> (<italic>n </italic>= 16)</td><td/><td align=\"left\">Buprenorphine/Naloxone- treated patients<break/> (<italic>n </italic>= 17)</td><td/></tr></thead><tbody><tr><td/><td align=\"left\">Proportion of patients</td><td align=\"left\">Dose, range</td><td align=\"left\">Proportion of patients</td><td align=\"left\">Dose, range</td></tr><tr><td colspan=\"5\"><hr/></td></tr><tr><td align=\"left\">Antidepressives (any)</td><td align=\"left\">44 %</td><td/><td align=\"left\">35\\'%</td><td/></tr><tr><td align=\"left\">&#8195;Essitalopram</td><td align=\"left\">6%</td><td align=\"left\">5 mg</td><td/><td/></tr><tr><td align=\"left\">&#8195;Citalopram</td><td align=\"left\">6 %</td><td align=\"left\">20 mg</td><td/><td/></tr><tr><td align=\"left\">&#8195;Doxepine</td><td/><td/><td align=\"left\">12%</td><td align=\"left\">75 &#8211; 100 mg</td></tr><tr><td align=\"left\">&#8195;Fluoxetine</td><td align=\"left\">13%</td><td align=\"left\">20 &#8211; 30 mg</td><td/><td/></tr><tr><td align=\"left\">&#8195;Mirtazapine</td><td align=\"left\">13%</td><td align=\"left\">15 mg</td><td/><td/></tr><tr><td align=\"left\">&#8195;Paroxetine</td><td/><td/><td align=\"left\">6%</td><td align=\"left\">50 mg</td></tr><tr><td align=\"left\">&#8195;Sertraline</td><td align=\"left\">6%</td><td align=\"left\">50 mg</td><td align=\"left\">12%</td><td align=\"left\">50 mg</td></tr><tr><td align=\"left\">&#8195;Venlaflaxine</td><td/><td/><td align=\"left\">12%</td><td align=\"left\">75 mg</td></tr><tr><td align=\"left\">Anxiolytics, sedatives and hypnotics:</td><td/><td/><td/><td/></tr><tr><td align=\"left\">Benzodiazepines (any)</td><td align=\"left\">81 %</td><td/><td align=\"left\">76%</td><td/></tr><tr><td align=\"left\">&#8195;Diazepam</td><td align=\"left\">38%</td><td align=\"left\">5&#8211;20 mg</td><td align=\"left\">29%</td><td align=\"left\">15 -40 mg</td></tr><tr><td align=\"left\">&#8195;Oxazepam</td><td align=\"left\">44%</td><td align=\"left\">45 &#8211; 120 mg</td><td align=\"left\">47%</td><td align=\"left\">30 &#8211; 90 mg</td></tr><tr><td align=\"left\">&#8195;Nitratzepam*</td><td align=\"left\">6%</td><td align=\"left\">20 mg</td><td/><td/></tr><tr><td align=\"left\">&#8195;Tematzepam *</td><td align=\"left\">19%</td><td align=\"left\">20 mg</td><td align=\"left\">12%</td><td align=\"left\">20 mg</td></tr><tr><td align=\"left\">Non-benzodiazepine hypnotics (any)</td><td align=\"left\">25%</td><td/><td align=\"left\">35%</td><td/></tr><tr><td align=\"left\">&#8195;Zolpidem *</td><td align=\"left\">6%</td><td align=\"left\">10 mg</td><td align=\"left\">6%</td><td align=\"left\">15 mg</td></tr><tr><td align=\"left\">&#8195;Zopiclone *</td><td align=\"left\">19%</td><td align=\"left\">7.5 &#8211; 15 mg</td><td align=\"left\">24%</td><td align=\"left\">7.5 &#8211; 15 mg</td></tr><tr><td align=\"left\">Neuroleptics &#8224; (any)</td><td align=\"left\">25%</td><td/><td align=\"left\">18%</td><td/></tr><tr><td align=\"left\">&#8195;Chlorpromazine</td><td/><td/><td align=\"left\">6%</td><td align=\"left\">50 mg</td></tr><tr><td align=\"left\">&#8195;Flupenthixole</td><td align=\"left\">6%</td><td align=\"left\">0.5 mg</td><td/><td/></tr><tr><td align=\"left\">&#8195;Levomepromazine</td><td align=\"left\">6%</td><td align=\"left\">150 mg</td><td align=\"left\">6%</td><td align=\"left\">100 mg</td></tr><tr><td align=\"left\">&#8195;Quetiapine</td><td align=\"left\">13%</td><td align=\"left\">50&#8211;100 mg</td><td align=\"left\">6%</td><td align=\"left\">300 mg</td></tr><tr><td align=\"left\">Opioid withdrawal symptom or pain relievers (any)</td><td align=\"left\">69 %</td><td/><td align=\"left\">53%</td><td/></tr><tr><td align=\"left\">&#8195;Hydroxyzine</td><td align=\"left\">38%</td><td align=\"left\">25&#8211;200 mg</td><td align=\"left\">24%</td><td align=\"left\">75 &#8211; 300 mg</td></tr><tr><td align=\"left\">&#8195;Ibuprofeine</td><td align=\"left\">13%</td><td align=\"left\">600&#8211; 2400 mg</td><td align=\"left\">6%</td><td align=\"left\">400 mg</td></tr><tr><td align=\"left\">&#8195;Lofexidine</td><td align=\"left\">6%</td><td align=\"left\">0.2mg</td><td align=\"left\">18%</td><td align=\"left\">0.2 &#8211; 0.6 mg</td></tr><tr><td align=\"left\">&#8195;Metoclopramide</td><td align=\"left\">6%</td><td align=\"left\">10 mg</td><td align=\"left\"/><td/></tr><tr><td align=\"left\">&#8195;Naproxen</td><td align=\"left\">6%</td><td align=\"left\">500 mg</td><td>6%</td><td align=\"left\">500 mg</td></tr><tr><td align=\"left\">&#8195;Propranol</td><td align=\"left\">6%</td><td align=\"left\">20 mg</td><td align=\"left\"/><td/></tr><tr><td align=\"left\">&#8195;Valproate</td><td align=\"left\">13%</td><td align=\"left\">500 &#8211; 1000 mg</td><td align=\"left\">24%</td><td align=\"left\">500 &#8211; 1000 mg</td></tr><tr><td align=\"left\">None medication</td><td align=\"left\">13%</td><td/><td align=\"left\">12%</td><td/></tr></tbody></table></body></html>","text":"Pmid= 1914339:Table= Table 2","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":1060163519,"_task_hash":1657873681,"_view_id":"choice","accept":[5],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":"tableclass-test-params-100-gill","sessions":["tableclass-test-params-100-frank","tableclass-test-params-100-gill","tableclass-test-params-100-joe","tableclass-test-params-100-vicky"],"default":true}],"view_id":"choice"}
{"html":"<!DOCTYPE html><html><body><h1>Groups comparisons of cognitive measures using ANOVA</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td align=\"left\"><bold>Domain Test</bold></td><td align=\"left\"><bold>Methadone (<italic>n </italic>= 16)</bold></td><td align=\"left\"><bold>Buprenorphine/Naloxone(<italic>n </italic>= 17)</bold></td><td align=\"left\"><bold>Control(<italic>n </italic>= 17)</bold></td><td align=\"left\"><bold>Statistical comparisons between groups showing better performance first</bold></td><td align=\"left\"><bold>Effect size (Cohen\\'s d)</bold></td></tr></thead><tbody><tr><td/><td align=\"left\"><bold>Mean &#177; SD</bold></td><td align=\"left\"><bold>Mean &#177; SD</bold></td><td align=\"left\"><bold>Mean &#177; SD</bold></td><td/><td/></tr><tr><td colspan=\"6\"><hr/></td></tr><tr><td align=\"left\">Attention</td><td/><td/><td/><td/><td/></tr><tr><td align=\"left\">&#8195;TAP Tonic Alertness, simple reaction time</td><td align=\"left\">257.6 &#177; 32.1</td><td align=\"left\">228.0 &#177; 13.0</td><td align=\"left\">244.4 &#177; 30.0</td><td align=\"left\">BN &lt; M **</td><td align=\"left\">1.11</td></tr><tr><td align=\"left\">&#8195;TAP Phasic Alertness, reaction time after warning signal</td><td align=\"left\">245.6 &#177; 30.4</td><td align=\"left\">227.4 &#177; 17.0</td><td align=\"left\">230.3 &#177; 31.7</td><td/><td/></tr><tr><td align=\"left\">&#8195;TAP Go/NoGo, reaction time</td><td align=\"left\">528.3 &#177; 82.0</td><td align=\"left\">496.9 &#177; 65.3<sup>a</sup></td><td align=\"left\">465.5 &#177; 39.5</td><td align=\"left\">C &lt; M*</td><td align=\"left\">0.88</td></tr><tr><td align=\"left\">&#8195;TAP Go/NoGo, errors</td><td align=\"left\">0.6 &#177; 0.7</td><td align=\"left\">1.2 &#177; 1.4<sup>a</sup></td><td align=\"left\">0.5 &#177; 0.6</td><td/><td/></tr><tr><td align=\"left\">Working memory</td><td/><td/><td/><td/><td/></tr><tr><td align=\"left\">&#8195;WMS-III LNS</td><td align=\"left\">8.8 &#177; 2.6<sup>b</sup></td><td align=\"left\">8.7 &#177; 1.7</td><td align=\"left\">11.8 &#177; 3.1</td><td align=\"left\">C &gt; M**<break/>C &gt; BN**</td><td align=\"left\">1.02<break/>1.21</td></tr><tr><td align=\"left\">&#8195;PASAT</td><td align=\"left\">34.9 &#177; 10.6<sup>b</sup></td><td align=\"left\">31.3 &#177; 10.8</td><td align=\"left\">47.8 &#177; 9.3</td><td align=\"left\">C &gt; M**<break/>C &gt; BN***</td><td align=\"left\">1.27<break/>1.60</td></tr><tr><td align=\"left\">Memory</td><td/><td/><td/><td/><td/></tr><tr><td align=\"left\">&#8195;MPD, first trial</td><td align=\"left\">10.1 &#177; 3.0</td><td align=\"left\">10.6 &#177; 2.4</td><td align=\"left\">13.0 &#177; 1.4</td><td align=\"left\">C &gt; M**<break/>C &gt; BN*</td><td align=\"left\">1.22<break/>1.19</td></tr><tr><td align=\"left\">&#8195;MPD, sum of two last trials</td><td align=\"left\">14.6 &#177; 1.0</td><td align=\"left\">14.8 &#177; 0.4</td><td align=\"left\">14.9 &#177; 0.2</td><td/><td/></tr><tr><td align=\"left\">&#8195;MPD, delayed recall</td><td align=\"left\">13.9 &#177; 1.0</td><td align=\"left\">14.2 &#177; 1.0</td><td align=\"left\">14.8 &#177; 0.4</td><td align=\"left\">C &gt; M**<break/>C &gt; BN*</td><td/></tr><tr><td align=\"left\">&#8195;WMS-III logical memory, immediate recall</td><td align=\"left\">12.5 &#177; 2.9</td><td align=\"left\">14.3 &#177; 3.6</td><td align=\"left\">16.3 &#177; 3.4</td><td align=\"left\">C &gt; M**</td><td align=\"left\">1.17</td></tr><tr><td align=\"left\">&#8195;WMS-III logical memory, delayed recall</td><td align=\"left\">11.1 &#177; 4.3</td><td align=\"left\">13.4 &#177; 3.3</td><td align=\"left\">14.5 &#177; 4.1</td><td/><td/></tr></tbody></table></body></html>","text":"Pmid= 1914339:Table= Table 3","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":-132312929,"_task_hash":-1260783404,"_view_id":"review","accept":[5],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":null,"sessions":["tableclass-test-params-100-frank","tableclass-test-params-100-gill","tableclass-test-params-100-vicky"],"versions":[{"html":"<!DOCTYPE html><html><body><h1>Groups comparisons of cognitive measures using ANOVA</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td align=\"left\"><bold>Domain Test</bold></td><td align=\"left\"><bold>Methadone (<italic>n </italic>= 16)</bold></td><td align=\"left\"><bold>Buprenorphine/Naloxone(<italic>n </italic>= 17)</bold></td><td align=\"left\"><bold>Control(<italic>n </italic>= 17)</bold></td><td align=\"left\"><bold>Statistical comparisons between groups showing better performance first</bold></td><td align=\"left\"><bold>Effect size (Cohen\\'s d)</bold></td></tr></thead><tbody><tr><td/><td align=\"left\"><bold>Mean &#177; SD</bold></td><td align=\"left\"><bold>Mean &#177; SD</bold></td><td align=\"left\"><bold>Mean &#177; SD</bold></td><td/><td/></tr><tr><td colspan=\"6\"><hr/></td></tr><tr><td align=\"left\">Attention</td><td/><td/><td/><td/><td/></tr><tr><td align=\"left\">&#8195;TAP Tonic Alertness, simple reaction time</td><td align=\"left\">257.6 &#177; 32.1</td><td align=\"left\">228.0 &#177; 13.0</td><td align=\"left\">244.4 &#177; 30.0</td><td align=\"left\">BN &lt; M **</td><td align=\"left\">1.11</td></tr><tr><td align=\"left\">&#8195;TAP Phasic Alertness, reaction time after warning signal</td><td align=\"left\">245.6 &#177; 30.4</td><td align=\"left\">227.4 &#177; 17.0</td><td align=\"left\">230.3 &#177; 31.7</td><td/><td/></tr><tr><td align=\"left\">&#8195;TAP Go/NoGo, reaction time</td><td align=\"left\">528.3 &#177; 82.0</td><td align=\"left\">496.9 &#177; 65.3<sup>a</sup></td><td align=\"left\">465.5 &#177; 39.5</td><td align=\"left\">C &lt; M*</td><td align=\"left\">0.88</td></tr><tr><td align=\"left\">&#8195;TAP Go/NoGo, errors</td><td align=\"left\">0.6 &#177; 0.7</td><td align=\"left\">1.2 &#177; 1.4<sup>a</sup></td><td align=\"left\">0.5 &#177; 0.6</td><td/><td/></tr><tr><td align=\"left\">Working memory</td><td/><td/><td/><td/><td/></tr><tr><td align=\"left\">&#8195;WMS-III LNS</td><td align=\"left\">8.8 &#177; 2.6<sup>b</sup></td><td align=\"left\">8.7 &#177; 1.7</td><td align=\"left\">11.8 &#177; 3.1</td><td align=\"left\">C &gt; M**<break/>C &gt; BN**</td><td align=\"left\">1.02<break/>1.21</td></tr><tr><td align=\"left\">&#8195;PASAT</td><td align=\"left\">34.9 &#177; 10.6<sup>b</sup></td><td align=\"left\">31.3 &#177; 10.8</td><td align=\"left\">47.8 &#177; 9.3</td><td align=\"left\">C &gt; M**<break/>C &gt; BN***</td><td align=\"left\">1.27<break/>1.60</td></tr><tr><td align=\"left\">Memory</td><td/><td/><td/><td/><td/></tr><tr><td align=\"left\">&#8195;MPD, first trial</td><td align=\"left\">10.1 &#177; 3.0</td><td align=\"left\">10.6 &#177; 2.4</td><td align=\"left\">13.0 &#177; 1.4</td><td align=\"left\">C &gt; M**<break/>C &gt; BN*</td><td align=\"left\">1.22<break/>1.19</td></tr><tr><td align=\"left\">&#8195;MPD, sum of two last trials</td><td align=\"left\">14.6 &#177; 1.0</td><td align=\"left\">14.8 &#177; 0.4</td><td align=\"left\">14.9 &#177; 0.2</td><td/><td/></tr><tr><td align=\"left\">&#8195;MPD, delayed recall</td><td align=\"left\">13.9 &#177; 1.0</td><td align=\"left\">14.2 &#177; 1.0</td><td align=\"left\">14.8 &#177; 0.4</td><td align=\"left\">C &gt; M**<break/>C &gt; BN*</td><td/></tr><tr><td align=\"left\">&#8195;WMS-III logical memory, immediate recall</td><td align=\"left\">12.5 &#177; 2.9</td><td align=\"left\">14.3 &#177; 3.6</td><td align=\"left\">16.3 &#177; 3.4</td><td align=\"left\">C &gt; M**</td><td align=\"left\">1.17</td></tr><tr><td align=\"left\">&#8195;WMS-III logical memory, delayed recall</td><td align=\"left\">11.1 &#177; 4.3</td><td align=\"left\">13.4 &#177; 3.3</td><td align=\"left\">14.5 &#177; 4.1</td><td/><td/></tr></tbody></table></body></html>","text":"Pmid= 1914339:Table= Table 3","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":-132312929,"_task_hash":-1260783404,"_view_id":"choice","accept":[5],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":"tableclass-test-params-100-gill","sessions":["tableclass-test-params-100-frank","tableclass-test-params-100-gill","tableclass-test-params-100-vicky"],"default":true},{"html":"<!DOCTYPE html><html><body><h1>Groups comparisons of cognitive measures using ANOVA</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td align=\"left\"><bold>Domain Test</bold></td><td align=\"left\"><bold>Methadone (<italic>n </italic>= 16)</bold></td><td align=\"left\"><bold>Buprenorphine/Naloxone(<italic>n </italic>= 17)</bold></td><td align=\"left\"><bold>Control(<italic>n </italic>= 17)</bold></td><td align=\"left\"><bold>Statistical comparisons between groups showing better performance first</bold></td><td align=\"left\"><bold>Effect size (Cohen\\'s d)</bold></td></tr></thead><tbody><tr><td/><td align=\"left\"><bold>Mean &#177; SD</bold></td><td align=\"left\"><bold>Mean &#177; SD</bold></td><td align=\"left\"><bold>Mean &#177; SD</bold></td><td/><td/></tr><tr><td colspan=\"6\"><hr/></td></tr><tr><td align=\"left\">Attention</td><td/><td/><td/><td/><td/></tr><tr><td align=\"left\">&#8195;TAP Tonic Alertness, simple reaction time</td><td align=\"left\">257.6 &#177; 32.1</td><td align=\"left\">228.0 &#177; 13.0</td><td align=\"left\">244.4 &#177; 30.0</td><td align=\"left\">BN &lt; M **</td><td align=\"left\">1.11</td></tr><tr><td align=\"left\">&#8195;TAP Phasic Alertness, reaction time after warning signal</td><td align=\"left\">245.6 &#177; 30.4</td><td align=\"left\">227.4 &#177; 17.0</td><td align=\"left\">230.3 &#177; 31.7</td><td/><td/></tr><tr><td align=\"left\">&#8195;TAP Go/NoGo, reaction time</td><td align=\"left\">528.3 &#177; 82.0</td><td align=\"left\">496.9 &#177; 65.3<sup>a</sup></td><td align=\"left\">465.5 &#177; 39.5</td><td align=\"left\">C &lt; M*</td><td align=\"left\">0.88</td></tr><tr><td align=\"left\">&#8195;TAP Go/NoGo, errors</td><td align=\"left\">0.6 &#177; 0.7</td><td align=\"left\">1.2 &#177; 1.4<sup>a</sup></td><td align=\"left\">0.5 &#177; 0.6</td><td/><td/></tr><tr><td align=\"left\">Working memory</td><td/><td/><td/><td/><td/></tr><tr><td align=\"left\">&#8195;WMS-III LNS</td><td align=\"left\">8.8 &#177; 2.6<sup>b</sup></td><td align=\"left\">8.7 &#177; 1.7</td><td align=\"left\">11.8 &#177; 3.1</td><td align=\"left\">C &gt; M**<break/>C &gt; BN**</td><td align=\"left\">1.02<break/>1.21</td></tr><tr><td align=\"left\">&#8195;PASAT</td><td align=\"left\">34.9 &#177; 10.6<sup>b</sup></td><td align=\"left\">31.3 &#177; 10.8</td><td align=\"left\">47.8 &#177; 9.3</td><td align=\"left\">C &gt; M**<break/>C &gt; BN***</td><td align=\"left\">1.27<break/>1.60</td></tr><tr><td align=\"left\">Memory</td><td/><td/><td/><td/><td/></tr><tr><td align=\"left\">&#8195;MPD, first trial</td><td align=\"left\">10.1 &#177; 3.0</td><td align=\"left\">10.6 &#177; 2.4</td><td align=\"left\">13.0 &#177; 1.4</td><td align=\"left\">C &gt; M**<break/>C &gt; BN*</td><td align=\"left\">1.22<break/>1.19</td></tr><tr><td align=\"left\">&#8195;MPD, sum of two last trials</td><td align=\"left\">14.6 &#177; 1.0</td><td align=\"left\">14.8 &#177; 0.4</td><td align=\"left\">14.9 &#177; 0.2</td><td/><td/></tr><tr><td align=\"left\">&#8195;MPD, delayed recall</td><td align=\"left\">13.9 &#177; 1.0</td><td align=\"left\">14.2 &#177; 1.0</td><td align=\"left\">14.8 &#177; 0.4</td><td align=\"left\">C &gt; M**<break/>C &gt; BN*</td><td/></tr><tr><td align=\"left\">&#8195;WMS-III logical memory, immediate recall</td><td align=\"left\">12.5 &#177; 2.9</td><td align=\"left\">14.3 &#177; 3.6</td><td align=\"left\">16.3 &#177; 3.4</td><td align=\"left\">C &gt; M**</td><td align=\"left\">1.17</td></tr><tr><td align=\"left\">&#8195;WMS-III logical memory, delayed recall</td><td align=\"left\">11.1 &#177; 4.3</td><td align=\"left\">13.4 &#177; 3.3</td><td align=\"left\">14.5 &#177; 4.1</td><td/><td/></tr></tbody></table></body></html>","text":"Pmid= 1914339:Table= Table 3","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":-132312929,"_task_hash":-467214323,"_view_id":"choice","accept":[4],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":"tableclass-test-params-100-joe","sessions":["tableclass-test-params-100-joe"],"default":false}],"view_id":"choice"}
{"html":"<!DOCTYPE html><html><body><h1>Patient characteristics</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td align=\"left\">Characteristics</td><td align=\"center\">Patients</td></tr></thead><tbody><tr><td align=\"left\">Entered</td><td align=\"center\">8</td></tr><tr><td align=\"left\">Karnofsky performance score</td><td align=\"center\">90&#8211;100%</td></tr><tr><td align=\"left\">Age (years)</td><td/></tr><tr><td align=\"left\">&#8195;Median (range)</td><td align=\"center\">65.5 years (range 53 &#8211; 73 y)</td></tr><tr><td align=\"left\">Stage (primary diagnosis)</td><td/></tr><tr><td align=\"left\">&#8195;I</td><td align=\"center\">-</td></tr><tr><td align=\"left\">&#8195;II</td><td align=\"center\">6 (75%)</td></tr><tr><td align=\"left\">&#8195;III</td><td align=\"center\">-</td></tr><tr><td align=\"left\">&#8195;IV</td><td align=\"center\">1 (12.5%)</td></tr><tr><td align=\"left\">&#8195;Not available</td><td align=\"center\">1 (12.5%)</td></tr><tr><td align=\"left\">Ductal/Lobular</td><td align=\"center\">7/0</td></tr><tr><td align=\"left\">&#8195;Not available</td><td align=\"center\">1 (12.5%)</td></tr><tr><td align=\"left\">Grading</td><td/></tr><tr><td align=\"left\">&#8195;1</td><td align=\"center\">-</td></tr><tr><td align=\"left\">&#8195;2</td><td align=\"center\">2 (25%)</td></tr><tr><td align=\"left\">&#8195;3</td><td align=\"center\">5 (62.5%)</td></tr><tr><td align=\"left\">&#8195;Not available</td><td align=\"center\">1 (12.5%)</td></tr><tr><td align=\"left\">Estrogens receptor/progesteron receptor positive</td><td align=\"center\">7/6</td></tr><tr><td align=\"left\">Her2 Status positive/negative (IHC/FISH*)</td><td align=\"center\">0/8</td></tr><tr><td align=\"left\">Adjuvant chemotherapy</td><td align=\"center\">3 (37.5%)</td></tr><tr><td align=\"left\">Adjuvant endocrine therapy</td><td align=\"center\">3 (37.5%)</td></tr><tr><td align=\"left\">Palliative endocrine therapy</td><td align=\"center\">4 (50%)</td></tr><tr><td align=\"left\">Prior anthracycline exposure</td><td align=\"center\">5 (62.5%)</td></tr><tr><td align=\"left\">Prior capecitabine exposure</td><td align=\"center\">2 (25%)</td></tr><tr><td align=\"left\">Time to recurrence</td><td/></tr><tr><td align=\"left\">&#8195;Median (range)</td><td align=\"center\">87 months (13 &#8211; 148 m)</td></tr><tr><td align=\"left\">Treatment line</td><td/></tr><tr><td align=\"left\">&#8195;First line</td><td align=\"center\">4 (50%)</td></tr><tr><td align=\"left\">&#8195;Second line</td><td align=\"center\">2 (25%)</td></tr><tr><td align=\"left\">&#8195;&gt;/= Third line</td><td align=\"center\">2 (25%)</td></tr><tr><td align=\"left\">Metastatic sites</td><td/></tr><tr><td align=\"left\">&#8195;Median (range)</td><td align=\"center\">2 (range 1 &#8211; 4)</td></tr><tr><td align=\"left\">&#8195;bones/soft tissue only</td><td align=\"center\">3 (37.5%)</td></tr><tr><td align=\"left\">&#8195;visceral only</td><td align=\"center\">-</td></tr><tr><td align=\"left\">&#8195;both</td><td align=\"center\">5 (62.5%)</td></tr><tr><td align=\"left\">Localisation</td><td/></tr><tr><td align=\"left\">&#8195;Lung</td><td align=\"center\">1</td></tr><tr><td align=\"left\">&#8195;Liver</td><td align=\"center\">3</td></tr><tr><td align=\"left\">&#8195;Bones</td><td align=\"center\">5</td></tr><tr><td align=\"left\">&#8195;Lymph nodes</td><td align=\"center\">6</td></tr><tr><td align=\"left\">&#8195;Soft tissue</td><td align=\"center\">2</td></tr><tr><td align=\"left\">&#8195;Brain</td><td align=\"center\">1</td></tr><tr><td align=\"left\">&#8195;Skin</td><td align=\"center\">1</td></tr><tr><td align=\"left\">More than one metastatic site</td><td align=\"center\">7 (87.5%)</td></tr></tbody></table></body></html>","text":"Pmid= 1939983:Table= Table 1","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":-71915965,"_task_hash":1442900108,"_view_id":"review","accept":[5],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":null,"sessions":["tableclass-test-params-100-frank","tableclass-test-params-100-gill","tableclass-test-params-100-joe","tableclass-test-params-100-vicky"],"versions":[{"html":"<!DOCTYPE html><html><body><h1>Patient characteristics</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td align=\"left\">Characteristics</td><td align=\"center\">Patients</td></tr></thead><tbody><tr><td align=\"left\">Entered</td><td align=\"center\">8</td></tr><tr><td align=\"left\">Karnofsky performance score</td><td align=\"center\">90&#8211;100%</td></tr><tr><td align=\"left\">Age (years)</td><td/></tr><tr><td align=\"left\">&#8195;Median (range)</td><td align=\"center\">65.5 years (range 53 &#8211; 73 y)</td></tr><tr><td align=\"left\">Stage (primary diagnosis)</td><td/></tr><tr><td align=\"left\">&#8195;I</td><td align=\"center\">-</td></tr><tr><td align=\"left\">&#8195;II</td><td align=\"center\">6 (75%)</td></tr><tr><td align=\"left\">&#8195;III</td><td align=\"center\">-</td></tr><tr><td align=\"left\">&#8195;IV</td><td align=\"center\">1 (12.5%)</td></tr><tr><td align=\"left\">&#8195;Not available</td><td align=\"center\">1 (12.5%)</td></tr><tr><td align=\"left\">Ductal/Lobular</td><td align=\"center\">7/0</td></tr><tr><td align=\"left\">&#8195;Not available</td><td align=\"center\">1 (12.5%)</td></tr><tr><td align=\"left\">Grading</td><td/></tr><tr><td align=\"left\">&#8195;1</td><td align=\"center\">-</td></tr><tr><td align=\"left\">&#8195;2</td><td align=\"center\">2 (25%)</td></tr><tr><td align=\"left\">&#8195;3</td><td align=\"center\">5 (62.5%)</td></tr><tr><td align=\"left\">&#8195;Not available</td><td align=\"center\">1 (12.5%)</td></tr><tr><td align=\"left\">Estrogens receptor/progesteron receptor positive</td><td align=\"center\">7/6</td></tr><tr><td align=\"left\">Her2 Status positive/negative (IHC/FISH*)</td><td align=\"center\">0/8</td></tr><tr><td align=\"left\">Adjuvant chemotherapy</td><td align=\"center\">3 (37.5%)</td></tr><tr><td align=\"left\">Adjuvant endocrine therapy</td><td align=\"center\">3 (37.5%)</td></tr><tr><td align=\"left\">Palliative endocrine therapy</td><td align=\"center\">4 (50%)</td></tr><tr><td align=\"left\">Prior anthracycline exposure</td><td align=\"center\">5 (62.5%)</td></tr><tr><td align=\"left\">Prior capecitabine exposure</td><td align=\"center\">2 (25%)</td></tr><tr><td align=\"left\">Time to recurrence</td><td/></tr><tr><td align=\"left\">&#8195;Median (range)</td><td align=\"center\">87 months (13 &#8211; 148 m)</td></tr><tr><td align=\"left\">Treatment line</td><td/></tr><tr><td align=\"left\">&#8195;First line</td><td align=\"center\">4 (50%)</td></tr><tr><td align=\"left\">&#8195;Second line</td><td align=\"center\">2 (25%)</td></tr><tr><td align=\"left\">&#8195;&gt;/= Third line</td><td align=\"center\">2 (25%)</td></tr><tr><td align=\"left\">Metastatic sites</td><td/></tr><tr><td align=\"left\">&#8195;Median (range)</td><td align=\"center\">2 (range 1 &#8211; 4)</td></tr><tr><td align=\"left\">&#8195;bones/soft tissue only</td><td align=\"center\">3 (37.5%)</td></tr><tr><td align=\"left\">&#8195;visceral only</td><td align=\"center\">-</td></tr><tr><td align=\"left\">&#8195;both</td><td align=\"center\">5 (62.5%)</td></tr><tr><td align=\"left\">Localisation</td><td/></tr><tr><td align=\"left\">&#8195;Lung</td><td align=\"center\">1</td></tr><tr><td align=\"left\">&#8195;Liver</td><td align=\"center\">3</td></tr><tr><td align=\"left\">&#8195;Bones</td><td align=\"center\">5</td></tr><tr><td align=\"left\">&#8195;Lymph nodes</td><td align=\"center\">6</td></tr><tr><td align=\"left\">&#8195;Soft tissue</td><td align=\"center\">2</td></tr><tr><td align=\"left\">&#8195;Brain</td><td align=\"center\">1</td></tr><tr><td align=\"left\">&#8195;Skin</td><td align=\"center\">1</td></tr><tr><td align=\"left\">More than one metastatic site</td><td align=\"center\">7 (87.5%)</td></tr></tbody></table></body></html>","text":"Pmid= 1939983:Table= Table 1","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":-71915965,"_task_hash":1442900108,"_view_id":"choice","accept":[5],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":"tableclass-test-params-100-gill","sessions":["tableclass-test-params-100-frank","tableclass-test-params-100-gill","tableclass-test-params-100-joe","tableclass-test-params-100-vicky"],"default":true}],"view_id":"choice"}
{"html":"<!DOCTYPE html><html><body><h1>Results</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td align=\"left\">Week</td><td align=\"left\">Measurement</td><td align=\"center\" colspan=\"2\">Results (TP ng/ml) (mean +/- SD; 95% CI; outliers)</td></tr></thead><tbody><tr><td align=\"left\">1</td><td align=\"left\">1</td><td align=\"left\">299.24 &#177; 35.09; 95% CI 199.09 &#8211; 258.58;</td><td align=\"left\">283.42; 169.49</td></tr><tr><td/><td align=\"left\">2</td><td align=\"left\">182.97 &#177; 56.18; 95% CI 136.00 &#8211; 229.93;</td><td align=\"left\">240.39; 93.80</td></tr><tr><td/><td align=\"left\">3</td><td align=\"left\">246.77 &#177; 70.14; 95% CI 188.13 &#8211; 305.41;</td><td align=\"left\">350.41; 173.99</td></tr><tr><td/><td align=\"left\">4</td><td align=\"left\">155.20 &#177; 72.11; 95% CI 94.92 &#8211; 215.49;</td><td align=\"left\">242.42; 49.57</td></tr><tr><td/><td align=\"left\">5</td><td align=\"left\">170.66 &#177; 47.63; 95% CI 130.84 &#8211; 210.47;</td><td align=\"left\">232.71; 115.57</td></tr><tr><td/><td align=\"left\">6</td><td align=\"left\">187.55 &#177; 67.24; 95% CI 131.33 &#8211; 243.76;</td><td align=\"left\">295.48; 79.59</td></tr><tr><td/><td align=\"left\">7</td><td align=\"left\">200.79 &#177; 105.45; 95% CI 112.64 &#8211; 288.95;</td><td align=\"left\">369.96; 17.24</td></tr><tr><td/><td align=\"left\">8</td><td align=\"left\">196.36 &#177; 139.83; 95% CI 79.46 &#8211; 313.27;</td><td align=\"left\">431.39; 4.74</td></tr><tr><td align=\"left\">6</td><td align=\"left\">1</td><td align=\"left\">233.98 &#177; 52.29; 95% CI 190.26 &#8211; 277.70;</td><td align=\"left\">297.52; 125.95</td></tr><tr><td/><td align=\"left\">2</td><td align=\"left\">177.54 &#177; 76.06; 95% CI 113.95 &#8211; 241.13;</td><td align=\"left\">258.41; 50.44</td></tr><tr><td/><td align=\"left\">3</td><td align=\"left\">179.14 &#177; 76.68; 95% CI 115.03 &#8211; 243.24;</td><td align=\"left\">273.87; 43.42</td></tr><tr><td/><td align=\"left\">4</td><td align=\"left\">110.93 &#177; 66.80; 95% CI 55.08 &#8211; 166.77;</td><td align=\"left\">187.07; 20.76</td></tr><tr><td/><td align=\"left\">5</td><td align=\"left\">183.81 &#177; 52.89; 95% CI 139.59 &#8211; 228.02;</td><td align=\"left\">228.32; 60.86</td></tr><tr><td/><td align=\"left\">6</td><td align=\"left\">185.02 &#177; 70.87; 95% CI 125.77 &#8211; 244.27;</td><td align=\"left\">251.34; 43.74</td></tr><tr><td/><td align=\"left\">7</td><td align=\"left\">232.50 &#177; 126.58; 95% CI 126.67 &#8211; 338.32;</td><td align=\"left\">371.45; 6.62</td></tr><tr><td/><td align=\"left\">8</td><td align=\"left\">215.03 &#177; 90.78; 95% CI 139.13 &#8211; 290.92;</td><td align=\"left\">297.99; 7.56</td></tr></tbody></table></body></html>","text":"Pmid= 1939983:Table= Table 2","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":-1187517244,"_task_hash":-1324118421,"_view_id":"review","accept":[5],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":null,"sessions":["tableclass-test-params-100-frank","tableclass-test-params-100-gill","tableclass-test-params-100-vicky"],"versions":[{"html":"<!DOCTYPE html><html><body><h1>Results</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td align=\"left\">Week</td><td align=\"left\">Measurement</td><td align=\"center\" colspan=\"2\">Results (TP ng/ml) (mean +/- SD; 95% CI; outliers)</td></tr></thead><tbody><tr><td align=\"left\">1</td><td align=\"left\">1</td><td align=\"left\">299.24 &#177; 35.09; 95% CI 199.09 &#8211; 258.58;</td><td align=\"left\">283.42; 169.49</td></tr><tr><td/><td align=\"left\">2</td><td align=\"left\">182.97 &#177; 56.18; 95% CI 136.00 &#8211; 229.93;</td><td align=\"left\">240.39; 93.80</td></tr><tr><td/><td align=\"left\">3</td><td align=\"left\">246.77 &#177; 70.14; 95% CI 188.13 &#8211; 305.41;</td><td align=\"left\">350.41; 173.99</td></tr><tr><td/><td align=\"left\">4</td><td align=\"left\">155.20 &#177; 72.11; 95% CI 94.92 &#8211; 215.49;</td><td align=\"left\">242.42; 49.57</td></tr><tr><td/><td align=\"left\">5</td><td align=\"left\">170.66 &#177; 47.63; 95% CI 130.84 &#8211; 210.47;</td><td align=\"left\">232.71; 115.57</td></tr><tr><td/><td align=\"left\">6</td><td align=\"left\">187.55 &#177; 67.24; 95% CI 131.33 &#8211; 243.76;</td><td align=\"left\">295.48; 79.59</td></tr><tr><td/><td align=\"left\">7</td><td align=\"left\">200.79 &#177; 105.45; 95% CI 112.64 &#8211; 288.95;</td><td align=\"left\">369.96; 17.24</td></tr><tr><td/><td align=\"left\">8</td><td align=\"left\">196.36 &#177; 139.83; 95% CI 79.46 &#8211; 313.27;</td><td align=\"left\">431.39; 4.74</td></tr><tr><td align=\"left\">6</td><td align=\"left\">1</td><td align=\"left\">233.98 &#177; 52.29; 95% CI 190.26 &#8211; 277.70;</td><td align=\"left\">297.52; 125.95</td></tr><tr><td/><td align=\"left\">2</td><td align=\"left\">177.54 &#177; 76.06; 95% CI 113.95 &#8211; 241.13;</td><td align=\"left\">258.41; 50.44</td></tr><tr><td/><td align=\"left\">3</td><td align=\"left\">179.14 &#177; 76.68; 95% CI 115.03 &#8211; 243.24;</td><td align=\"left\">273.87; 43.42</td></tr><tr><td/><td align=\"left\">4</td><td align=\"left\">110.93 &#177; 66.80; 95% CI 55.08 &#8211; 166.77;</td><td align=\"left\">187.07; 20.76</td></tr><tr><td/><td align=\"left\">5</td><td align=\"left\">183.81 &#177; 52.89; 95% CI 139.59 &#8211; 228.02;</td><td align=\"left\">228.32; 60.86</td></tr><tr><td/><td align=\"left\">6</td><td align=\"left\">185.02 &#177; 70.87; 95% CI 125.77 &#8211; 244.27;</td><td align=\"left\">251.34; 43.74</td></tr><tr><td/><td align=\"left\">7</td><td align=\"left\">232.50 &#177; 126.58; 95% CI 126.67 &#8211; 338.32;</td><td align=\"left\">371.45; 6.62</td></tr><tr><td/><td align=\"left\">8</td><td align=\"left\">215.03 &#177; 90.78; 95% CI 139.13 &#8211; 290.92;</td><td align=\"left\">297.99; 7.56</td></tr></tbody></table></body></html>","text":"Pmid= 1939983:Table= Table 2","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":-1187517244,"_task_hash":-1324118421,"_view_id":"choice","accept":[5],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":"tableclass-test-params-100-gill","sessions":["tableclass-test-params-100-frank","tableclass-test-params-100-gill","tableclass-test-params-100-vicky"],"default":true},{"html":"<!DOCTYPE html><html><body><h1>Results</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td align=\"left\">Week</td><td align=\"left\">Measurement</td><td align=\"center\" colspan=\"2\">Results (TP ng/ml) (mean +/- SD; 95% CI; outliers)</td></tr></thead><tbody><tr><td align=\"left\">1</td><td align=\"left\">1</td><td align=\"left\">299.24 &#177; 35.09; 95% CI 199.09 &#8211; 258.58;</td><td align=\"left\">283.42; 169.49</td></tr><tr><td/><td align=\"left\">2</td><td align=\"left\">182.97 &#177; 56.18; 95% CI 136.00 &#8211; 229.93;</td><td align=\"left\">240.39; 93.80</td></tr><tr><td/><td align=\"left\">3</td><td align=\"left\">246.77 &#177; 70.14; 95% CI 188.13 &#8211; 305.41;</td><td align=\"left\">350.41; 173.99</td></tr><tr><td/><td align=\"left\">4</td><td align=\"left\">155.20 &#177; 72.11; 95% CI 94.92 &#8211; 215.49;</td><td align=\"left\">242.42; 49.57</td></tr><tr><td/><td align=\"left\">5</td><td align=\"left\">170.66 &#177; 47.63; 95% CI 130.84 &#8211; 210.47;</td><td align=\"left\">232.71; 115.57</td></tr><tr><td/><td align=\"left\">6</td><td align=\"left\">187.55 &#177; 67.24; 95% CI 131.33 &#8211; 243.76;</td><td align=\"left\">295.48; 79.59</td></tr><tr><td/><td align=\"left\">7</td><td align=\"left\">200.79 &#177; 105.45; 95% CI 112.64 &#8211; 288.95;</td><td align=\"left\">369.96; 17.24</td></tr><tr><td/><td align=\"left\">8</td><td align=\"left\">196.36 &#177; 139.83; 95% CI 79.46 &#8211; 313.27;</td><td align=\"left\">431.39; 4.74</td></tr><tr><td align=\"left\">6</td><td align=\"left\">1</td><td align=\"left\">233.98 &#177; 52.29; 95% CI 190.26 &#8211; 277.70;</td><td align=\"left\">297.52; 125.95</td></tr><tr><td/><td align=\"left\">2</td><td align=\"left\">177.54 &#177; 76.06; 95% CI 113.95 &#8211; 241.13;</td><td align=\"left\">258.41; 50.44</td></tr><tr><td/><td align=\"left\">3</td><td align=\"left\">179.14 &#177; 76.68; 95% CI 115.03 &#8211; 243.24;</td><td align=\"left\">273.87; 43.42</td></tr><tr><td/><td align=\"left\">4</td><td align=\"left\">110.93 &#177; 66.80; 95% CI 55.08 &#8211; 166.77;</td><td align=\"left\">187.07; 20.76</td></tr><tr><td/><td align=\"left\">5</td><td align=\"left\">183.81 &#177; 52.89; 95% CI 139.59 &#8211; 228.02;</td><td align=\"left\">228.32; 60.86</td></tr><tr><td/><td align=\"left\">6</td><td align=\"left\">185.02 &#177; 70.87; 95% CI 125.77 &#8211; 244.27;</td><td align=\"left\">251.34; 43.74</td></tr><tr><td/><td align=\"left\">7</td><td align=\"left\">232.50 &#177; 126.58; 95% CI 126.67 &#8211; 338.32;</td><td align=\"left\">371.45; 6.62</td></tr><tr><td/><td align=\"left\">8</td><td align=\"left\">215.03 &#177; 90.78; 95% CI 139.13 &#8211; 290.92;</td><td align=\"left\">297.99; 7.56</td></tr></tbody></table></body></html>","text":"Pmid= 1939983:Table= Table 2","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":-1187517244,"_task_hash":-92617744,"_view_id":"choice","accept":[1],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":"tableclass-test-params-100-joe","sessions":["tableclass-test-params-100-joe"],"default":false}],"view_id":"choice"}
{"html":"<!DOCTYPE html><html><body><h1>Allelic and genotypic frequencies of</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td align=\"center\"><bold><italic>CYP2C19 </italic>Alleles</bold></td><td align=\"center\"><bold>Number of alleles</bold></td><td align=\"center\"><bold>Frequency (%) (95% CI)</bold></td></tr></thead><tbody><tr><td align=\"center\"><bold><italic>*1</italic></bold></td><td align=\"center\">345</td><td align=\"center\">91.3 (88.5&#8211;94.1)</td></tr><tr><td align=\"center\"><bold><italic>*2</italic></bold></td><td align=\"center\">33</td><td align=\"center\">8.7 (5.9&#8211;11.5)</td></tr><tr><td align=\"center\"><bold><italic>*3</italic></bold></td><td align=\"center\">0</td><td align=\"center\">0</td></tr><tr><td align=\"center\"><bold><italic>*4</italic></bold></td><td align=\"center\">0</td><td align=\"center\">0</td></tr><tr><td align=\"center\"><bold><italic>*5</italic></bold></td><td align=\"center\">0</td><td align=\"center\">0</td></tr><tr><td align=\"center\"><bold><italic>*6</italic></bold></td><td align=\"center\">0</td><td align=\"center\">0</td></tr><tr><td align=\"center\"><bold><italic>*8</italic></bold></td><td align=\"center\">0</td><td align=\"center\">0</td></tr><tr><td colspan=\"3\"><hr/></td></tr><tr><td align=\"center\"><bold><italic>CYP2C19 </italic>genotypes</bold></td><td align=\"center\"><bold>Number of subjects</bold></td><td align=\"center\"><bold>Frequency (%) (95% CI)</bold></td></tr><tr><td colspan=\"3\"><hr/></td></tr><tr><td align=\"center\"><bold><italic>*1/*1</italic></bold></td><td align=\"center\">158</td><td align=\"center\">83.6 (78.3&#8211;88.9)</td></tr><tr><td align=\"center\"><bold><italic>*1/*2</italic></bold></td><td align=\"center\">29</td><td align=\"center\">15.3 (10.2&#8211;20.4)</td></tr><tr><td align=\"center\"><bold><italic>*2/*2</italic></bold></td><td align=\"center\">2</td><td align=\"center\">1.1 (0.4&#8211;3)</td></tr></tbody></table></body></html>","text":"Pmid= 1950696:Table= Table 1","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":-1200015841,"_task_hash":861687497,"_view_id":"review","accept":[5],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":null,"sessions":["tableclass-test-params-100-frank","tableclass-test-params-100-gill","tableclass-test-params-100-joe","tableclass-test-params-100-vicky"],"versions":[{"html":"<!DOCTYPE html><html><body><h1>Allelic and genotypic frequencies of</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td align=\"center\"><bold><italic>CYP2C19 </italic>Alleles</bold></td><td align=\"center\"><bold>Number of alleles</bold></td><td align=\"center\"><bold>Frequency (%) (95% CI)</bold></td></tr></thead><tbody><tr><td align=\"center\"><bold><italic>*1</italic></bold></td><td align=\"center\">345</td><td align=\"center\">91.3 (88.5&#8211;94.1)</td></tr><tr><td align=\"center\"><bold><italic>*2</italic></bold></td><td align=\"center\">33</td><td align=\"center\">8.7 (5.9&#8211;11.5)</td></tr><tr><td align=\"center\"><bold><italic>*3</italic></bold></td><td align=\"center\">0</td><td align=\"center\">0</td></tr><tr><td align=\"center\"><bold><italic>*4</italic></bold></td><td align=\"center\">0</td><td align=\"center\">0</td></tr><tr><td align=\"center\"><bold><italic>*5</italic></bold></td><td align=\"center\">0</td><td align=\"center\">0</td></tr><tr><td align=\"center\"><bold><italic>*6</italic></bold></td><td align=\"center\">0</td><td align=\"center\">0</td></tr><tr><td align=\"center\"><bold><italic>*8</italic></bold></td><td align=\"center\">0</td><td align=\"center\">0</td></tr><tr><td colspan=\"3\"><hr/></td></tr><tr><td align=\"center\"><bold><italic>CYP2C19 </italic>genotypes</bold></td><td align=\"center\"><bold>Number of subjects</bold></td><td align=\"center\"><bold>Frequency (%) (95% CI)</bold></td></tr><tr><td colspan=\"3\"><hr/></td></tr><tr><td align=\"center\"><bold><italic>*1/*1</italic></bold></td><td align=\"center\">158</td><td align=\"center\">83.6 (78.3&#8211;88.9)</td></tr><tr><td align=\"center\"><bold><italic>*1/*2</italic></bold></td><td align=\"center\">29</td><td align=\"center\">15.3 (10.2&#8211;20.4)</td></tr><tr><td align=\"center\"><bold><italic>*2/*2</italic></bold></td><td align=\"center\">2</td><td align=\"center\">1.1 (0.4&#8211;3)</td></tr></tbody></table></body></html>","text":"Pmid= 1950696:Table= Table 1","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":-1200015841,"_task_hash":861687497,"_view_id":"choice","accept":[5],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":"tableclass-test-params-100-gill","sessions":["tableclass-test-params-100-frank","tableclass-test-params-100-gill","tableclass-test-params-100-joe","tableclass-test-params-100-vicky"],"default":true}],"view_id":"choice"}
{"html":"<!DOCTYPE html><html><body><h1>Correlation between CYP2C19 genotype and MR in Colombian Mestizo individuals (n = 44). MR: Metabolic ratio, n: number of subjects, SD standard deviation.</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td align=\"center\"><bold>GENOTYPE</bold></td><td align=\"center\"><bold><italic>n</italic></bold></td><td align=\"center\"><bold>MR (mean &#177; SD)</bold></td><td align=\"center\"><bold><italic>P</italic></bold></td></tr></thead><tbody><tr><td align=\"center\"><italic>*1/*</italic>1</td><td align=\"center\">39</td><td align=\"center\">-0.01 &#177; 0.15</td><td/></tr><tr><td align=\"center\"><italic>*1/*2</italic></td><td align=\"center\">3</td><td align=\"center\">0.23 &#177; 0.15</td><td/></tr><tr><td align=\"center\"><italic>*2/*2</italic></td><td align=\"center\">2</td><td align=\"center\">0.99 &#177; 0.35</td><td align=\"center\">&lt;0.01</td></tr></tbody></table></body></html>","text":"Pmid= 1950696:Table= Table 2","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":1000330481,"_task_hash":-2051042619,"_view_id":"review","accept":[5],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":null,"sessions":["tableclass-test-params-100-frank","tableclass-test-params-100-gill","tableclass-test-params-100-joe","tableclass-test-params-100-vicky"],"versions":[{"html":"<!DOCTYPE html><html><body><h1>Correlation between CYP2C19 genotype and MR in Colombian Mestizo individuals (n = 44). MR: Metabolic ratio, n: number of subjects, SD standard deviation.</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td align=\"center\"><bold>GENOTYPE</bold></td><td align=\"center\"><bold><italic>n</italic></bold></td><td align=\"center\"><bold>MR (mean &#177; SD)</bold></td><td align=\"center\"><bold><italic>P</italic></bold></td></tr></thead><tbody><tr><td align=\"center\"><italic>*1/*</italic>1</td><td align=\"center\">39</td><td align=\"center\">-0.01 &#177; 0.15</td><td/></tr><tr><td align=\"center\"><italic>*1/*2</italic></td><td align=\"center\">3</td><td align=\"center\">0.23 &#177; 0.15</td><td/></tr><tr><td align=\"center\"><italic>*2/*2</italic></td><td align=\"center\">2</td><td align=\"center\">0.99 &#177; 0.35</td><td align=\"center\">&lt;0.01</td></tr></tbody></table></body></html>","text":"Pmid= 1950696:Table= Table 2","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":1000330481,"_task_hash":-2051042619,"_view_id":"choice","accept":[5],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":"tableclass-test-params-100-gill","sessions":["tableclass-test-params-100-frank","tableclass-test-params-100-gill","tableclass-test-params-100-joe","tableclass-test-params-100-vicky"],"default":true}],"view_id":"choice"}
{"html":"<!DOCTYPE html><html><body><h1>Table depicting drugs and nature of adverse events seen during the study</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td align=\"left\">Drug Class/Drug</td><td align=\"left\"><bold>NO. (%) OF ADRS</bold></td><td align=\"left\">Individual drugs</td><td align=\"left\">Adverse Event</td></tr></thead><tbody><tr><td align=\"left\">Anti tubercular agents (AKT)</td><td align=\"left\">52</td><td align=\"left\">HRZ (35), AKT (7), Rifampin (4), Ethambutol (2), Pyrazinamide (2) Streptomycin (1), Isoniazid(1),</td><td align=\"left\">Thrombocytopenia, Hepatitis, Hepatic encephalopathy, Retro bulbar neuritis, Cholestatic jaundice, Erythema multiforme, Vestibular toxicity, Gastritis, Abdominal/Respiratory/Flu like syndrome, Hypersensitivity reaction, Psychosis, Peripheral neuropathy, dysglycemia</td></tr><tr><td align=\"left\">Antiepileptics</td><td align=\"left\">36</td><td align=\"left\">Phenytoin(24), Valproate (5), Phenobarbiturate(4) carbamazepine (3)</td><td align=\"left\">Erythema multiforme, Symptomatic toxic carbamazepine/phenytoin/valproate levels with cerebellar signs</td></tr><tr><td align=\"left\">Antimalarials</td><td align=\"left\">30</td><td align=\"left\">Chloroquine (29), Sulfadoxine-pyrimethamine (1)</td><td align=\"left\">Gastritis, Giddiness, Erthyema multiforme, Psychosis, Hypersensitivity reactions, Hypotension</td></tr><tr><td align=\"left\">Anticoagulants</td><td align=\"left\">25</td><td align=\"left\">Warfarin (24), Heparin (1)</td><td align=\"left\">GI bleeding, haematuria, high INR, Intracranial bleed</td></tr><tr><td align=\"left\">Oral hypoglycemic agents (OHA)</td><td align=\"left\">16</td><td align=\"left\">Glibenclamide (10), Glyburide (6)</td><td align=\"left\">Hypoglycemia, seizures,</td></tr><tr><td align=\"left\">NSAIDS</td><td align=\"left\">14</td><td align=\"left\">Paracetamol (6), Aspirin (3), Ibuprofen (1), Etoricoxib (1), Nimesulide (2), Diclofenac (1)</td><td align=\"left\">Hypersensitivity reaction, Gastritis, mucosal damage, Hematuria, (Etoricoxib) potentiates OHA induced Hypoglycemia, ARF on CRF, Thrombocytopenia</td></tr><tr><td align=\"left\">Antihypertensives</td><td align=\"left\">10</td><td align=\"left\">Atenolol (4), ACE inhibitors (2), Losartan (2), Clonidine (1), Isosorbide dinitrate (1)</td><td align=\"left\">Hypotension, Hypersensitivity reaction, AV block, Bradycardia, Hyperkalemia, Missed dose of clonidine leading to rebound hypertension, dry mouth</td></tr><tr><td align=\"left\">Cytotoxic drugs</td><td align=\"left\">9</td><td align=\"left\">Methotrexate (3), 5-Fluorouracil (2), Cisplatin (1), Etoposide (1), Paclitaxel (1), Chemo (1)</td><td align=\"left\">Bone marrow suppression (with opportunistic infection), Nephrotoxicity, Liver damage, GI mucositis, Anorexia, Myelodysplastic syndrome, Alopecia, Hyperuricemia, Abdominal pain, Neutropenia</td></tr><tr><td align=\"left\">Steroids</td><td align=\"left\">9</td><td align=\"left\">Prednisolone (7), Betamethasone (2)</td><td align=\"left\">Gastritis, Hypertension, Hyperglycemia, Mania, Fragile skin, Facial puffiness, Osteoporosis, Opportunistic infections</td></tr><tr><td align=\"left\">Insulin</td><td align=\"left\">8</td><td align=\"left\">Humulin70/30 (8)</td><td align=\"left\">Hypoglycemia, Erythema/swelling/stinging at injection site</td></tr><tr><td align=\"left\">Digoxin</td><td align=\"left\">8</td><td align=\"left\">--</td><td align=\"left\">Symptomatic toxic digoxin levels</td></tr><tr><td align=\"left\">Fluoroquinolones</td><td align=\"left\">8</td><td align=\"left\">Ciprofloxacin(4), Ofloxacin (2) Gatifloxacin (2)</td><td align=\"left\">Complex partial seizures, Peripheral neuropathy, Dystonia, Hypersensitivity reaction, tendinitis, dysguesia</td></tr><tr><td align=\"left\">B lactam antibiotics</td><td align=\"left\">8</td><td align=\"left\">Amoxicillin(3), Ampicillin(2), Cefadroxil (1), Ceftriaxone (1), Ceftazidime (1)</td><td align=\"left\">Hypersensitivity reaction, Fixed drug eruptions, Diarrhea, muscle spasm, Generalized tonic-clonic seizure</td></tr><tr><td align=\"left\">Antiretrovirals</td><td align=\"left\">4</td><td align=\"left\">Efavirenz (2), Stavudine (1), Zidovudine (1)</td><td align=\"left\">Metabolic acidosis, Drowsiness, hypokalemia, Peripheral neuropathy</td></tr><tr><td align=\"left\">Benzodiazepines</td><td align=\"left\">4</td><td align=\"left\">Chlordiazepoxide (2), Diazepam (2)</td><td align=\"left\">Increased appetite and weight gain, Drowsiness, Ataxia, Amnesia, Vertigo</td></tr><tr><td align=\"left\">Bronchodilators</td><td align=\"left\">4</td><td align=\"left\">Salbutamol (3), Theophylline (1)</td><td align=\"left\">Tremors</td></tr><tr><td align=\"left\">Haematinics</td><td align=\"left\">3</td><td align=\"left\">Ferrous fumarate(2) Ferrous sulfate (1)</td><td align=\"left\">Epigastric pain, Heart burn, Vomiting, Metallic taste in mouth</td></tr><tr><td align=\"left\">Fibrinolytics</td><td align=\"left\">2</td><td align=\"left\">Urokinase (2)</td><td align=\"left\">Hypotension, AV block</td></tr><tr><td align=\"left\">Miscellaneous</td><td align=\"left\">15</td><td align=\"left\">Metronidazole (1) Nicotinic acid (1) Fluconazole (1) Ethamsylate (1) Amitriptyline (1) Cotrimoxazole (1) Oxybutinin HCl (1) Dextropropoxy- phene (1) Urograffin (1) Amikacin (1) Benzthiazide (1) Amiodarone (1) Levodopa (1) Alendronate (1) Clozapine (1)</td><td align=\"left\">Gastritis Facial flush, Hypersensitivity reaction (4) Thrombocytopenia, dry mouth Perioral tingling numbness, Carpopedal spasm, Cochlear toxicity Muscle Cramps, Paresthesias raised liver functions Peak dose dyskinesias Esophagitis, constipation, seizure</td></tr></tbody></table></body></html>","text":"Pmid= 1963321:Table= Table 1","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":-981088410,"_task_hash":877105570,"_view_id":"review","accept":[5],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":null,"sessions":["tableclass-test-params-100-frank","tableclass-test-params-100-gill","tableclass-test-params-100-joe","tableclass-test-params-100-vicky"],"versions":[{"html":"<!DOCTYPE html><html><body><h1>Table depicting drugs and nature of adverse events seen during the study</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td align=\"left\">Drug Class/Drug</td><td align=\"left\"><bold>NO. (%) OF ADRS</bold></td><td align=\"left\">Individual drugs</td><td align=\"left\">Adverse Event</td></tr></thead><tbody><tr><td align=\"left\">Anti tubercular agents (AKT)</td><td align=\"left\">52</td><td align=\"left\">HRZ (35), AKT (7), Rifampin (4), Ethambutol (2), Pyrazinamide (2) Streptomycin (1), Isoniazid(1),</td><td align=\"left\">Thrombocytopenia, Hepatitis, Hepatic encephalopathy, Retro bulbar neuritis, Cholestatic jaundice, Erythema multiforme, Vestibular toxicity, Gastritis, Abdominal/Respiratory/Flu like syndrome, Hypersensitivity reaction, Psychosis, Peripheral neuropathy, dysglycemia</td></tr><tr><td align=\"left\">Antiepileptics</td><td align=\"left\">36</td><td align=\"left\">Phenytoin(24), Valproate (5), Phenobarbiturate(4) carbamazepine (3)</td><td align=\"left\">Erythema multiforme, Symptomatic toxic carbamazepine/phenytoin/valproate levels with cerebellar signs</td></tr><tr><td align=\"left\">Antimalarials</td><td align=\"left\">30</td><td align=\"left\">Chloroquine (29), Sulfadoxine-pyrimethamine (1)</td><td align=\"left\">Gastritis, Giddiness, Erthyema multiforme, Psychosis, Hypersensitivity reactions, Hypotension</td></tr><tr><td align=\"left\">Anticoagulants</td><td align=\"left\">25</td><td align=\"left\">Warfarin (24), Heparin (1)</td><td align=\"left\">GI bleeding, haematuria, high INR, Intracranial bleed</td></tr><tr><td align=\"left\">Oral hypoglycemic agents (OHA)</td><td align=\"left\">16</td><td align=\"left\">Glibenclamide (10), Glyburide (6)</td><td align=\"left\">Hypoglycemia, seizures,</td></tr><tr><td align=\"left\">NSAIDS</td><td align=\"left\">14</td><td align=\"left\">Paracetamol (6), Aspirin (3), Ibuprofen (1), Etoricoxib (1), Nimesulide (2), Diclofenac (1)</td><td align=\"left\">Hypersensitivity reaction, Gastritis, mucosal damage, Hematuria, (Etoricoxib) potentiates OHA induced Hypoglycemia, ARF on CRF, Thrombocytopenia</td></tr><tr><td align=\"left\">Antihypertensives</td><td align=\"left\">10</td><td align=\"left\">Atenolol (4), ACE inhibitors (2), Losartan (2), Clonidine (1), Isosorbide dinitrate (1)</td><td align=\"left\">Hypotension, Hypersensitivity reaction, AV block, Bradycardia, Hyperkalemia, Missed dose of clonidine leading to rebound hypertension, dry mouth</td></tr><tr><td align=\"left\">Cytotoxic drugs</td><td align=\"left\">9</td><td align=\"left\">Methotrexate (3), 5-Fluorouracil (2), Cisplatin (1), Etoposide (1), Paclitaxel (1), Chemo (1)</td><td align=\"left\">Bone marrow suppression (with opportunistic infection), Nephrotoxicity, Liver damage, GI mucositis, Anorexia, Myelodysplastic syndrome, Alopecia, Hyperuricemia, Abdominal pain, Neutropenia</td></tr><tr><td align=\"left\">Steroids</td><td align=\"left\">9</td><td align=\"left\">Prednisolone (7), Betamethasone (2)</td><td align=\"left\">Gastritis, Hypertension, Hyperglycemia, Mania, Fragile skin, Facial puffiness, Osteoporosis, Opportunistic infections</td></tr><tr><td align=\"left\">Insulin</td><td align=\"left\">8</td><td align=\"left\">Humulin70/30 (8)</td><td align=\"left\">Hypoglycemia, Erythema/swelling/stinging at injection site</td></tr><tr><td align=\"left\">Digoxin</td><td align=\"left\">8</td><td align=\"left\">--</td><td align=\"left\">Symptomatic toxic digoxin levels</td></tr><tr><td align=\"left\">Fluoroquinolones</td><td align=\"left\">8</td><td align=\"left\">Ciprofloxacin(4), Ofloxacin (2) Gatifloxacin (2)</td><td align=\"left\">Complex partial seizures, Peripheral neuropathy, Dystonia, Hypersensitivity reaction, tendinitis, dysguesia</td></tr><tr><td align=\"left\">B lactam antibiotics</td><td align=\"left\">8</td><td align=\"left\">Amoxicillin(3), Ampicillin(2), Cefadroxil (1), Ceftriaxone (1), Ceftazidime (1)</td><td align=\"left\">Hypersensitivity reaction, Fixed drug eruptions, Diarrhea, muscle spasm, Generalized tonic-clonic seizure</td></tr><tr><td align=\"left\">Antiretrovirals</td><td align=\"left\">4</td><td align=\"left\">Efavirenz (2), Stavudine (1), Zidovudine (1)</td><td align=\"left\">Metabolic acidosis, Drowsiness, hypokalemia, Peripheral neuropathy</td></tr><tr><td align=\"left\">Benzodiazepines</td><td align=\"left\">4</td><td align=\"left\">Chlordiazepoxide (2), Diazepam (2)</td><td align=\"left\">Increased appetite and weight gain, Drowsiness, Ataxia, Amnesia, Vertigo</td></tr><tr><td align=\"left\">Bronchodilators</td><td align=\"left\">4</td><td align=\"left\">Salbutamol (3), Theophylline (1)</td><td align=\"left\">Tremors</td></tr><tr><td align=\"left\">Haematinics</td><td align=\"left\">3</td><td align=\"left\">Ferrous fumarate(2) Ferrous sulfate (1)</td><td align=\"left\">Epigastric pain, Heart burn, Vomiting, Metallic taste in mouth</td></tr><tr><td align=\"left\">Fibrinolytics</td><td align=\"left\">2</td><td align=\"left\">Urokinase (2)</td><td align=\"left\">Hypotension, AV block</td></tr><tr><td align=\"left\">Miscellaneous</td><td align=\"left\">15</td><td align=\"left\">Metronidazole (1) Nicotinic acid (1) Fluconazole (1) Ethamsylate (1) Amitriptyline (1) Cotrimoxazole (1) Oxybutinin HCl (1) Dextropropoxy- phene (1) Urograffin (1) Amikacin (1) Benzthiazide (1) Amiodarone (1) Levodopa (1) Alendronate (1) Clozapine (1)</td><td align=\"left\">Gastritis Facial flush, Hypersensitivity reaction (4) Thrombocytopenia, dry mouth Perioral tingling numbness, Carpopedal spasm, Cochlear toxicity Muscle Cramps, Paresthesias raised liver functions Peak dose dyskinesias Esophagitis, constipation, seizure</td></tr></tbody></table></body></html>","text":"Pmid= 1963321:Table= Table 1","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":-981088410,"_task_hash":877105570,"_view_id":"choice","accept":[5],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":"tableclass-test-params-100-gill","sessions":["tableclass-test-params-100-frank","tableclass-test-params-100-gill","tableclass-test-params-100-joe","tableclass-test-params-100-vicky"],"default":true}],"view_id":"choice"}
{"html":"<!DOCTYPE html><html><body><h1>ICD-10 codes (Y40\u2013Y59) for drugs, medicaments and biological substances causing adverse effects in therapeutic use</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td align=\"left\"><bold>ICD-10</bold></td><td align=\"left\"><bold>External cause mortality/morbidity by:</bold></td></tr></thead><tbody><tr><td align=\"left\">Y40</td><td align=\"left\"><bold>Systemic antibiotics</bold>: Penicillins, cefalosporins and other beta-lactam antibiotics, chloramphenicol, macrolides, tetracyclines, aminoglycosides, rifamycins, antifungals, others</td></tr><tr><td align=\"left\">Y41</td><td align=\"left\"><bold>Other systemic anti-infectives and antiparasitics</bold>: Sulphonamides, other anti-mycobacterial, anti-malarials, anti-protozoal, anti-helminthics, anti-virals</td></tr><tr><td align=\"left\">Y42</td><td align=\"left\"><bold>Hormones and substitutes</bold>: Glucocorticoids, thyroid hormones, anti-thyroids, insulin, oral hypoglycaemics, oral contraceptives, oestrogen and progestogen, anti-gonadotrophins, anti-oestrogens, anti-progestogens, androgens</td></tr><tr><td align=\"left\">Y43</td><td align=\"left\"><bold>Systemic agents</bold>: Anti-allergic and anti-emetic drugs, anti-neoplastic and immunosuppressive drugs, acidifying/alkalising agents</td></tr><tr><td align=\"left\">Y44</td><td align=\"left\"><bold>Agents affecting blood constituents</bold>: Iron preparations, anti-megaloblastic-anaemia preparations, anticoagulants, anticoagulant antagonists, antithrombotic drugs, thrombolytic drugs, blood products, plasma substitutes</td></tr><tr><td align=\"left\">Y45</td><td align=\"left\"><bold>Analgesics, anti-pyretics and anti-inflammatory drugs</bold>: Opioids and related analgesics, salicylates, propionic acid derivatives, nonsteroidal anti-inflammatory drugs, antirheumatics, 4-aminophenol derivatives</td></tr><tr><td align=\"left\">Y46</td><td align=\"left\"><bold>Anti-epileptics and anti-parkinsonism drugs</bold>: Succinimides, oxazolidinediones, hydantoin derivatives, deoxybarbiturates, iminostilbenes, valproic acid, anti-parkinsonism drugs, anti-spasticity drugs</td></tr><tr><td align=\"left\">Y47</td><td align=\"left\"><bold>Sedatives, hypnotics and anti-anxiety drugs</bold>: Barbiturates, benzodiazepines, cloral derivatives, paraldehyde, bromine compounds, sedative, hypnotic and antianxiety drug, unspecified</td></tr><tr><td align=\"left\">Y48</td><td align=\"left\"><bold>Anaesthetics and therapeutic gases</bold>: Inhaled/parenteral anaesthetics, local anaesthetics, therapeutic gases</td></tr><tr><td align=\"left\">Y49</td><td align=\"left\"><bold>Psychotropic drugs</bold>: Tricyclic and tetracyclic antidepressants, monoamine-oxidase-inhibitor, phenothiazine antipsychotics and neuroleptics, butyrophenone and thioxanthene neuroleptics, other antidepressants, antipsychotics and neuroleptics</td></tr><tr><td align=\"left\">Y50</td><td align=\"left\"><bold>Central nervous system stimulants</bold>: Analeptics, opioid receptor antagonists, methylxanthines, other central nervous system stimulants</td></tr><tr><td align=\"left\">Y51</td><td align=\"left\"><bold>Drugs primarily affecting the autonomic nervous system</bold>: Anticholinesterase agents, cholinergics, ganglionic blocking drugs, anticholinergics, antimuscarinics, spasmolytics, alpha-adrenoreceptor agonists/antagonists, beta-adrenoreceptor agonists/antagonists, centrally acting and adrenergic-neuron-blocking agents</td></tr><tr><td align=\"left\">Y52</td><td align=\"left\"><bold>Agents affecting the cardiovascular system</bold>: Cardiac-stimulant glycosides, calcium-channel blockers, other anti-dysrhythmic drugs, other coronary vasodilators, angiotensin-converting-enzyme inhibitors, other anti-hypertensives, anti-hyperlipidaemic and anti-arteriosclerotic drugs, peripheral vasodilators, anti-varicose drugs</td></tr><tr><td align=\"left\">Y53</td><td align=\"left\"><bold>Agents affecting the gastrointestinal system</bold>: Antacids, anti-gastric-secretion drugs, laxatives, anti-diarrhoeal, emetics</td></tr><tr><td align=\"left\">Y54</td><td align=\"left\"><bold>Agents affecting water-balance and mineral and uric acid metabolism</bold>: Mineralocorticoids, mineralocorticoid antagonists, carbonic-anhydrase inhibitors, benzothiadiazine derivatives, other diuretics, electrolytic, caloric and water-balance agents, agents affecting calcification, agents affecting uric acid metabolism</td></tr><tr><td align=\"left\">Y55</td><td align=\"left\"><bold>Agents acting on smooth and skeletal muscles and the respiratory system</bold>: Oxytocic drugs, skeletal muscle relaxants, anti-tussives, expectorants, anti-common-cold drugs, anti-asthmatics</td></tr><tr><td align=\"left\">Y56</td><td align=\"left\"><bold>Topical agents primarily affecting skin and mucous membrane</bold>: Local anti-fungal, anti-infective, anti-inflammatory drugs, anti-pruritics, local detergents, emollients, keratolytics, ophthalmological drugs, otorhinolaryngological drugs, dental drugs</td></tr><tr><td align=\"left\">Y57</td><td align=\"left\"><bold>Other and unspecified drugs</bold>: Appetite depressants, lipotropic drugs, antidotes and chelating agents, alcohol deterrents, x-ray contrast media, vitamins</td></tr><tr><td align=\"left\">Y58</td><td align=\"left\"><bold>Bacterial vaccines</bold></td></tr><tr><td align=\"left\">Y59</td><td align=\"left\"><bold>Other vaccines</bold>: Viral/rickettsial/protozoal vaccines, immunoglobulin</td></tr></tbody></table></body></html>","text":"Pmid= 2093926:Table= Table 1","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":1309062929,"_task_hash":-768378880,"_view_id":"review","accept":[5],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":null,"sessions":["tableclass-test-params-100-frank","tableclass-test-params-100-gill","tableclass-test-params-100-joe","tableclass-test-params-100-vicky"],"versions":[{"html":"<!DOCTYPE html><html><body><h1>ICD-10 codes (Y40\u2013Y59) for drugs, medicaments and biological substances causing adverse effects in therapeutic use</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td align=\"left\"><bold>ICD-10</bold></td><td align=\"left\"><bold>External cause mortality/morbidity by:</bold></td></tr></thead><tbody><tr><td align=\"left\">Y40</td><td align=\"left\"><bold>Systemic antibiotics</bold>: Penicillins, cefalosporins and other beta-lactam antibiotics, chloramphenicol, macrolides, tetracyclines, aminoglycosides, rifamycins, antifungals, others</td></tr><tr><td align=\"left\">Y41</td><td align=\"left\"><bold>Other systemic anti-infectives and antiparasitics</bold>: Sulphonamides, other anti-mycobacterial, anti-malarials, anti-protozoal, anti-helminthics, anti-virals</td></tr><tr><td align=\"left\">Y42</td><td align=\"left\"><bold>Hormones and substitutes</bold>: Glucocorticoids, thyroid hormones, anti-thyroids, insulin, oral hypoglycaemics, oral contraceptives, oestrogen and progestogen, anti-gonadotrophins, anti-oestrogens, anti-progestogens, androgens</td></tr><tr><td align=\"left\">Y43</td><td align=\"left\"><bold>Systemic agents</bold>: Anti-allergic and anti-emetic drugs, anti-neoplastic and immunosuppressive drugs, acidifying/alkalising agents</td></tr><tr><td align=\"left\">Y44</td><td align=\"left\"><bold>Agents affecting blood constituents</bold>: Iron preparations, anti-megaloblastic-anaemia preparations, anticoagulants, anticoagulant antagonists, antithrombotic drugs, thrombolytic drugs, blood products, plasma substitutes</td></tr><tr><td align=\"left\">Y45</td><td align=\"left\"><bold>Analgesics, anti-pyretics and anti-inflammatory drugs</bold>: Opioids and related analgesics, salicylates, propionic acid derivatives, nonsteroidal anti-inflammatory drugs, antirheumatics, 4-aminophenol derivatives</td></tr><tr><td align=\"left\">Y46</td><td align=\"left\"><bold>Anti-epileptics and anti-parkinsonism drugs</bold>: Succinimides, oxazolidinediones, hydantoin derivatives, deoxybarbiturates, iminostilbenes, valproic acid, anti-parkinsonism drugs, anti-spasticity drugs</td></tr><tr><td align=\"left\">Y47</td><td align=\"left\"><bold>Sedatives, hypnotics and anti-anxiety drugs</bold>: Barbiturates, benzodiazepines, cloral derivatives, paraldehyde, bromine compounds, sedative, hypnotic and antianxiety drug, unspecified</td></tr><tr><td align=\"left\">Y48</td><td align=\"left\"><bold>Anaesthetics and therapeutic gases</bold>: Inhaled/parenteral anaesthetics, local anaesthetics, therapeutic gases</td></tr><tr><td align=\"left\">Y49</td><td align=\"left\"><bold>Psychotropic drugs</bold>: Tricyclic and tetracyclic antidepressants, monoamine-oxidase-inhibitor, phenothiazine antipsychotics and neuroleptics, butyrophenone and thioxanthene neuroleptics, other antidepressants, antipsychotics and neuroleptics</td></tr><tr><td align=\"left\">Y50</td><td align=\"left\"><bold>Central nervous system stimulants</bold>: Analeptics, opioid receptor antagonists, methylxanthines, other central nervous system stimulants</td></tr><tr><td align=\"left\">Y51</td><td align=\"left\"><bold>Drugs primarily affecting the autonomic nervous system</bold>: Anticholinesterase agents, cholinergics, ganglionic blocking drugs, anticholinergics, antimuscarinics, spasmolytics, alpha-adrenoreceptor agonists/antagonists, beta-adrenoreceptor agonists/antagonists, centrally acting and adrenergic-neuron-blocking agents</td></tr><tr><td align=\"left\">Y52</td><td align=\"left\"><bold>Agents affecting the cardiovascular system</bold>: Cardiac-stimulant glycosides, calcium-channel blockers, other anti-dysrhythmic drugs, other coronary vasodilators, angiotensin-converting-enzyme inhibitors, other anti-hypertensives, anti-hyperlipidaemic and anti-arteriosclerotic drugs, peripheral vasodilators, anti-varicose drugs</td></tr><tr><td align=\"left\">Y53</td><td align=\"left\"><bold>Agents affecting the gastrointestinal system</bold>: Antacids, anti-gastric-secretion drugs, laxatives, anti-diarrhoeal, emetics</td></tr><tr><td align=\"left\">Y54</td><td align=\"left\"><bold>Agents affecting water-balance and mineral and uric acid metabolism</bold>: Mineralocorticoids, mineralocorticoid antagonists, carbonic-anhydrase inhibitors, benzothiadiazine derivatives, other diuretics, electrolytic, caloric and water-balance agents, agents affecting calcification, agents affecting uric acid metabolism</td></tr><tr><td align=\"left\">Y55</td><td align=\"left\"><bold>Agents acting on smooth and skeletal muscles and the respiratory system</bold>: Oxytocic drugs, skeletal muscle relaxants, anti-tussives, expectorants, anti-common-cold drugs, anti-asthmatics</td></tr><tr><td align=\"left\">Y56</td><td align=\"left\"><bold>Topical agents primarily affecting skin and mucous membrane</bold>: Local anti-fungal, anti-infective, anti-inflammatory drugs, anti-pruritics, local detergents, emollients, keratolytics, ophthalmological drugs, otorhinolaryngological drugs, dental drugs</td></tr><tr><td align=\"left\">Y57</td><td align=\"left\"><bold>Other and unspecified drugs</bold>: Appetite depressants, lipotropic drugs, antidotes and chelating agents, alcohol deterrents, x-ray contrast media, vitamins</td></tr><tr><td align=\"left\">Y58</td><td align=\"left\"><bold>Bacterial vaccines</bold></td></tr><tr><td align=\"left\">Y59</td><td align=\"left\"><bold>Other vaccines</bold>: Viral/rickettsial/protozoal vaccines, immunoglobulin</td></tr></tbody></table></body></html>","text":"Pmid= 2093926:Table= Table 1","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":1309062929,"_task_hash":-768378880,"_view_id":"choice","accept":[5],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":"tableclass-test-params-100-gill","sessions":["tableclass-test-params-100-frank","tableclass-test-params-100-gill","tableclass-test-params-100-joe","tableclass-test-params-100-vicky"],"default":true}],"view_id":"choice"}
{"html":"<!DOCTYPE html><html><body><h1>Total number of Hospital Episode Statsitics for which there was a primary diagnosis or 'external cause' of ADR 1998\u20132005</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td/><td align=\"center\"><bold>1998&#8211;9</bold></td><td align=\"center\"><bold>1999&#8211;00</bold></td><td align=\"center\"><bold>2000&#8211;1</bold></td><td align=\"center\"><bold>2001&#8211;2</bold></td><td align=\"center\"><bold>2002&#8211;3</bold></td><td align=\"center\"><bold>2003&#8211;4</bold></td><td align=\"center\"><bold>2004&#8211;5</bold></td><td align=\"center\"><bold>% Change 1998&#8211;2005</bold></td></tr></thead><tbody><tr><td align=\"left\"><bold>Total No. of Episodes</bold></td><td align=\"center\">11,983,893</td><td align=\"center\">12,167,574</td><td align=\"center\">12,674,277</td><td align=\"center\">12,357,360</td><td align=\"center\">12,757,656</td><td align=\"center\">13,174,480</td><td align=\"center\">13,706,765</td><td align=\"center\">14.4</td></tr><tr><td align=\"left\"><bold>No. with \\'drug induced\\' codes</bold></td><td align=\"center\">10506</td><td align=\"center\">10105</td><td align=\"center\">9823</td><td align=\"center\">9442</td><td align=\"center\">9246</td><td align=\"center\">9453</td><td align=\"center\">10396</td><td align=\"center\">-1.0</td></tr><tr><td align=\"left\"><bold>No. with external cause codes</bold></td><td align=\"center\">42,555</td><td align=\"center\">47,385</td><td align=\"center\">50,113</td><td align=\"center\">52,160</td><td align=\"center\">56,943</td><td align=\"center\">62,618</td><td align=\"center\">66,296</td><td align=\"center\">55.8</td></tr><tr><td align=\"left\"><bold>Total Adverse Drug Reactions</bold></td><td align=\"center\">53,061</td><td align=\"center\">57,490</td><td align=\"center\">59,936</td><td align=\"center\">61,602</td><td align=\"center\">66,189</td><td align=\"center\">72,071</td><td align=\"center\">76,692</td><td align=\"center\">44.5</td></tr></tbody></table></body></html>","text":"Pmid= 2093926:Table= Table 2","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":1918751728,"_task_hash":-830463573,"_view_id":"review","accept":[5],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":null,"sessions":["tableclass-test-params-100-frank","tableclass-test-params-100-gill","tableclass-test-params-100-joe","tableclass-test-params-100-vicky"],"versions":[{"html":"<!DOCTYPE html><html><body><h1>Total number of Hospital Episode Statsitics for which there was a primary diagnosis or 'external cause' of ADR 1998\u20132005</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td/><td align=\"center\"><bold>1998&#8211;9</bold></td><td align=\"center\"><bold>1999&#8211;00</bold></td><td align=\"center\"><bold>2000&#8211;1</bold></td><td align=\"center\"><bold>2001&#8211;2</bold></td><td align=\"center\"><bold>2002&#8211;3</bold></td><td align=\"center\"><bold>2003&#8211;4</bold></td><td align=\"center\"><bold>2004&#8211;5</bold></td><td align=\"center\"><bold>% Change 1998&#8211;2005</bold></td></tr></thead><tbody><tr><td align=\"left\"><bold>Total No. of Episodes</bold></td><td align=\"center\">11,983,893</td><td align=\"center\">12,167,574</td><td align=\"center\">12,674,277</td><td align=\"center\">12,357,360</td><td align=\"center\">12,757,656</td><td align=\"center\">13,174,480</td><td align=\"center\">13,706,765</td><td align=\"center\">14.4</td></tr><tr><td align=\"left\"><bold>No. with \\'drug induced\\' codes</bold></td><td align=\"center\">10506</td><td align=\"center\">10105</td><td align=\"center\">9823</td><td align=\"center\">9442</td><td align=\"center\">9246</td><td align=\"center\">9453</td><td align=\"center\">10396</td><td align=\"center\">-1.0</td></tr><tr><td align=\"left\"><bold>No. with external cause codes</bold></td><td align=\"center\">42,555</td><td align=\"center\">47,385</td><td align=\"center\">50,113</td><td align=\"center\">52,160</td><td align=\"center\">56,943</td><td align=\"center\">62,618</td><td align=\"center\">66,296</td><td align=\"center\">55.8</td></tr><tr><td align=\"left\"><bold>Total Adverse Drug Reactions</bold></td><td align=\"center\">53,061</td><td align=\"center\">57,490</td><td align=\"center\">59,936</td><td align=\"center\">61,602</td><td align=\"center\">66,189</td><td align=\"center\">72,071</td><td align=\"center\">76,692</td><td align=\"center\">44.5</td></tr></tbody></table></body></html>","text":"Pmid= 2093926:Table= Table 2","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":1918751728,"_task_hash":-830463573,"_view_id":"choice","accept":[5],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":"tableclass-test-params-100-gill","sessions":["tableclass-test-params-100-frank","tableclass-test-params-100-gill","tableclass-test-params-100-joe","tableclass-test-params-100-vicky"],"default":true}],"view_id":"choice"}
{"html":"<!DOCTYPE html><html><body><h1>Annual number of Hospital Episode Statistics finished consultant episodes with a primary diagnosis for an ADR (ICD-10 code)</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td align=\"left\"><bold>ICD-10</bold></td><td/><td align=\"center\"><bold>1998&#8211;9</bold></td><td align=\"center\"><bold>1999&#8211;00</bold></td><td align=\"center\"><bold>2000&#8211;1</bold></td><td align=\"center\"><bold>2001&#8211;2</bold></td><td align=\"center\"><bold>2002&#8211;3</bold></td><td align=\"center\"><bold>2003&#8211;4</bold></td><td align=\"center\"><bold>2004&#8211;5</bold></td><td align=\"center\"><bold>% Change 1998&#8211;2005</bold></td></tr></thead><tbody><tr><td align=\"left\"><bold>D59.0/2</bold></td><td align=\"left\"><bold>Drug induced haemolytic anaemia</bold></td><td align=\"center\">15</td><td align=\"center\">30</td><td align=\"center\">28</td><td align=\"center\">37</td><td align=\"center\">34</td><td align=\"center\">36</td><td align=\"center\">154</td><td align=\"center\">926.7</td></tr><tr><td align=\"left\"><bold>D61.1</bold></td><td align=\"left\"><bold>Drug induced aplastic anaemia</bold></td><td align=\"center\">101</td><td align=\"center\">116</td><td align=\"center\">114</td><td align=\"center\">186</td><td align=\"center\">182</td><td align=\"center\">162</td><td align=\"center\">241</td><td align=\"center\">138.6</td></tr><tr><td align=\"left\"><bold>E03.2</bold></td><td align=\"left\"><bold>Hypothyroidism due to medicaments</bold></td><td align=\"center\">23</td><td align=\"center\">23</td><td align=\"center\">12</td><td align=\"center\">12</td><td align=\"center\">19</td><td align=\"center\">13</td><td align=\"center\">26</td><td align=\"center\">13.0</td></tr><tr><td align=\"left\"><bold>E27.3</bold></td><td align=\"left\"><bold>Drug induced adrenocortical failure</bold></td><td align=\"center\">24</td><td align=\"center\">22</td><td align=\"center\">24</td><td align=\"center\">38</td><td align=\"center\">39</td><td align=\"center\">53</td><td align=\"center\">59</td><td align=\"center\">145.8</td></tr><tr><td align=\"left\"><bold>F11</bold></td><td align=\"left\"><bold>Mental disorders due to opioids</bold></td><td align=\"center\">4360</td><td align=\"center\">4287</td><td align=\"center\">4398</td><td align=\"center\">4187</td><td align=\"center\">3916</td><td align=\"center\">3690</td><td align=\"center\">3746</td><td align=\"center\">-14.1</td></tr><tr><td align=\"left\"><bold>F13</bold></td><td align=\"left\"><bold>Mental disorders due to sedatives/hypnotics</bold></td><td align=\"center\">223</td><td align=\"center\">247</td><td align=\"center\">247</td><td align=\"center\">239</td><td align=\"center\">232</td><td align=\"center\">206</td><td align=\"center\">189</td><td align=\"center\">-15.2</td></tr><tr><td align=\"left\"><bold>F19</bold></td><td align=\"left\"><bold>Mental disorders due to multiple psychoactive drugs</bold></td><td align=\"center\">3513</td><td align=\"center\">3137</td><td align=\"center\">2725</td><td align=\"center\">2643</td><td align=\"center\">2601</td><td align=\"center\">2690</td><td align=\"center\">2775</td><td align=\"center\">-21.0</td></tr><tr><td align=\"left\"><bold>G21.0</bold></td><td align=\"left\"><bold>Malignant neuroleptic syndrome</bold></td><td align=\"center\">101</td><td align=\"center\">106</td><td align=\"center\">121</td><td align=\"center\">108</td><td align=\"center\">102</td><td align=\"center\">93</td><td align=\"center\">128</td><td align=\"center\">26.7</td></tr><tr><td align=\"left\"><bold>G21.1</bold></td><td align=\"left\"><bold>Drug induced Parkinsonism</bold></td><td align=\"center\">145</td><td align=\"center\">115</td><td align=\"center\">124</td><td align=\"center\">133</td><td align=\"center\">112</td><td align=\"center\">108</td><td align=\"center\">149</td><td align=\"center\">2.8</td></tr><tr><td align=\"left\"><bold>G24.0</bold></td><td align=\"left\"><bold>Drug induced dystonia</bold></td><td align=\"center\">149</td><td align=\"center\">130</td><td align=\"center\">145</td><td align=\"center\">130</td><td align=\"center\">115</td><td align=\"center\">152</td><td align=\"center\">109</td><td align=\"center\">-26.8</td></tr><tr><td align=\"left\"><bold>G25.1/4/6</bold></td><td align=\"left\"><bold>Drug induced extrapyramidal syndrome/chorea/tics</bold></td><td align=\"center\">136</td><td align=\"center\">146</td><td align=\"center\">110</td><td align=\"center\">125</td><td align=\"center\">44</td><td align=\"center\">51</td><td align=\"center\">48</td><td align=\"center\">-64.7</td></tr><tr><td align=\"left\"><bold>G72.0</bold></td><td align=\"left\"><bold>Drug induced myopathy</bold></td><td align=\"center\">47</td><td align=\"center\">53</td><td align=\"center\">51</td><td align=\"center\">51</td><td align=\"center\">57</td><td align=\"center\">39</td><td align=\"center\">55</td><td align=\"center\">17.0</td></tr><tr><td align=\"left\"><bold>H91.0</bold></td><td align=\"left\"><bold>Ototoxic hearing loss</bold></td><td align=\"center\">2</td><td align=\"center\">5</td><td align=\"center\">3</td><td align=\"center\">3</td><td align=\"center\">2</td><td align=\"center\">U/C<sup>1</sup></td><td align=\"center\">U/C</td><td align=\"center\">U/C</td></tr><tr><td align=\"left\"><bold>I42.7</bold></td><td align=\"left\"><bold>Drug induced cardiomyopathy</bold></td><td align=\"center\">25</td><td align=\"center\">25</td><td align=\"center\">53</td><td align=\"center\">38</td><td align=\"center\">67</td><td align=\"center\">77</td><td align=\"center\">61</td><td align=\"center\">144.0</td></tr><tr><td align=\"left\"><bold>J70.2/3/4</bold></td><td align=\"left\"><bold>Drug induced interstitial lung disorders</bold></td><td align=\"center\">54</td><td align=\"center\">45</td><td align=\"center\">43</td><td align=\"center\">43</td><td align=\"center\">86</td><td align=\"center\">71</td><td align=\"center\">94</td><td align=\"center\">74.1</td></tr><tr><td align=\"left\"><bold>K71</bold></td><td align=\"left\"><bold>Drug induced liver disease</bold></td><td align=\"center\">406</td><td align=\"center\">318</td><td align=\"center\">372</td><td align=\"center\">351</td><td align=\"center\">459</td><td align=\"center\">437</td><td align=\"center\">448</td><td align=\"center\">10.3</td></tr><tr><td align=\"left\"><bold>L56.0/1</bold></td><td align=\"left\"><bold>Drug induced phototoxicity</bold></td><td align=\"center\">4</td><td align=\"center\">5</td><td align=\"center\">2</td><td align=\"center\">4</td><td align=\"center\">1</td><td align=\"center\">3</td><td align=\"center\">5</td><td align=\"center\">25.0</td></tr><tr><td align=\"left\"><bold>M10.2</bold></td><td align=\"left\"><bold>Drug induced gout</bold></td><td align=\"center\">30</td><td align=\"center\">27</td><td align=\"center\">13</td><td align=\"center\">24</td><td align=\"center\">22</td><td align=\"center\">22</td><td align=\"center\">34</td><td align=\"center\">13.3</td></tr><tr><td align=\"left\"><bold>M32.0</bold></td><td align=\"left\"><bold>Drug induced systemic lupus erythematosus</bold></td><td align=\"center\">17</td><td align=\"center\">20</td><td align=\"center\">12</td><td align=\"center\">13</td><td align=\"center\">14</td><td align=\"center\">10</td><td align=\"center\">26</td><td align=\"center\">52.9</td></tr><tr><td align=\"left\"><bold>M34.2</bold></td><td align=\"left\"><bold>Drug induced systemic sclerosis</bold></td><td align=\"center\">3</td><td align=\"center\">3</td><td align=\"center\">4</td><td align=\"center\">3</td><td align=\"center\">U/C</td><td align=\"center\">U/C</td><td align=\"center\">U/C</td><td align=\"center\">U/C</td></tr><tr><td align=\"left\"><bold>N14</bold></td><td align=\"left\"><bold>Drug induced nephropathy</bold></td><td align=\"center\">60</td><td align=\"center\">69</td><td align=\"center\">92</td><td align=\"center\">85</td><td align=\"center\">100</td><td align=\"center\">318</td><td align=\"center\">414</td><td align=\"center\">590.0</td></tr><tr><td align=\"left\"><bold>T88.3</bold></td><td align=\"left\"><bold>Malignant hyperthermia due to anaesthesia</bold></td><td align=\"center\">6</td><td align=\"center\">4</td><td align=\"center\">10</td><td align=\"center\">3</td><td align=\"center\">3</td><td align=\"center\">5</td><td align=\"center\">4</td><td align=\"center\">-33.3</td></tr><tr><td align=\"left\"><bold>T88.6</bold></td><td align=\"left\"><bold>Drug induced anaphylaxis</bold></td><td align=\"center\">366</td><td align=\"center\">435</td><td align=\"center\">399</td><td align=\"center\">384</td><td align=\"center\">375</td><td align=\"center\">469</td><td align=\"center\">563</td><td align=\"center\">53.8</td></tr><tr><td align=\"left\"><bold>T88.7</bold></td><td align=\"left\"><bold>Unspecified adverse drug effect</bold></td><td align=\"center\">696</td><td align=\"center\">737</td><td align=\"center\">721</td><td align=\"center\">602</td><td align=\"center\">664</td><td align=\"center\">748</td><td align=\"center\">1068</td><td align=\"center\">53.4</td></tr><tr><td colspan=\"10\"><hr/></td></tr><tr><td align=\"left\"><bold>Total</bold></td><td/><td align=\"center\"><bold>10506</bold></td><td align=\"center\"><bold>10105</bold></td><td align=\"center\"><bold>9823</bold></td><td align=\"center\"><bold>9442</bold></td><td align=\"center\"><bold>9246</bold></td><td align=\"center\"><bold>9453</bold></td><td align=\"center\"><bold>10396</bold></td><td align=\"center\"><bold>-1.0</bold></td></tr></tbody></table></body></html>","text":"Pmid= 2093926:Table= Table 3","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":679683375,"_task_hash":-84303045,"_view_id":"review","accept":[5],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":null,"sessions":["tableclass-test-params-100-frank","tableclass-test-params-100-gill","tableclass-test-params-100-joe","tableclass-test-params-100-vicky"],"versions":[{"html":"<!DOCTYPE html><html><body><h1>Annual number of Hospital Episode Statistics finished consultant episodes with a primary diagnosis for an ADR (ICD-10 code)</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td align=\"left\"><bold>ICD-10</bold></td><td/><td align=\"center\"><bold>1998&#8211;9</bold></td><td align=\"center\"><bold>1999&#8211;00</bold></td><td align=\"center\"><bold>2000&#8211;1</bold></td><td align=\"center\"><bold>2001&#8211;2</bold></td><td align=\"center\"><bold>2002&#8211;3</bold></td><td align=\"center\"><bold>2003&#8211;4</bold></td><td align=\"center\"><bold>2004&#8211;5</bold></td><td align=\"center\"><bold>% Change 1998&#8211;2005</bold></td></tr></thead><tbody><tr><td align=\"left\"><bold>D59.0/2</bold></td><td align=\"left\"><bold>Drug induced haemolytic anaemia</bold></td><td align=\"center\">15</td><td align=\"center\">30</td><td align=\"center\">28</td><td align=\"center\">37</td><td align=\"center\">34</td><td align=\"center\">36</td><td align=\"center\">154</td><td align=\"center\">926.7</td></tr><tr><td align=\"left\"><bold>D61.1</bold></td><td align=\"left\"><bold>Drug induced aplastic anaemia</bold></td><td align=\"center\">101</td><td align=\"center\">116</td><td align=\"center\">114</td><td align=\"center\">186</td><td align=\"center\">182</td><td align=\"center\">162</td><td align=\"center\">241</td><td align=\"center\">138.6</td></tr><tr><td align=\"left\"><bold>E03.2</bold></td><td align=\"left\"><bold>Hypothyroidism due to medicaments</bold></td><td align=\"center\">23</td><td align=\"center\">23</td><td align=\"center\">12</td><td align=\"center\">12</td><td align=\"center\">19</td><td align=\"center\">13</td><td align=\"center\">26</td><td align=\"center\">13.0</td></tr><tr><td align=\"left\"><bold>E27.3</bold></td><td align=\"left\"><bold>Drug induced adrenocortical failure</bold></td><td align=\"center\">24</td><td align=\"center\">22</td><td align=\"center\">24</td><td align=\"center\">38</td><td align=\"center\">39</td><td align=\"center\">53</td><td align=\"center\">59</td><td align=\"center\">145.8</td></tr><tr><td align=\"left\"><bold>F11</bold></td><td align=\"left\"><bold>Mental disorders due to opioids</bold></td><td align=\"center\">4360</td><td align=\"center\">4287</td><td align=\"center\">4398</td><td align=\"center\">4187</td><td align=\"center\">3916</td><td align=\"center\">3690</td><td align=\"center\">3746</td><td align=\"center\">-14.1</td></tr><tr><td align=\"left\"><bold>F13</bold></td><td align=\"left\"><bold>Mental disorders due to sedatives/hypnotics</bold></td><td align=\"center\">223</td><td align=\"center\">247</td><td align=\"center\">247</td><td align=\"center\">239</td><td align=\"center\">232</td><td align=\"center\">206</td><td align=\"center\">189</td><td align=\"center\">-15.2</td></tr><tr><td align=\"left\"><bold>F19</bold></td><td align=\"left\"><bold>Mental disorders due to multiple psychoactive drugs</bold></td><td align=\"center\">3513</td><td align=\"center\">3137</td><td align=\"center\">2725</td><td align=\"center\">2643</td><td align=\"center\">2601</td><td align=\"center\">2690</td><td align=\"center\">2775</td><td align=\"center\">-21.0</td></tr><tr><td align=\"left\"><bold>G21.0</bold></td><td align=\"left\"><bold>Malignant neuroleptic syndrome</bold></td><td align=\"center\">101</td><td align=\"center\">106</td><td align=\"center\">121</td><td align=\"center\">108</td><td align=\"center\">102</td><td align=\"center\">93</td><td align=\"center\">128</td><td align=\"center\">26.7</td></tr><tr><td align=\"left\"><bold>G21.1</bold></td><td align=\"left\"><bold>Drug induced Parkinsonism</bold></td><td align=\"center\">145</td><td align=\"center\">115</td><td align=\"center\">124</td><td align=\"center\">133</td><td align=\"center\">112</td><td align=\"center\">108</td><td align=\"center\">149</td><td align=\"center\">2.8</td></tr><tr><td align=\"left\"><bold>G24.0</bold></td><td align=\"left\"><bold>Drug induced dystonia</bold></td><td align=\"center\">149</td><td align=\"center\">130</td><td align=\"center\">145</td><td align=\"center\">130</td><td align=\"center\">115</td><td align=\"center\">152</td><td align=\"center\">109</td><td align=\"center\">-26.8</td></tr><tr><td align=\"left\"><bold>G25.1/4/6</bold></td><td align=\"left\"><bold>Drug induced extrapyramidal syndrome/chorea/tics</bold></td><td align=\"center\">136</td><td align=\"center\">146</td><td align=\"center\">110</td><td align=\"center\">125</td><td align=\"center\">44</td><td align=\"center\">51</td><td align=\"center\">48</td><td align=\"center\">-64.7</td></tr><tr><td align=\"left\"><bold>G72.0</bold></td><td align=\"left\"><bold>Drug induced myopathy</bold></td><td align=\"center\">47</td><td align=\"center\">53</td><td align=\"center\">51</td><td align=\"center\">51</td><td align=\"center\">57</td><td align=\"center\">39</td><td align=\"center\">55</td><td align=\"center\">17.0</td></tr><tr><td align=\"left\"><bold>H91.0</bold></td><td align=\"left\"><bold>Ototoxic hearing loss</bold></td><td align=\"center\">2</td><td align=\"center\">5</td><td align=\"center\">3</td><td align=\"center\">3</td><td align=\"center\">2</td><td align=\"center\">U/C<sup>1</sup></td><td align=\"center\">U/C</td><td align=\"center\">U/C</td></tr><tr><td align=\"left\"><bold>I42.7</bold></td><td align=\"left\"><bold>Drug induced cardiomyopathy</bold></td><td align=\"center\">25</td><td align=\"center\">25</td><td align=\"center\">53</td><td align=\"center\">38</td><td align=\"center\">67</td><td align=\"center\">77</td><td align=\"center\">61</td><td align=\"center\">144.0</td></tr><tr><td align=\"left\"><bold>J70.2/3/4</bold></td><td align=\"left\"><bold>Drug induced interstitial lung disorders</bold></td><td align=\"center\">54</td><td align=\"center\">45</td><td align=\"center\">43</td><td align=\"center\">43</td><td align=\"center\">86</td><td align=\"center\">71</td><td align=\"center\">94</td><td align=\"center\">74.1</td></tr><tr><td align=\"left\"><bold>K71</bold></td><td align=\"left\"><bold>Drug induced liver disease</bold></td><td align=\"center\">406</td><td align=\"center\">318</td><td align=\"center\">372</td><td align=\"center\">351</td><td align=\"center\">459</td><td align=\"center\">437</td><td align=\"center\">448</td><td align=\"center\">10.3</td></tr><tr><td align=\"left\"><bold>L56.0/1</bold></td><td align=\"left\"><bold>Drug induced phototoxicity</bold></td><td align=\"center\">4</td><td align=\"center\">5</td><td align=\"center\">2</td><td align=\"center\">4</td><td align=\"center\">1</td><td align=\"center\">3</td><td align=\"center\">5</td><td align=\"center\">25.0</td></tr><tr><td align=\"left\"><bold>M10.2</bold></td><td align=\"left\"><bold>Drug induced gout</bold></td><td align=\"center\">30</td><td align=\"center\">27</td><td align=\"center\">13</td><td align=\"center\">24</td><td align=\"center\">22</td><td align=\"center\">22</td><td align=\"center\">34</td><td align=\"center\">13.3</td></tr><tr><td align=\"left\"><bold>M32.0</bold></td><td align=\"left\"><bold>Drug induced systemic lupus erythematosus</bold></td><td align=\"center\">17</td><td align=\"center\">20</td><td align=\"center\">12</td><td align=\"center\">13</td><td align=\"center\">14</td><td align=\"center\">10</td><td align=\"center\">26</td><td align=\"center\">52.9</td></tr><tr><td align=\"left\"><bold>M34.2</bold></td><td align=\"left\"><bold>Drug induced systemic sclerosis</bold></td><td align=\"center\">3</td><td align=\"center\">3</td><td align=\"center\">4</td><td align=\"center\">3</td><td align=\"center\">U/C</td><td align=\"center\">U/C</td><td align=\"center\">U/C</td><td align=\"center\">U/C</td></tr><tr><td align=\"left\"><bold>N14</bold></td><td align=\"left\"><bold>Drug induced nephropathy</bold></td><td align=\"center\">60</td><td align=\"center\">69</td><td align=\"center\">92</td><td align=\"center\">85</td><td align=\"center\">100</td><td align=\"center\">318</td><td align=\"center\">414</td><td align=\"center\">590.0</td></tr><tr><td align=\"left\"><bold>T88.3</bold></td><td align=\"left\"><bold>Malignant hyperthermia due to anaesthesia</bold></td><td align=\"center\">6</td><td align=\"center\">4</td><td align=\"center\">10</td><td align=\"center\">3</td><td align=\"center\">3</td><td align=\"center\">5</td><td align=\"center\">4</td><td align=\"center\">-33.3</td></tr><tr><td align=\"left\"><bold>T88.6</bold></td><td align=\"left\"><bold>Drug induced anaphylaxis</bold></td><td align=\"center\">366</td><td align=\"center\">435</td><td align=\"center\">399</td><td align=\"center\">384</td><td align=\"center\">375</td><td align=\"center\">469</td><td align=\"center\">563</td><td align=\"center\">53.8</td></tr><tr><td align=\"left\"><bold>T88.7</bold></td><td align=\"left\"><bold>Unspecified adverse drug effect</bold></td><td align=\"center\">696</td><td align=\"center\">737</td><td align=\"center\">721</td><td align=\"center\">602</td><td align=\"center\">664</td><td align=\"center\">748</td><td align=\"center\">1068</td><td align=\"center\">53.4</td></tr><tr><td colspan=\"10\"><hr/></td></tr><tr><td align=\"left\"><bold>Total</bold></td><td/><td align=\"center\"><bold>10506</bold></td><td align=\"center\"><bold>10105</bold></td><td align=\"center\"><bold>9823</bold></td><td align=\"center\"><bold>9442</bold></td><td align=\"center\"><bold>9246</bold></td><td align=\"center\"><bold>9453</bold></td><td align=\"center\"><bold>10396</bold></td><td align=\"center\"><bold>-1.0</bold></td></tr></tbody></table></body></html>","text":"Pmid= 2093926:Table= Table 3","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":679683375,"_task_hash":-84303045,"_view_id":"choice","accept":[5],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":"tableclass-test-params-100-gill","sessions":["tableclass-test-params-100-frank","tableclass-test-params-100-gill","tableclass-test-params-100-joe","tableclass-test-params-100-vicky"],"default":true}],"view_id":"choice"}
{"html":"<!DOCTYPE html><html><body><h1>Annual number of HES finished consultant episodes with an 'external code' for an adverse drug reaction</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td align=\"left\"><bold>ICD-10</bold></td><td/><td align=\"right\"><bold>1998&#8211;9</bold></td><td align=\"right\"><bold>1999&#8211;00</bold></td><td align=\"right\"><bold>2000&#8211;1</bold></td><td align=\"right\"><bold>2001&#8211;2</bold></td><td align=\"right\"><bold>2002&#8211;3</bold></td><td align=\"right\"><bold>2003&#8211;4</bold></td><td align=\"right\"><bold>2004&#8211;5</bold></td><td align=\"center\"><bold>% Change 1998&#8211;2005</bold></td></tr></thead><tbody><tr><td align=\"left\"><bold>Y40</bold></td><td align=\"left\"><bold>Systemic antibiotics</bold></td><td align=\"right\">4,206</td><td align=\"right\">4,212</td><td align=\"right\">4,533</td><td align=\"right\">4,341</td><td align=\"right\">4,697</td><td align=\"right\">5,624</td><td align=\"right\">6,449</td><td align=\"center\">53.3</td></tr><tr><td align=\"left\"><bold>Y41</bold></td><td align=\"left\"><bold>Other systemic anti-infectives/anti-parasitics</bold></td><td align=\"right\">829</td><td align=\"right\">816</td><td align=\"right\">1,017</td><td align=\"right\">945</td><td align=\"right\">1,195</td><td align=\"right\">1,134</td><td align=\"right\">1,453</td><td align=\"center\">75.3</td></tr><tr><td align=\"left\"><bold>Y42</bold></td><td align=\"left\"><bold>Hormones (including synthetic, antagonists)</bold></td><td align=\"right\">4,547</td><td align=\"right\">5,088</td><td align=\"right\">4,934</td><td align=\"right\">5,113</td><td align=\"right\">5,803</td><td align=\"right\">5,461</td><td align=\"right\">5,319</td><td align=\"center\">17</td></tr><tr><td align=\"left\"><bold>Y43</bold></td><td align=\"left\"><bold>Primarily systemic agents</bold></td><td align=\"right\">7,501</td><td align=\"right\">8,271</td><td align=\"right\">9,078</td><td align=\"right\">9,877</td><td align=\"right\">10,766</td><td align=\"right\">11,226</td><td align=\"right\">12,054</td><td align=\"center\">60.7</td></tr><tr><td align=\"left\"><bold>Y44</bold></td><td align=\"left\"><bold>Agents primarily affecting blood constituents</bold></td><td align=\"right\">4,062</td><td align=\"right\">4,483</td><td align=\"right\">4,723</td><td align=\"right\">4,797</td><td align=\"right\">5,230</td><td align=\"right\">5,995</td><td align=\"right\">4,272</td><td align=\"center\">5.2</td></tr><tr><td align=\"left\"><bold>Y45</bold></td><td align=\"left\"><bold>Analgesics/antipyretics/anti-inflammatory</bold></td><td align=\"right\">5,951</td><td align=\"right\">6,726</td><td align=\"right\">6,787</td><td align=\"right\">6,819</td><td align=\"right\">7,540</td><td align=\"right\">8,079</td><td align=\"right\">9,004</td><td align=\"center\">51.3</td></tr><tr><td align=\"left\"><bold>Y46</bold></td><td align=\"left\"><bold>Antiepileptics/antiParkinsonism drugs</bold></td><td align=\"right\">1,230</td><td align=\"right\">1,267</td><td align=\"right\">1,224</td><td align=\"right\">1,340</td><td align=\"right\">1,401</td><td align=\"right\">1,501</td><td align=\"right\">1,628</td><td align=\"center\">32.4</td></tr><tr><td align=\"left\"><bold>Y47</bold></td><td align=\"left\"><bold>Sedatives, hypnotics, anti-anxiety drugs</bold></td><td align=\"right\">370</td><td align=\"right\">400</td><td align=\"right\">450</td><td align=\"right\">430</td><td align=\"right\">480</td><td align=\"right\">586</td><td align=\"right\">560</td><td align=\"center\">51.4</td></tr><tr><td align=\"left\"><bold>Y48</bold></td><td align=\"left\"><bold>Anaesthetics, therapeutic gases</bold></td><td align=\"right\">414</td><td align=\"right\">538</td><td align=\"right\">502</td><td align=\"right\">440</td><td align=\"right\">505</td><td align=\"right\">521</td><td align=\"right\">531</td><td align=\"center\">28.3</td></tr><tr><td align=\"left\"><bold>Y49</bold></td><td align=\"left\"><bold>Psychotropic drugs</bold></td><td align=\"right\">1,653</td><td align=\"right\">1,678</td><td align=\"right\">2,008</td><td align=\"right\">1,992</td><td align=\"right\">1,953</td><td align=\"right\">2,364</td><td align=\"right\">2,544</td><td align=\"center\">53.9</td></tr><tr><td align=\"left\"><bold>Y50</bold></td><td align=\"left\"><bold>Central nervous system stimulants</bold></td><td align=\"right\">46</td><td align=\"right\">67</td><td align=\"right\">75</td><td align=\"right\">76</td><td align=\"right\">69</td><td align=\"right\">71</td><td align=\"right\">93</td><td align=\"center\">102.2</td></tr><tr><td align=\"left\"><bold>Y51</bold></td><td align=\"left\"><bold>Drugs affecting autonomic nervous system</bold></td><td align=\"right\">1,702</td><td align=\"right\">2,056</td><td align=\"right\">2,277</td><td align=\"right\">2,470</td><td align=\"right\">2,686</td><td align=\"right\">3,239</td><td align=\"right\">3,532</td><td align=\"center\">107.5</td></tr><tr><td align=\"left\"><bold>Y52</bold></td><td align=\"left\"><bold>Agents primarily affecting cardiovascular system</bold></td><td align=\"right\">4,044</td><td align=\"right\">4,752</td><td align=\"right\">5,376</td><td align=\"right\">5,667</td><td align=\"right\">6,234</td><td align=\"right\">6,836</td><td align=\"right\">7,768</td><td align=\"center\">92.1</td></tr><tr><td align=\"left\"><bold>Y53</bold></td><td align=\"left\"><bold>Agents primarily affecting gastrointestinal system</bold></td><td align=\"right\">398</td><td align=\"right\">410</td><td align=\"right\">486</td><td align=\"right\">416</td><td align=\"right\">461</td><td align=\"right\">579</td><td align=\"right\">656</td><td align=\"center\">64.8</td></tr><tr><td align=\"left\"><bold>Y54</bold></td><td align=\"left\"><bold>Agents affecting water/mineral balance/uric acid</bold></td><td align=\"right\">2,136</td><td align=\"right\">2,617</td><td align=\"right\">2,945</td><td align=\"right\">3,526</td><td align=\"right\">4,151</td><td align=\"right\">5,118</td><td align=\"right\">5,638</td><td align=\"center\">164</td></tr><tr><td align=\"left\"><bold>Y55</bold></td><td align=\"left\"><bold>Agents affecting muscle/respiratory system</bold></td><td align=\"right\">312</td><td align=\"right\">299</td><td align=\"right\">342</td><td align=\"right\">321</td><td align=\"right\">323</td><td align=\"right\">430</td><td align=\"right\">422</td><td align=\"center\">35.3</td></tr><tr><td align=\"left\"><bold>Y56</bold></td><td align=\"left\"><bold>Topical agents affecting skin/ENT, dental</bold></td><td align=\"right\">1,138</td><td align=\"right\">1,236</td><td align=\"right\">983</td><td align=\"right\">1,202</td><td align=\"right\">1,065</td><td align=\"right\">1,079</td><td align=\"right\">1,224</td><td align=\"center\">7.6</td></tr><tr><td align=\"left\"><bold>Y57</bold></td><td align=\"left\"><bold>Other and unspecified medicaments</bold></td><td align=\"right\">1,524</td><td align=\"right\">1,715</td><td align=\"right\">1,780</td><td align=\"right\">1,907</td><td align=\"right\">1,906</td><td align=\"right\">2,014</td><td align=\"right\">2,398</td><td align=\"center\">57.3</td></tr><tr><td align=\"left\"><bold>Y58</bold></td><td align=\"left\"><bold>Bacterial vaccines</bold></td><td align=\"right\">226</td><td align=\"right\">347</td><td align=\"right\">255</td><td align=\"right\">182</td><td align=\"right\">197</td><td align=\"right\">356</td><td align=\"right\">281</td><td align=\"center\">24.3</td></tr><tr><td align=\"left\"><bold>Y59</bold></td><td align=\"left\"><bold>Other vaccines/biologicals</bold></td><td align=\"right\">266</td><td align=\"right\">407</td><td align=\"right\">338</td><td align=\"right\">299</td><td align=\"right\">281</td><td align=\"right\">405</td><td align=\"right\">470</td><td align=\"center\">76.7</td></tr><tr><td colspan=\"10\"><hr/></td></tr><tr><td align=\"left\"><bold>Total</bold></td><td/><td align=\"right\">42,555</td><td align=\"right\">47,385</td><td align=\"right\">50,113</td><td align=\"right\">52,160</td><td align=\"right\">56,943</td><td align=\"right\">62,618</td><td align=\"right\">66,296</td><td align=\"center\"><bold>55.8</bold></td></tr></tbody></table></body></html>","text":"Pmid= 2093926:Table= Table 4","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":-1246735405,"_task_hash":-620337064,"_view_id":"review","accept":[5],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":null,"sessions":["tableclass-test-params-100-frank","tableclass-test-params-100-gill","tableclass-test-params-100-joe","tableclass-test-params-100-vicky"],"versions":[{"html":"<!DOCTYPE html><html><body><h1>Annual number of HES finished consultant episodes with an 'external code' for an adverse drug reaction</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td align=\"left\"><bold>ICD-10</bold></td><td/><td align=\"right\"><bold>1998&#8211;9</bold></td><td align=\"right\"><bold>1999&#8211;00</bold></td><td align=\"right\"><bold>2000&#8211;1</bold></td><td align=\"right\"><bold>2001&#8211;2</bold></td><td align=\"right\"><bold>2002&#8211;3</bold></td><td align=\"right\"><bold>2003&#8211;4</bold></td><td align=\"right\"><bold>2004&#8211;5</bold></td><td align=\"center\"><bold>% Change 1998&#8211;2005</bold></td></tr></thead><tbody><tr><td align=\"left\"><bold>Y40</bold></td><td align=\"left\"><bold>Systemic antibiotics</bold></td><td align=\"right\">4,206</td><td align=\"right\">4,212</td><td align=\"right\">4,533</td><td align=\"right\">4,341</td><td align=\"right\">4,697</td><td align=\"right\">5,624</td><td align=\"right\">6,449</td><td align=\"center\">53.3</td></tr><tr><td align=\"left\"><bold>Y41</bold></td><td align=\"left\"><bold>Other systemic anti-infectives/anti-parasitics</bold></td><td align=\"right\">829</td><td align=\"right\">816</td><td align=\"right\">1,017</td><td align=\"right\">945</td><td align=\"right\">1,195</td><td align=\"right\">1,134</td><td align=\"right\">1,453</td><td align=\"center\">75.3</td></tr><tr><td align=\"left\"><bold>Y42</bold></td><td align=\"left\"><bold>Hormones (including synthetic, antagonists)</bold></td><td align=\"right\">4,547</td><td align=\"right\">5,088</td><td align=\"right\">4,934</td><td align=\"right\">5,113</td><td align=\"right\">5,803</td><td align=\"right\">5,461</td><td align=\"right\">5,319</td><td align=\"center\">17</td></tr><tr><td align=\"left\"><bold>Y43</bold></td><td align=\"left\"><bold>Primarily systemic agents</bold></td><td align=\"right\">7,501</td><td align=\"right\">8,271</td><td align=\"right\">9,078</td><td align=\"right\">9,877</td><td align=\"right\">10,766</td><td align=\"right\">11,226</td><td align=\"right\">12,054</td><td align=\"center\">60.7</td></tr><tr><td align=\"left\"><bold>Y44</bold></td><td align=\"left\"><bold>Agents primarily affecting blood constituents</bold></td><td align=\"right\">4,062</td><td align=\"right\">4,483</td><td align=\"right\">4,723</td><td align=\"right\">4,797</td><td align=\"right\">5,230</td><td align=\"right\">5,995</td><td align=\"right\">4,272</td><td align=\"center\">5.2</td></tr><tr><td align=\"left\"><bold>Y45</bold></td><td align=\"left\"><bold>Analgesics/antipyretics/anti-inflammatory</bold></td><td align=\"right\">5,951</td><td align=\"right\">6,726</td><td align=\"right\">6,787</td><td align=\"right\">6,819</td><td align=\"right\">7,540</td><td align=\"right\">8,079</td><td align=\"right\">9,004</td><td align=\"center\">51.3</td></tr><tr><td align=\"left\"><bold>Y46</bold></td><td align=\"left\"><bold>Antiepileptics/antiParkinsonism drugs</bold></td><td align=\"right\">1,230</td><td align=\"right\">1,267</td><td align=\"right\">1,224</td><td align=\"right\">1,340</td><td align=\"right\">1,401</td><td align=\"right\">1,501</td><td align=\"right\">1,628</td><td align=\"center\">32.4</td></tr><tr><td align=\"left\"><bold>Y47</bold></td><td align=\"left\"><bold>Sedatives, hypnotics, anti-anxiety drugs</bold></td><td align=\"right\">370</td><td align=\"right\">400</td><td align=\"right\">450</td><td align=\"right\">430</td><td align=\"right\">480</td><td align=\"right\">586</td><td align=\"right\">560</td><td align=\"center\">51.4</td></tr><tr><td align=\"left\"><bold>Y48</bold></td><td align=\"left\"><bold>Anaesthetics, therapeutic gases</bold></td><td align=\"right\">414</td><td align=\"right\">538</td><td align=\"right\">502</td><td align=\"right\">440</td><td align=\"right\">505</td><td align=\"right\">521</td><td align=\"right\">531</td><td align=\"center\">28.3</td></tr><tr><td align=\"left\"><bold>Y49</bold></td><td align=\"left\"><bold>Psychotropic drugs</bold></td><td align=\"right\">1,653</td><td align=\"right\">1,678</td><td align=\"right\">2,008</td><td align=\"right\">1,992</td><td align=\"right\">1,953</td><td align=\"right\">2,364</td><td align=\"right\">2,544</td><td align=\"center\">53.9</td></tr><tr><td align=\"left\"><bold>Y50</bold></td><td align=\"left\"><bold>Central nervous system stimulants</bold></td><td align=\"right\">46</td><td align=\"right\">67</td><td align=\"right\">75</td><td align=\"right\">76</td><td align=\"right\">69</td><td align=\"right\">71</td><td align=\"right\">93</td><td align=\"center\">102.2</td></tr><tr><td align=\"left\"><bold>Y51</bold></td><td align=\"left\"><bold>Drugs affecting autonomic nervous system</bold></td><td align=\"right\">1,702</td><td align=\"right\">2,056</td><td align=\"right\">2,277</td><td align=\"right\">2,470</td><td align=\"right\">2,686</td><td align=\"right\">3,239</td><td align=\"right\">3,532</td><td align=\"center\">107.5</td></tr><tr><td align=\"left\"><bold>Y52</bold></td><td align=\"left\"><bold>Agents primarily affecting cardiovascular system</bold></td><td align=\"right\">4,044</td><td align=\"right\">4,752</td><td align=\"right\">5,376</td><td align=\"right\">5,667</td><td align=\"right\">6,234</td><td align=\"right\">6,836</td><td align=\"right\">7,768</td><td align=\"center\">92.1</td></tr><tr><td align=\"left\"><bold>Y53</bold></td><td align=\"left\"><bold>Agents primarily affecting gastrointestinal system</bold></td><td align=\"right\">398</td><td align=\"right\">410</td><td align=\"right\">486</td><td align=\"right\">416</td><td align=\"right\">461</td><td align=\"right\">579</td><td align=\"right\">656</td><td align=\"center\">64.8</td></tr><tr><td align=\"left\"><bold>Y54</bold></td><td align=\"left\"><bold>Agents affecting water/mineral balance/uric acid</bold></td><td align=\"right\">2,136</td><td align=\"right\">2,617</td><td align=\"right\">2,945</td><td align=\"right\">3,526</td><td align=\"right\">4,151</td><td align=\"right\">5,118</td><td align=\"right\">5,638</td><td align=\"center\">164</td></tr><tr><td align=\"left\"><bold>Y55</bold></td><td align=\"left\"><bold>Agents affecting muscle/respiratory system</bold></td><td align=\"right\">312</td><td align=\"right\">299</td><td align=\"right\">342</td><td align=\"right\">321</td><td align=\"right\">323</td><td align=\"right\">430</td><td align=\"right\">422</td><td align=\"center\">35.3</td></tr><tr><td align=\"left\"><bold>Y56</bold></td><td align=\"left\"><bold>Topical agents affecting skin/ENT, dental</bold></td><td align=\"right\">1,138</td><td align=\"right\">1,236</td><td align=\"right\">983</td><td align=\"right\">1,202</td><td align=\"right\">1,065</td><td align=\"right\">1,079</td><td align=\"right\">1,224</td><td align=\"center\">7.6</td></tr><tr><td align=\"left\"><bold>Y57</bold></td><td align=\"left\"><bold>Other and unspecified medicaments</bold></td><td align=\"right\">1,524</td><td align=\"right\">1,715</td><td align=\"right\">1,780</td><td align=\"right\">1,907</td><td align=\"right\">1,906</td><td align=\"right\">2,014</td><td align=\"right\">2,398</td><td align=\"center\">57.3</td></tr><tr><td align=\"left\"><bold>Y58</bold></td><td align=\"left\"><bold>Bacterial vaccines</bold></td><td align=\"right\">226</td><td align=\"right\">347</td><td align=\"right\">255</td><td align=\"right\">182</td><td align=\"right\">197</td><td align=\"right\">356</td><td align=\"right\">281</td><td align=\"center\">24.3</td></tr><tr><td align=\"left\"><bold>Y59</bold></td><td align=\"left\"><bold>Other vaccines/biologicals</bold></td><td align=\"right\">266</td><td align=\"right\">407</td><td align=\"right\">338</td><td align=\"right\">299</td><td align=\"right\">281</td><td align=\"right\">405</td><td align=\"right\">470</td><td align=\"center\">76.7</td></tr><tr><td colspan=\"10\"><hr/></td></tr><tr><td align=\"left\"><bold>Total</bold></td><td/><td align=\"right\">42,555</td><td align=\"right\">47,385</td><td align=\"right\">50,113</td><td align=\"right\">52,160</td><td align=\"right\">56,943</td><td align=\"right\">62,618</td><td align=\"right\">66,296</td><td align=\"center\"><bold>55.8</bold></td></tr></tbody></table></body></html>","text":"Pmid= 2093926:Table= Table 4","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":-1246735405,"_task_hash":-620337064,"_view_id":"choice","accept":[5],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":"tableclass-test-params-100-gill","sessions":["tableclass-test-params-100-frank","tableclass-test-params-100-gill","tableclass-test-params-100-joe","tableclass-test-params-100-vicky"],"default":true}],"view_id":"choice"}
{"html":"<!DOCTYPE html><html><body><h1>Number of HES finished consultant episodes with a primary diagnosis of an ADR in 2004/05: mean age of admissions, age & gender distribution of episodes and total bed days</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td align=\"left\"><bold>ICD-10</bold></td><td/><td align=\"center\"><bold>Male %</bold></td><td align=\"center\"><bold>Mean age</bold></td><td align=\"center\"><bold>Age 0&#8211;14 (%)</bold></td><td align=\"center\"><bold>Age 15&#8211;59 (%)</bold></td><td align=\"center\"><bold>Age 60&#8211;74 (%)</bold></td><td align=\"center\"><bold>Age 75+ (%)</bold></td><td align=\"center\"><bold>Total Bed days</bold></td></tr></thead><tbody><tr><td align=\"left\"><bold>D59.0/2</bold></td><td align=\"left\"><bold>Drug induced haemolytic anaemia</bold></td><td align=\"center\">49</td><td align=\"center\">63</td><td align=\"center\">0 (0.0)</td><td align=\"center\">52 (0.5)</td><td align=\"center\">75 (0.8)</td><td align=\"center\">27 (0.3)</td><td align=\"center\">160</td></tr><tr><td align=\"left\"><bold>D61.1</bold></td><td align=\"left\"><bold>Drug induced aplastic anaemia</bold></td><td align=\"center\">49</td><td align=\"center\">64</td><td align=\"center\">2 (0.0)</td><td align=\"center\">89 (0.9)</td><td align=\"center\">74 (0.7)</td><td align=\"center\">73 (0.7)</td><td align=\"center\">604</td></tr><tr><td align=\"left\"><bold>E03.2</bold></td><td align=\"left\"><bold>Hypothyroidism due to medicaments</bold></td><td align=\"center\">42</td><td align=\"center\">72</td><td align=\"center\">0 (0.0)</td><td align=\"center\">6 (0.1)</td><td align=\"center\">3 (0.0)</td><td align=\"center\">17 (0.2)</td><td align=\"center\">191</td></tr><tr><td align=\"left\"><bold>E27.3</bold></td><td align=\"left\"><bold>Drug induced adrenocortical failure</bold></td><td align=\"center\">41</td><td align=\"center\">48</td><td align=\"center\">11 (0.1)</td><td align=\"center\">22 (0.2)</td><td align=\"center\">12 (0.1)</td><td align=\"center\">14 (0.1)</td><td align=\"center\">584</td></tr><tr><td align=\"left\"><bold>F11</bold></td><td align=\"left\"><bold>Mental disorders due to opioids</bold></td><td align=\"center\">66</td><td align=\"center\">32</td><td align=\"center\">14 (0.1)</td><td align=\"center\">3681 (36.9)</td><td align=\"center\">33 (0.3)</td><td align=\"center\">14 (0.1)</td><td align=\"center\">47390</td></tr><tr><td align=\"left\"><bold>F13</bold></td><td align=\"left\"><bold>Mental disorders due to sedatives/hypnotics</bold></td><td align=\"center\">54</td><td align=\"center\">47</td><td align=\"center\">6 (0.1)</td><td align=\"center\">123 (1.2)</td><td align=\"center\">33 (0.3)</td><td align=\"center\">27 (0.3)</td><td align=\"center\">4922</td></tr><tr><td align=\"left\"><bold>F19</bold></td><td align=\"left\"><bold>Mental disorders due to multiple psychoactive drugs</bold></td><td align=\"center\">75</td><td align=\"center\">31</td><td align=\"center\">14 (0.1)</td><td align=\"center\">2734 (27.4)</td><td align=\"center\">17 (0.2)</td><td align=\"center\">10 (0.1)</td><td align=\"center\">64152</td></tr><tr><td align=\"left\"><bold>G21.0</bold></td><td align=\"left\"><bold>Malignant neuroleptic syndrome</bold></td><td align=\"center\">67</td><td align=\"center\">50</td><td align=\"center\">0 (0.0)</td><td align=\"center\">88 (0.9)</td><td align=\"center\">28 (0.3)</td><td align=\"center\">12 (0.1)</td><td align=\"center\">2,315</td></tr><tr><td align=\"left\"><bold>G21.1</bold></td><td align=\"left\"><bold>Drug induced Parkinsonism</bold></td><td align=\"center\">43</td><td align=\"center\">77</td><td align=\"center\">1 0.0)</td><td align=\"center\">11 (0.1)</td><td align=\"center\">44 (0.4)</td><td align=\"center\">93 (0.9)</td><td align=\"center\">1,964</td></tr><tr><td align=\"left\"><bold>G24.0</bold></td><td align=\"left\"><bold>Drug induced dystonia</bold></td><td align=\"center\">47</td><td align=\"center\">43</td><td align=\"center\">10 (0.1)</td><td align=\"center\">65 (0.7)</td><td align=\"center\">16 (0.2)</td><td align=\"center\">18 (0.2)</td><td align=\"center\">550</td></tr><tr><td align=\"left\"><bold>G25.1/4/6</bold></td><td align=\"left\"><bold>Drug induced extrapyramidal syndrome/chorea/tics</bold></td><td align=\"center\">40</td><td align=\"center\">64</td><td align=\"center\">2 (0.0)</td><td align=\"center\">15 (0.2)</td><td align=\"center\">18 (0.2)</td><td align=\"center\">13 (0.1)</td><td align=\"center\">407</td></tr><tr><td align=\"left\"><bold>G72.0</bold></td><td align=\"left\"><bold>Drug induced myopathy</bold></td><td align=\"center\">51</td><td align=\"center\">65</td><td align=\"center\">1 (0.0)</td><td align=\"center\">12 (0.1)</td><td align=\"center\">20 (0.2)</td><td align=\"center\">22 (0.2)</td><td align=\"center\">517</td></tr><tr><td align=\"left\"><bold>H91.0</bold></td><td align=\"left\"><bold>Ototoxic hearing loss</bold></td><td align=\"center\">U/C</td><td align=\"center\">U/C</td><td align=\"center\">U/C</td><td align=\"center\">U/C</td><td align=\"center\">U/C</td><td align=\"center\">U/C</td><td align=\"center\">U/C</td></tr><tr><td align=\"left\"><bold>I42.7</bold></td><td align=\"left\"><bold>Drug induced cardiomyopathy</bold></td><td align=\"center\">48</td><td align=\"center\">43</td><td align=\"center\">7 (0.1)</td><td align=\"center\">42 (0.4)</td><td align=\"center\">7 (0.1)</td><td align=\"center\">5 (0.1)</td><td align=\"center\">376</td></tr><tr><td align=\"left\"><bold>J70.2/3/4</bold></td><td align=\"left\"><bold>Drug induced interstitial lung disorders</bold></td><td align=\"center\">49</td><td align=\"center\">64</td><td align=\"center\">3 (0.0)</td><td align=\"center\">24 (0.2)</td><td align=\"center\">40 (0.4)</td><td align=\"center\">27 (0.3)</td><td align=\"center\">858</td></tr><tr><td align=\"left\"><bold>K71</bold></td><td align=\"left\"><bold>Drug induced liver disease</bold></td><td align=\"center\">43</td><td align=\"center\">47</td><td align=\"center\">12 (0.1)</td><td align=\"center\">315 (3.2)</td><td align=\"center\">50 (0.5)</td><td align=\"center\">71 (0.7)</td><td align=\"center\">3408</td></tr><tr><td align=\"left\"><bold>L56.0/1</bold></td><td align=\"left\"><bold>Drug induced phototoxicity</bold></td><td align=\"center\">0</td><td align=\"center\">47</td><td align=\"center\">1 (0.0)</td><td align=\"center\">2 (0.0)</td><td align=\"center\">2 (0.0)</td><td align=\"center\">0 (0.0)</td><td align=\"center\">17</td></tr><tr><td align=\"left\"><bold>M10.2</bold></td><td align=\"left\"><bold>Drug induced gout</bold></td><td align=\"center\">53</td><td align=\"center\">75</td><td align=\"center\">0 (0.0)</td><td align=\"center\">4 (0.0)</td><td align=\"center\">9 (0.1)</td><td align=\"center\">21 (0.2)</td><td align=\"center\">237</td></tr><tr><td align=\"left\"><bold>M32.0</bold></td><td align=\"left\"><bold>Drug induced systemic lupus erythematosus</bold></td><td align=\"center\">27</td><td align=\"center\">43</td><td align=\"center\">0 (0.0)</td><td align=\"center\">19 (0.2)</td><td align=\"center\">2 (0.0)</td><td align=\"center\">5 (0.1)</td><td align=\"center\">69</td></tr><tr><td align=\"left\"><bold>M34.2</bold></td><td align=\"left\"><bold>Drug induced systemic sclerosis</bold></td><td align=\"center\">U/C</td><td align=\"center\">U/C</td><td align=\"center\">U/C</td><td align=\"center\">U/C</td><td align=\"center\">U/C</td><td align=\"center\">U/C</td><td align=\"center\">U/C</td></tr><tr><td align=\"left\"><bold>N14</bold></td><td align=\"left\"><bold>Drug induced nephropathy</bold></td><td align=\"center\">2</td><td align=\"center\">58</td><td align=\"center\">0 (0.0)</td><td align=\"center\">3 (0.0)</td><td align=\"center\">5 (0.1)</td><td align=\"center\">3 (0.0)</td><td align=\"center\">111</td></tr><tr><td align=\"left\"><bold>T88.3</bold></td><td align=\"left\"><bold>Malignant hyperthermia due to anaesthesia</bold></td><td align=\"center\">75</td><td align=\"center\">20</td><td align=\"center\">2 (0.0)</td><td align=\"center\">2 (0.0)</td><td align=\"center\">0 (0.0)</td><td align=\"center\">0 (0.0)</td><td align=\"center\">8</td></tr><tr><td align=\"left\"><bold>T88.6</bold></td><td align=\"left\"><bold>Drug induced anaphylaxis</bold></td><td align=\"center\">37</td><td align=\"center\">52</td><td align=\"center\">19 (0.2)</td><td align=\"center\">326 (3.3)</td><td align=\"center\">130 (1.3)</td><td align=\"center\">87 (0.9)</td><td align=\"center\">883</td></tr><tr><td align=\"left\"><bold>T88.7</bold></td><td align=\"left\"><bold>Unspecified adverse drug effect</bold></td><td align=\"center\">33</td><td align=\"center\">50</td><td align=\"center\">80 (0.8)</td><td align=\"center\">565 (5.7)</td><td align=\"center\">203 (2.0)</td><td align=\"center\">217 (2.2)</td><td align=\"center\">2,471</td></tr><tr><td colspan=\"9\"><hr/></td></tr><tr><td align=\"left\"><bold>Total</bold></td><td/><td align=\"center\">33</td><td align=\"center\">40</td><td align=\"center\">185 (1.9)</td><td align=\"center\">8200 (82.1)</td><td align=\"center\">821 (8.2)</td><td align=\"center\">776 (7.8)</td><td align=\"center\">132194</td></tr></tbody></table></body></html>","text":"Pmid= 2093926:Table= Table 5","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":-1669846786,"_task_hash":-75555041,"_view_id":"review","accept":[5],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":null,"sessions":["tableclass-test-params-100-frank","tableclass-test-params-100-gill","tableclass-test-params-100-joe","tableclass-test-params-100-vicky"],"versions":[{"html":"<!DOCTYPE html><html><body><h1>Number of HES finished consultant episodes with a primary diagnosis of an ADR in 2004/05: mean age of admissions, age & gender distribution of episodes and total bed days</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td align=\"left\"><bold>ICD-10</bold></td><td/><td align=\"center\"><bold>Male %</bold></td><td align=\"center\"><bold>Mean age</bold></td><td align=\"center\"><bold>Age 0&#8211;14 (%)</bold></td><td align=\"center\"><bold>Age 15&#8211;59 (%)</bold></td><td align=\"center\"><bold>Age 60&#8211;74 (%)</bold></td><td align=\"center\"><bold>Age 75+ (%)</bold></td><td align=\"center\"><bold>Total Bed days</bold></td></tr></thead><tbody><tr><td align=\"left\"><bold>D59.0/2</bold></td><td align=\"left\"><bold>Drug induced haemolytic anaemia</bold></td><td align=\"center\">49</td><td align=\"center\">63</td><td align=\"center\">0 (0.0)</td><td align=\"center\">52 (0.5)</td><td align=\"center\">75 (0.8)</td><td align=\"center\">27 (0.3)</td><td align=\"center\">160</td></tr><tr><td align=\"left\"><bold>D61.1</bold></td><td align=\"left\"><bold>Drug induced aplastic anaemia</bold></td><td align=\"center\">49</td><td align=\"center\">64</td><td align=\"center\">2 (0.0)</td><td align=\"center\">89 (0.9)</td><td align=\"center\">74 (0.7)</td><td align=\"center\">73 (0.7)</td><td align=\"center\">604</td></tr><tr><td align=\"left\"><bold>E03.2</bold></td><td align=\"left\"><bold>Hypothyroidism due to medicaments</bold></td><td align=\"center\">42</td><td align=\"center\">72</td><td align=\"center\">0 (0.0)</td><td align=\"center\">6 (0.1)</td><td align=\"center\">3 (0.0)</td><td align=\"center\">17 (0.2)</td><td align=\"center\">191</td></tr><tr><td align=\"left\"><bold>E27.3</bold></td><td align=\"left\"><bold>Drug induced adrenocortical failure</bold></td><td align=\"center\">41</td><td align=\"center\">48</td><td align=\"center\">11 (0.1)</td><td align=\"center\">22 (0.2)</td><td align=\"center\">12 (0.1)</td><td align=\"center\">14 (0.1)</td><td align=\"center\">584</td></tr><tr><td align=\"left\"><bold>F11</bold></td><td align=\"left\"><bold>Mental disorders due to opioids</bold></td><td align=\"center\">66</td><td align=\"center\">32</td><td align=\"center\">14 (0.1)</td><td align=\"center\">3681 (36.9)</td><td align=\"center\">33 (0.3)</td><td align=\"center\">14 (0.1)</td><td align=\"center\">47390</td></tr><tr><td align=\"left\"><bold>F13</bold></td><td align=\"left\"><bold>Mental disorders due to sedatives/hypnotics</bold></td><td align=\"center\">54</td><td align=\"center\">47</td><td align=\"center\">6 (0.1)</td><td align=\"center\">123 (1.2)</td><td align=\"center\">33 (0.3)</td><td align=\"center\">27 (0.3)</td><td align=\"center\">4922</td></tr><tr><td align=\"left\"><bold>F19</bold></td><td align=\"left\"><bold>Mental disorders due to multiple psychoactive drugs</bold></td><td align=\"center\">75</td><td align=\"center\">31</td><td align=\"center\">14 (0.1)</td><td align=\"center\">2734 (27.4)</td><td align=\"center\">17 (0.2)</td><td align=\"center\">10 (0.1)</td><td align=\"center\">64152</td></tr><tr><td align=\"left\"><bold>G21.0</bold></td><td align=\"left\"><bold>Malignant neuroleptic syndrome</bold></td><td align=\"center\">67</td><td align=\"center\">50</td><td align=\"center\">0 (0.0)</td><td align=\"center\">88 (0.9)</td><td align=\"center\">28 (0.3)</td><td align=\"center\">12 (0.1)</td><td align=\"center\">2,315</td></tr><tr><td align=\"left\"><bold>G21.1</bold></td><td align=\"left\"><bold>Drug induced Parkinsonism</bold></td><td align=\"center\">43</td><td align=\"center\">77</td><td align=\"center\">1 0.0)</td><td align=\"center\">11 (0.1)</td><td align=\"center\">44 (0.4)</td><td align=\"center\">93 (0.9)</td><td align=\"center\">1,964</td></tr><tr><td align=\"left\"><bold>G24.0</bold></td><td align=\"left\"><bold>Drug induced dystonia</bold></td><td align=\"center\">47</td><td align=\"center\">43</td><td align=\"center\">10 (0.1)</td><td align=\"center\">65 (0.7)</td><td align=\"center\">16 (0.2)</td><td align=\"center\">18 (0.2)</td><td align=\"center\">550</td></tr><tr><td align=\"left\"><bold>G25.1/4/6</bold></td><td align=\"left\"><bold>Drug induced extrapyramidal syndrome/chorea/tics</bold></td><td align=\"center\">40</td><td align=\"center\">64</td><td align=\"center\">2 (0.0)</td><td align=\"center\">15 (0.2)</td><td align=\"center\">18 (0.2)</td><td align=\"center\">13 (0.1)</td><td align=\"center\">407</td></tr><tr><td align=\"left\"><bold>G72.0</bold></td><td align=\"left\"><bold>Drug induced myopathy</bold></td><td align=\"center\">51</td><td align=\"center\">65</td><td align=\"center\">1 (0.0)</td><td align=\"center\">12 (0.1)</td><td align=\"center\">20 (0.2)</td><td align=\"center\">22 (0.2)</td><td align=\"center\">517</td></tr><tr><td align=\"left\"><bold>H91.0</bold></td><td align=\"left\"><bold>Ototoxic hearing loss</bold></td><td align=\"center\">U/C</td><td align=\"center\">U/C</td><td align=\"center\">U/C</td><td align=\"center\">U/C</td><td align=\"center\">U/C</td><td align=\"center\">U/C</td><td align=\"center\">U/C</td></tr><tr><td align=\"left\"><bold>I42.7</bold></td><td align=\"left\"><bold>Drug induced cardiomyopathy</bold></td><td align=\"center\">48</td><td align=\"center\">43</td><td align=\"center\">7 (0.1)</td><td align=\"center\">42 (0.4)</td><td align=\"center\">7 (0.1)</td><td align=\"center\">5 (0.1)</td><td align=\"center\">376</td></tr><tr><td align=\"left\"><bold>J70.2/3/4</bold></td><td align=\"left\"><bold>Drug induced interstitial lung disorders</bold></td><td align=\"center\">49</td><td align=\"center\">64</td><td align=\"center\">3 (0.0)</td><td align=\"center\">24 (0.2)</td><td align=\"center\">40 (0.4)</td><td align=\"center\">27 (0.3)</td><td align=\"center\">858</td></tr><tr><td align=\"left\"><bold>K71</bold></td><td align=\"left\"><bold>Drug induced liver disease</bold></td><td align=\"center\">43</td><td align=\"center\">47</td><td align=\"center\">12 (0.1)</td><td align=\"center\">315 (3.2)</td><td align=\"center\">50 (0.5)</td><td align=\"center\">71 (0.7)</td><td align=\"center\">3408</td></tr><tr><td align=\"left\"><bold>L56.0/1</bold></td><td align=\"left\"><bold>Drug induced phototoxicity</bold></td><td align=\"center\">0</td><td align=\"center\">47</td><td align=\"center\">1 (0.0)</td><td align=\"center\">2 (0.0)</td><td align=\"center\">2 (0.0)</td><td align=\"center\">0 (0.0)</td><td align=\"center\">17</td></tr><tr><td align=\"left\"><bold>M10.2</bold></td><td align=\"left\"><bold>Drug induced gout</bold></td><td align=\"center\">53</td><td align=\"center\">75</td><td align=\"center\">0 (0.0)</td><td align=\"center\">4 (0.0)</td><td align=\"center\">9 (0.1)</td><td align=\"center\">21 (0.2)</td><td align=\"center\">237</td></tr><tr><td align=\"left\"><bold>M32.0</bold></td><td align=\"left\"><bold>Drug induced systemic lupus erythematosus</bold></td><td align=\"center\">27</td><td align=\"center\">43</td><td align=\"center\">0 (0.0)</td><td align=\"center\">19 (0.2)</td><td align=\"center\">2 (0.0)</td><td align=\"center\">5 (0.1)</td><td align=\"center\">69</td></tr><tr><td align=\"left\"><bold>M34.2</bold></td><td align=\"left\"><bold>Drug induced systemic sclerosis</bold></td><td align=\"center\">U/C</td><td align=\"center\">U/C</td><td align=\"center\">U/C</td><td align=\"center\">U/C</td><td align=\"center\">U/C</td><td align=\"center\">U/C</td><td align=\"center\">U/C</td></tr><tr><td align=\"left\"><bold>N14</bold></td><td align=\"left\"><bold>Drug induced nephropathy</bold></td><td align=\"center\">2</td><td align=\"center\">58</td><td align=\"center\">0 (0.0)</td><td align=\"center\">3 (0.0)</td><td align=\"center\">5 (0.1)</td><td align=\"center\">3 (0.0)</td><td align=\"center\">111</td></tr><tr><td align=\"left\"><bold>T88.3</bold></td><td align=\"left\"><bold>Malignant hyperthermia due to anaesthesia</bold></td><td align=\"center\">75</td><td align=\"center\">20</td><td align=\"center\">2 (0.0)</td><td align=\"center\">2 (0.0)</td><td align=\"center\">0 (0.0)</td><td align=\"center\">0 (0.0)</td><td align=\"center\">8</td></tr><tr><td align=\"left\"><bold>T88.6</bold></td><td align=\"left\"><bold>Drug induced anaphylaxis</bold></td><td align=\"center\">37</td><td align=\"center\">52</td><td align=\"center\">19 (0.2)</td><td align=\"center\">326 (3.3)</td><td align=\"center\">130 (1.3)</td><td align=\"center\">87 (0.9)</td><td align=\"center\">883</td></tr><tr><td align=\"left\"><bold>T88.7</bold></td><td align=\"left\"><bold>Unspecified adverse drug effect</bold></td><td align=\"center\">33</td><td align=\"center\">50</td><td align=\"center\">80 (0.8)</td><td align=\"center\">565 (5.7)</td><td align=\"center\">203 (2.0)</td><td align=\"center\">217 (2.2)</td><td align=\"center\">2,471</td></tr><tr><td colspan=\"9\"><hr/></td></tr><tr><td align=\"left\"><bold>Total</bold></td><td/><td align=\"center\">33</td><td align=\"center\">40</td><td align=\"center\">185 (1.9)</td><td align=\"center\">8200 (82.1)</td><td align=\"center\">821 (8.2)</td><td align=\"center\">776 (7.8)</td><td align=\"center\">132194</td></tr></tbody></table></body></html>","text":"Pmid= 2093926:Table= Table 5","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":-1669846786,"_task_hash":-75555041,"_view_id":"choice","accept":[5],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":"tableclass-test-params-100-gill","sessions":["tableclass-test-params-100-frank","tableclass-test-params-100-gill","tableclass-test-params-100-joe","tableclass-test-params-100-vicky"],"default":true}],"view_id":"choice"}
{"html":"<!DOCTYPE html><html><body><h1>Number of HES finished consultant episodes with an external ICD10 cause for an adverse drug reaction in 2004/05: mean age of admissions, age & gender distribution of episodes and total bed days</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td align=\"left\"><bold>ICD-10</bold></td><td/><td align=\"center\"><bold>Male %</bold></td><td align=\"center\"><bold>Mean age</bold></td><td align=\"center\"><bold>Age 0&#8211;14 (%)</bold></td><td align=\"center\"><bold>Age 15&#8211;59 (%)</bold></td><td align=\"center\"><bold>Age 60&#8211;74 (%)</bold></td><td align=\"center\"><bold>Age 75+ (%)</bold></td><td align=\"center\"><bold>Total bed days</bold></td></tr></thead><tbody><tr><td align=\"left\"><bold>Y40</bold></td><td align=\"left\"><bold>Antibiotics</bold></td><td align=\"center\">40</td><td align=\"center\">57</td><td align=\"center\">467 (0.7)</td><td align=\"center\">2468 (3.7)</td><td align=\"center\">1433 (2.2)</td><td align=\"center\">2064 (3.1)</td><td align=\"center\">48,868</td></tr><tr><td align=\"left\"><bold>Y41</bold></td><td align=\"left\"><bold>Other anti-infectives</bold></td><td align=\"center\">39</td><td align=\"center\">55</td><td align=\"center\">48 (0.1)</td><td align=\"center\">776 (1.2)</td><td align=\"center\">245 (0.4)</td><td align=\"center\">362 (0.5)</td><td align=\"center\">9,280</td></tr><tr><td align=\"left\"><bold>Y42</bold></td><td align=\"left\"><bold>Hormones</bold></td><td align=\"center\">37</td><td align=\"center\">61</td><td align=\"center\">173 (0.3)</td><td align=\"center\">2051 (3.1)</td><td align=\"center\">1571 (2.4)</td><td align=\"center\">1513 (2.3)</td><td align=\"center\">31,323</td></tr><tr><td align=\"left\"><bold>Y43</bold></td><td align=\"left\"><bold>Systemic agents</bold></td><td align=\"center\">46</td><td align=\"center\">52</td><td align=\"center\">1475 (2.2)</td><td align=\"center\">5123 (7.7)</td><td align=\"center\">4107 (6.2)</td><td align=\"center\">1323 (2.0)</td><td align=\"center\">83,049</td></tr><tr><td align=\"left\"><bold>Y44</bold></td><td align=\"left\"><bold>Blood constituents</bold></td><td align=\"center\">47</td><td align=\"center\">70</td><td align=\"center\">37 (0.1)</td><td align=\"center\">830 (1.3)</td><td align=\"center\">1331 (2.0)</td><td align=\"center\">2072 (3.1)</td><td align=\"center\">31,919</td></tr><tr><td align=\"left\"><bold>Y45</bold></td><td align=\"left\"><bold>Analgesics, antipyretics, anti-inflammatory</bold></td><td align=\"center\">44</td><td align=\"center\">66</td><td align=\"center\">101 (0.2)</td><td align=\"center\">2756 (4.2)</td><td align=\"center\">2392 (3.6)</td><td align=\"center\">3746 (5.7)</td><td align=\"center\">50,118</td></tr><tr><td align=\"left\"><bold>Y46</bold></td><td align=\"left\"><bold>Antiepileptics, antiparkinsonism</bold></td><td align=\"center\">51</td><td align=\"center\">59</td><td align=\"center\">69 (0.1)</td><td align=\"center\">641 (1.0)</td><td align=\"center\">434 (0.7)</td><td align=\"center\">484 (0.7)</td><td align=\"center\">15,002</td></tr><tr><td align=\"left\"><bold>Y47</bold></td><td align=\"left\"><bold>Sedatives, hypnotics, anti-anxiety</bold></td><td align=\"center\">43</td><td align=\"center\">56</td><td align=\"center\">54 (0.1)</td><td align=\"center\">210 (0.3)</td><td align=\"center\">104 (0.2)</td><td align=\"center\">190 (0.3)</td><td align=\"center\">4,782</td></tr><tr><td align=\"left\"><bold>Y48</bold></td><td align=\"left\"><bold>Anaesthetics, therapeutic gases</bold></td><td align=\"center\">47</td><td align=\"center\">50</td><td align=\"center\">32 (0.0)</td><td align=\"center\">275 (0.4)</td><td align=\"center\">145 (0.2)</td><td align=\"center\">78 (0.1)</td><td align=\"center\">2,263</td></tr><tr><td align=\"left\"><bold>Y49</bold></td><td align=\"left\"><bold>Psychotropic drugs</bold></td><td align=\"center\">39</td><td align=\"center\">65</td><td align=\"center\">33 (0.0)</td><td align=\"center\">822 (1.2)</td><td align=\"center\">610 (0.9)</td><td align=\"center\">1076 (1.6)</td><td align=\"center\">25,733</td></tr><tr><td align=\"left\"><bold>Y50</bold></td><td align=\"left\"><bold>Central nervous system stimulants</bold></td><td align=\"center\">46</td><td align=\"center\">51</td><td align=\"center\">6 (0.0)</td><td align=\"center\">47 (0.1)</td><td align=\"center\">17 (0.0)</td><td align=\"center\">23 (0.0)</td><td align=\"center\">404</td></tr><tr><td align=\"left\"><bold>Y51</bold></td><td align=\"left\"><bold>Autonomic nervous system</bold></td><td align=\"center\">49</td><td align=\"center\">73</td><td align=\"center\">16 (0.0)</td><td align=\"center\">473 (0.7)</td><td align=\"center\">1037 (1.6)</td><td align=\"center\">2006 (3.0)</td><td align=\"center\">16,886</td></tr><tr><td align=\"left\"><bold>Y52</bold></td><td align=\"left\"><bold>Cardiovascular system</bold></td><td align=\"center\">47</td><td align=\"center\">75</td><td align=\"center\">15 (0.0)</td><td align=\"center\">870 (1.3)</td><td align=\"center\">2210 (3.3)</td><td align=\"center\">4669 (7.1)</td><td align=\"center\">48,189</td></tr><tr><td align=\"left\"><bold>Y53</bold></td><td align=\"left\"><bold>Gastrointestinal system</bold></td><td align=\"center\">39</td><td align=\"center\">62</td><td align=\"center\">30 (0.0)</td><td align=\"center\">222 (0.3)</td><td align=\"center\">163 (0.2)</td><td align=\"center\">239 (0.4)</td><td align=\"center\">3,597</td></tr><tr><td align=\"left\"><bold>Y54</bold></td><td align=\"left\"><bold>Water-balance, mineral and uric acid</bold></td><td align=\"center\">33</td><td align=\"center\">77</td><td align=\"center\">13 (0.0)</td><td align=\"center\">411 (0.6)</td><td align=\"center\">1360 (2.1)</td><td align=\"center\">3848 (5.8)</td><td align=\"center\">42,568</td></tr><tr><td align=\"left\"><bold>Y55</bold></td><td align=\"left\"><bold>Smooth/skeletal muscle, respiratory system</bold></td><td align=\"center\">39</td><td align=\"center\">56</td><td align=\"center\">24 (0.0)</td><td align=\"center\">182 (0.3)</td><td align=\"center\">105 (0.2)</td><td align=\"center\">111 (0.2)</td><td align=\"center\">2,232</td></tr><tr><td align=\"left\"><bold>Y56</bold></td><td align=\"left\"><bold>Topical agents</bold></td><td align=\"center\">42</td><td align=\"center\">58</td><td align=\"center\">68 (0.1)</td><td align=\"center\">459 (0.7)</td><td align=\"center\">344 (0.5)</td><td align=\"center\">351 (0.5)</td><td align=\"center\">5,779</td></tr><tr><td align=\"left\"><bold>Y57</bold></td><td align=\"left\"><bold>Other unspecified drugs</bold></td><td align=\"center\">43</td><td align=\"center\">60</td><td align=\"center\">87 (0.1)</td><td align=\"center\">894 (1.4)</td><td align=\"center\">649 (1.0)</td><td align=\"center\">760 (1.1)</td><td align=\"center\">15,835</td></tr><tr><td align=\"left\"><bold>Y58</bold></td><td align=\"left\"><bold>Bacterial vaccines</bold></td><td align=\"center\">52</td><td align=\"center\">10</td><td align=\"center\">243 (0.4)</td><td align=\"center\">15 (0.0)</td><td align=\"center\">14 (0.0)</td><td align=\"center\">9 (0.0)</td><td align=\"center\">296</td></tr><tr><td align=\"left\"><bold>Y59</bold></td><td align=\"left\"><bold>Other vaccines, biological substance</bold></td><td align=\"center\">51</td><td align=\"center\">28</td><td align=\"center\">211 (0.3)</td><td align=\"center\">162 (0.2)</td><td align=\"center\">57 (0.1)</td><td align=\"center\">40 (0.1)</td><td align=\"center\">1,562</td></tr><tr><td colspan=\"9\"><hr/></td></tr><tr><td align=\"left\"><bold>Total</bold></td><td/><td align=\"center\"><bold>43</bold></td><td align=\"center\"><bold>63</bold></td><td align=\"center\"><bold>3202 (4.8)</bold></td><td align=\"center\"><bold>19687 (29.7)</bold></td><td align=\"center\"><bold>18328 (27.7)</bold></td><td align=\"center\"><bold>24964 (37.7)</bold></td><td align=\"center\"><bold>439,685</bold></td></tr><tr><td colspan=\"9\"><hr/></td></tr><tr><td align=\"left\" colspan=\"2\"><bold>Combined Primary Diagnosis and External Cause</bold></td><td align=\"center\"><bold>42</bold></td><td align=\"center\"><bold>60</bold></td><td align=\"center\"><bold>3387 (4.4)</bold></td><td align=\"center\"><bold>27887 (36.6)</bold></td><td align=\"center\"><bold>19149 (25.1)</bold></td><td align=\"center\"><bold>25740 (33.8)</bold></td><td align=\"center\"><bold>571,879</bold></td></tr></tbody></table></body></html>","text":"Pmid= 2093926:Table= Table 6","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":-1368220876,"_task_hash":2093500977,"_view_id":"review","accept":[5],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":null,"sessions":["tableclass-test-params-100-frank","tableclass-test-params-100-gill","tableclass-test-params-100-joe","tableclass-test-params-100-vicky"],"versions":[{"html":"<!DOCTYPE html><html><body><h1>Number of HES finished consultant episodes with an external ICD10 cause for an adverse drug reaction in 2004/05: mean age of admissions, age & gender distribution of episodes and total bed days</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td align=\"left\"><bold>ICD-10</bold></td><td/><td align=\"center\"><bold>Male %</bold></td><td align=\"center\"><bold>Mean age</bold></td><td align=\"center\"><bold>Age 0&#8211;14 (%)</bold></td><td align=\"center\"><bold>Age 15&#8211;59 (%)</bold></td><td align=\"center\"><bold>Age 60&#8211;74 (%)</bold></td><td align=\"center\"><bold>Age 75+ (%)</bold></td><td align=\"center\"><bold>Total bed days</bold></td></tr></thead><tbody><tr><td align=\"left\"><bold>Y40</bold></td><td align=\"left\"><bold>Antibiotics</bold></td><td align=\"center\">40</td><td align=\"center\">57</td><td align=\"center\">467 (0.7)</td><td align=\"center\">2468 (3.7)</td><td align=\"center\">1433 (2.2)</td><td align=\"center\">2064 (3.1)</td><td align=\"center\">48,868</td></tr><tr><td align=\"left\"><bold>Y41</bold></td><td align=\"left\"><bold>Other anti-infectives</bold></td><td align=\"center\">39</td><td align=\"center\">55</td><td align=\"center\">48 (0.1)</td><td align=\"center\">776 (1.2)</td><td align=\"center\">245 (0.4)</td><td align=\"center\">362 (0.5)</td><td align=\"center\">9,280</td></tr><tr><td align=\"left\"><bold>Y42</bold></td><td align=\"left\"><bold>Hormones</bold></td><td align=\"center\">37</td><td align=\"center\">61</td><td align=\"center\">173 (0.3)</td><td align=\"center\">2051 (3.1)</td><td align=\"center\">1571 (2.4)</td><td align=\"center\">1513 (2.3)</td><td align=\"center\">31,323</td></tr><tr><td align=\"left\"><bold>Y43</bold></td><td align=\"left\"><bold>Systemic agents</bold></td><td align=\"center\">46</td><td align=\"center\">52</td><td align=\"center\">1475 (2.2)</td><td align=\"center\">5123 (7.7)</td><td align=\"center\">4107 (6.2)</td><td align=\"center\">1323 (2.0)</td><td align=\"center\">83,049</td></tr><tr><td align=\"left\"><bold>Y44</bold></td><td align=\"left\"><bold>Blood constituents</bold></td><td align=\"center\">47</td><td align=\"center\">70</td><td align=\"center\">37 (0.1)</td><td align=\"center\">830 (1.3)</td><td align=\"center\">1331 (2.0)</td><td align=\"center\">2072 (3.1)</td><td align=\"center\">31,919</td></tr><tr><td align=\"left\"><bold>Y45</bold></td><td align=\"left\"><bold>Analgesics, antipyretics, anti-inflammatory</bold></td><td align=\"center\">44</td><td align=\"center\">66</td><td align=\"center\">101 (0.2)</td><td align=\"center\">2756 (4.2)</td><td align=\"center\">2392 (3.6)</td><td align=\"center\">3746 (5.7)</td><td align=\"center\">50,118</td></tr><tr><td align=\"left\"><bold>Y46</bold></td><td align=\"left\"><bold>Antiepileptics, antiparkinsonism</bold></td><td align=\"center\">51</td><td align=\"center\">59</td><td align=\"center\">69 (0.1)</td><td align=\"center\">641 (1.0)</td><td align=\"center\">434 (0.7)</td><td align=\"center\">484 (0.7)</td><td align=\"center\">15,002</td></tr><tr><td align=\"left\"><bold>Y47</bold></td><td align=\"left\"><bold>Sedatives, hypnotics, anti-anxiety</bold></td><td align=\"center\">43</td><td align=\"center\">56</td><td align=\"center\">54 (0.1)</td><td align=\"center\">210 (0.3)</td><td align=\"center\">104 (0.2)</td><td align=\"center\">190 (0.3)</td><td align=\"center\">4,782</td></tr><tr><td align=\"left\"><bold>Y48</bold></td><td align=\"left\"><bold>Anaesthetics, therapeutic gases</bold></td><td align=\"center\">47</td><td align=\"center\">50</td><td align=\"center\">32 (0.0)</td><td align=\"center\">275 (0.4)</td><td align=\"center\">145 (0.2)</td><td align=\"center\">78 (0.1)</td><td align=\"center\">2,263</td></tr><tr><td align=\"left\"><bold>Y49</bold></td><td align=\"left\"><bold>Psychotropic drugs</bold></td><td align=\"center\">39</td><td align=\"center\">65</td><td align=\"center\">33 (0.0)</td><td align=\"center\">822 (1.2)</td><td align=\"center\">610 (0.9)</td><td align=\"center\">1076 (1.6)</td><td align=\"center\">25,733</td></tr><tr><td align=\"left\"><bold>Y50</bold></td><td align=\"left\"><bold>Central nervous system stimulants</bold></td><td align=\"center\">46</td><td align=\"center\">51</td><td align=\"center\">6 (0.0)</td><td align=\"center\">47 (0.1)</td><td align=\"center\">17 (0.0)</td><td align=\"center\">23 (0.0)</td><td align=\"center\">404</td></tr><tr><td align=\"left\"><bold>Y51</bold></td><td align=\"left\"><bold>Autonomic nervous system</bold></td><td align=\"center\">49</td><td align=\"center\">73</td><td align=\"center\">16 (0.0)</td><td align=\"center\">473 (0.7)</td><td align=\"center\">1037 (1.6)</td><td align=\"center\">2006 (3.0)</td><td align=\"center\">16,886</td></tr><tr><td align=\"left\"><bold>Y52</bold></td><td align=\"left\"><bold>Cardiovascular system</bold></td><td align=\"center\">47</td><td align=\"center\">75</td><td align=\"center\">15 (0.0)</td><td align=\"center\">870 (1.3)</td><td align=\"center\">2210 (3.3)</td><td align=\"center\">4669 (7.1)</td><td align=\"center\">48,189</td></tr><tr><td align=\"left\"><bold>Y53</bold></td><td align=\"left\"><bold>Gastrointestinal system</bold></td><td align=\"center\">39</td><td align=\"center\">62</td><td align=\"center\">30 (0.0)</td><td align=\"center\">222 (0.3)</td><td align=\"center\">163 (0.2)</td><td align=\"center\">239 (0.4)</td><td align=\"center\">3,597</td></tr><tr><td align=\"left\"><bold>Y54</bold></td><td align=\"left\"><bold>Water-balance, mineral and uric acid</bold></td><td align=\"center\">33</td><td align=\"center\">77</td><td align=\"center\">13 (0.0)</td><td align=\"center\">411 (0.6)</td><td align=\"center\">1360 (2.1)</td><td align=\"center\">3848 (5.8)</td><td align=\"center\">42,568</td></tr><tr><td align=\"left\"><bold>Y55</bold></td><td align=\"left\"><bold>Smooth/skeletal muscle, respiratory system</bold></td><td align=\"center\">39</td><td align=\"center\">56</td><td align=\"center\">24 (0.0)</td><td align=\"center\">182 (0.3)</td><td align=\"center\">105 (0.2)</td><td align=\"center\">111 (0.2)</td><td align=\"center\">2,232</td></tr><tr><td align=\"left\"><bold>Y56</bold></td><td align=\"left\"><bold>Topical agents</bold></td><td align=\"center\">42</td><td align=\"center\">58</td><td align=\"center\">68 (0.1)</td><td align=\"center\">459 (0.7)</td><td align=\"center\">344 (0.5)</td><td align=\"center\">351 (0.5)</td><td align=\"center\">5,779</td></tr><tr><td align=\"left\"><bold>Y57</bold></td><td align=\"left\"><bold>Other unspecified drugs</bold></td><td align=\"center\">43</td><td align=\"center\">60</td><td align=\"center\">87 (0.1)</td><td align=\"center\">894 (1.4)</td><td align=\"center\">649 (1.0)</td><td align=\"center\">760 (1.1)</td><td align=\"center\">15,835</td></tr><tr><td align=\"left\"><bold>Y58</bold></td><td align=\"left\"><bold>Bacterial vaccines</bold></td><td align=\"center\">52</td><td align=\"center\">10</td><td align=\"center\">243 (0.4)</td><td align=\"center\">15 (0.0)</td><td align=\"center\">14 (0.0)</td><td align=\"center\">9 (0.0)</td><td align=\"center\">296</td></tr><tr><td align=\"left\"><bold>Y59</bold></td><td align=\"left\"><bold>Other vaccines, biological substance</bold></td><td align=\"center\">51</td><td align=\"center\">28</td><td align=\"center\">211 (0.3)</td><td align=\"center\">162 (0.2)</td><td align=\"center\">57 (0.1)</td><td align=\"center\">40 (0.1)</td><td align=\"center\">1,562</td></tr><tr><td colspan=\"9\"><hr/></td></tr><tr><td align=\"left\"><bold>Total</bold></td><td/><td align=\"center\"><bold>43</bold></td><td align=\"center\"><bold>63</bold></td><td align=\"center\"><bold>3202 (4.8)</bold></td><td align=\"center\"><bold>19687 (29.7)</bold></td><td align=\"center\"><bold>18328 (27.7)</bold></td><td align=\"center\"><bold>24964 (37.7)</bold></td><td align=\"center\"><bold>439,685</bold></td></tr><tr><td colspan=\"9\"><hr/></td></tr><tr><td align=\"left\" colspan=\"2\"><bold>Combined Primary Diagnosis and External Cause</bold></td><td align=\"center\"><bold>42</bold></td><td align=\"center\"><bold>60</bold></td><td align=\"center\"><bold>3387 (4.4)</bold></td><td align=\"center\"><bold>27887 (36.6)</bold></td><td align=\"center\"><bold>19149 (25.1)</bold></td><td align=\"center\"><bold>25740 (33.8)</bold></td><td align=\"center\"><bold>571,879</bold></td></tr></tbody></table></body></html>","text":"Pmid= 2093926:Table= Table 6","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":-1368220876,"_task_hash":2093500977,"_view_id":"choice","accept":[5],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":"tableclass-test-params-100-gill","sessions":["tableclass-test-params-100-frank","tableclass-test-params-100-gill","tableclass-test-params-100-joe","tableclass-test-params-100-vicky"],"default":true}],"view_id":"choice"}
{"html":"<!DOCTYPE html><html><body><h1>Summary of baseline subject demographic data</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td/><td align=\"left\"><bold>Mean</bold></td><td align=\"left\"><bold>SD</bold></td><td align=\"left\"><bold>Range</bold></td><td align=\"left\"><bold>n</bold></td></tr></thead><tbody><tr><td align=\"left\"><bold>Age (years)</bold></td><td align=\"left\">35.40</td><td align=\"left\">8.31</td><td align=\"left\">22.0; 49.0</td><td align=\"left\">38</td></tr><tr><td align=\"left\"><bold>Height (m)</bold></td><td align=\"left\">177.80</td><td align=\"left\">6.15</td><td align=\"left\">160.0; 188.0</td><td align=\"left\">38</td></tr><tr><td align=\"left\"><bold>Weight (kg)</bold></td><td align=\"left\">80.67</td><td align=\"left\">7.49</td><td align=\"left\">66.5; 97.5</td><td align=\"left\">38</td></tr><tr><td align=\"left\"><bold>BMI (kg/m<sup>2</sup>)</bold></td><td align=\"left\">25.50</td><td align=\"left\">1.82</td><td align=\"left\">22.2; 29.8</td><td align=\"left\">38</td></tr></tbody></table></body></html>","text":"Pmid= 2093927:Table= Table 1","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":1762523201,"_task_hash":-1842241418,"_view_id":"review","accept":[5],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":null,"sessions":["tableclass-test-params-100-frank","tableclass-test-params-100-gill","tableclass-test-params-100-joe","tableclass-test-params-100-vicky"],"versions":[{"html":"<!DOCTYPE html><html><body><h1>Summary of baseline subject demographic data</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td/><td align=\"left\"><bold>Mean</bold></td><td align=\"left\"><bold>SD</bold></td><td align=\"left\"><bold>Range</bold></td><td align=\"left\"><bold>n</bold></td></tr></thead><tbody><tr><td align=\"left\"><bold>Age (years)</bold></td><td align=\"left\">35.40</td><td align=\"left\">8.31</td><td align=\"left\">22.0; 49.0</td><td align=\"left\">38</td></tr><tr><td align=\"left\"><bold>Height (m)</bold></td><td align=\"left\">177.80</td><td align=\"left\">6.15</td><td align=\"left\">160.0; 188.0</td><td align=\"left\">38</td></tr><tr><td align=\"left\"><bold>Weight (kg)</bold></td><td align=\"left\">80.67</td><td align=\"left\">7.49</td><td align=\"left\">66.5; 97.5</td><td align=\"left\">38</td></tr><tr><td align=\"left\"><bold>BMI (kg/m<sup>2</sup>)</bold></td><td align=\"left\">25.50</td><td align=\"left\">1.82</td><td align=\"left\">22.2; 29.8</td><td align=\"left\">38</td></tr></tbody></table></body></html>","text":"Pmid= 2093927:Table= Table 1","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":1762523201,"_task_hash":-1842241418,"_view_id":"choice","accept":[5],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":"tableclass-test-params-100-gill","sessions":["tableclass-test-params-100-frank","tableclass-test-params-100-gill","tableclass-test-params-100-joe","tableclass-test-params-100-vicky"],"default":true}],"view_id":"choice"}
{"html":"<!DOCTYPE html><html><body><h1>Mean (CV%) pharmacokinetic parameters after subcutaneous administration of 2.92 mg r-hGH/subject by cool.click\u2122 2 or needle injection</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td/><td align=\"left\"><bold>cool.click&#8482; 2 (test) mean (CV%)</bold></td><td align=\"left\"><bold>Needle and syringe (reference) mean (CV%)</bold></td><td align=\"left\"><bold>Ratio (test/ref)</bold></td><td align=\"left\"><bold>90% CI for ratio</bold></td><td align=\"left\"><bold>Falls within 80&#8211;125% range?</bold></td><td align=\"left\"><bold>p-value</bold></td></tr></thead><tbody><tr><td align=\"left\"><bold>AUC<sub>0-last </sub>(hours&#183;ng/mL)</bold></td><td align=\"left\">125.1 (30)</td><td align=\"left\">119.3 (27)</td><td align=\"left\">104.8</td><td align=\"left\">98.1, 112.0</td><td align=\"left\">Yes</td><td/></tr><tr><td align=\"left\"><bold>AUC<sub>0-inf </sub>(hours&#183;ng/mL)</bold></td><td align=\"left\">135.5 (27)</td><td align=\"left\">131.1 (24)</td><td align=\"left\">103.4</td><td align=\"left\">97.1, 110.0</td><td align=\"left\">Yes</td><td/></tr><tr><td align=\"left\"><bold>C<sub>max </sub>(ng/mL)</bold></td><td align=\"left\">20.0 (43)</td><td align=\"left\">18.0 (37)</td><td align=\"left\">110.8</td><td align=\"left\">103.7, 118.3</td><td align=\"left\">Yes</td><td/></tr><tr><td align=\"left\"><bold>t<sub>max </sub>(hours)*</bold></td><td align=\"left\">3.0 (2&#8211;6)</td><td align=\"left\">4.5 (2&#8211;6)</td><td/><td/><td/><td align=\"left\">0.002</td></tr><tr><td align=\"left\"><bold>t<sub>1/2 </sub>(hours)</bold></td><td align=\"left\">2.17 (42)</td><td align=\"left\">2.26 (37)</td><td/><td/><td/><td/></tr></tbody></table></body></html>","text":"Pmid= 2093927:Table= Table 2","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":-676197261,"_task_hash":1483697010,"_view_id":"review","accept":[1,3],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":null,"sessions":["tableclass-test-params-100-frank","tableclass-test-params-100-joe","tableclass-test-params-100-vicky"],"versions":[{"html":"<!DOCTYPE html><html><body><h1>Mean (CV%) pharmacokinetic parameters after subcutaneous administration of 2.92 mg r-hGH/subject by cool.click\u2122 2 or needle injection</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td/><td align=\"left\"><bold>cool.click&#8482; 2 (test) mean (CV%)</bold></td><td align=\"left\"><bold>Needle and syringe (reference) mean (CV%)</bold></td><td align=\"left\"><bold>Ratio (test/ref)</bold></td><td align=\"left\"><bold>90% CI for ratio</bold></td><td align=\"left\"><bold>Falls within 80&#8211;125% range?</bold></td><td align=\"left\"><bold>p-value</bold></td></tr></thead><tbody><tr><td align=\"left\"><bold>AUC<sub>0-last </sub>(hours&#183;ng/mL)</bold></td><td align=\"left\">125.1 (30)</td><td align=\"left\">119.3 (27)</td><td align=\"left\">104.8</td><td align=\"left\">98.1, 112.0</td><td align=\"left\">Yes</td><td/></tr><tr><td align=\"left\"><bold>AUC<sub>0-inf </sub>(hours&#183;ng/mL)</bold></td><td align=\"left\">135.5 (27)</td><td align=\"left\">131.1 (24)</td><td align=\"left\">103.4</td><td align=\"left\">97.1, 110.0</td><td align=\"left\">Yes</td><td/></tr><tr><td align=\"left\"><bold>C<sub>max </sub>(ng/mL)</bold></td><td align=\"left\">20.0 (43)</td><td align=\"left\">18.0 (37)</td><td align=\"left\">110.8</td><td align=\"left\">103.7, 118.3</td><td align=\"left\">Yes</td><td/></tr><tr><td align=\"left\"><bold>t<sub>max </sub>(hours)*</bold></td><td align=\"left\">3.0 (2&#8211;6)</td><td align=\"left\">4.5 (2&#8211;6)</td><td/><td/><td/><td align=\"left\">0.002</td></tr><tr><td align=\"left\"><bold>t<sub>1/2 </sub>(hours)</bold></td><td align=\"left\">2.17 (42)</td><td align=\"left\">2.26 (37)</td><td/><td/><td/><td/></tr></tbody></table></body></html>","text":"Pmid= 2093927:Table= Table 2","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":-676197261,"_task_hash":-252580462,"_view_id":"choice","accept":[1,3],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":"tableclass-test-params-100-gill","sessions":["tableclass-test-params-100-gill"],"default":false},{"html":"<!DOCTYPE html><html><body><h1>Mean (CV%) pharmacokinetic parameters after subcutaneous administration of 2.92 mg r-hGH/subject by cool.click\u2122 2 or needle injection</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td/><td align=\"left\"><bold>cool.click&#8482; 2 (test) mean (CV%)</bold></td><td align=\"left\"><bold>Needle and syringe (reference) mean (CV%)</bold></td><td align=\"left\"><bold>Ratio (test/ref)</bold></td><td align=\"left\"><bold>90% CI for ratio</bold></td><td align=\"left\"><bold>Falls within 80&#8211;125% range?</bold></td><td align=\"left\"><bold>p-value</bold></td></tr></thead><tbody><tr><td align=\"left\"><bold>AUC<sub>0-last </sub>(hours&#183;ng/mL)</bold></td><td align=\"left\">125.1 (30)</td><td align=\"left\">119.3 (27)</td><td align=\"left\">104.8</td><td align=\"left\">98.1, 112.0</td><td align=\"left\">Yes</td><td/></tr><tr><td align=\"left\"><bold>AUC<sub>0-inf </sub>(hours&#183;ng/mL)</bold></td><td align=\"left\">135.5 (27)</td><td align=\"left\">131.1 (24)</td><td align=\"left\">103.4</td><td align=\"left\">97.1, 110.0</td><td align=\"left\">Yes</td><td/></tr><tr><td align=\"left\"><bold>C<sub>max </sub>(ng/mL)</bold></td><td align=\"left\">20.0 (43)</td><td align=\"left\">18.0 (37)</td><td align=\"left\">110.8</td><td align=\"left\">103.7, 118.3</td><td align=\"left\">Yes</td><td/></tr><tr><td align=\"left\"><bold>t<sub>max </sub>(hours)*</bold></td><td align=\"left\">3.0 (2&#8211;6)</td><td align=\"left\">4.5 (2&#8211;6)</td><td/><td/><td/><td align=\"left\">0.002</td></tr><tr><td align=\"left\"><bold>t<sub>1/2 </sub>(hours)</bold></td><td align=\"left\">2.17 (42)</td><td align=\"left\">2.26 (37)</td><td/><td/><td/><td/></tr></tbody></table></body></html>","text":"Pmid= 2093927:Table= Table 2","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":-676197261,"_task_hash":1483697010,"_view_id":"choice","accept":[1],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":"tableclass-test-params-100-frank","sessions":["tableclass-test-params-100-frank","tableclass-test-params-100-joe","tableclass-test-params-100-vicky"],"default":true}],"view_id":"choice"}
{"html":"<!DOCTYPE html><html><body><h1>Ethic committee approvals</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td align=\"left\"><bold>Study</bold></td><td align=\"center\"><bold>Ethical Committee</bold></td></tr></thead><tbody><tr><td align=\"left\">- single-dose, comparing 1 and 2 mg lozenges with 2 mg gum<break/>- multiple-dose, comparing 1 mg lozenge with 2 mg gum</td><td align=\"center\">CCPPRB de Franche-Comt&#233;, France</td></tr><tr><td align=\"left\">- multiple-dose, comparing 1 and 2 mg lozenges with 4 mg gum</td><td align=\"center\">CCPPRB of the H&#244;tel-Dieu Hospital (Lyon &#8211; France)</td></tr><tr><td align=\"left\">- safety assessment of 1 mg lozenge after swallowing</td><td align=\"center\">CREC Regipharm (Brussels &#8211; Belgium)</td></tr><tr><td align=\"left\">- French efficacy trial</td><td align=\"center\">CCPPRB of the Piti&#233;-Salp&#234;tri&#232;re Hospital (Paris &#8211; France)</td></tr><tr><td align=\"left\">- US efficacy trial</td><td align=\"center\">IRB at Research Testing Laboratories, Inc. (Great Neck, NY, USA)</td></tr></tbody></table></body></html>","text":"Pmid= 2194660:Table= Table 1","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":-83290448,"_task_hash":-703243464,"_view_id":"review","accept":[5],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":null,"sessions":["tableclass-test-params-100-frank","tableclass-test-params-100-gill","tableclass-test-params-100-joe","tableclass-test-params-100-vicky"],"versions":[{"html":"<!DOCTYPE html><html><body><h1>Ethic committee approvals</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td align=\"left\"><bold>Study</bold></td><td align=\"center\"><bold>Ethical Committee</bold></td></tr></thead><tbody><tr><td align=\"left\">- single-dose, comparing 1 and 2 mg lozenges with 2 mg gum<break/>- multiple-dose, comparing 1 mg lozenge with 2 mg gum</td><td align=\"center\">CCPPRB de Franche-Comt&#233;, France</td></tr><tr><td align=\"left\">- multiple-dose, comparing 1 and 2 mg lozenges with 4 mg gum</td><td align=\"center\">CCPPRB of the H&#244;tel-Dieu Hospital (Lyon &#8211; France)</td></tr><tr><td align=\"left\">- safety assessment of 1 mg lozenge after swallowing</td><td align=\"center\">CREC Regipharm (Brussels &#8211; Belgium)</td></tr><tr><td align=\"left\">- French efficacy trial</td><td align=\"center\">CCPPRB of the Piti&#233;-Salp&#234;tri&#232;re Hospital (Paris &#8211; France)</td></tr><tr><td align=\"left\">- US efficacy trial</td><td align=\"center\">IRB at Research Testing Laboratories, Inc. (Great Neck, NY, USA)</td></tr></tbody></table></body></html>","text":"Pmid= 2194660:Table= Table 1","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":-83290448,"_task_hash":-703243464,"_view_id":"choice","accept":[5],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":"tableclass-test-params-100-gill","sessions":["tableclass-test-params-100-frank","tableclass-test-params-100-gill","tableclass-test-params-100-joe","tableclass-test-params-100-vicky"],"default":true}],"view_id":"choice"}
{"html":"<!DOCTYPE html><html><body><h1>PK parameters of nicotine in plasma after intake of a single dose of lozenge or gum (mean \u00b1 SD; n = 9)</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td align=\"left\"><bold>Formulation\\\\PK parameter</bold></td><td align=\"center\" colspan=\"2\"><bold>Nicotinell<sup>&#174; </sup></bold><break/><bold>lozenge</bold></td><td align=\"center\"><bold>Nicorette<sup>&#174; </sup></bold><break/><bold>gum</bold></td></tr><tr><td/><td colspan=\"2\"><hr/></td><td colspan=\"1\"><hr/></td></tr><tr><td/><td align=\"center\"><bold>1 mg</bold></td><td align=\"center\"><bold>2 mg</bold></td><td align=\"center\"><bold>2 mg</bold></td></tr></thead><tbody><tr><td align=\"left\"><bold>Amount of nicotine released after 30 min (mg) </bold><break/>[% of minimal content]</td><td align=\"center\">0.67 &#177; 0.14 <break/>[67%]</td><td align=\"center\">1.39 &#177; 0.28 <break/>[67%]</td><td align=\"center\">0.81 &#177; 0.25 <break/>[42%]</td></tr><tr><td align=\"left\"><bold>observed C<sub>max </sub>(ng/ml) </bold><break/>[adjusted]<sup>&#8224;&#8225;</sup></td><td align=\"center\">2.3 &#177; 0.8 <break/>[3.5 &#177; 1.1]<sup>&#8224;</sup></td><td align=\"center\">4.8 &#177; 1.4<break/> [7.0 &#177; 1.7]</td><td align=\"center\">2.9 &#177; 1.2</td></tr><tr><td align=\"left\"><bold>t<sub>max </sub>(h) </bold><break/>[median (range)]</td><td align=\"center\">1.1 &#177; 0.7 <break/>[0.8 (0.8&#8211;3.0)]</td><td align=\"center\">0.8 &#177; 0.2 <break/>[0.8 (0.6&#8211;1.1)]</td><td align=\"center\">0.8 &#177; 0.1<break/> [0.8 (0.5&#8211;1.0)]</td></tr><tr><td align=\"left\"><bold>t<sub>1/2 </sub>(h)</bold></td><td align=\"center\">2.7 &#177; 0.7</td><td align=\"center\">2.8 &#177; 0.7</td><td align=\"center\">2.5 &#177; 1.0</td></tr><tr><td align=\"left\"><bold>AUC<sub>0-t </sub>(h&#183;ng/ml)</bold></td><td align=\"center\">8.3 &#177; 2.5</td><td align=\"center\">15.8 &#177; 4.1</td><td align=\"center\">10.6 &#177; 4.4</td></tr><tr><td align=\"left\"><bold>observed AUC<sub>0&#8211;&#8734;</sub>(h&#183;ng/ml) </bold><break/>[adjusted]<sup>&#8224;&#8225;</sup></td><td align=\"center\">10.7 &#177; 3.1 <break/>[16.5 &#177; 4.6]</td><td align=\"center\">20.0 &#177; 5.9 <break/>[30.1 &#177; 9.7]</td><td align=\"center\">13.8 &#177; 5.6</td></tr></tbody></table></body></html>","text":"Pmid= 2194660:Table= Table 2","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":-183718298,"_task_hash":2141585854,"_view_id":"review","accept":[1],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":null,"sessions":["tableclass-test-params-100-frank","tableclass-test-params-100-gill","tableclass-test-params-100-joe"],"versions":[{"html":"<!DOCTYPE html><html><body><h1>PK parameters of nicotine in plasma after intake of a single dose of lozenge or gum (mean \u00b1 SD; n = 9)</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td align=\"left\"><bold>Formulation\\\\PK parameter</bold></td><td align=\"center\" colspan=\"2\"><bold>Nicotinell<sup>&#174; </sup></bold><break/><bold>lozenge</bold></td><td align=\"center\"><bold>Nicorette<sup>&#174; </sup></bold><break/><bold>gum</bold></td></tr><tr><td/><td colspan=\"2\"><hr/></td><td colspan=\"1\"><hr/></td></tr><tr><td/><td align=\"center\"><bold>1 mg</bold></td><td align=\"center\"><bold>2 mg</bold></td><td align=\"center\"><bold>2 mg</bold></td></tr></thead><tbody><tr><td align=\"left\"><bold>Amount of nicotine released after 30 min (mg) </bold><break/>[% of minimal content]</td><td align=\"center\">0.67 &#177; 0.14 <break/>[67%]</td><td align=\"center\">1.39 &#177; 0.28 <break/>[67%]</td><td align=\"center\">0.81 &#177; 0.25 <break/>[42%]</td></tr><tr><td align=\"left\"><bold>observed C<sub>max </sub>(ng/ml) </bold><break/>[adjusted]<sup>&#8224;&#8225;</sup></td><td align=\"center\">2.3 &#177; 0.8 <break/>[3.5 &#177; 1.1]<sup>&#8224;</sup></td><td align=\"center\">4.8 &#177; 1.4<break/> [7.0 &#177; 1.7]</td><td align=\"center\">2.9 &#177; 1.2</td></tr><tr><td align=\"left\"><bold>t<sub>max </sub>(h) </bold><break/>[median (range)]</td><td align=\"center\">1.1 &#177; 0.7 <break/>[0.8 (0.8&#8211;3.0)]</td><td align=\"center\">0.8 &#177; 0.2 <break/>[0.8 (0.6&#8211;1.1)]</td><td align=\"center\">0.8 &#177; 0.1<break/> [0.8 (0.5&#8211;1.0)]</td></tr><tr><td align=\"left\"><bold>t<sub>1/2 </sub>(h)</bold></td><td align=\"center\">2.7 &#177; 0.7</td><td align=\"center\">2.8 &#177; 0.7</td><td align=\"center\">2.5 &#177; 1.0</td></tr><tr><td align=\"left\"><bold>AUC<sub>0-t </sub>(h&#183;ng/ml)</bold></td><td align=\"center\">8.3 &#177; 2.5</td><td align=\"center\">15.8 &#177; 4.1</td><td align=\"center\">10.6 &#177; 4.4</td></tr><tr><td align=\"left\"><bold>observed AUC<sub>0&#8211;&#8734;</sub>(h&#183;ng/ml) </bold><break/>[adjusted]<sup>&#8224;&#8225;</sup></td><td align=\"center\">10.7 &#177; 3.1 <break/>[16.5 &#177; 4.6]</td><td align=\"center\">20.0 &#177; 5.9 <break/>[30.1 &#177; 9.7]</td><td align=\"center\">13.8 &#177; 5.6</td></tr></tbody></table></body></html>","text":"Pmid= 2194660:Table= Table 2","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":-183718298,"_task_hash":2141585854,"_view_id":"choice","accept":[1],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":"tableclass-test-params-100-gill","sessions":["tableclass-test-params-100-frank","tableclass-test-params-100-gill","tableclass-test-params-100-joe"],"default":true},{"html":"<!DOCTYPE html><html><body><h1>PK parameters of nicotine in plasma after intake of a single dose of lozenge or gum (mean \u00b1 SD; n = 9)</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td align=\"left\"><bold>Formulation\\\\PK parameter</bold></td><td align=\"center\" colspan=\"2\"><bold>Nicotinell<sup>&#174; </sup></bold><break/><bold>lozenge</bold></td><td align=\"center\"><bold>Nicorette<sup>&#174; </sup></bold><break/><bold>gum</bold></td></tr><tr><td/><td colspan=\"2\"><hr/></td><td colspan=\"1\"><hr/></td></tr><tr><td/><td align=\"center\"><bold>1 mg</bold></td><td align=\"center\"><bold>2 mg</bold></td><td align=\"center\"><bold>2 mg</bold></td></tr></thead><tbody><tr><td align=\"left\"><bold>Amount of nicotine released after 30 min (mg) </bold><break/>[% of minimal content]</td><td align=\"center\">0.67 &#177; 0.14 <break/>[67%]</td><td align=\"center\">1.39 &#177; 0.28 <break/>[67%]</td><td align=\"center\">0.81 &#177; 0.25 <break/>[42%]</td></tr><tr><td align=\"left\"><bold>observed C<sub>max </sub>(ng/ml) </bold><break/>[adjusted]<sup>&#8224;&#8225;</sup></td><td align=\"center\">2.3 &#177; 0.8 <break/>[3.5 &#177; 1.1]<sup>&#8224;</sup></td><td align=\"center\">4.8 &#177; 1.4<break/> [7.0 &#177; 1.7]</td><td align=\"center\">2.9 &#177; 1.2</td></tr><tr><td align=\"left\"><bold>t<sub>max </sub>(h) </bold><break/>[median (range)]</td><td align=\"center\">1.1 &#177; 0.7 <break/>[0.8 (0.8&#8211;3.0)]</td><td align=\"center\">0.8 &#177; 0.2 <break/>[0.8 (0.6&#8211;1.1)]</td><td align=\"center\">0.8 &#177; 0.1<break/> [0.8 (0.5&#8211;1.0)]</td></tr><tr><td align=\"left\"><bold>t<sub>1/2 </sub>(h)</bold></td><td align=\"center\">2.7 &#177; 0.7</td><td align=\"center\">2.8 &#177; 0.7</td><td align=\"center\">2.5 &#177; 1.0</td></tr><tr><td align=\"left\"><bold>AUC<sub>0-t </sub>(h&#183;ng/ml)</bold></td><td align=\"center\">8.3 &#177; 2.5</td><td align=\"center\">15.8 &#177; 4.1</td><td align=\"center\">10.6 &#177; 4.4</td></tr><tr><td align=\"left\"><bold>observed AUC<sub>0&#8211;&#8734;</sub>(h&#183;ng/ml) </bold><break/>[adjusted]<sup>&#8224;&#8225;</sup></td><td align=\"center\">10.7 &#177; 3.1 <break/>[16.5 &#177; 4.6]</td><td align=\"center\">20.0 &#177; 5.9 <break/>[30.1 &#177; 9.7]</td><td align=\"center\">13.8 &#177; 5.6</td></tr></tbody></table></body></html>","text":"Pmid= 2194660:Table= Table 2","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":-183718298,"_task_hash":828671526,"_view_id":"choice","accept":[2],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":"tableclass-test-params-100-vicky","sessions":["tableclass-test-params-100-vicky"],"default":false}],"view_id":"choice"}
{"html":"<!DOCTYPE html><html><body><h1>PK parameters of nicotine in plasma at steady state after 12 hourly doses</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td align=\"left\"><bold>Formulation\\\\PK parameter</bold></td><td align=\"center\"><bold>Nicotinell<sup>&#174; </sup>lozenge</bold></td><td align=\"center\"><bold>Nicorette<sup>&#174; </sup>gum</bold></td><td align=\"center\"><bold>90% CI </bold>(lozenge/gum)<sup>#</sup></td></tr><tr><td/><td colspan=\"2\"><hr/></td><td/></tr><tr><td/><td align=\"center\"><bold>1 mg</bold></td><td align=\"center\"><bold>2 mg<sup>&#8225;</sup></bold></td><td/></tr></thead><tbody><tr><td align=\"left\"><bold>C<sub>max </sub>(ng/ml)</bold></td><td align=\"center\">10.6 &#177; 2.9</td><td align=\"center\">11.4 &#177; 3.8</td><td align=\"center\">0.86&#8211;1.04</td></tr><tr><td align=\"left\"><bold>C<sub>min </sub>(ng/ml)</bold></td><td align=\"center\">8.1 &#177; 2.4</td><td align=\"center\">9.3 &#177; 3.4</td><td align=\"center\">ND</td></tr><tr><td align=\"left\"><bold>t<sub>max </sub>(h) </bold>[range]</td><td align=\"center\">0.54 &#177; 0.21 [0.00&#8211;0.77]</td><td align=\"center\">0.47 &#177; 0.19 [0.20&#8211;0.95]</td><td align=\"center\">ND</td></tr><tr><td align=\"left\"><bold>t<sub>1/2 </sub>(h)</bold></td><td align=\"center\">3.6 &#177; 1.2</td><td align=\"center\">3.2 &#177; 0.9</td><td align=\"center\">ND</td></tr><tr><td align=\"left\"><bold>AUC<sub>11&#8211;12 </sub>(h&#183;ng/ml)</bold></td><td align=\"center\">9.2 &#177; 2.6</td><td align=\"center\">10.2 &#177; 3.4</td><td align=\"center\">0.84&#8211;1.01</td></tr></tbody></table></body></html>","text":"Pmid= 2194660:Table= Table 3","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":-68157420,"_task_hash":797015984,"_view_id":"review","accept":[1],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":null,"sessions":["tableclass-test-params-100-frank","tableclass-test-params-100-gill","tableclass-test-params-100-joe"],"versions":[{"html":"<!DOCTYPE html><html><body><h1>PK parameters of nicotine in plasma at steady state after 12 hourly doses</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td align=\"left\"><bold>Formulation\\\\PK parameter</bold></td><td align=\"center\"><bold>Nicotinell<sup>&#174; </sup>lozenge</bold></td><td align=\"center\"><bold>Nicorette<sup>&#174; </sup>gum</bold></td><td align=\"center\"><bold>90% CI </bold>(lozenge/gum)<sup>#</sup></td></tr><tr><td/><td colspan=\"2\"><hr/></td><td/></tr><tr><td/><td align=\"center\"><bold>1 mg</bold></td><td align=\"center\"><bold>2 mg<sup>&#8225;</sup></bold></td><td/></tr></thead><tbody><tr><td align=\"left\"><bold>C<sub>max </sub>(ng/ml)</bold></td><td align=\"center\">10.6 &#177; 2.9</td><td align=\"center\">11.4 &#177; 3.8</td><td align=\"center\">0.86&#8211;1.04</td></tr><tr><td align=\"left\"><bold>C<sub>min </sub>(ng/ml)</bold></td><td align=\"center\">8.1 &#177; 2.4</td><td align=\"center\">9.3 &#177; 3.4</td><td align=\"center\">ND</td></tr><tr><td align=\"left\"><bold>t<sub>max </sub>(h) </bold>[range]</td><td align=\"center\">0.54 &#177; 0.21 [0.00&#8211;0.77]</td><td align=\"center\">0.47 &#177; 0.19 [0.20&#8211;0.95]</td><td align=\"center\">ND</td></tr><tr><td align=\"left\"><bold>t<sub>1/2 </sub>(h)</bold></td><td align=\"center\">3.6 &#177; 1.2</td><td align=\"center\">3.2 &#177; 0.9</td><td align=\"center\">ND</td></tr><tr><td align=\"left\"><bold>AUC<sub>11&#8211;12 </sub>(h&#183;ng/ml)</bold></td><td align=\"center\">9.2 &#177; 2.6</td><td align=\"center\">10.2 &#177; 3.4</td><td align=\"center\">0.84&#8211;1.01</td></tr></tbody></table></body></html>","text":"Pmid= 2194660:Table= Table 3","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":-68157420,"_task_hash":797015984,"_view_id":"choice","accept":[1],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":"tableclass-test-params-100-gill","sessions":["tableclass-test-params-100-frank","tableclass-test-params-100-gill","tableclass-test-params-100-joe"],"default":true},{"html":"<!DOCTYPE html><html><body><h1>PK parameters of nicotine in plasma at steady state after 12 hourly doses</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td align=\"left\"><bold>Formulation\\\\PK parameter</bold></td><td align=\"center\"><bold>Nicotinell<sup>&#174; </sup>lozenge</bold></td><td align=\"center\"><bold>Nicorette<sup>&#174; </sup>gum</bold></td><td align=\"center\"><bold>90% CI </bold>(lozenge/gum)<sup>#</sup></td></tr><tr><td/><td colspan=\"2\"><hr/></td><td/></tr><tr><td/><td align=\"center\"><bold>1 mg</bold></td><td align=\"center\"><bold>2 mg<sup>&#8225;</sup></bold></td><td/></tr></thead><tbody><tr><td align=\"left\"><bold>C<sub>max </sub>(ng/ml)</bold></td><td align=\"center\">10.6 &#177; 2.9</td><td align=\"center\">11.4 &#177; 3.8</td><td align=\"center\">0.86&#8211;1.04</td></tr><tr><td align=\"left\"><bold>C<sub>min </sub>(ng/ml)</bold></td><td align=\"center\">8.1 &#177; 2.4</td><td align=\"center\">9.3 &#177; 3.4</td><td align=\"center\">ND</td></tr><tr><td align=\"left\"><bold>t<sub>max </sub>(h) </bold>[range]</td><td align=\"center\">0.54 &#177; 0.21 [0.00&#8211;0.77]</td><td align=\"center\">0.47 &#177; 0.19 [0.20&#8211;0.95]</td><td align=\"center\">ND</td></tr><tr><td align=\"left\"><bold>t<sub>1/2 </sub>(h)</bold></td><td align=\"center\">3.6 &#177; 1.2</td><td align=\"center\">3.2 &#177; 0.9</td><td align=\"center\">ND</td></tr><tr><td align=\"left\"><bold>AUC<sub>11&#8211;12 </sub>(h&#183;ng/ml)</bold></td><td align=\"center\">9.2 &#177; 2.6</td><td align=\"center\">10.2 &#177; 3.4</td><td align=\"center\">0.84&#8211;1.01</td></tr></tbody></table></body></html>","text":"Pmid= 2194660:Table= Table 3","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":-68157420,"_task_hash":817821829,"_view_id":"choice","accept":[2],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":"tableclass-test-params-100-vicky","sessions":["tableclass-test-params-100-vicky"],"default":false}],"view_id":"choice"}
{"html":"<!DOCTYPE html><html><body><h1>Steady state</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td align=\"left\"><bold>Formulation\\\\PK parameter</bold></td><td align=\"center\" colspan=\"2\"><bold>Nicotinell<sup>&#174; </sup>lozenge 1 mg</bold></td><td align=\"center\"><bold>Nicotinell<sup>&#174; </sup>lozenge</bold></td><td align=\"center\"><bold>90% CI </bold>(2 mg/1 mg)<sup>#</sup></td></tr><tr><td/><td colspan=\"3\"><hr/></td><td/></tr><tr><td/><td align=\"center\"><bold>observed</bold></td><td align=\"center\"><bold>adj. to 2 mg<sup>&#8225;</sup></bold></td><td align=\"center\"><bold>2 mg</bold></td><td/></tr></thead><tbody><tr><td align=\"left\"><bold>C<sub>max </sub>(ng/ml)</bold></td><td align=\"center\">11.0 &#177; 4.9</td><td align=\"center\">22.0 &#177; 9.8</td><td align=\"center\">22.5 &#177; 7.0</td><td align=\"center\">0.97&#8211;1.19 (F = 1.07)</td></tr><tr><td align=\"left\"><bold>t<sub>max </sub>(h) </bold>Median [range]</td><td align=\"center\">0.5 [0.25&#8211;1.00]</td><td align=\"center\">-</td><td align=\"center\">0.5 [0.25&#8211;1.02]</td><td align=\"center\">NS (Friedman ANOVA)</td></tr><tr><td align=\"left\"><bold>AUC<sub>11&#8211;12 </sub>(h&#183;ng/ml)</bold></td><td align=\"center\">9.7 &#177; 3.9</td><td align=\"center\">19.3 &#177; 7.8</td><td align=\"center\">20.2 &#177; 6.8</td><td align=\"center\">0.98&#8211;1.20 (F = 1.08)</td></tr></tbody></table></body></html>","text":"Pmid= 2194660:Table= Table 4","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":-1454680814,"_task_hash":409910454,"_view_id":"review","accept":[1],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":null,"sessions":["tableclass-test-params-100-frank","tableclass-test-params-100-gill","tableclass-test-params-100-joe"],"versions":[{"html":"<!DOCTYPE html><html><body><h1>Steady state</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td align=\"left\"><bold>Formulation\\\\PK parameter</bold></td><td align=\"center\" colspan=\"2\"><bold>Nicotinell<sup>&#174; </sup>lozenge 1 mg</bold></td><td align=\"center\"><bold>Nicotinell<sup>&#174; </sup>lozenge</bold></td><td align=\"center\"><bold>90% CI </bold>(2 mg/1 mg)<sup>#</sup></td></tr><tr><td/><td colspan=\"3\"><hr/></td><td/></tr><tr><td/><td align=\"center\"><bold>observed</bold></td><td align=\"center\"><bold>adj. to 2 mg<sup>&#8225;</sup></bold></td><td align=\"center\"><bold>2 mg</bold></td><td/></tr></thead><tbody><tr><td align=\"left\"><bold>C<sub>max </sub>(ng/ml)</bold></td><td align=\"center\">11.0 &#177; 4.9</td><td align=\"center\">22.0 &#177; 9.8</td><td align=\"center\">22.5 &#177; 7.0</td><td align=\"center\">0.97&#8211;1.19 (F = 1.07)</td></tr><tr><td align=\"left\"><bold>t<sub>max </sub>(h) </bold>Median [range]</td><td align=\"center\">0.5 [0.25&#8211;1.00]</td><td align=\"center\">-</td><td align=\"center\">0.5 [0.25&#8211;1.02]</td><td align=\"center\">NS (Friedman ANOVA)</td></tr><tr><td align=\"left\"><bold>AUC<sub>11&#8211;12 </sub>(h&#183;ng/ml)</bold></td><td align=\"center\">9.7 &#177; 3.9</td><td align=\"center\">19.3 &#177; 7.8</td><td align=\"center\">20.2 &#177; 6.8</td><td align=\"center\">0.98&#8211;1.20 (F = 1.08)</td></tr></tbody></table></body></html>","text":"Pmid= 2194660:Table= Table 4","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":-1454680814,"_task_hash":409910454,"_view_id":"choice","accept":[1],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":"tableclass-test-params-100-gill","sessions":["tableclass-test-params-100-frank","tableclass-test-params-100-gill","tableclass-test-params-100-joe"],"default":true},{"html":"<!DOCTYPE html><html><body><h1>Steady state</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td align=\"left\"><bold>Formulation\\\\PK parameter</bold></td><td align=\"center\" colspan=\"2\"><bold>Nicotinell<sup>&#174; </sup>lozenge 1 mg</bold></td><td align=\"center\"><bold>Nicotinell<sup>&#174; </sup>lozenge</bold></td><td align=\"center\"><bold>90% CI </bold>(2 mg/1 mg)<sup>#</sup></td></tr><tr><td/><td colspan=\"3\"><hr/></td><td/></tr><tr><td/><td align=\"center\"><bold>observed</bold></td><td align=\"center\"><bold>adj. to 2 mg<sup>&#8225;</sup></bold></td><td align=\"center\"><bold>2 mg</bold></td><td/></tr></thead><tbody><tr><td align=\"left\"><bold>C<sub>max </sub>(ng/ml)</bold></td><td align=\"center\">11.0 &#177; 4.9</td><td align=\"center\">22.0 &#177; 9.8</td><td align=\"center\">22.5 &#177; 7.0</td><td align=\"center\">0.97&#8211;1.19 (F = 1.07)</td></tr><tr><td align=\"left\"><bold>t<sub>max </sub>(h) </bold>Median [range]</td><td align=\"center\">0.5 [0.25&#8211;1.00]</td><td align=\"center\">-</td><td align=\"center\">0.5 [0.25&#8211;1.02]</td><td align=\"center\">NS (Friedman ANOVA)</td></tr><tr><td align=\"left\"><bold>AUC<sub>11&#8211;12 </sub>(h&#183;ng/ml)</bold></td><td align=\"center\">9.7 &#177; 3.9</td><td align=\"center\">19.3 &#177; 7.8</td><td align=\"center\">20.2 &#177; 6.8</td><td align=\"center\">0.98&#8211;1.20 (F = 1.08)</td></tr></tbody></table></body></html>","text":"Pmid= 2194660:Table= Table 4","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":-1454680814,"_task_hash":-1385144339,"_view_id":"choice","accept":[2],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":"tableclass-test-params-100-vicky","sessions":["tableclass-test-params-100-vicky"],"default":false}],"view_id":"choice"}
{"html":"<!DOCTYPE html><html><body><h1>PK parameters of nicotine in plasma at steady state after 12 hourly doses</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td align=\"left\"><bold>Formulation\\\\PK parameter</bold></td><td align=\"center\"><bold>Nicotinell<sup>&#174; </sup>lozenge</bold></td><td align=\"center\"><bold>Nicorette<sup>&#174; </sup>gum</bold></td><td align=\"center\"><bold>90% CI </bold>(lozenge/gum)<sup>&#8225;</sup></td></tr><tr><td/><td colspan=\"2\"><hr/></td><td/></tr><tr><td/><td align=\"center\"><bold>2 mg</bold></td><td align=\"center\"><bold>4 mg</bold></td><td/></tr></thead><tbody><tr><td align=\"left\"><bold>C<sub>max </sub>(ng/ml)</bold></td><td align=\"center\">22.5 &#177; 7.0</td><td align=\"center\">30.5 &#177; 12.8</td><td align=\"center\">0.69&#8211;0.89 (F = 0.78)</td></tr><tr><td align=\"left\"><bold>t<sub>max </sub>(h) </bold>Median [range]</td><td align=\"center\">0.5 [0.25&#8211;1.02]</td><td align=\"center\">0.5 [0.25&#8211;1.00]</td><td align=\"center\">NS (Friedman ANOVA)</td></tr><tr><td align=\"left\"><bold>AUC<sub>11&#8211;12 </sub>(h&#183;ng/ml)</bold></td><td align=\"center\">20.2 &#177; 6.8</td><td align=\"center\">27.5 &#177; 11.4</td><td align=\"center\">0.68&#8211;0.88 (F = 0.77)</td></tr></tbody></table></body></html>","text":"Pmid= 2194660:Table= Table 5","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":1673476983,"_task_hash":-826687773,"_view_id":"review","accept":[1],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":null,"sessions":["tableclass-test-params-100-frank","tableclass-test-params-100-gill","tableclass-test-params-100-joe","tableclass-test-params-100-vicky"],"versions":[{"html":"<!DOCTYPE html><html><body><h1>PK parameters of nicotine in plasma at steady state after 12 hourly doses</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td align=\"left\"><bold>Formulation\\\\PK parameter</bold></td><td align=\"center\"><bold>Nicotinell<sup>&#174; </sup>lozenge</bold></td><td align=\"center\"><bold>Nicorette<sup>&#174; </sup>gum</bold></td><td align=\"center\"><bold>90% CI </bold>(lozenge/gum)<sup>&#8225;</sup></td></tr><tr><td/><td colspan=\"2\"><hr/></td><td/></tr><tr><td/><td align=\"center\"><bold>2 mg</bold></td><td align=\"center\"><bold>4 mg</bold></td><td/></tr></thead><tbody><tr><td align=\"left\"><bold>C<sub>max </sub>(ng/ml)</bold></td><td align=\"center\">22.5 &#177; 7.0</td><td align=\"center\">30.5 &#177; 12.8</td><td align=\"center\">0.69&#8211;0.89 (F = 0.78)</td></tr><tr><td align=\"left\"><bold>t<sub>max </sub>(h) </bold>Median [range]</td><td align=\"center\">0.5 [0.25&#8211;1.02]</td><td align=\"center\">0.5 [0.25&#8211;1.00]</td><td align=\"center\">NS (Friedman ANOVA)</td></tr><tr><td align=\"left\"><bold>AUC<sub>11&#8211;12 </sub>(h&#183;ng/ml)</bold></td><td align=\"center\">20.2 &#177; 6.8</td><td align=\"center\">27.5 &#177; 11.4</td><td align=\"center\">0.68&#8211;0.88 (F = 0.77)</td></tr></tbody></table></body></html>","text":"Pmid= 2194660:Table= Table 5","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":1673476983,"_task_hash":-826687773,"_view_id":"choice","accept":[1],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":"tableclass-test-params-100-gill","sessions":["tableclass-test-params-100-frank","tableclass-test-params-100-gill","tableclass-test-params-100-joe","tableclass-test-params-100-vicky"],"default":true}],"view_id":"choice"}
{"html":"<!DOCTYPE html><html><body><h1>PK parameters of nicotine in plasma after swallowing without sucking of increasing numbers of 1 mg lozenge (mean \u00b1 SD; n = 8 per group)</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td align=\"left\"><bold>Group\\\\PK parameter</bold></td><td align=\"center\"><bold>A</bold></td><td align=\"center\"><bold>B</bold></td><td align=\"center\"><bold>C</bold></td></tr><tr><td/><td colspan=\"3\"><hr/></td></tr><tr><td/><td align=\"center\"><bold>3 lozenges</bold></td><td align=\"center\"><bold>6 lozenges</bold></td><td align=\"center\"><bold>12 lozenges</bold></td></tr></thead><tbody><tr><td align=\"left\"><bold>C<sub>max </sub>(ng/ml)</bold></td><td align=\"center\">8.2 &#177; 7.6</td><td align=\"center\">16.9 &#177; 11.8</td><td align=\"center\">20.5 &#177; 8.8</td></tr><tr><td align=\"left\"><bold>t<sub>max </sub>(h)</bold></td><td align=\"center\">2.7 &#177; 2.8</td><td align=\"center\">2.8 &#177; 2.0</td><td align=\"center\">2.2 &#177; 1.4</td></tr><tr><td align=\"left\"><bold>AUC<sub>10 min-12 h </sub>(h.ng/ml)</bold></td><td align=\"center\">37.0 &#177; 27.2</td><td align=\"center\">84.9 &#177; 48.9</td><td align=\"center\">103.1 &#177; 58.6</td></tr></tbody></table></body></html>","text":"Pmid= 2194660:Table= Table 6","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":1736663644,"_task_hash":-1246803444,"_view_id":"review","accept":[1],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":null,"sessions":["tableclass-test-params-100-frank","tableclass-test-params-100-gill","tableclass-test-params-100-joe","tableclass-test-params-100-vicky"],"versions":[{"html":"<!DOCTYPE html><html><body><h1>PK parameters of nicotine in plasma after swallowing without sucking of increasing numbers of 1 mg lozenge (mean \u00b1 SD; n = 8 per group)</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td align=\"left\"><bold>Group\\\\PK parameter</bold></td><td align=\"center\"><bold>A</bold></td><td align=\"center\"><bold>B</bold></td><td align=\"center\"><bold>C</bold></td></tr><tr><td/><td colspan=\"3\"><hr/></td></tr><tr><td/><td align=\"center\"><bold>3 lozenges</bold></td><td align=\"center\"><bold>6 lozenges</bold></td><td align=\"center\"><bold>12 lozenges</bold></td></tr></thead><tbody><tr><td align=\"left\"><bold>C<sub>max </sub>(ng/ml)</bold></td><td align=\"center\">8.2 &#177; 7.6</td><td align=\"center\">16.9 &#177; 11.8</td><td align=\"center\">20.5 &#177; 8.8</td></tr><tr><td align=\"left\"><bold>t<sub>max </sub>(h)</bold></td><td align=\"center\">2.7 &#177; 2.8</td><td align=\"center\">2.8 &#177; 2.0</td><td align=\"center\">2.2 &#177; 1.4</td></tr><tr><td align=\"left\"><bold>AUC<sub>10 min-12 h </sub>(h.ng/ml)</bold></td><td align=\"center\">37.0 &#177; 27.2</td><td align=\"center\">84.9 &#177; 48.9</td><td align=\"center\">103.1 &#177; 58.6</td></tr></tbody></table></body></html>","text":"Pmid= 2194660:Table= Table 6","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":1736663644,"_task_hash":-1246803444,"_view_id":"choice","accept":[1],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":"tableclass-test-params-100-gill","sessions":["tableclass-test-params-100-frank","tableclass-test-params-100-gill","tableclass-test-params-100-joe","tableclass-test-params-100-vicky"],"default":true}],"view_id":"choice"}
{"html":"<!DOCTYPE html><html><body><h1>Primary and secondary efficacy criteria: complete or partial abstinence during the 28 days preceding the 6-week visit (adopted from [17])</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td align=\"left\"><bold>Group\\\\Statistical results</bold></td><td align=\"center\"><bold>Nicotinell<sup>&#174; </sup></bold><break/><bold>lozenge 1 mg</bold></td><td align=\"center\" colspan=\"\"><bold>Placebo</bold></td></tr><tr><td/><td colspan=\"2\"><hr/></td></tr><tr><td/><td align=\"center\"><bold>(n = 211)</bold></td><td align=\"center\" colspan=\"\"><bold>(n = 222)</bold></td></tr></thead><tbody><tr><td align=\"left\"><bold>Complete abstinence (%)</bold></td><td align=\"center\">48 (23%)</td><td align=\"center\" colspan=\"\">32 (14%)</td></tr><tr><td align=\"left\"><bold>OR </bold>[95% CI]</td><td align=\"center\" colspan=\"2\"><bold>1.72 [1.05&#8211;2.80]</bold></td></tr><tr><td align=\"left\"><bold>Statistical significance</bold></td><td align=\"center\" colspan=\"2\"><bold>p = 0.03</bold></td></tr><tr><td align=\"left\"><bold>Complete or partial abstinence (%)</bold></td><td align=\"center\">68 (32%)</td><td align=\"center\">39 (18%)</td></tr><tr><td align=\"left\"><bold>OR </bold>[95% CI]</td><td align=\"center\" colspan=\"2\"><bold>2.18 </bold>[1.40&#8211;3.41]</td></tr><tr><td align=\"left\"><bold>Statistical significance</bold></td><td align=\"center\" colspan=\"2\"><bold>p = 0.001</bold></td></tr></tbody></table></body></html>","text":"Pmid= 2194660:Table= Table 7","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":-1731928479,"_task_hash":-1758458580,"_view_id":"review","accept":[5],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":null,"sessions":["tableclass-test-params-100-frank","tableclass-test-params-100-gill","tableclass-test-params-100-vicky"],"versions":[{"html":"<!DOCTYPE html><html><body><h1>Primary and secondary efficacy criteria: complete or partial abstinence during the 28 days preceding the 6-week visit (adopted from [17])</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td align=\"left\"><bold>Group\\\\Statistical results</bold></td><td align=\"center\"><bold>Nicotinell<sup>&#174; </sup></bold><break/><bold>lozenge 1 mg</bold></td><td align=\"center\" colspan=\"\"><bold>Placebo</bold></td></tr><tr><td/><td colspan=\"2\"><hr/></td></tr><tr><td/><td align=\"center\"><bold>(n = 211)</bold></td><td align=\"center\" colspan=\"\"><bold>(n = 222)</bold></td></tr></thead><tbody><tr><td align=\"left\"><bold>Complete abstinence (%)</bold></td><td align=\"center\">48 (23%)</td><td align=\"center\" colspan=\"\">32 (14%)</td></tr><tr><td align=\"left\"><bold>OR </bold>[95% CI]</td><td align=\"center\" colspan=\"2\"><bold>1.72 [1.05&#8211;2.80]</bold></td></tr><tr><td align=\"left\"><bold>Statistical significance</bold></td><td align=\"center\" colspan=\"2\"><bold>p = 0.03</bold></td></tr><tr><td align=\"left\"><bold>Complete or partial abstinence (%)</bold></td><td align=\"center\">68 (32%)</td><td align=\"center\">39 (18%)</td></tr><tr><td align=\"left\"><bold>OR </bold>[95% CI]</td><td align=\"center\" colspan=\"2\"><bold>2.18 </bold>[1.40&#8211;3.41]</td></tr><tr><td align=\"left\"><bold>Statistical significance</bold></td><td align=\"center\" colspan=\"2\"><bold>p = 0.001</bold></td></tr></tbody></table></body></html>","text":"Pmid= 2194660:Table= Table 7","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":-1731928479,"_task_hash":-1758458580,"_view_id":"choice","accept":[5],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":"tableclass-test-params-100-gill","sessions":["tableclass-test-params-100-frank","tableclass-test-params-100-gill","tableclass-test-params-100-vicky"],"default":true},{"html":"<!DOCTYPE html><html><body><h1>Primary and secondary efficacy criteria: complete or partial abstinence during the 28 days preceding the 6-week visit (adopted from [17])</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td align=\"left\"><bold>Group\\\\Statistical results</bold></td><td align=\"center\"><bold>Nicotinell<sup>&#174; </sup></bold><break/><bold>lozenge 1 mg</bold></td><td align=\"center\" colspan=\"\"><bold>Placebo</bold></td></tr><tr><td/><td colspan=\"2\"><hr/></td></tr><tr><td/><td align=\"center\"><bold>(n = 211)</bold></td><td align=\"center\" colspan=\"\"><bold>(n = 222)</bold></td></tr></thead><tbody><tr><td align=\"left\"><bold>Complete abstinence (%)</bold></td><td align=\"center\">48 (23%)</td><td align=\"center\" colspan=\"\">32 (14%)</td></tr><tr><td align=\"left\"><bold>OR </bold>[95% CI]</td><td align=\"center\" colspan=\"2\"><bold>1.72 [1.05&#8211;2.80]</bold></td></tr><tr><td align=\"left\"><bold>Statistical significance</bold></td><td align=\"center\" colspan=\"2\"><bold>p = 0.03</bold></td></tr><tr><td align=\"left\"><bold>Complete or partial abstinence (%)</bold></td><td align=\"center\">68 (32%)</td><td align=\"center\">39 (18%)</td></tr><tr><td align=\"left\"><bold>OR </bold>[95% CI]</td><td align=\"center\" colspan=\"2\"><bold>2.18 </bold>[1.40&#8211;3.41]</td></tr><tr><td align=\"left\"><bold>Statistical significance</bold></td><td align=\"center\" colspan=\"2\"><bold>p = 0.001</bold></td></tr></tbody></table></body></html>","text":"Pmid= 2194660:Table= Table 7","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":-1731928479,"_task_hash":1925416517,"_view_id":"choice","accept":[4],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":"tableclass-test-params-100-joe","sessions":["tableclass-test-params-100-joe"],"default":false}],"view_id":"choice"}
{"html":"<!DOCTYPE html><html><body><h1>Complete abstinence from week 2 at each visit</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td align=\"left\" colspan=\"2\"><bold>Time since treatment started</bold></td><td align=\"center\" colspan=\"2\"><bold>6 weeks</bold></td><td align=\"center\" colspan=\"2\"><bold>12 weeks</bold></td><td align=\"center\" colspan=\"2\"><bold>26 weeks</bold></td></tr></thead><tbody><tr><td align=\"left\" colspan=\"2\"><bold>French study (FTDN 4 to7)</bold></td><td align=\"center\" colspan=\"6\">Placebo n = 222, Nicotinell Lozenge 1 mg n = 211</td></tr><tr><td colspan=\"8\"><hr/></td></tr><tr><td align=\"left\"><bold>Completely abstinent</bold></td><td align=\"right\">active</td><td align=\"center\">48</td><td align=\"center\"><bold>22.7%</bold></td><td align=\"center\">28</td><td align=\"center\"><bold>13.3%</bold></td><td align=\"center\">25</td><td align=\"center\"><bold>11.8%</bold></td></tr><tr><td align=\"left\"><bold>N (%)</bold></td><td align=\"right\">placebo</td><td align=\"center\">32</td><td align=\"center\"><bold>14.4%</bold></td><td align=\"center\">20</td><td align=\"center\"><bold>9.0%</bold></td><td align=\"center\">18</td><td align=\"center\"><bold>8.1%</bold></td></tr><tr><td align=\"left\"><bold>OR </bold>[95% CI]</td><td/><td align=\"center\" colspan=\"2\"><bold>1.72 </bold>[1.05&#8211;2.80]</td><td align=\"center\" colspan=\"2\"><bold>1.47 </bold>[0.82&#8211;2.65]</td><td align=\"center\" colspan=\"2\"><bold>1.48 </bold>[0.78&#8211;2.79]</td></tr><tr><td align=\"left\"><bold>Statistical significance</bold></td><td/><td align=\"center\" colspan=\"2\"><bold>p = 0.03</bold></td><td align=\"center\" colspan=\"2\"><bold>p = 0.199</bold></td><td align=\"center\" colspan=\"2\"><bold>p = 0.227</bold></td></tr><tr><td colspan=\"8\"><hr/></td></tr><tr><td align=\"left\"><bold>USA study (FTND &#8805; 6)</bold></td><td/><td align=\"center\" colspan=\"6\">Placebo n = 230, Nicotinell Lozenge 1 mg n = 230</td></tr><tr><td colspan=\"8\"><hr/></td></tr><tr><td align=\"left\"><bold>Completely abstinent</bold></td><td align=\"right\">active</td><td align=\"center\">19</td><td align=\"center\"><bold>8.3%</bold></td><td align=\"center\">11</td><td align=\"center\"><bold>4.8%</bold></td><td align=\"center\">8</td><td align=\"center\"><bold>3.5%</bold></td></tr><tr><td align=\"left\"><bold>N (%)</bold></td><td align=\"right\">placebo</td><td align=\"center\">7</td><td align=\"center\"><bold>3.0%</bold></td><td align=\"center\">3</td><td align=\"center\"><bold>1.3%</bold></td><td align=\"center\">2</td><td align=\"center\"><bold>0.9%</bold></td></tr><tr><td align=\"left\"><bold>OR </bold>[95% CI]</td><td/><td align=\"center\" colspan=\"2\"><bold>2.87 </bold>[1.18&#8211;6.97]</td><td align=\"center\" colspan=\"2\"><bold>3.80 </bold>[1.05&#8211;13.80]</td><td align=\"center\" colspan=\"2\"><bold>4.11 </bold>[0.83&#8211;19.55]</td></tr><tr><td align=\"left\"><bold>Statistical significance</bold></td><td/><td align=\"center\" colspan=\"2\"><bold>p = 0.02</bold></td><td align=\"center\" colspan=\"2\"><bold>p = 0.03</bold></td><td align=\"center\" colspan=\"2\"><bold>p = 0.06</bold></td></tr></tbody></table></body></html>","text":"Pmid= 2194660:Table= Table 8","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":-2122861443,"_task_hash":880439935,"_view_id":"review","accept":[5],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":null,"sessions":["tableclass-test-params-100-frank","tableclass-test-params-100-gill","tableclass-test-params-100-vicky"],"versions":[{"html":"<!DOCTYPE html><html><body><h1>Complete abstinence from week 2 at each visit</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td align=\"left\" colspan=\"2\"><bold>Time since treatment started</bold></td><td align=\"center\" colspan=\"2\"><bold>6 weeks</bold></td><td align=\"center\" colspan=\"2\"><bold>12 weeks</bold></td><td align=\"center\" colspan=\"2\"><bold>26 weeks</bold></td></tr></thead><tbody><tr><td align=\"left\" colspan=\"2\"><bold>French study (FTDN 4 to7)</bold></td><td align=\"center\" colspan=\"6\">Placebo n = 222, Nicotinell Lozenge 1 mg n = 211</td></tr><tr><td colspan=\"8\"><hr/></td></tr><tr><td align=\"left\"><bold>Completely abstinent</bold></td><td align=\"right\">active</td><td align=\"center\">48</td><td align=\"center\"><bold>22.7%</bold></td><td align=\"center\">28</td><td align=\"center\"><bold>13.3%</bold></td><td align=\"center\">25</td><td align=\"center\"><bold>11.8%</bold></td></tr><tr><td align=\"left\"><bold>N (%)</bold></td><td align=\"right\">placebo</td><td align=\"center\">32</td><td align=\"center\"><bold>14.4%</bold></td><td align=\"center\">20</td><td align=\"center\"><bold>9.0%</bold></td><td align=\"center\">18</td><td align=\"center\"><bold>8.1%</bold></td></tr><tr><td align=\"left\"><bold>OR </bold>[95% CI]</td><td/><td align=\"center\" colspan=\"2\"><bold>1.72 </bold>[1.05&#8211;2.80]</td><td align=\"center\" colspan=\"2\"><bold>1.47 </bold>[0.82&#8211;2.65]</td><td align=\"center\" colspan=\"2\"><bold>1.48 </bold>[0.78&#8211;2.79]</td></tr><tr><td align=\"left\"><bold>Statistical significance</bold></td><td/><td align=\"center\" colspan=\"2\"><bold>p = 0.03</bold></td><td align=\"center\" colspan=\"2\"><bold>p = 0.199</bold></td><td align=\"center\" colspan=\"2\"><bold>p = 0.227</bold></td></tr><tr><td colspan=\"8\"><hr/></td></tr><tr><td align=\"left\"><bold>USA study (FTND &#8805; 6)</bold></td><td/><td align=\"center\" colspan=\"6\">Placebo n = 230, Nicotinell Lozenge 1 mg n = 230</td></tr><tr><td colspan=\"8\"><hr/></td></tr><tr><td align=\"left\"><bold>Completely abstinent</bold></td><td align=\"right\">active</td><td align=\"center\">19</td><td align=\"center\"><bold>8.3%</bold></td><td align=\"center\">11</td><td align=\"center\"><bold>4.8%</bold></td><td align=\"center\">8</td><td align=\"center\"><bold>3.5%</bold></td></tr><tr><td align=\"left\"><bold>N (%)</bold></td><td align=\"right\">placebo</td><td align=\"center\">7</td><td align=\"center\"><bold>3.0%</bold></td><td align=\"center\">3</td><td align=\"center\"><bold>1.3%</bold></td><td align=\"center\">2</td><td align=\"center\"><bold>0.9%</bold></td></tr><tr><td align=\"left\"><bold>OR </bold>[95% CI]</td><td/><td align=\"center\" colspan=\"2\"><bold>2.87 </bold>[1.18&#8211;6.97]</td><td align=\"center\" colspan=\"2\"><bold>3.80 </bold>[1.05&#8211;13.80]</td><td align=\"center\" colspan=\"2\"><bold>4.11 </bold>[0.83&#8211;19.55]</td></tr><tr><td align=\"left\"><bold>Statistical significance</bold></td><td/><td align=\"center\" colspan=\"2\"><bold>p = 0.02</bold></td><td align=\"center\" colspan=\"2\"><bold>p = 0.03</bold></td><td align=\"center\" colspan=\"2\"><bold>p = 0.06</bold></td></tr></tbody></table></body></html>","text":"Pmid= 2194660:Table= Table 8","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":-2122861443,"_task_hash":880439935,"_view_id":"choice","accept":[5],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":"tableclass-test-params-100-gill","sessions":["tableclass-test-params-100-frank","tableclass-test-params-100-gill","tableclass-test-params-100-vicky"],"default":true},{"html":"<!DOCTYPE html><html><body><h1>Complete abstinence from week 2 at each visit</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td align=\"left\" colspan=\"2\"><bold>Time since treatment started</bold></td><td align=\"center\" colspan=\"2\"><bold>6 weeks</bold></td><td align=\"center\" colspan=\"2\"><bold>12 weeks</bold></td><td align=\"center\" colspan=\"2\"><bold>26 weeks</bold></td></tr></thead><tbody><tr><td align=\"left\" colspan=\"2\"><bold>French study (FTDN 4 to7)</bold></td><td align=\"center\" colspan=\"6\">Placebo n = 222, Nicotinell Lozenge 1 mg n = 211</td></tr><tr><td colspan=\"8\"><hr/></td></tr><tr><td align=\"left\"><bold>Completely abstinent</bold></td><td align=\"right\">active</td><td align=\"center\">48</td><td align=\"center\"><bold>22.7%</bold></td><td align=\"center\">28</td><td align=\"center\"><bold>13.3%</bold></td><td align=\"center\">25</td><td align=\"center\"><bold>11.8%</bold></td></tr><tr><td align=\"left\"><bold>N (%)</bold></td><td align=\"right\">placebo</td><td align=\"center\">32</td><td align=\"center\"><bold>14.4%</bold></td><td align=\"center\">20</td><td align=\"center\"><bold>9.0%</bold></td><td align=\"center\">18</td><td align=\"center\"><bold>8.1%</bold></td></tr><tr><td align=\"left\"><bold>OR </bold>[95% CI]</td><td/><td align=\"center\" colspan=\"2\"><bold>1.72 </bold>[1.05&#8211;2.80]</td><td align=\"center\" colspan=\"2\"><bold>1.47 </bold>[0.82&#8211;2.65]</td><td align=\"center\" colspan=\"2\"><bold>1.48 </bold>[0.78&#8211;2.79]</td></tr><tr><td align=\"left\"><bold>Statistical significance</bold></td><td/><td align=\"center\" colspan=\"2\"><bold>p = 0.03</bold></td><td align=\"center\" colspan=\"2\"><bold>p = 0.199</bold></td><td align=\"center\" colspan=\"2\"><bold>p = 0.227</bold></td></tr><tr><td colspan=\"8\"><hr/></td></tr><tr><td align=\"left\"><bold>USA study (FTND &#8805; 6)</bold></td><td/><td align=\"center\" colspan=\"6\">Placebo n = 230, Nicotinell Lozenge 1 mg n = 230</td></tr><tr><td colspan=\"8\"><hr/></td></tr><tr><td align=\"left\"><bold>Completely abstinent</bold></td><td align=\"right\">active</td><td align=\"center\">19</td><td align=\"center\"><bold>8.3%</bold></td><td align=\"center\">11</td><td align=\"center\"><bold>4.8%</bold></td><td align=\"center\">8</td><td align=\"center\"><bold>3.5%</bold></td></tr><tr><td align=\"left\"><bold>N (%)</bold></td><td align=\"right\">placebo</td><td align=\"center\">7</td><td align=\"center\"><bold>3.0%</bold></td><td align=\"center\">3</td><td align=\"center\"><bold>1.3%</bold></td><td align=\"center\">2</td><td align=\"center\"><bold>0.9%</bold></td></tr><tr><td align=\"left\"><bold>OR </bold>[95% CI]</td><td/><td align=\"center\" colspan=\"2\"><bold>2.87 </bold>[1.18&#8211;6.97]</td><td align=\"center\" colspan=\"2\"><bold>3.80 </bold>[1.05&#8211;13.80]</td><td align=\"center\" colspan=\"2\"><bold>4.11 </bold>[0.83&#8211;19.55]</td></tr><tr><td align=\"left\"><bold>Statistical significance</bold></td><td/><td align=\"center\" colspan=\"2\"><bold>p = 0.02</bold></td><td align=\"center\" colspan=\"2\"><bold>p = 0.03</bold></td><td align=\"center\" colspan=\"2\"><bold>p = 0.06</bold></td></tr></tbody></table></body></html>","text":"Pmid= 2194660:Table= Table 8","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":-2122861443,"_task_hash":-1208551551,"_view_id":"choice","accept":[4],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":"tableclass-test-params-100-joe","sessions":["tableclass-test-params-100-joe"],"default":false}],"view_id":"choice"}
{"html":"<!DOCTYPE html><html><body><h1>Percentage rizatriptan of prescribed and sold triptans before (May \u2013 July 2004) and after (May \u2013 July 2005) the intervention and absolute change in percentage rizatriptan (after minus before).</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td/><td align=\"left\">Percentage rizatriptan before the intervention</td><td align=\"left\">Percentage rizatriptan after the intervention</td><td align=\"left\">Absolute change</td><td align=\"left\">Relative change</td><td align=\"left\">P-value</td></tr></thead><tbody><tr><td align=\"left\">Control</td><td align=\"left\">6 (2 &#8211; 13)</td><td align=\"left\">7 (2 &#8211; 11)</td><td align=\"left\">0 (-7 - 5)</td><td align=\"left\">-29 (-69 &#8211; 83)</td><td align=\"left\">-</td></tr><tr><td align=\"left\">Attachment I</td><td align=\"left\">3 (1 &#8211; 10)</td><td align=\"left\">8 (3 &#8211; 14)</td><td align=\"left\">3 (-2 &#8211; 8)</td><td align=\"left\">42 (-51 &#8211; 222)</td><td align=\"left\">0.071</td></tr><tr><td align=\"left\">Attachment II</td><td align=\"left\">7 (1 &#8211; 13)</td><td align=\"left\">8 (2 &#8211; 17)</td><td align=\"left\">1 (-4 &#8211; 6)</td><td align=\"left\">-1 (-59 &#8211; 70)</td><td align=\"left\">0.052</td></tr><tr><td align=\"left\">Attachment I + II</td><td align=\"left\">5 (1 &#8211; 12)</td><td align=\"left\">8 (3 &#8211; 16)</td><td align=\"left\">2 (-3 &#8211; 7)</td><td align=\"left\">20 (-54 &#8211; 140)</td><td align=\"left\">0.031</td></tr></tbody></table></body></html>","text":"Pmid= 2203966:Table= Table 1","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":-166826485,"_task_hash":830311580,"_view_id":"review","accept":[5],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":null,"sessions":["tableclass-test-params-100-frank","tableclass-test-params-100-gill","tableclass-test-params-100-joe","tableclass-test-params-100-vicky"],"versions":[{"html":"<!DOCTYPE html><html><body><h1>Percentage rizatriptan of prescribed and sold triptans before (May \u2013 July 2004) and after (May \u2013 July 2005) the intervention and absolute change in percentage rizatriptan (after minus before).</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td/><td align=\"left\">Percentage rizatriptan before the intervention</td><td align=\"left\">Percentage rizatriptan after the intervention</td><td align=\"left\">Absolute change</td><td align=\"left\">Relative change</td><td align=\"left\">P-value</td></tr></thead><tbody><tr><td align=\"left\">Control</td><td align=\"left\">6 (2 &#8211; 13)</td><td align=\"left\">7 (2 &#8211; 11)</td><td align=\"left\">0 (-7 - 5)</td><td align=\"left\">-29 (-69 &#8211; 83)</td><td align=\"left\">-</td></tr><tr><td align=\"left\">Attachment I</td><td align=\"left\">3 (1 &#8211; 10)</td><td align=\"left\">8 (3 &#8211; 14)</td><td align=\"left\">3 (-2 &#8211; 8)</td><td align=\"left\">42 (-51 &#8211; 222)</td><td align=\"left\">0.071</td></tr><tr><td align=\"left\">Attachment II</td><td align=\"left\">7 (1 &#8211; 13)</td><td align=\"left\">8 (2 &#8211; 17)</td><td align=\"left\">1 (-4 &#8211; 6)</td><td align=\"left\">-1 (-59 &#8211; 70)</td><td align=\"left\">0.052</td></tr><tr><td align=\"left\">Attachment I + II</td><td align=\"left\">5 (1 &#8211; 12)</td><td align=\"left\">8 (3 &#8211; 16)</td><td align=\"left\">2 (-3 &#8211; 7)</td><td align=\"left\">20 (-54 &#8211; 140)</td><td align=\"left\">0.031</td></tr></tbody></table></body></html>","text":"Pmid= 2203966:Table= Table 1","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":-166826485,"_task_hash":830311580,"_view_id":"choice","accept":[5],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":"tableclass-test-params-100-gill","sessions":["tableclass-test-params-100-frank","tableclass-test-params-100-gill","tableclass-test-params-100-joe","tableclass-test-params-100-vicky"],"default":true}],"view_id":"choice"}
{"html":"<!DOCTYPE html><html><body><h1>50% Inhibitory concentrations IC50 (nM) of ZL</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td/><td align=\"left\"><bold>3D7</bold></td><td align=\"left\"><bold>HB3</bold></td><td align=\"left\"><bold>W2</bold></td><td align=\"left\"><bold>Dd2</bold></td></tr></thead><tbody><tr><td align=\"left\"><bold>ZL<sub>3</sub>B</bold></td><td align=\"left\">40 &#177; 12</td><td align=\"left\">45 &#177; 5.8</td><td align=\"left\">34 &#177; 3.9</td><td align=\"left\">40 &#177; 11.1</td></tr><tr><td align=\"left\"><bold>Bortezomib</bold></td><td align=\"left\">31 &#177; 1.8</td><td align=\"left\">31 &#177; 2.7</td><td align=\"left\">43 &#177; 4</td><td align=\"left\">37 &#177; 5.1</td></tr><tr><td align=\"left\"><bold>Chloroquine</bold></td><td align=\"left\">6 &#177; 0.2</td><td align=\"left\">8 &#177; 1.4</td><td align=\"left\">90 &#177; 3.7</td><td align=\"left\">300 &#177; 21</td></tr><tr><td align=\"left\"><bold>Pyrimethamine</bold></td><td align=\"left\">5 &#177; 1.1</td><td align=\"left\">500 &#177; 45</td><td align=\"left\">1500 &#177; 5.8</td><td align=\"left\">2500 &#177; 97</td></tr></tbody></table></body></html>","text":"Pmid= 2213633:Table= Table 1","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":-864217404,"_task_hash":317192794,"_view_id":"review","accept":[4],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":null,"sessions":["tableclass-test-params-100-gill","tableclass-test-params-100-joe"],"versions":[{"html":"<!DOCTYPE html><html><body><h1>50% Inhibitory concentrations IC50 (nM) of ZL</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td/><td align=\"left\"><bold>3D7</bold></td><td align=\"left\"><bold>HB3</bold></td><td align=\"left\"><bold>W2</bold></td><td align=\"left\"><bold>Dd2</bold></td></tr></thead><tbody><tr><td align=\"left\"><bold>ZL<sub>3</sub>B</bold></td><td align=\"left\">40 &#177; 12</td><td align=\"left\">45 &#177; 5.8</td><td align=\"left\">34 &#177; 3.9</td><td align=\"left\">40 &#177; 11.1</td></tr><tr><td align=\"left\"><bold>Bortezomib</bold></td><td align=\"left\">31 &#177; 1.8</td><td align=\"left\">31 &#177; 2.7</td><td align=\"left\">43 &#177; 4</td><td align=\"left\">37 &#177; 5.1</td></tr><tr><td align=\"left\"><bold>Chloroquine</bold></td><td align=\"left\">6 &#177; 0.2</td><td align=\"left\">8 &#177; 1.4</td><td align=\"left\">90 &#177; 3.7</td><td align=\"left\">300 &#177; 21</td></tr><tr><td align=\"left\"><bold>Pyrimethamine</bold></td><td align=\"left\">5 &#177; 1.1</td><td align=\"left\">500 &#177; 45</td><td align=\"left\">1500 &#177; 5.8</td><td align=\"left\">2500 &#177; 97</td></tr></tbody></table></body></html>","text":"Pmid= 2213633:Table= Table 1","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":-864217404,"_task_hash":317192794,"_view_id":"choice","accept":[4],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":"tableclass-test-params-100-gill","sessions":["tableclass-test-params-100-gill","tableclass-test-params-100-joe"],"default":true},{"html":"<!DOCTYPE html><html><body><h1>50% Inhibitory concentrations IC50 (nM) of ZL</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td/><td align=\"left\"><bold>3D7</bold></td><td align=\"left\"><bold>HB3</bold></td><td align=\"left\"><bold>W2</bold></td><td align=\"left\"><bold>Dd2</bold></td></tr></thead><tbody><tr><td align=\"left\"><bold>ZL<sub>3</sub>B</bold></td><td align=\"left\">40 &#177; 12</td><td align=\"left\">45 &#177; 5.8</td><td align=\"left\">34 &#177; 3.9</td><td align=\"left\">40 &#177; 11.1</td></tr><tr><td align=\"left\"><bold>Bortezomib</bold></td><td align=\"left\">31 &#177; 1.8</td><td align=\"left\">31 &#177; 2.7</td><td align=\"left\">43 &#177; 4</td><td align=\"left\">37 &#177; 5.1</td></tr><tr><td align=\"left\"><bold>Chloroquine</bold></td><td align=\"left\">6 &#177; 0.2</td><td align=\"left\">8 &#177; 1.4</td><td align=\"left\">90 &#177; 3.7</td><td align=\"left\">300 &#177; 21</td></tr><tr><td align=\"left\"><bold>Pyrimethamine</bold></td><td align=\"left\">5 &#177; 1.1</td><td align=\"left\">500 &#177; 45</td><td align=\"left\">1500 &#177; 5.8</td><td align=\"left\">2500 &#177; 97</td></tr></tbody></table></body></html>","text":"Pmid= 2213633:Table= Table 1","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":-864217404,"_task_hash":1258044797,"_view_id":"choice","accept":[5],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":"tableclass-test-params-100-frank","sessions":["tableclass-test-params-100-frank","tableclass-test-params-100-vicky"],"default":false}],"view_id":"choice"}
{"html":"<!DOCTYPE html><html><body><h1>Mean prescribed daily dose (PDD) in milligrams of the different statins in three Norwegian counties</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td align=\"left\">Statin substance (C10AA)</td><td align=\"center\">DDD<sup>2</sup></td><td align=\"center\">High-c county (Hedmark) mg</td><td align=\"center\">Average-c county (Oppland) mg</td><td align=\"center\">Low-c county (Troms) mg</td></tr></thead><tbody><tr><td align=\"left\">Simvastatin (C10AA01)</td><td align=\"center\">15</td><td align=\"center\">25.9</td><td align=\"center\">24.0</td><td align=\"center\">22.5</td></tr><tr><td align=\"left\">Lovastatin (C10AA02)</td><td align=\"center\">30</td><td align=\"center\">31.8</td><td align=\"center\">30.3</td><td align=\"center\">28.2</td></tr><tr><td align=\"left\">Pravastatin (C10AA03)</td><td align=\"center\">20</td><td align=\"center\">32.1</td><td align=\"center\">32.1</td><td align=\"center\">32.3</td></tr><tr><td align=\"left\">Fluvastatin (C10AA04)</td><td align=\"center\">40</td><td align=\"center\">60.9</td><td align=\"center\">58.7</td><td align=\"center\">57.3</td></tr><tr><td align=\"left\">Atorvastatin (C10AA05)</td><td align=\"center\">10</td><td align=\"center\">21.9</td><td align=\"center\">19.8</td><td align=\"center\">18.0</td></tr></tbody></table></body></html>","text":"Pmid= 2234392:Table= Table 1","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":-872504336,"_task_hash":-635374326,"_view_id":"review","config":{"choice_style":"multiple"},"accept":[5],"answer":"accept","_session_id":null,"sessions":["tableclass-test-params-100-frank","tableclass-test-params-100-gill","tableclass-test-params-100-joe","tableclass-test-params-100-vicky"],"versions":[{"html":"<!DOCTYPE html><html><body><h1>Mean prescribed daily dose (PDD) in milligrams of the different statins in three Norwegian counties</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td align=\"left\">Statin substance (C10AA)</td><td align=\"center\">DDD<sup>2</sup></td><td align=\"center\">High-c county (Hedmark) mg</td><td align=\"center\">Average-c county (Oppland) mg</td><td align=\"center\">Low-c county (Troms) mg</td></tr></thead><tbody><tr><td align=\"left\">Simvastatin (C10AA01)</td><td align=\"center\">15</td><td align=\"center\">25.9</td><td align=\"center\">24.0</td><td align=\"center\">22.5</td></tr><tr><td align=\"left\">Lovastatin (C10AA02)</td><td align=\"center\">30</td><td align=\"center\">31.8</td><td align=\"center\">30.3</td><td align=\"center\">28.2</td></tr><tr><td align=\"left\">Pravastatin (C10AA03)</td><td align=\"center\">20</td><td align=\"center\">32.1</td><td align=\"center\">32.1</td><td align=\"center\">32.3</td></tr><tr><td align=\"left\">Fluvastatin (C10AA04)</td><td align=\"center\">40</td><td align=\"center\">60.9</td><td align=\"center\">58.7</td><td align=\"center\">57.3</td></tr><tr><td align=\"left\">Atorvastatin (C10AA05)</td><td align=\"center\">10</td><td align=\"center\">21.9</td><td align=\"center\">19.8</td><td align=\"center\">18.0</td></tr></tbody></table></body></html>","text":"Pmid= 2234392:Table= Table 1","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":-872504336,"_task_hash":-635374326,"_view_id":"choice","config":{"choice_style":"multiple"},"accept":[5],"answer":"accept","_session_id":"tableclass-test-params-100-gill","sessions":["tableclass-test-params-100-frank","tableclass-test-params-100-gill","tableclass-test-params-100-joe","tableclass-test-params-100-vicky"],"default":true}],"view_id":"choice"}
{"html":"<!DOCTYPE html><html><body><h1>ICSRs in children (<15 years old) and adults (\u226515 years old) during 2005.</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td/><td/><td align=\"center\" colspan=\"4\"><bold>Children</bold></td><td align=\"center\" colspan=\"4\"><bold>Adults</bold></td></tr></thead><tbody><tr><td align=\"left\"><bold>ATC code</bold></td><td align=\"left\"><bold>Name of group</bold></td><td align=\"center\"><bold>ICSR (n)</bold></td><td align=\"center\"><bold>Serious ADR (n)</bold></td><td align=\"center\"><bold>Million DDD (n)</bold></td><td align=\"center\"><bold>ICSR per million DDD (95% CI)</bold></td><td align=\"center\"><bold>ICSR (n)</bold></td><td align=\"center\"><bold>Serious ADR (n)</bold></td><td align=\"center\"><bold>Million DDD (n)</bold></td><td align=\"center\"><bold>ICSR per million DDD (95% CI)</bold></td></tr><tr><td colspan=\"10\"><hr/></td></tr><tr><td align=\"left\">R03DC</td><td align=\"left\">Leukotriene receptor antagonists</td><td align=\"center\">16</td><td align=\"center\">0</td><td align=\"center\">0.7</td><td align=\"center\">24 (13.6 &#8211; 38.6)</td><td align=\"center\">7</td><td align=\"center\">0</td><td align=\"center\">5.2</td><td align=\"center\">1.4 (0.5 &#8211; 2.8)</td></tr><tr><td align=\"left\">N06BA</td><td align=\"left\">Centrally acting sympathomimetics</td><td align=\"center\">12</td><td align=\"center\">0</td><td align=\"center\">1.5</td><td align=\"center\">7.8 (4.0 &#8211; 13.6)</td><td align=\"center\">15</td><td align=\"center\">2</td><td align=\"center\">2.6</td><td align=\"center\">5.7 (3.2 &#8211; 9.5)</td></tr><tr><td align=\"left\">H02AB</td><td align=\"left\">Glucocorticoids</td><td align=\"center\">3</td><td align=\"center\">0</td><td align=\"center\">0.7</td><td align=\"center\">4.5 (0.9 &#8211; 13.0)</td><td align=\"center\">31</td><td align=\"center\">21</td><td align=\"center\">32</td><td align=\"center\">1.0 (0.7 &#8211; 1.4)</td></tr><tr><td align=\"left\">H01BA</td><td align=\"left\">Vasopressin and analogues</td><td align=\"center\">3</td><td align=\"center\">0</td><td align=\"center\">1.1</td><td align=\"center\">2.8 (0.6 &#8211; 8.2)</td><td align=\"center\">5</td><td align=\"center\">2</td><td align=\"center\">1.3</td><td align=\"center\">3.9 (1.3 &#8211; 9.2)</td></tr><tr><td align=\"left\">N03AX</td><td align=\"left\">Other antiepileptics</td><td align=\"center\">1</td><td align=\"center\">0</td><td align=\"center\">0.4</td><td align=\"center\">2.4 (0.1 &#8211; 13.1)</td><td align=\"center\">58</td><td align=\"center\">19</td><td align=\"center\">9.7</td><td align=\"center\">6.0 (4.5 &#8211; 7.7)</td></tr><tr><td align=\"left\">R03CC</td><td align=\"left\">Selective beta-2-adrenoreceptor agonists</td><td align=\"center\">1</td><td align=\"center\">0</td><td align=\"center\">0.4</td><td align=\"center\">2.3 (0.1 &#8211; 12.6)</td><td align=\"center\">1</td><td align=\"center\">1</td><td align=\"center\">1.4</td><td align=\"center\">0.7 (0.02&#8211;3.9)</td></tr><tr><td align=\"left\">J01CA</td><td align=\"left\">Penicillins with extended spectrum</td><td align=\"center\">1</td><td align=\"center\">0</td><td align=\"center\">0.5</td><td align=\"center\">2.1 (0.1 &#8211; 11.5)</td><td align=\"center\">12</td><td align=\"center\">3</td><td align=\"center\">3.9</td><td align=\"center\">3.1 (1.6 &#8211; 5.4)</td></tr><tr><td align=\"left\">R05FA</td><td align=\"left\">Opium derivatives and expectorants</td><td align=\"center\">1</td><td align=\"center\">1</td><td align=\"center\">0.5</td><td align=\"center\">2.0 (0.1 &#8211; 11.4)</td><td align=\"center\">1</td><td align=\"center\">0</td><td align=\"center\">11</td><td align=\"center\">0.1 (0.002 &#8211; 0.5)</td></tr><tr><td align=\"left\">J01CE</td><td align=\"left\">Beta-lactamase sensitive penicillins</td><td align=\"center\">3</td><td align=\"center\">0</td><td align=\"center\">1.6</td><td align=\"center\">1.8 (0.4 &#8211; 5.3)</td><td align=\"center\">14</td><td align=\"center\">5</td><td align=\"center\">11</td><td align=\"center\">1.3 (0.7 &#8211; 2.1)</td></tr><tr><td align=\"left\">A10AE</td><td align=\"left\">Insulins and analogues. long-acting</td><td align=\"center\">1</td><td align=\"center\">0</td><td align=\"center\">0.7</td><td align=\"center\">1.5 (0.04&#8211;8.5)</td><td align=\"center\">7</td><td align=\"center\">2</td><td align=\"center\">11</td><td align=\"center\">0.6 (0.3 &#8211; 1.3)</td></tr><tr><td align=\"left\">R06AX</td><td align=\"left\">Other antihistamines for systemic use</td><td align=\"center\">5</td><td align=\"center\">1</td><td align=\"center\">3.4</td><td align=\"center\">1.5 (0.5 &#8211; 3.5)</td><td align=\"center\">14</td><td align=\"center\">3</td><td align=\"center\">31</td><td align=\"center\">0.5 (0.3 &#8211; 0.8)</td></tr><tr><td align=\"left\">H01AC</td><td align=\"left\">Somatropin and somatropin agonists</td><td align=\"center\">1</td><td align=\"center\">0</td><td align=\"center\">0.8</td><td align=\"center\">1.3 (0.03&#8211;7.1)</td><td align=\"center\">2</td><td align=\"center\">0</td><td align=\"center\">0.8</td><td align=\"center\">2.6 (0.3 &#8211; 9.5)</td></tr><tr><td align=\"left\">R03BA</td><td align=\"left\">Glucocorticoids, inhalants</td><td align=\"center\">4</td><td align=\"center\">0</td><td align=\"center\">3.6</td><td align=\"center\">1.1 (0.3 &#8211; 2.8)</td><td align=\"center\">5</td><td align=\"center\">0</td><td align=\"center\">37</td><td align=\"center\">0.1 (0.04 &#8211; 0.3)</td></tr><tr><td align=\"left\">R03AK</td><td align=\"left\">Adrenergics and other drugs for obstructive airway diseases</td><td align=\"center\">2</td><td align=\"center\">0</td><td align=\"center\">2.0</td><td align=\"center\">1.0 (0.1 &#8211; 3.7)</td><td align=\"center\">10</td><td align=\"center\">1</td><td align=\"center\">33</td><td align=\"center\">0.3 (0.1 &#8211; 0.6)</td></tr><tr><td align=\"left\">R05CB</td><td align=\"left\">Mucolytics</td><td align=\"center\">1</td><td align=\"center\">0</td><td align=\"center\">1.2</td><td align=\"center\">0.8 (0.02&#8211;4.5)</td><td align=\"center\">3</td><td align=\"center\">1</td><td align=\"center\">28</td><td align=\"center\">0.1 (0.02 &#8211; 0.3)</td></tr><tr><td align=\"left\">R06AE</td><td align=\"left\">Piperazine derivatives</td><td align=\"center\">1</td><td align=\"center\">0</td><td align=\"center\">1.5</td><td align=\"center\">0.7 (0.02&#8211;3.8)</td><td align=\"center\">3</td><td align=\"center\">1</td><td align=\"center\">19</td><td align=\"center\">0.2 (0.03 &#8211; 0.5)</td></tr><tr><td align=\"left\">R03AC</td><td align=\"left\">Selective beta-2-adrenoreceptor agonists</td><td align=\"center\">2</td><td align=\"center\">1</td><td align=\"center\">4.4</td><td align=\"center\">0.5 (0.1 &#8211; 1.7)</td><td align=\"center\">5</td><td align=\"center\">0</td><td align=\"center\">49</td><td align=\"center\">0.1 (0.03 &#8211; 0.2)</td></tr><tr><td align=\"left\">D07AA</td><td align=\"left\">Corticosteroids. weak (group I)</td><td align=\"center\">1</td><td align=\"center\">0</td><td align=\"center\">4.9</td><td align=\"center\">0.2 (0.01 &#8211; 1.1)</td><td align=\"center\">0</td><td align=\"center\">0</td><td align=\"center\">6.3</td><td align=\"center\">0.0 (-0.6)<sup>1</sup></td></tr><tr><td align=\"left\">D02AX</td><td align=\"left\">Other emollients and protectives</td><td align=\"center\">1</td><td align=\"center\">0</td><td align=\"center\">53</td><td align=\"center\">0.02 (0.001 &#8211; 0.1)</td><td align=\"center\">0</td><td align=\"center\">0</td><td align=\"center\">149</td><td align=\"center\">0 (-0.02)<sup>1</sup></td></tr></tbody></table></body></html>","text":"Pmid= 2279106:Table= Table 1","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":621813855,"_task_hash":528266900,"_view_id":"review","accept":[5],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":null,"sessions":["tableclass-test-params-100-frank","tableclass-test-params-100-gill","tableclass-test-params-100-joe","tableclass-test-params-100-vicky"],"versions":[{"html":"<!DOCTYPE html><html><body><h1>ICSRs in children (<15 years old) and adults (\u226515 years old) during 2005.</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td/><td/><td align=\"center\" colspan=\"4\"><bold>Children</bold></td><td align=\"center\" colspan=\"4\"><bold>Adults</bold></td></tr></thead><tbody><tr><td align=\"left\"><bold>ATC code</bold></td><td align=\"left\"><bold>Name of group</bold></td><td align=\"center\"><bold>ICSR (n)</bold></td><td align=\"center\"><bold>Serious ADR (n)</bold></td><td align=\"center\"><bold>Million DDD (n)</bold></td><td align=\"center\"><bold>ICSR per million DDD (95% CI)</bold></td><td align=\"center\"><bold>ICSR (n)</bold></td><td align=\"center\"><bold>Serious ADR (n)</bold></td><td align=\"center\"><bold>Million DDD (n)</bold></td><td align=\"center\"><bold>ICSR per million DDD (95% CI)</bold></td></tr><tr><td colspan=\"10\"><hr/></td></tr><tr><td align=\"left\">R03DC</td><td align=\"left\">Leukotriene receptor antagonists</td><td align=\"center\">16</td><td align=\"center\">0</td><td align=\"center\">0.7</td><td align=\"center\">24 (13.6 &#8211; 38.6)</td><td align=\"center\">7</td><td align=\"center\">0</td><td align=\"center\">5.2</td><td align=\"center\">1.4 (0.5 &#8211; 2.8)</td></tr><tr><td align=\"left\">N06BA</td><td align=\"left\">Centrally acting sympathomimetics</td><td align=\"center\">12</td><td align=\"center\">0</td><td align=\"center\">1.5</td><td align=\"center\">7.8 (4.0 &#8211; 13.6)</td><td align=\"center\">15</td><td align=\"center\">2</td><td align=\"center\">2.6</td><td align=\"center\">5.7 (3.2 &#8211; 9.5)</td></tr><tr><td align=\"left\">H02AB</td><td align=\"left\">Glucocorticoids</td><td align=\"center\">3</td><td align=\"center\">0</td><td align=\"center\">0.7</td><td align=\"center\">4.5 (0.9 &#8211; 13.0)</td><td align=\"center\">31</td><td align=\"center\">21</td><td align=\"center\">32</td><td align=\"center\">1.0 (0.7 &#8211; 1.4)</td></tr><tr><td align=\"left\">H01BA</td><td align=\"left\">Vasopressin and analogues</td><td align=\"center\">3</td><td align=\"center\">0</td><td align=\"center\">1.1</td><td align=\"center\">2.8 (0.6 &#8211; 8.2)</td><td align=\"center\">5</td><td align=\"center\">2</td><td align=\"center\">1.3</td><td align=\"center\">3.9 (1.3 &#8211; 9.2)</td></tr><tr><td align=\"left\">N03AX</td><td align=\"left\">Other antiepileptics</td><td align=\"center\">1</td><td align=\"center\">0</td><td align=\"center\">0.4</td><td align=\"center\">2.4 (0.1 &#8211; 13.1)</td><td align=\"center\">58</td><td align=\"center\">19</td><td align=\"center\">9.7</td><td align=\"center\">6.0 (4.5 &#8211; 7.7)</td></tr><tr><td align=\"left\">R03CC</td><td align=\"left\">Selective beta-2-adrenoreceptor agonists</td><td align=\"center\">1</td><td align=\"center\">0</td><td align=\"center\">0.4</td><td align=\"center\">2.3 (0.1 &#8211; 12.6)</td><td align=\"center\">1</td><td align=\"center\">1</td><td align=\"center\">1.4</td><td align=\"center\">0.7 (0.02&#8211;3.9)</td></tr><tr><td align=\"left\">J01CA</td><td align=\"left\">Penicillins with extended spectrum</td><td align=\"center\">1</td><td align=\"center\">0</td><td align=\"center\">0.5</td><td align=\"center\">2.1 (0.1 &#8211; 11.5)</td><td align=\"center\">12</td><td align=\"center\">3</td><td align=\"center\">3.9</td><td align=\"center\">3.1 (1.6 &#8211; 5.4)</td></tr><tr><td align=\"left\">R05FA</td><td align=\"left\">Opium derivatives and expectorants</td><td align=\"center\">1</td><td align=\"center\">1</td><td align=\"center\">0.5</td><td align=\"center\">2.0 (0.1 &#8211; 11.4)</td><td align=\"center\">1</td><td align=\"center\">0</td><td align=\"center\">11</td><td align=\"center\">0.1 (0.002 &#8211; 0.5)</td></tr><tr><td align=\"left\">J01CE</td><td align=\"left\">Beta-lactamase sensitive penicillins</td><td align=\"center\">3</td><td align=\"center\">0</td><td align=\"center\">1.6</td><td align=\"center\">1.8 (0.4 &#8211; 5.3)</td><td align=\"center\">14</td><td align=\"center\">5</td><td align=\"center\">11</td><td align=\"center\">1.3 (0.7 &#8211; 2.1)</td></tr><tr><td align=\"left\">A10AE</td><td align=\"left\">Insulins and analogues. long-acting</td><td align=\"center\">1</td><td align=\"center\">0</td><td align=\"center\">0.7</td><td align=\"center\">1.5 (0.04&#8211;8.5)</td><td align=\"center\">7</td><td align=\"center\">2</td><td align=\"center\">11</td><td align=\"center\">0.6 (0.3 &#8211; 1.3)</td></tr><tr><td align=\"left\">R06AX</td><td align=\"left\">Other antihistamines for systemic use</td><td align=\"center\">5</td><td align=\"center\">1</td><td align=\"center\">3.4</td><td align=\"center\">1.5 (0.5 &#8211; 3.5)</td><td align=\"center\">14</td><td align=\"center\">3</td><td align=\"center\">31</td><td align=\"center\">0.5 (0.3 &#8211; 0.8)</td></tr><tr><td align=\"left\">H01AC</td><td align=\"left\">Somatropin and somatropin agonists</td><td align=\"center\">1</td><td align=\"center\">0</td><td align=\"center\">0.8</td><td align=\"center\">1.3 (0.03&#8211;7.1)</td><td align=\"center\">2</td><td align=\"center\">0</td><td align=\"center\">0.8</td><td align=\"center\">2.6 (0.3 &#8211; 9.5)</td></tr><tr><td align=\"left\">R03BA</td><td align=\"left\">Glucocorticoids, inhalants</td><td align=\"center\">4</td><td align=\"center\">0</td><td align=\"center\">3.6</td><td align=\"center\">1.1 (0.3 &#8211; 2.8)</td><td align=\"center\">5</td><td align=\"center\">0</td><td align=\"center\">37</td><td align=\"center\">0.1 (0.04 &#8211; 0.3)</td></tr><tr><td align=\"left\">R03AK</td><td align=\"left\">Adrenergics and other drugs for obstructive airway diseases</td><td align=\"center\">2</td><td align=\"center\">0</td><td align=\"center\">2.0</td><td align=\"center\">1.0 (0.1 &#8211; 3.7)</td><td align=\"center\">10</td><td align=\"center\">1</td><td align=\"center\">33</td><td align=\"center\">0.3 (0.1 &#8211; 0.6)</td></tr><tr><td align=\"left\">R05CB</td><td align=\"left\">Mucolytics</td><td align=\"center\">1</td><td align=\"center\">0</td><td align=\"center\">1.2</td><td align=\"center\">0.8 (0.02&#8211;4.5)</td><td align=\"center\">3</td><td align=\"center\">1</td><td align=\"center\">28</td><td align=\"center\">0.1 (0.02 &#8211; 0.3)</td></tr><tr><td align=\"left\">R06AE</td><td align=\"left\">Piperazine derivatives</td><td align=\"center\">1</td><td align=\"center\">0</td><td align=\"center\">1.5</td><td align=\"center\">0.7 (0.02&#8211;3.8)</td><td align=\"center\">3</td><td align=\"center\">1</td><td align=\"center\">19</td><td align=\"center\">0.2 (0.03 &#8211; 0.5)</td></tr><tr><td align=\"left\">R03AC</td><td align=\"left\">Selective beta-2-adrenoreceptor agonists</td><td align=\"center\">2</td><td align=\"center\">1</td><td align=\"center\">4.4</td><td align=\"center\">0.5 (0.1 &#8211; 1.7)</td><td align=\"center\">5</td><td align=\"center\">0</td><td align=\"center\">49</td><td align=\"center\">0.1 (0.03 &#8211; 0.2)</td></tr><tr><td align=\"left\">D07AA</td><td align=\"left\">Corticosteroids. weak (group I)</td><td align=\"center\">1</td><td align=\"center\">0</td><td align=\"center\">4.9</td><td align=\"center\">0.2 (0.01 &#8211; 1.1)</td><td align=\"center\">0</td><td align=\"center\">0</td><td align=\"center\">6.3</td><td align=\"center\">0.0 (-0.6)<sup>1</sup></td></tr><tr><td align=\"left\">D02AX</td><td align=\"left\">Other emollients and protectives</td><td align=\"center\">1</td><td align=\"center\">0</td><td align=\"center\">53</td><td align=\"center\">0.02 (0.001 &#8211; 0.1)</td><td align=\"center\">0</td><td align=\"center\">0</td><td align=\"center\">149</td><td align=\"center\">0 (-0.02)<sup>1</sup></td></tr></tbody></table></body></html>","text":"Pmid= 2279106:Table= Table 1","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":621813855,"_task_hash":528266900,"_view_id":"choice","accept":[5],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":"tableclass-test-params-100-gill","sessions":["tableclass-test-params-100-frank","tableclass-test-params-100-gill","tableclass-test-params-100-joe","tableclass-test-params-100-vicky"],"default":true}],"view_id":"choice"}
{"html":"<!DOCTYPE html><html><body><h1>Description of ICSRs for children in the ATC code R03DC. All ICSRs concerned the substance montelukast.</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td align=\"center\"><bold>Age (years)</bold></td><td align=\"center\"><bold>Dose (mg/day)</bold></td><td align=\"center\"><bold>Treatment duration (when known)</bold></td><td align=\"left\"><bold>ADR</bold></td><td align=\"center\"><bold>SPC (Yes/No)</bold></td></tr></thead><tbody><tr><td align=\"center\">4</td><td align=\"center\">4</td><td align=\"center\">-</td><td align=\"left\">Night mares</td><td align=\"center\">Yes</td></tr><tr><td align=\"center\">3</td><td align=\"center\">4</td><td align=\"center\">-</td><td align=\"left\">Sleep disorders</td><td align=\"center\">Yes</td></tr><tr><td align=\"center\">3</td><td align=\"center\">4</td><td align=\"center\">-</td><td align=\"left\">Cranial nerve lesion</td><td align=\"center\">No</td></tr><tr><td align=\"center\">4</td><td align=\"center\">4</td><td align=\"center\">2 years</td><td align=\"left\">Haemorrhage</td><td align=\"center\">Yes</td></tr><tr><td/><td/><td/><td align=\"left\">Pruritus</td><td align=\"center\">Yes</td></tr><tr><td/><td/><td/><td align=\"left\">Abdominal pain</td><td align=\"center\">Yes</td></tr><tr><td/><td/><td/><td align=\"left\">Rectal pain</td><td align=\"center\">No</td></tr><tr><td align=\"center\">2</td><td align=\"center\">4</td><td align=\"center\">-</td><td align=\"left\">Fever</td><td align=\"center\">No</td></tr><tr><td/><td/><td/><td align=\"left\">Fatigue</td><td align=\"center\">Yes</td></tr><tr><td/><td/><td/><td align=\"left\">Rash</td><td align=\"center\">No</td></tr><tr><td align=\"center\">1</td><td align=\"center\">4</td><td align=\"center\">4 days</td><td align=\"left\">Anxiety</td><td align=\"center\">No</td></tr><tr><td align=\"center\">3</td><td align=\"center\">4</td><td align=\"center\">-</td><td align=\"left\">Night mares</td><td align=\"center\">Yes</td></tr><tr><td/><td/><td/><td align=\"left\">Aggressiveness</td><td align=\"center\">Yes</td></tr><tr><td align=\"center\">2</td><td align=\"center\">4</td><td align=\"center\">4 days</td><td align=\"left\">Aggressiveness</td><td align=\"center\">Yes</td></tr><tr><td align=\"center\">3</td><td align=\"center\">4</td><td align=\"center\">continuing</td><td align=\"left\">Night mares</td><td align=\"center\">Yes</td></tr><tr><td align=\"center\">3</td><td align=\"center\">4</td><td align=\"center\">2 doses</td><td align=\"left\">Asthma aggravated</td><td align=\"center\">No</td></tr><tr><td align=\"center\">2</td><td align=\"center\">4</td><td align=\"center\">11 days</td><td align=\"left\">Rash</td><td align=\"center\">No</td></tr><tr><td/><td/><td/><td align=\"left\">Pruritus</td><td align=\"center\">Yes</td></tr><tr><td/><td/><td/><td align=\"left\">Sleep disorder</td><td align=\"center\">Yes</td></tr><tr><td/><td/><td/><td align=\"left\">Night mares</td><td align=\"center\">Yes</td></tr><tr><td align=\"center\">1</td><td align=\"center\">4</td><td align=\"center\">2 weeks</td><td align=\"left\">Anxiety</td><td align=\"center\">No</td></tr><tr><td/><td/><td/><td align=\"left\">Sleep disorder</td><td align=\"center\">Yes</td></tr><tr><td align=\"center\">6</td><td align=\"center\">5</td><td align=\"center\">8 weeks</td><td align=\"left\">Xerophthalmia</td><td align=\"center\">No</td></tr><tr><td align=\"center\">5</td><td align=\"center\">4</td><td align=\"center\">3 weeks</td><td align=\"left\">Appetite increased</td><td align=\"center\">No</td></tr><tr><td align=\"center\">8</td><td align=\"center\">5 (on demand)</td><td align=\"center\">5 weeks</td><td align=\"left\">Leucopenia</td><td align=\"center\">No</td></tr><tr><td/><td/><td/><td align=\"left\">Red blood cell disorder</td><td align=\"center\">No</td></tr><tr><td align=\"center\">14</td><td align=\"center\">10</td><td align=\"center\">2 years</td><td align=\"left\">Arthralgia</td><td align=\"center\">Yes</td></tr><tr><td/><td/><td/><td align=\"left\">Myalgia</td><td align=\"center\">Yes</td></tr></tbody></table></body></html>","text":"Pmid= 2279106:Table= Table 2","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":1254630067,"_task_hash":-1096565916,"_view_id":"review","accept":[5],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":null,"sessions":["tableclass-test-params-100-frank","tableclass-test-params-100-gill","tableclass-test-params-100-joe","tableclass-test-params-100-vicky"],"versions":[{"html":"<!DOCTYPE html><html><body><h1>Description of ICSRs for children in the ATC code R03DC. All ICSRs concerned the substance montelukast.</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td align=\"center\"><bold>Age (years)</bold></td><td align=\"center\"><bold>Dose (mg/day)</bold></td><td align=\"center\"><bold>Treatment duration (when known)</bold></td><td align=\"left\"><bold>ADR</bold></td><td align=\"center\"><bold>SPC (Yes/No)</bold></td></tr></thead><tbody><tr><td align=\"center\">4</td><td align=\"center\">4</td><td align=\"center\">-</td><td align=\"left\">Night mares</td><td align=\"center\">Yes</td></tr><tr><td align=\"center\">3</td><td align=\"center\">4</td><td align=\"center\">-</td><td align=\"left\">Sleep disorders</td><td align=\"center\">Yes</td></tr><tr><td align=\"center\">3</td><td align=\"center\">4</td><td align=\"center\">-</td><td align=\"left\">Cranial nerve lesion</td><td align=\"center\">No</td></tr><tr><td align=\"center\">4</td><td align=\"center\">4</td><td align=\"center\">2 years</td><td align=\"left\">Haemorrhage</td><td align=\"center\">Yes</td></tr><tr><td/><td/><td/><td align=\"left\">Pruritus</td><td align=\"center\">Yes</td></tr><tr><td/><td/><td/><td align=\"left\">Abdominal pain</td><td align=\"center\">Yes</td></tr><tr><td/><td/><td/><td align=\"left\">Rectal pain</td><td align=\"center\">No</td></tr><tr><td align=\"center\">2</td><td align=\"center\">4</td><td align=\"center\">-</td><td align=\"left\">Fever</td><td align=\"center\">No</td></tr><tr><td/><td/><td/><td align=\"left\">Fatigue</td><td align=\"center\">Yes</td></tr><tr><td/><td/><td/><td align=\"left\">Rash</td><td align=\"center\">No</td></tr><tr><td align=\"center\">1</td><td align=\"center\">4</td><td align=\"center\">4 days</td><td align=\"left\">Anxiety</td><td align=\"center\">No</td></tr><tr><td align=\"center\">3</td><td align=\"center\">4</td><td align=\"center\">-</td><td align=\"left\">Night mares</td><td align=\"center\">Yes</td></tr><tr><td/><td/><td/><td align=\"left\">Aggressiveness</td><td align=\"center\">Yes</td></tr><tr><td align=\"center\">2</td><td align=\"center\">4</td><td align=\"center\">4 days</td><td align=\"left\">Aggressiveness</td><td align=\"center\">Yes</td></tr><tr><td align=\"center\">3</td><td align=\"center\">4</td><td align=\"center\">continuing</td><td align=\"left\">Night mares</td><td align=\"center\">Yes</td></tr><tr><td align=\"center\">3</td><td align=\"center\">4</td><td align=\"center\">2 doses</td><td align=\"left\">Asthma aggravated</td><td align=\"center\">No</td></tr><tr><td align=\"center\">2</td><td align=\"center\">4</td><td align=\"center\">11 days</td><td align=\"left\">Rash</td><td align=\"center\">No</td></tr><tr><td/><td/><td/><td align=\"left\">Pruritus</td><td align=\"center\">Yes</td></tr><tr><td/><td/><td/><td align=\"left\">Sleep disorder</td><td align=\"center\">Yes</td></tr><tr><td/><td/><td/><td align=\"left\">Night mares</td><td align=\"center\">Yes</td></tr><tr><td align=\"center\">1</td><td align=\"center\">4</td><td align=\"center\">2 weeks</td><td align=\"left\">Anxiety</td><td align=\"center\">No</td></tr><tr><td/><td/><td/><td align=\"left\">Sleep disorder</td><td align=\"center\">Yes</td></tr><tr><td align=\"center\">6</td><td align=\"center\">5</td><td align=\"center\">8 weeks</td><td align=\"left\">Xerophthalmia</td><td align=\"center\">No</td></tr><tr><td align=\"center\">5</td><td align=\"center\">4</td><td align=\"center\">3 weeks</td><td align=\"left\">Appetite increased</td><td align=\"center\">No</td></tr><tr><td align=\"center\">8</td><td align=\"center\">5 (on demand)</td><td align=\"center\">5 weeks</td><td align=\"left\">Leucopenia</td><td align=\"center\">No</td></tr><tr><td/><td/><td/><td align=\"left\">Red blood cell disorder</td><td align=\"center\">No</td></tr><tr><td align=\"center\">14</td><td align=\"center\">10</td><td align=\"center\">2 years</td><td align=\"left\">Arthralgia</td><td align=\"center\">Yes</td></tr><tr><td/><td/><td/><td align=\"left\">Myalgia</td><td align=\"center\">Yes</td></tr></tbody></table></body></html>","text":"Pmid= 2279106:Table= Table 2","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":1254630067,"_task_hash":-1096565916,"_view_id":"choice","accept":[5],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":"tableclass-test-params-100-gill","sessions":["tableclass-test-params-100-frank","tableclass-test-params-100-gill","tableclass-test-params-100-joe","tableclass-test-params-100-vicky"],"default":true}],"view_id":"choice"}
{"html":"<!DOCTYPE html><html><body><h1>Frequency of adverse effects (AE) during inhalation sedation observed for trainee and expert practitioners for each type of patient.</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td/><td/><td align=\"center\" colspan=\"2\"><bold>Anxious adult or child</bold></td><td align=\"center\" colspan=\"2\"><bold>Preschool children</bold></td><td align=\"center\" colspan=\"2\"><bold>Intellectual disability</bold></td><td align=\"center\" colspan=\"2\"><bold>Stressful act</bold></td><td align=\"center\" colspan=\"2\"><bold>Total</bold></td></tr><tr><td/><td/><td colspan=\"2\"><hr/></td><td colspan=\"2\"><hr/></td><td colspan=\"2\"><hr/></td><td colspan=\"2\"><hr/></td><td colspan=\"2\"><hr/></td></tr><tr><td align=\"center\">Type of adverse effect</td><td align=\"center\">Practitioners</td><td align=\"center\"><italic>Sessions (n)</italic></td><td align=\"center\"><italic>AE (%)</italic></td><td align=\"center\"><italic>Sessions (n)</italic></td><td align=\"center\"><italic>AE (%)</italic></td><td align=\"center\"><italic>Sessions (n)</italic></td><td align=\"center\"><italic>AE (%)</italic></td><td align=\"center\"><italic>Sessions (n)</italic></td><td align=\"center\"><italic>AE (%)</italic></td><td align=\"center\"><italic>Sessions (n)</italic></td><td align=\"center\"><italic>AE (%)</italic></td></tr></thead><tbody><tr><td align=\"center\"><bold>Respiratory</bold></td><td align=\"center\">Trainee</td><td align=\"center\">291</td><td align=\"center\">0</td><td align=\"center\">143</td><td align=\"center\">0</td><td align=\"center\">262</td><td align=\"center\"><bold>8**</bold></td><td align=\"center\">87</td><td align=\"center\">0</td><td align=\"center\">783</td><td align=\"center\"><bold>3*</bold></td></tr><tr><td/><td align=\"center\">Expert</td><td align=\"center\">139</td><td align=\"center\">0</td><td align=\"center\">30</td><td align=\"center\">0</td><td align=\"center\">202</td><td align=\"center\">0</td><td align=\"center\">1</td><td align=\"center\">0</td><td align=\"center\">372</td><td align=\"center\">0</td></tr><tr><td align=\"center\"><bold>Digestive</bold></td><td align=\"center\">Trainee</td><td align=\"center\">292</td><td align=\"center\">4</td><td align=\"center\">143</td><td align=\"center\">1</td><td align=\"center\">261</td><td align=\"center\"><bold>9**</bold></td><td align=\"center\">87</td><td align=\"center\">2</td><td align=\"center\">783</td><td align=\"center\">5</td></tr><tr><td/><td align=\"center\">Expert</td><td align=\"center\">139</td><td align=\"center\">5</td><td align=\"center\">30</td><td align=\"center\">0</td><td align=\"center\">202</td><td align=\"center\">2</td><td align=\"center\">1</td><td align=\"center\">0</td><td align=\"center\">372</td><td align=\"center\">3</td></tr><tr><td align=\"center\"><bold>Neurological</bold></td><td align=\"center\">Trainee</td><td align=\"center\">292</td><td align=\"center\">1</td><td align=\"center\">141</td><td align=\"center\">0</td><td align=\"center\">259</td><td align=\"center\">0</td><td align=\"center\">87</td><td align=\"center\">0</td><td align=\"center\">781</td><td align=\"center\">0</td></tr><tr><td/><td align=\"center\">Expert</td><td align=\"center\">139</td><td align=\"center\">1</td><td align=\"center\">30</td><td align=\"center\">0</td><td align=\"center\">203</td><td align=\"center\">0</td><td align=\"center\">1</td><td align=\"center\">0</td><td align=\"center\">373</td><td align=\"center\">0</td></tr><tr><td align=\"center\"><bold>Behavioural</bold></td><td align=\"center\">Trainee</td><td align=\"center\">292</td><td align=\"center\">1</td><td align=\"center\">142</td><td align=\"center\">3</td><td align=\"center\">266</td><td align=\"center\"><bold>12**</bold></td><td align=\"center\">87</td><td align=\"center\">6</td><td align=\"center\">787</td><td align=\"center\"><bold>6*</bold></td></tr><tr><td/><td align=\"center\">Expert</td><td align=\"center\">139</td><td align=\"center\">1</td><td align=\"center\">30</td><td align=\"center\">7</td><td align=\"center\">202</td><td align=\"center\">2</td><td align=\"center\">1</td><td align=\"center\">0</td><td align=\"center\">372</td><td align=\"center\">2</td></tr><tr><td align=\"center\"><bold>Vaso-vagal</bold></td><td align=\"center\">Trainee</td><td align=\"center\">292</td><td align=\"center\">1</td><td align=\"center\">143</td><td align=\"center\">1</td><td align=\"center\">263</td><td align=\"center\"><bold>10**</bold></td><td align=\"center\">87</td><td align=\"center\">2</td><td align=\"center\">785</td><td align=\"center\"><bold>4**</bold></td></tr><tr><td/><td align=\"center\">Expert</td><td align=\"center\">139</td><td align=\"center\">1</td><td align=\"center\">30</td><td align=\"center\">0</td><td align=\"center\">202</td><td align=\"center\">0</td><td align=\"center\">1</td><td align=\"center\">0</td><td align=\"center\">372</td><td align=\"center\">1</td></tr><tr><td align=\"center\"><bold>Others</bold></td><td align=\"center\">Trainee</td><td align=\"center\">291</td><td align=\"center\">1</td><td align=\"center\">143</td><td align=\"center\">0</td><td align=\"center\">254</td><td align=\"center\"><bold>7**</bold></td><td align=\"center\">87</td><td align=\"center\">3</td><td align=\"center\">775</td><td align=\"center\">3</td></tr><tr><td/><td align=\"center\">Expert</td><td align=\"center\">139</td><td align=\"center\">2</td><td align=\"center\">31</td><td align=\"center\">6</td><td align=\"center\">199</td><td align=\"center\">1</td><td align=\"center\">1</td><td align=\"center\">0</td><td align=\"center\">370</td><td align=\"center\">2</td></tr></tbody></table></body></html>","text":"Pmid= 2438323:Table= Table 1","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":-199989369,"_task_hash":-941741333,"_view_id":"review","accept":[5],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":null,"sessions":["tableclass-test-params-100-frank","tableclass-test-params-100-gill","tableclass-test-params-100-joe","tableclass-test-params-100-vicky"],"versions":[{"html":"<!DOCTYPE html><html><body><h1>Frequency of adverse effects (AE) during inhalation sedation observed for trainee and expert practitioners for each type of patient.</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td/><td/><td align=\"center\" colspan=\"2\"><bold>Anxious adult or child</bold></td><td align=\"center\" colspan=\"2\"><bold>Preschool children</bold></td><td align=\"center\" colspan=\"2\"><bold>Intellectual disability</bold></td><td align=\"center\" colspan=\"2\"><bold>Stressful act</bold></td><td align=\"center\" colspan=\"2\"><bold>Total</bold></td></tr><tr><td/><td/><td colspan=\"2\"><hr/></td><td colspan=\"2\"><hr/></td><td colspan=\"2\"><hr/></td><td colspan=\"2\"><hr/></td><td colspan=\"2\"><hr/></td></tr><tr><td align=\"center\">Type of adverse effect</td><td align=\"center\">Practitioners</td><td align=\"center\"><italic>Sessions (n)</italic></td><td align=\"center\"><italic>AE (%)</italic></td><td align=\"center\"><italic>Sessions (n)</italic></td><td align=\"center\"><italic>AE (%)</italic></td><td align=\"center\"><italic>Sessions (n)</italic></td><td align=\"center\"><italic>AE (%)</italic></td><td align=\"center\"><italic>Sessions (n)</italic></td><td align=\"center\"><italic>AE (%)</italic></td><td align=\"center\"><italic>Sessions (n)</italic></td><td align=\"center\"><italic>AE (%)</italic></td></tr></thead><tbody><tr><td align=\"center\"><bold>Respiratory</bold></td><td align=\"center\">Trainee</td><td align=\"center\">291</td><td align=\"center\">0</td><td align=\"center\">143</td><td align=\"center\">0</td><td align=\"center\">262</td><td align=\"center\"><bold>8**</bold></td><td align=\"center\">87</td><td align=\"center\">0</td><td align=\"center\">783</td><td align=\"center\"><bold>3*</bold></td></tr><tr><td/><td align=\"center\">Expert</td><td align=\"center\">139</td><td align=\"center\">0</td><td align=\"center\">30</td><td align=\"center\">0</td><td align=\"center\">202</td><td align=\"center\">0</td><td align=\"center\">1</td><td align=\"center\">0</td><td align=\"center\">372</td><td align=\"center\">0</td></tr><tr><td align=\"center\"><bold>Digestive</bold></td><td align=\"center\">Trainee</td><td align=\"center\">292</td><td align=\"center\">4</td><td align=\"center\">143</td><td align=\"center\">1</td><td align=\"center\">261</td><td align=\"center\"><bold>9**</bold></td><td align=\"center\">87</td><td align=\"center\">2</td><td align=\"center\">783</td><td align=\"center\">5</td></tr><tr><td/><td align=\"center\">Expert</td><td align=\"center\">139</td><td align=\"center\">5</td><td align=\"center\">30</td><td align=\"center\">0</td><td align=\"center\">202</td><td align=\"center\">2</td><td align=\"center\">1</td><td align=\"center\">0</td><td align=\"center\">372</td><td align=\"center\">3</td></tr><tr><td align=\"center\"><bold>Neurological</bold></td><td align=\"center\">Trainee</td><td align=\"center\">292</td><td align=\"center\">1</td><td align=\"center\">141</td><td align=\"center\">0</td><td align=\"center\">259</td><td align=\"center\">0</td><td align=\"center\">87</td><td align=\"center\">0</td><td align=\"center\">781</td><td align=\"center\">0</td></tr><tr><td/><td align=\"center\">Expert</td><td align=\"center\">139</td><td align=\"center\">1</td><td align=\"center\">30</td><td align=\"center\">0</td><td align=\"center\">203</td><td align=\"center\">0</td><td align=\"center\">1</td><td align=\"center\">0</td><td align=\"center\">373</td><td align=\"center\">0</td></tr><tr><td align=\"center\"><bold>Behavioural</bold></td><td align=\"center\">Trainee</td><td align=\"center\">292</td><td align=\"center\">1</td><td align=\"center\">142</td><td align=\"center\">3</td><td align=\"center\">266</td><td align=\"center\"><bold>12**</bold></td><td align=\"center\">87</td><td align=\"center\">6</td><td align=\"center\">787</td><td align=\"center\"><bold>6*</bold></td></tr><tr><td/><td align=\"center\">Expert</td><td align=\"center\">139</td><td align=\"center\">1</td><td align=\"center\">30</td><td align=\"center\">7</td><td align=\"center\">202</td><td align=\"center\">2</td><td align=\"center\">1</td><td align=\"center\">0</td><td align=\"center\">372</td><td align=\"center\">2</td></tr><tr><td align=\"center\"><bold>Vaso-vagal</bold></td><td align=\"center\">Trainee</td><td align=\"center\">292</td><td align=\"center\">1</td><td align=\"center\">143</td><td align=\"center\">1</td><td align=\"center\">263</td><td align=\"center\"><bold>10**</bold></td><td align=\"center\">87</td><td align=\"center\">2</td><td align=\"center\">785</td><td align=\"center\"><bold>4**</bold></td></tr><tr><td/><td align=\"center\">Expert</td><td align=\"center\">139</td><td align=\"center\">1</td><td align=\"center\">30</td><td align=\"center\">0</td><td align=\"center\">202</td><td align=\"center\">0</td><td align=\"center\">1</td><td align=\"center\">0</td><td align=\"center\">372</td><td align=\"center\">1</td></tr><tr><td align=\"center\"><bold>Others</bold></td><td align=\"center\">Trainee</td><td align=\"center\">291</td><td align=\"center\">1</td><td align=\"center\">143</td><td align=\"center\">0</td><td align=\"center\">254</td><td align=\"center\"><bold>7**</bold></td><td align=\"center\">87</td><td align=\"center\">3</td><td align=\"center\">775</td><td align=\"center\">3</td></tr><tr><td/><td align=\"center\">Expert</td><td align=\"center\">139</td><td align=\"center\">2</td><td align=\"center\">31</td><td align=\"center\">6</td><td align=\"center\">199</td><td align=\"center\">1</td><td align=\"center\">1</td><td align=\"center\">0</td><td align=\"center\">370</td><td align=\"center\">2</td></tr></tbody></table></body></html>","text":"Pmid= 2438323:Table= Table 1","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":-199989369,"_task_hash":-941741333,"_view_id":"choice","accept":[5],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":"tableclass-test-params-100-gill","sessions":["tableclass-test-params-100-frank","tableclass-test-params-100-gill","tableclass-test-params-100-joe","tableclass-test-params-100-vicky"],"default":true}],"view_id":"choice"}
{"html":"<!DOCTYPE html><html><body><h1>Peak Changes in Physiological Variables in Response to Inhaled l-Methamphetamine, IV phenylephrine and IV l-methamphetamine.</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td align=\"center\">Measure</td><td align=\"center\">16 Inhalations</td><td align=\"center\">32 Inhalations</td><td align=\"center\">64 Inhalations</td><td align=\"center\">PE<sub>1</sub></td><td align=\"center\">PE<sub>2</sub></td><td align=\"center\">IV l-Meth</td><td align=\"center\">Overall P-Value</td></tr></thead><tbody><tr><td align=\"center\">Systolic Blood Pressure (mmHg)</td><td align=\"center\">11.8 (16.2)<sup>&#8225;&#167;||</sup>**</td><td align=\"center\">12.3 (20.5)<sup>&#8225;&#167;||</sup>**</td><td align=\"center\">- 1.2 (16.0)</td><td align=\"center\">0.9 (10.1)</td><td align=\"center\">1.4 (9.8)</td><td align=\"center\">2.9 (9.3)</td><td align=\"center\">0.03</td></tr><tr><td align=\"center\">Diastolic Blood Pressure (mmHg)</td><td align=\"center\">8.7 (8.9)<sup>||</sup>**</td><td align=\"center\">6.6 (9.9)<sup>||</sup></td><td align=\"center\">9.0 (12.4)<sup>||</sup>**</td><td align=\"center\">1.9 (8.3)</td><td align=\"center\">-2 (10.2)</td><td align=\"center\">7.4 (12.5)<sup>||</sup></td><td align=\"center\">0.04</td></tr><tr><td align=\"center\">Heart Rate (beats/min)</td><td align=\"center\">1.3 (12.3)</td><td align=\"center\">4.2 (19.2)</td><td align=\"center\">2.3 (14.3)</td><td align=\"center\">2.8 (9.7)</td><td align=\"center\">-4.2 (7.9)</td><td align=\"center\">- 0.33 (8.4)</td><td align=\"center\">0.62</td></tr><tr><td align=\"center\">Respiratory Rate (breaths/min)</td><td align=\"center\">0.17 (4.3)</td><td align=\"center\">3 (2.5)*<sup>&#167;||</sup>**</td><td align=\"center\">2.4 (3.5)<sup>&#167;||</sup></td><td align=\"center\">- 1.9 (4.8)</td><td align=\"center\">-1.5 (3.3)</td><td align=\"center\">0.42 (4.4)</td><td align=\"center\">0.003</td></tr><tr><td align=\"center\">Core Temperature (&#176;C)</td><td align=\"center\">0.13 (0.8)</td><td align=\"center\">- 0.32 (0.9)</td><td align=\"center\">0.21 (0.9)</td><td align=\"center\">- 0.19(0.6)</td><td align=\"center\">0.08 (0.4)</td><td align=\"center\">0.09 (0.2)</td><td align=\"center\">0.41</td></tr></tbody></table></body></html>","text":"Pmid= 2496900:Table= Table 1","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":2111610847,"_task_hash":1201368755,"_view_id":"review","accept":[4],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":null,"sessions":["tableclass-test-params-100-frank","tableclass-test-params-100-gill","tableclass-test-params-100-vicky"],"versions":[{"html":"<!DOCTYPE html><html><body><h1>Peak Changes in Physiological Variables in Response to Inhaled l-Methamphetamine, IV phenylephrine and IV l-methamphetamine.</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td align=\"center\">Measure</td><td align=\"center\">16 Inhalations</td><td align=\"center\">32 Inhalations</td><td align=\"center\">64 Inhalations</td><td align=\"center\">PE<sub>1</sub></td><td align=\"center\">PE<sub>2</sub></td><td align=\"center\">IV l-Meth</td><td align=\"center\">Overall P-Value</td></tr></thead><tbody><tr><td align=\"center\">Systolic Blood Pressure (mmHg)</td><td align=\"center\">11.8 (16.2)<sup>&#8225;&#167;||</sup>**</td><td align=\"center\">12.3 (20.5)<sup>&#8225;&#167;||</sup>**</td><td align=\"center\">- 1.2 (16.0)</td><td align=\"center\">0.9 (10.1)</td><td align=\"center\">1.4 (9.8)</td><td align=\"center\">2.9 (9.3)</td><td align=\"center\">0.03</td></tr><tr><td align=\"center\">Diastolic Blood Pressure (mmHg)</td><td align=\"center\">8.7 (8.9)<sup>||</sup>**</td><td align=\"center\">6.6 (9.9)<sup>||</sup></td><td align=\"center\">9.0 (12.4)<sup>||</sup>**</td><td align=\"center\">1.9 (8.3)</td><td align=\"center\">-2 (10.2)</td><td align=\"center\">7.4 (12.5)<sup>||</sup></td><td align=\"center\">0.04</td></tr><tr><td align=\"center\">Heart Rate (beats/min)</td><td align=\"center\">1.3 (12.3)</td><td align=\"center\">4.2 (19.2)</td><td align=\"center\">2.3 (14.3)</td><td align=\"center\">2.8 (9.7)</td><td align=\"center\">-4.2 (7.9)</td><td align=\"center\">- 0.33 (8.4)</td><td align=\"center\">0.62</td></tr><tr><td align=\"center\">Respiratory Rate (breaths/min)</td><td align=\"center\">0.17 (4.3)</td><td align=\"center\">3 (2.5)*<sup>&#167;||</sup>**</td><td align=\"center\">2.4 (3.5)<sup>&#167;||</sup></td><td align=\"center\">- 1.9 (4.8)</td><td align=\"center\">-1.5 (3.3)</td><td align=\"center\">0.42 (4.4)</td><td align=\"center\">0.003</td></tr><tr><td align=\"center\">Core Temperature (&#176;C)</td><td align=\"center\">0.13 (0.8)</td><td align=\"center\">- 0.32 (0.9)</td><td align=\"center\">0.21 (0.9)</td><td align=\"center\">- 0.19(0.6)</td><td align=\"center\">0.08 (0.4)</td><td align=\"center\">0.09 (0.2)</td><td align=\"center\">0.41</td></tr></tbody></table></body></html>","text":"Pmid= 2496900:Table= Table 1","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":2111610847,"_task_hash":1201368755,"_view_id":"choice","accept":[5],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":"tableclass-test-params-100-gill","sessions":["tableclass-test-params-100-frank","tableclass-test-params-100-gill","tableclass-test-params-100-vicky"],"default":true},{"html":"<!DOCTYPE html><html><body><h1>Peak Changes in Physiological Variables in Response to Inhaled l-Methamphetamine, IV phenylephrine and IV l-methamphetamine.</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td align=\"center\">Measure</td><td align=\"center\">16 Inhalations</td><td align=\"center\">32 Inhalations</td><td align=\"center\">64 Inhalations</td><td align=\"center\">PE<sub>1</sub></td><td align=\"center\">PE<sub>2</sub></td><td align=\"center\">IV l-Meth</td><td align=\"center\">Overall P-Value</td></tr></thead><tbody><tr><td align=\"center\">Systolic Blood Pressure (mmHg)</td><td align=\"center\">11.8 (16.2)<sup>&#8225;&#167;||</sup>**</td><td align=\"center\">12.3 (20.5)<sup>&#8225;&#167;||</sup>**</td><td align=\"center\">- 1.2 (16.0)</td><td align=\"center\">0.9 (10.1)</td><td align=\"center\">1.4 (9.8)</td><td align=\"center\">2.9 (9.3)</td><td align=\"center\">0.03</td></tr><tr><td align=\"center\">Diastolic Blood Pressure (mmHg)</td><td align=\"center\">8.7 (8.9)<sup>||</sup>**</td><td align=\"center\">6.6 (9.9)<sup>||</sup></td><td align=\"center\">9.0 (12.4)<sup>||</sup>**</td><td align=\"center\">1.9 (8.3)</td><td align=\"center\">-2 (10.2)</td><td align=\"center\">7.4 (12.5)<sup>||</sup></td><td align=\"center\">0.04</td></tr><tr><td align=\"center\">Heart Rate (beats/min)</td><td align=\"center\">1.3 (12.3)</td><td align=\"center\">4.2 (19.2)</td><td align=\"center\">2.3 (14.3)</td><td align=\"center\">2.8 (9.7)</td><td align=\"center\">-4.2 (7.9)</td><td align=\"center\">- 0.33 (8.4)</td><td align=\"center\">0.62</td></tr><tr><td align=\"center\">Respiratory Rate (breaths/min)</td><td align=\"center\">0.17 (4.3)</td><td align=\"center\">3 (2.5)*<sup>&#167;||</sup>**</td><td align=\"center\">2.4 (3.5)<sup>&#167;||</sup></td><td align=\"center\">- 1.9 (4.8)</td><td align=\"center\">-1.5 (3.3)</td><td align=\"center\">0.42 (4.4)</td><td align=\"center\">0.003</td></tr><tr><td align=\"center\">Core Temperature (&#176;C)</td><td align=\"center\">0.13 (0.8)</td><td align=\"center\">- 0.32 (0.9)</td><td align=\"center\">0.21 (0.9)</td><td align=\"center\">- 0.19(0.6)</td><td align=\"center\">0.08 (0.4)</td><td align=\"center\">0.09 (0.2)</td><td align=\"center\">0.41</td></tr></tbody></table></body></html>","text":"Pmid= 2496900:Table= Table 1","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":2111610847,"_task_hash":-1519922053,"_view_id":"choice","accept":[4],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":"tableclass-test-params-100-joe","sessions":["tableclass-test-params-100-joe"],"default":false}],"view_id":"choice"}
{"html":"<!DOCTYPE html><html><body><h1>Change in Cardiovascular Variables in Response to Exercise After Vicks Inhalation and IV l-Methamphetamine As Measured by Stress Echocardiography. Data presented as mean (SD).</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td align=\"center\">Measure</td><td align=\"center\">16 Inhalations</td><td align=\"center\">32 Inhalations</td><td align=\"center\">64 Inhalations</td><td align=\"center\">IV l-Meth</td><td align=\"center\">Overall P-Value (time)</td><td align=\"center\">Overall P-Value (dose)</td></tr></thead><tbody><tr><td align=\"left\">Cardiac Output (l/min)</td><td align=\"center\">3.1 (2.0)</td><td align=\"center\">2.4 (2.2)</td><td align=\"center\">2.5 (2.5)</td><td align=\"center\">3.8 (2.3)</td><td align=\"center\">&lt; 0.001</td><td align=\"center\">0.10</td></tr><tr><td align=\"left\">Heart Rate (beats/min)</td><td align=\"center\">73.5 (26.7</td><td align=\"center\">66.3 (21.5)</td><td align=\"center\">64.5 (22.9)</td><td align=\"center\">76.9 (16.8)</td><td align=\"center\">&lt; 0.001</td><td align=\"center\">0.17</td></tr><tr><td align=\"left\">Systolic Blood Pressure (mmHg)</td><td align=\"center\">41.3 (18.7)</td><td align=\"center\">41.6 (42.6)</td><td align=\"center\">52.0 (13.9)</td><td align=\"center\">57.6 (11.6)</td><td align=\"center\">&lt; 0.001</td><td align=\"center\">0.35</td></tr><tr><td align=\"left\">Stroke Volume (ml)</td><td align=\"center\">3.3 (13.2)</td><td align=\"center\">2.5 (13.4)</td><td align=\"center\">2.1 (13.9)</td><td align=\"center\">-0.02 (7.3)</td><td align=\"center\">0.41</td><td align=\"center\">0.90</td></tr><tr><td align=\"left\">LV Internal Diameter (cm)</td><td align=\"center\">-2.6 (2.9)</td><td align=\"center\">-2.1 (3.5)</td><td align=\"center\">-1.8 (4.1)</td><td align=\"center\">-2.0 (4.6)</td><td align=\"center\">0.01</td><td align=\"center\">0.96</td></tr><tr><td align=\"left\">Ejection Fraction (%)</td><td align=\"center\">8.9 (5.8)</td><td align=\"center\">7.8 (7.6)</td><td align=\"center\">6.3 (6.4)</td><td align=\"center\">9.9 (6.5)</td><td align=\"center\">&lt; 0.001</td><td align=\"center\">0.62</td></tr><tr><td align=\"left\">Systolic Wall Stress(kdynes/cm<sup>2</sup>)</td><td align=\"center\">64.5 (62.8)</td><td align=\"center\">51.7 (61.6)</td><td align=\"center\">41.7 (79.3)</td><td align=\"center\">81.7 (90.6)</td><td align=\"center\">0.002</td><td align=\"center\">0.42</td></tr><tr><td align=\"left\">Posterior Wall Thickness (cm)</td><td align=\"center\">- 0.58 (1.4)</td><td align=\"center\">0.67 (1.3)</td><td align=\"center\">0.25 (0.97)</td><td align=\"center\">0.08 (1.5)</td><td align=\"center\">0.49</td><td align=\"center\">0.20</td></tr><tr><td align=\"left\">Septal Wall Thickness (mm)</td><td align=\"center\">0.08 (0.79)</td><td align=\"center\">0.08 (1.5)</td><td align=\"center\">2.0 (3.1)</td><td align=\"center\">0.25 (0.97)</td><td align=\"center\">0.05</td><td align=\"center\">0.04</td></tr></tbody></table></body></html>","text":"Pmid= 2496900:Table= Table 2","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":776867546,"_task_hash":1206455645,"_view_id":"review","accept":[4],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":null,"sessions":["tableclass-test-params-100-frank","tableclass-test-params-100-gill","tableclass-test-params-100-vicky"],"versions":[{"html":"<!DOCTYPE html><html><body><h1>Change in Cardiovascular Variables in Response to Exercise After Vicks Inhalation and IV l-Methamphetamine As Measured by Stress Echocardiography. Data presented as mean (SD).</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td align=\"center\">Measure</td><td align=\"center\">16 Inhalations</td><td align=\"center\">32 Inhalations</td><td align=\"center\">64 Inhalations</td><td align=\"center\">IV l-Meth</td><td align=\"center\">Overall P-Value (time)</td><td align=\"center\">Overall P-Value (dose)</td></tr></thead><tbody><tr><td align=\"left\">Cardiac Output (l/min)</td><td align=\"center\">3.1 (2.0)</td><td align=\"center\">2.4 (2.2)</td><td align=\"center\">2.5 (2.5)</td><td align=\"center\">3.8 (2.3)</td><td align=\"center\">&lt; 0.001</td><td align=\"center\">0.10</td></tr><tr><td align=\"left\">Heart Rate (beats/min)</td><td align=\"center\">73.5 (26.7</td><td align=\"center\">66.3 (21.5)</td><td align=\"center\">64.5 (22.9)</td><td align=\"center\">76.9 (16.8)</td><td align=\"center\">&lt; 0.001</td><td align=\"center\">0.17</td></tr><tr><td align=\"left\">Systolic Blood Pressure (mmHg)</td><td align=\"center\">41.3 (18.7)</td><td align=\"center\">41.6 (42.6)</td><td align=\"center\">52.0 (13.9)</td><td align=\"center\">57.6 (11.6)</td><td align=\"center\">&lt; 0.001</td><td align=\"center\">0.35</td></tr><tr><td align=\"left\">Stroke Volume (ml)</td><td align=\"center\">3.3 (13.2)</td><td align=\"center\">2.5 (13.4)</td><td align=\"center\">2.1 (13.9)</td><td align=\"center\">-0.02 (7.3)</td><td align=\"center\">0.41</td><td align=\"center\">0.90</td></tr><tr><td align=\"left\">LV Internal Diameter (cm)</td><td align=\"center\">-2.6 (2.9)</td><td align=\"center\">-2.1 (3.5)</td><td align=\"center\">-1.8 (4.1)</td><td align=\"center\">-2.0 (4.6)</td><td align=\"center\">0.01</td><td align=\"center\">0.96</td></tr><tr><td align=\"left\">Ejection Fraction (%)</td><td align=\"center\">8.9 (5.8)</td><td align=\"center\">7.8 (7.6)</td><td align=\"center\">6.3 (6.4)</td><td align=\"center\">9.9 (6.5)</td><td align=\"center\">&lt; 0.001</td><td align=\"center\">0.62</td></tr><tr><td align=\"left\">Systolic Wall Stress(kdynes/cm<sup>2</sup>)</td><td align=\"center\">64.5 (62.8)</td><td align=\"center\">51.7 (61.6)</td><td align=\"center\">41.7 (79.3)</td><td align=\"center\">81.7 (90.6)</td><td align=\"center\">0.002</td><td align=\"center\">0.42</td></tr><tr><td align=\"left\">Posterior Wall Thickness (cm)</td><td align=\"center\">- 0.58 (1.4)</td><td align=\"center\">0.67 (1.3)</td><td align=\"center\">0.25 (0.97)</td><td align=\"center\">0.08 (1.5)</td><td align=\"center\">0.49</td><td align=\"center\">0.20</td></tr><tr><td align=\"left\">Septal Wall Thickness (mm)</td><td align=\"center\">0.08 (0.79)</td><td align=\"center\">0.08 (1.5)</td><td align=\"center\">2.0 (3.1)</td><td align=\"center\">0.25 (0.97)</td><td align=\"center\">0.05</td><td align=\"center\">0.04</td></tr></tbody></table></body></html>","text":"Pmid= 2496900:Table= Table 2","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":776867546,"_task_hash":1206455645,"_view_id":"choice","accept":[5],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":"tableclass-test-params-100-gill","sessions":["tableclass-test-params-100-frank","tableclass-test-params-100-gill","tableclass-test-params-100-vicky"],"default":true},{"html":"<!DOCTYPE html><html><body><h1>Change in Cardiovascular Variables in Response to Exercise After Vicks Inhalation and IV l-Methamphetamine As Measured by Stress Echocardiography. Data presented as mean (SD).</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td align=\"center\">Measure</td><td align=\"center\">16 Inhalations</td><td align=\"center\">32 Inhalations</td><td align=\"center\">64 Inhalations</td><td align=\"center\">IV l-Meth</td><td align=\"center\">Overall P-Value (time)</td><td align=\"center\">Overall P-Value (dose)</td></tr></thead><tbody><tr><td align=\"left\">Cardiac Output (l/min)</td><td align=\"center\">3.1 (2.0)</td><td align=\"center\">2.4 (2.2)</td><td align=\"center\">2.5 (2.5)</td><td align=\"center\">3.8 (2.3)</td><td align=\"center\">&lt; 0.001</td><td align=\"center\">0.10</td></tr><tr><td align=\"left\">Heart Rate (beats/min)</td><td align=\"center\">73.5 (26.7</td><td align=\"center\">66.3 (21.5)</td><td align=\"center\">64.5 (22.9)</td><td align=\"center\">76.9 (16.8)</td><td align=\"center\">&lt; 0.001</td><td align=\"center\">0.17</td></tr><tr><td align=\"left\">Systolic Blood Pressure (mmHg)</td><td align=\"center\">41.3 (18.7)</td><td align=\"center\">41.6 (42.6)</td><td align=\"center\">52.0 (13.9)</td><td align=\"center\">57.6 (11.6)</td><td align=\"center\">&lt; 0.001</td><td align=\"center\">0.35</td></tr><tr><td align=\"left\">Stroke Volume (ml)</td><td align=\"center\">3.3 (13.2)</td><td align=\"center\">2.5 (13.4)</td><td align=\"center\">2.1 (13.9)</td><td align=\"center\">-0.02 (7.3)</td><td align=\"center\">0.41</td><td align=\"center\">0.90</td></tr><tr><td align=\"left\">LV Internal Diameter (cm)</td><td align=\"center\">-2.6 (2.9)</td><td align=\"center\">-2.1 (3.5)</td><td align=\"center\">-1.8 (4.1)</td><td align=\"center\">-2.0 (4.6)</td><td align=\"center\">0.01</td><td align=\"center\">0.96</td></tr><tr><td align=\"left\">Ejection Fraction (%)</td><td align=\"center\">8.9 (5.8)</td><td align=\"center\">7.8 (7.6)</td><td align=\"center\">6.3 (6.4)</td><td align=\"center\">9.9 (6.5)</td><td align=\"center\">&lt; 0.001</td><td align=\"center\">0.62</td></tr><tr><td align=\"left\">Systolic Wall Stress(kdynes/cm<sup>2</sup>)</td><td align=\"center\">64.5 (62.8)</td><td align=\"center\">51.7 (61.6)</td><td align=\"center\">41.7 (79.3)</td><td align=\"center\">81.7 (90.6)</td><td align=\"center\">0.002</td><td align=\"center\">0.42</td></tr><tr><td align=\"left\">Posterior Wall Thickness (cm)</td><td align=\"center\">- 0.58 (1.4)</td><td align=\"center\">0.67 (1.3)</td><td align=\"center\">0.25 (0.97)</td><td align=\"center\">0.08 (1.5)</td><td align=\"center\">0.49</td><td align=\"center\">0.20</td></tr><tr><td align=\"left\">Septal Wall Thickness (mm)</td><td align=\"center\">0.08 (0.79)</td><td align=\"center\">0.08 (1.5)</td><td align=\"center\">2.0 (3.1)</td><td align=\"center\">0.25 (0.97)</td><td align=\"center\">0.05</td><td align=\"center\">0.04</td></tr></tbody></table></body></html>","text":"Pmid= 2496900:Table= Table 2","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":776867546,"_task_hash":-463953199,"_view_id":"choice","accept":[4],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":"tableclass-test-params-100-joe","sessions":["tableclass-test-params-100-joe"],"default":false}],"view_id":"choice"}
{"html":"<!DOCTYPE html><html><body><h1>Change in Cardiovascular Variables in Response to Inhaler Condition and IV l-Methamphetamine as Measured by Impedance Cardiography.</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td align=\"left\">Measure</td><td align=\"center\">16 Inhalations</td><td align=\"center\">32 Inhalations</td><td align=\"center\">64 Inhalations</td><td align=\"center\">IV l-Meth</td><td align=\"center\">Overall P-Value (time)</td><td align=\"center\">Overall P-Value (dose)</td></tr></thead><tbody><tr><td align=\"left\">Cardiac Output (l/min)</td><td/><td/><td/><td/><td/><td/></tr><tr><td align=\"left\">15 minutes</td><td align=\"center\">-0.53 (0.66)</td><td align=\"center\">-0.46 (1.3)</td><td align=\"center\">-0.56 (0.52)</td><td align=\"center\">-0.01 (0.54)</td><td align=\"center\">0.02</td><td align=\"center\">0.67</td></tr><tr><td align=\"left\">2 Hours</td><td align=\"center\">0.0 (0.67)</td><td align=\"center\">0.05 (1.6)</td><td align=\"center\">0.31 (0.77)</td><td align=\"center\">0.28 (1.0)</td><td align=\"center\">0.32</td><td/></tr><tr><td align=\"left\">Heart Rate (beats/min)</td><td/><td/><td/><td/><td/><td/></tr><tr><td align=\"left\">15 Minutes</td><td align=\"center\">-2.6 (4.9)</td><td align=\"center\">-2.1 (5.8)</td><td align=\"center\">-1.7 (5.9)</td><td align=\"center\">1.0 (5.8)</td><td align=\"center\">0.38</td><td align=\"center\">0.60</td></tr><tr><td align=\"left\">2 Hours</td><td align=\"center\">4.3 (6.0)</td><td align=\"center\">5.4 (11.3)</td><td align=\"center\">4.3 (7.7)</td><td align=\"center\">6.1 (9.5)</td><td align=\"center\">0.003</td><td/></tr><tr><td align=\"left\">Systolic Blood Pressure (mmHg)</td><td/><td/><td/><td/><td/><td/></tr><tr><td align=\"left\">15 Minutes</td><td align=\"center\">1.0 (12.5)</td><td align=\"center\">-1.2 (6.6)</td><td align=\"center\">-3.0 (6.4)</td><td align=\"center\">4.8 (9.0)</td><td align=\"center\">0.76</td><td align=\"center\">0.09</td></tr><tr><td align=\"left\">2 Hours</td><td align=\"center\">1.8 (7.9)</td><td align=\"center\">-0.17 (7.0)</td><td align=\"center\">3.1 (6.9)</td><td align=\"center\">5.9 (6.9)</td><td align=\"center\">0.06</td><td/></tr><tr><td align=\"left\">Diastolic Blood Pressure (mmHg)</td><td/><td/><td/><td/><td/><td/></tr><tr><td align=\"left\">15 Minutes</td><td align=\"center\">0.50 (7.5)</td><td align=\"center\">1.4 (6.7)</td><td align=\"center\">1.2 (6.4)</td><td align=\"center\">4.3 (8.8)</td><td align=\"center\">0.09</td><td align=\"center\">0.23</td></tr><tr><td align=\"left\">2 Hours</td><td align=\"center\">2.2 (4.2)</td><td align=\"center\">2.6 (6.5)</td><td align=\"center\">1.2 (4.9)</td><td align=\"center\">6.5 (8.1)</td><td align=\"center\">0.007</td><td/></tr><tr><td colspan=\"7\"><hr/></td></tr><tr><td align=\"left\">Stroke Volume</td><td/><td/><td/><td/><td/><td/></tr><tr><td align=\"left\">15 Minutes</td><td align=\"center\">-3.9 (7.3)</td><td align=\"center\">-4.9 (16.0)</td><td align=\"center\">-6.0 (6.4)</td><td align=\"center\">-1.0 (5.4)</td><td align=\"center\">0.008</td><td align=\"center\">0.66</td></tr><tr><td align=\"left\">2 Hours</td><td align=\"center\">-5.4 (6.6)</td><td align=\"center\">-6.2 (17.5)</td><td align=\"center\">-1.6 (7.8)</td><td align=\"center\">-0.67 (6.4)</td><td align=\"center\">0.02</td><td/></tr><tr><td align=\"left\">Systemic Vascular Resistance (dynes*sec*cm<sup>5</sup>)</td><td/><td/><td/><td/><td/><td/></tr><tr><td align=\"left\">15 Minutes</td><td align=\"center\">106.0 (168.9)</td><td align=\"center\">137.1 (388.5)</td><td align=\"center\">129.1 (169.5)</td><td align=\"center\">48.8 (112.7)</td><td align=\"center\">0.004</td><td align=\"center\">0.89</td></tr><tr><td align=\"left\">2 Hours</td><td align=\"center\">47.2 (140.2)</td><td align=\"center\">72.0 (441.7)</td><td align=\"center\">-10.2 (204.0)</td><td align=\"center\">12.3 (127.2)</td><td align=\"center\">0.36</td><td/></tr><tr><td align=\"left\">Left CardiacWork</td><td/><td/><td/><td/><td/><td/></tr><tr><td align=\"left\">15 Minutes</td><td align=\"center\">-0.51 (1.0)</td><td align=\"center\">-0.48 (1.6)</td><td align=\"center\">-0.59 (0.64)</td><td align=\"center\">0.44 (0.93)</td><td align=\"center\">0.21</td><td align=\"center\">0.12</td></tr><tr><td align=\"left\">2 Hours</td><td align=\"center\">0.22 (0.91)</td><td align=\"center\">0.23 (2.1)</td><td align=\"center\">0.53 (0.78)</td><td align=\"center\">1.1 (1.5)</td><td align=\"center\">0.03</td><td/></tr><tr><td align=\"left\">LV Ejection Time</td><td/><td/><td/><td/><td/><td/></tr><tr><td align=\"left\">15 Minutes</td><td align=\"center\">-0.75 (12.4)</td><td align=\"center\">-4.8 (16.4)</td><td align=\"center\">-12.4 (19.1)</td><td align=\"center\">-0.25 (10.4)</td><td align=\"center\">0.19</td><td align=\"center\">0.54</td></tr><tr><td align=\"left\">2 Hours</td><td align=\"center\">-11.8 (16.4)</td><td align=\"center\">-12.1 (26.8)</td><td align=\"center\">-11.8 (19.9)</td><td align=\"center\">-6.4 (26.5)</td><td align=\"center\">0.005</td><td/></tr></tbody></table></body></html>","text":"Pmid= 2496900:Table= Table 3","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":315488574,"_task_hash":1054658528,"_view_id":"review","accept":[4],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":null,"sessions":["tableclass-test-params-100-frank","tableclass-test-params-100-gill","tableclass-test-params-100-vicky"],"versions":[{"html":"<!DOCTYPE html><html><body><h1>Change in Cardiovascular Variables in Response to Inhaler Condition and IV l-Methamphetamine as Measured by Impedance Cardiography.</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td align=\"left\">Measure</td><td align=\"center\">16 Inhalations</td><td align=\"center\">32 Inhalations</td><td align=\"center\">64 Inhalations</td><td align=\"center\">IV l-Meth</td><td align=\"center\">Overall P-Value (time)</td><td align=\"center\">Overall P-Value (dose)</td></tr></thead><tbody><tr><td align=\"left\">Cardiac Output (l/min)</td><td/><td/><td/><td/><td/><td/></tr><tr><td align=\"left\">15 minutes</td><td align=\"center\">-0.53 (0.66)</td><td align=\"center\">-0.46 (1.3)</td><td align=\"center\">-0.56 (0.52)</td><td align=\"center\">-0.01 (0.54)</td><td align=\"center\">0.02</td><td align=\"center\">0.67</td></tr><tr><td align=\"left\">2 Hours</td><td align=\"center\">0.0 (0.67)</td><td align=\"center\">0.05 (1.6)</td><td align=\"center\">0.31 (0.77)</td><td align=\"center\">0.28 (1.0)</td><td align=\"center\">0.32</td><td/></tr><tr><td align=\"left\">Heart Rate (beats/min)</td><td/><td/><td/><td/><td/><td/></tr><tr><td align=\"left\">15 Minutes</td><td align=\"center\">-2.6 (4.9)</td><td align=\"center\">-2.1 (5.8)</td><td align=\"center\">-1.7 (5.9)</td><td align=\"center\">1.0 (5.8)</td><td align=\"center\">0.38</td><td align=\"center\">0.60</td></tr><tr><td align=\"left\">2 Hours</td><td align=\"center\">4.3 (6.0)</td><td align=\"center\">5.4 (11.3)</td><td align=\"center\">4.3 (7.7)</td><td align=\"center\">6.1 (9.5)</td><td align=\"center\">0.003</td><td/></tr><tr><td align=\"left\">Systolic Blood Pressure (mmHg)</td><td/><td/><td/><td/><td/><td/></tr><tr><td align=\"left\">15 Minutes</td><td align=\"center\">1.0 (12.5)</td><td align=\"center\">-1.2 (6.6)</td><td align=\"center\">-3.0 (6.4)</td><td align=\"center\">4.8 (9.0)</td><td align=\"center\">0.76</td><td align=\"center\">0.09</td></tr><tr><td align=\"left\">2 Hours</td><td align=\"center\">1.8 (7.9)</td><td align=\"center\">-0.17 (7.0)</td><td align=\"center\">3.1 (6.9)</td><td align=\"center\">5.9 (6.9)</td><td align=\"center\">0.06</td><td/></tr><tr><td align=\"left\">Diastolic Blood Pressure (mmHg)</td><td/><td/><td/><td/><td/><td/></tr><tr><td align=\"left\">15 Minutes</td><td align=\"center\">0.50 (7.5)</td><td align=\"center\">1.4 (6.7)</td><td align=\"center\">1.2 (6.4)</td><td align=\"center\">4.3 (8.8)</td><td align=\"center\">0.09</td><td align=\"center\">0.23</td></tr><tr><td align=\"left\">2 Hours</td><td align=\"center\">2.2 (4.2)</td><td align=\"center\">2.6 (6.5)</td><td align=\"center\">1.2 (4.9)</td><td align=\"center\">6.5 (8.1)</td><td align=\"center\">0.007</td><td/></tr><tr><td colspan=\"7\"><hr/></td></tr><tr><td align=\"left\">Stroke Volume</td><td/><td/><td/><td/><td/><td/></tr><tr><td align=\"left\">15 Minutes</td><td align=\"center\">-3.9 (7.3)</td><td align=\"center\">-4.9 (16.0)</td><td align=\"center\">-6.0 (6.4)</td><td align=\"center\">-1.0 (5.4)</td><td align=\"center\">0.008</td><td align=\"center\">0.66</td></tr><tr><td align=\"left\">2 Hours</td><td align=\"center\">-5.4 (6.6)</td><td align=\"center\">-6.2 (17.5)</td><td align=\"center\">-1.6 (7.8)</td><td align=\"center\">-0.67 (6.4)</td><td align=\"center\">0.02</td><td/></tr><tr><td align=\"left\">Systemic Vascular Resistance (dynes*sec*cm<sup>5</sup>)</td><td/><td/><td/><td/><td/><td/></tr><tr><td align=\"left\">15 Minutes</td><td align=\"center\">106.0 (168.9)</td><td align=\"center\">137.1 (388.5)</td><td align=\"center\">129.1 (169.5)</td><td align=\"center\">48.8 (112.7)</td><td align=\"center\">0.004</td><td align=\"center\">0.89</td></tr><tr><td align=\"left\">2 Hours</td><td align=\"center\">47.2 (140.2)</td><td align=\"center\">72.0 (441.7)</td><td align=\"center\">-10.2 (204.0)</td><td align=\"center\">12.3 (127.2)</td><td align=\"center\">0.36</td><td/></tr><tr><td align=\"left\">Left CardiacWork</td><td/><td/><td/><td/><td/><td/></tr><tr><td align=\"left\">15 Minutes</td><td align=\"center\">-0.51 (1.0)</td><td align=\"center\">-0.48 (1.6)</td><td align=\"center\">-0.59 (0.64)</td><td align=\"center\">0.44 (0.93)</td><td align=\"center\">0.21</td><td align=\"center\">0.12</td></tr><tr><td align=\"left\">2 Hours</td><td align=\"center\">0.22 (0.91)</td><td align=\"center\">0.23 (2.1)</td><td align=\"center\">0.53 (0.78)</td><td align=\"center\">1.1 (1.5)</td><td align=\"center\">0.03</td><td/></tr><tr><td align=\"left\">LV Ejection Time</td><td/><td/><td/><td/><td/><td/></tr><tr><td align=\"left\">15 Minutes</td><td align=\"center\">-0.75 (12.4)</td><td align=\"center\">-4.8 (16.4)</td><td align=\"center\">-12.4 (19.1)</td><td align=\"center\">-0.25 (10.4)</td><td align=\"center\">0.19</td><td align=\"center\">0.54</td></tr><tr><td align=\"left\">2 Hours</td><td align=\"center\">-11.8 (16.4)</td><td align=\"center\">-12.1 (26.8)</td><td align=\"center\">-11.8 (19.9)</td><td align=\"center\">-6.4 (26.5)</td><td align=\"center\">0.005</td><td/></tr></tbody></table></body></html>","text":"Pmid= 2496900:Table= Table 3","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":315488574,"_task_hash":1054658528,"_view_id":"choice","accept":[5],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":"tableclass-test-params-100-gill","sessions":["tableclass-test-params-100-frank","tableclass-test-params-100-gill","tableclass-test-params-100-vicky"],"default":true},{"html":"<!DOCTYPE html><html><body><h1>Change in Cardiovascular Variables in Response to Inhaler Condition and IV l-Methamphetamine as Measured by Impedance Cardiography.</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td align=\"left\">Measure</td><td align=\"center\">16 Inhalations</td><td align=\"center\">32 Inhalations</td><td align=\"center\">64 Inhalations</td><td align=\"center\">IV l-Meth</td><td align=\"center\">Overall P-Value (time)</td><td align=\"center\">Overall P-Value (dose)</td></tr></thead><tbody><tr><td align=\"left\">Cardiac Output (l/min)</td><td/><td/><td/><td/><td/><td/></tr><tr><td align=\"left\">15 minutes</td><td align=\"center\">-0.53 (0.66)</td><td align=\"center\">-0.46 (1.3)</td><td align=\"center\">-0.56 (0.52)</td><td align=\"center\">-0.01 (0.54)</td><td align=\"center\">0.02</td><td align=\"center\">0.67</td></tr><tr><td align=\"left\">2 Hours</td><td align=\"center\">0.0 (0.67)</td><td align=\"center\">0.05 (1.6)</td><td align=\"center\">0.31 (0.77)</td><td align=\"center\">0.28 (1.0)</td><td align=\"center\">0.32</td><td/></tr><tr><td align=\"left\">Heart Rate (beats/min)</td><td/><td/><td/><td/><td/><td/></tr><tr><td align=\"left\">15 Minutes</td><td align=\"center\">-2.6 (4.9)</td><td align=\"center\">-2.1 (5.8)</td><td align=\"center\">-1.7 (5.9)</td><td align=\"center\">1.0 (5.8)</td><td align=\"center\">0.38</td><td align=\"center\">0.60</td></tr><tr><td align=\"left\">2 Hours</td><td align=\"center\">4.3 (6.0)</td><td align=\"center\">5.4 (11.3)</td><td align=\"center\">4.3 (7.7)</td><td align=\"center\">6.1 (9.5)</td><td align=\"center\">0.003</td><td/></tr><tr><td align=\"left\">Systolic Blood Pressure (mmHg)</td><td/><td/><td/><td/><td/><td/></tr><tr><td align=\"left\">15 Minutes</td><td align=\"center\">1.0 (12.5)</td><td align=\"center\">-1.2 (6.6)</td><td align=\"center\">-3.0 (6.4)</td><td align=\"center\">4.8 (9.0)</td><td align=\"center\">0.76</td><td align=\"center\">0.09</td></tr><tr><td align=\"left\">2 Hours</td><td align=\"center\">1.8 (7.9)</td><td align=\"center\">-0.17 (7.0)</td><td align=\"center\">3.1 (6.9)</td><td align=\"center\">5.9 (6.9)</td><td align=\"center\">0.06</td><td/></tr><tr><td align=\"left\">Diastolic Blood Pressure (mmHg)</td><td/><td/><td/><td/><td/><td/></tr><tr><td align=\"left\">15 Minutes</td><td align=\"center\">0.50 (7.5)</td><td align=\"center\">1.4 (6.7)</td><td align=\"center\">1.2 (6.4)</td><td align=\"center\">4.3 (8.8)</td><td align=\"center\">0.09</td><td align=\"center\">0.23</td></tr><tr><td align=\"left\">2 Hours</td><td align=\"center\">2.2 (4.2)</td><td align=\"center\">2.6 (6.5)</td><td align=\"center\">1.2 (4.9)</td><td align=\"center\">6.5 (8.1)</td><td align=\"center\">0.007</td><td/></tr><tr><td colspan=\"7\"><hr/></td></tr><tr><td align=\"left\">Stroke Volume</td><td/><td/><td/><td/><td/><td/></tr><tr><td align=\"left\">15 Minutes</td><td align=\"center\">-3.9 (7.3)</td><td align=\"center\">-4.9 (16.0)</td><td align=\"center\">-6.0 (6.4)</td><td align=\"center\">-1.0 (5.4)</td><td align=\"center\">0.008</td><td align=\"center\">0.66</td></tr><tr><td align=\"left\">2 Hours</td><td align=\"center\">-5.4 (6.6)</td><td align=\"center\">-6.2 (17.5)</td><td align=\"center\">-1.6 (7.8)</td><td align=\"center\">-0.67 (6.4)</td><td align=\"center\">0.02</td><td/></tr><tr><td align=\"left\">Systemic Vascular Resistance (dynes*sec*cm<sup>5</sup>)</td><td/><td/><td/><td/><td/><td/></tr><tr><td align=\"left\">15 Minutes</td><td align=\"center\">106.0 (168.9)</td><td align=\"center\">137.1 (388.5)</td><td align=\"center\">129.1 (169.5)</td><td align=\"center\">48.8 (112.7)</td><td align=\"center\">0.004</td><td align=\"center\">0.89</td></tr><tr><td align=\"left\">2 Hours</td><td align=\"center\">47.2 (140.2)</td><td align=\"center\">72.0 (441.7)</td><td align=\"center\">-10.2 (204.0)</td><td align=\"center\">12.3 (127.2)</td><td align=\"center\">0.36</td><td/></tr><tr><td align=\"left\">Left CardiacWork</td><td/><td/><td/><td/><td/><td/></tr><tr><td align=\"left\">15 Minutes</td><td align=\"center\">-0.51 (1.0)</td><td align=\"center\">-0.48 (1.6)</td><td align=\"center\">-0.59 (0.64)</td><td align=\"center\">0.44 (0.93)</td><td align=\"center\">0.21</td><td align=\"center\">0.12</td></tr><tr><td align=\"left\">2 Hours</td><td align=\"center\">0.22 (0.91)</td><td align=\"center\">0.23 (2.1)</td><td align=\"center\">0.53 (0.78)</td><td align=\"center\">1.1 (1.5)</td><td align=\"center\">0.03</td><td/></tr><tr><td align=\"left\">LV Ejection Time</td><td/><td/><td/><td/><td/><td/></tr><tr><td align=\"left\">15 Minutes</td><td align=\"center\">-0.75 (12.4)</td><td align=\"center\">-4.8 (16.4)</td><td align=\"center\">-12.4 (19.1)</td><td align=\"center\">-0.25 (10.4)</td><td align=\"center\">0.19</td><td align=\"center\">0.54</td></tr><tr><td align=\"left\">2 Hours</td><td align=\"center\">-11.8 (16.4)</td><td align=\"center\">-12.1 (26.8)</td><td align=\"center\">-11.8 (19.9)</td><td align=\"center\">-6.4 (26.5)</td><td align=\"center\">0.005</td><td/></tr></tbody></table></body></html>","text":"Pmid= 2496900:Table= Table 3","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":315488574,"_task_hash":1335458052,"_view_id":"choice","accept":[4],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":"tableclass-test-params-100-joe","sessions":["tableclass-test-params-100-joe"],"default":false}],"view_id":"choice"}
{"html":"<!DOCTYPE html><html><body><h1>Peak Changes in VAS Subjective Variables in Response to Inhaled l-Methamphetamine, IV phenylephrine and IV l-methamphetamine.</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td align=\"left\">Measure</td><td align=\"center\">16 Inhalations</td><td align=\"center\">32 Inhalations</td><td align=\"center\">64 Inhalations</td><td align=\"center\">PE<sub>1</sub></td><td align=\"center\">PE<sub>2</sub></td><td align=\"center\">IV l-Meth</td><td align=\"center\">Overall P-Value</td></tr></thead><tbody><tr><td align=\"left\">Any Drug Effect</td><td align=\"center\">9.0 (13.9)<sup>&#167;||</sup>**</td><td align=\"center\">7.3 (10.5)<sup>&#167;||</sup>**</td><td align=\"center\">9.8 (7.9)<sup>&#167;||&#182;</sup>**</td><td align=\"center\">1.5 (2.1)</td><td align=\"center\">1.7 (2.4)</td><td align=\"center\">4.5 (8.6)</td><td align=\"center\">0.001</td></tr><tr><td align=\"left\">Bad Drug Effect</td><td align=\"center\">6.8 (13.7)</td><td align=\"center\">2.8 (4.6)</td><td align=\"center\">4.9 (5.0)</td><td align=\"center\">0.33 (0.9)</td><td align=\"center\">1.1 (0.79)</td><td align=\"center\">5.3 (10.7)</td><td align=\"center\">0.07</td></tr><tr><td align=\"left\">Dizziness</td><td align=\"center\">9.3 (14.0)<sup>&#167;||&#182;</sup>**</td><td align=\"center\">6.5 (6.4)<sup>&#182;</sup>**</td><td align=\"center\">9.0 (13.5)<sup>&#167;||&#182;</sup>**</td><td align=\"center\">1.5 (2.9)</td><td align=\"center\">0.92 (2.2)</td><td align=\"center\">-0.67 (5.7)</td><td align=\"center\">0.004</td></tr><tr><td align=\"left\">Good Drug Effect</td><td align=\"center\">5.8 (13.0)<sup>||</sup>**</td><td align=\"center\">5.7 (10.5)**</td><td align=\"center\">9.7 (13.0)<sup>&#167;||&#182;</sup>**</td><td align=\"center\">0.42 (2.9)</td><td align=\"center\">0.25 (1.5)</td><td align=\"center\">2.7 (4.7)</td><td align=\"center\">0.005</td></tr><tr><td align=\"left\">Headache</td><td align=\"center\">5.1 (18.1)</td><td align=\"center\">4.8 (5.1)<sup>||</sup></td><td align=\"center\">12.7 (17.0)<sup>&#167;||&#182;</sup>**</td><td align=\"center\">-0.08 (1.7)</td><td align=\"center\">1.8 (3.3)</td><td align=\"center\">-3.8 (13.4)</td><td align=\"center\">0.02</td></tr><tr><td align=\"left\">Nasal Dryness</td><td align=\"center\">5.2 (16.2)</td><td align=\"center\">3.3 (9.6)</td><td align=\"center\">4.1 (9.9)</td><td align=\"center\">-0.75 (2.1)</td><td align=\"center\">-0.50 (1.7)</td><td align=\"center\">-0.42 (2.7)</td><td align=\"center\">0.20</td></tr><tr><td align=\"left\">Nasal Stuffiness</td><td align=\"center\">1.1 (16.9)</td><td align=\"center\">2.8 (4.8)</td><td align=\"center\">1.4 (6.7)</td><td align=\"center\">0.50 (4.4)</td><td align=\"center\">-1.6 (3.6)</td><td align=\"center\">0.42 (1.2)</td><td align=\"center\">0.88</td></tr></tbody></table></body></html>","text":"Pmid= 2496900:Table= Table 4","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":-331022407,"_task_hash":95097377,"_view_id":"review","accept":[4],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":null,"sessions":["tableclass-test-params-100-frank","tableclass-test-params-100-gill","tableclass-test-params-100-vicky"],"versions":[{"html":"<!DOCTYPE html><html><body><h1>Peak Changes in VAS Subjective Variables in Response to Inhaled l-Methamphetamine, IV phenylephrine and IV l-methamphetamine.</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td align=\"left\">Measure</td><td align=\"center\">16 Inhalations</td><td align=\"center\">32 Inhalations</td><td align=\"center\">64 Inhalations</td><td align=\"center\">PE<sub>1</sub></td><td align=\"center\">PE<sub>2</sub></td><td align=\"center\">IV l-Meth</td><td align=\"center\">Overall P-Value</td></tr></thead><tbody><tr><td align=\"left\">Any Drug Effect</td><td align=\"center\">9.0 (13.9)<sup>&#167;||</sup>**</td><td align=\"center\">7.3 (10.5)<sup>&#167;||</sup>**</td><td align=\"center\">9.8 (7.9)<sup>&#167;||&#182;</sup>**</td><td align=\"center\">1.5 (2.1)</td><td align=\"center\">1.7 (2.4)</td><td align=\"center\">4.5 (8.6)</td><td align=\"center\">0.001</td></tr><tr><td align=\"left\">Bad Drug Effect</td><td align=\"center\">6.8 (13.7)</td><td align=\"center\">2.8 (4.6)</td><td align=\"center\">4.9 (5.0)</td><td align=\"center\">0.33 (0.9)</td><td align=\"center\">1.1 (0.79)</td><td align=\"center\">5.3 (10.7)</td><td align=\"center\">0.07</td></tr><tr><td align=\"left\">Dizziness</td><td align=\"center\">9.3 (14.0)<sup>&#167;||&#182;</sup>**</td><td align=\"center\">6.5 (6.4)<sup>&#182;</sup>**</td><td align=\"center\">9.0 (13.5)<sup>&#167;||&#182;</sup>**</td><td align=\"center\">1.5 (2.9)</td><td align=\"center\">0.92 (2.2)</td><td align=\"center\">-0.67 (5.7)</td><td align=\"center\">0.004</td></tr><tr><td align=\"left\">Good Drug Effect</td><td align=\"center\">5.8 (13.0)<sup>||</sup>**</td><td align=\"center\">5.7 (10.5)**</td><td align=\"center\">9.7 (13.0)<sup>&#167;||&#182;</sup>**</td><td align=\"center\">0.42 (2.9)</td><td align=\"center\">0.25 (1.5)</td><td align=\"center\">2.7 (4.7)</td><td align=\"center\">0.005</td></tr><tr><td align=\"left\">Headache</td><td align=\"center\">5.1 (18.1)</td><td align=\"center\">4.8 (5.1)<sup>||</sup></td><td align=\"center\">12.7 (17.0)<sup>&#167;||&#182;</sup>**</td><td align=\"center\">-0.08 (1.7)</td><td align=\"center\">1.8 (3.3)</td><td align=\"center\">-3.8 (13.4)</td><td align=\"center\">0.02</td></tr><tr><td align=\"left\">Nasal Dryness</td><td align=\"center\">5.2 (16.2)</td><td align=\"center\">3.3 (9.6)</td><td align=\"center\">4.1 (9.9)</td><td align=\"center\">-0.75 (2.1)</td><td align=\"center\">-0.50 (1.7)</td><td align=\"center\">-0.42 (2.7)</td><td align=\"center\">0.20</td></tr><tr><td align=\"left\">Nasal Stuffiness</td><td align=\"center\">1.1 (16.9)</td><td align=\"center\">2.8 (4.8)</td><td align=\"center\">1.4 (6.7)</td><td align=\"center\">0.50 (4.4)</td><td align=\"center\">-1.6 (3.6)</td><td align=\"center\">0.42 (1.2)</td><td align=\"center\">0.88</td></tr></tbody></table></body></html>","text":"Pmid= 2496900:Table= Table 4","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":-331022407,"_task_hash":95097377,"_view_id":"choice","accept":[5],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":"tableclass-test-params-100-gill","sessions":["tableclass-test-params-100-frank","tableclass-test-params-100-gill","tableclass-test-params-100-vicky"],"default":true},{"html":"<!DOCTYPE html><html><body><h1>Peak Changes in VAS Subjective Variables in Response to Inhaled l-Methamphetamine, IV phenylephrine and IV l-methamphetamine.</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td align=\"left\">Measure</td><td align=\"center\">16 Inhalations</td><td align=\"center\">32 Inhalations</td><td align=\"center\">64 Inhalations</td><td align=\"center\">PE<sub>1</sub></td><td align=\"center\">PE<sub>2</sub></td><td align=\"center\">IV l-Meth</td><td align=\"center\">Overall P-Value</td></tr></thead><tbody><tr><td align=\"left\">Any Drug Effect</td><td align=\"center\">9.0 (13.9)<sup>&#167;||</sup>**</td><td align=\"center\">7.3 (10.5)<sup>&#167;||</sup>**</td><td align=\"center\">9.8 (7.9)<sup>&#167;||&#182;</sup>**</td><td align=\"center\">1.5 (2.1)</td><td align=\"center\">1.7 (2.4)</td><td align=\"center\">4.5 (8.6)</td><td align=\"center\">0.001</td></tr><tr><td align=\"left\">Bad Drug Effect</td><td align=\"center\">6.8 (13.7)</td><td align=\"center\">2.8 (4.6)</td><td align=\"center\">4.9 (5.0)</td><td align=\"center\">0.33 (0.9)</td><td align=\"center\">1.1 (0.79)</td><td align=\"center\">5.3 (10.7)</td><td align=\"center\">0.07</td></tr><tr><td align=\"left\">Dizziness</td><td align=\"center\">9.3 (14.0)<sup>&#167;||&#182;</sup>**</td><td align=\"center\">6.5 (6.4)<sup>&#182;</sup>**</td><td align=\"center\">9.0 (13.5)<sup>&#167;||&#182;</sup>**</td><td align=\"center\">1.5 (2.9)</td><td align=\"center\">0.92 (2.2)</td><td align=\"center\">-0.67 (5.7)</td><td align=\"center\">0.004</td></tr><tr><td align=\"left\">Good Drug Effect</td><td align=\"center\">5.8 (13.0)<sup>||</sup>**</td><td align=\"center\">5.7 (10.5)**</td><td align=\"center\">9.7 (13.0)<sup>&#167;||&#182;</sup>**</td><td align=\"center\">0.42 (2.9)</td><td align=\"center\">0.25 (1.5)</td><td align=\"center\">2.7 (4.7)</td><td align=\"center\">0.005</td></tr><tr><td align=\"left\">Headache</td><td align=\"center\">5.1 (18.1)</td><td align=\"center\">4.8 (5.1)<sup>||</sup></td><td align=\"center\">12.7 (17.0)<sup>&#167;||&#182;</sup>**</td><td align=\"center\">-0.08 (1.7)</td><td align=\"center\">1.8 (3.3)</td><td align=\"center\">-3.8 (13.4)</td><td align=\"center\">0.02</td></tr><tr><td align=\"left\">Nasal Dryness</td><td align=\"center\">5.2 (16.2)</td><td align=\"center\">3.3 (9.6)</td><td align=\"center\">4.1 (9.9)</td><td align=\"center\">-0.75 (2.1)</td><td align=\"center\">-0.50 (1.7)</td><td align=\"center\">-0.42 (2.7)</td><td align=\"center\">0.20</td></tr><tr><td align=\"left\">Nasal Stuffiness</td><td align=\"center\">1.1 (16.9)</td><td align=\"center\">2.8 (4.8)</td><td align=\"center\">1.4 (6.7)</td><td align=\"center\">0.50 (4.4)</td><td align=\"center\">-1.6 (3.6)</td><td align=\"center\">0.42 (1.2)</td><td align=\"center\">0.88</td></tr></tbody></table></body></html>","text":"Pmid= 2496900:Table= Table 4","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":-331022407,"_task_hash":1711760108,"_view_id":"choice","accept":[4],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":"tableclass-test-params-100-joe","sessions":["tableclass-test-params-100-joe"],"default":false}],"view_id":"choice"}
{"html":"<!DOCTYPE html><html><body><h1>Treatments and Dosing Regimens</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td align=\"center\">Treatment</td><td align=\"center\">Number</td><td align=\"left\">Study medication</td><td align=\"center\">Water volume</td><td align=\"center\">Dosing time pre-meal</td></tr></thead><tbody><tr><td align=\"center\">1</td><td align=\"center\"><italic>n </italic>= 40</td><td align=\"left\">SMC021 0.8 mg</td><td align=\"center\">50 ml</td><td align=\"center\">10 min</td></tr><tr><td align=\"center\">2</td><td align=\"center\"><italic>n </italic>= 40</td><td align=\"left\">SMC021 0.8 mg</td><td align=\"center\">50 ml</td><td align=\"center\">30 min</td></tr><tr><td align=\"center\">3</td><td align=\"center\"><italic>n </italic>= 40</td><td align=\"left\">SMC021 0.8 mg</td><td align=\"center\">50 ml</td><td align=\"center\">60 min</td></tr><tr><td colspan=\"5\"><hr/></td></tr><tr><td align=\"center\">4</td><td align=\"center\"><italic>n </italic>= 40</td><td align=\"left\">SMC021 0.8 mg</td><td align=\"center\">200 ml</td><td align=\"center\">10 min</td></tr><tr><td align=\"center\">5</td><td align=\"center\"><italic>n </italic>= 40</td><td align=\"left\">SMC021 0.8 mg</td><td align=\"center\">200 ml</td><td align=\"center\">30 min</td></tr><tr><td align=\"center\">6</td><td align=\"center\"><italic>n </italic>= 40</td><td align=\"left\">SMC021 0.8 mg</td><td align=\"center\">200 ml</td><td align=\"center\">60 min</td></tr><tr><td colspan=\"5\"><hr/></td></tr><tr><td align=\"center\">7</td><td align=\"center\"><italic>n </italic>= 10</td><td align=\"left\">Placebo</td><td align=\"center\">200 ml</td><td align=\"center\">10 min</td></tr><tr><td align=\"center\">8</td><td align=\"center\"><italic>n </italic>= 10</td><td align=\"left\">Placebo</td><td align=\"center\">200 ml</td><td align=\"center\">30 min</td></tr><tr><td align=\"center\">9</td><td align=\"center\"><italic>n </italic>= 10</td><td align=\"left\">Placebo</td><td align=\"center\">200 ml</td><td align=\"center\">60 min</td></tr><tr><td align=\"center\">10</td><td align=\"center\"><italic>n </italic>= 10</td><td align=\"left\">Miacalcic<sup>&#174;</sup>200 IU NS</td><td align=\"center\">N/A</td><td align=\"center\">60 min</td></tr></tbody></table></body></html>","text":"Pmid= 2551583:Table= Table 1","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":-1367409279,"_task_hash":-1944991711,"_view_id":"review","accept":[5],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":null,"sessions":["tableclass-test-params-100-frank","tableclass-test-params-100-gill","tableclass-test-params-100-joe","tableclass-test-params-100-vicky"],"versions":[{"html":"<!DOCTYPE html><html><body><h1>Treatments and Dosing Regimens</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td align=\"center\">Treatment</td><td align=\"center\">Number</td><td align=\"left\">Study medication</td><td align=\"center\">Water volume</td><td align=\"center\">Dosing time pre-meal</td></tr></thead><tbody><tr><td align=\"center\">1</td><td align=\"center\"><italic>n </italic>= 40</td><td align=\"left\">SMC021 0.8 mg</td><td align=\"center\">50 ml</td><td align=\"center\">10 min</td></tr><tr><td align=\"center\">2</td><td align=\"center\"><italic>n </italic>= 40</td><td align=\"left\">SMC021 0.8 mg</td><td align=\"center\">50 ml</td><td align=\"center\">30 min</td></tr><tr><td align=\"center\">3</td><td align=\"center\"><italic>n </italic>= 40</td><td align=\"left\">SMC021 0.8 mg</td><td align=\"center\">50 ml</td><td align=\"center\">60 min</td></tr><tr><td colspan=\"5\"><hr/></td></tr><tr><td align=\"center\">4</td><td align=\"center\"><italic>n </italic>= 40</td><td align=\"left\">SMC021 0.8 mg</td><td align=\"center\">200 ml</td><td align=\"center\">10 min</td></tr><tr><td align=\"center\">5</td><td align=\"center\"><italic>n </italic>= 40</td><td align=\"left\">SMC021 0.8 mg</td><td align=\"center\">200 ml</td><td align=\"center\">30 min</td></tr><tr><td align=\"center\">6</td><td align=\"center\"><italic>n </italic>= 40</td><td align=\"left\">SMC021 0.8 mg</td><td align=\"center\">200 ml</td><td align=\"center\">60 min</td></tr><tr><td colspan=\"5\"><hr/></td></tr><tr><td align=\"center\">7</td><td align=\"center\"><italic>n </italic>= 10</td><td align=\"left\">Placebo</td><td align=\"center\">200 ml</td><td align=\"center\">10 min</td></tr><tr><td align=\"center\">8</td><td align=\"center\"><italic>n </italic>= 10</td><td align=\"left\">Placebo</td><td align=\"center\">200 ml</td><td align=\"center\">30 min</td></tr><tr><td align=\"center\">9</td><td align=\"center\"><italic>n </italic>= 10</td><td align=\"left\">Placebo</td><td align=\"center\">200 ml</td><td align=\"center\">60 min</td></tr><tr><td align=\"center\">10</td><td align=\"center\"><italic>n </italic>= 10</td><td align=\"left\">Miacalcic<sup>&#174;</sup>200 IU NS</td><td align=\"center\">N/A</td><td align=\"center\">60 min</td></tr></tbody></table></body></html>","text":"Pmid= 2551583:Table= Table 1","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":-1367409279,"_task_hash":-1944991711,"_view_id":"choice","accept":[5],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":"tableclass-test-params-100-gill","sessions":["tableclass-test-params-100-frank","tableclass-test-params-100-gill","tableclass-test-params-100-joe","tableclass-test-params-100-vicky"],"default":true}],"view_id":"choice"}
{"html":"<!DOCTYPE html><html><body><h1>Characteristics of study population (</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td/><td align=\"center\">Mean (SD)</td><td align=\"center\">Range</td></tr></thead><tbody><tr><td align=\"left\">Age (Yrs)</td><td align=\"center\">64.2 (3.5)</td><td align=\"center\">56 &#8211; 70</td></tr><tr><td align=\"left\">Height (m)</td><td align=\"center\">163.9 (5.9)</td><td align=\"center\">151 &#8211; 177</td></tr><tr><td align=\"left\">Weight (kg)</td><td align=\"center\">68.4 (7.8)</td><td align=\"center\">53.4 &#8211; 87.5</td></tr><tr><td align=\"left\">BMI (kg/m<sup>2</sup>)</td><td align=\"center\">25.5 (2.8)</td><td align=\"center\">20.1 &#8211; 30.1</td></tr></tbody></table></body></html>","text":"Pmid= 2551583:Table= Table 2","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":-1428564977,"_task_hash":3589118,"_view_id":"review","accept":[5],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":null,"sessions":["tableclass-test-params-100-frank","tableclass-test-params-100-gill","tableclass-test-params-100-joe","tableclass-test-params-100-vicky"],"versions":[{"html":"<!DOCTYPE html><html><body><h1>Characteristics of study population (</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td/><td align=\"center\">Mean (SD)</td><td align=\"center\">Range</td></tr></thead><tbody><tr><td align=\"left\">Age (Yrs)</td><td align=\"center\">64.2 (3.5)</td><td align=\"center\">56 &#8211; 70</td></tr><tr><td align=\"left\">Height (m)</td><td align=\"center\">163.9 (5.9)</td><td align=\"center\">151 &#8211; 177</td></tr><tr><td align=\"left\">Weight (kg)</td><td align=\"center\">68.4 (7.8)</td><td align=\"center\">53.4 &#8211; 87.5</td></tr><tr><td align=\"left\">BMI (kg/m<sup>2</sup>)</td><td align=\"center\">25.5 (2.8)</td><td align=\"center\">20.1 &#8211; 30.1</td></tr></tbody></table></body></html>","text":"Pmid= 2551583:Table= Table 2","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":-1428564977,"_task_hash":3589118,"_view_id":"choice","accept":[5],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":"tableclass-test-params-100-gill","sessions":["tableclass-test-params-100-frank","tableclass-test-params-100-gill","tableclass-test-params-100-joe","tableclass-test-params-100-vicky"],"default":true}],"view_id":"choice"}
{"html":"<!DOCTYPE html><html><body><h1>Pharmacokinetic profile</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td align=\"left\">Study medication</td><td align=\"center\">Water Volume</td><td align=\"center\">Dose pre-meal</td><td align=\"center\">AUC<sub>0&#8211;4 </sub>pg/ml &#215; hrs</td><td align=\"center\">C<sub>max </sub>pg/ml</td><td align=\"center\">T<sub>max </sub>minutes</td></tr></thead><tbody><tr><td align=\"left\">SMC021</td><td align=\"center\">50 ml</td><td align=\"center\">10 min</td><td align=\"center\">52.2 (46.0&#8211;59.4)</td><td align=\"center\">103 (89&#8211;118)</td><td align=\"center\">15 (10&#8211;23)</td></tr><tr><td align=\"left\">SMC021</td><td align=\"center\">50 ml</td><td align=\"center\">30 min</td><td align=\"center\">68.9 (60.2&#8211;78.9)</td><td align=\"center\">125 (110&#8211;144)</td><td align=\"center\">15 (15&#8211;30)</td></tr><tr><td align=\"left\">SMC021</td><td align=\"center\">50 ml</td><td align=\"center\">60 min</td><td align=\"center\">74.4 (64.0&#8211;86.5)</td><td align=\"center\">145 (125&#8211;168)</td><td align=\"center\">15 (15&#8211;30)</td></tr><tr><td colspan=\"6\"><hr/></td></tr><tr><td align=\"left\">SMC021</td><td align=\"center\">200 ml</td><td align=\"center\">10 min</td><td align=\"center\">27.4 (25.2&#8211;29.7)</td><td align=\"center\">52 (45&#8211;59)</td><td align=\"center\">15 (10&#8211;15)</td></tr><tr><td align=\"left\">SMC021</td><td align=\"center\">200 ml</td><td align=\"center\">30 min</td><td align=\"center\">32.9 (29.1&#8211;37.3)</td><td align=\"center\">56 (48&#8211;67)</td><td align=\"center\">15 (15&#8211;30)</td></tr><tr><td align=\"left\">SMC021</td><td align=\"center\">200 ml</td><td align=\"center\">60 min</td><td align=\"center\">33.6 (29.5&#8211;38.1)</td><td align=\"center\">49 (42&#8211;58)</td><td align=\"center\">15 (12.5&#8211;30)</td></tr><tr><td colspan=\"6\"><hr/></td></tr><tr><td align=\"left\">Miacalcic</td><td align=\"center\">N/A</td><td align=\"center\">60 min</td><td align=\"center\">16.4 (13.8&#8211;19.4)</td><td align=\"center\">11.4 (8.3&#8211;15.5)</td><td align=\"center\">15 (10&#8211;15)</td></tr></tbody></table></body></html>","text":"Pmid= 2551583:Table= Table 3","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":-554684465,"_task_hash":-1016625584,"_view_id":"review","accept":[1],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":null,"sessions":["tableclass-test-params-100-frank","tableclass-test-params-100-gill","tableclass-test-params-100-joe","tableclass-test-params-100-vicky"],"versions":[{"html":"<!DOCTYPE html><html><body><h1>Pharmacokinetic profile</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td align=\"left\">Study medication</td><td align=\"center\">Water Volume</td><td align=\"center\">Dose pre-meal</td><td align=\"center\">AUC<sub>0&#8211;4 </sub>pg/ml &#215; hrs</td><td align=\"center\">C<sub>max </sub>pg/ml</td><td align=\"center\">T<sub>max </sub>minutes</td></tr></thead><tbody><tr><td align=\"left\">SMC021</td><td align=\"center\">50 ml</td><td align=\"center\">10 min</td><td align=\"center\">52.2 (46.0&#8211;59.4)</td><td align=\"center\">103 (89&#8211;118)</td><td align=\"center\">15 (10&#8211;23)</td></tr><tr><td align=\"left\">SMC021</td><td align=\"center\">50 ml</td><td align=\"center\">30 min</td><td align=\"center\">68.9 (60.2&#8211;78.9)</td><td align=\"center\">125 (110&#8211;144)</td><td align=\"center\">15 (15&#8211;30)</td></tr><tr><td align=\"left\">SMC021</td><td align=\"center\">50 ml</td><td align=\"center\">60 min</td><td align=\"center\">74.4 (64.0&#8211;86.5)</td><td align=\"center\">145 (125&#8211;168)</td><td align=\"center\">15 (15&#8211;30)</td></tr><tr><td colspan=\"6\"><hr/></td></tr><tr><td align=\"left\">SMC021</td><td align=\"center\">200 ml</td><td align=\"center\">10 min</td><td align=\"center\">27.4 (25.2&#8211;29.7)</td><td align=\"center\">52 (45&#8211;59)</td><td align=\"center\">15 (10&#8211;15)</td></tr><tr><td align=\"left\">SMC021</td><td align=\"center\">200 ml</td><td align=\"center\">30 min</td><td align=\"center\">32.9 (29.1&#8211;37.3)</td><td align=\"center\">56 (48&#8211;67)</td><td align=\"center\">15 (15&#8211;30)</td></tr><tr><td align=\"left\">SMC021</td><td align=\"center\">200 ml</td><td align=\"center\">60 min</td><td align=\"center\">33.6 (29.5&#8211;38.1)</td><td align=\"center\">49 (42&#8211;58)</td><td align=\"center\">15 (12.5&#8211;30)</td></tr><tr><td colspan=\"6\"><hr/></td></tr><tr><td align=\"left\">Miacalcic</td><td align=\"center\">N/A</td><td align=\"center\">60 min</td><td align=\"center\">16.4 (13.8&#8211;19.4)</td><td align=\"center\">11.4 (8.3&#8211;15.5)</td><td align=\"center\">15 (10&#8211;15)</td></tr></tbody></table></body></html>","text":"Pmid= 2551583:Table= Table 3","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":-554684465,"_task_hash":-1016625584,"_view_id":"choice","accept":[1],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":"tableclass-test-params-100-gill","sessions":["tableclass-test-params-100-frank","tableclass-test-params-100-gill","tableclass-test-params-100-joe","tableclass-test-params-100-vicky"],"default":true}],"view_id":"choice"}
{"html":"<!DOCTYPE html><html><body><h1>Patient characteristics (N = 1,218)</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td/><td align=\"left\">&#946;-blockers <break/>(n = 307)</td><td align=\"left\">Thiazide <break/>(n = 196)</td><td align=\"left\">CCBs <break/>(n = 322)</td><td align=\"left\">RAS <break/>(n = 55)</td><td align=\"left\">Others* <break/>(n = 338)</td><td align=\"left\">p value<break/></td></tr></thead><tbody><tr><td align=\"left\">Age (years)</td><td/><td/><td/><td/><td/><td/></tr><tr><td align=\"left\">&lt;50</td><td align=\"left\">85 (27.7)</td><td align=\"left\">38 (19.4)</td><td align=\"left\">74 (23.0)</td><td align=\"left\">9 (16.4)</td><td align=\"left\">58 (17.2)</td><td align=\"left\">&lt;0.001</td></tr><tr><td align=\"left\">50&#8211;59</td><td align=\"left\">113 (36.8)</td><td align=\"left\">62 (31.6)</td><td align=\"left\">87 (27.0)</td><td align=\"left\">22 (40.0)</td><td align=\"left\">84 (24.9)</td><td/></tr><tr><td align=\"left\">60&#8211;69</td><td align=\"left\">59 (19.2)</td><td align=\"left\">51 (26.0)</td><td align=\"left\">70 (21.7)</td><td align=\"left\">11 (20.0)</td><td align=\"left\">77 (22.8)</td><td/></tr><tr><td align=\"left\">&#8805; 70</td><td align=\"left\">50 (16.3)</td><td align=\"left\">45 (23.0)</td><td align=\"left\">91 (28.3)</td><td align=\"left\">13 (23.6)</td><td align=\"left\">119 (35.2)</td><td/></tr><tr><td align=\"left\">Mean Age</td><td align=\"left\">56.96</td><td align=\"left\">60.14</td><td align=\"left\">60.80</td><td align=\"left\">60.02</td><td align=\"left\">63.30</td><td align=\"left\">&lt;0.001</td></tr><tr><td align=\"left\">(SD)</td><td align=\"left\">(11.67)</td><td align=\"left\">(11.37)</td><td align=\"left\">(13.21)</td><td align=\"left\">(12.83)</td><td align=\"left\">(13.42)</td><td/></tr><tr><td align=\"left\">(95% CI)</td><td align=\"left\">(55.651,58.27)</td><td align=\"left\">(58.54, 61.74)</td><td align=\"left\">(59.36, 62.25)</td><td align=\"left\">(56.55, 63.49)</td><td align=\"left\">(61.87, 64.74)</td><td/></tr><tr><td align=\"left\">Gender (no./%)</td><td/><td/><td/><td/><td/><td/></tr><tr><td align=\"left\">Female</td><td align=\"left\">200 (65.1)</td><td align=\"left\">124 (63.3)</td><td align=\"left\">168 (52.2)</td><td align=\"left\">33 (60.0)</td><td align=\"left\">189 (55.9)</td><td align=\"left\">0.008</td></tr><tr><td align=\"left\">Male</td><td align=\"left\">107 (34.9)</td><td align=\"left\">72 (36.7)</td><td align=\"left\">154 (47.8)</td><td align=\"left\">22 (40.0)</td><td align=\"left\">149 (44.1)</td><td/></tr><tr><td align=\"left\">Payment</td><td/><td/><td/><td/><td/><td/></tr><tr><td align=\"left\">Fee-waivers</td><td align=\"left\">107 (34.9)</td><td align=\"left\">68 (34.7)</td><td align=\"left\">107 (33.2)</td><td align=\"left\">17 (30.9)</td><td align=\"left\">96 (28.4)</td><td align=\"left\">0.415</td></tr><tr><td align=\"left\">Payers</td><td align=\"left\">200 (65.1)</td><td align=\"left\">128 (65.3)</td><td align=\"left\">215 (66.8)</td><td align=\"left\">38 (69.1)</td><td align=\"left\">242 (71.6)</td><td/></tr><tr><td align=\"left\">District of residence</td><td/><td/><td/><td/><td/><td/></tr><tr><td align=\"left\">Shatin</td><td align=\"left\">85 (27.7)</td><td align=\"left\">44 (22.4)</td><td align=\"left\">84 (26.1)</td><td align=\"left\">12 (21.8)</td><td align=\"left\">135 (39.9)</td><td align=\"left\">&lt;0.001</td></tr><tr><td align=\"left\">Taipo</td><td align=\"left\">31 (10.1)</td><td align=\"left\">13 (6.6)</td><td align=\"left\">52 (16.1)</td><td align=\"left\">5 (9.1)</td><td align=\"left\">37 (10.9)</td><td/></tr><tr><td align=\"left\">Northern</td><td align=\"left\">161 (52.8)</td><td align=\"left\">127 (64.8)</td><td align=\"left\">169 (52.5)</td><td align=\"left\">34 (61.8)</td><td align=\"left\">134 (39.6)</td><td/></tr><tr><td align=\"left\">Others</td><td align=\"left\">30 (9.4)</td><td align=\"left\">12 (6.1)</td><td align=\"left\">17 (5.3)</td><td align=\"left\">4 (7.3)</td><td align=\"left\">32 (9.5)</td><td/></tr><tr><td align=\"left\">Service type</td><td/><td/><td/><td/><td/><td/></tr><tr><td align=\"left\">General</td><td align=\"left\">264 (86.0)</td><td align=\"left\">179 (91.3)</td><td align=\"left\">288 (89.4)</td><td align=\"left\">48 (87.3)</td><td align=\"left\">275 (81.4)</td><td align=\"left\">&lt;0.001</td></tr><tr><td align=\"left\">FMSC</td><td align=\"left\">29 (9.4)</td><td align=\"left\">7 (3.6)</td><td align=\"left\">27 (8.4)</td><td align=\"left\">4 (7.3)</td><td align=\"left\">56 (16.6)</td><td/></tr><tr><td align=\"left\">Staff clinic</td><td align=\"left\">14 (4.6)</td><td align=\"left\">10 (5.1)</td><td align=\"left\">7 (2.2)</td><td align=\"left\">3 (5.5)</td><td align=\"left\">7 (2.1)</td><td/></tr><tr><td align=\"left\">Glucose Profile</td><td align=\"left\">5.42</td><td align=\"left\">5.48</td><td align=\"left\">5.46</td><td align=\"left\">5.41</td><td align=\"left\">5.60</td><td align=\"left\">0.786</td></tr><tr><td align=\"left\">(mean &#177; 95% CI)</td><td align=\"left\">(5.34, 5.51)</td><td align=\"left\">(5.38, 5.59)</td><td align=\"left\">(5.37, 5.54)</td><td align=\"left\">(5.20, 5.61)</td><td align=\"left\">(5.52, 5.68)</td><td/></tr><tr><td align=\"left\">Period from drug prescription to blood taking (weeks)</td><td align=\"left\">7.43</td><td align=\"left\">7.00</td><td align=\"left\">7.79</td><td align=\"left\">6.71</td><td align=\"left\">8.00</td><td align=\"left\">0.054**</td></tr><tr><td align=\"left\">Median (IQR)</td><td align=\"left\">(5.86, 10.00)</td><td align=\"left\">(5.18, 8.96)</td><td align=\"left\">(5.57, 10.32)</td><td align=\"left\">(5.00, 10.00)</td><td align=\"left\">(6.00, 12.00)</td><td/></tr></tbody></table></body></html>","text":"Pmid= 2551584:Table= Table 1","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":1630572828,"_task_hash":1682565756,"_view_id":"review","accept":[5],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":null,"sessions":["tableclass-test-params-100-frank","tableclass-test-params-100-gill","tableclass-test-params-100-joe","tableclass-test-params-100-vicky"],"versions":[{"html":"<!DOCTYPE html><html><body><h1>Patient characteristics (N = 1,218)</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td/><td align=\"left\">&#946;-blockers <break/>(n = 307)</td><td align=\"left\">Thiazide <break/>(n = 196)</td><td align=\"left\">CCBs <break/>(n = 322)</td><td align=\"left\">RAS <break/>(n = 55)</td><td align=\"left\">Others* <break/>(n = 338)</td><td align=\"left\">p value<break/></td></tr></thead><tbody><tr><td align=\"left\">Age (years)</td><td/><td/><td/><td/><td/><td/></tr><tr><td align=\"left\">&lt;50</td><td align=\"left\">85 (27.7)</td><td align=\"left\">38 (19.4)</td><td align=\"left\">74 (23.0)</td><td align=\"left\">9 (16.4)</td><td align=\"left\">58 (17.2)</td><td align=\"left\">&lt;0.001</td></tr><tr><td align=\"left\">50&#8211;59</td><td align=\"left\">113 (36.8)</td><td align=\"left\">62 (31.6)</td><td align=\"left\">87 (27.0)</td><td align=\"left\">22 (40.0)</td><td align=\"left\">84 (24.9)</td><td/></tr><tr><td align=\"left\">60&#8211;69</td><td align=\"left\">59 (19.2)</td><td align=\"left\">51 (26.0)</td><td align=\"left\">70 (21.7)</td><td align=\"left\">11 (20.0)</td><td align=\"left\">77 (22.8)</td><td/></tr><tr><td align=\"left\">&#8805; 70</td><td align=\"left\">50 (16.3)</td><td align=\"left\">45 (23.0)</td><td align=\"left\">91 (28.3)</td><td align=\"left\">13 (23.6)</td><td align=\"left\">119 (35.2)</td><td/></tr><tr><td align=\"left\">Mean Age</td><td align=\"left\">56.96</td><td align=\"left\">60.14</td><td align=\"left\">60.80</td><td align=\"left\">60.02</td><td align=\"left\">63.30</td><td align=\"left\">&lt;0.001</td></tr><tr><td align=\"left\">(SD)</td><td align=\"left\">(11.67)</td><td align=\"left\">(11.37)</td><td align=\"left\">(13.21)</td><td align=\"left\">(12.83)</td><td align=\"left\">(13.42)</td><td/></tr><tr><td align=\"left\">(95% CI)</td><td align=\"left\">(55.651,58.27)</td><td align=\"left\">(58.54, 61.74)</td><td align=\"left\">(59.36, 62.25)</td><td align=\"left\">(56.55, 63.49)</td><td align=\"left\">(61.87, 64.74)</td><td/></tr><tr><td align=\"left\">Gender (no./%)</td><td/><td/><td/><td/><td/><td/></tr><tr><td align=\"left\">Female</td><td align=\"left\">200 (65.1)</td><td align=\"left\">124 (63.3)</td><td align=\"left\">168 (52.2)</td><td align=\"left\">33 (60.0)</td><td align=\"left\">189 (55.9)</td><td align=\"left\">0.008</td></tr><tr><td align=\"left\">Male</td><td align=\"left\">107 (34.9)</td><td align=\"left\">72 (36.7)</td><td align=\"left\">154 (47.8)</td><td align=\"left\">22 (40.0)</td><td align=\"left\">149 (44.1)</td><td/></tr><tr><td align=\"left\">Payment</td><td/><td/><td/><td/><td/><td/></tr><tr><td align=\"left\">Fee-waivers</td><td align=\"left\">107 (34.9)</td><td align=\"left\">68 (34.7)</td><td align=\"left\">107 (33.2)</td><td align=\"left\">17 (30.9)</td><td align=\"left\">96 (28.4)</td><td align=\"left\">0.415</td></tr><tr><td align=\"left\">Payers</td><td align=\"left\">200 (65.1)</td><td align=\"left\">128 (65.3)</td><td align=\"left\">215 (66.8)</td><td align=\"left\">38 (69.1)</td><td align=\"left\">242 (71.6)</td><td/></tr><tr><td align=\"left\">District of residence</td><td/><td/><td/><td/><td/><td/></tr><tr><td align=\"left\">Shatin</td><td align=\"left\">85 (27.7)</td><td align=\"left\">44 (22.4)</td><td align=\"left\">84 (26.1)</td><td align=\"left\">12 (21.8)</td><td align=\"left\">135 (39.9)</td><td align=\"left\">&lt;0.001</td></tr><tr><td align=\"left\">Taipo</td><td align=\"left\">31 (10.1)</td><td align=\"left\">13 (6.6)</td><td align=\"left\">52 (16.1)</td><td align=\"left\">5 (9.1)</td><td align=\"left\">37 (10.9)</td><td/></tr><tr><td align=\"left\">Northern</td><td align=\"left\">161 (52.8)</td><td align=\"left\">127 (64.8)</td><td align=\"left\">169 (52.5)</td><td align=\"left\">34 (61.8)</td><td align=\"left\">134 (39.6)</td><td/></tr><tr><td align=\"left\">Others</td><td align=\"left\">30 (9.4)</td><td align=\"left\">12 (6.1)</td><td align=\"left\">17 (5.3)</td><td align=\"left\">4 (7.3)</td><td align=\"left\">32 (9.5)</td><td/></tr><tr><td align=\"left\">Service type</td><td/><td/><td/><td/><td/><td/></tr><tr><td align=\"left\">General</td><td align=\"left\">264 (86.0)</td><td align=\"left\">179 (91.3)</td><td align=\"left\">288 (89.4)</td><td align=\"left\">48 (87.3)</td><td align=\"left\">275 (81.4)</td><td align=\"left\">&lt;0.001</td></tr><tr><td align=\"left\">FMSC</td><td align=\"left\">29 (9.4)</td><td align=\"left\">7 (3.6)</td><td align=\"left\">27 (8.4)</td><td align=\"left\">4 (7.3)</td><td align=\"left\">56 (16.6)</td><td/></tr><tr><td align=\"left\">Staff clinic</td><td align=\"left\">14 (4.6)</td><td align=\"left\">10 (5.1)</td><td align=\"left\">7 (2.2)</td><td align=\"left\">3 (5.5)</td><td align=\"left\">7 (2.1)</td><td/></tr><tr><td align=\"left\">Glucose Profile</td><td align=\"left\">5.42</td><td align=\"left\">5.48</td><td align=\"left\">5.46</td><td align=\"left\">5.41</td><td align=\"left\">5.60</td><td align=\"left\">0.786</td></tr><tr><td align=\"left\">(mean &#177; 95% CI)</td><td align=\"left\">(5.34, 5.51)</td><td align=\"left\">(5.38, 5.59)</td><td align=\"left\">(5.37, 5.54)</td><td align=\"left\">(5.20, 5.61)</td><td align=\"left\">(5.52, 5.68)</td><td/></tr><tr><td align=\"left\">Period from drug prescription to blood taking (weeks)</td><td align=\"left\">7.43</td><td align=\"left\">7.00</td><td align=\"left\">7.79</td><td align=\"left\">6.71</td><td align=\"left\">8.00</td><td align=\"left\">0.054**</td></tr><tr><td align=\"left\">Median (IQR)</td><td align=\"left\">(5.86, 10.00)</td><td align=\"left\">(5.18, 8.96)</td><td align=\"left\">(5.57, 10.32)</td><td align=\"left\">(5.00, 10.00)</td><td align=\"left\">(6.00, 12.00)</td><td/></tr></tbody></table></body></html>","text":"Pmid= 2551584:Table= Table 1","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":1630572828,"_task_hash":1682565756,"_view_id":"choice","accept":[5],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":"tableclass-test-params-100-gill","sessions":["tableclass-test-params-100-frank","tableclass-test-params-100-gill","tableclass-test-params-100-joe","tableclass-test-params-100-vicky"],"default":true}],"view_id":"choice"}
{"html":"<!DOCTYPE html><html><body><h1>Patterns of glucose profiles by drug group (No./%)</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td/><td align=\"left\">&#946;-blockers</td><td align=\"left\">Thiazide</td><td align=\"left\">CCBs</td><td align=\"left\">RAS</td><td align=\"left\">Others</td><td align=\"left\">P (&#967;<sup>2</sup>)</td></tr></thead><tbody><tr><td align=\"left\">Glucose (mmol/l)</td><td align=\"left\">(n = 280)</td><td align=\"left\">(n = 180)</td><td align=\"left\">(n = 291)</td><td align=\"left\">(n = 50)</td><td align=\"left\">(n = 296)</td><td/></tr><tr><td align=\"left\">Desirable (&#8804; 6.0)</td><td align=\"left\">236 (84.3)</td><td align=\"left\">153 (85.0)</td><td align=\"left\">253 (86.9)</td><td align=\"left\">42 (84.0)</td><td align=\"left\">229 (77.4)</td><td align=\"left\">0.849</td></tr><tr><td align=\"left\">Borderline (6.1&#8211;6.9)</td><td align=\"left\">35 (12.5)</td><td align=\"left\">22 (12.2)</td><td align=\"left\">28 (9.6)</td><td align=\"left\">5 (10.0)</td><td align=\"left\">59 (19.9)</td><td/></tr><tr><td align=\"left\">Adverse (&#8805; 7.0)</td><td align=\"left\">9 (3.2)</td><td align=\"left\">5 (2.8)</td><td align=\"left\">10 (3.4)</td><td align=\"left\">3 (6.0)</td><td align=\"left\">8 (2.7)</td><td/></tr></tbody></table></body></html>","text":"Pmid= 2551584:Table= Table 2","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":-218843802,"_task_hash":1477893406,"_view_id":"review","accept":[5],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":null,"sessions":["tableclass-test-params-100-frank","tableclass-test-params-100-gill","tableclass-test-params-100-joe","tableclass-test-params-100-vicky"],"versions":[{"html":"<!DOCTYPE html><html><body><h1>Patterns of glucose profiles by drug group (No./%)</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td/><td align=\"left\">&#946;-blockers</td><td align=\"left\">Thiazide</td><td align=\"left\">CCBs</td><td align=\"left\">RAS</td><td align=\"left\">Others</td><td align=\"left\">P (&#967;<sup>2</sup>)</td></tr></thead><tbody><tr><td align=\"left\">Glucose (mmol/l)</td><td align=\"left\">(n = 280)</td><td align=\"left\">(n = 180)</td><td align=\"left\">(n = 291)</td><td align=\"left\">(n = 50)</td><td align=\"left\">(n = 296)</td><td/></tr><tr><td align=\"left\">Desirable (&#8804; 6.0)</td><td align=\"left\">236 (84.3)</td><td align=\"left\">153 (85.0)</td><td align=\"left\">253 (86.9)</td><td align=\"left\">42 (84.0)</td><td align=\"left\">229 (77.4)</td><td align=\"left\">0.849</td></tr><tr><td align=\"left\">Borderline (6.1&#8211;6.9)</td><td align=\"left\">35 (12.5)</td><td align=\"left\">22 (12.2)</td><td align=\"left\">28 (9.6)</td><td align=\"left\">5 (10.0)</td><td align=\"left\">59 (19.9)</td><td/></tr><tr><td align=\"left\">Adverse (&#8805; 7.0)</td><td align=\"left\">9 (3.2)</td><td align=\"left\">5 (2.8)</td><td align=\"left\">10 (3.4)</td><td align=\"left\">3 (6.0)</td><td align=\"left\">8 (2.7)</td><td/></tr></tbody></table></body></html>","text":"Pmid= 2551584:Table= Table 2","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":-218843802,"_task_hash":1477893406,"_view_id":"choice","accept":[5],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":"tableclass-test-params-100-gill","sessions":["tableclass-test-params-100-frank","tableclass-test-params-100-gill","tableclass-test-params-100-joe","tableclass-test-params-100-vicky"],"default":true}],"view_id":"choice"}
{"html":"<!DOCTYPE html><html><body><h1>The crude hazard ratios of having above borderline and adverse glucose profiles for each antihypertensive drug group</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td/><td align=\"left\">Bivariate Analysis Crude Odds Ratios for above borderline results (95% C.I.) (&#8805; 6.1 mmol/l)</td><td align=\"left\">p value</td><td align=\"left\">Bivariate Analysis Crude Odds Ratios for adverse results (95% C.I.) (&#8805; 7.0 mmol/l)</td><td align=\"left\">p value</td></tr></thead><tbody><tr><td align=\"left\">(1). &#946;-blockers</td><td align=\"left\">0.881 (0.586, 1.323)</td><td align=\"left\">0.540</td><td align=\"left\">0.993 (0.459, 2.150)</td><td align=\"left\">0.986</td></tr><tr><td align=\"left\">(2). Thiazide Diuretics</td><td align=\"left\">0.860 (0.530, 1.397)</td><td align=\"left\">0.543</td><td align=\"left\">0.828 (0.316, 2.168)</td><td align=\"left\">0.700</td></tr><tr><td align=\"left\">(3). CCB</td><td align=\"left\">0.604 (0.390, 0.933)</td><td align=\"left\">0.022</td><td align=\"left\">1.043 (0.494, 2.204)</td><td align=\"left\">0.911</td></tr><tr><td align=\"left\">(4). RAS</td><td align=\"left\">0.720 (0.280, 1.850)</td><td align=\"left\">0.493</td><td align=\"left\">1.944 (0.572, 6.607)</td><td align=\"left\">0.278</td></tr></tbody></table></body></html>","text":"Pmid= 2551584:Table= Table 3","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":-1782266261,"_task_hash":-1484606432,"_view_id":"review","accept":[5],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":null,"sessions":["tableclass-test-params-100-frank","tableclass-test-params-100-gill","tableclass-test-params-100-joe","tableclass-test-params-100-vicky"],"versions":[{"html":"<!DOCTYPE html><html><body><h1>The crude hazard ratios of having above borderline and adverse glucose profiles for each antihypertensive drug group</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td/><td align=\"left\">Bivariate Analysis Crude Odds Ratios for above borderline results (95% C.I.) (&#8805; 6.1 mmol/l)</td><td align=\"left\">p value</td><td align=\"left\">Bivariate Analysis Crude Odds Ratios for adverse results (95% C.I.) (&#8805; 7.0 mmol/l)</td><td align=\"left\">p value</td></tr></thead><tbody><tr><td align=\"left\">(1). &#946;-blockers</td><td align=\"left\">0.881 (0.586, 1.323)</td><td align=\"left\">0.540</td><td align=\"left\">0.993 (0.459, 2.150)</td><td align=\"left\">0.986</td></tr><tr><td align=\"left\">(2). Thiazide Diuretics</td><td align=\"left\">0.860 (0.530, 1.397)</td><td align=\"left\">0.543</td><td align=\"left\">0.828 (0.316, 2.168)</td><td align=\"left\">0.700</td></tr><tr><td align=\"left\">(3). CCB</td><td align=\"left\">0.604 (0.390, 0.933)</td><td align=\"left\">0.022</td><td align=\"left\">1.043 (0.494, 2.204)</td><td align=\"left\">0.911</td></tr><tr><td align=\"left\">(4). RAS</td><td align=\"left\">0.720 (0.280, 1.850)</td><td align=\"left\">0.493</td><td align=\"left\">1.944 (0.572, 6.607)</td><td align=\"left\">0.278</td></tr></tbody></table></body></html>","text":"Pmid= 2551584:Table= Table 3","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":-1782266261,"_task_hash":-1484606432,"_view_id":"choice","accept":[5],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":"tableclass-test-params-100-gill","sessions":["tableclass-test-params-100-frank","tableclass-test-params-100-gill","tableclass-test-params-100-joe","tableclass-test-params-100-vicky"],"default":true}],"view_id":"choice"}
{"html":"<!DOCTYPE html><html><body><h1>Factors associated with hyperglycemia with above borderline and adverse readings*</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td/><td align=\"center\" colspan=\"2\">Above Borderline readings</td><td align=\"center\" colspan=\"2\">Adverse readings</td></tr><tr><td/><td colspan=\"4\"><hr/></td></tr><tr><td/><td align=\"left\">Odds Ratios (95% CI)</td><td align=\"left\">p</td><td align=\"left\">Odds Ratios (95% CI)</td><td align=\"left\">p</td></tr></thead><tbody><tr><td align=\"left\">Age (years)</td><td/><td/><td/><td/></tr><tr><td align=\"left\">&lt;50</td><td align=\"left\">1.0 (ref)</td><td/><td align=\"left\">1.0 (ref)</td><td/></tr><tr><td align=\"left\">50&#8211;59</td><td align=\"left\">1.249 (0.648, 2.408)</td><td align=\"left\">0.506</td><td align=\"left\">1.776 (0.533, 5.919)</td><td align=\"left\">0.349</td></tr><tr><td align=\"left\">60&#8211;69</td><td align=\"left\">1.344 (0.654, 2.759)</td><td align=\"left\">0.421</td><td align=\"left\">0.784 (0.167, 3.685)</td><td align=\"left\">0.758</td></tr><tr><td align=\"left\">&#8805; 70</td><td align=\"left\">2.103 (1.051, 4.207)</td><td align=\"left\">0.036</td><td align=\"left\">1.359 (0.372, 4.962)</td><td align=\"left\">0.643</td></tr><tr><td align=\"left\">Gender</td><td/><td/><td/><td/></tr><tr><td align=\"left\">Male</td><td align=\"left\">1.0 (ref)</td><td/><td align=\"left\">1.0 (ref)</td><td/></tr><tr><td align=\"left\">Female</td><td align=\"left\">1.464 (0.927, 2.313)</td><td align=\"left\">0.102</td><td align=\"left\">0.223 (0.074, 0.674)</td><td align=\"left\">0.008</td></tr><tr><td align=\"left\">Payment status</td><td/><td/><td/><td/></tr><tr><td align=\"left\">Fee waiver</td><td align=\"left\">1.0 (ref)</td><td/><td align=\"left\">1.0 (ref)</td><td/></tr><tr><td align=\"left\">Fee payers</td><td align=\"left\">1.328 (0.789, 2.236)</td><td align=\"left\">0.286</td><td align=\"left\">0.759 (0.320, 1.798)</td><td align=\"left\">0.530</td></tr><tr><td align=\"left\">District of residence</td><td/><td/><td/><td/></tr><tr><td align=\"left\">Shatin</td><td align=\"left\">1.0 (ref)</td><td/><td align=\"left\">1.0 (ref)</td><td/></tr><tr><td align=\"left\">Taipo</td><td align=\"left\">0.967 (0.433, 2.156)</td><td align=\"left\">0.934</td><td align=\"left\">1.676 (0.588, 4.778)</td><td align=\"left\">0.334</td></tr><tr><td align=\"left\">North</td><td align=\"left\">0.707 (0.392, 1.273)</td><td align=\"left\">0.248</td><td align=\"left\">0.311 (0.115, 0.841)</td><td align=\"left\">0.021</td></tr><tr><td align=\"left\">Others</td><td align=\"left\">0.909 (0.363, 2.279)</td><td align=\"left\">0.839</td><td align=\"left\">N/A</td><td align=\"left\">N/A</td></tr><tr><td align=\"left\">Clinics</td><td/><td/><td/><td/></tr><tr><td align=\"left\">GOPC</td><td align=\"left\">1.0 (ref)</td><td/><td/><td/></tr><tr><td align=\"left\">FMSC</td><td align=\"left\">0.652 (0.234, 1.818)</td><td align=\"left\">0.414</td><td align=\"left\">0.299 (0.036, 2.507)</td><td align=\"left\">0.266</td></tr><tr><td align=\"left\">Staff clinics</td><td align=\"left\">2.071 (0.717, 5.984)</td><td align=\"left\">0.179</td><td align=\"left\">0.614 (0.066, 5.732)</td><td align=\"left\">0.668</td></tr><tr><td align=\"left\">Drug class</td><td/><td/><td/><td/></tr><tr><td align=\"left\">RAS</td><td align=\"left\">1.0 (ref)</td><td/><td align=\"left\">1.0 (ref)</td><td/></tr><tr><td align=\"left\">&#946;-blockers</td><td align=\"left\">1.360 (0.497, 3.721)</td><td align=\"left\">0.549</td><td align=\"left\">0.518 (0.125, 2.151)</td><td align=\"left\">0.365</td></tr><tr><td align=\"left\">Thiazide</td><td align=\"left\">1.252 (0.443, 3.537)</td><td align=\"left\">0.672</td><td align=\"left\">0.466 (0.099, 2.190)</td><td align=\"left\">0.334</td></tr><tr><td align=\"left\">CCB</td><td align=\"left\">0.888 (0.320, 2.463)</td><td align=\"left\">0.819</td><td align=\"left\">0.575 (0.140, 2.353)</td><td align=\"left\">0.441</td></tr></tbody></table></body></html>","text":"Pmid= 2551584:Table= Table 4","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":2111141017,"_task_hash":-438219585,"_view_id":"review","accept":[5],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":null,"sessions":["tableclass-test-params-100-frank","tableclass-test-params-100-gill","tableclass-test-params-100-joe","tableclass-test-params-100-vicky"],"versions":[{"html":"<!DOCTYPE html><html><body><h1>Factors associated with hyperglycemia with above borderline and adverse readings*</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td/><td align=\"center\" colspan=\"2\">Above Borderline readings</td><td align=\"center\" colspan=\"2\">Adverse readings</td></tr><tr><td/><td colspan=\"4\"><hr/></td></tr><tr><td/><td align=\"left\">Odds Ratios (95% CI)</td><td align=\"left\">p</td><td align=\"left\">Odds Ratios (95% CI)</td><td align=\"left\">p</td></tr></thead><tbody><tr><td align=\"left\">Age (years)</td><td/><td/><td/><td/></tr><tr><td align=\"left\">&lt;50</td><td align=\"left\">1.0 (ref)</td><td/><td align=\"left\">1.0 (ref)</td><td/></tr><tr><td align=\"left\">50&#8211;59</td><td align=\"left\">1.249 (0.648, 2.408)</td><td align=\"left\">0.506</td><td align=\"left\">1.776 (0.533, 5.919)</td><td align=\"left\">0.349</td></tr><tr><td align=\"left\">60&#8211;69</td><td align=\"left\">1.344 (0.654, 2.759)</td><td align=\"left\">0.421</td><td align=\"left\">0.784 (0.167, 3.685)</td><td align=\"left\">0.758</td></tr><tr><td align=\"left\">&#8805; 70</td><td align=\"left\">2.103 (1.051, 4.207)</td><td align=\"left\">0.036</td><td align=\"left\">1.359 (0.372, 4.962)</td><td align=\"left\">0.643</td></tr><tr><td align=\"left\">Gender</td><td/><td/><td/><td/></tr><tr><td align=\"left\">Male</td><td align=\"left\">1.0 (ref)</td><td/><td align=\"left\">1.0 (ref)</td><td/></tr><tr><td align=\"left\">Female</td><td align=\"left\">1.464 (0.927, 2.313)</td><td align=\"left\">0.102</td><td align=\"left\">0.223 (0.074, 0.674)</td><td align=\"left\">0.008</td></tr><tr><td align=\"left\">Payment status</td><td/><td/><td/><td/></tr><tr><td align=\"left\">Fee waiver</td><td align=\"left\">1.0 (ref)</td><td/><td align=\"left\">1.0 (ref)</td><td/></tr><tr><td align=\"left\">Fee payers</td><td align=\"left\">1.328 (0.789, 2.236)</td><td align=\"left\">0.286</td><td align=\"left\">0.759 (0.320, 1.798)</td><td align=\"left\">0.530</td></tr><tr><td align=\"left\">District of residence</td><td/><td/><td/><td/></tr><tr><td align=\"left\">Shatin</td><td align=\"left\">1.0 (ref)</td><td/><td align=\"left\">1.0 (ref)</td><td/></tr><tr><td align=\"left\">Taipo</td><td align=\"left\">0.967 (0.433, 2.156)</td><td align=\"left\">0.934</td><td align=\"left\">1.676 (0.588, 4.778)</td><td align=\"left\">0.334</td></tr><tr><td align=\"left\">North</td><td align=\"left\">0.707 (0.392, 1.273)</td><td align=\"left\">0.248</td><td align=\"left\">0.311 (0.115, 0.841)</td><td align=\"left\">0.021</td></tr><tr><td align=\"left\">Others</td><td align=\"left\">0.909 (0.363, 2.279)</td><td align=\"left\">0.839</td><td align=\"left\">N/A</td><td align=\"left\">N/A</td></tr><tr><td align=\"left\">Clinics</td><td/><td/><td/><td/></tr><tr><td align=\"left\">GOPC</td><td align=\"left\">1.0 (ref)</td><td/><td/><td/></tr><tr><td align=\"left\">FMSC</td><td align=\"left\">0.652 (0.234, 1.818)</td><td align=\"left\">0.414</td><td align=\"left\">0.299 (0.036, 2.507)</td><td align=\"left\">0.266</td></tr><tr><td align=\"left\">Staff clinics</td><td align=\"left\">2.071 (0.717, 5.984)</td><td align=\"left\">0.179</td><td align=\"left\">0.614 (0.066, 5.732)</td><td align=\"left\">0.668</td></tr><tr><td align=\"left\">Drug class</td><td/><td/><td/><td/></tr><tr><td align=\"left\">RAS</td><td align=\"left\">1.0 (ref)</td><td/><td align=\"left\">1.0 (ref)</td><td/></tr><tr><td align=\"left\">&#946;-blockers</td><td align=\"left\">1.360 (0.497, 3.721)</td><td align=\"left\">0.549</td><td align=\"left\">0.518 (0.125, 2.151)</td><td align=\"left\">0.365</td></tr><tr><td align=\"left\">Thiazide</td><td align=\"left\">1.252 (0.443, 3.537)</td><td align=\"left\">0.672</td><td align=\"left\">0.466 (0.099, 2.190)</td><td align=\"left\">0.334</td></tr><tr><td align=\"left\">CCB</td><td align=\"left\">0.888 (0.320, 2.463)</td><td align=\"left\">0.819</td><td align=\"left\">0.575 (0.140, 2.353)</td><td align=\"left\">0.441</td></tr></tbody></table></body></html>","text":"Pmid= 2551584:Table= Table 4","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":2111141017,"_task_hash":-438219585,"_view_id":"choice","accept":[5],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":"tableclass-test-params-100-gill","sessions":["tableclass-test-params-100-frank","tableclass-test-params-100-gill","tableclass-test-params-100-joe","tableclass-test-params-100-vicky"],"default":true}],"view_id":"choice"}
{"html":"<!DOCTYPE html><html><body><h1>Characteristics of doctors who returned a filled-in questionnaire.</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td/><td/><td align=\"center\">n (%)</td></tr></thead><tbody><tr><td align=\"left\">Male/female</td><td/><td align=\"center\">321/277 (54/46)</td></tr><tr><td colspan=\"3\"><hr/></td></tr><tr><td align=\"left\">Type of organization</td><td align=\"left\">Publicly run multi-doctor-unit</td><td align=\"center\">486 (82)</td></tr><tr><td/><td align=\"left\">Privately run multi-doctor-unit</td><td align=\"center\">76 (13)</td></tr><tr><td/><td align=\"left\">Business of one\\'s own</td><td align=\"center\">32 (5)</td></tr><tr><td colspan=\"3\"><hr/></td></tr><tr><td align=\"left\">Level of doctor competence</td><td align=\"left\">Specialist in primary health care</td><td align=\"center\">430 (72)</td></tr><tr><td/><td align=\"left\">Resident</td><td align=\"center\">100 (17)</td></tr><tr><td/><td align=\"left\">Intern</td><td align=\"center\">30 (5)</td></tr><tr><td/><td align=\"left\">Any other competence</td><td align=\"center\">40 (7)</td></tr></tbody></table></body></html>","text":"Pmid= 2556993:Table= Table 1","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":-231303107,"_task_hash":1943509452,"_view_id":"review","accept":[5],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":null,"sessions":["tableclass-test-params-100-frank","tableclass-test-params-100-gill","tableclass-test-params-100-joe","tableclass-test-params-100-vicky"],"versions":[{"html":"<!DOCTYPE html><html><body><h1>Characteristics of doctors who returned a filled-in questionnaire.</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td/><td/><td align=\"center\">n (%)</td></tr></thead><tbody><tr><td align=\"left\">Male/female</td><td/><td align=\"center\">321/277 (54/46)</td></tr><tr><td colspan=\"3\"><hr/></td></tr><tr><td align=\"left\">Type of organization</td><td align=\"left\">Publicly run multi-doctor-unit</td><td align=\"center\">486 (82)</td></tr><tr><td/><td align=\"left\">Privately run multi-doctor-unit</td><td align=\"center\">76 (13)</td></tr><tr><td/><td align=\"left\">Business of one\\'s own</td><td align=\"center\">32 (5)</td></tr><tr><td colspan=\"3\"><hr/></td></tr><tr><td align=\"left\">Level of doctor competence</td><td align=\"left\">Specialist in primary health care</td><td align=\"center\">430 (72)</td></tr><tr><td/><td align=\"left\">Resident</td><td align=\"center\">100 (17)</td></tr><tr><td/><td align=\"left\">Intern</td><td align=\"center\">30 (5)</td></tr><tr><td/><td align=\"left\">Any other competence</td><td align=\"center\">40 (7)</td></tr></tbody></table></body></html>","text":"Pmid= 2556993:Table= Table 1","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":-231303107,"_task_hash":1943509452,"_view_id":"choice","accept":[5],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":"tableclass-test-params-100-gill","sessions":["tableclass-test-params-100-frank","tableclass-test-params-100-gill","tableclass-test-params-100-joe","tableclass-test-params-100-vicky"],"default":true}],"view_id":"choice"}
{"html":"<!DOCTYPE html><html><body><h1>Use of the drug recommendations varies with both type of organization and level of competence.</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td/><td align=\"left\">Prescribing of a drug for a new diagnosis</td><td align=\"left\">P-value*</td><td align=\"left\">Active change to a recommended drug upon renewal of a prescription</td><td align=\"left\">P-value*</td></tr></thead><tbody><tr><td align=\"left\">Publicly run units</td><td align=\"left\">80 (76&#8211;90)</td><td/><td align=\"left\">50 (20&#8211;70)</td><td/></tr><tr><td align=\"left\">Privately run units</td><td align=\"left\">80 (75&#8211;90)</td><td/><td align=\"left\">50 (20&#8211;79)</td><td/></tr><tr><td align=\"left\">Own business</td><td align=\"left\">65 (50&#8211;80)</td><td align=\"left\">0.0003</td><td align=\"left\">22 (11&#8211;50)</td><td align=\"left\">0.048</td></tr><tr><td colspan=\"5\"><hr/></td></tr><tr><td align=\"left\">Specialists</td><td align=\"left\">80 (75&#8211;90)</td><td/><td align=\"left\">50 (25&#8211;75)</td><td/></tr><tr><td align=\"left\">Residents</td><td align=\"left\">80 (72&#8211;90)</td><td/><td align=\"left\">30 (10&#8211;50)</td><td/></tr><tr><td align=\"left\">Interns</td><td align=\"left\">80 (55&#8211;90)</td><td align=\"left\">0.81</td><td align=\"left\">10 (0&#8211;28)</td><td align=\"left\">10<sup>-10</sup></td></tr></tbody></table></body></html>","text":"Pmid= 2556993:Table= Table 2","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":-385649243,"_task_hash":-250832422,"_view_id":"review","accept":[5],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":null,"sessions":["tableclass-test-params-100-frank","tableclass-test-params-100-gill","tableclass-test-params-100-joe","tableclass-test-params-100-vicky"],"versions":[{"html":"<!DOCTYPE html><html><body><h1>Use of the drug recommendations varies with both type of organization and level of competence.</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td/><td align=\"left\">Prescribing of a drug for a new diagnosis</td><td align=\"left\">P-value*</td><td align=\"left\">Active change to a recommended drug upon renewal of a prescription</td><td align=\"left\">P-value*</td></tr></thead><tbody><tr><td align=\"left\">Publicly run units</td><td align=\"left\">80 (76&#8211;90)</td><td/><td align=\"left\">50 (20&#8211;70)</td><td/></tr><tr><td align=\"left\">Privately run units</td><td align=\"left\">80 (75&#8211;90)</td><td/><td align=\"left\">50 (20&#8211;79)</td><td/></tr><tr><td align=\"left\">Own business</td><td align=\"left\">65 (50&#8211;80)</td><td align=\"left\">0.0003</td><td align=\"left\">22 (11&#8211;50)</td><td align=\"left\">0.048</td></tr><tr><td colspan=\"5\"><hr/></td></tr><tr><td align=\"left\">Specialists</td><td align=\"left\">80 (75&#8211;90)</td><td/><td align=\"left\">50 (25&#8211;75)</td><td/></tr><tr><td align=\"left\">Residents</td><td align=\"left\">80 (72&#8211;90)</td><td/><td align=\"left\">30 (10&#8211;50)</td><td/></tr><tr><td align=\"left\">Interns</td><td align=\"left\">80 (55&#8211;90)</td><td align=\"left\">0.81</td><td align=\"left\">10 (0&#8211;28)</td><td align=\"left\">10<sup>-10</sup></td></tr></tbody></table></body></html>","text":"Pmid= 2556993:Table= Table 2","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":-385649243,"_task_hash":-250832422,"_view_id":"choice","accept":[5],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":"tableclass-test-params-100-gill","sessions":["tableclass-test-params-100-frank","tableclass-test-params-100-gill","tableclass-test-params-100-joe","tableclass-test-params-100-vicky"],"default":true}],"view_id":"choice"}
{"html":"<!DOCTYPE html><html><body><h1>Characteristics of participants</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td/><td align=\"left\"><bold>Cisplatin</bold></td><td align=\"left\"><bold>Oxaliplatin</bold></td></tr></thead><tbody><tr><td align=\"left\">Gender (m/f)</td><td align=\"left\">13 m/7 f</td><td align=\"left\">20 m/5 f</td></tr><tr><td align=\"left\">Age at time of follow-up (median)</td><td align=\"left\">49 years</td><td align=\"left\">64 years</td></tr><tr><td align=\"left\">Duration of follow-up</td><td align=\"left\">18&#8211;75 months (median 41)</td><td align=\"left\">8&#8211;33 months (median 18)</td></tr><tr><td align=\"left\">Tumour type</td><td align=\"left\">Testicular carcinoma (9)</td><td align=\"left\">Colorectal carcinoma (25)</td></tr><tr><td/><td align=\"left\">Yolk sac carcinoma (1)</td><td/></tr><tr><td/><td align=\"left\">Non small cell lung cancer (1)</td><td/></tr><tr><td/><td align=\"left\">Small cell lung cancer (1)</td><td/></tr><tr><td/><td align=\"left\">Head and neck carcinoma (8)</td><td/></tr><tr><td align=\"left\">Cumulative dose</td><td align=\"left\">300&#8211;600 mg/m<sup>2 </sup>cisplatin (median 350)</td><td align=\"left\">585&#8211;1170 mg/m<sup>2 </sup>oxaliplatin (median 878)</td></tr><tr><td/><td align=\"left\">195&#8211;390 mg/m<sup>2 </sup>Pt</td><td align=\"left\">287&#8211;575 mg/m<sup>2 </sup>Pt</td></tr><tr><td/><td align=\"left\">(median 227)</td><td align=\"left\">(median 431)</td></tr><tr><td align=\"left\">Sodium thiosulfate</td><td align=\"left\">5 head and neck carcinoma patients treated intra-arterially with 600 mg/m<sup>2 </sup>cisplatin</td><td align=\"left\">NA</td></tr><tr><td align=\"left\">Ca/Mg infusion</td><td align=\"left\">NA</td><td align=\"left\">24/25</td></tr><tr><td align=\"left\">GSTM1</td><td align=\"left\">8/20 positive, 12/20 negative</td><td align=\"left\">10/25 positive, 15/25 negative</td></tr><tr><td align=\"left\">GSTT1</td><td align=\"left\">17/20 wildtype, 3/20 negative</td><td align=\"left\">21/25 positive, 4/25 negative</td></tr><tr><td align=\"left\">GSTP1</td><td align=\"left\">12/20<sup>105</sup>Ile/<sup>105</sup>Ile-<italic>GSTP1</italic></td><td align=\"left\">9/25<sup>105</sup>Ile/<sup>105</sup>Ile-<italic>GSTP1</italic></td></tr><tr><td/><td align=\"left\">7/20<sup>105</sup>Val/<sup>105</sup>Ile-<italic>GSTP1</italic></td><td align=\"left\">10/25<sup>105</sup>Val/<sup>105</sup>Ile-<italic>GSTP1</italic></td></tr><tr><td/><td align=\"left\">1/20<sup>105</sup>Val/<sup>105</sup>Val-<italic>GSTP1</italic></td><td align=\"left\">6/25<sup>105</sup>Val/<sup>105</sup>Val-<italic>GSTP1</italic></td></tr></tbody></table></body></html>","text":"Pmid= 2559818:Table= Table 1","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":215178517,"_task_hash":1472983334,"_view_id":"review","accept":[5],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":null,"sessions":["tableclass-test-params-100-frank","tableclass-test-params-100-gill","tableclass-test-params-100-joe","tableclass-test-params-100-vicky"],"versions":[{"html":"<!DOCTYPE html><html><body><h1>Characteristics of participants</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td/><td align=\"left\"><bold>Cisplatin</bold></td><td align=\"left\"><bold>Oxaliplatin</bold></td></tr></thead><tbody><tr><td align=\"left\">Gender (m/f)</td><td align=\"left\">13 m/7 f</td><td align=\"left\">20 m/5 f</td></tr><tr><td align=\"left\">Age at time of follow-up (median)</td><td align=\"left\">49 years</td><td align=\"left\">64 years</td></tr><tr><td align=\"left\">Duration of follow-up</td><td align=\"left\">18&#8211;75 months (median 41)</td><td align=\"left\">8&#8211;33 months (median 18)</td></tr><tr><td align=\"left\">Tumour type</td><td align=\"left\">Testicular carcinoma (9)</td><td align=\"left\">Colorectal carcinoma (25)</td></tr><tr><td/><td align=\"left\">Yolk sac carcinoma (1)</td><td/></tr><tr><td/><td align=\"left\">Non small cell lung cancer (1)</td><td/></tr><tr><td/><td align=\"left\">Small cell lung cancer (1)</td><td/></tr><tr><td/><td align=\"left\">Head and neck carcinoma (8)</td><td/></tr><tr><td align=\"left\">Cumulative dose</td><td align=\"left\">300&#8211;600 mg/m<sup>2 </sup>cisplatin (median 350)</td><td align=\"left\">585&#8211;1170 mg/m<sup>2 </sup>oxaliplatin (median 878)</td></tr><tr><td/><td align=\"left\">195&#8211;390 mg/m<sup>2 </sup>Pt</td><td align=\"left\">287&#8211;575 mg/m<sup>2 </sup>Pt</td></tr><tr><td/><td align=\"left\">(median 227)</td><td align=\"left\">(median 431)</td></tr><tr><td align=\"left\">Sodium thiosulfate</td><td align=\"left\">5 head and neck carcinoma patients treated intra-arterially with 600 mg/m<sup>2 </sup>cisplatin</td><td align=\"left\">NA</td></tr><tr><td align=\"left\">Ca/Mg infusion</td><td align=\"left\">NA</td><td align=\"left\">24/25</td></tr><tr><td align=\"left\">GSTM1</td><td align=\"left\">8/20 positive, 12/20 negative</td><td align=\"left\">10/25 positive, 15/25 negative</td></tr><tr><td align=\"left\">GSTT1</td><td align=\"left\">17/20 wildtype, 3/20 negative</td><td align=\"left\">21/25 positive, 4/25 negative</td></tr><tr><td align=\"left\">GSTP1</td><td align=\"left\">12/20<sup>105</sup>Ile/<sup>105</sup>Ile-<italic>GSTP1</italic></td><td align=\"left\">9/25<sup>105</sup>Ile/<sup>105</sup>Ile-<italic>GSTP1</italic></td></tr><tr><td/><td align=\"left\">7/20<sup>105</sup>Val/<sup>105</sup>Ile-<italic>GSTP1</italic></td><td align=\"left\">10/25<sup>105</sup>Val/<sup>105</sup>Ile-<italic>GSTP1</italic></td></tr><tr><td/><td align=\"left\">1/20<sup>105</sup>Val/<sup>105</sup>Val-<italic>GSTP1</italic></td><td align=\"left\">6/25<sup>105</sup>Val/<sup>105</sup>Val-<italic>GSTP1</italic></td></tr></tbody></table></body></html>","text":"Pmid= 2559818:Table= Table 1","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":215178517,"_task_hash":1472983334,"_view_id":"choice","accept":[5],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":"tableclass-test-params-100-gill","sessions":["tableclass-test-params-100-frank","tableclass-test-params-100-gill","tableclass-test-params-100-joe","tableclass-test-params-100-vicky"],"default":true}],"view_id":"choice"}
{"html":"<!DOCTYPE html><html><body><h1>Pt concentrations in eight pUF samples before and after storage</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td align=\"left\"><bold>Compound</bold></td><td align=\"center\"><bold>Percentage of plasma Pt recovered in pUF before storage</bold></td><td align=\"center\"><bold>Percentage of plasma Pt recovered in pUF after storage</bold></td><td align=\"center\"><bold>Days of storage</bold></td></tr></thead><tbody><tr><td align=\"left\">Cisplatin</td><td align=\"center\">19.4</td><td align=\"center\">8.1</td><td align=\"center\">278</td></tr><tr><td/><td align=\"center\">19.7</td><td align=\"center\">8.4</td><td align=\"center\">278</td></tr><tr><td/><td align=\"center\">15.1</td><td align=\"center\">5.5</td><td align=\"center\">276</td></tr><tr><td/><td align=\"center\">12.3</td><td align=\"center\">7.4</td><td align=\"center\">276</td></tr><tr><td align=\"left\">Oxaliplatin</td><td align=\"center\">27.8</td><td align=\"center\">21.2</td><td align=\"center\">180</td></tr><tr><td/><td align=\"center\">25.9</td><td align=\"center\">16</td><td align=\"center\">161</td></tr><tr><td/><td align=\"center\">22.9</td><td align=\"center\">15.8</td><td align=\"center\">157</td></tr><tr><td/><td align=\"center\">28.2</td><td align=\"center\">25.2</td><td align=\"center\">144</td></tr></tbody></table></body></html>","text":"Pmid= 2559818:Table= Table 2","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":1417598459,"_task_hash":742731448,"_view_id":"review","accept":[5],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":null,"sessions":["tableclass-test-params-100-frank","tableclass-test-params-100-joe","tableclass-test-params-100-vicky"],"versions":[{"html":"<!DOCTYPE html><html><body><h1>Pt concentrations in eight pUF samples before and after storage</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td align=\"left\"><bold>Compound</bold></td><td align=\"center\"><bold>Percentage of plasma Pt recovered in pUF before storage</bold></td><td align=\"center\"><bold>Percentage of plasma Pt recovered in pUF after storage</bold></td><td align=\"center\"><bold>Days of storage</bold></td></tr></thead><tbody><tr><td align=\"left\">Cisplatin</td><td align=\"center\">19.4</td><td align=\"center\">8.1</td><td align=\"center\">278</td></tr><tr><td/><td align=\"center\">19.7</td><td align=\"center\">8.4</td><td align=\"center\">278</td></tr><tr><td/><td align=\"center\">15.1</td><td align=\"center\">5.5</td><td align=\"center\">276</td></tr><tr><td/><td align=\"center\">12.3</td><td align=\"center\">7.4</td><td align=\"center\">276</td></tr><tr><td align=\"left\">Oxaliplatin</td><td align=\"center\">27.8</td><td align=\"center\">21.2</td><td align=\"center\">180</td></tr><tr><td/><td align=\"center\">25.9</td><td align=\"center\">16</td><td align=\"center\">161</td></tr><tr><td/><td align=\"center\">22.9</td><td align=\"center\">15.8</td><td align=\"center\">157</td></tr><tr><td/><td align=\"center\">28.2</td><td align=\"center\">25.2</td><td align=\"center\">144</td></tr></tbody></table></body></html>","text":"Pmid= 2559818:Table= Table 2","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":1417598459,"_task_hash":1532529373,"_view_id":"choice","accept":[4],"config":{"choice_style":"multiple"},"user_input":"Debatable - I wouldn't class  concentrations as a parameter (Cmax being the obvious exception), but plasma concs are clearly related to PK.  I've chosen cat. 4, but could have just as easily chosen cat. 5","answer":"accept","_session_id":"tableclass-test-params-100-gill","sessions":["tableclass-test-params-100-gill"],"default":false},{"html":"<!DOCTYPE html><html><body><h1>Pt concentrations in eight pUF samples before and after storage</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td align=\"left\"><bold>Compound</bold></td><td align=\"center\"><bold>Percentage of plasma Pt recovered in pUF before storage</bold></td><td align=\"center\"><bold>Percentage of plasma Pt recovered in pUF after storage</bold></td><td align=\"center\"><bold>Days of storage</bold></td></tr></thead><tbody><tr><td align=\"left\">Cisplatin</td><td align=\"center\">19.4</td><td align=\"center\">8.1</td><td align=\"center\">278</td></tr><tr><td/><td align=\"center\">19.7</td><td align=\"center\">8.4</td><td align=\"center\">278</td></tr><tr><td/><td align=\"center\">15.1</td><td align=\"center\">5.5</td><td align=\"center\">276</td></tr><tr><td/><td align=\"center\">12.3</td><td align=\"center\">7.4</td><td align=\"center\">276</td></tr><tr><td align=\"left\">Oxaliplatin</td><td align=\"center\">27.8</td><td align=\"center\">21.2</td><td align=\"center\">180</td></tr><tr><td/><td align=\"center\">25.9</td><td align=\"center\">16</td><td align=\"center\">161</td></tr><tr><td/><td align=\"center\">22.9</td><td align=\"center\">15.8</td><td align=\"center\">157</td></tr><tr><td/><td align=\"center\">28.2</td><td align=\"center\">25.2</td><td align=\"center\">144</td></tr></tbody></table></body></html>","text":"Pmid= 2559818:Table= Table 2","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":1417598459,"_task_hash":742731448,"_view_id":"choice","accept":[5],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":"tableclass-test-params-100-frank","sessions":["tableclass-test-params-100-frank","tableclass-test-params-100-joe","tableclass-test-params-100-vicky"],"default":true}],"view_id":"choice"}
{"html":"<!DOCTYPE html><html><body><h1>Pt concentrations in eight pUF samples with and without incubation with STS</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td align=\"left\"><bold>Compound</bold></td><td align=\"center\"><bold>Percentage of plasma Pt recovered in pUF</bold></td><td align=\"center\"><bold>Percentage of plasma Pt recovered in pUF after STS incubation</bold></td><td align=\"center\"><bold>Factor increase of Pt in pUF after STS incubation</bold></td></tr></thead><tbody><tr><td align=\"left\">Cisplatin</td><td align=\"center\">12.4</td><td align=\"center\">17.5</td><td align=\"center\">1.4-fold</td></tr><tr><td/><td align=\"center\">12.7</td><td align=\"center\">34.9</td><td align=\"center\">2.7-fold</td></tr><tr><td/><td align=\"center\">13.2</td><td align=\"center\">30.7</td><td align=\"center\">2.3-fold</td></tr><tr><td/><td align=\"center\">12.5</td><td align=\"center\">36.6</td><td align=\"center\">2.9-fold</td></tr><tr><td align=\"left\">Oxaliplatin</td><td align=\"center\">32.2</td><td align=\"center\">46.2</td><td align=\"center\">1.4-fold</td></tr><tr><td/><td align=\"center\">20</td><td align=\"center\">39.5</td><td align=\"center\">2.0-fold</td></tr><tr><td/><td align=\"center\">26.5</td><td align=\"center\">38.7</td><td align=\"center\">1.5-fold</td></tr><tr><td/><td align=\"center\">27.2</td><td align=\"center\">40.4</td><td align=\"center\">1.5-fold</td></tr></tbody></table></body></html>","text":"Pmid= 2559818:Table= Table 3","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":1246861322,"_task_hash":-624839623,"_view_id":"review","accept":[5],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":null,"sessions":["tableclass-test-params-100-frank","tableclass-test-params-100-joe","tableclass-test-params-100-vicky"],"versions":[{"html":"<!DOCTYPE html><html><body><h1>Pt concentrations in eight pUF samples with and without incubation with STS</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td align=\"left\"><bold>Compound</bold></td><td align=\"center\"><bold>Percentage of plasma Pt recovered in pUF</bold></td><td align=\"center\"><bold>Percentage of plasma Pt recovered in pUF after STS incubation</bold></td><td align=\"center\"><bold>Factor increase of Pt in pUF after STS incubation</bold></td></tr></thead><tbody><tr><td align=\"left\">Cisplatin</td><td align=\"center\">12.4</td><td align=\"center\">17.5</td><td align=\"center\">1.4-fold</td></tr><tr><td/><td align=\"center\">12.7</td><td align=\"center\">34.9</td><td align=\"center\">2.7-fold</td></tr><tr><td/><td align=\"center\">13.2</td><td align=\"center\">30.7</td><td align=\"center\">2.3-fold</td></tr><tr><td/><td align=\"center\">12.5</td><td align=\"center\">36.6</td><td align=\"center\">2.9-fold</td></tr><tr><td align=\"left\">Oxaliplatin</td><td align=\"center\">32.2</td><td align=\"center\">46.2</td><td align=\"center\">1.4-fold</td></tr><tr><td/><td align=\"center\">20</td><td align=\"center\">39.5</td><td align=\"center\">2.0-fold</td></tr><tr><td/><td align=\"center\">26.5</td><td align=\"center\">38.7</td><td align=\"center\">1.5-fold</td></tr><tr><td/><td align=\"center\">27.2</td><td align=\"center\">40.4</td><td align=\"center\">1.5-fold</td></tr></tbody></table></body></html>","text":"Pmid= 2559818:Table= Table 3","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":1246861322,"_task_hash":-2022148725,"_view_id":"choice","accept":[4],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":"tableclass-test-params-100-gill","sessions":["tableclass-test-params-100-gill"],"default":false},{"html":"<!DOCTYPE html><html><body><h1>Pt concentrations in eight pUF samples with and without incubation with STS</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td align=\"left\"><bold>Compound</bold></td><td align=\"center\"><bold>Percentage of plasma Pt recovered in pUF</bold></td><td align=\"center\"><bold>Percentage of plasma Pt recovered in pUF after STS incubation</bold></td><td align=\"center\"><bold>Factor increase of Pt in pUF after STS incubation</bold></td></tr></thead><tbody><tr><td align=\"left\">Cisplatin</td><td align=\"center\">12.4</td><td align=\"center\">17.5</td><td align=\"center\">1.4-fold</td></tr><tr><td/><td align=\"center\">12.7</td><td align=\"center\">34.9</td><td align=\"center\">2.7-fold</td></tr><tr><td/><td align=\"center\">13.2</td><td align=\"center\">30.7</td><td align=\"center\">2.3-fold</td></tr><tr><td/><td align=\"center\">12.5</td><td align=\"center\">36.6</td><td align=\"center\">2.9-fold</td></tr><tr><td align=\"left\">Oxaliplatin</td><td align=\"center\">32.2</td><td align=\"center\">46.2</td><td align=\"center\">1.4-fold</td></tr><tr><td/><td align=\"center\">20</td><td align=\"center\">39.5</td><td align=\"center\">2.0-fold</td></tr><tr><td/><td align=\"center\">26.5</td><td align=\"center\">38.7</td><td align=\"center\">1.5-fold</td></tr><tr><td/><td align=\"center\">27.2</td><td align=\"center\">40.4</td><td align=\"center\">1.5-fold</td></tr></tbody></table></body></html>","text":"Pmid= 2559818:Table= Table 3","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":1246861322,"_task_hash":-624839623,"_view_id":"choice","accept":[5],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":"tableclass-test-params-100-frank","sessions":["tableclass-test-params-100-frank","tableclass-test-params-100-joe","tableclass-test-params-100-vicky"],"default":true}],"view_id":"choice"}
{"html":"<!DOCTYPE html><html><body><h1>Frequency of review of medication charts on general medicine rounds</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td/><td align=\"center\"><bold>No. of Patients Seen on Ward Round</bold></td><td align=\"center\"><bold>Frequency of Medication Chart Review</bold></td></tr></thead><tbody><tr><td align=\"left\"><bold>Routine Ward Rounds</bold></td><td/><td/></tr><tr><td align=\"left\">A</td><td align=\"center\">7</td><td align=\"center\">100%</td></tr><tr><td align=\"left\">B</td><td align=\"center\">15</td><td align=\"center\">87%</td></tr><tr><td align=\"left\">C</td><td align=\"center\">8</td><td align=\"center\">87%</td></tr><tr><td align=\"left\">D</td><td align=\"center\">11</td><td align=\"center\">82%</td></tr><tr><td align=\"left\">E</td><td align=\"center\">6</td><td align=\"center\">67%</td></tr><tr><td align=\"left\">F</td><td align=\"center\">8</td><td align=\"center\">75%</td></tr><tr><td align=\"left\">G</td><td align=\"center\">11</td><td align=\"center\">73%</td></tr><tr><td align=\"left\">H</td><td align=\"center\">11</td><td align=\"center\">45%</td></tr><tr><td align=\"left\">Mean</td><td align=\"center\">10</td><td align=\"center\">77%</td></tr><tr><td/><td/><td/></tr><tr><td align=\"left\"><bold>Post Admission Rounds</bold></td><td/><td/></tr><tr><td align=\"left\">A</td><td align=\"center\">15</td><td align=\"center\">80%</td></tr><tr><td align=\"left\">B</td><td align=\"center\">12</td><td align=\"center\">67%</td></tr><tr><td align=\"left\">C</td><td align=\"center\">17</td><td align=\"center\">41%</td></tr><tr><td align=\"left\">D</td><td align=\"center\">17</td><td align=\"center\">76%</td></tr><tr><td align=\"left\">E</td><td align=\"center\">11</td><td align=\"center\">64%</td></tr><tr><td align=\"left\">F</td><td align=\"center\">17</td><td align=\"center\">76%</td></tr><tr><td align=\"left\">G</td><td align=\"center\">12</td><td align=\"center\">50%</td></tr><tr><td align=\"left\">H</td><td align=\"center\">21</td><td align=\"center\">67%</td></tr><tr><td align=\"left\">Mean</td><td align=\"center\">15</td><td align=\"center\">65%</td></tr></tbody></table></body></html>","text":"Pmid= 2566971:Table= Table 1","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":-1038499663,"_task_hash":651066376,"_view_id":"review","accept":[5],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":null,"sessions":["tableclass-test-params-100-frank","tableclass-test-params-100-gill","tableclass-test-params-100-joe","tableclass-test-params-100-vicky"],"versions":[{"html":"<!DOCTYPE html><html><body><h1>Frequency of review of medication charts on general medicine rounds</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td/><td align=\"center\"><bold>No. of Patients Seen on Ward Round</bold></td><td align=\"center\"><bold>Frequency of Medication Chart Review</bold></td></tr></thead><tbody><tr><td align=\"left\"><bold>Routine Ward Rounds</bold></td><td/><td/></tr><tr><td align=\"left\">A</td><td align=\"center\">7</td><td align=\"center\">100%</td></tr><tr><td align=\"left\">B</td><td align=\"center\">15</td><td align=\"center\">87%</td></tr><tr><td align=\"left\">C</td><td align=\"center\">8</td><td align=\"center\">87%</td></tr><tr><td align=\"left\">D</td><td align=\"center\">11</td><td align=\"center\">82%</td></tr><tr><td align=\"left\">E</td><td align=\"center\">6</td><td align=\"center\">67%</td></tr><tr><td align=\"left\">F</td><td align=\"center\">8</td><td align=\"center\">75%</td></tr><tr><td align=\"left\">G</td><td align=\"center\">11</td><td align=\"center\">73%</td></tr><tr><td align=\"left\">H</td><td align=\"center\">11</td><td align=\"center\">45%</td></tr><tr><td align=\"left\">Mean</td><td align=\"center\">10</td><td align=\"center\">77%</td></tr><tr><td/><td/><td/></tr><tr><td align=\"left\"><bold>Post Admission Rounds</bold></td><td/><td/></tr><tr><td align=\"left\">A</td><td align=\"center\">15</td><td align=\"center\">80%</td></tr><tr><td align=\"left\">B</td><td align=\"center\">12</td><td align=\"center\">67%</td></tr><tr><td align=\"left\">C</td><td align=\"center\">17</td><td align=\"center\">41%</td></tr><tr><td align=\"left\">D</td><td align=\"center\">17</td><td align=\"center\">76%</td></tr><tr><td align=\"left\">E</td><td align=\"center\">11</td><td align=\"center\">64%</td></tr><tr><td align=\"left\">F</td><td align=\"center\">17</td><td align=\"center\">76%</td></tr><tr><td align=\"left\">G</td><td align=\"center\">12</td><td align=\"center\">50%</td></tr><tr><td align=\"left\">H</td><td align=\"center\">21</td><td align=\"center\">67%</td></tr><tr><td align=\"left\">Mean</td><td align=\"center\">15</td><td align=\"center\">65%</td></tr></tbody></table></body></html>","text":"Pmid= 2566971:Table= Table 1","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":-1038499663,"_task_hash":651066376,"_view_id":"choice","accept":[5],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":"tableclass-test-params-100-gill","sessions":["tableclass-test-params-100-frank","tableclass-test-params-100-gill","tableclass-test-params-100-joe","tableclass-test-params-100-vicky"],"default":true}],"view_id":"choice"}
{"html":"<!DOCTYPE html><html><body><h1>Frequency of review of medication charts on subspecialty ward rounds</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td align=\"left\"><bold>Specialty</bold></td><td align=\"center\"><bold>No. of Patients Seen on Ward Round</bold></td><td align=\"center\"><bold>Frequency of Medication Chart Review</bold></td></tr></thead><tbody><tr><td align=\"left\"><bold>Haematology</bold></td><td/><td/></tr><tr><td align=\"left\">A</td><td align=\"center\">6</td><td align=\"center\">83%</td></tr><tr><td/><td align=\"center\">3</td><td align=\"center\">100%</td></tr><tr><td align=\"left\">B</td><td align=\"center\">3</td><td align=\"center\">100%</td></tr><tr><td/><td align=\"center\">8</td><td align=\"center\">75%</td></tr><tr><td align=\"left\">Mean</td><td align=\"center\">5</td><td align=\"center\">90%</td></tr><tr><td/><td/><td/></tr><tr><td align=\"left\"><bold>Liver Transplant</bold></td><td/><td/></tr><tr><td align=\"left\">A</td><td align=\"center\">5</td><td align=\"center\">100%</td></tr><tr><td align=\"left\">B</td><td align=\"center\">5</td><td align=\"center\">100%</td></tr><tr><td align=\"left\">C</td><td align=\"center\">4</td><td align=\"center\">75%</td></tr><tr><td align=\"left\">D</td><td align=\"center\">5</td><td align=\"center\">80%</td></tr><tr><td align=\"left\">E</td><td align=\"center\">5</td><td align=\"center\">80%</td></tr><tr><td align=\"left\">Mean</td><td align=\"center\">5</td><td align=\"center\">87%</td></tr><tr><td/><td/><td/></tr><tr><td align=\"left\"><bold>Gastroenterology</bold></td><td/><td/></tr><tr><td align=\"left\">A</td><td align=\"center\">11</td><td align=\"center\">45%</td></tr><tr><td align=\"left\">B</td><td align=\"center\">7</td><td align=\"center\">43%</td></tr><tr><td/><td align=\"center\">5</td><td align=\"center\">80%</td></tr><tr><td align=\"left\">C</td><td align=\"center\">10</td><td align=\"center\">50%</td></tr><tr><td/><td align=\"center\">9</td><td align=\"center\">44%</td></tr><tr><td align=\"left\">Mean</td><td align=\"center\">8</td><td align=\"center\">52%</td></tr><tr><td/><td/><td/></tr><tr><td align=\"left\"><bold>Cardiology</bold></td><td/><td/></tr><tr><td align=\"left\">A</td><td align=\"center\">13</td><td align=\"center\">61%</td></tr><tr><td align=\"left\">B</td><td align=\"center\">4</td><td align=\"center\">75%</td></tr><tr><td align=\"left\">Mean</td><td align=\"center\">8</td><td align=\"center\">68%</td></tr><tr><td/><td/><td/></tr><tr><td align=\"left\"><bold>Renal Medicine</bold></td><td/><td/></tr><tr><td align=\"left\">A</td><td align=\"center\">16</td><td align=\"center\">87%</td></tr></tbody></table></body></html>","text":"Pmid= 2566971:Table= Table 2","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":532451913,"_task_hash":-630630738,"_view_id":"review","accept":[5],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":null,"sessions":["tableclass-test-params-100-frank","tableclass-test-params-100-gill","tableclass-test-params-100-joe","tableclass-test-params-100-vicky"],"versions":[{"html":"<!DOCTYPE html><html><body><h1>Frequency of review of medication charts on subspecialty ward rounds</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td align=\"left\"><bold>Specialty</bold></td><td align=\"center\"><bold>No. of Patients Seen on Ward Round</bold></td><td align=\"center\"><bold>Frequency of Medication Chart Review</bold></td></tr></thead><tbody><tr><td align=\"left\"><bold>Haematology</bold></td><td/><td/></tr><tr><td align=\"left\">A</td><td align=\"center\">6</td><td align=\"center\">83%</td></tr><tr><td/><td align=\"center\">3</td><td align=\"center\">100%</td></tr><tr><td align=\"left\">B</td><td align=\"center\">3</td><td align=\"center\">100%</td></tr><tr><td/><td align=\"center\">8</td><td align=\"center\">75%</td></tr><tr><td align=\"left\">Mean</td><td align=\"center\">5</td><td align=\"center\">90%</td></tr><tr><td/><td/><td/></tr><tr><td align=\"left\"><bold>Liver Transplant</bold></td><td/><td/></tr><tr><td align=\"left\">A</td><td align=\"center\">5</td><td align=\"center\">100%</td></tr><tr><td align=\"left\">B</td><td align=\"center\">5</td><td align=\"center\">100%</td></tr><tr><td align=\"left\">C</td><td align=\"center\">4</td><td align=\"center\">75%</td></tr><tr><td align=\"left\">D</td><td align=\"center\">5</td><td align=\"center\">80%</td></tr><tr><td align=\"left\">E</td><td align=\"center\">5</td><td align=\"center\">80%</td></tr><tr><td align=\"left\">Mean</td><td align=\"center\">5</td><td align=\"center\">87%</td></tr><tr><td/><td/><td/></tr><tr><td align=\"left\"><bold>Gastroenterology</bold></td><td/><td/></tr><tr><td align=\"left\">A</td><td align=\"center\">11</td><td align=\"center\">45%</td></tr><tr><td align=\"left\">B</td><td align=\"center\">7</td><td align=\"center\">43%</td></tr><tr><td/><td align=\"center\">5</td><td align=\"center\">80%</td></tr><tr><td align=\"left\">C</td><td align=\"center\">10</td><td align=\"center\">50%</td></tr><tr><td/><td align=\"center\">9</td><td align=\"center\">44%</td></tr><tr><td align=\"left\">Mean</td><td align=\"center\">8</td><td align=\"center\">52%</td></tr><tr><td/><td/><td/></tr><tr><td align=\"left\"><bold>Cardiology</bold></td><td/><td/></tr><tr><td align=\"left\">A</td><td align=\"center\">13</td><td align=\"center\">61%</td></tr><tr><td align=\"left\">B</td><td align=\"center\">4</td><td align=\"center\">75%</td></tr><tr><td align=\"left\">Mean</td><td align=\"center\">8</td><td align=\"center\">68%</td></tr><tr><td/><td/><td/></tr><tr><td align=\"left\"><bold>Renal Medicine</bold></td><td/><td/></tr><tr><td align=\"left\">A</td><td align=\"center\">16</td><td align=\"center\">87%</td></tr></tbody></table></body></html>","text":"Pmid= 2566971:Table= Table 2","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":532451913,"_task_hash":-630630738,"_view_id":"choice","accept":[5],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":"tableclass-test-params-100-gill","sessions":["tableclass-test-params-100-frank","tableclass-test-params-100-gill","tableclass-test-params-100-joe","tableclass-test-params-100-vicky"],"default":true}],"view_id":"choice"}
{"html":"<!DOCTYPE html><html><body><h1>Summary table of randomised trials included in the review</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td/><td align=\"center\" colspan=\"4\"><bold>Number of:</bold></td><td align=\"center\" colspan=\"2\"><bold>Number of patients</bold></td><td/><td/></tr><tr><td/><td colspan=\"6\"><hr/></td><td/><td/></tr><tr><td align=\"left\"><bold>Pain condition</bold></td><td align=\"center\"><bold>Studies</bold></td><td align=\"center\"><bold>Studies with QS &#8805; 3/5</bold></td><td align=\"center\"><bold>Studies with OPVS &#8805; 9/16</bold></td><td align=\"center\"><bold>Trials of group size &#8805; 100</bold></td><td align=\"center\"><bold>In total</bold></td><td align=\"center\"><bold>Given dexketoprofen</bold></td><td align=\"center\"><bold>Better than placebo/total comparisons</bold></td><td align=\"center\"><bold>At least equivalent to effective analgesic/total comparisons</bold></td></tr></thead><tbody><tr><td align=\"left\">Dental pain</td><td align=\"center\">7</td><td align=\"center\">6</td><td align=\"center\">6</td><td align=\"center\">0</td><td align=\"center\">994</td><td align=\"center\">618</td><td align=\"center\">4/4</td><td align=\"center\">3/4</td></tr><tr><td align=\"left\">Postsurgical</td><td align=\"center\">13</td><td align=\"center\">11</td><td align=\"center\">11</td><td align=\"center\">2</td><td align=\"center\">2185</td><td align=\"center\">1022</td><td align=\"center\">7/7</td><td align=\"center\">11/11</td></tr><tr><td align=\"left\">Renal colic</td><td align=\"center\">3</td><td align=\"center\">3</td><td align=\"center\">3</td><td align=\"center\">3</td><td align=\"center\">838</td><td align=\"center\">526</td><td/><td align=\"center\">3/3</td></tr><tr><td align=\"left\">Gynaecologic pain</td><td align=\"center\">2</td><td align=\"center\">2</td><td align=\"center\">1</td><td align=\"center\">1</td><td align=\"center\">350</td><td align=\"center\">200</td><td align=\"center\">1/1</td><td align=\"center\">2/2</td></tr><tr><td align=\"left\">Lower limb injury</td><td align=\"center\">1</td><td align=\"center\">1</td><td align=\"center\">1</td><td align=\"center\">0</td><td align=\"center\">122</td><td align=\"center\">65</td><td/><td align=\"center\">1/1</td></tr><tr><td align=\"left\">Ankle sprain</td><td align=\"center\">1</td><td align=\"center\">1</td><td align=\"center\">1</td><td align=\"center\">1</td><td align=\"center\">209</td><td align=\"center\">106</td><td/><td align=\"center\">1/1</td></tr><tr><td align=\"left\">Acute bone pain in cancer</td><td align=\"center\">1</td><td align=\"center\">1</td><td align=\"center\">1</td><td align=\"center\">0</td><td align=\"center\">115</td><td align=\"center\">57</td><td/><td align=\"center\">1/1</td></tr><tr><td align=\"left\">Acute low back pain</td><td align=\"center\">5</td><td align=\"center\">5</td><td align=\"center\">5</td><td align=\"center\">3</td><td align=\"center\">1267</td><td align=\"center\">635</td><td/><td align=\"center\">5/5</td></tr><tr><td align=\"left\">OA/RA</td><td align=\"center\">2</td><td align=\"center\">2</td><td align=\"center\">2</td><td align=\"center\">0</td><td align=\"center\">300</td><td align=\"center\">152</td><td/><td align=\"center\">2/2</td></tr><tr><td colspan=\"9\"><hr/></td></tr><tr><td align=\"left\">Total</td><td align=\"center\">35</td><td align=\"center\">32</td><td align=\"center\">31</td><td align=\"center\">10</td><td align=\"center\">6380</td><td align=\"center\">3381</td><td align=\"center\">12/12</td><td align=\"center\">29/30</td></tr></tbody></table></body></html>","text":"Pmid= 2585070:Table= Table 1","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":-651186990,"_task_hash":-2115651754,"_view_id":"review","accept":[5],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":null,"sessions":["tableclass-test-params-100-frank","tableclass-test-params-100-gill","tableclass-test-params-100-vicky"],"versions":[{"html":"<!DOCTYPE html><html><body><h1>Summary table of randomised trials included in the review</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td/><td align=\"center\" colspan=\"4\"><bold>Number of:</bold></td><td align=\"center\" colspan=\"2\"><bold>Number of patients</bold></td><td/><td/></tr><tr><td/><td colspan=\"6\"><hr/></td><td/><td/></tr><tr><td align=\"left\"><bold>Pain condition</bold></td><td align=\"center\"><bold>Studies</bold></td><td align=\"center\"><bold>Studies with QS &#8805; 3/5</bold></td><td align=\"center\"><bold>Studies with OPVS &#8805; 9/16</bold></td><td align=\"center\"><bold>Trials of group size &#8805; 100</bold></td><td align=\"center\"><bold>In total</bold></td><td align=\"center\"><bold>Given dexketoprofen</bold></td><td align=\"center\"><bold>Better than placebo/total comparisons</bold></td><td align=\"center\"><bold>At least equivalent to effective analgesic/total comparisons</bold></td></tr></thead><tbody><tr><td align=\"left\">Dental pain</td><td align=\"center\">7</td><td align=\"center\">6</td><td align=\"center\">6</td><td align=\"center\">0</td><td align=\"center\">994</td><td align=\"center\">618</td><td align=\"center\">4/4</td><td align=\"center\">3/4</td></tr><tr><td align=\"left\">Postsurgical</td><td align=\"center\">13</td><td align=\"center\">11</td><td align=\"center\">11</td><td align=\"center\">2</td><td align=\"center\">2185</td><td align=\"center\">1022</td><td align=\"center\">7/7</td><td align=\"center\">11/11</td></tr><tr><td align=\"left\">Renal colic</td><td align=\"center\">3</td><td align=\"center\">3</td><td align=\"center\">3</td><td align=\"center\">3</td><td align=\"center\">838</td><td align=\"center\">526</td><td/><td align=\"center\">3/3</td></tr><tr><td align=\"left\">Gynaecologic pain</td><td align=\"center\">2</td><td align=\"center\">2</td><td align=\"center\">1</td><td align=\"center\">1</td><td align=\"center\">350</td><td align=\"center\">200</td><td align=\"center\">1/1</td><td align=\"center\">2/2</td></tr><tr><td align=\"left\">Lower limb injury</td><td align=\"center\">1</td><td align=\"center\">1</td><td align=\"center\">1</td><td align=\"center\">0</td><td align=\"center\">122</td><td align=\"center\">65</td><td/><td align=\"center\">1/1</td></tr><tr><td align=\"left\">Ankle sprain</td><td align=\"center\">1</td><td align=\"center\">1</td><td align=\"center\">1</td><td align=\"center\">1</td><td align=\"center\">209</td><td align=\"center\">106</td><td/><td align=\"center\">1/1</td></tr><tr><td align=\"left\">Acute bone pain in cancer</td><td align=\"center\">1</td><td align=\"center\">1</td><td align=\"center\">1</td><td align=\"center\">0</td><td align=\"center\">115</td><td align=\"center\">57</td><td/><td align=\"center\">1/1</td></tr><tr><td align=\"left\">Acute low back pain</td><td align=\"center\">5</td><td align=\"center\">5</td><td align=\"center\">5</td><td align=\"center\">3</td><td align=\"center\">1267</td><td align=\"center\">635</td><td/><td align=\"center\">5/5</td></tr><tr><td align=\"left\">OA/RA</td><td align=\"center\">2</td><td align=\"center\">2</td><td align=\"center\">2</td><td align=\"center\">0</td><td align=\"center\">300</td><td align=\"center\">152</td><td/><td align=\"center\">2/2</td></tr><tr><td colspan=\"9\"><hr/></td></tr><tr><td align=\"left\">Total</td><td align=\"center\">35</td><td align=\"center\">32</td><td align=\"center\">31</td><td align=\"center\">10</td><td align=\"center\">6380</td><td align=\"center\">3381</td><td align=\"center\">12/12</td><td align=\"center\">29/30</td></tr></tbody></table></body></html>","text":"Pmid= 2585070:Table= Table 1","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":-651186990,"_task_hash":-2115651754,"_view_id":"choice","accept":[5],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":"tableclass-test-params-100-gill","sessions":["tableclass-test-params-100-frank","tableclass-test-params-100-gill","tableclass-test-params-100-vicky"],"default":true}],"view_id":"choice"}
{"html":"<!DOCTYPE html><html><body><h1>Results of single dose trials in dental and postsurgical pain for comparison of dexketoprofen with placebo, and dexketoprofen with ketoprofen</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td align=\"left\" colspan=\"7\"><bold>Dexketoprofen versus placebo</bold></td></tr></thead><tbody><tr><td/><td align=\"center\" colspan=\"2\"><bold>Number of</bold></td><td align=\"center\" colspan=\"2\"><bold>Percent of patients with at least 50% pain relief</bold></td><td/><td/></tr><tr><td/><td colspan=\"4\"><hr/></td><td/><td/></tr><tr><td align=\"left\"><bold>Dexketoprofen dose (mg)</bold></td><td align=\"center\"><bold>Trials</bold></td><td align=\"center\"><bold>Patients</bold></td><td align=\"center\"><bold>Dexketoprofen</bold></td><td align=\"center\"><bold>Placebo</bold></td><td align=\"center\"><bold>Relative benefit (95% CI)</bold></td><td align=\"center\"><bold>NNT (95% CI)</bold></td></tr><tr><td colspan=\"7\"><hr/></td></tr><tr><td align=\"left\" colspan=\"7\"><bold>All trials</bold></td></tr><tr><td align=\"left\">10/12.5 mg</td><td align=\"center\">5</td><td align=\"center\">462</td><td align=\"center\">45</td><td align=\"center\">17</td><td align=\"center\">3.4 (2.2 to 5.6)</td><td align=\"center\">3.5 (2.7 to 4.9)</td></tr><tr><td align=\"left\">20/25 mg</td><td align=\"center\">5</td><td align=\"center\">455</td><td align=\"center\">50</td><td align=\"center\">17</td><td align=\"center\">3.9 (2.4 to 6.3)</td><td align=\"center\">3.0 (2.4 to 3.9)</td></tr><tr><td align=\"left\">50 mg</td><td align=\"center\">1</td><td align=\"center\">67</td><td align=\"center\">56</td><td align=\"center\">8</td><td align=\"center\">6.7 (1.7 to 26)</td><td align=\"center\">2.1 (1.5 to 3.5)</td></tr><tr><td colspan=\"7\"><hr/></td></tr><tr><td align=\"left\" colspan=\"7\"><bold>Dental</bold></td></tr><tr><td align=\"left\">10/12.5 mg</td><td align=\"center\">3</td><td align=\"center\">261</td><td align=\"center\">47</td><td align=\"center\">13</td><td align=\"center\">3.5 (2.2 to 5.6)</td><td align=\"center\">3.0 (2.3 to 4.4)</td></tr><tr><td align=\"left\">20/25 mg</td><td align=\"center\">3</td><td align=\"center\">254</td><td align=\"center\">52</td><td align=\"center\">13</td><td align=\"center\">3.9 (2.4 to 6.3)</td><td align=\"center\">2.6 (2.0 to 3.5)</td></tr><tr><td align=\"left\">50 mg</td><td align=\"center\">1</td><td align=\"center\">67</td><td align=\"center\">56</td><td align=\"center\">8</td><td align=\"center\">6.7 (1.7 to 26)</td><td align=\"center\">2.1 (1.5 to 3.5)</td></tr><tr><td colspan=\"7\"><hr/></td></tr><tr><td align=\"left\" colspan=\"7\"><bold>Postsurgical</bold></td></tr><tr><td align=\"left\">10/12.5 mg</td><td align=\"center\">2</td><td align=\"center\">201</td><td align=\"center\">43</td><td align=\"center\">21</td><td align=\"center\">2.1 (1.4 to 3.3)</td><td align=\"center\">4.4 (2.8 to 9.7)</td></tr><tr><td align=\"left\">20/25 mg</td><td align=\"center\">2</td><td align=\"center\">201</td><td align=\"center\">47</td><td align=\"center\">21</td><td align=\"center\">2.3 (1.5 to 3.6)</td><td align=\"center\">3.7 (2.5 to 7.0)</td></tr><tr><td colspan=\"7\"><hr/></td></tr><tr><td align=\"left\" colspan=\"7\"><bold>Dexketoprofen versus ketoprofen</bold></td></tr><tr><td colspan=\"7\"><hr/></td></tr><tr><td/><td align=\"center\" colspan=\"2\"><bold>Number of</bold></td><td align=\"center\" colspan=\"2\"><bold>Percent of patients with at least 50% pain relief</bold></td><td/><td/></tr><tr><td/><td colspan=\"4\"><hr/></td><td/><td/></tr><tr><td align=\"left\"><bold>Dexketoprofen/ketoprofen dose (mg)</bold></td><td align=\"center\"><bold>Trials</bold></td><td align=\"center\"><bold>Patients</bold></td><td align=\"center\"><bold>Dexketoprofen</bold></td><td align=\"center\"><bold>Ketoprofen</bold></td><td align=\"center\"><bold>Relative benefit (95% CI)</bold></td><td align=\"center\"><bold>NNT (95% CI)</bold></td></tr><tr><td colspan=\"7\"><hr/></td></tr><tr><td align=\"left\"><bold>All trials</bold></td><td/><td/><td/><td/><td/><td/></tr><tr><td align=\"left\">12.5 vs 50</td><td align=\"center\">3</td><td align=\"center\">287</td><td align=\"center\">44</td><td align=\"center\">35</td><td align=\"center\">0.8 (0.5 to 1.2)</td><td align=\"center\">not calculated</td></tr><tr><td align=\"left\">25 vs 50</td><td align=\"center\">3</td><td align=\"center\">284</td><td align=\"center\">51</td><td align=\"center\">35</td><td align=\"center\">1.1 (0.7 to 1.5)</td><td align=\"center\">not calculated</td></tr><tr><td align=\"left\">50 vs 100</td><td align=\"center\">1</td><td align=\"center\">247</td><td align=\"center\">82</td><td align=\"center\">77</td><td align=\"center\">1.1 (0.9 to 1.2)</td><td align=\"center\">not calculated</td></tr><tr><td colspan=\"7\"><hr/></td></tr><tr><td align=\"left\">25/50 vs 50/100</td><td align=\"center\">4</td><td align=\"center\">531</td><td align=\"center\">65</td><td align=\"center\">54</td><td align=\"center\">1.2 (1.1 to 1.4)</td><td align=\"center\">8.8 (5.1 to 33)</td></tr></tbody></table></body></html>","text":"Pmid= 2585070:Table= Table 2","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":-1757366116,"_task_hash":1718695502,"_view_id":"review","accept":[5],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":null,"sessions":["tableclass-test-params-100-frank","tableclass-test-params-100-gill","tableclass-test-params-100-vicky"],"versions":[{"html":"<!DOCTYPE html><html><body><h1>Results of single dose trials in dental and postsurgical pain for comparison of dexketoprofen with placebo, and dexketoprofen with ketoprofen</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td align=\"left\" colspan=\"7\"><bold>Dexketoprofen versus placebo</bold></td></tr></thead><tbody><tr><td/><td align=\"center\" colspan=\"2\"><bold>Number of</bold></td><td align=\"center\" colspan=\"2\"><bold>Percent of patients with at least 50% pain relief</bold></td><td/><td/></tr><tr><td/><td colspan=\"4\"><hr/></td><td/><td/></tr><tr><td align=\"left\"><bold>Dexketoprofen dose (mg)</bold></td><td align=\"center\"><bold>Trials</bold></td><td align=\"center\"><bold>Patients</bold></td><td align=\"center\"><bold>Dexketoprofen</bold></td><td align=\"center\"><bold>Placebo</bold></td><td align=\"center\"><bold>Relative benefit (95% CI)</bold></td><td align=\"center\"><bold>NNT (95% CI)</bold></td></tr><tr><td colspan=\"7\"><hr/></td></tr><tr><td align=\"left\" colspan=\"7\"><bold>All trials</bold></td></tr><tr><td align=\"left\">10/12.5 mg</td><td align=\"center\">5</td><td align=\"center\">462</td><td align=\"center\">45</td><td align=\"center\">17</td><td align=\"center\">3.4 (2.2 to 5.6)</td><td align=\"center\">3.5 (2.7 to 4.9)</td></tr><tr><td align=\"left\">20/25 mg</td><td align=\"center\">5</td><td align=\"center\">455</td><td align=\"center\">50</td><td align=\"center\">17</td><td align=\"center\">3.9 (2.4 to 6.3)</td><td align=\"center\">3.0 (2.4 to 3.9)</td></tr><tr><td align=\"left\">50 mg</td><td align=\"center\">1</td><td align=\"center\">67</td><td align=\"center\">56</td><td align=\"center\">8</td><td align=\"center\">6.7 (1.7 to 26)</td><td align=\"center\">2.1 (1.5 to 3.5)</td></tr><tr><td colspan=\"7\"><hr/></td></tr><tr><td align=\"left\" colspan=\"7\"><bold>Dental</bold></td></tr><tr><td align=\"left\">10/12.5 mg</td><td align=\"center\">3</td><td align=\"center\">261</td><td align=\"center\">47</td><td align=\"center\">13</td><td align=\"center\">3.5 (2.2 to 5.6)</td><td align=\"center\">3.0 (2.3 to 4.4)</td></tr><tr><td align=\"left\">20/25 mg</td><td align=\"center\">3</td><td align=\"center\">254</td><td align=\"center\">52</td><td align=\"center\">13</td><td align=\"center\">3.9 (2.4 to 6.3)</td><td align=\"center\">2.6 (2.0 to 3.5)</td></tr><tr><td align=\"left\">50 mg</td><td align=\"center\">1</td><td align=\"center\">67</td><td align=\"center\">56</td><td align=\"center\">8</td><td align=\"center\">6.7 (1.7 to 26)</td><td align=\"center\">2.1 (1.5 to 3.5)</td></tr><tr><td colspan=\"7\"><hr/></td></tr><tr><td align=\"left\" colspan=\"7\"><bold>Postsurgical</bold></td></tr><tr><td align=\"left\">10/12.5 mg</td><td align=\"center\">2</td><td align=\"center\">201</td><td align=\"center\">43</td><td align=\"center\">21</td><td align=\"center\">2.1 (1.4 to 3.3)</td><td align=\"center\">4.4 (2.8 to 9.7)</td></tr><tr><td align=\"left\">20/25 mg</td><td align=\"center\">2</td><td align=\"center\">201</td><td align=\"center\">47</td><td align=\"center\">21</td><td align=\"center\">2.3 (1.5 to 3.6)</td><td align=\"center\">3.7 (2.5 to 7.0)</td></tr><tr><td colspan=\"7\"><hr/></td></tr><tr><td align=\"left\" colspan=\"7\"><bold>Dexketoprofen versus ketoprofen</bold></td></tr><tr><td colspan=\"7\"><hr/></td></tr><tr><td/><td align=\"center\" colspan=\"2\"><bold>Number of</bold></td><td align=\"center\" colspan=\"2\"><bold>Percent of patients with at least 50% pain relief</bold></td><td/><td/></tr><tr><td/><td colspan=\"4\"><hr/></td><td/><td/></tr><tr><td align=\"left\"><bold>Dexketoprofen/ketoprofen dose (mg)</bold></td><td align=\"center\"><bold>Trials</bold></td><td align=\"center\"><bold>Patients</bold></td><td align=\"center\"><bold>Dexketoprofen</bold></td><td align=\"center\"><bold>Ketoprofen</bold></td><td align=\"center\"><bold>Relative benefit (95% CI)</bold></td><td align=\"center\"><bold>NNT (95% CI)</bold></td></tr><tr><td colspan=\"7\"><hr/></td></tr><tr><td align=\"left\"><bold>All trials</bold></td><td/><td/><td/><td/><td/><td/></tr><tr><td align=\"left\">12.5 vs 50</td><td align=\"center\">3</td><td align=\"center\">287</td><td align=\"center\">44</td><td align=\"center\">35</td><td align=\"center\">0.8 (0.5 to 1.2)</td><td align=\"center\">not calculated</td></tr><tr><td align=\"left\">25 vs 50</td><td align=\"center\">3</td><td align=\"center\">284</td><td align=\"center\">51</td><td align=\"center\">35</td><td align=\"center\">1.1 (0.7 to 1.5)</td><td align=\"center\">not calculated</td></tr><tr><td align=\"left\">50 vs 100</td><td align=\"center\">1</td><td align=\"center\">247</td><td align=\"center\">82</td><td align=\"center\">77</td><td align=\"center\">1.1 (0.9 to 1.2)</td><td align=\"center\">not calculated</td></tr><tr><td colspan=\"7\"><hr/></td></tr><tr><td align=\"left\">25/50 vs 50/100</td><td align=\"center\">4</td><td align=\"center\">531</td><td align=\"center\">65</td><td align=\"center\">54</td><td align=\"center\">1.2 (1.1 to 1.4)</td><td align=\"center\">8.8 (5.1 to 33)</td></tr></tbody></table></body></html>","text":"Pmid= 2585070:Table= Table 2","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":-1757366116,"_task_hash":1718695502,"_view_id":"choice","accept":[5],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":"tableclass-test-params-100-gill","sessions":["tableclass-test-params-100-frank","tableclass-test-params-100-gill","tableclass-test-params-100-vicky"],"default":true}],"view_id":"choice"}
{"html":"<!DOCTYPE html><html><body><h1>Adverse event withdrawal rates in trials where at least two doses of drug were given</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td/><td align=\"center\" colspan=\"2\"><bold>Dental and postsurgical pain</bold></td><td align=\"center\" colspan=\"2\"><bold>Other acute, back pain, arthritis</bold></td></tr><tr><td/><td colspan=\"4\"><hr/></td></tr><tr><td align=\"center\"><bold>Drug</bold></td><td align=\"center\"><bold>Number of patients</bold></td><td align=\"center\"><bold>Adverse event withdrawal (%)</bold></td><td align=\"center\"><bold>Number of patients</bold></td><td align=\"center\"><bold>Adverse event withdrawal (%)</bold></td></tr></thead><tbody><tr><td align=\"left\">Placebo</td><td align=\"center\">236</td><td align=\"center\">2.5</td><td align=\"center\" colspan=\"2\">no data</td></tr><tr><td align=\"left\">Dexketoprofen</td><td align=\"center\">652</td><td align=\"center\">1.8</td><td align=\"center\">844</td><td align=\"center\">3.2</td></tr><tr><td align=\"left\">Ketoprofen</td><td align=\"center\">301</td><td align=\"center\">1.3</td><td align=\"center\">152</td><td align=\"center\">7.9</td></tr><tr><td align=\"left\">Diclofenac</td><td align=\"center\">80</td><td align=\"center\">0.0</td><td align=\"center\">272</td><td align=\"center\">3.7</td></tr><tr><td align=\"left\">Tramadol</td><td align=\"center\">72</td><td align=\"center\">1.4</td><td align=\"center\">247</td><td align=\"center\">9.7</td></tr><tr><td align=\"left\">Paracetamol + opioid</td><td align=\"center\">100</td><td align=\"center\">0.0</td><td align=\"center\">167</td><td align=\"center\">1.2</td></tr></tbody></table></body></html>","text":"Pmid= 2585070:Table= Table 3","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":231480117,"_task_hash":-1754019779,"_view_id":"review","accept":[5],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":null,"sessions":["tableclass-test-params-100-frank","tableclass-test-params-100-gill","tableclass-test-params-100-vicky"],"versions":[{"html":"<!DOCTYPE html><html><body><h1>Adverse event withdrawal rates in trials where at least two doses of drug were given</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td/><td align=\"center\" colspan=\"2\"><bold>Dental and postsurgical pain</bold></td><td align=\"center\" colspan=\"2\"><bold>Other acute, back pain, arthritis</bold></td></tr><tr><td/><td colspan=\"4\"><hr/></td></tr><tr><td align=\"center\"><bold>Drug</bold></td><td align=\"center\"><bold>Number of patients</bold></td><td align=\"center\"><bold>Adverse event withdrawal (%)</bold></td><td align=\"center\"><bold>Number of patients</bold></td><td align=\"center\"><bold>Adverse event withdrawal (%)</bold></td></tr></thead><tbody><tr><td align=\"left\">Placebo</td><td align=\"center\">236</td><td align=\"center\">2.5</td><td align=\"center\" colspan=\"2\">no data</td></tr><tr><td align=\"left\">Dexketoprofen</td><td align=\"center\">652</td><td align=\"center\">1.8</td><td align=\"center\">844</td><td align=\"center\">3.2</td></tr><tr><td align=\"left\">Ketoprofen</td><td align=\"center\">301</td><td align=\"center\">1.3</td><td align=\"center\">152</td><td align=\"center\">7.9</td></tr><tr><td align=\"left\">Diclofenac</td><td align=\"center\">80</td><td align=\"center\">0.0</td><td align=\"center\">272</td><td align=\"center\">3.7</td></tr><tr><td align=\"left\">Tramadol</td><td align=\"center\">72</td><td align=\"center\">1.4</td><td align=\"center\">247</td><td align=\"center\">9.7</td></tr><tr><td align=\"left\">Paracetamol + opioid</td><td align=\"center\">100</td><td align=\"center\">0.0</td><td align=\"center\">167</td><td align=\"center\">1.2</td></tr></tbody></table></body></html>","text":"Pmid= 2585070:Table= Table 3","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":231480117,"_task_hash":-1754019779,"_view_id":"choice","accept":[5],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":"tableclass-test-params-100-gill","sessions":["tableclass-test-params-100-frank","tableclass-test-params-100-gill","tableclass-test-params-100-vicky"],"default":true}],"view_id":"choice"}
{"html":"<!DOCTYPE html><html><body><h1>Baseline characteristics of the subjects</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><tbody><tr><td align=\"left\">Glucose (mmol/L)</td><td align=\"left\">5.5 &#177; 1.2</td></tr><tr><td align=\"left\">Insulin (pmol/L)</td><td align=\"left\">55.5 &#177; 46.9</td></tr><tr><td align=\"left\">HOMA</td><td align=\"left\">302 &#177; 259</td></tr><tr><td align=\"left\">Creatinine (mmol/L)</td><td align=\"left\">85 &#177; 17</td></tr><tr><td align=\"left\">C reactive protein (mg/dl)</td><td align=\"left\">2.7 &#177; 3.9</td></tr><tr><td align=\"left\">Fibrinogen (g/L)</td><td align=\"left\">3.3 &#177; 0.6</td></tr><tr><td align=\"left\">Weight (kg)</td><td align=\"left\">82.1 &#177; 12.8</td></tr><tr><td align=\"left\">Height (cm)</td><td align=\"left\">170.2 &#177; 9.8</td></tr><tr><td align=\"left\">Body mass index</td><td align=\"left\">28.5 &#177; 4.2</td></tr><tr><td align=\"left\">Lipid profile</td><td/></tr><tr><td align=\"left\">Total Cholesterol (mmol/L)</td><td align=\"left\">6.7 &#177; 1.3</td></tr><tr><td align=\"left\">LDL-C (mmol/L)</td><td align=\"left\">4.4 &#177; 1.1</td></tr><tr><td align=\"left\">HDL-C (mmol/L)</td><td align=\"left\">1.1 &#177; 0.4</td></tr><tr><td align=\"left\">Triglycerides (mmol/L)</td><td align=\"left\">2.6 &#177; 1.4</td></tr><tr><td align=\"left\">ApoB (g/L)</td><td align=\"left\">1.4 &#177; 0.3</td></tr></tbody></table></body></html>","text":"Pmid= 2586010:Table= Table 1","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":1501329977,"_task_hash":-154445441,"_view_id":"review","accept":[5],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":null,"sessions":["tableclass-test-params-100-frank","tableclass-test-params-100-gill","tableclass-test-params-100-vicky"],"versions":[{"html":"<!DOCTYPE html><html><body><h1>Baseline characteristics of the subjects</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><tbody><tr><td align=\"left\">Glucose (mmol/L)</td><td align=\"left\">5.5 &#177; 1.2</td></tr><tr><td align=\"left\">Insulin (pmol/L)</td><td align=\"left\">55.5 &#177; 46.9</td></tr><tr><td align=\"left\">HOMA</td><td align=\"left\">302 &#177; 259</td></tr><tr><td align=\"left\">Creatinine (mmol/L)</td><td align=\"left\">85 &#177; 17</td></tr><tr><td align=\"left\">C reactive protein (mg/dl)</td><td align=\"left\">2.7 &#177; 3.9</td></tr><tr><td align=\"left\">Fibrinogen (g/L)</td><td align=\"left\">3.3 &#177; 0.6</td></tr><tr><td align=\"left\">Weight (kg)</td><td align=\"left\">82.1 &#177; 12.8</td></tr><tr><td align=\"left\">Height (cm)</td><td align=\"left\">170.2 &#177; 9.8</td></tr><tr><td align=\"left\">Body mass index</td><td align=\"left\">28.5 &#177; 4.2</td></tr><tr><td align=\"left\">Lipid profile</td><td/></tr><tr><td align=\"left\">Total Cholesterol (mmol/L)</td><td align=\"left\">6.7 &#177; 1.3</td></tr><tr><td align=\"left\">LDL-C (mmol/L)</td><td align=\"left\">4.4 &#177; 1.1</td></tr><tr><td align=\"left\">HDL-C (mmol/L)</td><td align=\"left\">1.1 &#177; 0.4</td></tr><tr><td align=\"left\">Triglycerides (mmol/L)</td><td align=\"left\">2.6 &#177; 1.4</td></tr><tr><td align=\"left\">ApoB (g/L)</td><td align=\"left\">1.4 &#177; 0.3</td></tr></tbody></table></body></html>","text":"Pmid= 2586010:Table= Table 1","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":1501329977,"_task_hash":-154445441,"_view_id":"choice","accept":[5],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":"tableclass-test-params-100-gill","sessions":["tableclass-test-params-100-frank","tableclass-test-params-100-gill","tableclass-test-params-100-vicky"],"default":true}],"view_id":"choice"}
{"html":"<!DOCTYPE html><html><body><h1>described the study design in the 3 parts with the time of meal and dosing of oral calcitonin.</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td align=\"center\" colspan=\"13\">Study Design: Timing of Dosing and Meal Intake</td></tr></thead><tbody><tr><td/><td align=\"center\">08:00</td><td align=\"center\">09:00</td><td align=\"center\">13:00</td><td align=\"center\">17:00</td><td align=\"center\">18:00</td><td align=\"center\">22:00</td><td align=\"center\">08:00</td><td align=\"center\">09:00</td><td align=\"center\">13:00</td><td align=\"center\">17:00</td><td align=\"center\">18:00</td><td align=\"center\">22:00</td></tr><tr><td colspan=\"13\"><hr/></td></tr><tr><td align=\"left\">Part 1 Morning Dosing</td><td align=\"center\">Dose</td><td align=\"center\">Meal</td><td align=\"center\">Meal</td><td align=\"center\">-</td><td align=\"center\">Meal</td><td align=\"center\">-</td><td align=\"center\">End</td><td align=\"center\">x</td><td align=\"center\">x</td><td align=\"center\">x</td><td align=\"center\">x</td><td align=\"center\">x</td></tr><tr><td colspan=\"13\"><hr/></td></tr><tr><td align=\"left\">Part 2 Pre-dinner Dosing</td><td align=\"center\">x</td><td align=\"center\">x</td><td align=\"center\">Meal</td><td align=\"center\">Dose</td><td align=\"center\">Meal</td><td align=\"center\">-</td><td align=\"center\">-</td><td align=\"center\">Meal</td><td align=\"center\">Meal</td><td align=\"center\">End</td><td align=\"center\">x</td><td align=\"center\">x</td></tr><tr><td colspan=\"13\"><hr/></td></tr><tr><td align=\"left\">Part 3 Evening Dosing</td><td align=\"center\">x</td><td align=\"center\">x</td><td align=\"center\">x</td><td align=\"center\">x</td><td align=\"center\">Meal</td><td align=\"center\">Dose</td><td align=\"center\">-</td><td align=\"center\">Meal</td><td align=\"center\">Meal</td><td align=\"center\">-</td><td align=\"center\">Meal</td><td align=\"center\">End</td></tr></tbody></table></body></html>","text":"Pmid= 2611964:Table= Table 1","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":-378603972,"_task_hash":1075463359,"_view_id":"review","accept":[5],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":null,"sessions":["tableclass-test-params-100-frank","tableclass-test-params-100-gill","tableclass-test-params-100-vicky"],"versions":[{"html":"<!DOCTYPE html><html><body><h1>described the study design in the 3 parts with the time of meal and dosing of oral calcitonin.</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td align=\"center\" colspan=\"13\">Study Design: Timing of Dosing and Meal Intake</td></tr></thead><tbody><tr><td/><td align=\"center\">08:00</td><td align=\"center\">09:00</td><td align=\"center\">13:00</td><td align=\"center\">17:00</td><td align=\"center\">18:00</td><td align=\"center\">22:00</td><td align=\"center\">08:00</td><td align=\"center\">09:00</td><td align=\"center\">13:00</td><td align=\"center\">17:00</td><td align=\"center\">18:00</td><td align=\"center\">22:00</td></tr><tr><td colspan=\"13\"><hr/></td></tr><tr><td align=\"left\">Part 1 Morning Dosing</td><td align=\"center\">Dose</td><td align=\"center\">Meal</td><td align=\"center\">Meal</td><td align=\"center\">-</td><td align=\"center\">Meal</td><td align=\"center\">-</td><td align=\"center\">End</td><td align=\"center\">x</td><td align=\"center\">x</td><td align=\"center\">x</td><td align=\"center\">x</td><td align=\"center\">x</td></tr><tr><td colspan=\"13\"><hr/></td></tr><tr><td align=\"left\">Part 2 Pre-dinner Dosing</td><td align=\"center\">x</td><td align=\"center\">x</td><td align=\"center\">Meal</td><td align=\"center\">Dose</td><td align=\"center\">Meal</td><td align=\"center\">-</td><td align=\"center\">-</td><td align=\"center\">Meal</td><td align=\"center\">Meal</td><td align=\"center\">End</td><td align=\"center\">x</td><td align=\"center\">x</td></tr><tr><td colspan=\"13\"><hr/></td></tr><tr><td align=\"left\">Part 3 Evening Dosing</td><td align=\"center\">x</td><td align=\"center\">x</td><td align=\"center\">x</td><td align=\"center\">x</td><td align=\"center\">Meal</td><td align=\"center\">Dose</td><td align=\"center\">-</td><td align=\"center\">Meal</td><td align=\"center\">Meal</td><td align=\"center\">-</td><td align=\"center\">Meal</td><td align=\"center\">End</td></tr></tbody></table></body></html>","text":"Pmid= 2611964:Table= Table 1","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":-378603972,"_task_hash":1075463359,"_view_id":"choice","accept":[5],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":"tableclass-test-params-100-gill","sessions":["tableclass-test-params-100-frank","tableclass-test-params-100-gill","tableclass-test-params-100-vicky"],"default":true}],"view_id":"choice"}
{"html":"<!DOCTYPE html><html><body><h1>Age characteristics of study population</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td/><td align=\"center\">Part 1<break/><italic>n </italic>= 42<break/>Morning Dosing</td><td align=\"center\">Part 2<break/><italic>n </italic>= 20<break/>Pre-Dinner Dosing</td><td align=\"center\">Part 3<break/><italic>n </italic>= 19<break/>Evening Dosing</td></tr></thead><tbody><tr><td align=\"left\">Age (years)</td><td align=\"center\">65.5 (3.8)</td><td align=\"center\">64.6 (4.2)</td><td align=\"center\">64.4 (2.9)</td></tr></tbody></table></body></html>","text":"Pmid= 2611964:Table= Table 2","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":57661258,"_task_hash":-1022020747,"_view_id":"review","accept":[5],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":null,"sessions":["tableclass-test-params-100-frank","tableclass-test-params-100-gill","tableclass-test-params-100-vicky"],"versions":[{"html":"<!DOCTYPE html><html><body><h1>Age characteristics of study population</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td/><td align=\"center\">Part 1<break/><italic>n </italic>= 42<break/>Morning Dosing</td><td align=\"center\">Part 2<break/><italic>n </italic>= 20<break/>Pre-Dinner Dosing</td><td align=\"center\">Part 3<break/><italic>n </italic>= 19<break/>Evening Dosing</td></tr></thead><tbody><tr><td align=\"left\">Age (years)</td><td align=\"center\">65.5 (3.8)</td><td align=\"center\">64.6 (4.2)</td><td align=\"center\">64.4 (2.9)</td></tr></tbody></table></body></html>","text":"Pmid= 2611964:Table= Table 2","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":57661258,"_task_hash":-1022020747,"_view_id":"choice","accept":[5],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":"tableclass-test-params-100-gill","sessions":["tableclass-test-params-100-frank","tableclass-test-params-100-gill","tableclass-test-params-100-vicky"],"default":true}],"view_id":"choice"}
{"html":"<!DOCTYPE html><html><body><h1>Pharmacokinetic profile</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td/><td align=\"center\">Part 1<break/><italic>n </italic>= 42<break/>Morning dosing</td><td align=\"center\">Part 2<break/><italic>n </italic>= 20<break/>Pre-dinner dosing</td><td align=\"center\">Part 3<break/><italic>n </italic>= 19<break/>Evening dosing</td></tr></thead><tbody><tr><td align=\"left\">C<sub>max </sub>(pg/ml)</td><td align=\"center\">45.1 (39.1&#8211;52.0)</td><td align=\"center\">44.7 (31.8&#8211;62.9)</td><td align=\"center\">23.8 (16.9&#8211;33.5)</td></tr><tr><td colspan=\"4\"><hr/></td></tr><tr><td align=\"left\">T<sub>max </sub>(minutes)</td><td align=\"center\">30 (15&#8211;30)</td><td align=\"center\">30 (15&#8211;30)</td><td align=\"center\">30 (30&#8211;33.8)</td></tr><tr><td colspan=\"4\"><hr/></td></tr><tr><td align=\"left\">AUC<sub>0&#8211;4 hrs</sub></td><td align=\"center\">30.6 (27.2&#8211;34.4)</td><td align=\"center\">36.3 (28.6&#8211;46.1)</td><td align=\"center\">28.1 (21.6&#8211;36.6)</td></tr></tbody></table></body></html>","text":"Pmid= 2611964:Table= Table 3","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":1966596260,"_task_hash":1433355468,"_view_id":"review","accept":[1],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":null,"sessions":["tableclass-test-params-100-frank","tableclass-test-params-100-gill","tableclass-test-params-100-vicky"],"versions":[{"html":"<!DOCTYPE html><html><body><h1>Pharmacokinetic profile</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td/><td align=\"center\">Part 1<break/><italic>n </italic>= 42<break/>Morning dosing</td><td align=\"center\">Part 2<break/><italic>n </italic>= 20<break/>Pre-dinner dosing</td><td align=\"center\">Part 3<break/><italic>n </italic>= 19<break/>Evening dosing</td></tr></thead><tbody><tr><td align=\"left\">C<sub>max </sub>(pg/ml)</td><td align=\"center\">45.1 (39.1&#8211;52.0)</td><td align=\"center\">44.7 (31.8&#8211;62.9)</td><td align=\"center\">23.8 (16.9&#8211;33.5)</td></tr><tr><td colspan=\"4\"><hr/></td></tr><tr><td align=\"left\">T<sub>max </sub>(minutes)</td><td align=\"center\">30 (15&#8211;30)</td><td align=\"center\">30 (15&#8211;30)</td><td align=\"center\">30 (30&#8211;33.8)</td></tr><tr><td colspan=\"4\"><hr/></td></tr><tr><td align=\"left\">AUC<sub>0&#8211;4 hrs</sub></td><td align=\"center\">30.6 (27.2&#8211;34.4)</td><td align=\"center\">36.3 (28.6&#8211;46.1)</td><td align=\"center\">28.1 (21.6&#8211;36.6)</td></tr></tbody></table></body></html>","text":"Pmid= 2611964:Table= Table 3","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":1966596260,"_task_hash":1433355468,"_view_id":"choice","accept":[1],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":"tableclass-test-params-100-gill","sessions":["tableclass-test-params-100-frank","tableclass-test-params-100-gill","tableclass-test-params-100-vicky"],"default":true}],"view_id":"choice"}
{"html":"<!DOCTYPE html><html><body><h1>Subject demographics by treatment allocation</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td/><td align=\"center\" colspan=\"2\"><bold>Panel A</bold></td><td align=\"center\" colspan=\"2\"><bold>Panel B</bold></td><td align=\"center\" colspan=\"2\"><bold>Panel C</bold></td></tr></thead><tbody><tr><td/><td align=\"center\"><bold>Category</bold></td><td align=\"center\"><bold>AVI-014 4 &#956;g/kg</bold></td><td align=\"center\"><bold>AVI-014 4 &#956;g/kg</bold></td><td align=\"center\"><bold>Filgrastim 4 &#956;g/kg</bold></td><td align=\"center\"><bold>AVI-014 8 &#956;g/kg</bold></td><td align=\"center\"><bold>Filgrastim 8 &#956;g/kg</bold></td></tr><tr><td colspan=\"7\"><hr/></td></tr><tr><td/><td align=\"center\">n</td><td align=\"center\">8</td><td align=\"center\">8</td><td align=\"center\">8</td><td align=\"center\">8</td><td align=\"center\">8</td></tr><tr><td colspan=\"7\"><hr/></td></tr><tr><td align=\"center\">Race n (%)</td><td align=\"center\">White</td><td align=\"center\">4 (50.0)</td><td align=\"center\">2 (25.0)</td><td align=\"center\">3 (37.5)</td><td align=\"center\">3 (37.5)</td><td align=\"center\">1 (12.5)</td></tr><tr><td/><td colspan=\"6\"><hr/></td></tr><tr><td/><td align=\"center\">Black</td><td align=\"center\">4 (50.0)</td><td align=\"center\">6 (75.0)</td><td align=\"center\">5 (62.5)</td><td align=\"center\">5 (62.5)</td><td align=\"center\">7 (87.5)</td></tr><tr><td colspan=\"7\"><hr/></td></tr><tr><td align=\"center\">Gender n (%)</td><td align=\"center\">Male</td><td align=\"center\">7 (87.5)</td><td align=\"center\">5 (62.5)</td><td align=\"center\">4 (50.0)</td><td align=\"center\">5 (62.5)</td><td align=\"center\">8 (100.0)</td></tr><tr><td/><td colspan=\"6\"><hr/></td></tr><tr><td/><td align=\"center\">Female</td><td align=\"center\">1 (12.5)</td><td align=\"center\">3 (37.5)</td><td align=\"center\">4 (50.0)</td><td align=\"center\">3 (37.5)</td><td align=\"center\">0 (0.0)</td></tr><tr><td colspan=\"7\"><hr/></td></tr><tr><td align=\"center\">Age (years)</td><td align=\"center\">Mean (SD)</td><td align=\"center\">33.6 (7.8)</td><td align=\"center\">35.4 (6.6)</td><td align=\"center\">30.3 (5.1)</td><td align=\"center\">33.8 (5.7)</td><td align=\"center\">39.6 (7.3)</td></tr><tr><td colspan=\"7\"><hr/></td></tr><tr><td align=\"center\">Weight (kg)</td><td align=\"center\">Mean (SD)</td><td align=\"center\">78.3 (10.4)</td><td align=\"center\">81.2 (12.1)</td><td align=\"center\">79.4 (7.9)</td><td align=\"center\">76.3 (6.1)</td><td align=\"center\">90.6 (11.9)</td></tr><tr><td colspan=\"7\"><hr/></td></tr><tr><td align=\"center\">Height (cm)</td><td align=\"center\">Mean (SD)</td><td align=\"center\">177 (11)</td><td align=\"center\">175 (8)</td><td align=\"center\">170 (10)</td><td align=\"center\">173 (5)</td><td align=\"center\">181 (4)</td></tr></tbody></table></body></html>","text":"Pmid= 2639539:Table= Table 1","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":621623890,"_task_hash":-762565745,"_view_id":"review","accept":[5],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":null,"sessions":["tableclass-test-params-100-frank","tableclass-test-params-100-gill","tableclass-test-params-100-vicky"],"versions":[{"html":"<!DOCTYPE html><html><body><h1>Subject demographics by treatment allocation</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td/><td align=\"center\" colspan=\"2\"><bold>Panel A</bold></td><td align=\"center\" colspan=\"2\"><bold>Panel B</bold></td><td align=\"center\" colspan=\"2\"><bold>Panel C</bold></td></tr></thead><tbody><tr><td/><td align=\"center\"><bold>Category</bold></td><td align=\"center\"><bold>AVI-014 4 &#956;g/kg</bold></td><td align=\"center\"><bold>AVI-014 4 &#956;g/kg</bold></td><td align=\"center\"><bold>Filgrastim 4 &#956;g/kg</bold></td><td align=\"center\"><bold>AVI-014 8 &#956;g/kg</bold></td><td align=\"center\"><bold>Filgrastim 8 &#956;g/kg</bold></td></tr><tr><td colspan=\"7\"><hr/></td></tr><tr><td/><td align=\"center\">n</td><td align=\"center\">8</td><td align=\"center\">8</td><td align=\"center\">8</td><td align=\"center\">8</td><td align=\"center\">8</td></tr><tr><td colspan=\"7\"><hr/></td></tr><tr><td align=\"center\">Race n (%)</td><td align=\"center\">White</td><td align=\"center\">4 (50.0)</td><td align=\"center\">2 (25.0)</td><td align=\"center\">3 (37.5)</td><td align=\"center\">3 (37.5)</td><td align=\"center\">1 (12.5)</td></tr><tr><td/><td colspan=\"6\"><hr/></td></tr><tr><td/><td align=\"center\">Black</td><td align=\"center\">4 (50.0)</td><td align=\"center\">6 (75.0)</td><td align=\"center\">5 (62.5)</td><td align=\"center\">5 (62.5)</td><td align=\"center\">7 (87.5)</td></tr><tr><td colspan=\"7\"><hr/></td></tr><tr><td align=\"center\">Gender n (%)</td><td align=\"center\">Male</td><td align=\"center\">7 (87.5)</td><td align=\"center\">5 (62.5)</td><td align=\"center\">4 (50.0)</td><td align=\"center\">5 (62.5)</td><td align=\"center\">8 (100.0)</td></tr><tr><td/><td colspan=\"6\"><hr/></td></tr><tr><td/><td align=\"center\">Female</td><td align=\"center\">1 (12.5)</td><td align=\"center\">3 (37.5)</td><td align=\"center\">4 (50.0)</td><td align=\"center\">3 (37.5)</td><td align=\"center\">0 (0.0)</td></tr><tr><td colspan=\"7\"><hr/></td></tr><tr><td align=\"center\">Age (years)</td><td align=\"center\">Mean (SD)</td><td align=\"center\">33.6 (7.8)</td><td align=\"center\">35.4 (6.6)</td><td align=\"center\">30.3 (5.1)</td><td align=\"center\">33.8 (5.7)</td><td align=\"center\">39.6 (7.3)</td></tr><tr><td colspan=\"7\"><hr/></td></tr><tr><td align=\"center\">Weight (kg)</td><td align=\"center\">Mean (SD)</td><td align=\"center\">78.3 (10.4)</td><td align=\"center\">81.2 (12.1)</td><td align=\"center\">79.4 (7.9)</td><td align=\"center\">76.3 (6.1)</td><td align=\"center\">90.6 (11.9)</td></tr><tr><td colspan=\"7\"><hr/></td></tr><tr><td align=\"center\">Height (cm)</td><td align=\"center\">Mean (SD)</td><td align=\"center\">177 (11)</td><td align=\"center\">175 (8)</td><td align=\"center\">170 (10)</td><td align=\"center\">173 (5)</td><td align=\"center\">181 (4)</td></tr></tbody></table></body></html>","text":"Pmid= 2639539:Table= Table 1","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":621623890,"_task_hash":-762565745,"_view_id":"choice","accept":[5],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":"tableclass-test-params-100-gill","sessions":["tableclass-test-params-100-frank","tableclass-test-params-100-gill","tableclass-test-params-100-vicky"],"default":true}],"view_id":"choice"}
{"html":"<!DOCTYPE html><html><body><h1>Pharmacokinetic parameters by treatment and dose level</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td align=\"center\">Treatment</td><td align=\"center\">Dose</td><td align=\"center\">N</td><td align=\"center\">Cmax</td><td align=\"center\">AUC<sub>(0&#8211;72)</sub></td><td align=\"center\">AUC<sub>(0-&#8734;)</sub></td><td align=\"center\">Clearance</td><td align=\"center\">Terminal elimination half life</td><td align=\"center\">Estimated Alpha half life</td><td align=\"center\">Volume of distribution</td><td align=\"center\">Volume of distribution</td><td align=\"center\">Tmax*</td></tr></thead><tbody><tr><td/><td align=\"center\">mcg/kg</td><td/><td align=\"center\">pg/mL</td><td align=\"center\">hr*pg/mL</td><td align=\"center\">hr*pg/mL</td><td align=\"center\">mL/min</td><td align=\"center\">hr</td><td align=\"center\">hr</td><td align=\"center\">L</td><td align=\"center\">L/kg</td><td align=\"center\">hr</td></tr><tr><td colspan=\"12\"><hr/></td></tr><tr><td align=\"center\">AVI-014</td><td align=\"center\">4</td><td align=\"center\">16</td><td align=\"center\">16,944 <italic>(5,804)</italic></td><td align=\"center\">138,993 <italic>(48,262)</italic></td><td align=\"center\">139,818 <italic>(48,332)</italic></td><td align=\"center\">43 <italic>(18)</italic></td><td align=\"center\">15.1 <italic>(3.6)</italic></td><td align=\"center\">3.4 <italic>(0.5)</italic></td><td align=\"center\">58 <italic>(33)</italic></td><td align=\"center\">0.73 <italic>(0.37)</italic></td><td align=\"center\">4.5</td></tr><tr><td colspan=\"12\"><hr/></td></tr><tr><td align=\"center\">Filgrastim</td><td align=\"center\">4</td><td align=\"center\">8</td><td align=\"center\">22,595 <italic>(6,076)</italic></td><td align=\"center\">175,323 <italic>(50,665)</italic></td><td align=\"center\">176,145 <italic>(51,004)</italic></td><td align=\"center\">32 <italic>(8)</italic></td><td align=\"center\">14.7 (<italic>3.9)</italic></td><td align=\"center\">2.8 <italic>(0.6)</italic></td><td align=\"center\">42 <italic>(19)</italic></td><td align=\"center\">0.54 <italic>(0.27)</italic></td><td align=\"center\">5</td></tr><tr><td colspan=\"12\"><hr/></td></tr><tr><td align=\"center\">AVI-014</td><td align=\"center\">8</td><td align=\"center\">8</td><td align=\"center\">31,460 <italic>(7,927)</italic></td><td align=\"center\">312,569 <italic>(81,029)</italic></td><td align=\"center\">313,525 <italic>(81,043)</italic></td><td align=\"center\">35 <italic>(11)</italic></td><td align=\"center\">11.0 <italic>(2.2)</italic></td><td align=\"center\">3.7 <italic>(0.3)</italic></td><td align=\"center\">35 <italic>(18)</italic></td><td align=\"center\">0.45 <italic>(0.23)</italic></td><td align=\"center\">5</td></tr><tr><td colspan=\"12\"><hr/></td></tr><tr><td align=\"center\">Filgrastim</td><td align=\"center\">8</td><td align=\"center\">8</td><td align=\"center\">41,442 <italic>(9,986)</italic></td><td align=\"center\">347,053 <italic>(70,749)</italic></td><td align=\"center\">347,489 <italic>(70,698)</italic></td><td align=\"center\">36 <italic>(10)</italic></td><td align=\"center\">9.8 <italic>(2.3)</italic></td><td align=\"center\">3.1 <italic>(0.5)</italic></td><td align=\"center\">31 <italic>(15)</italic></td><td align=\"center\">0.35 <italic>(0.14)</italic></td><td align=\"center\">6</td></tr></tbody></table></body></html>","text":"Pmid= 2639539:Table= Table 2","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":517785415,"_task_hash":1853283191,"_view_id":"review","accept":[2,1],"config":{"choice_style":"multiple"},"answer":"accept","user_input":"Cmax, AUC and Tmax could equally be from NCA, or could be secondary parameters to a compartmental analysis","_session_id":null,"sessions":["tableclass-test-params-100-gill"],"versions":[{"html":"<!DOCTYPE html><html><body><h1>Pharmacokinetic parameters by treatment and dose level</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td align=\"center\">Treatment</td><td align=\"center\">Dose</td><td align=\"center\">N</td><td align=\"center\">Cmax</td><td align=\"center\">AUC<sub>(0&#8211;72)</sub></td><td align=\"center\">AUC<sub>(0-&#8734;)</sub></td><td align=\"center\">Clearance</td><td align=\"center\">Terminal elimination half life</td><td align=\"center\">Estimated Alpha half life</td><td align=\"center\">Volume of distribution</td><td align=\"center\">Volume of distribution</td><td align=\"center\">Tmax*</td></tr></thead><tbody><tr><td/><td align=\"center\">mcg/kg</td><td/><td align=\"center\">pg/mL</td><td align=\"center\">hr*pg/mL</td><td align=\"center\">hr*pg/mL</td><td align=\"center\">mL/min</td><td align=\"center\">hr</td><td align=\"center\">hr</td><td align=\"center\">L</td><td align=\"center\">L/kg</td><td align=\"center\">hr</td></tr><tr><td colspan=\"12\"><hr/></td></tr><tr><td align=\"center\">AVI-014</td><td align=\"center\">4</td><td align=\"center\">16</td><td align=\"center\">16,944 <italic>(5,804)</italic></td><td align=\"center\">138,993 <italic>(48,262)</italic></td><td align=\"center\">139,818 <italic>(48,332)</italic></td><td align=\"center\">43 <italic>(18)</italic></td><td align=\"center\">15.1 <italic>(3.6)</italic></td><td align=\"center\">3.4 <italic>(0.5)</italic></td><td align=\"center\">58 <italic>(33)</italic></td><td align=\"center\">0.73 <italic>(0.37)</italic></td><td align=\"center\">4.5</td></tr><tr><td colspan=\"12\"><hr/></td></tr><tr><td align=\"center\">Filgrastim</td><td align=\"center\">4</td><td align=\"center\">8</td><td align=\"center\">22,595 <italic>(6,076)</italic></td><td align=\"center\">175,323 <italic>(50,665)</italic></td><td align=\"center\">176,145 <italic>(51,004)</italic></td><td align=\"center\">32 <italic>(8)</italic></td><td align=\"center\">14.7 (<italic>3.9)</italic></td><td align=\"center\">2.8 <italic>(0.6)</italic></td><td align=\"center\">42 <italic>(19)</italic></td><td align=\"center\">0.54 <italic>(0.27)</italic></td><td align=\"center\">5</td></tr><tr><td colspan=\"12\"><hr/></td></tr><tr><td align=\"center\">AVI-014</td><td align=\"center\">8</td><td align=\"center\">8</td><td align=\"center\">31,460 <italic>(7,927)</italic></td><td align=\"center\">312,569 <italic>(81,029)</italic></td><td align=\"center\">313,525 <italic>(81,043)</italic></td><td align=\"center\">35 <italic>(11)</italic></td><td align=\"center\">11.0 <italic>(2.2)</italic></td><td align=\"center\">3.7 <italic>(0.3)</italic></td><td align=\"center\">35 <italic>(18)</italic></td><td align=\"center\">0.45 <italic>(0.23)</italic></td><td align=\"center\">5</td></tr><tr><td colspan=\"12\"><hr/></td></tr><tr><td align=\"center\">Filgrastim</td><td align=\"center\">8</td><td align=\"center\">8</td><td align=\"center\">41,442 <italic>(9,986)</italic></td><td align=\"center\">347,053 <italic>(70,749)</italic></td><td align=\"center\">347,489 <italic>(70,698)</italic></td><td align=\"center\">36 <italic>(10)</italic></td><td align=\"center\">9.8 <italic>(2.3)</italic></td><td align=\"center\">3.1 <italic>(0.5)</italic></td><td align=\"center\">31 <italic>(15)</italic></td><td align=\"center\">0.35 <italic>(0.14)</italic></td><td align=\"center\">6</td></tr></tbody></table></body></html>","text":"Pmid= 2639539:Table= Table 2","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":517785415,"_task_hash":1853283191,"_view_id":"choice","accept":[2,1],"config":{"choice_style":"multiple"},"answer":"accept","user_input":"Cmax, AUC and Tmax could equally be from NCA, or could be secondary parameters to a compartmental analysis","_session_id":"tableclass-test-params-100-gill","sessions":["tableclass-test-params-100-gill"],"default":true},{"html":"<!DOCTYPE html><html><body><h1>Pharmacokinetic parameters by treatment and dose level</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td align=\"center\">Treatment</td><td align=\"center\">Dose</td><td align=\"center\">N</td><td align=\"center\">Cmax</td><td align=\"center\">AUC<sub>(0&#8211;72)</sub></td><td align=\"center\">AUC<sub>(0-&#8734;)</sub></td><td align=\"center\">Clearance</td><td align=\"center\">Terminal elimination half life</td><td align=\"center\">Estimated Alpha half life</td><td align=\"center\">Volume of distribution</td><td align=\"center\">Volume of distribution</td><td align=\"center\">Tmax*</td></tr></thead><tbody><tr><td/><td align=\"center\">mcg/kg</td><td/><td align=\"center\">pg/mL</td><td align=\"center\">hr*pg/mL</td><td align=\"center\">hr*pg/mL</td><td align=\"center\">mL/min</td><td align=\"center\">hr</td><td align=\"center\">hr</td><td align=\"center\">L</td><td align=\"center\">L/kg</td><td align=\"center\">hr</td></tr><tr><td colspan=\"12\"><hr/></td></tr><tr><td align=\"center\">AVI-014</td><td align=\"center\">4</td><td align=\"center\">16</td><td align=\"center\">16,944 <italic>(5,804)</italic></td><td align=\"center\">138,993 <italic>(48,262)</italic></td><td align=\"center\">139,818 <italic>(48,332)</italic></td><td align=\"center\">43 <italic>(18)</italic></td><td align=\"center\">15.1 <italic>(3.6)</italic></td><td align=\"center\">3.4 <italic>(0.5)</italic></td><td align=\"center\">58 <italic>(33)</italic></td><td align=\"center\">0.73 <italic>(0.37)</italic></td><td align=\"center\">4.5</td></tr><tr><td colspan=\"12\"><hr/></td></tr><tr><td align=\"center\">Filgrastim</td><td align=\"center\">4</td><td align=\"center\">8</td><td align=\"center\">22,595 <italic>(6,076)</italic></td><td align=\"center\">175,323 <italic>(50,665)</italic></td><td align=\"center\">176,145 <italic>(51,004)</italic></td><td align=\"center\">32 <italic>(8)</italic></td><td align=\"center\">14.7 (<italic>3.9)</italic></td><td align=\"center\">2.8 <italic>(0.6)</italic></td><td align=\"center\">42 <italic>(19)</italic></td><td align=\"center\">0.54 <italic>(0.27)</italic></td><td align=\"center\">5</td></tr><tr><td colspan=\"12\"><hr/></td></tr><tr><td align=\"center\">AVI-014</td><td align=\"center\">8</td><td align=\"center\">8</td><td align=\"center\">31,460 <italic>(7,927)</italic></td><td align=\"center\">312,569 <italic>(81,029)</italic></td><td align=\"center\">313,525 <italic>(81,043)</italic></td><td align=\"center\">35 <italic>(11)</italic></td><td align=\"center\">11.0 <italic>(2.2)</italic></td><td align=\"center\">3.7 <italic>(0.3)</italic></td><td align=\"center\">35 <italic>(18)</italic></td><td align=\"center\">0.45 <italic>(0.23)</italic></td><td align=\"center\">5</td></tr><tr><td colspan=\"12\"><hr/></td></tr><tr><td align=\"center\">Filgrastim</td><td align=\"center\">8</td><td align=\"center\">8</td><td align=\"center\">41,442 <italic>(9,986)</italic></td><td align=\"center\">347,053 <italic>(70,749)</italic></td><td align=\"center\">347,489 <italic>(70,698)</italic></td><td align=\"center\">36 <italic>(10)</italic></td><td align=\"center\">9.8 <italic>(2.3)</italic></td><td align=\"center\">3.1 <italic>(0.5)</italic></td><td align=\"center\">31 <italic>(15)</italic></td><td align=\"center\">0.35 <italic>(0.14)</italic></td><td align=\"center\">6</td></tr></tbody></table></body></html>","text":"Pmid= 2639539:Table= Table 2","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":517785415,"_task_hash":608428273,"_view_id":"choice","accept":[1],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":"tableclass-test-params-100-frank","sessions":["tableclass-test-params-100-frank"],"default":false},{"html":"<!DOCTYPE html><html><body><h1>Pharmacokinetic parameters by treatment and dose level</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td align=\"center\">Treatment</td><td align=\"center\">Dose</td><td align=\"center\">N</td><td align=\"center\">Cmax</td><td align=\"center\">AUC<sub>(0&#8211;72)</sub></td><td align=\"center\">AUC<sub>(0-&#8734;)</sub></td><td align=\"center\">Clearance</td><td align=\"center\">Terminal elimination half life</td><td align=\"center\">Estimated Alpha half life</td><td align=\"center\">Volume of distribution</td><td align=\"center\">Volume of distribution</td><td align=\"center\">Tmax*</td></tr></thead><tbody><tr><td/><td align=\"center\">mcg/kg</td><td/><td align=\"center\">pg/mL</td><td align=\"center\">hr*pg/mL</td><td align=\"center\">hr*pg/mL</td><td align=\"center\">mL/min</td><td align=\"center\">hr</td><td align=\"center\">hr</td><td align=\"center\">L</td><td align=\"center\">L/kg</td><td align=\"center\">hr</td></tr><tr><td colspan=\"12\"><hr/></td></tr><tr><td align=\"center\">AVI-014</td><td align=\"center\">4</td><td align=\"center\">16</td><td align=\"center\">16,944 <italic>(5,804)</italic></td><td align=\"center\">138,993 <italic>(48,262)</italic></td><td align=\"center\">139,818 <italic>(48,332)</italic></td><td align=\"center\">43 <italic>(18)</italic></td><td align=\"center\">15.1 <italic>(3.6)</italic></td><td align=\"center\">3.4 <italic>(0.5)</italic></td><td align=\"center\">58 <italic>(33)</italic></td><td align=\"center\">0.73 <italic>(0.37)</italic></td><td align=\"center\">4.5</td></tr><tr><td colspan=\"12\"><hr/></td></tr><tr><td align=\"center\">Filgrastim</td><td align=\"center\">4</td><td align=\"center\">8</td><td align=\"center\">22,595 <italic>(6,076)</italic></td><td align=\"center\">175,323 <italic>(50,665)</italic></td><td align=\"center\">176,145 <italic>(51,004)</italic></td><td align=\"center\">32 <italic>(8)</italic></td><td align=\"center\">14.7 (<italic>3.9)</italic></td><td align=\"center\">2.8 <italic>(0.6)</italic></td><td align=\"center\">42 <italic>(19)</italic></td><td align=\"center\">0.54 <italic>(0.27)</italic></td><td align=\"center\">5</td></tr><tr><td colspan=\"12\"><hr/></td></tr><tr><td align=\"center\">AVI-014</td><td align=\"center\">8</td><td align=\"center\">8</td><td align=\"center\">31,460 <italic>(7,927)</italic></td><td align=\"center\">312,569 <italic>(81,029)</italic></td><td align=\"center\">313,525 <italic>(81,043)</italic></td><td align=\"center\">35 <italic>(11)</italic></td><td align=\"center\">11.0 <italic>(2.2)</italic></td><td align=\"center\">3.7 <italic>(0.3)</italic></td><td align=\"center\">35 <italic>(18)</italic></td><td align=\"center\">0.45 <italic>(0.23)</italic></td><td align=\"center\">5</td></tr><tr><td colspan=\"12\"><hr/></td></tr><tr><td align=\"center\">Filgrastim</td><td align=\"center\">8</td><td align=\"center\">8</td><td align=\"center\">41,442 <italic>(9,986)</italic></td><td align=\"center\">347,053 <italic>(70,749)</italic></td><td align=\"center\">347,489 <italic>(70,698)</italic></td><td align=\"center\">36 <italic>(10)</italic></td><td align=\"center\">9.8 <italic>(2.3)</italic></td><td align=\"center\">3.1 <italic>(0.5)</italic></td><td align=\"center\">31 <italic>(15)</italic></td><td align=\"center\">0.35 <italic>(0.14)</italic></td><td align=\"center\">6</td></tr></tbody></table></body></html>","text":"Pmid= 2639539:Table= Table 2","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":517785415,"_task_hash":45268430,"_view_id":"choice","accept":[1,2],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":"tableclass-test-params-100-vicky","sessions":["tableclass-test-params-100-vicky"],"default":false}],"view_id":"choice"}
{"html":"<!DOCTYPE html><html><body><h1>Pharmacokinetic geometric mean ratios of AVI-014/filgrastim at 4 \u03bcg/kg</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td align=\"center\">PK parameter</td><td align=\"center\">Dose mcg/kg</td><td align=\"center\">Geo Mean AVI-014 (n = 16)</td><td align=\"center\">Geo Mean Filgrastin (n = 8)</td><td align=\"center\">P value</td><td align=\"center\">Geo Mean Ratio (90% CI)</td></tr></thead><tbody><tr><td align=\"center\">AUC<sub>(0&#8211;72)</sub></td><td align=\"center\">4</td><td align=\"center\">169.545</td><td align=\"center\">170,259</td><td align=\"center\">0.9766</td><td align=\"center\">1.00 (0.76, 1.31)</td></tr><tr><td colspan=\"6\"><hr/></td></tr><tr><td align=\"center\">Cmax</td><td align=\"center\">4</td><td align=\"center\">18,830</td><td align=\"center\">21,855</td><td align=\"center\">0.2952</td><td align=\"center\">0.86 (0.66, 1.13)</td></tr></tbody></table></body></html>","text":"Pmid= 2639539:Table= Table 3","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":-1936698014,"_task_hash":-1619281899,"_view_id":"review","accept":[3],"config":{"choice_style":"multiple"},"answer":"accept","user_input":"","_session_id":null,"sessions":["tableclass-test-params-100-gill","tableclass-test-params-100-vicky"],"versions":[{"html":"<!DOCTYPE html><html><body><h1>Pharmacokinetic geometric mean ratios of AVI-014/filgrastim at 4 \u03bcg/kg</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td align=\"center\">PK parameter</td><td align=\"center\">Dose mcg/kg</td><td align=\"center\">Geo Mean AVI-014 (n = 16)</td><td align=\"center\">Geo Mean Filgrastin (n = 8)</td><td align=\"center\">P value</td><td align=\"center\">Geo Mean Ratio (90% CI)</td></tr></thead><tbody><tr><td align=\"center\">AUC<sub>(0&#8211;72)</sub></td><td align=\"center\">4</td><td align=\"center\">169.545</td><td align=\"center\">170,259</td><td align=\"center\">0.9766</td><td align=\"center\">1.00 (0.76, 1.31)</td></tr><tr><td colspan=\"6\"><hr/></td></tr><tr><td align=\"center\">Cmax</td><td align=\"center\">4</td><td align=\"center\">18,830</td><td align=\"center\">21,855</td><td align=\"center\">0.2952</td><td align=\"center\">0.86 (0.66, 1.13)</td></tr></tbody></table></body></html>","text":"Pmid= 2639539:Table= Table 3","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":-1936698014,"_task_hash":-1619281899,"_view_id":"choice","accept":[3],"config":{"choice_style":"multiple"},"answer":"accept","user_input":"","_session_id":"tableclass-test-params-100-gill","sessions":["tableclass-test-params-100-gill","tableclass-test-params-100-vicky"],"default":true},{"html":"<!DOCTYPE html><html><body><h1>Pharmacokinetic geometric mean ratios of AVI-014/filgrastim at 4 \u03bcg/kg</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td align=\"center\">PK parameter</td><td align=\"center\">Dose mcg/kg</td><td align=\"center\">Geo Mean AVI-014 (n = 16)</td><td align=\"center\">Geo Mean Filgrastin (n = 8)</td><td align=\"center\">P value</td><td align=\"center\">Geo Mean Ratio (90% CI)</td></tr></thead><tbody><tr><td align=\"center\">AUC<sub>(0&#8211;72)</sub></td><td align=\"center\">4</td><td align=\"center\">169.545</td><td align=\"center\">170,259</td><td align=\"center\">0.9766</td><td align=\"center\">1.00 (0.76, 1.31)</td></tr><tr><td colspan=\"6\"><hr/></td></tr><tr><td align=\"center\">Cmax</td><td align=\"center\">4</td><td align=\"center\">18,830</td><td align=\"center\">21,855</td><td align=\"center\">0.2952</td><td align=\"center\">0.86 (0.66, 1.13)</td></tr></tbody></table></body></html>","text":"Pmid= 2639539:Table= Table 3","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":-1936698014,"_task_hash":-1574792456,"_view_id":"choice","accept":[1],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":"tableclass-test-params-100-frank","sessions":["tableclass-test-params-100-frank"],"default":false}],"view_id":"choice"}
{"html":"<!DOCTYPE html><html><body><h1>Pharmacokinetic Geometric Mean ratios of AVI-014/Filgrastim at 8 \u03bcg/kg</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td align=\"center\"><bold>PK parameter</bold></td><td align=\"center\"><bold>Dose &#956;g/kg</bold></td><td align=\"center\"><bold>Geometric Mean AVI-014 (n = 8)</bold></td><td align=\"center\"><bold>Geometric Mean Filgrastin (n = 8)</bold></td><td align=\"center\"><bold>P value</bold></td><td align=\"center\"><bold>Geometric Mean Ratio (90% CI)</bold></td></tr></thead><tbody><tr><td align=\"center\">AUC<sub>(0&#8211;72)</sub></td><td align=\"center\">8</td><td align=\"center\">301,979</td><td align=\"center\">340,837</td><td align=\"center\">0.3669</td><td align=\"center\">0.89 (0.69, 1.14)</td></tr><tr><td colspan=\"6\"><hr/></td></tr><tr><td align=\"center\">Cmax</td><td align=\"center\">8</td><td align=\"center\">30,467</td><td align=\"center\">40,325</td><td align=\"center\">0.0550</td><td align=\"center\">0.76 (0.58, 0.98)</td></tr></tbody></table></body></html>","text":"Pmid= 2639539:Table= Table 4","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":-1326532006,"_task_hash":1058093661,"_view_id":"review","accept":[3],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":null,"sessions":["tableclass-test-params-100-gill","tableclass-test-params-100-vicky"],"versions":[{"html":"<!DOCTYPE html><html><body><h1>Pharmacokinetic Geometric Mean ratios of AVI-014/Filgrastim at 8 \u03bcg/kg</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td align=\"center\"><bold>PK parameter</bold></td><td align=\"center\"><bold>Dose &#956;g/kg</bold></td><td align=\"center\"><bold>Geometric Mean AVI-014 (n = 8)</bold></td><td align=\"center\"><bold>Geometric Mean Filgrastin (n = 8)</bold></td><td align=\"center\"><bold>P value</bold></td><td align=\"center\"><bold>Geometric Mean Ratio (90% CI)</bold></td></tr></thead><tbody><tr><td align=\"center\">AUC<sub>(0&#8211;72)</sub></td><td align=\"center\">8</td><td align=\"center\">301,979</td><td align=\"center\">340,837</td><td align=\"center\">0.3669</td><td align=\"center\">0.89 (0.69, 1.14)</td></tr><tr><td colspan=\"6\"><hr/></td></tr><tr><td align=\"center\">Cmax</td><td align=\"center\">8</td><td align=\"center\">30,467</td><td align=\"center\">40,325</td><td align=\"center\">0.0550</td><td align=\"center\">0.76 (0.58, 0.98)</td></tr></tbody></table></body></html>","text":"Pmid= 2639539:Table= Table 4","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":-1326532006,"_task_hash":1058093661,"_view_id":"choice","accept":[3],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":"tableclass-test-params-100-gill","sessions":["tableclass-test-params-100-gill","tableclass-test-params-100-vicky"],"default":true},{"html":"<!DOCTYPE html><html><body><h1>Pharmacokinetic Geometric Mean ratios of AVI-014/Filgrastim at 8 \u03bcg/kg</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td align=\"center\"><bold>PK parameter</bold></td><td align=\"center\"><bold>Dose &#956;g/kg</bold></td><td align=\"center\"><bold>Geometric Mean AVI-014 (n = 8)</bold></td><td align=\"center\"><bold>Geometric Mean Filgrastin (n = 8)</bold></td><td align=\"center\"><bold>P value</bold></td><td align=\"center\"><bold>Geometric Mean Ratio (90% CI)</bold></td></tr></thead><tbody><tr><td align=\"center\">AUC<sub>(0&#8211;72)</sub></td><td align=\"center\">8</td><td align=\"center\">301,979</td><td align=\"center\">340,837</td><td align=\"center\">0.3669</td><td align=\"center\">0.89 (0.69, 1.14)</td></tr><tr><td colspan=\"6\"><hr/></td></tr><tr><td align=\"center\">Cmax</td><td align=\"center\">8</td><td align=\"center\">30,467</td><td align=\"center\">40,325</td><td align=\"center\">0.0550</td><td align=\"center\">0.76 (0.58, 0.98)</td></tr></tbody></table></body></html>","text":"Pmid= 2639539:Table= Table 4","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":-1326532006,"_task_hash":-790151576,"_view_id":"choice","accept":[1],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":"tableclass-test-params-100-frank","sessions":["tableclass-test-params-100-frank"],"default":false}],"view_id":"choice"}
{"html":"<!DOCTYPE html><html><body><h1>Pharmacodynamic geometric mean ratios of AVI-014/filgrastim at 4 \u03bcg/kg</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td align=\"center\"><bold>Hematologic</bold></td><td align=\"center\"><bold>Parameter</bold></td><td align=\"center\"><bold>Dose &#956;g/kg</bold></td><td align=\"center\"><bold>Geometric Mean AVI-014 (n = 8)</bold></td><td align=\"center\"><bold>Geometric Mean Filgrastin (n = 8)</bold></td><td align=\"center\"><bold>P value</bold></td><td align=\"center\"><bold>Geometric Mean Ratio (90% CI)</bold></td></tr></thead><tbody><tr><td align=\"center\">WBC</td><td align=\"center\">AUC<sub>(0&#8211;9)</sub></td><td align=\"center\">4</td><td align=\"center\">1343.9</td><td align=\"center\">1193.6</td><td align=\"center\">0.1473</td><td align=\"center\">1.13 (0.98, 1.29)</td></tr><tr><td colspan=\"7\"><hr/></td></tr><tr><td/><td align=\"center\">Cmax</td><td align=\"center\">4</td><td align=\"center\">375.1</td><td align=\"center\">326.7</td><td align=\"center\">0.1737</td><td align=\"center\">1.15 (0.97, 1.36)</td></tr><tr><td colspan=\"7\"><hr/></td></tr><tr><td align=\"center\">ANC</td><td align=\"center\">AUC<sub>(0&#8211;9)</sub></td><td align=\"center\">4</td><td align=\"center\">2146.3</td><td align=\"center\">1560.3</td><td align=\"center\">0.0489</td><td align=\"center\">1.38 (1.06, 1.78)</td></tr><tr><td colspan=\"7\"><hr/></td></tr><tr><td/><td align=\"center\">Cmax</td><td align=\"center\">4</td><td align=\"center\">735.9</td><td align=\"center\">515.8</td><td align=\"center\">0.0690</td><td align=\"center\">1.43 (1.04, 1.96)</td></tr><tr><td colspan=\"7\"><hr/></td></tr><tr><td align=\"center\">CD 34+</td><td align=\"center\">AUC<sub>(0&#8211;6)</sub></td><td align=\"center\">4</td><td align=\"center\">3208.8</td><td align=\"center\">3088.9</td><td align=\"center\">0.9613</td><td align=\"center\">1.04 (0.27, 4.06)</td></tr><tr><td colspan=\"7\"><hr/></td></tr><tr><td/><td align=\"center\">Cmax</td><td align=\"center\">4</td><td align=\"center\">1322.7</td><td align=\"center\">1186.3</td><td align=\"center\">0.8875</td><td align=\"center\">1.12 (0.29, 4.24)</td></tr></tbody></table></body></html>","text":"Pmid= 2639539:Table= Table 5","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":1281013541,"_task_hash":282087216,"_view_id":"review","accept":[4,3],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":null,"sessions":["tableclass-test-params-100-gill"],"versions":[{"html":"<!DOCTYPE html><html><body><h1>Pharmacodynamic geometric mean ratios of AVI-014/filgrastim at 4 \u03bcg/kg</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td align=\"center\"><bold>Hematologic</bold></td><td align=\"center\"><bold>Parameter</bold></td><td align=\"center\"><bold>Dose &#956;g/kg</bold></td><td align=\"center\"><bold>Geometric Mean AVI-014 (n = 8)</bold></td><td align=\"center\"><bold>Geometric Mean Filgrastin (n = 8)</bold></td><td align=\"center\"><bold>P value</bold></td><td align=\"center\"><bold>Geometric Mean Ratio (90% CI)</bold></td></tr></thead><tbody><tr><td align=\"center\">WBC</td><td align=\"center\">AUC<sub>(0&#8211;9)</sub></td><td align=\"center\">4</td><td align=\"center\">1343.9</td><td align=\"center\">1193.6</td><td align=\"center\">0.1473</td><td align=\"center\">1.13 (0.98, 1.29)</td></tr><tr><td colspan=\"7\"><hr/></td></tr><tr><td/><td align=\"center\">Cmax</td><td align=\"center\">4</td><td align=\"center\">375.1</td><td align=\"center\">326.7</td><td align=\"center\">0.1737</td><td align=\"center\">1.15 (0.97, 1.36)</td></tr><tr><td colspan=\"7\"><hr/></td></tr><tr><td align=\"center\">ANC</td><td align=\"center\">AUC<sub>(0&#8211;9)</sub></td><td align=\"center\">4</td><td align=\"center\">2146.3</td><td align=\"center\">1560.3</td><td align=\"center\">0.0489</td><td align=\"center\">1.38 (1.06, 1.78)</td></tr><tr><td colspan=\"7\"><hr/></td></tr><tr><td/><td align=\"center\">Cmax</td><td align=\"center\">4</td><td align=\"center\">735.9</td><td align=\"center\">515.8</td><td align=\"center\">0.0690</td><td align=\"center\">1.43 (1.04, 1.96)</td></tr><tr><td colspan=\"7\"><hr/></td></tr><tr><td align=\"center\">CD 34+</td><td align=\"center\">AUC<sub>(0&#8211;6)</sub></td><td align=\"center\">4</td><td align=\"center\">3208.8</td><td align=\"center\">3088.9</td><td align=\"center\">0.9613</td><td align=\"center\">1.04 (0.27, 4.06)</td></tr><tr><td colspan=\"7\"><hr/></td></tr><tr><td/><td align=\"center\">Cmax</td><td align=\"center\">4</td><td align=\"center\">1322.7</td><td align=\"center\">1186.3</td><td align=\"center\">0.8875</td><td align=\"center\">1.12 (0.29, 4.24)</td></tr></tbody></table></body></html>","text":"Pmid= 2639539:Table= Table 5","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":1281013541,"_task_hash":282087216,"_view_id":"choice","accept":[4,3],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":"tableclass-test-params-100-gill","sessions":["tableclass-test-params-100-gill"],"default":true},{"html":"<!DOCTYPE html><html><body><h1>Pharmacodynamic geometric mean ratios of AVI-014/filgrastim at 4 \u03bcg/kg</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td align=\"center\"><bold>Hematologic</bold></td><td align=\"center\"><bold>Parameter</bold></td><td align=\"center\"><bold>Dose &#956;g/kg</bold></td><td align=\"center\"><bold>Geometric Mean AVI-014 (n = 8)</bold></td><td align=\"center\"><bold>Geometric Mean Filgrastin (n = 8)</bold></td><td align=\"center\"><bold>P value</bold></td><td align=\"center\"><bold>Geometric Mean Ratio (90% CI)</bold></td></tr></thead><tbody><tr><td align=\"center\">WBC</td><td align=\"center\">AUC<sub>(0&#8211;9)</sub></td><td align=\"center\">4</td><td align=\"center\">1343.9</td><td align=\"center\">1193.6</td><td align=\"center\">0.1473</td><td align=\"center\">1.13 (0.98, 1.29)</td></tr><tr><td colspan=\"7\"><hr/></td></tr><tr><td/><td align=\"center\">Cmax</td><td align=\"center\">4</td><td align=\"center\">375.1</td><td align=\"center\">326.7</td><td align=\"center\">0.1737</td><td align=\"center\">1.15 (0.97, 1.36)</td></tr><tr><td colspan=\"7\"><hr/></td></tr><tr><td align=\"center\">ANC</td><td align=\"center\">AUC<sub>(0&#8211;9)</sub></td><td align=\"center\">4</td><td align=\"center\">2146.3</td><td align=\"center\">1560.3</td><td align=\"center\">0.0489</td><td align=\"center\">1.38 (1.06, 1.78)</td></tr><tr><td colspan=\"7\"><hr/></td></tr><tr><td/><td align=\"center\">Cmax</td><td align=\"center\">4</td><td align=\"center\">735.9</td><td align=\"center\">515.8</td><td align=\"center\">0.0690</td><td align=\"center\">1.43 (1.04, 1.96)</td></tr><tr><td colspan=\"7\"><hr/></td></tr><tr><td align=\"center\">CD 34+</td><td align=\"center\">AUC<sub>(0&#8211;6)</sub></td><td align=\"center\">4</td><td align=\"center\">3208.8</td><td align=\"center\">3088.9</td><td align=\"center\">0.9613</td><td align=\"center\">1.04 (0.27, 4.06)</td></tr><tr><td colspan=\"7\"><hr/></td></tr><tr><td/><td align=\"center\">Cmax</td><td align=\"center\">4</td><td align=\"center\">1322.7</td><td align=\"center\">1186.3</td><td align=\"center\">0.8875</td><td align=\"center\">1.12 (0.29, 4.24)</td></tr></tbody></table></body></html>","text":"Pmid= 2639539:Table= Table 5","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":1281013541,"_task_hash":-242458785,"_view_id":"choice","accept":[1],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":"tableclass-test-params-100-frank","sessions":["tableclass-test-params-100-frank"],"default":false},{"html":"<!DOCTYPE html><html><body><h1>Pharmacodynamic geometric mean ratios of AVI-014/filgrastim at 4 \u03bcg/kg</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td align=\"center\"><bold>Hematologic</bold></td><td align=\"center\"><bold>Parameter</bold></td><td align=\"center\"><bold>Dose &#956;g/kg</bold></td><td align=\"center\"><bold>Geometric Mean AVI-014 (n = 8)</bold></td><td align=\"center\"><bold>Geometric Mean Filgrastin (n = 8)</bold></td><td align=\"center\"><bold>P value</bold></td><td align=\"center\"><bold>Geometric Mean Ratio (90% CI)</bold></td></tr></thead><tbody><tr><td align=\"center\">WBC</td><td align=\"center\">AUC<sub>(0&#8211;9)</sub></td><td align=\"center\">4</td><td align=\"center\">1343.9</td><td align=\"center\">1193.6</td><td align=\"center\">0.1473</td><td align=\"center\">1.13 (0.98, 1.29)</td></tr><tr><td colspan=\"7\"><hr/></td></tr><tr><td/><td align=\"center\">Cmax</td><td align=\"center\">4</td><td align=\"center\">375.1</td><td align=\"center\">326.7</td><td align=\"center\">0.1737</td><td align=\"center\">1.15 (0.97, 1.36)</td></tr><tr><td colspan=\"7\"><hr/></td></tr><tr><td align=\"center\">ANC</td><td align=\"center\">AUC<sub>(0&#8211;9)</sub></td><td align=\"center\">4</td><td align=\"center\">2146.3</td><td align=\"center\">1560.3</td><td align=\"center\">0.0489</td><td align=\"center\">1.38 (1.06, 1.78)</td></tr><tr><td colspan=\"7\"><hr/></td></tr><tr><td/><td align=\"center\">Cmax</td><td align=\"center\">4</td><td align=\"center\">735.9</td><td align=\"center\">515.8</td><td align=\"center\">0.0690</td><td align=\"center\">1.43 (1.04, 1.96)</td></tr><tr><td colspan=\"7\"><hr/></td></tr><tr><td align=\"center\">CD 34+</td><td align=\"center\">AUC<sub>(0&#8211;6)</sub></td><td align=\"center\">4</td><td align=\"center\">3208.8</td><td align=\"center\">3088.9</td><td align=\"center\">0.9613</td><td align=\"center\">1.04 (0.27, 4.06)</td></tr><tr><td colspan=\"7\"><hr/></td></tr><tr><td/><td align=\"center\">Cmax</td><td align=\"center\">4</td><td align=\"center\">1322.7</td><td align=\"center\">1186.3</td><td align=\"center\">0.8875</td><td align=\"center\">1.12 (0.29, 4.24)</td></tr></tbody></table></body></html>","text":"Pmid= 2639539:Table= Table 5","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":1281013541,"_task_hash":1969614755,"_view_id":"choice","accept":[3],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":"tableclass-test-params-100-vicky","sessions":["tableclass-test-params-100-vicky"],"default":false}],"view_id":"choice"}
{"html":"<!DOCTYPE html><html><body><h1>Pharmacodynamic geometric mean ratios of AVI-014/filgrastim at 8 \u03bcg/kg</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td align=\"center\"><bold>Hematologic</bold></td><td align=\"center\"><bold>Parameter</bold></td><td align=\"center\"><bold>Dose &#956;g/kg</bold></td><td align=\"center\"><bold>Geometric Mean AVI-014 (n = 8)</bold></td><td align=\"center\"><bold>Geometric Mean Filgrastin (n = 8)</bold></td><td align=\"center\"><bold>P value</bold></td><td align=\"center\"><bold>Geometric Mean Ratio (90% CI)</bold></td></tr></thead><tbody><tr><td align=\"center\">WBC</td><td align=\"center\">AUC<sub>(0&#8211;9)</sub></td><td align=\"center\">8</td><td align=\"center\">1444.7</td><td align=\"center\">1574.1</td><td align=\"center\">0.3824</td><td align=\"center\">0.92 (0.78, 1.09)</td></tr><tr><td colspan=\"7\"><hr/></td></tr><tr><td/><td align=\"center\">Cmax</td><td align=\"center\">8</td><td align=\"center\">415.9</td><td align=\"center\">435.7</td><td align=\"center\">0.6617</td><td align=\"center\">0.95 (0.79, 1.15)</td></tr><tr><td colspan=\"7\"><hr/></td></tr><tr><td align=\"center\">ANC</td><td align=\"center\">AUC<sub>(0&#8211;9)</sub></td><td align=\"center\">8</td><td align=\"center\">1974.4</td><td align=\"center\">2268.9</td><td align=\"center\">0.4626</td><td align=\"center\">0.87 (0.63, 1.21)</td></tr><tr><td colspan=\"7\"><hr/></td></tr><tr><td/><td align=\"center\">Cmax</td><td align=\"center\">8</td><td align=\"center\">661.3</td><td align=\"center\">739.6</td><td align=\"center\">0.6230</td><td align=\"center\">0.89 (0.60, 1.34)</td></tr><tr><td colspan=\"7\"><hr/></td></tr><tr><td align=\"center\">CD 34+</td><td align=\"center\">AUC<sub>(0&#8211;6)</sub></td><td align=\"center\">8</td><td align=\"center\">3121.6</td><td align=\"center\">2791.2</td><td align=\"center\">0.8785</td><td align=\"center\">1.12 (0.31, 3.99)</td></tr><tr><td colspan=\"7\"><hr/></td></tr><tr><td/><td align=\"center\">Cmax</td><td align=\"center\">8</td><td align=\"center\">1373.2</td><td align=\"center\">1315.9</td><td align=\"center\">0.9569</td><td align=\"center\">1.04 (0.26, 4.11)</td></tr></tbody></table></body></html>","text":"Pmid= 2639539:Table= Table 6","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":-659370700,"_task_hash":1795413076,"_view_id":"review","accept":[4,3],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":null,"sessions":["tableclass-test-params-100-gill"],"versions":[{"html":"<!DOCTYPE html><html><body><h1>Pharmacodynamic geometric mean ratios of AVI-014/filgrastim at 8 \u03bcg/kg</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td align=\"center\"><bold>Hematologic</bold></td><td align=\"center\"><bold>Parameter</bold></td><td align=\"center\"><bold>Dose &#956;g/kg</bold></td><td align=\"center\"><bold>Geometric Mean AVI-014 (n = 8)</bold></td><td align=\"center\"><bold>Geometric Mean Filgrastin (n = 8)</bold></td><td align=\"center\"><bold>P value</bold></td><td align=\"center\"><bold>Geometric Mean Ratio (90% CI)</bold></td></tr></thead><tbody><tr><td align=\"center\">WBC</td><td align=\"center\">AUC<sub>(0&#8211;9)</sub></td><td align=\"center\">8</td><td align=\"center\">1444.7</td><td align=\"center\">1574.1</td><td align=\"center\">0.3824</td><td align=\"center\">0.92 (0.78, 1.09)</td></tr><tr><td colspan=\"7\"><hr/></td></tr><tr><td/><td align=\"center\">Cmax</td><td align=\"center\">8</td><td align=\"center\">415.9</td><td align=\"center\">435.7</td><td align=\"center\">0.6617</td><td align=\"center\">0.95 (0.79, 1.15)</td></tr><tr><td colspan=\"7\"><hr/></td></tr><tr><td align=\"center\">ANC</td><td align=\"center\">AUC<sub>(0&#8211;9)</sub></td><td align=\"center\">8</td><td align=\"center\">1974.4</td><td align=\"center\">2268.9</td><td align=\"center\">0.4626</td><td align=\"center\">0.87 (0.63, 1.21)</td></tr><tr><td colspan=\"7\"><hr/></td></tr><tr><td/><td align=\"center\">Cmax</td><td align=\"center\">8</td><td align=\"center\">661.3</td><td align=\"center\">739.6</td><td align=\"center\">0.6230</td><td align=\"center\">0.89 (0.60, 1.34)</td></tr><tr><td colspan=\"7\"><hr/></td></tr><tr><td align=\"center\">CD 34+</td><td align=\"center\">AUC<sub>(0&#8211;6)</sub></td><td align=\"center\">8</td><td align=\"center\">3121.6</td><td align=\"center\">2791.2</td><td align=\"center\">0.8785</td><td align=\"center\">1.12 (0.31, 3.99)</td></tr><tr><td colspan=\"7\"><hr/></td></tr><tr><td/><td align=\"center\">Cmax</td><td align=\"center\">8</td><td align=\"center\">1373.2</td><td align=\"center\">1315.9</td><td align=\"center\">0.9569</td><td align=\"center\">1.04 (0.26, 4.11)</td></tr></tbody></table></body></html>","text":"Pmid= 2639539:Table= Table 6","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":-659370700,"_task_hash":1795413076,"_view_id":"choice","accept":[4,3],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":"tableclass-test-params-100-gill","sessions":["tableclass-test-params-100-gill"],"default":true},{"html":"<!DOCTYPE html><html><body><h1>Pharmacodynamic geometric mean ratios of AVI-014/filgrastim at 8 \u03bcg/kg</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td align=\"center\"><bold>Hematologic</bold></td><td align=\"center\"><bold>Parameter</bold></td><td align=\"center\"><bold>Dose &#956;g/kg</bold></td><td align=\"center\"><bold>Geometric Mean AVI-014 (n = 8)</bold></td><td align=\"center\"><bold>Geometric Mean Filgrastin (n = 8)</bold></td><td align=\"center\"><bold>P value</bold></td><td align=\"center\"><bold>Geometric Mean Ratio (90% CI)</bold></td></tr></thead><tbody><tr><td align=\"center\">WBC</td><td align=\"center\">AUC<sub>(0&#8211;9)</sub></td><td align=\"center\">8</td><td align=\"center\">1444.7</td><td align=\"center\">1574.1</td><td align=\"center\">0.3824</td><td align=\"center\">0.92 (0.78, 1.09)</td></tr><tr><td colspan=\"7\"><hr/></td></tr><tr><td/><td align=\"center\">Cmax</td><td align=\"center\">8</td><td align=\"center\">415.9</td><td align=\"center\">435.7</td><td align=\"center\">0.6617</td><td align=\"center\">0.95 (0.79, 1.15)</td></tr><tr><td colspan=\"7\"><hr/></td></tr><tr><td align=\"center\">ANC</td><td align=\"center\">AUC<sub>(0&#8211;9)</sub></td><td align=\"center\">8</td><td align=\"center\">1974.4</td><td align=\"center\">2268.9</td><td align=\"center\">0.4626</td><td align=\"center\">0.87 (0.63, 1.21)</td></tr><tr><td colspan=\"7\"><hr/></td></tr><tr><td/><td align=\"center\">Cmax</td><td align=\"center\">8</td><td align=\"center\">661.3</td><td align=\"center\">739.6</td><td align=\"center\">0.6230</td><td align=\"center\">0.89 (0.60, 1.34)</td></tr><tr><td colspan=\"7\"><hr/></td></tr><tr><td align=\"center\">CD 34+</td><td align=\"center\">AUC<sub>(0&#8211;6)</sub></td><td align=\"center\">8</td><td align=\"center\">3121.6</td><td align=\"center\">2791.2</td><td align=\"center\">0.8785</td><td align=\"center\">1.12 (0.31, 3.99)</td></tr><tr><td colspan=\"7\"><hr/></td></tr><tr><td/><td align=\"center\">Cmax</td><td align=\"center\">8</td><td align=\"center\">1373.2</td><td align=\"center\">1315.9</td><td align=\"center\">0.9569</td><td align=\"center\">1.04 (0.26, 4.11)</td></tr></tbody></table></body></html>","text":"Pmid= 2639539:Table= Table 6","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":-659370700,"_task_hash":-1269837377,"_view_id":"choice","accept":[1],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":"tableclass-test-params-100-frank","sessions":["tableclass-test-params-100-frank"],"default":false},{"html":"<!DOCTYPE html><html><body><h1>Pharmacodynamic geometric mean ratios of AVI-014/filgrastim at 8 \u03bcg/kg</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td align=\"center\"><bold>Hematologic</bold></td><td align=\"center\"><bold>Parameter</bold></td><td align=\"center\"><bold>Dose &#956;g/kg</bold></td><td align=\"center\"><bold>Geometric Mean AVI-014 (n = 8)</bold></td><td align=\"center\"><bold>Geometric Mean Filgrastin (n = 8)</bold></td><td align=\"center\"><bold>P value</bold></td><td align=\"center\"><bold>Geometric Mean Ratio (90% CI)</bold></td></tr></thead><tbody><tr><td align=\"center\">WBC</td><td align=\"center\">AUC<sub>(0&#8211;9)</sub></td><td align=\"center\">8</td><td align=\"center\">1444.7</td><td align=\"center\">1574.1</td><td align=\"center\">0.3824</td><td align=\"center\">0.92 (0.78, 1.09)</td></tr><tr><td colspan=\"7\"><hr/></td></tr><tr><td/><td align=\"center\">Cmax</td><td align=\"center\">8</td><td align=\"center\">415.9</td><td align=\"center\">435.7</td><td align=\"center\">0.6617</td><td align=\"center\">0.95 (0.79, 1.15)</td></tr><tr><td colspan=\"7\"><hr/></td></tr><tr><td align=\"center\">ANC</td><td align=\"center\">AUC<sub>(0&#8211;9)</sub></td><td align=\"center\">8</td><td align=\"center\">1974.4</td><td align=\"center\">2268.9</td><td align=\"center\">0.4626</td><td align=\"center\">0.87 (0.63, 1.21)</td></tr><tr><td colspan=\"7\"><hr/></td></tr><tr><td/><td align=\"center\">Cmax</td><td align=\"center\">8</td><td align=\"center\">661.3</td><td align=\"center\">739.6</td><td align=\"center\">0.6230</td><td align=\"center\">0.89 (0.60, 1.34)</td></tr><tr><td colspan=\"7\"><hr/></td></tr><tr><td align=\"center\">CD 34+</td><td align=\"center\">AUC<sub>(0&#8211;6)</sub></td><td align=\"center\">8</td><td align=\"center\">3121.6</td><td align=\"center\">2791.2</td><td align=\"center\">0.8785</td><td align=\"center\">1.12 (0.31, 3.99)</td></tr><tr><td colspan=\"7\"><hr/></td></tr><tr><td/><td align=\"center\">Cmax</td><td align=\"center\">8</td><td align=\"center\">1373.2</td><td align=\"center\">1315.9</td><td align=\"center\">0.9569</td><td align=\"center\">1.04 (0.26, 4.11)</td></tr></tbody></table></body></html>","text":"Pmid= 2639539:Table= Table 6","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":-659370700,"_task_hash":-1679473759,"_view_id":"choice","accept":[3],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":"tableclass-test-params-100-vicky","sessions":["tableclass-test-params-100-vicky"],"default":false}],"view_id":"choice"}
{"html":"<!DOCTYPE html><html><body><h1>Source and batch of antibiotics included in the study</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td align=\"left\"><bold>Product Code</bold></td><td align=\"left\"><bold>Batch</bold></td><td align=\"left\"><bold>Manufacturer</bold></td><td align=\"left\"><bold>Distributor</bold></td></tr></thead><tbody><tr><td align=\"left\">AMK-BMS (innovator)</td><td align=\"left\">01J115</td><td align=\"left\">Bristol-Myers Squibb (BMS), Guayaquil, Ecuador</td><td align=\"left\">Bristol-Myers Squibb, Cali, Colombia</td></tr><tr><td colspan=\"4\"><hr/></td></tr><tr><td align=\"left\">AMK-Carlon</td><td align=\"left\">278V0704</td><td align=\"left\">Carlon Ltda, Bogota, Colombia</td><td align=\"left\">Item</td></tr><tr><td colspan=\"4\"><hr/></td></tr><tr><td align=\"left\">AMK-Gencol</td><td align=\"left\">0200</td><td align=\"left\">Laboratorios Chalver, Bogota, Colombia</td><td align=\"left\">Genericos de Colombia (Gencol), Bogota, Colombia</td></tr><tr><td colspan=\"4\"><hr/></td></tr><tr><td align=\"left\">AMK-Pisa</td><td align=\"left\">121859</td><td align=\"left\">Laboratorios Pisa SA de CV, Guadalajara, Mexico</td><td align=\"left\">Laboratorios ECAR Ltda, Medellin, Colombia</td></tr><tr><td colspan=\"4\"><hr/></td></tr><tr><td align=\"left\">AMK-Scalpi</td><td align=\"left\">AK010348</td><td align=\"left\">Consorcio Farmionni-Lubelca, Bogota, Colombia</td><td align=\"left\">Farmionni Scalpi SA, Bogota, Colombia</td></tr><tr><td colspan=\"4\"><hr/></td></tr><tr><td align=\"left\">AMK-Sigma (Reference Powder)</td><td align=\"left\">120K1643</td><td align=\"left\">Sigma Chemical Co, St Louis, MO, USA</td><td align=\"left\">Not applicable</td></tr><tr><td colspan=\"4\"><hr/></td></tr><tr><td align=\"left\">GNT-SP (innovator)</td><td align=\"left\">CB3AMKB04</td><td align=\"left\">Schering-Plough SA (SP), Bogota, Colombia</td><td align=\"left\">Item</td></tr><tr><td colspan=\"4\"><hr/></td></tr><tr><td align=\"left\">GNT-Abbott</td><td align=\"left\">75-024-DK</td><td align=\"left\">Abbott Laboratories, North Chicago, IL, USA</td><td align=\"left\">Not available</td></tr><tr><td colspan=\"4\"><hr/></td></tr><tr><td align=\"left\">GNT-Az pharma</td><td align=\"left\">303030</td><td align=\"left\">Vitrofarma SA, Bogota DC, Colombia</td><td align=\"left\">AZ-Pharma SA, Bogota, Colombia</td></tr><tr><td colspan=\"4\"><hr/></td></tr><tr><td align=\"left\">GNT-Biochemie</td><td align=\"left\">07102321</td><td align=\"left\">Biochemie GmbH, Kundl, Austria</td><td align=\"left\">Novartis de Colombia SA, Bogota, Colombia</td></tr><tr><td colspan=\"4\"><hr/></td></tr><tr><td align=\"left\">GNT-Biogenta</td><td align=\"left\">0402</td><td align=\"left\">Laboratorios Chalver, Bogot&#225;, Colombia</td><td align=\"left\">Chalver Farmaceutica (Biogenta), Bogota Colombia</td></tr><tr><td colspan=\"4\"><hr/></td></tr><tr><td align=\"left\">GNT-Colmed</td><td align=\"left\">01005</td><td align=\"left\">Colmed Internacional, Barranquilla, Colombia</td><td align=\"left\">Procaps SA, Barranquilla, Colombia</td></tr><tr><td colspan=\"4\"><hr/></td></tr><tr><td align=\"left\">GNT-Genfar</td><td align=\"left\">030703</td><td align=\"left\">Viteco SA, Bogota, Colombia</td><td align=\"left\">Lab. Genericos Farmaceuticos, Bogota, Colombia</td></tr><tr><td colspan=\"4\"><hr/></td></tr><tr><td align=\"left\">GNT-Lab America</td><td align=\"left\">0980303</td><td align=\"left\">Arbofarma SA, Bogota, Colombia</td><td align=\"left\">Laboratorios America SA, Medellin, Colombia</td></tr><tr><td colspan=\"4\"><hr/></td></tr><tr><td align=\"left\">GNT-Labinco</td><td align=\"left\">01013C</td><td align=\"left\">Laboratorios Ryan, Bogota, Colombia</td><td align=\"left\">Laboratorio Internacional (Labinco), Bogota, Colombia</td></tr><tr><td colspan=\"4\"><hr/></td></tr><tr><td align=\"left\">GNT-La Sante</td><td align=\"left\">0310</td><td align=\"left\">Viteco SA, Bogota, Colombia</td><td align=\"left\">Laboratorios La Sante, Bogota, Colombia</td></tr><tr><td colspan=\"4\"><hr/></td></tr><tr><td align=\"left\">GNT-Memphis</td><td align=\"left\">2208I101</td><td align=\"left\">Vitrofarma SA, Bogota, Colombia</td><td align=\"left\">Memphis products SA, Bogota, Colombia</td></tr><tr><td colspan=\"4\"><hr/></td></tr><tr><td align=\"left\">GNT-MK</td><td align=\"left\">3P066</td><td align=\"left\">Vitrofarma SA, Bogota, Colombia</td><td align=\"left\">Tecnoquimica SA (MK), Cali Colombia</td></tr><tr><td colspan=\"4\"><hr/></td></tr><tr><td align=\"left\">GNT-Ophalac</td><td align=\"left\">004013</td><td align=\"left\">Vitrofarma SA, Bogota, Colombia</td><td align=\"left\">Laboratorios Farmaceuticos Ophalac, Bogota, Colombia</td></tr><tr><td colspan=\"4\"><hr/></td></tr><tr><td align=\"left\">GNT-Pentacoop</td><td align=\"left\">33544</td><td align=\"left\">Laboratorios Ryan, Bogota, Colombia</td><td align=\"left\">Pentacoop SA, Bogota DC, Colombia</td></tr><tr><td colspan=\"4\"><hr/></td></tr><tr><td align=\"left\">GNT-Recipe</td><td align=\"left\">301094</td><td align=\"left\">Vitrofarma SA, Bogota, Colombia</td><td align=\"left\">Linea Recipe<sup>&#174; </sup>of Laboratorios Bussi&#233; SA, Colombia</td></tr><tr><td colspan=\"4\"><hr/></td></tr><tr><td align=\"left\">GNT-Scalpi</td><td align=\"left\">GE020619</td><td align=\"left\">Consorcio Farmionni-Lubelca, Bogota, Colombia</td><td align=\"left\">Farmionni Scalpi SA, Bogota, Colombia</td></tr><tr><td colspan=\"4\"><hr/></td></tr><tr><td align=\"left\">GNT-Sigma (Reference Powder)</td><td align=\"left\">10k1510</td><td align=\"left\">Sigma Chemical Co, St Louis, MO, USA</td><td align=\"left\">Not applicable</td></tr><tr><td colspan=\"4\"><hr/></td></tr><tr><td align=\"left\">VAN-Lilly (Innovator)</td><td align=\"left\">A014744</td><td align=\"left\">Eli Lilly &amp; Compa&#241;ia de Mexico, Mexico</td><td align=\"left\">Eli Lilly Interamericana Inc., Bogota, Colombia</td></tr><tr><td colspan=\"4\"><hr/></td></tr><tr><td align=\"left\">VAN-Abbott</td><td align=\"left\">03703Z7</td><td align=\"left\">Abbott Laboratories, Chicago, IL, USA</td><td align=\"left\">Abbott Laboratories de Colombia, Bogota, Colombia</td></tr><tr><td colspan=\"4\"><hr/></td></tr><tr><td align=\"left\">VAN-APP</td><td align=\"left\">120740</td><td align=\"left\">American Pharmaceutical Partners (APP), LA, USA</td><td align=\"left\">Comedica Ltda., Bogota, Colombia</td></tr><tr><td colspan=\"4\"><hr/></td></tr><tr><td align=\"left\">VAN-Proclin</td><td align=\"left\">6679</td><td align=\"left\">Laboratorios Northia S.A.C.I.F.I.A, Argentina</td><td align=\"left\">Proclin Pharma SA, Bogota, Colombia</td></tr><tr><td colspan=\"4\"><hr/></td></tr><tr><td align=\"left\">VAN-USP</td><td align=\"left\">70900L</td><td align=\"left\">United States Pharmacopeia (USP), Rockville, MD, USA</td><td align=\"left\">Not applicable</td></tr></tbody></table></body></html>","text":"Pmid= 2640365:Table= Table 1","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":1350767799,"_task_hash":-2061650476,"_view_id":"review","accept":[5],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":null,"sessions":["tableclass-test-params-100-frank","tableclass-test-params-100-gill","tableclass-test-params-100-vicky"],"versions":[{"html":"<!DOCTYPE html><html><body><h1>Source and batch of antibiotics included in the study</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td align=\"left\"><bold>Product Code</bold></td><td align=\"left\"><bold>Batch</bold></td><td align=\"left\"><bold>Manufacturer</bold></td><td align=\"left\"><bold>Distributor</bold></td></tr></thead><tbody><tr><td align=\"left\">AMK-BMS (innovator)</td><td align=\"left\">01J115</td><td align=\"left\">Bristol-Myers Squibb (BMS), Guayaquil, Ecuador</td><td align=\"left\">Bristol-Myers Squibb, Cali, Colombia</td></tr><tr><td colspan=\"4\"><hr/></td></tr><tr><td align=\"left\">AMK-Carlon</td><td align=\"left\">278V0704</td><td align=\"left\">Carlon Ltda, Bogota, Colombia</td><td align=\"left\">Item</td></tr><tr><td colspan=\"4\"><hr/></td></tr><tr><td align=\"left\">AMK-Gencol</td><td align=\"left\">0200</td><td align=\"left\">Laboratorios Chalver, Bogota, Colombia</td><td align=\"left\">Genericos de Colombia (Gencol), Bogota, Colombia</td></tr><tr><td colspan=\"4\"><hr/></td></tr><tr><td align=\"left\">AMK-Pisa</td><td align=\"left\">121859</td><td align=\"left\">Laboratorios Pisa SA de CV, Guadalajara, Mexico</td><td align=\"left\">Laboratorios ECAR Ltda, Medellin, Colombia</td></tr><tr><td colspan=\"4\"><hr/></td></tr><tr><td align=\"left\">AMK-Scalpi</td><td align=\"left\">AK010348</td><td align=\"left\">Consorcio Farmionni-Lubelca, Bogota, Colombia</td><td align=\"left\">Farmionni Scalpi SA, Bogota, Colombia</td></tr><tr><td colspan=\"4\"><hr/></td></tr><tr><td align=\"left\">AMK-Sigma (Reference Powder)</td><td align=\"left\">120K1643</td><td align=\"left\">Sigma Chemical Co, St Louis, MO, USA</td><td align=\"left\">Not applicable</td></tr><tr><td colspan=\"4\"><hr/></td></tr><tr><td align=\"left\">GNT-SP (innovator)</td><td align=\"left\">CB3AMKB04</td><td align=\"left\">Schering-Plough SA (SP), Bogota, Colombia</td><td align=\"left\">Item</td></tr><tr><td colspan=\"4\"><hr/></td></tr><tr><td align=\"left\">GNT-Abbott</td><td align=\"left\">75-024-DK</td><td align=\"left\">Abbott Laboratories, North Chicago, IL, USA</td><td align=\"left\">Not available</td></tr><tr><td colspan=\"4\"><hr/></td></tr><tr><td align=\"left\">GNT-Az pharma</td><td align=\"left\">303030</td><td align=\"left\">Vitrofarma SA, Bogota DC, Colombia</td><td align=\"left\">AZ-Pharma SA, Bogota, Colombia</td></tr><tr><td colspan=\"4\"><hr/></td></tr><tr><td align=\"left\">GNT-Biochemie</td><td align=\"left\">07102321</td><td align=\"left\">Biochemie GmbH, Kundl, Austria</td><td align=\"left\">Novartis de Colombia SA, Bogota, Colombia</td></tr><tr><td colspan=\"4\"><hr/></td></tr><tr><td align=\"left\">GNT-Biogenta</td><td align=\"left\">0402</td><td align=\"left\">Laboratorios Chalver, Bogot&#225;, Colombia</td><td align=\"left\">Chalver Farmaceutica (Biogenta), Bogota Colombia</td></tr><tr><td colspan=\"4\"><hr/></td></tr><tr><td align=\"left\">GNT-Colmed</td><td align=\"left\">01005</td><td align=\"left\">Colmed Internacional, Barranquilla, Colombia</td><td align=\"left\">Procaps SA, Barranquilla, Colombia</td></tr><tr><td colspan=\"4\"><hr/></td></tr><tr><td align=\"left\">GNT-Genfar</td><td align=\"left\">030703</td><td align=\"left\">Viteco SA, Bogota, Colombia</td><td align=\"left\">Lab. Genericos Farmaceuticos, Bogota, Colombia</td></tr><tr><td colspan=\"4\"><hr/></td></tr><tr><td align=\"left\">GNT-Lab America</td><td align=\"left\">0980303</td><td align=\"left\">Arbofarma SA, Bogota, Colombia</td><td align=\"left\">Laboratorios America SA, Medellin, Colombia</td></tr><tr><td colspan=\"4\"><hr/></td></tr><tr><td align=\"left\">GNT-Labinco</td><td align=\"left\">01013C</td><td align=\"left\">Laboratorios Ryan, Bogota, Colombia</td><td align=\"left\">Laboratorio Internacional (Labinco), Bogota, Colombia</td></tr><tr><td colspan=\"4\"><hr/></td></tr><tr><td align=\"left\">GNT-La Sante</td><td align=\"left\">0310</td><td align=\"left\">Viteco SA, Bogota, Colombia</td><td align=\"left\">Laboratorios La Sante, Bogota, Colombia</td></tr><tr><td colspan=\"4\"><hr/></td></tr><tr><td align=\"left\">GNT-Memphis</td><td align=\"left\">2208I101</td><td align=\"left\">Vitrofarma SA, Bogota, Colombia</td><td align=\"left\">Memphis products SA, Bogota, Colombia</td></tr><tr><td colspan=\"4\"><hr/></td></tr><tr><td align=\"left\">GNT-MK</td><td align=\"left\">3P066</td><td align=\"left\">Vitrofarma SA, Bogota, Colombia</td><td align=\"left\">Tecnoquimica SA (MK), Cali Colombia</td></tr><tr><td colspan=\"4\"><hr/></td></tr><tr><td align=\"left\">GNT-Ophalac</td><td align=\"left\">004013</td><td align=\"left\">Vitrofarma SA, Bogota, Colombia</td><td align=\"left\">Laboratorios Farmaceuticos Ophalac, Bogota, Colombia</td></tr><tr><td colspan=\"4\"><hr/></td></tr><tr><td align=\"left\">GNT-Pentacoop</td><td align=\"left\">33544</td><td align=\"left\">Laboratorios Ryan, Bogota, Colombia</td><td align=\"left\">Pentacoop SA, Bogota DC, Colombia</td></tr><tr><td colspan=\"4\"><hr/></td></tr><tr><td align=\"left\">GNT-Recipe</td><td align=\"left\">301094</td><td align=\"left\">Vitrofarma SA, Bogota, Colombia</td><td align=\"left\">Linea Recipe<sup>&#174; </sup>of Laboratorios Bussi&#233; SA, Colombia</td></tr><tr><td colspan=\"4\"><hr/></td></tr><tr><td align=\"left\">GNT-Scalpi</td><td align=\"left\">GE020619</td><td align=\"left\">Consorcio Farmionni-Lubelca, Bogota, Colombia</td><td align=\"left\">Farmionni Scalpi SA, Bogota, Colombia</td></tr><tr><td colspan=\"4\"><hr/></td></tr><tr><td align=\"left\">GNT-Sigma (Reference Powder)</td><td align=\"left\">10k1510</td><td align=\"left\">Sigma Chemical Co, St Louis, MO, USA</td><td align=\"left\">Not applicable</td></tr><tr><td colspan=\"4\"><hr/></td></tr><tr><td align=\"left\">VAN-Lilly (Innovator)</td><td align=\"left\">A014744</td><td align=\"left\">Eli Lilly &amp; Compa&#241;ia de Mexico, Mexico</td><td align=\"left\">Eli Lilly Interamericana Inc., Bogota, Colombia</td></tr><tr><td colspan=\"4\"><hr/></td></tr><tr><td align=\"left\">VAN-Abbott</td><td align=\"left\">03703Z7</td><td align=\"left\">Abbott Laboratories, Chicago, IL, USA</td><td align=\"left\">Abbott Laboratories de Colombia, Bogota, Colombia</td></tr><tr><td colspan=\"4\"><hr/></td></tr><tr><td align=\"left\">VAN-APP</td><td align=\"left\">120740</td><td align=\"left\">American Pharmaceutical Partners (APP), LA, USA</td><td align=\"left\">Comedica Ltda., Bogota, Colombia</td></tr><tr><td colspan=\"4\"><hr/></td></tr><tr><td align=\"left\">VAN-Proclin</td><td align=\"left\">6679</td><td align=\"left\">Laboratorios Northia S.A.C.I.F.I.A, Argentina</td><td align=\"left\">Proclin Pharma SA, Bogota, Colombia</td></tr><tr><td colspan=\"4\"><hr/></td></tr><tr><td align=\"left\">VAN-USP</td><td align=\"left\">70900L</td><td align=\"left\">United States Pharmacopeia (USP), Rockville, MD, USA</td><td align=\"left\">Not applicable</td></tr></tbody></table></body></html>","text":"Pmid= 2640365:Table= Table 1","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":1350767799,"_task_hash":-2061650476,"_view_id":"choice","accept":[5],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":"tableclass-test-params-100-gill","sessions":["tableclass-test-params-100-frank","tableclass-test-params-100-gill","tableclass-test-params-100-vicky"],"default":true}],"view_id":"choice"}
{"html":"<!DOCTYPE html><html><body><h1>Potency estimate and parameters derived from linear regression with their statistical comparison of generics versus innovator by Curve Fitting Analysis</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td align=\"left\"><bold>Product</bold></td><td align=\"center\"><bold>r</bold><sup>2</sup></td><td align=\"center\"><bold>Intercept [95% CI]</bold></td><td align=\"center\"><bold>P-value</bold></td><td align=\"center\"><bold>Slope [95% CI]</bold></td><td align=\"center\"><bold>P-value</bold></td><td align=\"center\"><bold>Potency Estimate (%)</bold></td></tr></thead><tbody><tr><td align=\"left\">AMK-BMS</td><td align=\"center\">0.99</td><td align=\"center\">9.006 [8.646 to 9.366]</td><td align=\"center\">0.8799</td><td align=\"center\">3.884 [3.619 to 4.148]</td><td align=\"center\">0.6559</td><td align=\"center\">100.00</td></tr><tr><td colspan=\"7\"><hr/></td></tr><tr><td align=\"left\">AMK-Carlon</td><td align=\"center\">0.99</td><td align=\"center\">9.082 [8.651 to 9.514]</td><td/><td align=\"center\">3.789 [3.472 to 4.105]</td><td/><td align=\"center\">99.83</td></tr><tr><td colspan=\"7\"><hr/></td></tr><tr><td align=\"left\">AMK-Gencol</td><td align=\"center\">0.99</td><td align=\"center\">9.238 [8.738 to 9.737]</td><td/><td align=\"center\">3.731 [3.365 to 4.098]</td><td/><td align=\"center\">100.51</td></tr><tr><td colspan=\"7\"><hr/></td></tr><tr><td align=\"left\">AMK-Pisa</td><td align=\"center\">0.99</td><td align=\"center\">9.244 [8.860 to 9.629]</td><td/><td align=\"center\">3.698 [3.416 to 3.980]</td><td/><td align=\"center\">100.31</td></tr><tr><td colspan=\"7\"><hr/></td></tr><tr><td align=\"left\">AMK-Scalpi</td><td align=\"center\">0.99</td><td align=\"center\">8.920 [8.552 to 9.287]</td><td/><td align=\"center\">3.935 [3.665 to 4.204]</td><td/><td align=\"center\">99.77</td></tr><tr><td colspan=\"7\"><hr/></td></tr><tr><td align=\"left\">AMK-Sigma</td><td align=\"center\">0.99</td><td align=\"center\">8.945 [8.575 to 9.315]</td><td/><td align=\"center\">3.926 [3.655 to 4.198]</td><td/><td align=\"center\">99.89</td></tr><tr><td colspan=\"7\"><hr/></td></tr><tr><td align=\"left\">GNT-SP</td><td align=\"center\">0.99</td><td align=\"center\">10.44 [10.16 to 10.720]</td><td align=\"center\">0.9472</td><td align=\"center\">3.881 [3.594 to 4.167]</td><td align=\"center\">0.9984</td><td align=\"center\">100.00</td></tr><tr><td colspan=\"7\"><hr/></td></tr><tr><td align=\"left\">GNT-Abbott</td><td align=\"center\">0.98</td><td align=\"center\">10.00 [9.557 to 10.440]</td><td/><td align=\"center\">4.150 [3.695 to 4.605]</td><td/><td align=\"center\">99.72</td></tr><tr><td colspan=\"7\"><hr/></td></tr><tr><td align=\"left\">GNT-Az pharma</td><td align=\"center\">0.98</td><td align=\"center\">10.02 [9.576 to 10.460]</td><td/><td align=\"center\">4.021 [3.570 to 4.473]</td><td/><td align=\"center\">99.68</td></tr><tr><td colspan=\"7\"><hr/></td></tr><tr><td align=\"left\">GNT-Biochemie</td><td align=\"center\">0.98</td><td align=\"center\">10.08 [9.668 to 10.500]</td><td/><td align=\"center\">4.038 [3.613 to 4.463]</td><td/><td align=\"center\">99.75</td></tr><tr><td colspan=\"7\"><hr/></td></tr><tr><td align=\"left\">GNT-Biogenta</td><td align=\"center\">0.98</td><td align=\"center\">10.13 [9.736 to 10.510]</td><td/><td align=\"center\">3.925 [3.526 to 4.324]</td><td/><td align=\"center\">99.74</td></tr><tr><td colspan=\"7\"><hr/></td></tr><tr><td align=\"left\">GNT-Colmed</td><td align=\"center\">0.98</td><td align=\"center\">10.13 [9.701 to 10.550]</td><td/><td align=\"center\">3.918 [3.483 to 4.354]</td><td/><td align=\"center\">99.74</td></tr><tr><td colspan=\"7\"><hr/></td></tr><tr><td align=\"left\">GNT-Genfar</td><td align=\"center\">0.99</td><td align=\"center\">10.04 [9.697 to 10.380]</td><td/><td align=\"center\">4.091 [3.738 to 4.443]</td><td/><td align=\"center\">99.73</td></tr><tr><td colspan=\"7\"><hr/></td></tr><tr><td align=\"left\">GNT-Lab America</td><td align=\"center\">0.99</td><td align=\"center\">10.09 [9.708 to 10.470]</td><td/><td align=\"center\">4.143 [3.754 to 4.532]</td><td/><td align=\"center\">99.79</td></tr><tr><td colspan=\"7\"><hr/></td></tr><tr><td align=\"left\">GNT-Labinco</td><td align=\"center\">0.99</td><td align=\"center\">10.11 [9.749 to 10.470]</td><td/><td align=\"center\">3.994 [3.623 to 4.366]</td><td/><td align=\"center\">99.76</td></tr><tr><td colspan=\"7\"><hr/></td></tr><tr><td align=\"left\">GNT-La Sante</td><td align=\"center\">0.98</td><td align=\"center\">10.11 [9.668 to 10.550]</td><td/><td align=\"center\">4.106 [3.655 to 4.558]</td><td/><td align=\"center\">99.80</td></tr><tr><td colspan=\"7\"><hr/></td></tr><tr><td align=\"left\">GNT-Memphis</td><td align=\"center\">0.98</td><td align=\"center\">10.15 [9.694 to 10.610]</td><td/><td align=\"center\">3.935 [3.465 to 4.406]</td><td/><td align=\"center\">99.77</td></tr><tr><td colspan=\"7\"><hr/></td></tr><tr><td align=\"left\">GNT-MK</td><td align=\"center\">0.98</td><td align=\"center\">10.09 [9.672 to 10.510]</td><td/><td align=\"center\">4.146 [3.715 to 4.577]</td><td/><td align=\"center\">99.68</td></tr><tr><td colspan=\"7\"><hr/></td></tr><tr><td align=\"left\">GNT-Ophalac</td><td align=\"center\">0.98</td><td align=\"center\">10.02 [9.571 to 10.460]</td><td/><td align=\"center\">4.006 [3.549 to 4.463]</td><td/><td align=\"center\">99.68</td></tr><tr><td colspan=\"7\"><hr/></td></tr><tr><td align=\"left\">GNT-Pentacoop</td><td align=\"center\">0.98</td><td align=\"center\">10.13 [9.690 to 10.560]</td><td/><td align=\"center\">3.962 [3.514 to 4.409]</td><td/><td align=\"center\">99.76</td></tr><tr><td colspan=\"7\"><hr/></td></tr><tr><td align=\"left\">GNT-Recipe</td><td align=\"center\">0.98</td><td align=\"center\">10.10 [9.700 to 10.510]</td><td/><td align=\"center\">3.926 [3.512 to 4.340]</td><td/><td align=\"center\">99.72</td></tr><tr><td colspan=\"7\"><hr/></td></tr><tr><td align=\"left\">GNT-Scalpi</td><td align=\"center\">0.98</td><td align=\"center\">10.13 [9.720 to 10.540]</td><td/><td align=\"center\">3.919 [3.501 to 4.337]</td><td/><td align=\"center\">99.74</td></tr><tr><td colspan=\"7\"><hr/></td></tr><tr><td align=\"left\">GNT-Sigma</td><td align=\"center\">0.98</td><td align=\"center\">10.36 [9.889 to 10.830]</td><td/><td align=\"center\">4.109 [3.629 to 4.590]</td><td/><td align=\"center\">100.02</td></tr><tr><td colspan=\"7\"><hr/></td></tr><tr><td align=\"left\">VAN-Lilly</td><td align=\"center\">0.99</td><td align=\"center\">6.320 [5.715 to 6.924]</td><td align=\"center\">0.0201</td><td align=\"center\">5.562 [5.082 to 6.042]</td><td align=\"center\">0.8594</td><td align=\"center\">100.00</td></tr><tr><td colspan=\"7\"><hr/></td></tr><tr><td align=\"left\">VAN-Abbott</td><td align=\"center\">0.99</td><td align=\"center\">5.782 [5.248 to 6.316]</td><td/><td align=\"center\">5.558 [5.134 to 5.982]</td><td/><td align=\"center\">98.51</td></tr><tr><td colspan=\"7\"><hr/></td></tr><tr><td align=\"left\">VAN-APP</td><td align=\"center\">0.99</td><td align=\"center\">6.281 [5.734 to 6.828]</td><td/><td align=\"center\">5.359 [4.925 to 5.793]</td><td/><td align=\"center\">99.30</td></tr><tr><td colspan=\"7\"><hr/></td></tr><tr><td align=\"left\">VAN-Proclin</td><td align=\"center\">0.99</td><td align=\"center\">6.388 [5.721 to 7.054]</td><td/><td align=\"center\">5.462 [4.933 to 5.991]</td><td/><td align=\"center\">99.90</td></tr></tbody></table></body></html>","text":"Pmid= 2640365:Table= Table 2","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":-1796635809,"_task_hash":936275901,"_view_id":"review","accept":[4],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":null,"sessions":["tableclass-test-params-100-frank","tableclass-test-params-100-vicky"],"versions":[{"html":"<!DOCTYPE html><html><body><h1>Potency estimate and parameters derived from linear regression with their statistical comparison of generics versus innovator by Curve Fitting Analysis</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td align=\"left\"><bold>Product</bold></td><td align=\"center\"><bold>r</bold><sup>2</sup></td><td align=\"center\"><bold>Intercept [95% CI]</bold></td><td align=\"center\"><bold>P-value</bold></td><td align=\"center\"><bold>Slope [95% CI]</bold></td><td align=\"center\"><bold>P-value</bold></td><td align=\"center\"><bold>Potency Estimate (%)</bold></td></tr></thead><tbody><tr><td align=\"left\">AMK-BMS</td><td align=\"center\">0.99</td><td align=\"center\">9.006 [8.646 to 9.366]</td><td align=\"center\">0.8799</td><td align=\"center\">3.884 [3.619 to 4.148]</td><td align=\"center\">0.6559</td><td align=\"center\">100.00</td></tr><tr><td colspan=\"7\"><hr/></td></tr><tr><td align=\"left\">AMK-Carlon</td><td align=\"center\">0.99</td><td align=\"center\">9.082 [8.651 to 9.514]</td><td/><td align=\"center\">3.789 [3.472 to 4.105]</td><td/><td align=\"center\">99.83</td></tr><tr><td colspan=\"7\"><hr/></td></tr><tr><td align=\"left\">AMK-Gencol</td><td align=\"center\">0.99</td><td align=\"center\">9.238 [8.738 to 9.737]</td><td/><td align=\"center\">3.731 [3.365 to 4.098]</td><td/><td align=\"center\">100.51</td></tr><tr><td colspan=\"7\"><hr/></td></tr><tr><td align=\"left\">AMK-Pisa</td><td align=\"center\">0.99</td><td align=\"center\">9.244 [8.860 to 9.629]</td><td/><td align=\"center\">3.698 [3.416 to 3.980]</td><td/><td align=\"center\">100.31</td></tr><tr><td colspan=\"7\"><hr/></td></tr><tr><td align=\"left\">AMK-Scalpi</td><td align=\"center\">0.99</td><td align=\"center\">8.920 [8.552 to 9.287]</td><td/><td align=\"center\">3.935 [3.665 to 4.204]</td><td/><td align=\"center\">99.77</td></tr><tr><td colspan=\"7\"><hr/></td></tr><tr><td align=\"left\">AMK-Sigma</td><td align=\"center\">0.99</td><td align=\"center\">8.945 [8.575 to 9.315]</td><td/><td align=\"center\">3.926 [3.655 to 4.198]</td><td/><td align=\"center\">99.89</td></tr><tr><td colspan=\"7\"><hr/></td></tr><tr><td align=\"left\">GNT-SP</td><td align=\"center\">0.99</td><td align=\"center\">10.44 [10.16 to 10.720]</td><td align=\"center\">0.9472</td><td align=\"center\">3.881 [3.594 to 4.167]</td><td align=\"center\">0.9984</td><td align=\"center\">100.00</td></tr><tr><td colspan=\"7\"><hr/></td></tr><tr><td align=\"left\">GNT-Abbott</td><td align=\"center\">0.98</td><td align=\"center\">10.00 [9.557 to 10.440]</td><td/><td align=\"center\">4.150 [3.695 to 4.605]</td><td/><td align=\"center\">99.72</td></tr><tr><td colspan=\"7\"><hr/></td></tr><tr><td align=\"left\">GNT-Az pharma</td><td align=\"center\">0.98</td><td align=\"center\">10.02 [9.576 to 10.460]</td><td/><td align=\"center\">4.021 [3.570 to 4.473]</td><td/><td align=\"center\">99.68</td></tr><tr><td colspan=\"7\"><hr/></td></tr><tr><td align=\"left\">GNT-Biochemie</td><td align=\"center\">0.98</td><td align=\"center\">10.08 [9.668 to 10.500]</td><td/><td align=\"center\">4.038 [3.613 to 4.463]</td><td/><td align=\"center\">99.75</td></tr><tr><td colspan=\"7\"><hr/></td></tr><tr><td align=\"left\">GNT-Biogenta</td><td align=\"center\">0.98</td><td align=\"center\">10.13 [9.736 to 10.510]</td><td/><td align=\"center\">3.925 [3.526 to 4.324]</td><td/><td align=\"center\">99.74</td></tr><tr><td colspan=\"7\"><hr/></td></tr><tr><td align=\"left\">GNT-Colmed</td><td align=\"center\">0.98</td><td align=\"center\">10.13 [9.701 to 10.550]</td><td/><td align=\"center\">3.918 [3.483 to 4.354]</td><td/><td align=\"center\">99.74</td></tr><tr><td colspan=\"7\"><hr/></td></tr><tr><td align=\"left\">GNT-Genfar</td><td align=\"center\">0.99</td><td align=\"center\">10.04 [9.697 to 10.380]</td><td/><td align=\"center\">4.091 [3.738 to 4.443]</td><td/><td align=\"center\">99.73</td></tr><tr><td colspan=\"7\"><hr/></td></tr><tr><td align=\"left\">GNT-Lab America</td><td align=\"center\">0.99</td><td align=\"center\">10.09 [9.708 to 10.470]</td><td/><td align=\"center\">4.143 [3.754 to 4.532]</td><td/><td align=\"center\">99.79</td></tr><tr><td colspan=\"7\"><hr/></td></tr><tr><td align=\"left\">GNT-Labinco</td><td align=\"center\">0.99</td><td align=\"center\">10.11 [9.749 to 10.470]</td><td/><td align=\"center\">3.994 [3.623 to 4.366]</td><td/><td align=\"center\">99.76</td></tr><tr><td colspan=\"7\"><hr/></td></tr><tr><td align=\"left\">GNT-La Sante</td><td align=\"center\">0.98</td><td align=\"center\">10.11 [9.668 to 10.550]</td><td/><td align=\"center\">4.106 [3.655 to 4.558]</td><td/><td align=\"center\">99.80</td></tr><tr><td colspan=\"7\"><hr/></td></tr><tr><td align=\"left\">GNT-Memphis</td><td align=\"center\">0.98</td><td align=\"center\">10.15 [9.694 to 10.610]</td><td/><td align=\"center\">3.935 [3.465 to 4.406]</td><td/><td align=\"center\">99.77</td></tr><tr><td colspan=\"7\"><hr/></td></tr><tr><td align=\"left\">GNT-MK</td><td align=\"center\">0.98</td><td align=\"center\">10.09 [9.672 to 10.510]</td><td/><td align=\"center\">4.146 [3.715 to 4.577]</td><td/><td align=\"center\">99.68</td></tr><tr><td colspan=\"7\"><hr/></td></tr><tr><td align=\"left\">GNT-Ophalac</td><td align=\"center\">0.98</td><td align=\"center\">10.02 [9.571 to 10.460]</td><td/><td align=\"center\">4.006 [3.549 to 4.463]</td><td/><td align=\"center\">99.68</td></tr><tr><td colspan=\"7\"><hr/></td></tr><tr><td align=\"left\">GNT-Pentacoop</td><td align=\"center\">0.98</td><td align=\"center\">10.13 [9.690 to 10.560]</td><td/><td align=\"center\">3.962 [3.514 to 4.409]</td><td/><td align=\"center\">99.76</td></tr><tr><td colspan=\"7\"><hr/></td></tr><tr><td align=\"left\">GNT-Recipe</td><td align=\"center\">0.98</td><td align=\"center\">10.10 [9.700 to 10.510]</td><td/><td align=\"center\">3.926 [3.512 to 4.340]</td><td/><td align=\"center\">99.72</td></tr><tr><td colspan=\"7\"><hr/></td></tr><tr><td align=\"left\">GNT-Scalpi</td><td align=\"center\">0.98</td><td align=\"center\">10.13 [9.720 to 10.540]</td><td/><td align=\"center\">3.919 [3.501 to 4.337]</td><td/><td align=\"center\">99.74</td></tr><tr><td colspan=\"7\"><hr/></td></tr><tr><td align=\"left\">GNT-Sigma</td><td align=\"center\">0.98</td><td align=\"center\">10.36 [9.889 to 10.830]</td><td/><td align=\"center\">4.109 [3.629 to 4.590]</td><td/><td align=\"center\">100.02</td></tr><tr><td colspan=\"7\"><hr/></td></tr><tr><td align=\"left\">VAN-Lilly</td><td align=\"center\">0.99</td><td align=\"center\">6.320 [5.715 to 6.924]</td><td align=\"center\">0.0201</td><td align=\"center\">5.562 [5.082 to 6.042]</td><td align=\"center\">0.8594</td><td align=\"center\">100.00</td></tr><tr><td colspan=\"7\"><hr/></td></tr><tr><td align=\"left\">VAN-Abbott</td><td align=\"center\">0.99</td><td align=\"center\">5.782 [5.248 to 6.316]</td><td/><td align=\"center\">5.558 [5.134 to 5.982]</td><td/><td align=\"center\">98.51</td></tr><tr><td colspan=\"7\"><hr/></td></tr><tr><td align=\"left\">VAN-APP</td><td align=\"center\">0.99</td><td align=\"center\">6.281 [5.734 to 6.828]</td><td/><td align=\"center\">5.359 [4.925 to 5.793]</td><td/><td align=\"center\">99.30</td></tr><tr><td colspan=\"7\"><hr/></td></tr><tr><td align=\"left\">VAN-Proclin</td><td align=\"center\">0.99</td><td align=\"center\">6.388 [5.721 to 7.054]</td><td/><td align=\"center\">5.462 [4.933 to 5.991]</td><td/><td align=\"center\">99.90</td></tr></tbody></table></body></html>","text":"Pmid= 2640365:Table= Table 2","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":-1796635809,"_task_hash":-1226277865,"_view_id":"choice","accept":[4,3],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":"tableclass-test-params-100-gill","sessions":["tableclass-test-params-100-gill"],"default":false},{"html":"<!DOCTYPE html><html><body><h1>Potency estimate and parameters derived from linear regression with their statistical comparison of generics versus innovator by Curve Fitting Analysis</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td align=\"left\"><bold>Product</bold></td><td align=\"center\"><bold>r</bold><sup>2</sup></td><td align=\"center\"><bold>Intercept [95% CI]</bold></td><td align=\"center\"><bold>P-value</bold></td><td align=\"center\"><bold>Slope [95% CI]</bold></td><td align=\"center\"><bold>P-value</bold></td><td align=\"center\"><bold>Potency Estimate (%)</bold></td></tr></thead><tbody><tr><td align=\"left\">AMK-BMS</td><td align=\"center\">0.99</td><td align=\"center\">9.006 [8.646 to 9.366]</td><td align=\"center\">0.8799</td><td align=\"center\">3.884 [3.619 to 4.148]</td><td align=\"center\">0.6559</td><td align=\"center\">100.00</td></tr><tr><td colspan=\"7\"><hr/></td></tr><tr><td align=\"left\">AMK-Carlon</td><td align=\"center\">0.99</td><td align=\"center\">9.082 [8.651 to 9.514]</td><td/><td align=\"center\">3.789 [3.472 to 4.105]</td><td/><td align=\"center\">99.83</td></tr><tr><td colspan=\"7\"><hr/></td></tr><tr><td align=\"left\">AMK-Gencol</td><td align=\"center\">0.99</td><td align=\"center\">9.238 [8.738 to 9.737]</td><td/><td align=\"center\">3.731 [3.365 to 4.098]</td><td/><td align=\"center\">100.51</td></tr><tr><td colspan=\"7\"><hr/></td></tr><tr><td align=\"left\">AMK-Pisa</td><td align=\"center\">0.99</td><td align=\"center\">9.244 [8.860 to 9.629]</td><td/><td align=\"center\">3.698 [3.416 to 3.980]</td><td/><td align=\"center\">100.31</td></tr><tr><td colspan=\"7\"><hr/></td></tr><tr><td align=\"left\">AMK-Scalpi</td><td align=\"center\">0.99</td><td align=\"center\">8.920 [8.552 to 9.287]</td><td/><td align=\"center\">3.935 [3.665 to 4.204]</td><td/><td align=\"center\">99.77</td></tr><tr><td colspan=\"7\"><hr/></td></tr><tr><td align=\"left\">AMK-Sigma</td><td align=\"center\">0.99</td><td align=\"center\">8.945 [8.575 to 9.315]</td><td/><td align=\"center\">3.926 [3.655 to 4.198]</td><td/><td align=\"center\">99.89</td></tr><tr><td colspan=\"7\"><hr/></td></tr><tr><td align=\"left\">GNT-SP</td><td align=\"center\">0.99</td><td align=\"center\">10.44 [10.16 to 10.720]</td><td align=\"center\">0.9472</td><td align=\"center\">3.881 [3.594 to 4.167]</td><td align=\"center\">0.9984</td><td align=\"center\">100.00</td></tr><tr><td colspan=\"7\"><hr/></td></tr><tr><td align=\"left\">GNT-Abbott</td><td align=\"center\">0.98</td><td align=\"center\">10.00 [9.557 to 10.440]</td><td/><td align=\"center\">4.150 [3.695 to 4.605]</td><td/><td align=\"center\">99.72</td></tr><tr><td colspan=\"7\"><hr/></td></tr><tr><td align=\"left\">GNT-Az pharma</td><td align=\"center\">0.98</td><td align=\"center\">10.02 [9.576 to 10.460]</td><td/><td align=\"center\">4.021 [3.570 to 4.473]</td><td/><td align=\"center\">99.68</td></tr><tr><td colspan=\"7\"><hr/></td></tr><tr><td align=\"left\">GNT-Biochemie</td><td align=\"center\">0.98</td><td align=\"center\">10.08 [9.668 to 10.500]</td><td/><td align=\"center\">4.038 [3.613 to 4.463]</td><td/><td align=\"center\">99.75</td></tr><tr><td colspan=\"7\"><hr/></td></tr><tr><td align=\"left\">GNT-Biogenta</td><td align=\"center\">0.98</td><td align=\"center\">10.13 [9.736 to 10.510]</td><td/><td align=\"center\">3.925 [3.526 to 4.324]</td><td/><td align=\"center\">99.74</td></tr><tr><td colspan=\"7\"><hr/></td></tr><tr><td align=\"left\">GNT-Colmed</td><td align=\"center\">0.98</td><td align=\"center\">10.13 [9.701 to 10.550]</td><td/><td align=\"center\">3.918 [3.483 to 4.354]</td><td/><td align=\"center\">99.74</td></tr><tr><td colspan=\"7\"><hr/></td></tr><tr><td align=\"left\">GNT-Genfar</td><td align=\"center\">0.99</td><td align=\"center\">10.04 [9.697 to 10.380]</td><td/><td align=\"center\">4.091 [3.738 to 4.443]</td><td/><td align=\"center\">99.73</td></tr><tr><td colspan=\"7\"><hr/></td></tr><tr><td align=\"left\">GNT-Lab America</td><td align=\"center\">0.99</td><td align=\"center\">10.09 [9.708 to 10.470]</td><td/><td align=\"center\">4.143 [3.754 to 4.532]</td><td/><td align=\"center\">99.79</td></tr><tr><td colspan=\"7\"><hr/></td></tr><tr><td align=\"left\">GNT-Labinco</td><td align=\"center\">0.99</td><td align=\"center\">10.11 [9.749 to 10.470]</td><td/><td align=\"center\">3.994 [3.623 to 4.366]</td><td/><td align=\"center\">99.76</td></tr><tr><td colspan=\"7\"><hr/></td></tr><tr><td align=\"left\">GNT-La Sante</td><td align=\"center\">0.98</td><td align=\"center\">10.11 [9.668 to 10.550]</td><td/><td align=\"center\">4.106 [3.655 to 4.558]</td><td/><td align=\"center\">99.80</td></tr><tr><td colspan=\"7\"><hr/></td></tr><tr><td align=\"left\">GNT-Memphis</td><td align=\"center\">0.98</td><td align=\"center\">10.15 [9.694 to 10.610]</td><td/><td align=\"center\">3.935 [3.465 to 4.406]</td><td/><td align=\"center\">99.77</td></tr><tr><td colspan=\"7\"><hr/></td></tr><tr><td align=\"left\">GNT-MK</td><td align=\"center\">0.98</td><td align=\"center\">10.09 [9.672 to 10.510]</td><td/><td align=\"center\">4.146 [3.715 to 4.577]</td><td/><td align=\"center\">99.68</td></tr><tr><td colspan=\"7\"><hr/></td></tr><tr><td align=\"left\">GNT-Ophalac</td><td align=\"center\">0.98</td><td align=\"center\">10.02 [9.571 to 10.460]</td><td/><td align=\"center\">4.006 [3.549 to 4.463]</td><td/><td align=\"center\">99.68</td></tr><tr><td colspan=\"7\"><hr/></td></tr><tr><td align=\"left\">GNT-Pentacoop</td><td align=\"center\">0.98</td><td align=\"center\">10.13 [9.690 to 10.560]</td><td/><td align=\"center\">3.962 [3.514 to 4.409]</td><td/><td align=\"center\">99.76</td></tr><tr><td colspan=\"7\"><hr/></td></tr><tr><td align=\"left\">GNT-Recipe</td><td align=\"center\">0.98</td><td align=\"center\">10.10 [9.700 to 10.510]</td><td/><td align=\"center\">3.926 [3.512 to 4.340]</td><td/><td align=\"center\">99.72</td></tr><tr><td colspan=\"7\"><hr/></td></tr><tr><td align=\"left\">GNT-Scalpi</td><td align=\"center\">0.98</td><td align=\"center\">10.13 [9.720 to 10.540]</td><td/><td align=\"center\">3.919 [3.501 to 4.337]</td><td/><td align=\"center\">99.74</td></tr><tr><td colspan=\"7\"><hr/></td></tr><tr><td align=\"left\">GNT-Sigma</td><td align=\"center\">0.98</td><td align=\"center\">10.36 [9.889 to 10.830]</td><td/><td align=\"center\">4.109 [3.629 to 4.590]</td><td/><td align=\"center\">100.02</td></tr><tr><td colspan=\"7\"><hr/></td></tr><tr><td align=\"left\">VAN-Lilly</td><td align=\"center\">0.99</td><td align=\"center\">6.320 [5.715 to 6.924]</td><td align=\"center\">0.0201</td><td align=\"center\">5.562 [5.082 to 6.042]</td><td align=\"center\">0.8594</td><td align=\"center\">100.00</td></tr><tr><td colspan=\"7\"><hr/></td></tr><tr><td align=\"left\">VAN-Abbott</td><td align=\"center\">0.99</td><td align=\"center\">5.782 [5.248 to 6.316]</td><td/><td align=\"center\">5.558 [5.134 to 5.982]</td><td/><td align=\"center\">98.51</td></tr><tr><td colspan=\"7\"><hr/></td></tr><tr><td align=\"left\">VAN-APP</td><td align=\"center\">0.99</td><td align=\"center\">6.281 [5.734 to 6.828]</td><td/><td align=\"center\">5.359 [4.925 to 5.793]</td><td/><td align=\"center\">99.30</td></tr><tr><td colspan=\"7\"><hr/></td></tr><tr><td align=\"left\">VAN-Proclin</td><td align=\"center\">0.99</td><td align=\"center\">6.388 [5.721 to 7.054]</td><td/><td align=\"center\">5.462 [4.933 to 5.991]</td><td/><td align=\"center\">99.90</td></tr></tbody></table></body></html>","text":"Pmid= 2640365:Table= Table 2","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":-1796635809,"_task_hash":936275901,"_view_id":"choice","accept":[5],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":"tableclass-test-params-100-frank","sessions":["tableclass-test-params-100-frank","tableclass-test-params-100-vicky"],"default":true}],"view_id":"choice"}
{"html":"<!DOCTYPE html><html><body><h1>Precision of the vancomycin bioassay</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td align=\"center\"><bold>Vancomycin concentration (mg/L)</bold></td><td align=\"center\"><bold>Inhibition zone diameters (mean in mm &#177; SD)</bold></td><td align=\"center\"><bold>Coefficient of variation (%) Intra-day</bold></td><td align=\"center\"><bold>Coefficient of variation (%) Inter-day</bold></td></tr></thead><tbody><tr><td align=\"center\">128</td><td align=\"center\">18.00 &#177; 0.04</td><td align=\"center\">8.3</td><td align=\"center\">10.3</td></tr><tr><td colspan=\"4\"><hr/></td></tr><tr><td align=\"center\">64</td><td align=\"center\">16.33 &#177; 0.02</td><td align=\"center\">5.6</td><td align=\"center\">10.5</td></tr><tr><td colspan=\"4\"><hr/></td></tr><tr><td align=\"center\">32</td><td align=\"center\">14.16 &#177; 0.11</td><td align=\"center\">11.0</td><td align=\"center\">1.0</td></tr><tr><td colspan=\"4\"><hr/></td></tr><tr><td align=\"center\">16</td><td align=\"center\">11.62 &#177; 0.37</td><td align=\"center\">7.4*</td><td align=\"center\">2.3</td></tr><tr><td colspan=\"4\"><hr/></td></tr><tr><td align=\"center\">8</td><td align=\"center\">9.59 &#177; 0.00</td><td align=\"center\">4.6</td><td align=\"center\">6.5</td></tr></tbody></table></body></html>","text":"Pmid= 2640365:Table= Table 3","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":-844025138,"_task_hash":-415999180,"_view_id":"review","accept":[5],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":null,"sessions":["tableclass-test-params-100-frank","tableclass-test-params-100-gill","tableclass-test-params-100-vicky"],"versions":[{"html":"<!DOCTYPE html><html><body><h1>Precision of the vancomycin bioassay</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td align=\"center\"><bold>Vancomycin concentration (mg/L)</bold></td><td align=\"center\"><bold>Inhibition zone diameters (mean in mm &#177; SD)</bold></td><td align=\"center\"><bold>Coefficient of variation (%) Intra-day</bold></td><td align=\"center\"><bold>Coefficient of variation (%) Inter-day</bold></td></tr></thead><tbody><tr><td align=\"center\">128</td><td align=\"center\">18.00 &#177; 0.04</td><td align=\"center\">8.3</td><td align=\"center\">10.3</td></tr><tr><td colspan=\"4\"><hr/></td></tr><tr><td align=\"center\">64</td><td align=\"center\">16.33 &#177; 0.02</td><td align=\"center\">5.6</td><td align=\"center\">10.5</td></tr><tr><td colspan=\"4\"><hr/></td></tr><tr><td align=\"center\">32</td><td align=\"center\">14.16 &#177; 0.11</td><td align=\"center\">11.0</td><td align=\"center\">1.0</td></tr><tr><td colspan=\"4\"><hr/></td></tr><tr><td align=\"center\">16</td><td align=\"center\">11.62 &#177; 0.37</td><td align=\"center\">7.4*</td><td align=\"center\">2.3</td></tr><tr><td colspan=\"4\"><hr/></td></tr><tr><td align=\"center\">8</td><td align=\"center\">9.59 &#177; 0.00</td><td align=\"center\">4.6</td><td align=\"center\">6.5</td></tr></tbody></table></body></html>","text":"Pmid= 2640365:Table= Table 3","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":-844025138,"_task_hash":-415999180,"_view_id":"choice","accept":[5],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":"tableclass-test-params-100-gill","sessions":["tableclass-test-params-100-frank","tableclass-test-params-100-gill","tableclass-test-params-100-vicky"],"default":true}],"view_id":"choice"}
{"html":"<!DOCTYPE html><html><body><h1>Clinical grading of severity of acute propanil poisoning</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td align=\"left\">Minor</td><td align=\"left\">Asymptomatic or mild symptoms (usually gastrointestinal or sedation) with stable vital signs and no other organ involvement</td></tr></thead><tbody><tr><td align=\"left\">Moderate to severe</td><td align=\"left\">Poisoning requiring intervention (eg. clinical evidence of cyanosis, hypotension (MABP &lt; 70 mmHg), hypoventilation requiring intubation, cardiac arrest or evidence of ischaemia, sedation or coma (GCS &lt; 10), seizures, oliguria)</td></tr><tr><td colspan=\"2\"><hr/></td></tr><tr><td align=\"left\">Death</td><td/></tr></tbody></table></body></html>","text":"Pmid= 2656468:Table= Table 1","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":-1233086899,"_task_hash":1791465733,"_view_id":"review","accept":[5],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":null,"sessions":["tableclass-test-params-100-frank","tableclass-test-params-100-gill","tableclass-test-params-100-vicky"],"versions":[{"html":"<!DOCTYPE html><html><body><h1>Clinical grading of severity of acute propanil poisoning</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td align=\"left\">Minor</td><td align=\"left\">Asymptomatic or mild symptoms (usually gastrointestinal or sedation) with stable vital signs and no other organ involvement</td></tr></thead><tbody><tr><td align=\"left\">Moderate to severe</td><td align=\"left\">Poisoning requiring intervention (eg. clinical evidence of cyanosis, hypotension (MABP &lt; 70 mmHg), hypoventilation requiring intubation, cardiac arrest or evidence of ischaemia, sedation or coma (GCS &lt; 10), seizures, oliguria)</td></tr><tr><td colspan=\"2\"><hr/></td></tr><tr><td align=\"left\">Death</td><td/></tr></tbody></table></body></html>","text":"Pmid= 2656468:Table= Table 1","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":-1233086899,"_task_hash":1791465733,"_view_id":"choice","accept":[5],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":"tableclass-test-params-100-gill","sessions":["tableclass-test-params-100-frank","tableclass-test-params-100-gill","tableclass-test-params-100-vicky"],"default":true}],"view_id":"choice"}
{"html":"<!DOCTYPE html><html><body><h1>Clinical outcomes, demographics and clinical features on admission</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td align=\"center\">Severity of poisoning</td><td align=\"center\">Minor</td><td align=\"center\">Moderate to severe</td><td align=\"center\">Death</td><td align=\"center\">Statistical significance&#167;</td></tr></thead><tbody><tr><td align=\"center\">N/Total (%)</td><td align=\"center\">225/391 (57)</td><td align=\"center\">124/391 (32)</td><td align=\"center\">42/391 (11)</td><td/></tr><tr><td align=\"center\">Gender (M:F)</td><td align=\"center\">139:86</td><td align=\"center\">64:60</td><td align=\"center\">34:8</td><td align=\"center\">P = 0.003</td></tr><tr><td align=\"center\">Age (years)</td><td align=\"center\">24 (20&#8211;34)*<sup>$</sup></td><td align=\"center\">22 (18&#8211;33)*<sup>$</sup></td><td align=\"center\">45 (37&#8211;54)<sup>$#</sup></td><td align=\"center\"><sup>$#</sup>P &lt; 0.001; *P &gt; 0.05</td></tr><tr><td align=\"center\">TTP (hours)</td><td align=\"center\">4.6 (2.7&#8211;-7.1)</td><td align=\"center\">5.3 (3.4&#8211;8.8)</td><td align=\"center\">4.5 (3.4&#8211;5.8)</td><td align=\"center\">P = 0.1431</td></tr><tr><td align=\"center\">GCS</td><td align=\"center\">15 (15-15)*<sup>$</sup></td><td align=\"center\">15 (12&#8211;15)*<sup>$</sup></td><td align=\"center\">7 (3&#8211;13)<sup>$#</sup></td><td align=\"center\"><sup>$# </sup>*P &lt; 0.0001</td></tr><tr><td align=\"center\">MABP (mmHg)</td><td align=\"center\">89 (82&#8211;97)<sup>$#</sup></td><td align=\"center\">83 (76&#8211;90)*<sup>$</sup></td><td align=\"center\">78 (72&#8211;86)*<sup>#</sup></td><td align=\"center\"><sup>$#</sup>P &lt; 0.001; *P &gt; 0.05</td></tr><tr><td align=\"center\">TTD (days)</td><td align=\"center\">2.2 (1.7&#8211;3.1)*</td><td align=\"center\">3.3 (2.6&#8211;5.0)*</td><td align=\"center\">1.5 (1.1&#8211;2.4)</td><td align=\"center\">*P &lt; 0.001</td></tr><tr><td align=\"center\">Admission propanil concentration (&#956;M)</td><td align=\"center\">1.3 (0.0&#8211;7.7)<sup>$</sup>*<break/>(n = 125)</td><td align=\"center\">8.9 (2.8&#8211;35.2)<sup>#</sup>*<break/>(n = 67)</td><td align=\"center\">72.0(45.8&#8211;128.3)<sup>#$</sup><break/>(n = 19)</td><td align=\"center\">*<sup>$#</sup>P &lt; 0.001</td></tr></tbody></table></body></html>","text":"Pmid= 2656468:Table= Table 2","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":-1983168865,"_task_hash":1541940421,"_view_id":"review","accept":[5],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":null,"sessions":["tableclass-test-params-100-frank","tableclass-test-params-100-gill","tableclass-test-params-100-vicky"],"versions":[{"html":"<!DOCTYPE html><html><body><h1>Clinical outcomes, demographics and clinical features on admission</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td align=\"center\">Severity of poisoning</td><td align=\"center\">Minor</td><td align=\"center\">Moderate to severe</td><td align=\"center\">Death</td><td align=\"center\">Statistical significance&#167;</td></tr></thead><tbody><tr><td align=\"center\">N/Total (%)</td><td align=\"center\">225/391 (57)</td><td align=\"center\">124/391 (32)</td><td align=\"center\">42/391 (11)</td><td/></tr><tr><td align=\"center\">Gender (M:F)</td><td align=\"center\">139:86</td><td align=\"center\">64:60</td><td align=\"center\">34:8</td><td align=\"center\">P = 0.003</td></tr><tr><td align=\"center\">Age (years)</td><td align=\"center\">24 (20&#8211;34)*<sup>$</sup></td><td align=\"center\">22 (18&#8211;33)*<sup>$</sup></td><td align=\"center\">45 (37&#8211;54)<sup>$#</sup></td><td align=\"center\"><sup>$#</sup>P &lt; 0.001; *P &gt; 0.05</td></tr><tr><td align=\"center\">TTP (hours)</td><td align=\"center\">4.6 (2.7&#8211;-7.1)</td><td align=\"center\">5.3 (3.4&#8211;8.8)</td><td align=\"center\">4.5 (3.4&#8211;5.8)</td><td align=\"center\">P = 0.1431</td></tr><tr><td align=\"center\">GCS</td><td align=\"center\">15 (15-15)*<sup>$</sup></td><td align=\"center\">15 (12&#8211;15)*<sup>$</sup></td><td align=\"center\">7 (3&#8211;13)<sup>$#</sup></td><td align=\"center\"><sup>$# </sup>*P &lt; 0.0001</td></tr><tr><td align=\"center\">MABP (mmHg)</td><td align=\"center\">89 (82&#8211;97)<sup>$#</sup></td><td align=\"center\">83 (76&#8211;90)*<sup>$</sup></td><td align=\"center\">78 (72&#8211;86)*<sup>#</sup></td><td align=\"center\"><sup>$#</sup>P &lt; 0.001; *P &gt; 0.05</td></tr><tr><td align=\"center\">TTD (days)</td><td align=\"center\">2.2 (1.7&#8211;3.1)*</td><td align=\"center\">3.3 (2.6&#8211;5.0)*</td><td align=\"center\">1.5 (1.1&#8211;2.4)</td><td align=\"center\">*P &lt; 0.001</td></tr><tr><td align=\"center\">Admission propanil concentration (&#956;M)</td><td align=\"center\">1.3 (0.0&#8211;7.7)<sup>$</sup>*<break/>(n = 125)</td><td align=\"center\">8.9 (2.8&#8211;35.2)<sup>#</sup>*<break/>(n = 67)</td><td align=\"center\">72.0(45.8&#8211;128.3)<sup>#$</sup><break/>(n = 19)</td><td align=\"center\">*<sup>$#</sup>P &lt; 0.001</td></tr></tbody></table></body></html>","text":"Pmid= 2656468:Table= Table 2","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":-1983168865,"_task_hash":1541940421,"_view_id":"choice","accept":[5],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":"tableclass-test-params-100-gill","sessions":["tableclass-test-params-100-frank","tableclass-test-params-100-gill","tableclass-test-params-100-vicky"],"default":true}],"view_id":"choice"}
{"html":"<!DOCTYPE html><html><body><h1>Rawlins' classification system of ADRs</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td align=\"left\">Type</td><td align=\"left\">Definition</td></tr></thead><tbody><tr><td align=\"left\">A</td><td align=\"left\">Dose-dependent ADRs related to the pharmacological effect of the drug:</td></tr><tr><td/><td align=\"left\">&#8195;&#8226; Increased pharmacological effect</td></tr><tr><td/><td align=\"left\">&#8195;&#8226; ADRs that occur secondarily to the desired pharmacological effect</td></tr><tr><td/><td align=\"left\">&#8195;&#8226; ADRs due to other well known pharmacological effects</td></tr><tr><td colspan=\"2\"><hr/></td></tr><tr><td align=\"left\">B</td><td align=\"left\">Sensitivity reactions &#8211; not dose-dependent</td></tr><tr><td/><td align=\"left\">&#8195;&#8226; Allergic reactions</td></tr><tr><td/><td align=\"left\">&#8195;&#8226; Idiosyncratic reaction</td></tr><tr><td colspan=\"2\"><hr/></td></tr><tr><td align=\"left\">C</td><td align=\"left\">Long-term ADRs</td></tr><tr><td/><td align=\"left\">&#8195;&#8226; Carcinogines</td></tr><tr><td/><td align=\"left\">&#8195;&#8226; Teratogenes</td></tr><tr><td/><td align=\"left\">&#8195;&#8226; Chronic organ damage</td></tr><tr><td colspan=\"2\"><hr/></td></tr><tr><td align=\"left\">D</td><td align=\"left\">Drug-drug interactions</td></tr><tr><td/><td align=\"left\">&#8195;&#8226; Pharmacodynamic</td></tr><tr><td/><td align=\"left\">&#8195;&#8226; Pharmacokinetic</td></tr><tr><td/><td align=\"left\">&#8195;&#8226; Non-classifiable</td></tr></tbody></table></body></html>","text":"Pmid= 2656469:Table= Table 1","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":1502126019,"_task_hash":1773498508,"_view_id":"review","accept":[5],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":null,"sessions":["tableclass-test-params-100-frank","tableclass-test-params-100-gill","tableclass-test-params-100-vicky"],"versions":[{"html":"<!DOCTYPE html><html><body><h1>Rawlins' classification system of ADRs</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td align=\"left\">Type</td><td align=\"left\">Definition</td></tr></thead><tbody><tr><td align=\"left\">A</td><td align=\"left\">Dose-dependent ADRs related to the pharmacological effect of the drug:</td></tr><tr><td/><td align=\"left\">&#8195;&#8226; Increased pharmacological effect</td></tr><tr><td/><td align=\"left\">&#8195;&#8226; ADRs that occur secondarily to the desired pharmacological effect</td></tr><tr><td/><td align=\"left\">&#8195;&#8226; ADRs due to other well known pharmacological effects</td></tr><tr><td colspan=\"2\"><hr/></td></tr><tr><td align=\"left\">B</td><td align=\"left\">Sensitivity reactions &#8211; not dose-dependent</td></tr><tr><td/><td align=\"left\">&#8195;&#8226; Allergic reactions</td></tr><tr><td/><td align=\"left\">&#8195;&#8226; Idiosyncratic reaction</td></tr><tr><td colspan=\"2\"><hr/></td></tr><tr><td align=\"left\">C</td><td align=\"left\">Long-term ADRs</td></tr><tr><td/><td align=\"left\">&#8195;&#8226; Carcinogines</td></tr><tr><td/><td align=\"left\">&#8195;&#8226; Teratogenes</td></tr><tr><td/><td align=\"left\">&#8195;&#8226; Chronic organ damage</td></tr><tr><td colspan=\"2\"><hr/></td></tr><tr><td align=\"left\">D</td><td align=\"left\">Drug-drug interactions</td></tr><tr><td/><td align=\"left\">&#8195;&#8226; Pharmacodynamic</td></tr><tr><td/><td align=\"left\">&#8195;&#8226; Pharmacokinetic</td></tr><tr><td/><td align=\"left\">&#8195;&#8226; Non-classifiable</td></tr></tbody></table></body></html>","text":"Pmid= 2656469:Table= Table 1","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":1502126019,"_task_hash":1773498508,"_view_id":"choice","accept":[5],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":"tableclass-test-params-100-gill","sessions":["tableclass-test-params-100-frank","tableclass-test-params-100-gill","tableclass-test-params-100-vicky"],"default":true}],"view_id":"choice"}
{"html":"<!DOCTYPE html><html><body><h1>The analysed studies categorised by study design</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td align=\"left\"><bold>Study design</bold></td><td align=\"left\"><bold>Rank in evidence hierarchy</bold></td><td/><td align=\"left\"><bold>Therapeutic</bold><break/><bold>cases</bold></td><td/><td/></tr></thead><tbody><tr><td/><td/><td align=\"left\"><bold>Antibiotics</bold></td><td align=\"left\"><bold>NSAIDs</bold></td><td align=\"left\"><bold>SSRIs</bold></td><td align=\"left\"><bold>Total</bold></td></tr><tr><td colspan=\"6\"><hr/></td></tr><tr><td align=\"left\">Cohort</td><td align=\"left\">4</td><td align=\"left\">5</td><td align=\"left\">4</td><td align=\"left\">1</td><td align=\"left\">10</td></tr><tr><td colspan=\"6\"><hr/></td></tr><tr><td align=\"left\">Case control</td><td align=\"left\">5</td><td align=\"left\">2</td><td align=\"left\">3</td><td align=\"left\">2</td><td align=\"left\">8</td></tr><tr><td colspan=\"6\"><hr/></td></tr><tr><td align=\"left\">PEM*</td><td align=\"left\">6</td><td align=\"left\">2</td><td align=\"left\">9</td><td align=\"left\">4</td><td align=\"left\">15</td></tr><tr><td colspan=\"6\"><hr/></td></tr><tr><td align=\"left\">National ADR databases</td><td align=\"left\">7</td><td align=\"left\">7</td><td align=\"left\">14</td><td align=\"left\">11</td><td align=\"left\">32</td></tr><tr><td colspan=\"6\"><hr/></td></tr><tr><td align=\"left\">Case series</td><td align=\"left\">7</td><td align=\"left\">2</td><td align=\"left\">3</td><td align=\"left\">1</td><td align=\"left\">6</td></tr><tr><td colspan=\"6\"><hr/></td></tr><tr><td align=\"left\">Case reports</td><td align=\"left\">7</td><td align=\"left\">5</td><td align=\"left\">2</td><td align=\"left\">1</td><td align=\"left\">8</td></tr><tr><td colspan=\"6\"><hr/></td></tr><tr><td align=\"left\"><bold>Total number of studies</bold></td><td/><td align=\"left\"><bold>23</bold></td><td align=\"left\"><bold>36</bold></td><td align=\"left\"><bold>20</bold></td><td align=\"left\"><bold>79</bold></td></tr></tbody></table></body></html>","text":"Pmid= 2656469:Table= Table 2","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":1899807403,"_task_hash":1178616835,"_view_id":"review","accept":[5],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":null,"sessions":["tableclass-test-params-100-frank","tableclass-test-params-100-gill","tableclass-test-params-100-vicky"],"versions":[{"html":"<!DOCTYPE html><html><body><h1>The analysed studies categorised by study design</h1><head><style> table, th, td {border: 1px solid black;}</style></head><body><table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\"><thead><tr><td align=\"left\"><bold>Study design</bold></td><td align=\"left\"><bold>Rank in evidence hierarchy</bold></td><td/><td align=\"left\"><bold>Therapeutic</bold><break/><bold>cases</bold></td><td/><td/></tr></thead><tbody><tr><td/><td/><td align=\"left\"><bold>Antibiotics</bold></td><td align=\"left\"><bold>NSAIDs</bold></td><td align=\"left\"><bold>SSRIs</bold></td><td align=\"left\"><bold>Total</bold></td></tr><tr><td colspan=\"6\"><hr/></td></tr><tr><td align=\"left\">Cohort</td><td align=\"left\">4</td><td align=\"left\">5</td><td align=\"left\">4</td><td align=\"left\">1</td><td align=\"left\">10</td></tr><tr><td colspan=\"6\"><hr/></td></tr><tr><td align=\"left\">Case control</td><td align=\"left\">5</td><td align=\"left\">2</td><td align=\"left\">3</td><td align=\"left\">2</td><td align=\"left\">8</td></tr><tr><td colspan=\"6\"><hr/></td></tr><tr><td align=\"left\">PEM*</td><td align=\"left\">6</td><td align=\"left\">2</td><td align=\"left\">9</td><td align=\"left\">4</td><td align=\"left\">15</td></tr><tr><td colspan=\"6\"><hr/></td></tr><tr><td align=\"left\">National ADR databases</td><td align=\"left\">7</td><td align=\"left\">7</td><td align=\"left\">14</td><td align=\"left\">11</td><td align=\"left\">32</td></tr><tr><td colspan=\"6\"><hr/></td></tr><tr><td align=\"left\">Case series</td><td align=\"left\">7</td><td align=\"left\">2</td><td align=\"left\">3</td><td align=\"left\">1</td><td align=\"left\">6</td></tr><tr><td colspan=\"6\"><hr/></td></tr><tr><td align=\"left\">Case reports</td><td align=\"left\">7</td><td align=\"left\">5</td><td align=\"left\">2</td><td align=\"left\">1</td><td align=\"left\">8</td></tr><tr><td colspan=\"6\"><hr/></td></tr><tr><td align=\"left\"><bold>Total number of studies</bold></td><td/><td align=\"left\"><bold>23</bold></td><td align=\"left\"><bold>36</bold></td><td align=\"left\"><bold>20</bold></td><td align=\"left\"><bold>79</bold></td></tr></tbody></table></body></html>","text":"Pmid= 2656469:Table= Table 2","options":[{"id":1,"text":"Non-compartmental Parameters"},{"id":2,"text":"Compartmental Parameters"},{"id":3,"text":"Parameter-Covariate Relationships (ratios/percentages)"},{"id":4,"text":"Parameters Other"},{"id":5,"text":"Not Relevant"}],"_input_hash":1899807403,"_task_hash":1178616835,"_view_id":"choice","accept":[5],"config":{"choice_style":"multiple"},"answer":"accept","_session_id":"tableclass-test-params-100-gill","sessions":["tableclass-test-params-100-frank","tableclass-test-params-100-gill","tableclass-test-params-100-vicky"],"default":true}],"view_id":"choice"}
